<SEC-DOCUMENT>0001459839-21-000061.txt : 20211109
<SEC-HEADER>0001459839-21-000061.hdr.sgml : 20211109
<ACCEPTANCE-DATETIME>20211109161053
ACCESSION NUMBER:		0001459839-21-000061
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		65
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211109
DATE AS OF CHANGE:		20211109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SI-BONE, Inc.
		CENTRAL INDEX KEY:			0001459839
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				262216351
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38701
		FILM NUMBER:		211392231

	BUSINESS ADDRESS:	
		STREET 1:		471 EL CAMINO REAL, SUITE 101
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95050
		BUSINESS PHONE:		4082070700

	MAIL ADDRESS:	
		STREET 1:		471 EL CAMINO REAL, SUITE 101
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95050

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SI-Bone Inc.
		DATE OF NAME CHANGE:	20090326
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>sibn-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:c8537e76-3d0d-41fe-8011-c02f9e3c1997,g:6717da7c-7375-4e6f-9fbf-fa93aabe50cb,d:b00d06b2519f421eb73a3aa86da814ca--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:sibn="http://si-bone.com/20210930" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sibn-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80L2ZyYWc6MGNlNDc2NmQ5NGNjNDI0OThlMTAzYjg1MmE5ODNjMzgvdGFibGU6YzMwNmY0M2E4NWI4NGQyODliYWUxYzE1MDg5MGVlNWIvdGFibGVyYW5nZTpjMzA2ZjQzYTg1Yjg0ZDI4OWJhZTFjMTUwODkwZWU1Yl8xLTEtMS0xLTE_a472e842-4088-450d-8f13-158627f7c9cd">0001459839</ix:nonNumeric><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80L2ZyYWc6MGNlNDc2NmQ5NGNjNDI0OThlMTAzYjg1MmE5ODNjMzgvdGFibGU6YzMwNmY0M2E4NWI4NGQyODliYWUxYzE1MDg5MGVlNWIvdGFibGVyYW5nZTpjMzA2ZjQzYTg1Yjg0ZDI4OWJhZTFjMTUwODkwZWU1Yl8yLTEtMS0xLTE_831cee7f-b03f-4c1a-bbfa-e3d782495b96">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80L2ZyYWc6MGNlNDc2NmQ5NGNjNDI0OThlMTAzYjg1MmE5ODNjMzgvdGFibGU6YzMwNmY0M2E4NWI4NGQyODliYWUxYzE1MDg5MGVlNWIvdGFibGVyYW5nZTpjMzA2ZjQzYTg1Yjg0ZDI4OWJhZTFjMTUwODkwZWU1Yl8zLTEtMS0xLTE_d19964f2-f3f6-424d-9568-975adade52ec">2021</ix:nonNumeric><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80L2ZyYWc6MGNlNDc2NmQ5NGNjNDI0OThlMTAzYjg1MmE5ODNjMzgvdGFibGU6YzMwNmY0M2E4NWI4NGQyODliYWUxYzE1MDg5MGVlNWIvdGFibGVyYW5nZTpjMzA2ZjQzYTg1Yjg0ZDI4OWJhZTFjMTUwODkwZWU1Yl80LTEtMS0xLTE_d019912c-acb3-404e-8ddd-f976478660a1">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80L2ZyYWc6MGNlNDc2NmQ5NGNjNDI0OThlMTAzYjg1MmE5ODNjMzgvdGFibGU6YzMwNmY0M2E4NWI4NGQyODliYWUxYzE1MDg5MGVlNWIvdGFibGVyYW5nZTpjMzA2ZjQzYTg1Yjg0ZDI4OWJhZTFjMTUwODkwZWU1Yl81LTEtMS0xLTE_5031cd4c-6bb5-4cad-9f47-db37e98f71d6">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sibn-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i357c3dc213a54bb18148da0ae1debda3_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i9db2347a40b8493cbe05311630711796_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cb4295888e44afca3a0e40aa138b826_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i419d7376a11a4f999760045756fc1697_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c64a70df00648478c80144873723f9d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00e5b99cc6f44c89bffc8842ab1cc43f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2b9c3748b62489b87de37d50a5ee65e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c0c789badb24a7a900f02455d94a596_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3478645a9bc24eaf82a0f884d4e7301f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6305ce423c24473be85c1772c0267e2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb4574bb241d4e00bfb9eaee77d0f93e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1159e4f921fa4ba09c9b2b7bb7978816_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b886e77773d4100b841947a370dbd45_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44b3f6ddf6bd462b9a921c7660367222_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40496ae85a1c42a5b586e6a69298a32f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fdbf7f9eee94fd99865f6c845fc9e5c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic05d1aa069db477fb7428cb7052a36ba_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bc41da9d91a4b3ebbf8a73d9351127d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50c3adee274e4d9897c1e9b97580f092_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b44971cd3d44f208027309c7bec414e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i012e884dcba141699671d533f8f9d6d5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25d6449704a74361b824fbddaab1b298_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92f4fbe9f6904a2a84b286559158e8ae_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie62877f00b8945bc828ba27d3c2bbdc8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c273f41c79c4fbdb0d1230fd0559e14_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2093b54ed2e847d8acdb383a67170813_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e87b080b86f4c85a1a6027779356588_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b6779adb1074d70a27f1bd8c370bdd2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf8d120fadaf4453aef93c87406ea34a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id07b214d4e3f413786721103a10a44e5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98959cdb5f6c4fe6bbf1638730028292_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa96cfe1e061452eab347a7417e00927_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i859739929cdc49feb9e1b5e371f5be77_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6a7688791524893986b66bd6348be2b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccb5bcce85274a778eab4af6eb1d355b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief8c77e32bdc4fd0aff571107321d934_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a812a4bda164222b3c7aea2c545528d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21d4eb0fbe1b4f2082f7882f874778fc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e3370ae52f94141aa28c7b6558b03f8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8c36c532ca54066828971da81e190b9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d59943d7b8c4788bf7ebb802bf66b71_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89789d0c91fe4169839f59b9bd5ea2df_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2073aa5d83e1437fbb0649d1c506d3fe_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37dff38285374aa6920e237cc777bdab_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i390582358ab4487fba346af76b925fb2_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i169c05e9512945e6a8746c4ef8542f10_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b13a3cd460d43529a51830c587f1ae4_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00aae33ac66f498b91c8304d0a3684e6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5f4f5a94479403fa8baf12ad75427e3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f8c0ef6b0b142b08f6da44a05bdb9e8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29ed3ed441cb4fa78bb6e83cf96aedef_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id216b900385f40ddb4e3e20115d76dc5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7452925b0e5546ac8e3a5572be6ec889_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc576cf893e347489acff339085d0f95_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i610b8b3420f644baacc410f92061ab95_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ff5e648858d44668dc102d8309e731c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24f538cb702e4c0c8e346a1f3598951b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbfd8a209c764a95b7ea7a91a7fc9474_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i245280170e0946e9aea8da85b267bfe2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i051e88f32e88449d8536056f5184fd50_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81b69c135aa5478fb8c1e2ad5ddcee2c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i165ebc065905414c9459402dde0eea16_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia51f1dbf872743908801048a58b16c15_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d612f341375492d8de3802bb7d01ce5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ed0f6117ecf4e2cb1bee31260a098b5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia481f049459c472a9b4860fc2be9a142_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i426469690ff2417c9f81c8a4128839c6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i010b44ff2d3446fa8e15486e55a92e47_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic84bb4fdd42940249648de647e304e0a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i715926d08424490aabf690d9fa2f75e2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d2b391980d14a2aaf03c702bc7ee2f8_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:FollowOnPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9010c1b3cf4c4b1a9c2136e170a13186_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:FollowOnPublicOfferingAndSecondaryOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69d57d1462cc4484b5d209182af32f3f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i109df68e90ee490a9db47812746364dc_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:FollowOnPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib80c352eab074e7f8283e97c5bcd56d3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:SecondaryOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic20806741c494cdba90d292fbf08fc22_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:SecondFollowOnPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff1f8e32880046b2b07d08aa6eea7ef8_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43f819d6ee994d6087b5510e48ec11a2_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:SecondFollowOnPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7415c778d8224834a93c6630cef41f4e_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:SecondaryOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i278b0ccaf44c482899bd7ba4f716814d_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:SecondaryOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>sibn:segment</xbrli:measure></xbrli:unit><xbrli:context id="ie659bc55581349eca6480acadb12d4f9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i976ed3cd496b4e58a4dc4becdbc4161b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if12a2b6dbfac4d1ab143dfbd3f951b36_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46482b4e0b8440ce80cee026cd1125e8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1317afa536514c45b39738af99fef75c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ff853edb14242bc858575b0953b7ca6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd3e395480d74661ada50ae4fd7afc82_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacd5d89692c34b9496302d55a55bc7ce_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i380833eacc394ce0bea4afe14c77beb8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5b1f78d1cc14db3aff7642b38d0594b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b457a33537545b79259df1751c27179_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ec84971611b4b4b9fb02e3e0833ebe2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0cb0da3346b4ba79a69c2838e5d4b76_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idac9e0269b454ee2a0357ade267691e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie171077119e94be4b547961f085b9ae7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i054dc78f1b714085a5838ba8d5780e3e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if50d4b24e0734d79ba8b9edd1e805e40_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57ab096c74ac4847b7ee788ce1789d46_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id144f1a299a84ecbbb8e3d9cd71920cf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i433ab522b59a4aa783879f2118cf5b5a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i725fda3b69fb42b69214192df2b4307e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cdbdee501ca4f0b85e078944f534f65_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41b6362dacd34d9f88a9c8993387770b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf59194f545044df83f3f403416ed170_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i241fe256234a44b3b77f08e14eca6888_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i686c44112b5d4f3ba9a4d54da9d73cbf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00577f535d504af0be68212884f55f8b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ea729b060074c5899a64ea1337e293b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i102d310b7d67475fb03b9907bc7c3d46_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d3079b6c3604eddb06b821bf1c2d0b7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie78d10f8420241fe8b24a9e42e1f528a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27fdd2acd64a4b8d85de92ce53842683_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0ab19ddd1d0461c9e0d4e27776d7d1f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98e6ede9aecc414587ca1f1a67b50d01_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i987e7b13124e43d7b5ae40e6246e58cc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e29646458c343d4b6be0890911f4d9c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ecf8bebd1ef4e9ab058a08dfe87ac43_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41f57a77065c4ecf98478986ebfac018_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e6ed7e99cde4d7c92e1b6df344d0083_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibde2c8052a5648118d562a14a46b38fe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80b10d0cb3ff49df8d232f17ea2522e9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a26c11caa9041ccaf5933b7b93b6d6c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68990ae0b9c64420ab7d40fcde0e4612_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b8c7b83b4a74dd6b717a704b99447b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica53df319b9b4f6b8b770a1f538ab111_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b60576a921b48b680618b3810b404bd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66fdccee615a470db6971cc34c65e8c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e5ba73a05ed40299cc3f10f52f1b435_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb844642c3174f18a5186ba1283f54e9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id53205439e8b4340b3ce102dd284cbde_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b4f96fcd7e24f62a9e449453e2b6f9a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6911b659231424280f48b741135ca13_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia33d55a979204b7f9ccc70abb78a1a48_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6360a4b99f2b445481090bd10f1bbeff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a1f642004944d43b7569e23fd29e61c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i757d3032f8fc4a71b0a40a93905bf6dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id245cbf5f02e45a6bad677ee88cd874f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24eb57cd3b86414f942f4026431cbebc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea20d262a08e4a9686dd6fc4c64b6cbc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i737a4beebbff4635b25833b31ee0943e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6421c98b366e420ca30776333d1e2c0a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie875541c2b924f32a637a5864a311bb1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icca253489e02432f8f1edbe1cd8e4d4a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20f42e5899834f1d97e11131b6de99de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i678091eb517f46e1b50ede7a3998b1b3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8864c9b1ec194188b89a16633da21be7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78e300a956264748aa120a323a6cb2b5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ConstructionInProgressSurgicalPlacementInstrumentSetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac1bec7b510c4ec2b6a53deea9267b72_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ConstructionInProgressSantaClaraLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="i96d95d6a89cf4265bdd53a11781c3f3b_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="renewal_option"><xbrli:measure>sibn:renewal_option</xbrli:measure></xbrli:unit><xbrli:context id="ieccec3c1ede24d35a58527aa4850247b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9791c5febf8a46f2885eb2f4b7f67d9e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cb314875c314dbaa8fbacdb1b38b748_D20171001-20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:PharmakonTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2017-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i76a103c32c444270af93260d49552321_I20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:PharmakonTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38122eef897040fe8f70c368cf10c531_I20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sibn:DebtPrepaymentPenaltyPeriodAxis">sibn:PrepaymentPenalty3148MonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:PharmakonTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61a838a9e8594bccb6b1be280637f067_I20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sibn:DebtPrepaymentPenaltyPeriodAxis">sibn:PrepaymentPenalty4960MonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:PharmakonTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id10385b30b3442289883167a68f5b983_I20200529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba585a7740f44fc985da65b9dcbe6ac1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie50ee0dd6f3a424dbe678afcb26fe615_D20200529-20200529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">sibn:VariableOptionOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-29</xbrli:startDate><xbrli:endDate>2020-05-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i974cd92ce36a4cd597746c92af7a0c88_D20200529-20200529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-29</xbrli:startDate><xbrli:endDate>2020-05-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33f72faa097e4cae973ab53d793b2746_I20210812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2787e6887df4eadbb3510bc237985e9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i166abb90ea7347a7abf6019141e814f4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2011a05c7ea34cd28f12c592fe8857e3_D20210812-20210812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-12</xbrli:startDate><xbrli:endDate>2021-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9064792f4ac4436e8f82e1ce978a4834_I20210812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sibn:DebtPrepaymentPenaltyPeriodAxis">sibn:PrepaymentPenalty124MonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a17d4dc3afb45438117bbf39fc37e29_I20210812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sibn:DebtPrepaymentPenaltyPeriodAxis">sibn:PrepaymentPenalty24MonthsOnMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i843aa4772ef6448490b75f692b0f1072_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id34bef8ef9284847bf96f011100e54b4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fcc266ce2fc436cacae32e6275aaae0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16d63c9eb96e480599824e634ad5d531_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b5a42a702a94c05bf97ad13f96a9b57_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:PharmakonTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i523c84bcfc6d4d41a3fcb3cba85341bb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:PharmakonTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i803e769cd5f448a08a337153cbee48f7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95bf6c7ddfa44e2d8791432453dc5213_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i124ee46b86c74090ae66a0e1d2bb09bc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc837735671140f3b29b3df351abc460_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63d41e579cfd47938da6de7aa8a1649a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2386ac78016144aaa0d5030bad947246_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0544c913fcda445c9dc02da47fd8e3f3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55b87ead255e4fb486d98dd4fd6bc105_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2557cc90be53464ba8c0545cd23e3d1e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07d829ca6e82422aa5687003ba7c3973_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89018ddd42954af7a9c4116beb0b2c43_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i628c4f2ee72e4e8e876d8acc49956b8b_D20200101-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93c681895e154204b4fbed253a591a2f_D20200501-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="purchase_period"><xbrli:measure>sibn:purchase_period</xbrli:measure></xbrli:unit><xbrli:context id="id87cc2d1c9b043f287619c8da2816e8a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e7f9f8af7df41879076b4ffe0b5ee6e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i640640c163644c5ea76e4fa756cfc106_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib695fc1f6bb041edb51e55dea1b41799_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91cd631ed91d4a67ac1fc657545f5f45_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if87f81e2cc0d49b29ee4c705174cb8c5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i960acef0c23e41da8c4a82a8f9881c4d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77ae5cbb20b6488383046b736d749e54_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i994609a27d9e4161b8ab111b4129abd7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb7dadad6be64748a0c1ae6be3e11291_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ad191f36bb94c309b0048f07d23eca2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cf34fb005a349d0af6d06e2e451cc1e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8203731a1314feda1245f5c58a2e0b8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf70a00d6a1245cda39d6c5734cbbedc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad6ad9876dc54b99b44b939e6c69da80_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbcd4bb50a164a709140bf9796c663bc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fefa124b4804563b8e9ddcbdcb4d0b1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdd8b69590ec442bb21d4bd6827a9b49_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i322ec7cf7cef4568a7a538070a8ff21e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0bf7856168a4bbc8d608e2a53cbc8dc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c468269d170486eb2b4e64a4513440d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36d4c1a69b2b4a54b975f3d9b0099fc6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia72aa66ef16743e19faa81de6f8529b0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc3c26de486d43ca9dd20ec5d101e9dc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77acbbe553ec4a43a1af07135f846a82_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b097d0adc3b46ba9ea4861ea981873d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9639632395d7474d8c63fe4431f760f8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d7cc7784aab4de0a474421d3860f6ac_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:ShareSubjectToRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i270de781b3674556993d7df5c50f4257_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:ShareSubjectToRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2d646eaf6f3487b995e90e7b3f9638d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:ShareSubjectToRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26c2606ec5ae4f489f0d680cc4f0ba15_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:ShareSubjectToRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1310e619e2754e27ad6c1651d898e04e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:EmployeeStockPurchasePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06fea0e7101e40dba2eb84ffe5da4f05_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:EmployeeStockPurchasePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7aed40f2b6841ce8093e0bbc418e41e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:EmployeeStockPurchasePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba3d79dab9b744f8a0b82ce2c0c46ba4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:EmployeeStockPurchasePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8d65fa942e24ab2b39884d55f6a927d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7310fa50c10c46c8bbee63a8ff92f106_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id66e6a0d9d334aeca662f79c0d8aab8b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifad8a990e145427785bb494543f4b493_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i828e66a96b3b4c439de37f099c818aac_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa0e01356bc64335a99cd3efce7ed726_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2a91817bfc9420fbad12b231fb60c11_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i196e2035a7634702ac62a3f024b8006f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8afc1805c1c46b7ab718de87f1939ab_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6308366c8e94613b5653738e3f24c14_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001459839</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib00d06b2519f421eb73a3aa86da814ca_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:27.916%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTUx_450a79d3-5046-4729-b19f-3dec2647c7ed">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:27.916%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Mark one)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTUy_d49f1a8a-bb2a-4b18-8378-596f7b3e2c64">&#9746;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMjk_4ae37e60-f483-40d1-9882-543ef8a5fe06">September 30, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTU1_a8e8a01f-7416-4129-ab73-bde9420598f9">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from __________ to __________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number:  <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTUz_73f93b11-9929-42f9-a698-2b3da5ba3a17">001-38701</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTQ3_c41d6373-307e-4f7f-9549-5ae1d9cad9fa">SI-BONE,&#160;INC.</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in its Charter) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:27.916%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.527%"><tr><td style="width:1.0%"></td><td style="width:41.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.036%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6ZmQwN2NkMzJlYTAzNDEzNWJjNWU4ZjUwNDc3MGE0OGIvdGFibGVyYW5nZTpmZDA3Y2QzMmVhMDM0MTM1YmM1ZThmNTA0NzcwYTQ4Yl8wLTAtMS0xLTE_5817d817-f047-45e8-9891-8be44b7504cd">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6ZmQwN2NkMzJlYTAzNDEzNWJjNWU4ZjUwNDc3MGE0OGIvdGFibGVyYW5nZTpmZDA3Y2QzMmVhMDM0MTM1YmM1ZThmNTA0NzcwYTQ4Yl8wLTItMS0xLTE_477d2021-c69b-4574-8b3c-2142eb7b53bd">26-2216351</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State&#160;or&#160;Other&#160;Jurisdiction&#160;of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.944%"><tr><td style="width:1.0%"></td><td style="width:41.306%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.440%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6YjMwYmY1M2E0MTFkNDZmNzk5NjVhMzljZDY2YThkOTQvdGFibGVyYW5nZTpiMzBiZjUzYTQxMWQ0NmY3OTk2NWEzOWNkNjZhOGQ5NF8wLTAtMS0xLTEvdGV4dHJlZ2lvbjpkYzEwODkwZDJkNTE0NzgwODQzZjdlODg0NWIyOTcwOV80_82e82dba-97e6-4332-9b27-be4d7495f4c4">471 El Camino Real</ix:nonNumeric>, <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6YjMwYmY1M2E0MTFkNDZmNzk5NjVhMzljZDY2YThkOTQvdGFibGVyYW5nZTpiMzBiZjUzYTQxMWQ0NmY3OTk2NWEzOWNkNjZhOGQ5NF8wLTAtMS0xLTEvdGV4dHJlZ2lvbjpkYzEwODkwZDJkNTE0NzgwODQzZjdlODg0NWIyOTcwOV84_1728fd91-5f89-4629-acf5-cd64a4e741f5">Suite 101</ix:nonNumeric>, <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6YjMwYmY1M2E0MTFkNDZmNzk5NjVhMzljZDY2YThkOTQvdGFibGVyYW5nZTpiMzBiZjUzYTQxMWQ0NmY3OTk2NWEzOWNkNjZhOGQ5NF8wLTAtMS0xLTEvdGV4dHJlZ2lvbjpkYzEwODkwZDJkNTE0NzgwODQzZjdlODg0NWIyOTcwOV8xMg_8b53173f-d00a-4ccc-8704-250d08771d77">Santa Clara</ix:nonNumeric>, <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6YjMwYmY1M2E0MTFkNDZmNzk5NjVhMzljZDY2YThkOTQvdGFibGVyYW5nZTpiMzBiZjUzYTQxMWQ0NmY3OTk2NWEzOWNkNjZhOGQ5NF8wLTAtMS0xLTEvdGV4dHJlZ2lvbjpkYzEwODkwZDJkNTE0NzgwODQzZjdlODg0NWIyOTcwOV8xNg_984a4d04-4b10-450f-aca2-cd5d062068e2">California</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6YjMwYmY1M2E0MTFkNDZmNzk5NjVhMzljZDY2YThkOTQvdGFibGVyYW5nZTpiMzBiZjUzYTQxMWQ0NmY3OTk2NWEzOWNkNjZhOGQ5NF8wLTItMS0xLTE_561b47e0-ff25-405b-91b3-991c27702863">95050</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Registrant's telephone number, including area code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTQz_eb3e6a6b-34c5-43fe-a742-5ce24360fc75">408</ix:nonNumeric>) <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTQ0_1c074996-0d71-4b64-96ac-61d8a1e4816d">207-0700</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:27.777%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.361%"><tr><td style="width:1.0%"></td><td style="width:38.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.483%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6NDJkNWRlMTgxOWUxNDEzOWJmZTU3NTA5YzFkYzM5ZDIvdGFibGVyYW5nZTo0MmQ1ZGUxODE5ZTE0MTM5YmZlNTc1MDljMWRjMzlkMl8xLTAtMS0xLTE_2abf13c4-2df4-4712-9a07-9fa9b4eeac34">Common Stock, par value $0.0001&#160;per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6NDJkNWRlMTgxOWUxNDEzOWJmZTU3NTA5YzFkYzM5ZDIvdGFibGVyYW5nZTo0MmQ1ZGUxODE5ZTE0MTM5YmZlNTc1MDljMWRjMzlkMl8xLTEtMS0xLTE_9f4cd499-27d0-4b28-a5e6-9d9564cacbaf">SIBN</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6NDJkNWRlMTgxOWUxNDEzOWJmZTU3NTA5YzFkYzM5ZDIvdGFibGVyYW5nZTo0MmQ1ZGUxODE5ZTE0MTM5YmZlNTc1MDljMWRjMzlkMl8xLTItMS0xLTE_d14cd898-4d11-4302-83a2-f48cea72a61a">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160; <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTQ4_27151d8a-5a19-481e-8757-0f627eebfb28">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;<ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTQ5_5ae98c33-2324-4569-b99e-2bf142db457b">Yes</ix:nonNumeric> &#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">   No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.722%"><tr><td style="width:1.0%"></td><td style="width:23.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6MGJmMjkzZTMzMTI3NDAzMjk5MDM2MzI1NTBiYmZiZWUvdGFibGVyYW5nZTowYmYyOTNlMzMxMjc0MDMyOTkwMzYzMjU1MGJiZmJlZV8wLTYtMS0xLTE_e71f5455-dcb4-45a2-b2c7-13a283662223">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" format="ixt:fixed-true" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6MGJmMjkzZTMzMTI3NDAzMjk5MDM2MzI1NTBiYmZiZWUvdGFibGVyYW5nZTowYmYyOTNlMzMxMjc0MDMyOTkwMzYzMjU1MGJiZmJlZV8xLTEtMS0xLTE_59da4ed7-9ac7-438f-bfaa-f6e4a81ef44b">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6MGJmMjkzZTMzMTI3NDAzMjk5MDM2MzI1NTBiYmZiZWUvdGFibGVyYW5nZTowYmYyOTNlMzMxMjc0MDMyOTkwMzYzMjU1MGJiZmJlZV8xLTQtMS0xLTE_1fd8dd95-7a30-4172-a483-020b1e803c2d">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act.&#160;<ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" format="ixt:fixed-false" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTQ1_9702a934-1dde-49b3-a28c-a7bb758fdd43">&#9744;</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;Yes &#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">    No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" format="ixt:fixed-false" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTUw_dce29958-67df-4a91-92f6-be314d1d9c1b">x</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares outstanding of the registrant&#8217;s Common Stock was <ix:nonFraction unitRef="shares" contextRef="i357c3dc213a54bb18148da0ae1debda3_I20211031" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTMx_0919da6a-0e3c-47ef-b368-fd01db974f89">33,489,778</ix:nonFraction> as of October&#160;31, 2021.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.485%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I-FINANCIAL INFORMATION</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_13">Item 1.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_13">Financial Statements </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_16">Condensed Consolidated Balance Sheets</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_13">(Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_19">Condensed Consolidated Statements of Operations and Comprehensive Loss</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_13">(Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_22">Condensed Consolidated Statements of Changes in Stockholders' Equity</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_13">(Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_25">Condensed Consolidated Statements of Cash Flows</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_13">(Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_25">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_28">Notes to Condensed Consolidated Financial Statements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_13">(Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_28">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_67">Item 2.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_67">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_67">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_112">Item 3.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_112">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_112">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_115">Item 4.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_115">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_115">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II-OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_121">Item 1.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_121">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_121">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_124">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_124">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_124">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_127">Item 2.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_127">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_127">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_130">Item 3.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_130">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_130">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_133">Item 4.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_133">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_133">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_136">Item 5.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_136">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_136">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_139">Item 6.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_139">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_139">68</a></span></div></td></tr><tr style="height:14pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_142">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib00d06b2519f421eb73a3aa86da814ca_142">69</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:18pt"><span><br/></span></div><div style="margin-top:18pt"><span><br/></span></div><div style="margin-top:18pt"><span><br/></span></div><div style="margin-top:18pt"><span><br/></span></div><div style="margin-top:18pt"><span><br/></span></div><div style="margin-top:18pt"><span><br/></span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:18pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form&#160;10-Q contains forward-looking statements. All statements other than statements of historical facts contained in this Quarterly Report, including statements regarding our future results of operations and financial position, business strategy, prospective products and product candidates, sales force expansion, surgeon adoption, reimbursement determinations, clinical trial results, and U.S. Food and Drug Administration ("FDA") approvals, are forward-looking statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions, although not all forward-looking statements contain these identifying words. These forward-looking statements speak only as of the date of this Quarterly Report and are subject to a number of risks, uncertainties and assumptions, including those described under the sections in this Quarterly Report entitled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; These forward-looking statements include, but are not limited to, statements about the following:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact the COVID-19 pandemic and governmental actions taken to combat the COVID-19 pandemic will have on  us, including our operations, financial results, liquidity and capital resources, the existence and duration of state and local orders temporarily prohibiting elective procedures including procedures using our products, the ability and desire of patients and physicians to undergo and perform such procedures, the duration and any potential resurgence of the COVID-19 pandemic, and whether the COVID-19 pandemic will recur in the future;</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our ability to maintain a healthy workforce in light of the ongoing COVID-19 pandemic;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to source products and materials included in our surgical systems at prices and on the basis of lead times required to grow and sustain our business; </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectation that a significant portion of our revenues will be derived from sales of the iFuse Implant System, or iFuse;</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop additional revenue opportunities, including new indications for use and new devices;</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to retain and grow our sales team based on the demand for our products;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to identify, train, and retain surgeons to perform procedures using our products;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain and maintain favorable coverage and reimbursement determinations from third-party payors;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates of our market opportunity;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the scope of protection from intellectual property rights covering our products;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments or disputes concerning our intellectual property or other proprietary rights;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">timing of and results from clinical and other trials;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">marketing clearances and authorization from the FDA and regulators in other jurisdictions;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">timing of regulatory filings and feedback;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition in the markets we serve;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations of the reliability and performance of our products;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations of the benefits to patients, providers, and payors of our products;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reliance on a limited number of suppliers, including sole source suppliers, which may impact the availability of instruments and materials;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to sustain or increase demand for our products;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates regarding our costs and risks associated with our international operations and expansion;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our ability to retain and recruit key personnel;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding acquisitions and strategic operations;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to fund our working capital requirements;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our compliance with, and the cost of, federal, state, and foreign regulatory requirements;</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the factors that may impact our financial results; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated trends and challenges in our business and the markets in which we operate.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are based on management&#8217;s current expectations, estimates, forecasts, and projections about our business and the industry in which we operate, and management&#8217;s beliefs and assumptions are not guarantees of future performance or development and involve known and unknown risks, uncertainties, and other factors that are in some cases beyond our control. As a result, any or all of our forward-looking statements in this report may turn out to be inaccurate. Furthermore, if the forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under &#8220;Risk Factors&#8221; and elsewhere in this report. These statements, like all statements in this report, speak only as of their date. We caution investors that our business and financial performance are subject to substantial risks and uncertainties. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future, except as may be required by law.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Quarterly Report on Form 10-Q, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_13"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I-FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div><span><br/></span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:73.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.067%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMy0xLTEtMS0x_6125483f-0b97-40c8-aa86-9b25ad05ffe3">59,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMy0zLTEtMS0x_366b215b-a336-4bbc-b72e-b6ad8241401f">53,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNC0xLTEtMS0x_2f79d5ce-bfea-40c3-a238-0bf777a10c90">100,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNC0zLTEtMS0x_3878a403-8509-45fd-b90f-16651eb32fe7">142,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNS0wLTEtMS0xL3RleHRyZWdpb246NmUxYTI0YjMxZGVkNGMwYzgwOTJhNTJlNmNhNWQ4ZDJfNjc_e718d135-5825-4d62-b9f0-eda07847a5d2">264</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNS0wLTEtMS0xL3RleHRyZWdpb246NmUxYTI0YjMxZGVkNGMwYzgwOTJhNTJlNmNhNWQ4ZDJfNzU_7309bdec-4a79-45e8-a8d6-176594fd71fe">263</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNS0xLTEtMS0x_bda90363-73b8-4534-a9d7-8cd809e2c8fa">12,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNS0zLTEtMS0x_651b3628-b413-4ea3-8829-69052f6aa091">13,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNi0xLTEtMS0x_388b88d8-eab8-4612-b574-b3c92e1de584">10,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNi0zLTEtMS0x_1b5559a1-2fa5-46b4-af42-e85fd464808d">5,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNy0xLTEtMS0x_5a68ee51-7a03-42e9-822f-823c05545903">1,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNy0zLTEtMS0x_b98a592b-85d2-4a8c-addf-04b5c7c50ae4">2,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfOC0xLTEtMS0x_0456d4c0-6867-4381-94bf-a327b4a6c46a">185,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfOC0zLTEtMS0x_fc198b8c-d23a-4d85-a3ff-8f39db3a1d8a">218,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTAtMS0xLTEtMQ_37d3ab29-9ecc-4d06-8dff-50799df0a95e">7,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTAtMy0xLTEtMQ_8a13b156-54c2-4159-bad4-6b448108ffbc">4,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTEtMS0xLTEtMQ_4e9341fa-c868-447e-b554-f3ec46f0252e">405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTEtMy0xLTEtMQ_32788204-d76d-4736-8e35-8ef586891b7f">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL ASSETS </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTItMS0xLTEtMQ_075b5cf0-02fa-4ad5-9054-dd484ad9ef86">193,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTItMy0xLTEtMQ_04b4248c-e40f-440c-b163-72f2f33d43fa">223,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTYtMS0xLTEtMQ_5d041a4f-58d4-47e6-b110-12f80b381de6">4,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTYtMy0xLTEtMQ_7c6ce597-4525-4baf-a9f3-0a852dcd6454">3,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTctMS0xLTEtMQ_e42e034b-ea72-4b9b-9b34-d498dd88b3d1">10,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTctMy0xLTEtMQ_7ed6bddb-d1a2-4b42-8e60-ff0f61f26da7">10,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTktMS0xLTEtMQ_56adb4f5-cbec-44cc-91a9-d5dcf8baef5b">14,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTktMy0xLTEtMQ_e8e6b696-44de-4680-83d4-2193f9ac58da">13,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjAtMS0xLTEtMQ_8af95b54-7996-4878-9a19-02866abc70db">34,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjAtMy0xLTEtMQ_bc316509-988a-40f5-95c9-785a33bf4d61">39,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjEtMS0xLTEtMQ_bd13b237-d1d4-42cd-ace7-153b94963c95">862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjEtMy0xLTEtMQ_ed18dde6-2af4-4df6-b38a-6ae374a5c19e">854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL LIABILITIES</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjItMS0xLTEtMQ_0ae3f1f6-f758-4c18-ac73-11b767f855da">50,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjItMy0xLTEtMQ_aec1664a-4754-472e-9bd7-85f9069fe038">53,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 6)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjQtMS0xLTEtMQ_231780e4-c959-40fa-bc8e-3d06146a51f2"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjQtMy0xLTEtMQ_45a04c61-db89-4a6c-911d-4b9667f4b181"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">STOCKHOLDERS&#8217; EQUITY</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzIy_015365ba-1025-4c9b-8d8d-69beb77a23f6"><ix:nonFraction unitRef="usdPerShare" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzIy_c88fb6d9-d134-49b1-883b-2ed0e97242ed">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzM2_bed9710b-4bb0-49a9-9bff-f2bf7913fd6e"><ix:nonFraction unitRef="shares" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzM2_e0c75e12-530b-431f-95de-7ba2cae06493">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzU4_220f036c-0c60-4bc3-b4ea-ceb3929d9d08"><ix:nonFraction unitRef="shares" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzU4_2a081aca-e5fa-44e0-bd46-6c634f66b9ca"><ix:nonFraction unitRef="shares" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzU4_4ee18b6a-db97-42d4-95b9-69965fb8e09a"><ix:nonFraction unitRef="shares" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzU4_c8f35244-a555-4efd-b2f5-c00df0cbf66f">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMS0xLTEtMQ_ea379a9b-0417-442b-ab7c-50625e03ffd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMy0xLTEtMQ_389606e6-b09e-4c72-b8e3-a7fee07f708b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzE5_4ee57d0f-be78-4329-839a-4c78da748244"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzE5_8227ed57-ddef-463a-8236-21af9b10ae84">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzMz_332d7c04-ae99-43e6-99ff-99d03bc6e5af"><ix:nonFraction unitRef="shares" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzMz_d2552b64-ad80-4b76-9b9a-17d25d235a3e">100,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzU1_4277f255-8324-4f09-bef8-f06701269133"><ix:nonFraction unitRef="shares" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzU1_5b964c5f-b18a-4777-8481-4144ffcd4bb9">33,450,995</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzYy_a822d292-0723-40b4-a6a3-411d1b858cef"><ix:nonFraction unitRef="shares" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzYy_b284481e-a475-49aa-8b97-29f841cfcc29">32,583,220</ix:nonFraction></ix:nonFraction> shares issued and outstanding, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMS0xLTEtMQ_27da2c77-08d2-4e0d-bc2d-a4596f5da7cd">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMy0xLTEtMQ_52bff8da-2e64-43d1-a49f-c8d0a1845d48">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjktMS0xLTEtMQ_44ce7c50-707b-4d6f-bf32-592ad99ca369">424,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjktMy0xLTEtMQ_63925fbd-de9a-4e08-be6c-f0ef49dafd21">408,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzAtMS0xLTEtMQ_4dbec0d6-99e0-41ba-beb3-ec163f15ca64">426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzAtMy0xLTEtMQ_db6b3f53-7539-4e6c-ba37-78d367f1bc3c">524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzEtMS0xLTEtMQ_1a7dfee4-d31a-42d7-83cb-bce8f5117d63">281,372</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzEtMy0xLTEtMQ_8346094a-4237-448c-a7bb-972a9591e7fa">239,277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzItMS0xLTEtMQ_d9c9323d-56b6-4ee3-bdad-2830415e4fb2">143,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzItMy0xLTEtMQ_36ffaf3e-67e7-415c-b3e7-425433a39a20">169,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzMtMS0xLTEtMQ_30b545f2-cde1-4965-9324-046c73b0e87a">193,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzMtMy0xLTEtMQ_3fd3f028-1535-4fa6-be30-a387bea81ec7">223,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div><div><span><br/></span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_19"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share amounts) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.571%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMi0xLTEtMS0x_354eee5c-34f3-4735-b942-1755d7f6e962">22,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMi0zLTEtMS0x_70e26977-9a46-4cd4-ab22-7cbfdecc88b8">20,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMi01LTEtMS0x_b59513d8-5a7e-4d17-91cf-bd5af0a77326">64,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMi03LTEtMS0x_76a19540-fe75-4a83-bbd8-9d2395587a34">51,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMy0xLTEtMS0x_1eec18ce-2f19-4a37-a23c-81bc87f21d36">2,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMy0zLTEtMS0x_1f3893bf-8142-4e1a-b8dc-d5d9dbfbd6f7">2,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMy01LTEtMS0x_b0022467-2807-4f6c-8111-e0ebf5af34b5">7,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMy03LTEtMS0x_f32ea8c4-c9c7-4237-9a70-8f22f2f26e2e">6,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNC0xLTEtMS0x_0a552328-ed8d-4350-941e-23f9d6b73fda">19,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNC0zLTEtMS0x_266584c3-5aad-4d40-906b-c48a80f6c2f3">17,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNC01LTEtMS0x_2b822025-3e65-4d1e-8dd3-3a0e847d05e0">57,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNC03LTEtMS0x_40b0ab65-8d95-449c-89f1-4eaebb416351">44,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNi0xLTEtMS0x_b93383c1-293a-4b38-991b-4a0389271a84">23,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNi0zLTEtMS0x_4be1578a-915d-455d-9bda-ced1ad8bfc17">18,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNi01LTEtMS0x_1b70b1b3-dc8f-4a4c-b2b1-3c9d7a2664f4">67,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNi03LTEtMS0x_99d58524-1b6e-4637-8cb9-73d4e3079766">53,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNy0xLTEtMS0x_58ddaa65-a9f5-4e86-aff0-053dcd985ed9">3,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNy0zLTEtMS0x_afd3829b-b7b1-414e-98a4-84e5a6fbc844">2,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNy01LTEtMS0x_7297c102-3f50-4511-b7ad-f7c3eb6979fb">9,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNy03LTEtMS0x_9024b298-7c7e-4e95-8ae3-7fbe267dac61">7,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOC0xLTEtMS0x_16c798bf-f651-456b-a3d4-317e101341f7">6,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOC0zLTEtMS0x_d028fbf9-6e68-4545-a21b-1578ed4365d8">4,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOC01LTEtMS0x_cfdc5bf6-c7b0-4d62-9971-b97b1016c36d">18,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOC03LTEtMS0x_c2240925-70e4-4f9b-9267-6d646bd29d85">14,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOS0xLTEtMS0x_a8c616fb-9b88-413d-a033-2fef403c6394">33,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOS0zLTEtMS0x_5a195e7a-a621-4dea-ac2a-55d7435642cd">26,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOS01LTEtMS0x_94c8dedf-681d-42b5-9c12-e9afc19b6803">95,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOS03LTEtMS0x_b7c28bac-4838-49ce-976c-5dea41a7b114">75,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTAtMS0xLTEtMQ_98a82284-2108-4b31-9b68-97e1021b38c7">13,199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTAtMy0xLTEtMQ_e530959b-6a28-45a9-8740-18373d922fc0">8,675</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTAtNS0xLTEtMQ_29f2a152-6e78-4736-8cf6-0d61f9c0a9c2">37,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTAtNy0xLTEtMQ_d3eb544f-00e3-40ed-9c54-700a87d51d0e">30,696</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income (expense), net:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTItMS0xLTEtMQ_3445e2be-ec70-4c5b-8fed-be47540443dd">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTItMy0xLTEtMQ_fd5a31f9-a48c-4b8a-a1fc-b90d4785fc82">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTItNS0xLTEtMQ_5f0236f7-66bc-46f5-812e-b5ed319cf1fa">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTItNy0xLTEtMQ_01be217f-9e53-44f8-a078-e35c4037efc9">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTMtMS0xLTEtMQ_957eb324-4531-4e70-b5fa-8a15588b5838">2,658</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTMtMy0xLTEtMQ_a15e313a-778f-41d8-8dc8-1523e3a78714">1,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTMtNS0xLTEtMQ_d0833abb-03e3-4a6a-87c2-cd7620fb5e09">4,797</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTMtNy0xLTEtMQ_81707ada-08d1-4d85-b3d0-f02dc2651159">5,016</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTQtMS0xLTEtMQ_7222cad0-5f1f-4d6c-ab90-98f825ccb7c7">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTQtMy0xLTEtMQ_a062ff79-8fdd-4716-a2ec-12160e35ec25">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTQtNS0xLTEtMQ_4dae9daa-b579-45e9-a09a-345eb316c8b1">290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTQtNy0xLTEtMQ_85f1e63a-5cc9-4b77-b686-7f8a47b65acb">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTUtMS0xLTEtMQ_e516ab9a-9131-4f56-9c34-1bb58a705c80">15,872</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTUtMy0xLTEtMQ_e1550665-98b5-4de3-abe6-7a1dc2a9d78a">9,474</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTUtNS0xLTEtMQ_08164429-95a6-4154-8ecd-82dc44c1c91e">42,095</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTUtNy0xLTEtMQ_f4d84f3c-dfc6-4181-a23a-6554267e7769">34,718</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in foreign currency translation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTctMS0xLTEtMQ_93986fc6-c8dc-4ba9-9d1b-582a589defdd">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTctMy0xLTEtMQ_87dce1c7-37dd-4fbc-b0f6-124adb01f2fa">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTctNS0xLTEtMQ_5d6995b1-2c4a-4392-aa8b-7a83bc92ad22">103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTctNy0xLTEtMQ_91e451f9-16fd-4e9c-bce9-d0fdbe67dd9b">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTgtMS0xLTEtMQ_a6c0b822-7b97-4023-ae7b-84429c74453d">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTgtMy0xLTEtMQ_050e7dc1-b5b2-498d-8107-459c2e5e9694">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTgtNS0xLTEtMQ_476ed4fc-1e48-4dc7-a176-3f5a9010f4ea">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTgtNy0xLTEtMQ_44575ba8-63cc-4d6e-919f-870c5d2ff2ef">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTktMS0xLTEtMQ_7a30a54b-53fd-48d5-ac4b-f1f3e49f7cb4">15,906</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTktMy0xLTEtMQ_6400fdc1-31a2-4ccc-b2bb-fc17e6cd1aea">9,654</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTktNS0xLTEtMQ_1a24904e-307c-4979-99ac-8cd78f6822ed">42,193</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTktNy0xLTEtMQ_1c55c1cc-6fcd-48b4-acf9-dfaf411ffb54">34,752</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtMS0xLTEtMQ_391491d9-cbdf-4860-9a39-472d0bb22b38"><ix:nonFraction unitRef="usdPerShare" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtMS0xLTEtMQ_4c9d128f-e587-4193-9cc3-20f1eee19670">0.48</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtMy0xLTEtMQ_38a6c922-224f-448f-8a2c-5ca149be9733"><ix:nonFraction unitRef="usdPerShare" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtMy0xLTEtMQ_e13fcdef-c6ae-4da9-8a6a-5d36784d3bc1">0.33</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtNS0xLTEtMQ_6fbb9a08-b8cc-4a83-a104-23ba74001e66"><ix:nonFraction unitRef="usdPerShare" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtNS0xLTEtMQ_f5a373d5-10dd-49b0-9f66-978c7bb073ab">1.28</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtNy0xLTEtMQ_67038e76-2eb2-4a12-b7a3-f412abd646d1"><ix:nonFraction unitRef="usdPerShare" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtNy0xLTEtMQ_a4ee5fdc-802a-459e-ab47-7d5cb73d7a67">1.23</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares used to compute basic and diluted net loss per share</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtMS0xLTEtMQ_2e1276ab-9ad9-488a-8b47-c9c3959826da"><ix:nonFraction unitRef="shares" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtMS0xLTEtMQ_48c5097a-d00d-4b8a-8e48-34430a959d87">33,340,093</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtMy0xLTEtMQ_04c64e22-6ec9-42a1-9deb-4cad34d5e622"><ix:nonFraction unitRef="shares" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtMy0xLTEtMQ_65958481-fb18-469c-afdf-cf61e3af0122">28,713,418</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtNS0xLTEtMQ_3b649b20-8d52-4e34-95d8-d59643b102d3"><ix:nonFraction unitRef="shares" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtNS0xLTEtMQ_ad8419fb-5079-4db6-92f4-baed044f7398">33,005,904</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtNy0xLTEtMQ_61a9f38c-6cc2-4c95-99ad-abda11534c0a"><ix:nonFraction unitRef="shares" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtNy0xLTEtMQ_9b48a954-a5c3-45fe-8999-ba20092a72c8">28,155,561</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_22"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">SI-BONE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">(In thousands, except share amounts)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.375%"><tr><td style="width:1.0%"></td><td style="width:45.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.290%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Paid-in  </span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Capital</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other  </span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive  </span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deficit</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00e5b99cc6f44c89bffc8842ab1cc43f_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMi0yLTEtMS0x_45422655-2e32-49d8-a457-930ce51f0d68">32,583,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e5b99cc6f44c89bffc8842ab1cc43f_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMi00LTEtMS0x_cac3032f-7caf-457c-ba14-021d81d40a2a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2b9c3748b62489b87de37d50a5ee65e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMi02LTEtMS0x_67a47429-d1a4-4f37-80e4-3fc77a24b536">408,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0c789badb24a7a900f02455d94a596_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMi04LTEtMS0x_136bca5b-9d81-4047-9b84-eac43afd28ea">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3478645a9bc24eaf82a0f884d4e7301f_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMi0xMC0xLTEtMQ_ea776422-a4aa-49f5-a88c-8d79280a9bb1">239,277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMi0xMi0xLTEtMQ_fe0274d8-ca58-46a7-9fb0-cfb85d116161">169,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options, net of shares withheld</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6305ce423c24473be85c1772c0267e2_D20210101-20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMy0yLTEtMS0x_c2965b46-0d74-4d7b-9af8-e38b45430da2">93,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb4574bb241d4e00bfb9eaee77d0f93e_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMy02LTEtMS0x_63fb51ad-795a-4481-8cc9-5519e27b81af">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1159e4f921fa4ba09c9b2b7bb7978816_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMy0xMi0xLTEtMQ_f93d188a-20df-4ec5-82f1-51789b69c901">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon vesting of restricted stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6305ce423c24473be85c1772c0267e2_D20210101-20210331" decimals="INF" format="ixt:num-dot-decimal" name="sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNC0yLTEtMS0x_28a1b2ea-cd31-483c-9bb1-d3f0719f1cfc">131,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb4574bb241d4e00bfb9eaee77d0f93e_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNS02LTEtMS0x_2ba6cb54-4c7d-4dc6-8436-195e6e059605">4,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1159e4f921fa4ba09c9b2b7bb7978816_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNS0xMi0xLTEtMQ_e623f9d5-11e0-4fdd-983a-d262fb4f5a4a">4,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of early exercised stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb4574bb241d4e00bfb9eaee77d0f93e_D20210101-20210331" decimals="-3" name="sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNi02LTEtMS0x_7ec5e871-f2b9-4308-958a-3d731813becb">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1159e4f921fa4ba09c9b2b7bb7978816_D20210101-20210331" decimals="-3" name="sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNi0xMi0xLTEtMQ_881ef045-5940-470e-8e12-47ae35fc4540">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b886e77773d4100b841947a370dbd45_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNy04LTEtMS0x_6ffe9dff-868d-41d5-84ae-168241e6ec4a">115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1159e4f921fa4ba09c9b2b7bb7978816_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNy0xMi0xLTEtMQ_8cfa636f-d325-46dd-872d-728223ac98f0">115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b886e77773d4100b841947a370dbd45_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfOC04LTEtMS0x_2969c351-59c9-4fc3-a521-01965dc52bdf">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1159e4f921fa4ba09c9b2b7bb7978816_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfOC0xMi0xLTEtMQ_44a793fa-b61d-4454-b6c7-c5de8a0119e2">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44b3f6ddf6bd462b9a921c7660367222_D20210101-20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfOS0xMC0xLTEtMQ_1301be42-124b-480d-8fde-0437c3be7f6d">12,242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1159e4f921fa4ba09c9b2b7bb7978816_D20210101-20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfOS0xMi0xLTEtMQ_6bb9f8be-d984-4b55-9449-119d49bcdf27">12,242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40496ae85a1c42a5b586e6a69298a32f_I20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTAtMi0xLTEtMQ_8f4e5d0e-ca9c-4789-8910-0bf0e1fcf311">32,808,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40496ae85a1c42a5b586e6a69298a32f_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTAtNC0xLTEtMQ_acff3dab-32a7-4a97-a432-c6dcc7f55831">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fdbf7f9eee94fd99865f6c845fc9e5c_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTAtNi0xLTEtMQ_e56ea169-74d5-4b67-8f17-84595c32d1e7">412,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05d1aa069db477fb7428cb7052a36ba_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTAtOC0xLTEtMQ_ebb27259-c321-4e88-9cca-794dd3ba06b8">430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc41da9d91a4b3ebbf8a73d9351127d_I20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTAtMTAtMS0xLTE_b7c0461a-929e-4fd4-9775-e372f1439846">251,519</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c3adee274e4d9897c1e9b97580f092_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTAtMTItMS0xLTE_cb9043ea-4427-4a86-827a-563f489f05b4">161,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options, net of shares withheld</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b44971cd3d44f208027309c7bec414e_D20210401-20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTEtMi0xLTEtMQ_2c034017-000f-4291-8e95-bc891498929f">140,917</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i012e884dcba141699671d533f8f9d6d5_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTEtNi0xLTEtMQ_51bf1181-60bd-44d8-8555-42021655893e">650</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d6449704a74361b824fbddaab1b298_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTEtMTItMS0xLTE_a2d9b403-4150-4379-bb20-46130c2de106">650</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock related to employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b44971cd3d44f208027309c7bec414e_D20210401-20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTItMi0xLTEtMQ_e85acc8e-8c1f-446e-8812-38e3661d4fc5">104,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i012e884dcba141699671d533f8f9d6d5_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTItNi0xLTEtMQ_aceed5b3-cd5c-4b8e-b5c8-070a4cd86404">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d6449704a74361b824fbddaab1b298_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTItMTItMS0xLTE_7be9e259-0eac-48ef-8aed-1f518612251c">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon vesting of restricted stock units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b44971cd3d44f208027309c7bec414e_D20210401-20210630" decimals="INF" format="ixt:num-dot-decimal" name="sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTMtMi0xLTEtMQ_f05a46ac-410e-4f38-b277-b2a0678ecd1c">181,958</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i012e884dcba141699671d533f8f9d6d5_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTQtNi0xLTEtMQ_ca23935d-c3e7-4483-ab6f-2f2ade3943cf">4,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d6449704a74361b824fbddaab1b298_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTQtMTItMS0xLTE_39215b03-c197-496b-85df-8223d425ca0c">4,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of early exercised stock options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i012e884dcba141699671d533f8f9d6d5_D20210401-20210630" decimals="-3" name="sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTUtNi0xLTEtMQ_8c9097aa-4304-4fcc-b85c-16b2a60dfbc5">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d6449704a74361b824fbddaab1b298_D20210401-20210630" decimals="-3" name="sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTUtMTItMS0xLTE_f35e32f7-ede8-4d8e-bfb6-364ec687cebc">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92f4fbe9f6904a2a84b286559158e8ae_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTYtOC0xLTEtMQ_f429748c-4e07-44fa-b1ee-34478d57f7e1">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d6449704a74361b824fbddaab1b298_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTYtMTItMS0xLTE_c3a5ea58-23c3-4fd3-96e2-c22aa5a84d0f">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on marketable securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92f4fbe9f6904a2a84b286559158e8ae_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTctOC0xLTEtMQ_bfad061f-2912-4cfb-8cec-ed4ea0119c01">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25d6449704a74361b824fbddaab1b298_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTctMTItMS0xLTE_a29d2953-1c82-40bb-9cf1-4795e2d56334">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie62877f00b8945bc828ba27d3c2bbdc8_D20210401-20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTgtMTAtMS0xLTE_d47cf183-468a-4a1f-a045-d2fb4a5a2715">13,981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25d6449704a74361b824fbddaab1b298_D20210401-20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTgtMTItMS0xLTE_c11fa765-3bca-4f9d-b0e2-3d50c6eb4651">13,981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c273f41c79c4fbdb0d1230fd0559e14_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTktMi0xLTEtMQ_9574577a-8a4d-4de6-928e-7369f620b573">33,236,270</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c273f41c79c4fbdb0d1230fd0559e14_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTktNC0xLTEtMQ_945216ac-e07b-4648-81ac-d05819af21ed">3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2093b54ed2e847d8acdb383a67170813_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTktNi0xLTEtMQ_42b9efcf-d306-4c5d-85f6-b8251f4169f8">419,235</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e87b080b86f4c85a1a6027779356588_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTktOC0xLTEtMQ_445b358d-652e-4ea3-8ecd-b966940e056b">460</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b6779adb1074d70a27f1bd8c370bdd2_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTktMTAtMS0xLTE_396b8ddd-ea94-4074-88fd-90550a03b8dc">265,500</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf8d120fadaf4453aef93c87406ea34a_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTktMTItMS0xLTE_21790c3d-5086-454e-a9f9-17aae43a2125">154,198</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options, net of shares withheld</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id07b214d4e3f413786721103a10a44e5_D20210701-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjAtMi0xLTEtOTI3NA_746127ce-13b6-47bb-88f9-58bb541f7f53">82,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98959cdb5f6c4fe6bbf1638730028292_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjAtNi0xLTEtOTI5MA_87e45729-a674-4de9-b32d-2da9cded94f4">1,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjAtMTItMS0xLTExMTkx_a2f2607e-2aa9-4618-bc1b-5e368a80b863">1,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon vesting of restricted stock units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id07b214d4e3f413786721103a10a44e5_D20210701-20210930" decimals="INF" format="ixt:num-dot-decimal" name="sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjEtMi0xLTEtOTI4MQ_5eea1b22-48e4-4b11-b530-10ee5faa1f80">132,616</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98959cdb5f6c4fe6bbf1638730028292_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjItNi0xLTEtOTI5OA_e6027c09-4c84-4026-8525-3fc9e7cc61f4">4,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjItMTItMS0xLTExMjA0_a1e8a4ca-4635-4fc3-b85d-6d3e263c9c1c">4,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of early exercised stock options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98959cdb5f6c4fe6bbf1638730028292_D20210701-20210930" decimals="-3" name="sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjMtNi0xLTEtOTMwNQ_cefa069d-a50e-4e59-a9ab-babe7ba24976">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" name="sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjMtMTItMS0xLTExMjA2_7c37d1aa-2f59-4637-839a-0ed45d500587">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa96cfe1e061452eab347a7417e00927_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjQtOC0xLTEtOTMxMw_80e0a2ca-a17a-4b1f-9bd1-110585ca1b6e">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjQtMTItMS0xLTExMjA4_41c3cff3-2bd4-4eca-ad44-a6af2188d8e4">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain of marketable securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa96cfe1e061452eab347a7417e00927_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjUtOC0xLTEtOTMxMw_9dafff72-55ac-4137-bc1a-2e1dfcb22570">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjUtMTItMS0xLTExMjEw_1b1b2d37-2613-41ff-8d70-cb518de4159a">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i859739929cdc49feb9e1b5e371f5be77_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjYtMTAtMS0xLTkzMjE_7fb8100f-80f8-4135-b116-16e58801289a">15,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjYtMTItMS0xLTExMjEw_97cb3f3d-609f-40ec-855b-43b7d19ee207">15,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6a7688791524893986b66bd6348be2b_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjctMi0xLTEtNDYx_53190c20-679c-47f5-af85-20af947e7d7e">33,450,995</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6a7688791524893986b66bd6348be2b_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjctNC0xLTEtNDYx_5ed0c011-a6be-4109-a304-c76a473a795b">3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccb5bcce85274a778eab4af6eb1d355b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjctNi0xLTEtNDYx_0d0de86b-e985-4a9f-97f6-ab9aa0fb71f1">424,561</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8c77e32bdc4fd0aff571107321d934_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjctOC0xLTEtNDYx_31df67ff-cb86-47c8-827c-32ac54995f67">426</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a812a4bda164222b3c7aea2c545528d_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjctMTAtMS0xLTQ2MQ_20f41ed3-12b8-4bcc-9eec-23f7568764b6">281,372</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjctMTItMS0xLTQ2MQ_568f1ce7-e9c9-4300-9df0-3b16a2ed54b7">143,618</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.375%"><tr><td style="width:1.0%"></td><td style="width:45.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.290%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Paid-in  </span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Capital</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other  </span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive  </span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deficit</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21d4eb0fbe1b4f2082f7882f874778fc_I20191231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzgtMi0xLTEtMQ_3e44c484-99fa-46df-8b53-dd36fd2f86d7">25,163,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21d4eb0fbe1b4f2082f7882f874778fc_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzgtNC0xLTEtMQ_d67cbc3a-333c-4073-af64-7f72d26f589d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e3370ae52f94141aa28c7b6558b03f8_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzgtNi0xLTEtMQ_cee62935-26c7-4d81-b583-2faa58b45b43">258,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8c36c532ca54066828971da81e190b9_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzgtOC0xLTEtMQ_73060499-c8aa-44b3-aa69-2f3db5ba739e">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d59943d7b8c4788bf7ebb802bf66b71_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzgtMTAtMS0xLTE_48f6de5c-b176-4b8d-a9fa-32d0a9edb971">195,580</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89789d0c91fe4169839f59b9bd5ea2df_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzgtMTItMS0xLTE_3dd89f7e-bb27-4087-b890-67c8f8b51208">63,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock from public offering, net of underwriting discounts, commissions and offering costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2073aa5d83e1437fbb0649d1c506d3fe_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzktMi0xLTEtMQ_392169c1-1bf5-4016-b49d-6f9f2a5d5d21">3,135,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37dff38285374aa6920e237cc777bdab_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzktNi0xLTEtMQ_14eaf39c-c19d-4315-8812-e56ad0768bf2">62,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390582358ab4487fba346af76b925fb2_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzktMTItMS0xLTE_78fb429f-337a-49c1-9bba-e9f12c9fe557">62,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options, net of shares withheld</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2073aa5d83e1437fbb0649d1c506d3fe_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDAtMi0xLTEtMQ_ee16b926-ad34-4cdc-8d0d-ff2a0e93f870">43,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37dff38285374aa6920e237cc777bdab_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDAtNi0xLTEtMQ_6d8c0117-9992-4282-9281-ff2bf0145e23">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390582358ab4487fba346af76b925fb2_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDAtMTItMS0xLTE_75fe1d38-7f4d-42f6-9078-6ccb08406645">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon vesting of restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2073aa5d83e1437fbb0649d1c506d3fe_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDEtMi0xLTEtMQ_75676609-ddac-4369-9100-9908f182b5aa">63,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37dff38285374aa6920e237cc777bdab_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDItNi0xLTEtMQ_da2143ff-32a7-44f6-9f68-3c23b953354b">2,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390582358ab4487fba346af76b925fb2_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDItMTItMS0xLTE_201892f4-9631-4d39-8b7a-6a9a0311e697">2,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of early exercised stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37dff38285374aa6920e237cc777bdab_D20200101-20200331" decimals="-3" name="sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDMtNi0xLTEtMQ_07f856ad-6b86-431a-a922-273dc017a4d0">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390582358ab4487fba346af76b925fb2_D20200101-20200331" decimals="-3" name="sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDMtMTItMS0xLTE_e11ebe42-c714-40be-b720-d9c4e03d2f86">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169c05e9512945e6a8746c4ef8542f10_D20200101-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDQtOC0xLTEtMQ_8291d1a6-f400-431c-9bcc-b4d3f6d212bf">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390582358ab4487fba346af76b925fb2_D20200101-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDQtMTItMS0xLTE_9d98b57a-d706-4d94-bd6c-267ef2df84f2">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169c05e9512945e6a8746c4ef8542f10_D20200101-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDUtOC0xLTEtMQ_55c6cd2d-b3f8-47fb-b037-666ffbe8bd7e">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390582358ab4487fba346af76b925fb2_D20200101-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDUtMTItMS0xLTE_1e4f8375-5c78-4092-b25b-ff1fdcfc823f">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b13a3cd460d43529a51830c587f1ae4_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDYtMTAtMS0xLTE_e3d0c44c-657e-4f1d-a5b7-c73dc490f22d">12,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i390582358ab4487fba346af76b925fb2_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDYtMTItMS0xLTE_57285d4f-f1d0-44b0-be97-62bb2e7ad579">12,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00aae33ac66f498b91c8304d0a3684e6_I20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDctMi0xLTEtMQ_0f69376f-5e65-4fe5-949e-b5bd648d9af7">28,406,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00aae33ac66f498b91c8304d0a3684e6_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDctNC0xLTEtMQ_a1612313-bb54-4c4d-b447-4cd40f40b777">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f4f5a94479403fa8baf12ad75427e3_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDctNi0xLTEtMQ_33733c84-fb1f-479c-b74c-7a32573e31bc">323,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f8c0ef6b0b142b08f6da44a05bdb9e8_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDctOC0xLTEtMQ_41cc8ba7-ba4b-42c5-b8f8-3d99f9e7c53a">697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29ed3ed441cb4fa78bb6e83cf96aedef_I20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDctMTAtMS0xLTE_c9b418e6-fc60-4466-8e04-232ea5dc6e89">208,352</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id216b900385f40ddb4e3e20115d76dc5_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDctMTItMS0xLTE_3597bda6-7892-401e-a2b9-497443ccfc91">116,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options, net of shares withheld</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7452925b0e5546ac8e3a5572be6ec889_D20200401-20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDgtMi0xLTEtMQ_3fa945b6-4257-4019-b836-063e78eac60b">46,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc576cf893e347489acff339085d0f95_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDgtNi0xLTEtMQ_24845afe-654e-4ada-9737-2818fa423fa3">185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDgtMTItMS0xLTE_fd546cd3-3939-478e-a324-80550a59024c">185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock related to employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7452925b0e5546ac8e3a5572be6ec889_D20200401-20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDktMi0xLTEtMQ_8aa6238a-003f-441e-aa9c-8ad5cf603e39">74,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc576cf893e347489acff339085d0f95_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDktNi0xLTEtMQ_a6a6ad8e-2abd-4ce8-8a2a-59f4223899b4">991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDktMTItMS0xLTE_0474f231-e41e-4500-948e-8d7e789ae8e9">991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon vesting of restricted stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7452925b0e5546ac8e3a5572be6ec889_D20200401-20200630" decimals="INF" format="ixt:num-dot-decimal" name="sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTAtMi0xLTEtMQ_fc0fac99-5b8d-494a-bcd2-0b451bbd785b">85,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc576cf893e347489acff339085d0f95_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTEtNi0xLTEtMQ_f0f31162-8087-4692-9f8f-5221776aa6bb">2,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTEtMTItMS0xLTE_6643bacd-3d51-4b73-af61-571c3ff312b9">2,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of early exercised stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc576cf893e347489acff339085d0f95_D20200401-20200630" decimals="-3" name="sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTItNi0xLTEtMQ_a7a9ab0b-edb1-4cd9-85a5-57147f125849">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630" decimals="-3" name="sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTItMTItMS0xLTE_23055ceb-8c02-4e87-b189-0cba57d56277">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i610b8b3420f644baacc410f92061ab95_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTMtOC0xLTEtMQ_12ff7410-fc35-4184-8100-d549508509b6">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTMtMTItMS0xLTE_580af263-2f49-4130-a276-46b2faaf975d">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i610b8b3420f644baacc410f92061ab95_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTQtOC0xLTEtMQ_e4d0632f-1d39-45bb-b97b-caee804f7443">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTQtMTItMS0xLTE_2875569a-8b9c-430c-8898-20d01c213193">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ff5e648858d44668dc102d8309e731c_D20200401-20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTUtMTAtMS0xLTE_e864d1f1-0631-47f7-bf3a-bcd69fa397da">12,472</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTUtMTItMS0xLTE_ce9b5d47-6ef8-4b30-99ed-a7c5cf96a51d">12,472</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24f538cb702e4c0c8e346a1f3598951b_I20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTYtMi0xLTEtMQ_90186739-e74d-43f3-91b1-206dd680d7e2">28,612,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f538cb702e4c0c8e346a1f3598951b_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTYtNC0xLTEtMQ_ef967805-e846-4668-bb06-7131f7175d01">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbfd8a209c764a95b7ea7a91a7fc9474_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTYtNi0xLTEtMQ_4653d3c3-216e-4777-8542-5c5f088b5b14">328,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245280170e0946e9aea8da85b267bfe2_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTYtOC0xLTEtMQ_63f955fd-b524-4afb-a02f-626f374ffa54">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i051e88f32e88449d8536056f5184fd50_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTYtMTAtMS0xLTE_37a76779-6eb1-421c-8f86-ce00cdeca2ce">220,824</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81b69c135aa5478fb8c1e2ad5ddcee2c_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTYtMTItMS0xLTE_b1e638dd-69f5-4711-a15a-5fd4f3213f7d">107,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options, net of shares withheld</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i165ebc065905414c9459402dde0eea16_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTQtMi0xLTEtMzA5_51787b97-93ed-409b-80f4-58d19a003094">137,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia51f1dbf872743908801048a58b16c15_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTQtNi0xLTEtMzM5_6b6fdfe6-2415-4ff6-80de-e56be19e07a1">628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTQtMTItMS0xLTM4OA_29de5a0e-3487-46ae-9a34-a5b569613867">628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon vesting of restricted stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i165ebc065905414c9459402dde0eea16_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTYtMi0xLTEtMzI0_ef658bcc-026c-4e5b-8d9e-2c3bbb634fa7">88,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia51f1dbf872743908801048a58b16c15_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTctNi0xLTEtMzQx_6f896929-abaa-44c7-8f27-a799bc905f19">3,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTctMTItMS0xLTM5OQ_1e95b493-a512-452e-bdba-794edfdb7c83">3,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of early exercised stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia51f1dbf872743908801048a58b16c15_D20200701-20200930" decimals="-3" name="sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTgtNi0xLTEtMzUy_6a038865-f29a-4e47-bb01-49934ec57035">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" name="sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTgtMTItMS0xLTQwNw_ce909bfa-e832-4243-9d6f-d69082e95a64">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d612f341375492d8de3802bb7d01ce5_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTktOC0xLTEtMzU4_cc6e7a61-4ada-4a74-807c-fcfb46feb20e">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTktMTItMS0xLTQxOA_3f897b06-5bb6-4d27-b7fc-1d605dbb20d1">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d612f341375492d8de3802bb7d01ce5_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjAtOC0xLTEtMzcy_d48d32ce-8067-41fe-afaf-0643b4c23ea6">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjAtMTItMS0xLTQzMQ_7a6e9276-0e0d-402c-bea8-df6d7596a603">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ed0f6117ecf4e2cb1bee31260a098b5_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjEtMTAtMS0xLTM4NQ_569faac7-be89-472b-a3ec-e1712491331c">9,474</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjEtMTItMS0xLTQzOA_5fd7a767-aaa0-490d-a544-2b80228c948f">9,474</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia481f049459c472a9b4860fc2be9a142_I20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjItMi0xLTEtNDQ5_85c42b69-defb-4f21-9049-b95b2c8786b0">28,838,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia481f049459c472a9b4860fc2be9a142_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjItNC0xLTEtNDQ5_26b47fb9-33fd-4388-9257-4e3be5815e34">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426469690ff2417c9f81c8a4128839c6_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjItNi0xLTEtNDQ5_3b20d2bd-34c3-4b4a-846d-0fc0f23d20d2">331,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010b44ff2d3446fa8e15486e55a92e47_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjItOC0xLTEtNDQ5_67a495cb-b4c4-4ad5-ba41-21f89d6f71c2">430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic84bb4fdd42940249648de647e304e0a_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjItMTAtMS0xLTQ0OQ_0246317c-af8c-4c62-adb7-c3731f62e437">230,298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i715926d08424490aabf690d9fa2f75e2_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjItMTItMS0xLTQ0OQ_d02df379-0226-45b5-9e0d-a6892e1825b4">102,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_25"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.388%"><tr><td style="width:1.0%"></td><td style="width:73.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.147%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMy0xLTEtMS0x_35c965b0-1621-4e60-a33c-d671488e8491">42,095</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMy0zLTEtMS0x_3f2bb278-dc55-401b-9ce2-3b70710d0d81">34,718</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNS0xLTEtMS0x_69f58b65-6485-4913-a3a3-7a76b610ce18">12,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNS0zLTEtMS0x_da4975f5-c844-40ee-aa20-e923d9d843db">8,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNi0xLTEtMS0x_6d68eb8f-9063-43b7-bf80-d3be6b35addd">1,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNi0zLTEtMS0x_6d44f238-3652-4218-b66b-753da7d47444">786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bad debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNy0xLTEtMS0x_0a7d5517-edcf-4138-960f-57d4899c2d10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNy0zLTEtMS0x_e850501b-c444-481e-8343-d2cec0c67b5a">235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accretion (amortization) of discount on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfOC0xLTEtMS0x_1d53e937-d569-4ffb-bd4b-d609a7d880e7">1,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfOC0zLTEtMS0x_6b2ad2d1-ce71-4a9c-8067-72632c14feca">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized gain on marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:MarketableSecuritiesRealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfOS0xLTEtMS0x_ca0d63be-268a-4179-bd2a-7f450fb4cc7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" name="us-gaap:MarketableSecuritiesRealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfOS0zLTEtMS0x_437152dc-23cd-44b9-ae3b-2f3531e50515">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTAtMS0xLTEtMQ_46f30a3d-f292-4fa9-b811-2901f8e0fdfd">234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTAtMy0xLTEtMQ_3b94ed6c-a246-44e4-90f6-84a94de70204">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTEtMS0xLTEtMQ_32fb416e-dfe4-49fb-bb40-fed2b281c489">1,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTEtMy0xLTEtMQ_b3c0de99-b108-470b-a835-b9a3dda93511">1,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sale and disposal of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTItMS0xLTEtMQ_c1112d83-563e-4c41-913f-89c7e09a63c5">304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTItMy0xLTEtMQ_07445e1a-fbe2-4e88-81b7-12c0f1ca4f56">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTQtMS0xLTEtMQ_f2574cdb-27e9-4a74-9885-3372d234ab1d">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTQtMy0xLTEtMQ_faada87e-7468-4235-bc0b-c8cc4e6b951f">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTUtMS0xLTEtMQ_7d151a2e-d447-4999-86bf-d81fd6cf14e3">4,545</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTUtMy0xLTEtMQ_27005a46-0e87-4423-8a44-58cf82ba7abf">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTYtMS0xLTEtMQ_73aaec4c-9bbe-4e84-902b-d271041b83e2">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTYtMy0xLTEtMQ_e810fa36-f435-4d68-b09b-e9ca9dfd62ef">1,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTctMS0xLTEtMQ_a70c6208-2c7e-4d66-b64d-507fe90ce232">425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTctMy0xLTEtMQ_839a34f7-6f95-4c88-9f7b-381b9d2d7f6b">416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTgtMS0xLTEtMQ_a75a646d-eb29-46f3-8c4b-f12c3ef00382">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTgtMy0xLTEtMQ_3635e757-97e5-4b09-9e38-0481063e43bb">2,072</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTktMS0xLTEtMQ_c3ab24d8-d03e-409c-8a4b-5a8da88ec9fc">26,819</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTktMy0xLTEtMQ_f92c9739-ccfe-4222-a826-0c23089d9e24">22,780</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Maturities of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="sibn:ProceedsFromMaturityOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjEtMS0xLTEtMQ_999edc64-3492-4a4a-9b43-afba186ed243">107,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="sibn:ProceedsFromMaturityOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjEtMy0xLTEtMQ_6f56e3b8-1948-4e58-8e2c-abbe331a3eb8">63,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="sibn:ProceedsFromSaleOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjItMS0xLTEtMQ_ad4343a9-cfd0-48cd-bbfd-32cfccddb050">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="sibn:ProceedsFromSaleOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjItMy0xLTEtMQ_85618402-4ba1-456e-971c-5e69954fd006">12,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjMtMS0xLTEtMQ_fe0bdab8-dab9-41ca-bbfb-e1156b461802">66,678</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjMtMy0xLTEtMQ_852b6fc7-b282-49f0-9368-bb94671bde27">69,145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjQtMS0xLTEtMQ_a9540654-1617-477b-a00e-a87decf62e17">4,614</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjQtMy0xLTEtMQ_292d2a83-5ed0-48ef-afb3-aaa65d5e75bd">1,744</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">investing activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjUtMS0xLTEtMQ_a0429255-02fb-43d5-b4e7-9363de48e81b">36,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjUtMy0xLTEtMQ_4dec5612-58ca-437a-857d-9d3f0085f440">4,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from follow-on public offering, net of underwriting discounts, commissions and offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjctMS0xLTEtMQ_7fe17282-95d3-440d-a251-49f196abfe76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjctMy0xLTEtMQ_1f2bde5a-6bf0-484c-b71c-208990619c86">62,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from debt financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjgtMS0xLTEtMQ_0fa85d2c-dd1a-4683-a8cc-4dd3f6aef26a">35,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjgtMy0xLTEtMQ_d0df410a-b66b-4c86-a1d1-02215130f649">45,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of debt financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjktMS0xLTEtMQ_e306f011-f500-40af-9b61-e4a40f1d9b13">41,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjktMy0xLTEtMQ_8a33d560-a547-4ee2-85f2-af29183d42cb">45,297</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzAtMS0xLTEtMQ_ca6878f1-ff83-4c0d-a05a-2eecb85c4e03">111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzAtMy0xLTEtMQ_3300d1df-754c-44af-9bb0-363a9a277832">750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of prepayment penalty and lender fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzEtMS0xLTEtMQ_00cde4f2-0a60-40de-9358-75f7c4f47c8a">508</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzEtMy0xLTEtMQ_5f45950e-7207-4504-b7cc-61f8366a04d8">843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzItMS0xLTEtMQ_45a60bd5-48b7-4844-9ca0-d6604e928428">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" name="us-gaap:ProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzItMy0xLTEtMQ_a7574ef8-9d15-46bc-9a13-81a24c8c142d">991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from the exercise of stock options </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzMtMS0xLTEtMQ_de149ad4-9e23-4d86-b43b-1345cbfabe3b">2,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzMtMy0xLTEtMQ_371ff197-9579-461c-aa85-5107786ec14d">987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzYtMS0xLTEtMQ_7e768b4d-7056-4789-82b5-af9afa47f9be">2,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzYtMy0xLTEtMQ_c0d53c82-4c61-46b6-bdbd-d84402fd79f2">63,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:17.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzctMS0xLTEtMQ_7e4999d0-f49d-414b-ad46-d94fef36c4d8">375</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzctMy0xLTEtMQ_2d8c66fe-670f-47bb-af7a-ac1ae109eb51">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzgtMS0xLTEtMQ_56759390-de4c-4291-b8e8-191d98dc15da">6,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzgtMy0xLTEtMQ_adc39722-659c-4425-9e82-9a3c2049963a">45,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents at</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDAtMS0xLTEtMQ_825c342b-992c-4205-aa4b-6d03357a1763">53,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89789d0c91fe4169839f59b9bd5ea2df_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDAtMy0xLTEtMQ_d5b90d4e-7aaf-4047-86b5-c7eb7ef718cd">10,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">End of period</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDEtMS0xLTEtMQ_ad8cf144-2bb3-4736-b069-ff2ad959fc9c">59,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i715926d08424490aabf690d9fa2f75e2_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDEtMy0xLTEtMQ_25c1672d-af71-4818-8189-ca876e46e10b">55,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental disclosure of non-cash information</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of early exercised stock options</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" name="sibn:VestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDYtMS0xLTEtMQ_4d13b123-9e66-4227-acd6-1c86efc16ade">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" name="sibn:VestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDYtMy0xLTEtMQ_08d1a743-4e99-465b-83e4-ae5ee274fa9f">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unpaid purchases of property and equipment </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDctMS0xLTEtMQ_4964cb1d-6daf-4de4-9ec0-7a83dfb11f92">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDctMy0xLTEtMQ_9f1a105d-efb0-4748-a381-7110378aea71">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div><div><span><br/></span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_28"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_31"></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfNDI0Mw_fbbdf7db-6e13-4313-8c2b-0f4f1223df25" continuedAt="i520b710d954c4772a0dd796875e3be7f" escape="true">The Company and Nature of Business</ix:nonNumeric></span></div><ix:continuation id="i520b710d954c4772a0dd796875e3be7f" continuedAt="i0c66b6c80369442c9d82864b92973996"><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SI-BONE, Inc. (the &#8220;Company&#8221;) was incorporated in the state of Delaware on March&#160;18, 2008 and is headquartered in Santa Clara, California. The Company is a medical device company that has pioneered a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of the most common types of sacroiliac joint disorders that cause lower back pain. The Company introduced its primary product, the iFuse Implant System, or iFuse, in 2009 in the U.S., in 2010 in certain countries in the European Union, and in 2015 in certain countries in the rest of the world.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, the Company received $<ix:nonFraction unitRef="usd" contextRef="i4d2b391980d14a2aaf03c702bc7ee2f8_D20200101-20200331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfNjg3_dca8de9d-bc94-402f-973c-a802495f7c4e">63.0</ix:nonFraction> million of net proceeds from its first follow-on public offering of <ix:nonFraction unitRef="shares" contextRef="i9010c1b3cf4c4b1a9c2136e170a13186_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="sibn:SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfNzUw_795bc94a-64c7-43ee-9ff9-0ff7634941e1">4,300,000</ix:nonFraction> shares of the Company's common stock, of which <ix:nonFraction unitRef="shares" contextRef="i4d2b391980d14a2aaf03c702bc7ee2f8_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfODAw_241ccf89-7eb4-4ee9-8670-39a1406a197a">2,490,053</ix:nonFraction> shares were offered and sold by the Company, and the exercise of underwriter's option to purchase from the Company an additional <ix:nonFraction unitRef="shares" contextRef="i69d57d1462cc4484b5d209182af32f3f_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfOTMy_8fefa565-dbfe-4541-8adc-f5aa0d11f0a9">645,000</ix:nonFraction> shares of the Company's common stock, at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i109df68e90ee490a9db47812746364dc_I20200331" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMTAwMw_09184647-344b-4be0-afd0-73d41cc45460">21.50</ix:nonFraction> per share. The total public offering costs incurred in connection with the follow-on offering were allocated based on the gross proceeds received by the Company and the other selling shareholders on a pro-rated basis. Public offering cost of $<ix:nonFraction unitRef="usd" contextRef="i4d2b391980d14a2aaf03c702bc7ee2f8_D20200101-20200331" decimals="-5" format="ixt:num-dot-decimal" name="sibn:AllocatedPublicOfferingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMTI0OA_bacb2f00-42b3-4cd3-9171-f977eba8432f">0.4</ix:nonFraction> million allocated to selling of shares by the Company was charged against the gross proceeds received from the follow-on offering. Public offering costs of $<ix:nonFraction unitRef="usd" contextRef="ib80c352eab074e7f8283e97c5bcd56d3_D20200101-20201231" decimals="-5" format="ixt:num-dot-decimal" name="sibn:AllocatedPublicOfferingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMTM5OQ_e9b8fc56-2dc6-4d81-88e4-5d495415a377">0.2</ix:nonFraction> million allocated to selling of shares by the selling shareholders was recognized as transaction costs within general and administrative expenses on the consolidated statements of operations in the year ended December 31, 2020.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company received $<ix:nonFraction unitRef="usd" contextRef="ic20806741c494cdba90d292fbf08fc22_D20201001-20201031" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMTY0NQ_83c766c3-d2a1-4fe9-8600-3cd024231cea">71.6</ix:nonFraction>&#160;million of net proceeds from its second follow-on public offering of shares of the Company's common stock, of which <ix:nonFraction unitRef="shares" contextRef="ic20806741c494cdba90d292fbf08fc22_D20201001-20201031" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMTc1Ng_80b5c89c-e9e4-4b88-a2b2-54b7a86bb4f7">3,000,000</ix:nonFraction> shares were offered and sold by the Company, and the exercise of underwriter's option to purchase from the Company an additional <ix:nonFraction unitRef="shares" contextRef="iff1f8e32880046b2b07d08aa6eea7ef8_D20201001-20201031" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMTg4OA_ed5bcf94-5e53-4a26-a2b4-5c247c09156a">478,507</ix:nonFraction> shares of the Company's common stock, at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i43f819d6ee994d6087b5510e48ec11a2_I20201031" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMTk1OQ_d2e71f29-66e7-459e-a6cd-374110d74b59">22.00</ix:nonFraction> per share. In addition to the shares sold by the Company in this second follow-on offering, the selling stockholder sold <ix:nonFraction unitRef="shares" contextRef="i7415c778d8224834a93c6630cef41f4e_D20201001-20201031" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMjA4Mw_a115582d-b1a0-4612-b54a-7c81d2e86a24">190,053</ix:nonFraction> shares of the Company's common stock previously held by the selling stockholder at a price to the public of $<ix:nonFraction unitRef="usdPerShare" contextRef="i278b0ccaf44c482899bd7ba4f716814d_I20201031" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMjE5NA_929931a4-a644-477f-a778-04e44dd0537b">22.00</ix:nonFraction> per share. The Company did not receive any proceeds from the sale by the selling stockholder.  </span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i0c66b6c80369442c9d82864b92973996">The Company is subject to continuing risk and uncertainties as a result of the COVID-19 pandemic, and is closely monitoring the impact of the pandemic on all aspects of its business, including the impacts on its customers, patients that would benefit from procedures involving the Company's products, employees, suppliers, vendors, business partners and distribution channels. Economies worldwide continue to be negatively impacted by the COVID-19 pandemic, in particular with recurrent outbreaks and mutations of the virus, despite advances in vaccines, and the Company anticipates these disruptions will continue. While the Company has not experienced material disruptions to its supply chain to date, certain of its third-party suppliers have faced delays, product shortages and rising costs resulting from disruptions in the global supply chain, primarily related to the instruments. As a result, the Company is continuing to work closely with its manufacturing partners and suppliers, as well as determining alternative sourcing strategies to enable the Company to source key components and maintain appropriate inventory levels to meet customer demand. As such the Company's future results of operations and liquidity could be adversely impacted by a variety of factors related to the COVID-19 pandemic, including those discussed in the section entitled "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended December 31, 2020.  As of the date of issuance of these condensed consolidated financial statements, the extent to which the COVID-19 pandemic may materially impact the Company's financial condition, liquidity, or results of operations remains uncertain</ix:continuation>.</span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_34"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNjE_d6f71096-96ff-4cf1-8c0d-a23ffefee714" continuedAt="i763cd0de7e304fd7a9b4fc24dd53d78d" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i763cd0de7e304fd7a9b4fc24dd53d78d" continuedAt="i7607493f996a4b2f813633ddeb77b31c"><div style="margin-bottom:12pt;margin-top:9pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNTY_4b6ff75f-21f3-461e-9ffc-a62983894956" escape="true">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all of the information required by GAAP for complete financial statements.</ix:nonNumeric> <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNTc_ed5eaec3-a979-4327-9b99-6139b497514e" escape="true">These unaudited interim condensed consolidated financial statements have been prepared on the same basis as the Company&#8217;s annual financial statements and, in the opinion of management, reflect all adjustments that are necessary for a fair statement of the Company&#8217;s consolidated financial information. The results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any other interim period or for any other future year.</ix:nonNumeric> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements should be read in conjunction with the audited financial statements and related notes thereto for the year ended December 31, 2020 contained in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 10, 2021.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i7607493f996a4b2f813633ddeb77b31c" continuedAt="i70132c6ffebd4cbf806d8c10a7d088a7"><div style="margin-top:9pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNTg_f103ff6e-5a31-4df6-a7a9-521609cb4edd" continuedAt="i8092efbc5b6d424aaec74eb68eb2e534" escape="true">Use of Estimates </ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8092efbc5b6d424aaec74eb68eb2e534">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are based on historical experience, where applicable and other assumptions believed to be reasonable by the management. Actual results could differ from those estimates.</ix:continuation> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s significant accounting policies are disclosed in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020. There have been no material changes to these accounting policies.</span></div><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="sibn:EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNjM_4616d7f0-e207-4ee6-9e36-1496e6ea7dcf" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">JOBS Act Accounting Election</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an emerging growth company under the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), the Company has been eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. The Company has elected to take advantage of the extended transition period for adopting new or revised accounting standards that have different effective dates for public and private companies. As a result, these condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 30, 2021, the Company&#8217;s public float exceeded $700&#160;million and as such the Company will be deemed to be a large accelerated filer under Rule 12b-2 of the Exchange Act, commencing with the Company&#8217;s Annual Report on Form 10-K for the 2021 fiscal year. The Company will retain its current filer status until the end of 2021. As a large accelerated filer, the Company will no longer qualify as an emerging growth company nor be eligible to rely on the benefits afforded to emerging growth companies under the JOBS Act.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNTk_5607564d-9a1f-45e4-b095-8b385e46f451" continuedAt="if37480e9193341cf97ff57e109e1c751" escape="true">Segments</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if37480e9193341cf97ff57e109e1c751">The Company manages and operates as <ix:nonFraction unitRef="segment" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMzg0OQ_35598f75-33c7-4f3b-8953-6409139b36bc"><ix:nonFraction unitRef="segment" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMzg0OQ_c3b35009-d259-4958-b7f0-6ece9e22238c">one</ix:nonFraction></ix:nonFraction> reportable segment. The Company derives substantially all of its revenue from sales to customers in the U.S. Revenue by geography is based on billing address of the customer.</ix:continuation> No single country outside the U.S.  accounts for more than 10% of the total revenue during the periods presented. Long-lived assets held outside the U.S. are immaterial. <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNjA_4ac52d2f-eff8-4dd9-bc8a-56543de54235" continuedAt="i2d544eb0b0de4815a620ba86166868fb" escape="true">The table below summarizes the Company's revenue by geography:</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><ix:continuation id="i2d544eb0b0de4815a620ba86166868fb"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"><tr><td style="width:1.0%"></td><td style="width:46.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.605%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie659bc55581349eca6480acadb12d4f9_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfMy0xLTEtMS0x_dfc7b507-211d-4795-b12d-6fed7ea2b9bb">20,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976ed3cd496b4e58a4dc4becdbc4161b_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfMy0zLTEtMS0x_66e33f76-bbf2-4f9e-8519-9f9733091f31">18,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12a2b6dbfac4d1ab143dfbd3f951b36_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfMy01LTEtMS0x_08ab8037-bb0a-4f38-8ad7-456dee5f5465">59,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46482b4e0b8440ce80cee026cd1125e8_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfMy02LTEtMS0x_1053b6a1-540e-42be-86e1-e281a686b971">47,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1317afa536514c45b39738af99fef75c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNC0xLTEtMS0x_4555aa33-1f3c-42db-9783-32a911de4172">1,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ff853edb14242bc858575b0953b7ca6_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNC0zLTEtMS0x_9d3d2be6-9b39-42c7-8834-8c25bbb021c2">1,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd3e395480d74661ada50ae4fd7afc82_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNC01LTEtMS0x_b5c7eaa2-a0d7-45a7-aa8c-0bc4dfa71f14">5,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd5d89692c34b9496302d55a55bc7ce_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNC02LTEtMS0x_f54bd98a-5a2e-41a2-a6d6-ac340fbf2356">3,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNS0xLTEtMS0x_af778005-c0cc-44ff-bdef-0f7199ba8a36">22,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNS0zLTEtMS0x_1908fbbc-f257-49b9-8bbb-5c92061e3961">20,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNS01LTEtMS0x_af86df93-68ae-40cd-a5ab-40fdcc771f95">64,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNS02LTEtMS0x_d1121878-09c0-4a5f-b141-8a0d76ff11d3">51,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i70132c6ffebd4cbf806d8c10a7d088a7"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNjQ_a887c5fb-7e97-479b-9806-8a015a227dcd" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Effective</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-02, Leases (Topic 842), which requires that lessee's recognize a right-of-use asset and a lease liability for all leases with lease terms greater than twelve months in the balance sheet.&#160;A lease liability is a lessee's obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset is an asset that represents the lessee&#8217;s right to use, or control use of, a specified asset for the lease term for all leases (with the exception of short-term leases) at the adoption date. In July 2018, the FASB issued&#160;ASU&#160;2018-10 and&#160;ASU 2018-11, which provides clarification on the narrow aspects of the guidance and provide an additional transition method to adopt the new leases standard. The new transition method allows an entity to recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. In March 2019, the FASB issued&#160;ASU 2019-01, which provides clarification on implementation issues associated with adopting&#160;ASU 2016-02.&#160;The new leases standard must be adopted using a modified retrospective transition method and allows for the application of the new guidance at the beginning of the earliest comparative period presented or at the adoption date. In November 2019, the FASB issued ASU 2019-10, which revised the mandatory effective dates of the new leases standard. Further, due to the impact of the COVID-19, in June 2020, the FASB issued ASU 2020-05 to further defer the effective date for one year for entities in the &#8220;all other&#8221; categories. For public companies, the new guidance became effective for fiscal years, and for interim periods within those fiscal years, beginning after December&#160;15, 2018. For all other entities, the new guidance is now effective for fiscal years beginning after December&#160;15, 2021 and interim periods within fiscal years beginning after December 15, 2022. Early adoption is still permitted for any interim or annual financial statements not yet issued.  The Company expects to disclose the adoption of this standard for the fiscal year ending December 31, 2021. The Company is currently evaluating the impact of this standard on its consolidated financial statements including the timing of its adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (1) whether a contract is or contains a lease, (2) the classification of existing leases, and (3) whether previously capitalized initial direct costs would qualify for capitalization under ASC 842. The Company expects that the adoption of this new standard will have a material impact on its balance sheet. The most significant impact would be the recognition of operating lease right-of-use assets and liability. The standard is not expected to have a material impact to the Company's consolidated statements of income and cash flows.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued&#160;ASU 2016-13,&#160;Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. FASB issued ASU 2019-05 in May 2019, ASU 2019-08 and ASU 2019-11 in November 2019 for codification improvements of Topic 326. The new standard revises the accounting requirements related to the measurement of credit losses and will require organizations to measure all expected credit losses for financial assets based on historical experience, current conditions and reasonable and supportable forecasts about collectability. Assets must be presented in the financial statements at the net amount expected to be collected.&#160;In November 2019, the FASB issued ASU 2019-10,&#160;which defers the effective date of&#160;ASU 2016-13&#160;for public companies that are eligible to be smaller reporting companies and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.&#160;In February 2020, the FASB issued ASU 2020-02, which provides guidance regarding methodologies, documentation, and internal controls related to expected credit losses. The Company is currently evaluating the impact of this standard on its consolidated financial statements but does not expect the standard will have a material impact on the Company's consolidated financial statements. The Company expects to disclose the adoption of this standard for the fiscal year ending December 31, 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the FASB issued&#160;ASU&#160;2021-04&#160;&#8220;Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212; Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815- 40) Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#8221; which clarifies and reduces diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options that remain equity classified after modification or exchange. An entity should measure the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as follows: i) for a modification or an exchange that is a part of or directly related to a modification or an exchange of an existing debt instrument or line-of-credit or revolving-debt arrangements (hereinafter, referred to as a &#8220;debt&#8221; or &#8220;debt instrument&#8221;), as the difference between the fair value of the modified or exchanged written call option and the fair value of that written call option immediately before it is modified or exchanged; ii) for all other modifications or exchanges, as the excess, if any, of the fair value of the modified or exchanged written call option over the fair value of that written call option immediately before it is modified or exchanged. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. The Company is currently evaluating the impact of this update on its consolidated financial statements. While the Company does not expect the adoption of ASU 2021-04 to materially impact the Company's consolidated financial statements and related disclosures because it does not currently anticipate modifications to its outstanding equity-classified written call options, the impact on the Company's consolidated financial statements and disclosures will depend on the facts and circumstances of any specific future transactions.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div><div><span><br/></span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_37"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RleHRyZWdpb246Y2UyNGVmZTc2ZTIyNDY1OGE5NjViYWYzNGRmYWI2YzhfMTIyMw_d45118fb-e9cc-42b4-92bb-72cd264d1076" continuedAt="i6e170bd9dd4249e0a872e0f9698f4564" escape="true">Marketable Securities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6e170bd9dd4249e0a872e0f9698f4564"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company's marketable securities were available-for-sale and were classified based on their maturities. Marketable securities with remaining maturities at the date of purchase of three months or less are classified as cash equivalents. Short-term investments are securities that original maturity or remaining maturity is greater than three months and not more than twelve months. Long-term investments are securities for which the original maturity or remaining maturity is greater than twelve months.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RleHRyZWdpb246Y2UyNGVmZTc2ZTIyNDY1OGE5NjViYWYzNGRmYWI2YzhfMTIyMg_7ea4082e-36b3-4bd6-aab4-70f45114ffca" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the marketable securities:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"><tr><td style="width:1.0%"></td><td style="width:36.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i380833eacc394ce0bea4afe14c77beb8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMy0xLTEtMS0x_243e93f4-9bc7-4b31-829a-284843523928">54,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i380833eacc394ce0bea4afe14c77beb8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMy03LTEtMS0x_c294c74a-646d-4e09-a50e-59c2306cf8ed">54,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfNS0xLTEtMS0x_ca97db6f-aeaf-4394-8137-69a4d87778b8">54,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfNS03LTEtMS0x_c45c9f4e-c324-450d-9f44-1bbc7617eedc">54,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b1f78d1cc14db3aff7642b38d0594b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfNy0xLTEtMS0x_8d7dae84-a902-4a63-8d6a-a2c08f4e203a">52,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b1f78d1cc14db3aff7642b38d0594b_I20210930" decimals="-3" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfNy0zLTEtMS0x_3ad2d805-e37d-4a1b-bf7e-8e0c1282012e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b1f78d1cc14db3aff7642b38d0594b_I20210930" decimals="-3" format="ixt:fixed-zero" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfNy01LTEtMS0x_a0864f5e-3d08-4a67-8c17-385c824cb009">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b1f78d1cc14db3aff7642b38d0594b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfNy03LTEtMS0x_eee9dea4-e172-493d-b43c-8adf16cb32b5">52,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b457a33537545b79259df1751c27179_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOC0xLTEtMS0x_c24a998f-3c09-45d4-bc91-e70d8621ac64">15,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b457a33537545b79259df1751c27179_I20210930" decimals="-3" format="ixt:fixed-zero" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOC0zLTEtMS0x_78268b09-ad40-4131-a856-adde692bec30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b457a33537545b79259df1751c27179_I20210930" decimals="-3" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOC01LTEtMS0x_4392113b-a66a-4e5e-b50f-c5a45abf0644">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b457a33537545b79259df1751c27179_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOC03LTEtMS0x_ecb61980-7af6-494a-8363-521a10426196">15,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec84971611b4b4b9fb02e3e0833ebe2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOS0xLTEtMS0x_ec08b662-b6b4-4787-b0d2-ad4ec38e2829">33,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec84971611b4b4b9fb02e3e0833ebe2_I20210930" decimals="-3" format="ixt:fixed-zero" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOS0zLTEtMS0x_dcdafa72-0ad2-41ad-976d-9bb2b9d9d460">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec84971611b4b4b9fb02e3e0833ebe2_I20210930" decimals="-3" format="ixt:fixed-zero" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOS01LTEtMS0x_058249bf-8b9a-4b68-9b0b-399056b28d4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec84971611b4b4b9fb02e3e0833ebe2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOS03LTEtMS0x_de15c2ec-8ef3-45f0-ae14-a0a793133e69">33,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTAtMS0xLTEtMQ_fd152a77-464c-4367-b287-441f511e3d65">100,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTAtMy0xLTEtMQ_ca483538-46db-40f2-b61c-f19353f86430">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTAtNS0xLTEtMQ_32586f36-dab5-4e01-9a97-c4d37080adfd">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTAtNy0xLTEtMQ_a6c7a0a6-55f4-4494-a57b-1c66ee499ac2">100,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="sibn:MarketableSecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTQtMS0xLTEtMQ_f41ec146-415b-4a41-b5da-66a10e632d19">155,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="sibn:MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTQtMy0xLTEtMQ_47f3662e-2ec4-4fba-8fd8-904fda8e430c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="sibn:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTQtNS0xLTEtMQ_7168712e-d12b-490c-8518-4aa2521aeffa">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="sibn:MarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTQtNy0xLTEtMQ_7b882b12-96b2-4a76-a8a3-8c75faeddd3a">155,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"><tr><td style="width:1.0%"></td><td style="width:36.620%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.667%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0cb0da3346b4ba79a69c2838e5d4b76_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMy0xLTEtMS0x_8528f6be-d6c9-478b-8e7d-3414dce71eff">45,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0cb0da3346b4ba79a69c2838e5d4b76_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMy03LTEtMS0x_c353266c-cad7-4d69-8f66-4d43c7b9385c">45,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac9e0269b454ee2a0357ade267691e5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNC0xLTEtMS0x_9d16f3ce-e638-45a0-a6e8-54bcd46e95d8">1,400</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac9e0269b454ee2a0357ade267691e5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNC03LTEtMS0x_04d2cd3f-330b-4959-902c-84b519dd4a8b">1,400</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNS0xLTEtMS0x_197a2139-1f4a-4efc-aa24-c5ce103248ed">47,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNS03LTEtMS0x_e9686df7-9ad8-4655-a1ff-2d24b3c1e39c">47,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie171077119e94be4b547961f085b9ae7_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNy0xLTEtMS0x_704e9b7f-a656-4ce2-a1df-2ed88005674f">74,779</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie171077119e94be4b547961f085b9ae7_I20201231" decimals="-3" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNy0zLTEtMS0x_5382311b-e0d1-4d6f-8bf2-017576b8ccb8">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie171077119e94be4b547961f085b9ae7_I20201231" decimals="-3" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNy01LTEtMS0x_fadc1bce-3bb5-4795-a2b7-b6a89b56d945">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie171077119e94be4b547961f085b9ae7_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNy03LTEtMS0x_ac037569-1f62-450a-a309-23ebce41a965">74,776</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054dc78f1b714085a5838ba8d5780e3e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOC0xLTEtMS0x_d09ebdb8-bad7-4bc5-b204-02e0972acf40">8,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054dc78f1b714085a5838ba8d5780e3e_I20201231" decimals="-3" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOC0zLTEtMS0x_4f4faee4-d42e-42b4-ac00-8e1b2e5525aa">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i054dc78f1b714085a5838ba8d5780e3e_I20201231" decimals="-3" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOC01LTEtMS0x_52f9d9ac-5bbf-4421-ac3d-94983eaaa4b8">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054dc78f1b714085a5838ba8d5780e3e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOC03LTEtMS0x_b6a1d176-5209-4b9d-bfb3-29992dae435d">8,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac9e0269b454ee2a0357ade267691e5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOS0xLTEtMS0x_8ed23a1d-9c30-4940-91b9-1891f521ec07">59,137</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac9e0269b454ee2a0357ade267691e5_I20201231" decimals="-3" format="ixt:fixed-zero" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOS0zLTEtMS0x_5301addf-eb12-4a1b-b46e-5e67da2c8f04">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac9e0269b454ee2a0357ade267691e5_I20201231" decimals="-3" format="ixt:fixed-zero" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOS01LTEtMS0x_884facaa-6eff-495a-b328-1646bdd97995">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac9e0269b454ee2a0357ade267691e5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOS03LTEtMS0x_59a5a393-8f16-49a3-b7df-3ff463141e58">59,137</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTAtMS0xLTEtMQ_b08f3348-32a2-42cd-b5f4-eb60c5017995">142,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTAtMy0xLTEtMQ_23af7d99-497a-4d51-9f02-be1e4f547309">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" name="sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTAtNS0xLTEtMQ_a937723c-2762-4d25-bea9-5a0cf71e0cce">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTAtNy0xLTEtMQ_237fc2c3-7ea9-4f80-b874-b60a5cba3dbc">142,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="sibn:MarketableSecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTQtMS0xLTEtMQ_647163fc-1d09-4eb7-ada9-e5f586c978a0">190,204</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" name="sibn:MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTQtMy0xLTEtMQ_6bfe07c8-358a-4930-9d6e-e537f32ca5ef">8</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" name="sibn:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTQtNS0xLTEtMQ_a1534996-2aff-4203-9d64-4676bd623f40">13</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="sibn:MarketableSecuritiesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTQtNy0xLTEtMQ_4bc66c45-18f9-424e-9509-578e5bf34334">190,199</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:7pt;margin-top:15pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gains and losses on available-for-sale securities are recorded in accumulated other comprehensive income (loss) on the condensed consolidated balance sheets. The Company evaluates its investments to assess whether those in unrealized loss positions are other-than-temporarily impaired. The Company considers impairments to be other-than-temporary if it is related to deterioration in credit risk or if it is likely the Company will sell the securities before the recovery of their cost basis. The Company did not identify any of its marketable securities as other-than-temporarily impaired as of September 30, 2021 or December 31, 2020.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div><div><span><br/></span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_40"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RleHRyZWdpb246YTAyOTg1YmEyNDEzNDFmMjlhYjExYzEyZDk0MGVmZDFfODA1_fca39770-2fe0-40fd-9482-eb753d7595c7" continuedAt="i10583d50436047b5ae05558a46bb9885" escape="true">Fair Value Measurement</ix:nonNumeric></span></div><ix:continuation id="i10583d50436047b5ae05558a46bb9885"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carrying amounts of certain of the Company&#8217;s financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities and market interest rates, if applicable. The carrying value of the Company&#8217;s long-term debt also approximates fair value based on management&#8217;s estimation that a current interest rate would not differ materially from the stated rate. There were no other financial assets or liabilities that required fair value hierarchy measurements and disclosures for the periods presented. </span></div><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RleHRyZWdpb246YTAyOTg1YmEyNDEzNDFmMjlhYjExYzEyZDk0MGVmZDFfODA0_d5fb21db-1584-40e2-84e3-a2ecbbcfc12f" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the fair value of the Company&#8217;s marketable securities measured at fair value on a recurring basis based on the three-tier fair value hierarchy:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.888%"><tr><td style="width:1.0%"></td><td style="width:45.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.775%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if50d4b24e0734d79ba8b9edd1e805e40_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNC0xLTEtMS0x_b7ffd7d1-601c-4506-82d7-0613cc1e29b2">54,218</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57ab096c74ac4847b7ee788ce1789d46_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNC0zLTEtMS0x_e12df0f2-f118-4fcf-860e-244d5d52976a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id144f1a299a84ecbbb8e3d9cd71920cf_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNC01LTEtMS0x_b7785442-6035-4638-8067-c164efca727e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i433ab522b59a4aa783879f2118cf5b5a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNC03LTEtMS0x_b9e3d38c-19a2-481d-a2a5-b05decf6b31c">54,218</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725fda3b69fb42b69214192df2b4307e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNS0xLTEtMS0x_44501589-fe07-4794-9988-fb5edcdaf4fe">52,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cdbdee501ca4f0b85e078944f534f65_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNS0zLTEtMS0x_8895fb8e-22f4-4b08-9175-72ee0c15f643">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41b6362dacd34d9f88a9c8993387770b_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNS01LTEtMS0x_9f2e331d-bc41-4846-bf9f-fd6aed02974b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf59194f545044df83f3f403416ed170_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNS03LTEtMS0x_7d0eb627-0f4b-4f35-90e9-3a94d893b907">52,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i241fe256234a44b3b77f08e14eca6888_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNi0xLTEtMS0x_50cc8ae8-2c8b-4282-ac52-bd6c860d5f6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i686c44112b5d4f3ba9a4d54da9d73cbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNi0zLTEtMS0x_4480999a-8b5a-4742-918d-5aa8c1a6848e">15,370</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00577f535d504af0be68212884f55f8b_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNi01LTEtMS0x_debd7bce-02da-45d7-a3d6-210ba8514cb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ea729b060074c5899a64ea1337e293b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNi03LTEtMS0x_4b5e7e1a-06e0-4eca-b2d4-f3cdfd273115">15,370</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102d310b7d67475fb03b9907bc7c3d46_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNy0xLTEtMS0x_fef71ad0-645a-4842-997d-096e0990fc2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3079b6c3604eddb06b821bf1c2d0b7_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNy0zLTEtMS0x_d4e3ae00-befb-4e3f-bea4-bd6c80231bd2">33,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78d10f8420241fe8b24a9e42e1f528a_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNy01LTEtMS0x_70c4221c-5daf-42ba-a8b0-21cd142aea56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27fdd2acd64a4b8d85de92ce53842683_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNy03LTEtMS0x_abe1475f-306f-45e0-81af-579331a00212">33,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0ab19ddd1d0461c9e0d4e27776d7d1f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfOC0xLTEtMS0x_10adbedc-b663-49b3-adbb-8a7d00febf9d">106,361</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e6ede9aecc414587ca1f1a67b50d01_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfOC0zLTEtMS0x_3913c711-def1-49fc-ba02-82b76f557661">48,845</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987e7b13124e43d7b5ae40e6246e58cc_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfOC01LTEtMS0x_5bba6f38-caae-44c8-9ac9-b8a68d59db32">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e29646458c343d4b6be0890911f4d9c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfOC03LTEtMS0x_2f30b3a5-c40d-4a0f-aaec-e0183410beae">155,206</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ecf8bebd1ef4e9ab058a08dfe87ac43_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTQtMS0xLTEtMQ_c7fa3900-e6dc-4f86-91c6-9713608fe7c3">45,948</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41f57a77065c4ecf98478986ebfac018_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTQtMy0xLTEtMQ_fb39e479-26f8-4349-a5a1-d6beb547d8f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e6ed7e99cde4d7c92e1b6df344d0083_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTQtNS0xLTEtMQ_926a2a69-7103-4456-957f-ce442e0d3450">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde2c8052a5648118d562a14a46b38fe_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTQtNy0xLTEtMQ_63a0505c-da50-4f4b-a03c-22befea53b0d">45,948</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b10d0cb3ff49df8d232f17ea2522e9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTUtMS0xLTEtMQ_b0d28e7c-adc2-4ce1-961a-c9221dd7d7df">74,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a26c11caa9041ccaf5933b7b93b6d6c_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTUtMy0xLTEtMQ_5b5dcfc9-d1e0-4cc7-9b3b-3afe56bae6f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68990ae0b9c64420ab7d40fcde0e4612_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTUtNS0xLTEtMQ_7a8e02a4-4478-4f87-aa51-a9e0180d0c21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b8c7b83b4a74dd6b717a704b99447b4_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTUtNy0xLTEtMQ_66ed69b4-4164-434a-8502-ebe7d83a761d">74,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica53df319b9b4f6b8b770a1f538ab111_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTYtMS0xLTEtMQ_45a3f05d-9b7c-4a5f-965f-a006871560f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b60576a921b48b680618b3810b404bd_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTYtMy0xLTEtMQ_abc8299f-57eb-456f-a720-656d5e36f9cd">8,938</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66fdccee615a470db6971cc34c65e8c9_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTYtNS0xLTEtMQ_afd7c4a9-d2c0-41f0-8464-c27604fb924e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e5ba73a05ed40299cc3f10f52f1b435_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTYtNy0xLTEtMQ_0e5e11b3-ac58-4bf7-ba79-b098daea5396">8,938</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb844642c3174f18a5186ba1283f54e9_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTctMS0xLTEtMQ_2e6560d2-57b8-4c69-b743-2389551dcd57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53205439e8b4340b3ce102dd284cbde_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTctMy0xLTEtMQ_1f50f766-a9d3-479c-ab7e-a42f2a35bc4b">60,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4f96fcd7e24f62a9e449453e2b6f9a_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTctNS0xLTEtMQ_7216ae65-7fa9-4d74-8910-823d362e281a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6911b659231424280f48b741135ca13_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTctNy0xLTEtMQ_e8527f2f-e2b4-4681-a66e-e7ead68580f8">60,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33d55a979204b7f9ccc70abb78a1a48_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTgtMS0xLTEtMQ_0d7596d6-3f02-497b-9b98-3f219a1b248b">120,724</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6360a4b99f2b445481090bd10f1bbeff_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTgtMy0xLTEtMQ_ed049a08-fb18-41cb-8dc0-41ebc46ea95e">69,475</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a1f642004944d43b7569e23fd29e61c_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTgtNS0xLTEtMQ_652565db-f9c0-41d9-8aba-4aa30199cb63">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757d3032f8fc4a71b0a40a93905bf6dc_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTgtNy0xLTEtMQ_603031cb-8923-4f07-92b5-82f82ad8d984">190,199</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div><div><span><br/></span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_43"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfNDg4_99c86472-8185-449d-ba1d-5905a9580f27" continuedAt="i1d530530d1764cb595df45dae6615eca" escape="true">Balance Sheet Components</ix:nonNumeric></span></div><ix:continuation id="i1d530530d1764cb595df45dae6615eca"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021 and December 31, 2020, inventory consisted entirely of finished goods.</span></div><div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfNDg5_ca8aa6cd-f5d8-42e3-8d3e-6a3667c0a8ae" continuedAt="i7b82ba454f0642adac1be932aafae2d6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></ix:nonNumeric></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"><ix:continuation id="i7b82ba454f0642adac1be932aafae2d6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"></td><td style="width:66.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id245cbf5f02e45a6bad677ee88cd874f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfMi0xLTEtMS0x_bc648991-279a-407f-955b-047264f5976d">9,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24eb57cd3b86414f942f4026431cbebc_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfMi0zLTEtMS0x_df8e20d2-e731-4b42-b777-52d935eb4484">6,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea20d262a08e4a9686dd6fc4c64b6cbc_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfMy0xLTEtMS0x_9083e29e-fa53-44a9-a6d0-cb364b4e851b">2,906</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i737a4beebbff4635b25833b31ee0943e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfMy0zLTEtMS0x_456b3861-870b-470e-b784-d50c405fe387">1,692</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6421c98b366e420ca30776333d1e2c0a_I20210930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNC0xLTEtMS0x_1bea646e-7ee8-4f47-98ba-631b8339eb54">878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie875541c2b924f32a637a5864a311bb1_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNC0zLTEtMS0x_268820d2-c726-43ba-aa73-5efb096e9900">714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icca253489e02432f8f1edbe1cd8e4d4a_I20210930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNS0xLTEtMS0x_e4e51762-db27-4611-a0ce-9e6cee563848">503</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f42e5899834f1d97e11131b6de99de_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNS0zLTEtMS0x_0040f6f4-3a7a-4edf-93a0-7a3f4d13bab0">503</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i678091eb517f46e1b50ede7a3998b1b3_I20210930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNi0xLTEtMS0x_804148d4-7142-4f4c-b4e2-2784e5406a2f">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8864c9b1ec194188b89a16633da21be7_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNi0zLTEtMS0x_9661d291-c715-43f7-8955-ba7619f6d10a">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNy0xLTEtMS0x_7b4fd809-5ef6-49e3-9755-a72ce3a44bc7">14,247</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNy0zLTEtMS0x_1d8cc6b6-f486-4f70-bdfc-6a5d6f62b842">9,484</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfOC0xLTEtMS0x_69c07fae-a156-480c-b545-bd8d3d957e66">6,334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfOC0zLTEtMS0x_f64c5647-70e3-432d-af99-95c5e27d1020">4,957</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfOS0xLTEtMS0x_c11acf19-93e5-4071-8f3e-b06042aaca36">7,913</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfOS0zLTEtMS0x_89abaf73-590a-4bf0-adb5-4dc2ff43b251">4,527</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction in progress consists of cost of individual components of a custom instrument set used for surgical placement of the Company&#8217;s products that have not yet been placed into service of $<ix:nonFraction unitRef="usd" contextRef="i78e300a956264748aa120a323a6cb2b5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfMTA5OTUxMTYyODkzNw_445412d2-4ded-4298-9c5c-d68601b0961e">2.8</ix:nonFraction> million and construction costs related to the new lease in Santa Clara of $<ix:nonFraction unitRef="usd" contextRef="iac1bec7b510c4ec2b6a53deea9267b72_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfMTA5OTUxMTYyODk1OA_733363d0-2842-4c35-b223-92cf3e827ab9">0.1</ix:nonFraction> million. Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfMTA5OTUxMTYyODI3Mg_93109fa9-2b01-49ee-9161-e587e013fefa">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfMzY3_b43c96ad-ec6d-4b10-8d2e-b951759fb90c">0.3</ix:nonFraction> million for the three months ended September 30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfNDEw_4272ba67-0d53-418d-9e8c-1f68cc109f8a">1.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfNDE3_5b8f6aac-66d5-4a61-a3e2-3f067d9982d8">0.8</ix:nonFraction> million for the nine months ended September 30, 2021 and 2020, respectively.</span></div><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfNDkx_caa7a641-9eb8-495c-8d24-bfec4d24a836" escape="true"><div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"></td><td style="width:66.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and related expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfMi0xLTEtMS0x_a6af9552-149d-4f88-814a-c3e470a748cd">8,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfMi0zLTEtMS0x_321afa9c-0e66-47f1-9c23-f13596185bca">9,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accrued professional services </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfNC0xLTEtMS0x_a99c5f16-504d-4c35-9ec6-b691001fbf76">719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfNC0zLTEtMS0x_a76896f5-84a5-48d4-9cb1-bae690dab5a1">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfNS0xLTEtMS0x_0d6ab78a-57a4-4d46-ac44-36e59fe7548e">1,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfNS0zLTEtMS0x_29ee294d-ef1e-49d4-b59a-1563724a4daa">513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfNi0xLTEtMS0x_7c759b00-7fa7-4f9d-813b-59b719229500">10,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfNi0zLTEtMS0x_46f3765f-44a7-4dee-bd6d-2f5e8aef56b8">10,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_46"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMjk1NQ_10ac1054-2840-4a21-82a5-12dbe801fa4b" continuedAt="i2bee458681234e34b9d71272b4117d02" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i2bee458681234e34b9d71272b4117d02" continuedAt="ic30390a3fd8d45a781e5465ab176789d"><div style="margin-top:9pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a non-cancelable operating lease for an office building space, located in Santa Clara, California which expires in May 2025. The Company also has non-cancelable operating leases for its office building spaces in Gallarate, Italy and Knaresborough, United Kingdom, which expire in August 2027 and December 2025, respectively. Effective April 30, 2021, the Company terminated its office lease in Mannheim, Germany, and commenced a new lease that can be terminated at any time with <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="sibn:OperatingLeaseTermOfWrittenNoticeForTermination" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMzg0ODI5MDcwMDMwNg_80fbd1f3-141b-42db-992b-34b217330dd2">six months</ix:nonNumeric> written notice to the landlord. Further, the Company also leases vehicles under operating lease arrangements for certain of its personnel in Europe which expire at various times throughout 2021 to 2025. In August 2021, the Company signed a new lease for <ix:nonFraction unitRef="sqft" contextRef="i96d95d6a89cf4265bdd53a11781c3f3b_I20210831" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AreaOfRealEstateProperty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMzg0ODI5MDcwMTk4Nw_fe3e8a80-89b9-4419-af19-8b6675f6f1b4">19,534</ix:nonFraction> square feet of research and development and warehouse space in Santa Clara, California. The term of the new lease will commence on November 1, 2021 and will terminate on October 31, 2026, with an option to renew for <ix:nonFraction unitRef="renewal_option" contextRef="i96d95d6a89cf4265bdd53a11781c3f3b_I20210831" decimals="INF" format="ixt-sec:numwordsen" name="sibn:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMzg0ODI5MDcwMTk5NA_7343204f-8bb7-4be7-a364-f2f2997e87cd">one</ix:nonFraction> additional <ix:nonNumeric contextRef="i96d95d6a89cf4265bdd53a11781c3f3b_I20210831" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMzg0ODI5MDcwMjAyMQ_7e5c219a-4179-481e-abe2-f83ff859aaec">three year</ix:nonNumeric> term. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense is recorded over the lease terms on a straight-line basis. Rent expenses charged to operations under operating leases were $<ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMTA5OTUxMTYzMDg3MA_8043f6a5-d334-41f7-847f-84e835e9f88a">0.3</ix:nonFraction> million for the three months ended September 30, 2021 and 2020, and $<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-5" name="us-gaap:OperatingLeasesRentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMTA5OTUxMTYzMDgyNA_b70c75fe-367b-46eb-920a-4c96ef884b5f">0.9</ix:nonFraction> million for the nine months ended September 30, 2021 and 2020, respectively.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ic30390a3fd8d45a781e5465ab176789d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">           <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMjk1Ng_4de55f52-d585-4b9f-85cb-7eb2553c2db4" continuedAt="i2e18fa3eee7f4d948446e74ab1acf57b" escape="true">The table below summarizes aggregate future minimum lease payments under all leases as of September 30, 2021: </ix:nonNumeric></span></div><div><span><br/></span></div><div style="padding-left:72pt"><ix:continuation id="i2e18fa3eee7f4d948446e74ab1acf57b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.722%"><tr><td style="width:1.0%"></td><td style="width:81.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.231%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RhYmxlOjhiNDZkOWRjMTFlYTQ2Y2Q5MTJkYTIyNTNlNTQwNzRiL3RhYmxlcmFuZ2U6OGI0NmQ5ZGMxMWVhNDZjZDkxMmRhMjI1M2U1NDA3NGJfMS0xLTEtMS0x_4eaed362-79de-4381-8424-7b34b36ae357">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RhYmxlOjhiNDZkOWRjMTFlYTQ2Y2Q5MTJkYTIyNTNlNTQwNzRiL3RhYmxlcmFuZ2U6OGI0NmQ5ZGMxMWVhNDZjZDkxMmRhMjI1M2U1NDA3NGJfMi0xLTEtMS0x_99610a05-38e4-4b43-b3dd-f72b2d26c1ab">1,641</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RhYmxlOjhiNDZkOWRjMTFlYTQ2Y2Q5MTJkYTIyNTNlNTQwNzRiL3RhYmxlcmFuZ2U6OGI0NmQ5ZGMxMWVhNDZjZDkxMmRhMjI1M2U1NDA3NGJfMy0xLTEtMS0x_d2430c10-a3e4-460a-bf0a-87d12179400d">1,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RhYmxlOjhiNDZkOWRjMTFlYTQ2Y2Q5MTJkYTIyNTNlNTQwNzRiL3RhYmxlcmFuZ2U6OGI0NmQ5ZGMxMWVhNDZjZDkxMmRhMjI1M2U1NDA3NGJfNC0xLTEtMS0x_bba09c35-09e3-449d-90ae-89371eadc490">1,510</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RhYmxlOjhiNDZkOWRjMTFlYTQ2Y2Q5MTJkYTIyNTNlNTQwNzRiL3RhYmxlcmFuZ2U6OGI0NmQ5ZGMxMWVhNDZjZDkxMmRhMjI1M2U1NDA3NGJfNS0xLTEtMS0x_298534eb-76dd-445c-b1fb-e182ed183ddd">987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="sibn:OperatingLeasesFutureMinimumPaymentsDueAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RhYmxlOjhiNDZkOWRjMTFlYTQ2Y2Q5MTJkYTIyNTNlNTQwNzRiL3RhYmxlcmFuZ2U6OGI0NmQ5ZGMxMWVhNDZjZDkxMmRhMjI1M2U1NDA3NGJfNi0xLTEtMS0x_a9364966-7635-4ccf-a0e6-0cdf36e6376d">540</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RhYmxlOjhiNDZkOWRjMTFlYTQ2Y2Q5MTJkYTIyNTNlNTQwNzRiL3RhYmxlcmFuZ2U6OGI0NmQ5ZGMxMWVhNDZjZDkxMmRhMjI1M2U1NDA3NGJfNy0xLTEtMS0x_407a3e3e-64f5-45ca-9cc0-14439c3cc344">6,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments and Obligations</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has certain purchase commitments related to its inventory management and training materials with certain suppliers wherein the Company is required to provide forecasts and purchase certain amounts included in such forecasts. The contractual obligations represent future cash commitments and liabilities under agreements with third parties and exclude orders for goods and services entered into in the normal course of business that are not enforceable or legally binding. These outstanding commitments amounted to $<ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PurchaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMTYyNw_40a469aa-5a08-4117-9bdd-8e72a4d10d8d">1.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PurchaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMTYzNA_5f46cda9-b3d6-4e65-8e14-0d89ce9c0009">0.3</ix:nonFraction> million as of September 30, 2021 and December 31, 2020, respectively. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company&#8217;s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="usd" contextRef="ieccec3c1ede24d35a58527aa4850247b_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:LitigationSettlementExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMjc3OQ_ab71f70b-47a1-402a-867f-758a41ddc716">no</ix:nonFraction>t incurred costs to defend lawsuits or settle claims related to these indemnification agreements. <ix:nonFraction unitRef="usd" contextRef="i9791c5febf8a46f2885eb2f4b7f67d9e_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:LitigationReserve" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMjg3OQ_6f446a10-aba2-4938-93d4-08721a9e14ba">No</ix:nonFraction> liability associated with such indemnifications has been recorded to date.</span></div></ix:continuation><div id="ib00d06b2519f421eb73a3aa86da814ca_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQwNA_280c8171-8335-4b7e-a405-ed4d458107f2" continuedAt="i1b4f6369660c450b9dba663239465fe5" escape="true">Borrowings</ix:nonNumeric></span></div><ix:continuation id="i1b4f6369660c450b9dba663239465fe5" continuedAt="ice3a4916f5874e89889fea8c7416790d"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span></div><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTc5OA_b26a7bc4-56f8-4449-809b-4f588b79530d" escape="true"><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding borrowings from the term loan described below, as of the dates presented:</span></div><div style="margin-bottom:12pt;margin-top:9pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.583%"><tr><td style="width:1.0%"></td><td style="width:66.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.405%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal outstanding and final fee</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfMi0xLTEtMS0x_53643730-38c7-4846-b73c-6129493b2ad9">35,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfMi0zLTEtMS0x_b1c9bc4e-fe1f-4302-984e-fe203f4b5a88">41,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfMy0xLTEtMS0x_b97b2430-79cb-491e-b36e-d371f2cc0215">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfMy0zLTEtMS0x_56b22748-f8b6-4e82-85a0-5c212e802e35">661</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unaccreted value of final fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" name="us-gaap:DebtInstrumentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfNC0xLTEtMS0x_684c2e25-4c11-499e-bc24-de0668dd84f1">671</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" name="us-gaap:DebtInstrumentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfNC0zLTEtMS0x_6260a078-b3f6-4401-acec-6743b9566b26">884</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding debt, net of debt issuance costs and unaccreted value of final fee</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfNS0xLTEtMS0x_0bde597e-3486-47f9-b1c1-5d49f9086a63">34,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfNS0zLTEtMS0x_be9729c7-b20b-4986-8086-480ea84d47ac">39,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classified as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term borrowings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfOC0xLTEtMS0x_934d5cdf-654b-41a5-acb9-6077c09dfb38">34,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfOC0zLTEtMS0x_8cda8be9-3c36-4383-a9ab-660fd819f286">39,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2017, the Company entered into a term loan with Biopharma Credit Investments IV Sub LP (&#8220;Pharmakon&#8221;) in for total loan proceeds of $<ix:nonFraction unitRef="usd" contextRef="i0cb314875c314dbaa8fbacdb1b38b748_D20171001-20171031" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0Mzg4NA_b9cc9062-fea8-40e0-80f0-998b51a51719">40.0</ix:nonFraction>&#160;million (the &#8220;Pharmakon Term Loan&#8221;). The Pharmakon Term Loan included an interest-only period for <ix:nonNumeric contextRef="i0cb314875c314dbaa8fbacdb1b38b748_D20171001-20171031" format="ixt-sec:durmonth" name="sibn:DebtInstrumentPeriodicPaymentInterestOnlyPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0Mzk3OA_4aac58bd-795c-4b11-98d8-1ecbee0406a3">35</ix:nonNumeric> months through September 2020 and then equal quarterly principal payments plus interest through December 2022. The </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ice3a4916f5874e89889fea8c7416790d" continuedAt="i9853f8844ad04a4aaca25c7d22e0f138"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pharmakon Term Loan carried a fixed interest rate of <ix:nonFraction unitRef="number" contextRef="i76a103c32c444270af93260d49552321_I20171031" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NDE0Mw_866dea3a-0c66-4025-b3bf-f8151eb41a89">11.5</ix:nonFraction>% and allowed for early prepayment. The prepayment penalty fee was equal to the remaining interest due if prepaid within the first 30 months, a <ix:nonFraction unitRef="number" contextRef="i38122eef897040fe8f70c368cf10c531_I20171031" decimals="INF" name="sibn:DebtInstrumentPrepaymentPenaltyPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NDI4OQ_db9144fd-fb12-49b2-a14d-9a7d8ac999e6">2</ix:nonFraction>% penalty for months 31-48, and a <ix:nonFraction unitRef="number" contextRef="i61a838a9e8594bccb6b1be280637f067_I20171031" decimals="INF" name="sibn:DebtInstrumentPrepaymentPenaltyPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NDMyNQ_edca78d7-eec9-4ea5-893a-a4a9a885e04f">1</ix:nonFraction>% penalty for months 49-60. The Company paid in full and terminated the Pharmakon Term Loan in May 2020.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The outstanding debt as of December 31, 2020 is related to a term loan pursuant to the Loan and Security Agreement dated May 29, 2020, entered into by the Company with Solar Capital Partners (&#8220;Solar&#8221;). Pursuant to the Loan and Security Agreement, Solar provided an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="id10385b30b3442289883167a68f5b983_I20200529" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NjExOA_35adeeea-dd60-4353-8400-4340c49590ae">40.0</ix:nonFraction>&#160;million term loan (the &#8220;Solar Term Loan&#8221;). The total debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="id10385b30b3442289883167a68f5b983_I20200529" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NjE5MA_527493c6-61f2-4abe-b481-f9d43552ac15">0.8</ix:nonFraction>&#160;million associated with the Solar Term Loan were recorded in the condensed consolidated balance sheet as a direct deduction from the carrying amount of the loan, and are amortized as a component of interest expense using straight-line method over the life of the term loan.  In accordance with the Loan and Security Agreement with Solar, the Company paid in full and terminated the Pharmakon Term Loan, which was accounted for as debt extinguishment in accordance with the accounting standards. The Company recognized the unamortized debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="iba585a7740f44fc985da65b9dcbe6ac1_D20210101-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NjczMg_60bb0503-9e41-4ed9-abd9-b4ea6222f16a">0.7</ix:nonFraction>&#160;million and the prepayment penalty and lender fees of $<ix:nonFraction unitRef="usd" contextRef="iba585a7740f44fc985da65b9dcbe6ac1_D20210101-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0Njc4Mg_d64ab544-6c23-4077-86cf-854b15c2230b">0.8</ix:nonFraction>&#160;million related to Pharmakon Term Loan as a loss on debt extinguishment. The costs and fees are reflected as interest expense in the consolidated statement of operations for the year ended December 31, 2020. The Solar Term Loan bore interest at a rate per annum equal to <ix:nonFraction unitRef="number" contextRef="id10385b30b3442289883167a68f5b983_I20200529" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NzAzNw_ac54f51c-ff0b-491e-b74d-90a14e7916f7">9.40</ix:nonFraction>% plus London Interbank Offered Rate (&#8220;LIBOR&#8221;), payable monthly in arrears. LIBOR means the greater of (i) <ix:nonFraction unitRef="number" contextRef="ie50ee0dd6f3a424dbe678afcb26fe615_D20200529-20200529" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NzE0Ng_0eb9e959-d694-4c6d-b083-5b98a04ec49c">0.33</ix:nonFraction>% or (ii) one-month LIBOR (or a comparable replacement rate to be determined by the collateral agent if the LIBOR is no longer available), which rate shall reset monthly. The Solar Term Loan included an interest-only period of <ix:nonNumeric contextRef="i974cd92ce36a4cd597746c92af7a0c88_D20200529-20200529" format="ixt-sec:durmonth" name="sibn:DebtInstrumentPeriodicPaymentInterestOnlyPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NzQyMQ_c2c9b57a-62c6-42ff-9a6b-4297bfbc18c5">36</ix:nonNumeric> months through June 2023, and then repaid in equal monthly principal payments plus interest through  June 1, 2025. Pursuant to the Loan and Security Agreement with Solar, the Company could voluntarily prepay the Solar Term Loan, in full or in part, but only in increments of $<ix:nonFraction unitRef="usd" contextRef="id10385b30b3442289883167a68f5b983_I20200529" decimals="-5" format="ixt:num-dot-decimal" name="sibn:DebtInstrumentPrepaymentAllowableIncrementsPerAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NzY4MA_d198c2c8-6225-4ad7-948c-4534a68a4ed5">10.0</ix:nonFraction>&#160;million, for a prepayment premium in an amount equal to <ix:nonFraction unitRef="number" contextRef="id10385b30b3442289883167a68f5b983_I20200529" decimals="INF" name="sibn:DebtInstrumentPrepaymentPremiumYearOnePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NzczMg_3a845e7b-9ddb-4494-bf13-f9fa8e0c9e63">3.0</ix:nonFraction>% of the principal if prepaid in year one, <ix:nonFraction unitRef="number" contextRef="id10385b30b3442289883167a68f5b983_I20200529" decimals="INF" name="sibn:DebtInstrumentPrepaymentPremiumYearTwoPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0Nzc3Nw_4898d507-3dbe-4b1c-84ab-6642f6e9e7ff">1.25</ix:nonFraction>% of the principal if prepaid in year two, and <ix:nonFraction unitRef="number" contextRef="id10385b30b3442289883167a68f5b983_I20200529" decimals="INF" name="sibn:DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NzgyNg_127f13cd-deba-4bcd-b38c-c21ad4de5089">0.50</ix:nonFraction>% of the principal if prepaid in year three or later. The Solar Term Loan was secured by substantially all of the Company&#8217;s assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:line-through"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company was also obligated to pay a final fee equal to $<ix:nonFraction unitRef="usd" contextRef="id10385b30b3442289883167a68f5b983_I20200529" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0ODE0MQ_a6dd3940-b465-4c25-a507-8b3119679bcd">1.0</ix:nonFraction>&#160;million or <ix:nonFraction unitRef="number" contextRef="id10385b30b3442289883167a68f5b983_I20200529" decimals="INF" name="sibn:DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0ODE0OA_488b1e54-abeb-4d98-adc7-0bc1d0639b70">2.5</ix:nonFraction>% of the aggregate principal amount of the Solar Term Loan, which was fully earned by Solar on the effective date of the Loan and Security Agreement with Solar. With respect to the Solar Term Loan, this final fee shall be due and payable on the earliest of (i) the maturity date, (ii) the acceleration of the loan balance or (iii) its full prepayment, refinancing, substitution or replacement. The final fee was included within the long-term borrowings and was accreted to interest expense using straight-line method over the life of the term loan. The Company paid in full and terminated the Solar Term Loan in August 2021. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The outstanding debt as of September 30, 2021 is related to a term loan pursuant to the Loan and Security Agreement dated August 12, 2021 (the &#8220;Effective Date&#8221;), entered into by the Company with Silicon Valley Bank (&#8220;SVB&#8221;). Pursuant the agreement, SVB provided an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i33f72faa097e4cae973ab53d793b2746_I20210812" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjM3MQ_32ced9ed-cfb2-4e7e-b043-9d45672c95f0">35.0</ix:nonFraction>&#160;million to the Company (the &#8220;SVB Term Loan&#8221;). The Company used the proceeds of the SVB Term Loan to repay in full and terminate the Solar Term Loan, which was accounted for as debt extinguishment in accordance with the accounting standards. The Company recognized the unamortized debt issuance costs and unaccreted value of final fee of $<ix:nonFraction unitRef="usd" contextRef="ia2787e6887df4eadbb3510bc237985e9_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjM5MQ_5f9c699f-f05f-4128-881f-00f4f1d9fa72"><ix:nonFraction unitRef="usd" contextRef="i166abb90ea7347a7abf6019141e814f4_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjM5MQ_adcd6e88-cb64-4e4a-b881-739c230f6aca">1.3</ix:nonFraction></ix:nonFraction>&#160;million and the prepayment penalty and lender fees of $<ix:nonFraction unitRef="usd" contextRef="ia2787e6887df4eadbb3510bc237985e9_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQxMQ_a178f793-fc2f-4a84-95cc-b077bafbe670"><ix:nonFraction unitRef="usd" contextRef="i166abb90ea7347a7abf6019141e814f4_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQxMQ_ac090db8-0088-46b0-b513-5278f1ade607">0.5</ix:nonFraction></ix:nonFraction>&#160;million related to Solar Term Loan as a loss on debt extinguishment. The costs and fees are reflected as interest expense in the condensed consolidated statement of operations for the three and nine months ended September 30, 2021. The total debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i33f72faa097e4cae973ab53d793b2746_I20210812" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQzMA_212d79e9-1bfc-4482-8bcf-b96a9ac201b1">0.1</ix:nonFraction>&#160;million associated with the SVB Term Loan were recorded in the condensed consolidated balance sheet as a direct deduction from the carrying amount of the loan, and are amortized as a component of interest expense using straight-line method over the life of the term loan. The SVB Term Loan matures (the &#8220;Maturity Date&#8221;) on either (a) August 1, 2025 or (b) August 1, 2026 dependent on the Company&#8217;s achievement of a certain financial performance milestone as of December 31, 2022, as set forth in the Loan Agreement. Interest on the SVB Term Loan is payable monthly at an annual rate set at the greater of (a) <ix:nonFraction unitRef="number" contextRef="i33f72faa097e4cae973ab53d793b2746_I20210812" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQ0NA_d49faf60-d1c8-4a26-9046-908bdd1431f9">5.75</ix:nonFraction>% and (b) prime rate as published in the Wall Street Journal plus <ix:nonFraction unitRef="number" contextRef="i2011a05c7ea34cd28f12c592fe8857e3_D20210812-20210812" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQ1MQ_ab9b0bc2-9f32-49d9-b8f9-c0ffbd2a61a8">2.5</ix:nonFraction>%. Commencing on September 1, 2023, the Company will be required to make monthly principal amortization payments. The Company may elect to prepay the SVB Term Loan prior to the Maturity Date subject to a prepayment fee equal to <ix:nonFraction unitRef="number" contextRef="i9064792f4ac4436e8f82e1ce978a4834_I20210812" decimals="2" name="sibn:DebtInstrumentPrepaymentPenaltyPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQ1Nw_c2eefd0d-5103-4c9c-a2e1-4a36dd58f14e">1</ix:nonFraction>% if  the prepayment occurs prior to the second anniversary of the Effective Date and <ix:nonFraction unitRef="number" contextRef="i0a17d4dc3afb45438117bbf39fc37e29_I20210812" decimals="3" format="ixt:fixed-zero" name="sibn:DebtInstrumentPrepaymentPenaltyPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQ2MQ_f4a4a11f-ca48-49d0-a8b9-8cdff1c26f58">&#8212;</ix:nonFraction>% if the prepayment occurs on or at any time after the second anniversary of the Effective Date. The SVB Term Loan is secured by substantially all the Company's assets other than the Company's intellectual property. The Company is also obligated to pay a final payment equal to $<ix:nonFraction unitRef="usd" contextRef="i33f72faa097e4cae973ab53d793b2746_I20210812" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjM1MQ_329fdc39-8be9-499a-8a55-3b02eff9423e">0.7</ix:nonFraction>&#160;million or <ix:nonFraction unitRef="number" contextRef="i33f72faa097e4cae973ab53d793b2746_I20210812" decimals="INF" name="sibn:DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0MDIxNw_16bfad3c-3e85-42a7-9939-5211166150fa">2</ix:nonFraction>% of the aggregate principal amount of the SVB Term Loan, which is considered fully earned by SVB on the effective date of the Loan and Security Agreement with SVB. This final payment shall be due and payable on the earliest of (i) the maturity date, (ii) the full repayment of the loan, (iii) permitted prepayment and mandatory prepayment upon an acceleration as specified in the agreement or (iv) the termination of the agreement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The final payment is included within the long-term borrowings and is accreted to interest expense using straight-line method over the life of the term loan.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The effective interest rate related to the SVB Term Loan and Solar Term Loan (excluding the write-down of unamortized debt issuance costs and prepayment penalty related to the Solar Term Loan) was <ix:nonFraction unitRef="number" contextRef="i843aa4772ef6448490b75f692b0f1072_D20210101-20210930" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDUyNw_a28f4e3d-8f5d-47d7-8a6e-af1eb86583ef"><ix:nonFraction unitRef="number" contextRef="i166abb90ea7347a7abf6019141e814f4_D20210101-20210930" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDUyNw_e4ebd7b4-142c-47ef-88eb-1efee5a4c49c"><ix:nonFraction unitRef="number" contextRef="id34bef8ef9284847bf96f011100e54b4_D20210701-20210930" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDUyNw_ec398794-cd20-4232-9231-f819c64b4ac2"><ix:nonFraction unitRef="number" contextRef="ia2787e6887df4eadbb3510bc237985e9_D20210701-20210930" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDUyNw_ed94cabb-5ea9-4904-9b8b-2afd3be902ec">8.5</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% for both the three and nine months ended September 30, 2021. The effective interest rate related to the Solar Term Loan and Pharmakon Term Loan (excluding the write-down of unamortized debt issuance costs and prepayment penalty related to the Pharmakon Term Loan) was <ix:nonFraction unitRef="number" contextRef="i2fcc266ce2fc436cacae32e6275aaae0_D20200701-20200930" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDUwMg_265b246c-83b7-441b-a179-521064bade0d"><ix:nonFraction unitRef="number" contextRef="i16d63c9eb96e480599824e634ad5d531_D20200101-20200930" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDUwMg_a5d81fd1-c8bd-4076-8411-5f72985ed424">10.8</ix:nonFraction></ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i5b5a42a702a94c05bf97ad13f96a9b57_D20200101-20200930" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDQ5NQ_197f4351-9f88-4fac-b4a2-c0dbdc4ecc93"><ix:nonFraction unitRef="number" contextRef="i523c84bcfc6d4d41a3fcb3cba85341bb_D20200701-20200930" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDQ5NQ_b51d21f7-6605-4e81-bcfd-cdd20e089b53">11.6</ix:nonFraction></ix:nonFraction>% for the three and nine months ended September 30, 2020, respectively. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i9853f8844ad04a4aaca25c7d22e0f138"><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">         <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTgwMA_9d3a0669-350d-48d5-a818-e550e3a6dca3" continuedAt="i159db35eddd8423eb5caca988011eaed" escape="true">The table below summarizes the future principal and final fee payments under the SVB Term Loan as of September 30, 2021:</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:36pt"><ix:continuation id="i159db35eddd8423eb5caca988011eaed"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"><tr><td style="width:1.0%"></td><td style="width:84.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.888%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjQxMWU4OGI1YjAxOTRjNzNhNjdjNTg0ZTQ5MGVlM2EyL3RhYmxlcmFuZ2U6NDExZTg4YjViMDE5NGM3M2E2N2M1ODRlNDkwZWUzYTJfMS0xLTEtMS0x_c54c0eed-1cf3-46c0-95d1-1c36aea40ff5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjQxMWU4OGI1YjAxOTRjNzNhNjdjNTg0ZTQ5MGVlM2EyL3RhYmxlcmFuZ2U6NDExZTg4YjViMDE5NGM3M2E2N2M1ODRlNDkwZWUzYTJfMi0xLTEtMS0x_612e203d-4e64-4a95-b7e0-b21df5c9fbf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjQxMWU4OGI1YjAxOTRjNzNhNjdjNTg0ZTQ5MGVlM2EyL3RhYmxlcmFuZ2U6NDExZTg4YjViMDE5NGM3M2E2N2M1ODRlNDkwZWUzYTJfMy0xLTEtMS0x_45cc2943-fc0a-426e-a1a9-7e3ee5122f04">7,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjQxMWU4OGI1YjAxOTRjNzNhNjdjNTg0ZTQ5MGVlM2EyL3RhYmxlcmFuZ2U6NDExZTg4YjViMDE5NGM3M2E2N2M1ODRlNDkwZWUzYTJfNC0xLTEtMS0x_d5a08f14-45e1-4852-afda-31bed58ec47b">17,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjQxMWU4OGI1YjAxOTRjNzNhNjdjNTg0ZTQ5MGVlM2EyL3RhYmxlcmFuZ2U6NDExZTg4YjViMDE5NGM3M2E2N2M1ODRlNDkwZWUzYTJfNS0xLTEtMS0x_f7cf653c-14cf-46ad-a462-c268619f4018">10,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal and final fee payments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjQxMWU4OGI1YjAxOTRjNzNhNjdjNTg0ZTQ5MGVlM2EyL3RhYmxlcmFuZ2U6NDExZTg4YjViMDE5NGM3M2E2N2M1ODRlNDkwZWUzYTJfNy0xLTEtMS0x_db5b7218-e252-4a43-bc00-9424fd8f1835">35,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Loan Agreement includes affirmative and negative covenants applicable to the Company and certain of its foreign subsidiaries. The affirmative covenants include, among others, covenants requiring the Company to maintain its legal existence and governmental compliance, deliver certain financial reports, and maintain insurance coverage. The negative covenants include, among others, restrictions regarding transferring collateral, pledging the Company's intellectual property to other parties, engaging in mergers or acquisitions, paying dividends or making other distributions, incurring indebtedness, transacting with affiliates, and entering into certain investments, in each case subject to certain exceptions. As of September 30, 2021, the Company was in compliance with all debt covenants. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">CARES Act</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 27, 2020, the U.S. federal government enacted the &#8220;Coronavirus Aid, Relief and Economic Security (CARES) Act,&#8221; which, among other things, allowed employers to defer the deposit and payment of an employer's share of social security taxes through December 31, 2020. The Company recorded a total liability of $<ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="sibn:SocialSecurityTaxEmployerDeferralCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTU4NA_023d8034-eab1-4024-9aa3-7ee34bc9d8c6"><ix:nonFraction unitRef="usd" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="sibn:SocialSecurityTaxEmployerDeferralCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTU4NA_bda0c518-32e2-4cd8-9c4f-266d01280b57">1.0</ix:nonFraction></ix:nonFraction> million related to the deferral of the social security taxes of which $<ix:nonFraction unitRef="usd" contextRef="i803e769cd5f448a08a337153cbee48f7_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="sibn:SocialSecurityTaxEmployerDeferralCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTY0OQ_195f6b8a-b560-46c9-a601-73ba58b79a90"><ix:nonFraction unitRef="usd" contextRef="i95bf6c7ddfa44e2d8791432453dc5213_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="sibn:SocialSecurityTaxEmployerDeferralCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTY0OQ_69482178-d3a7-4e18-a341-d57a42ea145b"><ix:nonFraction unitRef="usd" contextRef="i124ee46b86c74090ae66a0e1d2bb09bc_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="sibn:SocialSecurityTaxEmployerDeferralCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTY0OQ_a02c893f-e2f6-4c6a-9e14-4f4411e29747"><ix:nonFraction unitRef="usd" contextRef="ibc837735671140f3b29b3df351abc460_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="sibn:SocialSecurityTaxEmployerDeferralCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTY0OQ_e84df552-062f-4433-b22b-d7dc614de007">0.5</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million is included in each accrued liabilities and other and other long-term liabilities in the condensed consolidated balance sheets as of September 30, 2021 and December 31, 2020.</span></div></ix:continuation><div id="ib00d06b2519f421eb73a3aa86da814ca_52"></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMzE5Ng_8a61b2e2-bc9e-4474-88bf-618d0aadcd81" continuedAt="i4b918a3747e64c5cb99cdf220c8ffa43" escape="true">Stock-Based Incentive Compensation Plans </ix:nonNumeric></span></div><ix:continuation id="i4b918a3747e64c5cb99cdf220c8ffa43" continuedAt="i4a952aeb6ca844268de17444d45c0d71"><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMzIwMg_f75fff88-2f6e-4a17-900c-0aeaf5e9a690" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the stock option activity for the nine months ended September 30, 2021:</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"><tr><td style="width:1.0%"></td><td style="width:62.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of <br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted- <br/>Average <br/>Exercise <br/>Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfMS0yLTEtMS0x_56eb8530-3cfb-4d6a-a10f-ced1ef81c425">2,405,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfMS00LTEtMS0x_f0c85f70-7330-46ff-b07f-70bd0de16427">8.54</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfMy0yLTEtMS0x_d15aca93-f163-4fa4-b807-691d75d61168">317,001</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfMy00LTEtMS0x_0b81fa89-aae0-45c8-b56b-afbb9f932bc9">7.34</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfNC0yLTEtMS0x_e5ba4d84-6850-461a-bf93-79a296cd219d">25,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfNC00LTEtMS0x_ca8b1d56-0add-434f-af28-5a02f65827d5">15.78</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfNS0yLTEtMS0x_c469ab37-d6fa-4145-b2e7-d631911d962b">2,063,739</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfNS00LTEtMS0x_271a1c7d-7340-4568-9a57-daa33ae886f1">10.00</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, the unrecognized compensation cost related to stock options was $<ix:nonFraction unitRef="usd" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjEw_f229f9e8-8c4a-4a53-b57c-8d460d76de12">1.7</ix:nonFraction> million, which is expected to be recognized over a period of approximately <ix:nonNumeric contextRef="i63d41e579cfd47938da6de7aa8a1649a_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjgw_d9a05f38-e699-4f8c-8903-4829b0a8097e">1.2</ix:nonNumeric> years.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i4a952aeb6ca844268de17444d45c0d71" continuedAt="i51a57d858b84475c91a91541f00ada4e"><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjk2_52e19e5c-5980-4c21-a72f-a30443c9e9b1"><ix:nonFraction unitRef="shares" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjk2_9b616c0f-4d6c-4357-b9bd-c7ec1cbaa193">no</ix:nonFraction></ix:nonFraction> stock options granted during the three months ended September 30, 2020 and nine months ended September 30, 2021. <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMzE5Nw_06e4b3b9-da26-41f5-9876-391a036dcd55" continuedAt="i5d274948696440619a0f11cc1ef832ea" escape="true">The table below summarizes the weighted average grant date fair value per share and the assumptions used to estimate the grant date fair value using the Black-Scholes option-pricing model of the stock options granted in the nine months ended September 30, 2020:</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify"><ix:continuation id="i5d274948696440619a0f11cc1ef832ea"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.416%"><tr><td style="width:1.0%"></td><td style="width:43.673%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.045%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.045%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value per share</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfMi0xMy0xLTEtMQ_e0e19d9f-22a9-4a3b-8a18-7067c218a928">8.37</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2386ac78016144aaa0d5030bad947246_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfMy0xMy0xLTEtMQ_19d4a87d-aeb1-41f7-9d1d-08b1a69a4944">5.5</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0544c913fcda445c9dc02da47fd8e3f3_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfMy0xNS0xLTEtMQ_d7d7f817-535c-438c-bb24-efb6ceb23f22">7.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55b87ead255e4fb486d98dd4fd6bc105_D20200101-20200930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfNC0xMy0xLTEtMQ_6c6c3f50-745e-4777-b31e-acc3bbe1cd3f">46.7</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55b87ead255e4fb486d98dd4fd6bc105_D20200101-20200930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfNC0xNS0xLTEtMQ_f238fdbe-9988-4e71-a0cc-0f6583c8b449">47.2</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55b87ead255e4fb486d98dd4fd6bc105_D20200101-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfNS0xMy0xLTEtMQ_0f82aa85-2e14-4dbc-a658-aeb29931a21c">1.56</ix:nonFraction>%</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55b87ead255e4fb486d98dd4fd6bc105_D20200101-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfNS0xNS0xLTEtMQ_057d9616-f32e-4fd6-a766-96fd89e1bfb4">1.64</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55b87ead255e4fb486d98dd4fd6bc105_D20200101-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfNi0xMy0xLTEtMQ_949f642b-8b73-4615-9c41-6fcc8fe06a48">&#8212;</ix:nonFraction>%</span></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Early Exercise of Unvested Stock Options</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Early exercises of stock options under the Company's 2008 Stock Option Plan are subject to a right of repurchase by the Company of any unvested shares. The repurchase rights lapse over the original vesting period of the options. The Company accounts for the cash received in consideration for the early exercised options as a liability included in accrued liabilities, which is then reclassified to stockholders&#8217; equity as the options vest. As of September 30, 2021, the Company had <ix:nonFraction unitRef="shares" contextRef="i9db2347a40b8493cbe05311630711796_I20210930" decimals="INF" format="ixt:fixed-zero" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMzg0ODI5MDcwMDc3OQ_7859704b-32e8-4278-b856-bca1a32180f8">no</ix:nonFraction> shares subject to repurchase. As of December 31, 2020, the Company had a total of <ix:nonFraction unitRef="shares" contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMTE2Ng_2071eb34-812d-4d64-8cbc-edd8167f3575">5,836</ix:nonFraction> shares of common stock subject to repurchase under the 2008 Stock Option Plan.</span></div><div style="margin-top:18pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMzE5OA_303f6b9e-6ec0-4db5-a34b-ec2b67551e47" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes restricted stock units activity for the nine months ended September 30, 2021:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.666%"><tr><td style="width:1.0%"></td><td style="width:60.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2557cc90be53464ba8c0545cd23e3d1e_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfMS0yLTEtMS0x_f78f9aa1-708a-4fc7-a23c-e7d647b8c6aa">1,165,295</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i2557cc90be53464ba8c0545cd23e3d1e_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfMS00LTEtMS0x_46b924b2-1b87-4f50-829c-421c0fffe97e">20.07</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfMi0yLTEtMS0x_c4109105-1202-4321-808f-68aedd236fbd">1,049,699</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfMi00LTEtMS0x_832dc463-ba6e-44a3-9199-4a38ca729b48">29.56</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfMy0yLTEtMS0x_05d592a4-686e-4976-98c7-efa9e421ffa3">445,913</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfMy00LTEtMS0x_e7b99f60-f338-4356-bee9-38deb12710b0">21.19</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfNC0yLTEtMS0x_ef965ccc-cbd5-4ab5-94d6-9fdbab5b1819">171,872</ix:nonFraction>)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfNC00LTEtMS0x_efa3a2f8-4a3d-4216-8589-849829b80b1f">24.84</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07d829ca6e82422aa5687003ba7c3973_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfNS0yLTEtMS0x_1961e7ff-6ecc-41d8-b270-01f1dcbf09f7">1,597,209</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i07d829ca6e82422aa5687003ba7c3973_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfNS00LTEtMS0x_e97ade85-2796-4e3b-aabb-56120f412fd0">25.48</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, the unrecognized compensation cost related to the restricted stock units was $<ix:nonFraction unitRef="usd" contextRef="i07d829ca6e82422aa5687003ba7c3973_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMTQ2MA_5cb0b3b2-454b-4d85-87dd-37a03d00336a">34.4</ix:nonFraction> million, which is expected to be recognized over a period of approximately <ix:nonNumeric contextRef="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMTUzMA_29dd6b88-fdb5-4eb3-a1f8-fa5397ff4a0f">2.9</ix:nonNumeric> years.</span></div><div style="margin-top:18pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2018 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) allows eligible employees to purchase shares of the Company's common stock through payroll deductions at the price equal to <ix:nonFraction unitRef="number" contextRef="i89018ddd42954af7a9c4116beb0b2c43_D20210101-20210930" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMTc0OA_e54c7bf9-822a-446c-aded-d6f1a3ab9140">85</ix:nonFraction>% of the lesser of the fair market value of the stock as of the first date or the ending date of each <ix:nonNumeric contextRef="i628c4f2ee72e4e8e876d8acc49956b8b_D20200101-20200430" format="ixt-sec:durwordsen" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMzg0ODI5MDcwMDg0Ng_7ba44a1e-6e47-4901-9d56-de532441b588">six month</ix:nonNumeric> offering period. The offering period generally commences in May and November. On March 26, 2020, the Company's Compensation Committee approved the amendment of the terms of future offerings under the ESPP which, among other things, increased the maximum number of shares that may be purchased on any single purchase date, provided for automatic enrollment in a new offering, and provided that the offering which commenced in May 2020 be <ix:nonNumeric contextRef="i93c681895e154204b4fbed253a591a2f_D20200501-20201231" format="ixt-sec:durwordsen" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjI5Nw_0f59c18d-905e-4a28-86a4-c89882637b23">twelve months</ix:nonNumeric> in duration and consist of <ix:nonFraction unitRef="purchase_period" contextRef="i93c681895e154204b4fbed253a591a2f_D20200501-20201231" decimals="INF" format="ixt-sec:numwordsen" name="sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjMyNw_62705785-78f7-4a40-835c-48797e02d73c">two</ix:nonFraction> purchase periods. The current offering period under the ESPP began on May 17, 2021 and the related purchase will occur on November 15, 2021.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i51a57d858b84475c91a91541f00ada4e"><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the ESPP shares is estimated using the Black-Scholes option pricing model, which is being amortized over the requisite service period. The Company issued <ix:nonFraction unitRef="shares" contextRef="i89018ddd42954af7a9c4116beb0b2c43_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjY0Mw_40801cf7-2174-4d03-8bff-3d8e857e682e">104,861</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="id87cc2d1c9b043f287619c8da2816e8a_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjY1Nw_6ee12162-5c58-4c41-8cdf-014855f117f3">74,685</ix:nonFraction> shares under the ESPP, representing approximately $<ix:nonFraction unitRef="usd" contextRef="i89018ddd42954af7a9c4116beb0b2c43_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjcxMA_3f0fb5f1-b18d-4f0e-99c9-ebf8534f41ea">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id87cc2d1c9b043f287619c8da2816e8a_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjcxNw_bcbdbe4c-3a4d-4047-9a07-4352762bb776">1.0</ix:nonFraction>&#160;million in employee contributions, for nine months ended September 30, 2021 and September 30, 2020, respectively. As of September 30, 2021 and December 31, 2020, total accumulated ESPP related employee payroll deductions amounted to $<ix:nonFraction unitRef="usd" contextRef="i6e7f9f8af7df41879076b4ffe0b5ee6e_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OtherEmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjg4MQ_68c60033-89c2-4f35-a894-ca1fd434fcc4">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i640640c163644c5ea76e4fa756cfc106_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OtherEmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjg4OA_8eab607a-a2db-4765-876b-16d18b038e0e">0.4</ix:nonFraction> million, respectively, which were included within accrued compensation and related expenses in the condensed consolidated balance sheets. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMzE5OQ_f20e33ca-2edb-48a8-8717-5282b35119f9" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the detail of stock-based compensation expense amounts included in the condensed consolidated statements of operations:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.083%"><tr><td style="width:1.0%"></td><td style="width:46.253%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib695fc1f6bb041edb51e55dea1b41799_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfMy0yLTEtMS0x_27fd6321-14d2-4783-b2f7-978d8434cd73">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91cd631ed91d4a67ac1fc657545f5f45_D20200701-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfMy00LTEtMS0x_c70cfc4a-5107-49e9-9eec-752f0ff9f911">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if87f81e2cc0d49b29ee4c705174cb8c5_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfMy02LTEtMS0x_11530e6b-7b21-4b09-8685-b250e7798a93">432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i960acef0c23e41da8c4a82a8f9881c4d_D20200101-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfMy04LTEtMS0x_16b53fd2-2380-40c1-b3ed-42b2fd06921f">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77ae5cbb20b6488383046b736d749e54_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNC0yLTEtMS0x_30b78c0c-925d-4d9e-a369-f5bed6319bc1">2,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i994609a27d9e4161b8ab111b4129abd7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNC00LTEtMS0x_b958ee5a-457f-4ad3-9a3c-835236c57c07">1,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb7dadad6be64748a0c1ae6be3e11291_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNC02LTEtMS0x_52ed6469-22e5-485b-a4f9-dc3fa2bcbbc3">6,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad191f36bb94c309b0048f07d23eca2_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNC04LTEtMS0x_674f8186-7d7b-4299-89ef-38ab6a9ddab6">3,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cf34fb005a349d0af6d06e2e451cc1e_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNS0yLTEtMS0x_f33b0669-4f98-4fa9-bb60-cab5c1ae86eb">434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8203731a1314feda1245f5c58a2e0b8_D20200701-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNS00LTEtMS0x_d9e631c8-c298-4f7d-9a6f-f6cd2d104feb">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf70a00d6a1245cda39d6c5734cbbedc_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNS02LTEtMS0x_1a9eb766-a2d3-4c5a-ae6a-0d7d2ab58395">1,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad6ad9876dc54b99b44b939e6c69da80_D20200101-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNS04LTEtMS0x_47761a5c-24fe-4a61-bd65-c4ea860d5d33">827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbcd4bb50a164a709140bf9796c663bc_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNi0yLTEtMS0x_50fd85a4-e8f2-4c81-bff6-2f98153b94d3">1,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fefa124b4804563b8e9ddcbdcb4d0b1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNi00LTEtMS0x_e8dd9c88-1386-46c1-a89e-ae241d06eafd">1,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdd8b69590ec442bb21d4bd6827a9b49_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNi02LTEtMS0x_c417347d-463c-4b05-abec-1a08668cc2b7">4,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i322ec7cf7cef4568a7a538070a8ff21e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNi04LTEtMS0x_1b448808-c6ce-46fe-9c0a-0d8c434ab3a4">3,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNy0yLTEtMS0x_80bcd2d5-d6e4-48a4-a0c4-5c4566a6a135">4,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNy00LTEtMS0x_16c6cac6-2b47-4dec-b05c-8fb86480589f">3,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNy02LTEtMS0x_5b74e05b-f0bd-4617-8cad-518741ba0299">12,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNy04LTEtMS0x_fe06febf-2bdf-4e19-83ae-60eaf55cd13d">8,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RleHRyZWdpb246NTdkOTUyZWRmMzEyNDM0ODkzNDVkYTRhMTE2M2Q1MjRfNjI3_04f3144b-a5ca-4093-824c-2e29a14ee2bd" continuedAt="ibcb96820115a4f08a4106f5258724dfd" escape="true">Net Loss Per Share of Common Stock</ix:nonNumeric></span></div><ix:continuation id="ibcb96820115a4f08a4106f5258724dfd" continuedAt="i00880e618df9454694425e2f0c6826c1"><ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RleHRyZWdpb246NTdkOTUyZWRmMzEyNDM0ODkzNDVkYTRhMTE2M2Q1MjRfNjI4_2f6d7df8-d0c5-45b6-b2cb-3bdfa0806259" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the computation of basic and diluted net loss per share:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfMy0xLTEtMS0x_ba164d8d-8ae7-442c-9b0c-bd524775d027">15,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfMy0zLTEtMS0x_e32f40cf-64d8-420d-9dcf-f4b22e5c49ff">9,474</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfMy01LTEtMS0x_6e8e93af-07c7-4c76-a312-ad70659f5bd5">42,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfMy03LTEtMS0x_b2fed48c-f526-4cd1-8095-77d264afe4a2">34,718</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used to compute basic and diluted net loss per share</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS0xLTEtMS0x_766cca22-3e06-43c0-8dd8-a05b396564aa"><ix:nonFraction unitRef="shares" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS0xLTEtMS0x_c69378d1-8288-43d6-aba1-db685e44964e">33,340,093</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS0zLTEtMS0x_8ec35982-3ad7-45be-9dd3-a4a3267e7b0a"><ix:nonFraction unitRef="shares" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS0zLTEtMS0x_9f7e37be-cb83-453d-be09-715e606bf7c3">28,713,418</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS01LTEtMS0x_6f48a73e-ee22-439d-92b0-003f47b8ad3b"><ix:nonFraction unitRef="shares" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS01LTEtMS0x_79efd023-4e46-46f5-abfd-c1bc0b0e948a">33,005,904</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS03LTEtMS0x_493d1fe0-e08b-4a75-bf60-d97a53db606a"><ix:nonFraction unitRef="shares" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS03LTEtMS0x_d9c740d7-40c8-4947-9518-409fac8e3724">28,155,561</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy0xLTEtMS0x_8c1fa5de-1411-4cae-b770-f2cc7e5f33e4"><ix:nonFraction unitRef="usdPerShare" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy0xLTEtMS0x_adb8f738-02bc-40e6-9d07-11414c83b370">0.48</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy0zLTEtMS0x_06d0e723-1635-4831-9083-799cb703c2ae"><ix:nonFraction unitRef="usdPerShare" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy0zLTEtMS0x_c3f1b00c-d983-4646-b9ca-2082b293c40c">0.33</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy01LTEtMS0x_1ae656a8-3cf5-475c-abe7-a8793f985c7e"><ix:nonFraction unitRef="usdPerShare" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy01LTEtMS0x_7c707a75-6c0d-4e7f-83fc-cdc8ed20e03c">1.28</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy03LTEtMS0x_33cac9dc-c743-45f8-a66c-330ae5d39bca"><ix:nonFraction unitRef="usdPerShare" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy03LTEtMS0x_c044c48e-21dd-400b-8ec5-043989a6fc9e">1.23</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the Company has reported a net loss in all periods presented, outstanding stock options, restricted stock units, shares subject to repurchase, ESPP purchase rights and common stock warrants are anti-dilutive and therefore diluted net loss per common share is the same as basic net loss per common share for the periods presented. <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RleHRyZWdpb246NTdkOTUyZWRmMzEyNDM0ODkzNDVkYTRhMTE2M2Q1MjRfNjI5_afc1ee33-6ecb-4595-9112-c5a9a950f5d6" continuedAt="i5392aa5ac0dc40a3a0f1dc1098a17869" escape="true">The following anti-dilutive common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented:</ix:nonNumeric></span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) </span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><ix:continuation id="i00880e618df9454694425e2f0c6826c1"><ix:continuation id="i5392aa5ac0dc40a3a0f1dc1098a17869"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">            </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0bf7856168a4bbc8d608e2a53cbc8dc_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMi0xLTEtMS0x_8e038bc0-885d-4a7b-9fa0-a96bf1deb780">2,063,739</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c468269d170486eb2b4e64a4513440d_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMi0zLTEtMS0x_6286ecf3-1a10-42e9-aced-c4a4f782839f">2,504,349</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i36d4c1a69b2b4a54b975f3d9b0099fc6_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMi01LTEtMS0x_e8dd5773-02c6-4b69-a6b6-d7a748a2c7ea">2,063,739</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia72aa66ef16743e19faa81de6f8529b0_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMi03LTEtMS0x_a71902a0-981b-403d-88d3-a12886ebcfa1">2,504,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibc3c26de486d43ca9dd20ec5d101e9dc_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMy0xLTEtMS0x_c676b9cc-dbf6-4733-8849-fe5adc35becb">1,597,209</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77acbbe553ec4a43a1af07135f846a82_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMy0zLTEtMS0x_8da0c34e-2792-4c81-a86b-ef825483da25">1,250,173</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b097d0adc3b46ba9ea4861ea981873d_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMy01LTEtMS0x_cd6606ab-af44-416f-b1a0-2d49fead882b">1,597,209</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9639632395d7474d8c63fe4431f760f8_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMy03LTEtMS0x_c0c320e1-7783-405c-bfa5-067e610c1a33">1,250,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares subject to repurchase</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d7cc7784aab4de0a474421d3860f6ac_D20210701-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNC0xLTEtMS0x_04d6767d-adf6-4f08-b515-aa0a9f7f687b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i270de781b3674556993d7df5c50f4257_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNC0zLTEtMS0x_fd355f7a-a675-46f4-a123-0fb3b1b73d15">7,784</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic2d646eaf6f3487b995e90e7b3f9638d_D20210101-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNC01LTEtMS0x_70a13f18-c89c-42ef-9d39-62734f397632">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i26c2606ec5ae4f489f0d680cc4f0ba15_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNC03LTEtMS0x_bdece395-0970-4307-bcf3-fa52ebebb136">7,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP purchase rights</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1310e619e2754e27ad6c1651d898e04e_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNS0xLTEtMS0x_a272e9f5-b1b7-4cab-b9a1-e475e71eef02">34,070</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i06fea0e7101e40dba2eb84ffe5da4f05_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNS0zLTEtMS0x_a90e5af9-ea71-45cd-869a-7dca02e8cb61">138,950</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7aed40f2b6841ce8093e0bbc418e41e_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNS01LTEtMS0x_93b64930-9544-4a30-ba78-6a747fcafde3">34,070</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iba3d79dab9b744f8a0b82ce2c0c46ba4_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNS03LTEtMS0x_c523e03d-75b9-463a-b71c-910ba68b0a85">138,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock warrants</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id8d65fa942e24ab2b39884d55f6a927d_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNi0xLTEtMS0x_e30c7682-b2c2-4178-8c24-d1121a1d0304">118,122</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7310fa50c10c46c8bbee63a8ff92f106_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNi0zLTEtMS0x_e8e084e3-4113-4550-bc3b-7c2ff9e5c0e8">118,122</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id66e6a0d9d334aeca662f79c0d8aab8b_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNi01LTEtMS0x_2c8d57c1-5619-4a99-9797-4a1bb63eb5e1">118,122</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifad8a990e145427785bb494543f4b493_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNi03LTEtMS0x_b2bb4ab9-d498-4cfb-8a19-bd762c231c0b">118,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNy0xLTEtMS0x_8958cb35-74ae-488e-b127-dd2047c66315">3,813,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNy0zLTEtMS0x_20ee0b60-8349-44c1-9f3a-1190e611f182">4,019,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNy01LTEtMS0x_e03f833d-1175-4b75-85b9-f444c035aa4c">3,813,140</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNy03LTEtMS0x_dc5c945b-0fe2-4289-a4a8-205459187908">4,019,378</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-top:6pt"><span><br/></span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMjQ2NA_2c819f15-3d77-4878-a5a9-1c2f96b77d25" continuedAt="ibadfd56a42c5449cbbe3de20f5e4a779" escape="true">Related Party Transaction </ix:nonNumeric></span></div><ix:continuation id="ibadfd56a42c5449cbbe3de20f5e4a779" continuedAt="i66e954c78de94d84b9d24fc090d10e54"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2020, the Company entered into a joint development agreement (the &#8220;Development Agreement&#8221;) with SeaSpine Orthopedics Corporation (&#8220;SeaSpine&#8221;) to develop a next generation device for sacropelvic fixation. Mr. Keith Valentine, who serves as the President, Chief Executive Officer and a member of the board of directors of SeaSpine, also serves as a member of the Company's Board of Directors since August 2015. On April 27, 2021, Addendum No.1 to the Development Agreement was entered into by and between the Company and SeaSpine to extend certain obligations as described under the Development Agreement to a consultant of the Company.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the development plan, SeaSpine shall use reasonable efforts to assist in the development of the potential product offering, including licensing certain existing intellectual property to be incorporated into such product. Under the terms of the&#160;Development Agreement, the Company agreed to make monthly payments to SeaSpine to reimburse for full time resources employed by SeaSpine responsible to conduct the development activities. For the three months ended September 30, 2021 and 2020, the Company expensed $<ix:nonFraction unitRef="usd" contextRef="i828e66a96b3b4c439de37f099c818aac_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMTA5OTUxMTYzMDI2MA_ae245e8c-1147-4a67-97ce-fb3f9a06ac63">5,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iaa0e01356bc64335a99cd3efce7ed726_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMTA5OTUxMTYzMDI0Ng_fb740c3d-78ac-4e6d-ad60-6b14619ff901">40,000</ix:nonFraction>, respectively, of the reimbursement charges from SeaSpine. For the nine months ended September 30, 2021 and 2020, the Company expensed $<ix:nonFraction unitRef="usd" contextRef="ia2a91817bfc9420fbad12b231fb60c11_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMTI4Ng_ebbb25da-3289-4726-b206-62073ca66370">29,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i196e2035a7634702ac62a3f024b8006f_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMTI5Mw_a4d00fd3-a887-4442-82b5-09a395005c60">86,000</ix:nonFraction>, respectively, of the reimbursement charges from SeaSpine. The reimbursement charges were recorded within research and development expense in the condensed consolidated statements of operations. There were <ix:nonFraction unitRef="usd" contextRef="ib8afc1805c1c46b7ab718de87f1939ab_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:DueToAffiliateCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMTUwMg_cb3b823c-9c70-4306-95bc-25bdd0c8b5a2"><ix:nonFraction unitRef="usd" contextRef="if6308366c8e94613b5653738e3f24c14_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:DueToAffiliateCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMTUwMg_f28cdef9-9369-4658-bc58-2d6f9399197c">no</ix:nonFraction></ix:nonFraction> outstanding liabilities to SeaSpine as of September 30, 2021 and December 31, 2020.</span></div></ix:continuation><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i66e954c78de94d84b9d24fc090d10e54">Certain intellectual property developed pursuant to the project plan will be owned by the Company, certain intellectual property developed pursuant to the project plan will be owned by SeaSpine, and other intellectual property developed pursuant to the project plan will be jointly owned by SeaSpine and the Company. The Company also agreed to provide SeaSpine a royalty-free, worldwide, perpetual, non-exclusive license of certain of the Company's intellectual property incorporated into the product to be developed. The Company also agreed to pay SeaSpine a product royalty, in an amount specified in the Development Agreement, for each resulting product sold for a period of <ix:nonNumeric contextRef="ia2a91817bfc9420fbad12b231fb60c11_D20210101-20210930" format="ixt-sec:duryear" name="sibn:RelatedPartyTransactionTermOfAgreement" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMjIzNg_97679650-0946-4976-a7c2-f086309e69dd">10</ix:nonNumeric> years beginning on the initial market launch. The term of the Development Agreement shall continue until the expiration of all royalty terms, unless earlier terminated by either party, as provided for by the Development Agreement.</ix:continuation> </span></div><div><span><br/></span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV82MS9mcmFnOmZjYTNmNjE3Mjg1ODQzMmRiZWRlYjRmYmRmMDcyNzc4L3RleHRyZWdpb246ZmNhM2Y2MTcyODU4NDMyZGJlZGViNGZiZGYwNzI3NzhfMTE0MA_f2f3c581-76a1-423c-9be3-a4a3d5187277" continuedAt="i2e7595e84a234549a3cda73a854aeb3c" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2e7595e84a234549a3cda73a854aeb3c" continuedAt="i224b2fe6b3a645b39fea974aeb2233a4">In determining quarterly provisions for income taxes, the Company uses the annual estimated effective tax rate applied to the actual year-to-date profit or loss, adjusted for discrete items arising in that quarter. The Company updates its estimate of its annual effective tax rate at the end of each quarterly period. The estimate takes into account annual forecasted income (loss) before income taxes, the geographic mix of income (loss) before income taxes and any significant permanent tax items. The Company did not have provision for income taxes for the three and nine months ended September 30, 2021 and 2020. The Company continues to maintain a full valuation allowance against its net deferred tax assets due to the uncertainty surrounding realization of such assets. </ix:continuation></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i224b2fe6b3a645b39fea974aeb2233a4">The Company accounts for the uncertainty in income taxes by utilizing a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of any uncertain tax positions that have been taken or are expected to be taken on an income tax return. There had been no changes in the estimated uncertain tax benefits recorded as of December 31, 2020.</ix:continuation> </span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_64"></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div><div><span><br/></span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_67"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the related notes to those statements included elsewhere in this Quarterly Report on Form 10-Q, and with the consolidated financial statements and management&#8217;s discussion and analysis of our financial condition and results of operations in our Annual Report on Form 10-K filed with the SEC on March&#160;10, 2021. Some of the information contained in this discussion and analysis, or set forth elsewhere in this Quarterly Report on Form 10-Q, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As a result of many important factors, including those set forth in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> section of this Quarterly Report on Form 10-Q, our actual results could differ materially from the results described in, or implied, by these forward-looking statements.</span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_70"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are a medical device company dedicated to solving musculoskeletal disorders of the scropelvic anatomy. We have pioneered a proprietary minimally invasive surgical implant system, which we call iFuse, to fuse the sacroiliac joint and treat sacroiliac joint dysfunction, which often causes severe lower back pain. Since we introduced iFuse in 2009, as of September 30, 2021, more than 60,000 procedures have been performed by over 2,500 surgeons in the U.S. and 36 other countries. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our iFuse Implant System includes a series of patented triangular titanium implants and the instruments we have developed to enable surgeons to perform the procedure. Surgeons place our implants across the sacroiliac joint, either from a lateral approach through the iliac bones into the sacrum, or from a posterior approach through the sacrum and into the iliac bones. Surgeons typically use three iFuse implants to fuse a sacroiliac joint in the lateral procedure, and one iFuse implant in each sacroiliac joint, typically alongside another device crossing the joint and joining to the spinal construct.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our iFuse implants have a triangular cross section that resists twisting or rotation of the implant within the bone in which it is implanted, regardless of the surgical approach and technique used to place the implants. The triangular shape of our implants helps stabilize the joint, and the implants&#8217; porous surface enables biologic fixation of the bone onto the implant, or bony ongrowth and ingrowth, that results in fusion. Each titanium iFuse implant has at least three times the strength of a typical eight-millimeter cannulated surgical screw. We hold issued patents on implants with cross-sections of many non-round shapes, including the triangular shape of the iFuse implant. We also hold issued patents for the method of placing those implants across the sacroiliac joint, as well as other parts of the spine and pelvis.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We introduced our second-generation implant, the iFuse-3D, in 2017. This patented titanium implant combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design.  This design also allows the surgeon to fill the implant with ground-up bone before implantation, which some surgeons believe accelerates bone through-growth and biological fixation. iFuse-3D implants have shown positive bony ingrowth, ongrowth and through-growth and in animal studies, whether or not ground-up bone is used. We hold issued patents on 3D-printed triangular implants with fenestrations, or holes, which allow bone to grow into and through the implants.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, we received clearance from the United States Food and Drug Administration, or FDA, to promote the use of our iFuse Implant System for fusion of the sacroiliac joint in conjunction with multi-level spinal fusion procedures to provide further stabilization and immobilization of the sacroiliac joint.  For this indication, surgeons typically use the posterior approach, through the sacrum and into the iliac bones, which we call the Bedrock technique. We received CE marking and began marketing our iFuse Implant System for this indication and surgical technique in Europe in December 2019. In March 2020, we received FDA 510(k) clearance for an expanded indication for the iFuse Implant System to support our trauma program.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2021, we received clearance from the FDA for iFuse-TORQ, a 3D-printed portfolio of threaded implants designed to meet the needs of pelvic trauma and minimally invasive sacroiliac joint fusion applications. In the pelvic trauma segment, we are targeting an unmet clinical needs for low energy pelvic ring fractures and chronic sacroiliac joint pain after high energy pelvic ring trauma. iFuse-TORQ also provides an opportunity for us to convert competitive screw business for minimally invasive sacroiliac joint fusions.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We market our products primarily with a direct sales force as well as a number of distributors in the U.S., and with a combination of a direct sales force and distributors in other countries. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2018, we completed our initial public offering (&#8220;IPO&#8221;) resulting in net proceeds of $113.4 million after deducting underwriting discounts and commissions and offering expenses. In January and February 2020, we received a total of $63.0 million of net proceeds, after deducting the underwriting discounts, commissions and offering costs, from our first follow-on public offering of our common stock. In October 2020, we received a total of $71.6 million of net proceeds from our second follow-on offering of our common stock. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_73"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of the COVID-19 Pandemic</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The global COVID-19 pandemic presents significant risks to us and has impacted, and continues to impact our business, operations, and financial results and condition, directly and indirectly, including, without limitation, impacts on the health of our management and employees; our manufacturing, distribution, marketing and sales operations; our research and development activities, including clinical activities; and customer and patient behaviors. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Access to many hospitals and other customer sites continues to be impacted by prevalence of COVID-19, which negatively impacts our ability to promote the use of our products with physicians. Additionally, many hospitals and ambulatory surgery centers have in the past suspended and may suspend or continue to suspend in the future, many elective procedures, resulting in a reduced volume of procedures using our products. Our customer behavior is impacted by the prevalence of COVID-19 and changes in the infection rates in the locations where our customers reside. Quarantines, shelter-in-place, elective procedure moratoria and similar government orders have also impacted, and may continue to impact, our third-party manufacturers and suppliers, and could in turn adversely impact the availability or cost of materials, which could disrupt our supply chain. Resurgence of the COVID-19 pandemic driven by the Delta variant negatively impacted our revenues for the three months ended September 30, 2021, as evidenced by increased case cancellations attributed to COVID-19 recorded in August 2021 and September 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We took a variety of steps to address the impact of the COVID-19 pandemic, while attempting to minimize business disruption. Essential staff in operations and limited support functions worked from our Santa Clara headquarters throughout the pandemic, following appropriate hygiene and social distancing protocols. To reduce risk to our employees and families from potential exposure to COVID-19, other staff in our Santa Clara headquarters worked from home. We also restricted non-essential travel to protect the health and safety of our employees and customers. Starting June 15, 2021, we began the return to work for many of our headquarter-based personnel based upon new guidelines from the State of California. We are continuing to monitor the impact of the COVID-19 pandemic on our employees and customers and on the markets in which we operate, and will take further actions that are considered prudent to address the COVID-19 pandemic, while ensuring that we can support our customers and continue to develop our products.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">While we have not experienced material disruptions to our supply chain to date, certain of our third-party suppliers have faced delays, product shortages and rising costs resulting from disruptions in the global supply chain, primarily related to our instruments. As a result, we are continuing to work closely with our manufacturing partners and suppliers, as well as determining alternative sourcing strategies to enable us to source key components and maintain appropriate inventory levels to meet customer demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The existence and further duration of the COVID-19 pandemic may also further exacerbate certain risks as described in &#8220;Item 1A - Risk Factors&#8221;. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We cannot currently predict with certainty the full extent to which the COVID-19 pandemic will impact demand for our products in the future, or the impact of the COVID-19 pandemic on our supply chain or other aspects of our business.  Accordingly, the COVID-19 pandemic could have a material adverse effect on our results of operations, financial condition and capital resources. </span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_76"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Factors Affecting Results of Operations and Key Performance Indicators</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor certain key performance indicators that we believe provide us and our investors indications of conditions that may affect results of our operations. Our revenue growth rate and commercial progress is impacted by, among other things, our key performance indicators, including our ability to leverage our sales force, increase surgeon activity and training, engage key opinion leaders, and leverage broad coverage. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leverage our sales force </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have made significant investments in our sales force since our initial public offering in 2018. We have built a valuable sales team, and we believe they are the key to the recovery that follows the pandemic. We limited new sales force hiring in the second and third quarter of 2020 due to uncertainty from the COVID-19 pandemic and focused on sales force productivity during this period, but resumed hiring of salespeople in the fourth quarter of 2020, expanded the sales team in the first nine months of 2021 and expect to further expand it in the remainder of 2021.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, our U.S. sales force consisted of 78 territory sales managers and 57 clinical support specialists directly employed by us and 53 third-party distributors, compared to 59 territory sales managers and 57 clinical support specialists directly employed by us and 39 third-party distributors as of September 30, 2020. As of September 30, 2021, our international sales force consisted of 20 sales representatives directly employed by us and 33 third-party distributors, compared to 20 sales representatives directly employed by us and 31 third-party distributors as of September 30, 2020. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increase surgeon activity and training</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our medical affairs team works closely with our sales team to increase surgeon activity and training. Surgeon activity includes both the number of surgeons performing iFuse procedures as well as the number of procedures performed per surgeon. As of September 30, 2021 and 2020, in the U.S., more than 1,700 surgeons and 1,500 surgeons, respectively, have been trained on our products and have treated at least one patient. Outside the U.S., as of September 30, 2021 and 2020, more than 700 surgeons and 600 surgeons, respectively, have been trained on iFuse and have treated at least one patient. We will continue to pursue the remainder of the approximately 7,500 target surgeons in the U.S., as well as international surgeons for training in the future. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 outbreak challenged our traditional method of hands-on cadaveric and dry-lab training. Therefore, in addition to utilizing a virtual education series for surgeons and mid-level practitioners for training activities, we began using the SI-BONE SImulator; a portable, radiation-free, haptics and computer-based simulator for training purposes. Starting in July 2020 we began deploying the SImulators to cover all US regions and European subsidiaries and had 24 SImulators in our offices and the field as of the date of this report.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Launch new products</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bedrock technique is used in the treatment of adult spinal deformity. We introduced this technique in June 2019 for use in the fusion of the sacroiliac joints in conjunction with a multi-segment spinal fusion, or long construct, procedure. The Bedrock technique utilizes our proprietary iFuse Implants, with one implant placed across each sacroiliac joint (for a total of two implants per case) using a posterior approach, through the sacrum, across the sacroiliac joint, and into the ilium. The Bedrock technique differs from our traditional iFuse procedure, whereby three iFuse Implants are placed across one sacroiliac joint via a lateral transarticular approach through the ilium and into the sacrum. The Bedrock technique is performed to increase stability at the base of a long construct. Biomechanical testing has shown that iFuse Implants placed in this position reduce sacroiliac joint motion by approximately 30% in conjunction with a long construct. We received CE mark clearance for the promotion of the Bedrock technique in Europe in November 2019 and we launched the promotion of this technique in select European markets in December 2019. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we received FDA clearance for our new trauma product, iFuse-TORQ, in the first quarter of 2021. iFuse-TORQ is a highly differentiated 3D-printed threaded implant for pelvic trauma and minimally invasive sacroiliac joint fusion applications. Relative to competitive trauma products, iFuse-TORQ is roughly 2 times stronger in bending and requires 10 times the rotational resistance, or torque, to insert due to its porosity and other design features. We believe that this rotational resistance gives surgeons confidence in the strength of mechanical fixation that iFuse-TORQ provides, and that the technological advancements incorporated into iFuse-TORQ represent a significant improvement compared to conventional trauma screws. Furthermore, iFuse-TORQ has a larger surface area for bone ingrowth than competitive trauma products and was specifically designed to allow for osteointegration. The addition of iFuse-TORQ to our product portfolio will allow us to serve a significant unmet need for patients with pelvic trauma, as well as sacroiliac joint dysfunction and degeneration.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engage key opinion leaders</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conduct training courses in several academic centers in the U.S. and engage key opinion leaders to support our development efforts. Interest in the Bedrock technique among deformity surgeons, including many key opinion leaders, has provided our sales representatives with access to important academic medical centers in the U.S. This enables our representatives to train a broader group of spine surgeons, including residents and fellows at these centers, on both the Bedrock technique and minimally invasive sacroiliac fusion. To date, we have trained residents and fellows in approximately 150 academic programs in the U.S., resulting in the training of approximately 800 surgical residents and fellows since August 1, 2018.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leverage broad coverage</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We made significant progress in the number of covered lives for minimally invasive sacroiliac fusion in the U.S.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As of September 30, 2021, substantially all U.S. payors reimburse for iFuse. As of September 30, 2021, over 35 U.S. payors have issued positive coverage policies exclusive to iFuse for sacroiliac joint fusion because of the clinical evidence.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective July 3, 2021, Centene established positive coverage for minimally invasive SI joint fusion. Centene is a major intermediary for both government-sponsored and privately insured health care programs and covers more than 25 million members.  Anthem adopted coverage guidelines that are exclusive to our iFuse triangular titanium implants for minimally invasive SI joint fusion which begin taking effect on July 30, 2021. Anthem is the second largest private payor in the U.S. with over 40 million members. Effective October 1, 2021, UnitedHealthcare has changed its minimally invasive SI joint fusion policy from covering all devices to covering exclusively our triangular iFuse Implants. UnitedHealthcare is the largest commercial payor in the U.S. with over 45 million members. With this updated policy, UnitedHealthcare joins more than 35 other health plans that collectively cover approximately 160 million insured, requiring the use of the iFuse Implant System for minimally invasive SI joint fusion. We believe that the full impact of each coverage decision grows over time as surgeons gain confidence that they will receive reimbursement for the majority of their diagnosed patients. With recent payor decisions, over 300 million people in the U.S. now have access to minimally invasive SI joint fusion, representing nearly universal coverage of the procedure.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_79"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Results of Operations</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate most of our revenue from sales of iFuse. Revenue from sales of iFuse fluctuate based on volume of cases (procedures performed), discounts, mix of international and U.S. sales, and the number of implants used for a particular patient. Similar to other orthopedic companies, our case volume can vary from quarter to quarter due to a variety of factors including reimbursement, sales force changes, physician activities, and seasonality.  In addition, our revenue is impacted by changes in average selling price as we respond to the competitive landscape and price differences at different medical facilities, such as hospitals and ambulatory surgical centers, or ASCs. Further, revenue results can differ based upon the mix of business between U.S. and international sales and mix of our products either delivered at the point of implantation at the hospital or other medical facilities or delivered through distributors or to hospitals where the products were ordered in advance of the procedure. Our revenue from international sales is impacted by fluctuations in foreign currency exchange rates between the U.S. dollar (our reporting currency) and the local currency.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Starting March 2020, the impact of COVID-19 pandemic on our revenue has varied by period and region based on various factors, including stage of containment, resurgence of variants, success of regional vaccination campaigns, and associated government and hospital actions around elective procedures. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Goods Sold, Gross Profit, and Gross Margin</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize third-party manufacturers for production of our implants and instrument sets. Cost of goods sold consists primarily of costs of the components of iFuse implants and instruments, instrument set depreciation, scrap and inventory obsolescence, as well as distribution-related expenses such as logistics and shipping costs. Our cost of goods sold has historically increased as case levels increase. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gross profit and gross margin are affected by factors impacting revenue and cost of goods sold. In addition, our gross margins are typically higher on products we sell directly as compared to products we sell through third-party distributors. As a result, changes in the mix of direct versus distributor sales can directly influence our gross margins. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses consist of sales and marketing, research and development, and general and administrative expenses. Personnel costs are the most significant component of operating expenses and consist of salaries, sales commissions and other cash and stock-based compensation related expenses. We anticipate operating expenses will continue to increase to support our growth.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, we took steps to reduce variable expenses that were ineffective and slowed down hiring due to the impact to our revenue from COVID-19. W</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e returned to more normalized spending levels in the fourth quarter of 2020. We continue to monitor the rapidly evolving situation, but as operations return to normal levels, we intend to make investments to execute our strategic plans and operational initiatives.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and Marketing Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses primarily consist of salaries, stock-based compensation expense, and other compensation related costs, for personnel employed in sales, marketing, medical affairs, reimbursement and professional education departments. In addition, our sales and marketing expenses include commissions and bonuses, generally based on a percentage of sales, as well as certain commission guarantees paid to our senior sales management, direct territory sales managers, clinical support specialists and third-party distributors. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses primarily consist of engineering, product development, clinical and regulatory expenses (including clinical study expenses), and consulting services, outside prototyping services, outside research activities, materials, depreciation, and other costs associated with development of our products. Research and development expenses also include related personnel compensation and stock-based compensation expense. We expense research and development costs as they are incurred. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for engineering projects fluctuate with project timing. Based upon our broader set of product development initiatives and the stage of the underlying projects, we expect to continue to make investments in research and development. As such, we anticipate that research and development expenses will continue to increase in the future. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses primarily consist of salaries, stock-based compensation expense, and other costs for finance, accounting, legal, insurance, compliance, and administrative matters. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income is primarily related to our investments of excess cash in money market funds and marketable securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense is primarily related to borrowings, amortization of debt issuance costs and accretion of final fees on our Solar Term Loan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net consists primarily of net foreign exchange gains and losses on foreign transactions.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_82"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage and operate as one reportable segment. The table below summarizes our results of operations for the periods presented (percentages are amounts as a percentage of revenue), which we derived from the accompanying condensed consolidated financial statements:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.416%"><tr><td style="width:1.0%"></td><td style="width:25.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.652%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.652%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.652%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.886%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.652%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except for percentages)</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Operations Data:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,478&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,053&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,627&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,808&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,288&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,778&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,033&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,007&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,470&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,608&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,312&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,199)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,675)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,739)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,696)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income (expense), net:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,658)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,102)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,797)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,016)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,872)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,474)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,095)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,718)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive the majority of our revenue from sales to customers in the U.S. Revenue by geography is based on billing address of the customer. No single country outside the U.S. accounts for more than 10% of the total revenue during the periods presented. The table below summarizes our revenue by geography:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.083%"><tr><td style="width:1.0%"></td><td style="width:25.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.485%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.196%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.485%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.196%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.485%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.196%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.485%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,449&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,531&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,286&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,373&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,922&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,243&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comparison of the Three Months Ended September 30, 2021 and September 30, 2020 </span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue, Cost of Goods Sold, Gross Profit, and Gross Margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.111%"><tr><td style="width:1.0%"></td><td style="width:41.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,478&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,808&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The increase in revenue for the three months ended September 30, 2021 as compared to the three months ended September 30, 2020 comprised a $1.5 million increase in our U.S. revenue and an increase of $0.4 million in our international revenue. The increase in revenue is due to the increase in domestic and international case volumes and increased active surgeons, partially offset by lower average selling prices in the U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We believe that revenues for the three months ended September 30, 2021 were impacted by the resurgence in the pandemic due to the Delta variant based upon recorded case deferrals, which impacted case volumes in August 2021 and September 2021. Conversely, we believe that revenue for the three months ended September 30, 2020 may have benefited from rescheduled case procedures from prior period deferrals due to COVID-19.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross Profit and Gross Margin.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Gross profit increased $2.0 million for the three months ended September 30, 2021 as compared to the three months ended September 30, 2020, mainly driven by higher revenue. The gross margin increased to 89% for the three months ended September 30, 2021 as compared to 87% for the three months ended September 30, 2020 primarily due to lower inventory write-downs.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.111%"><tr><td style="width:1.0%"></td><td style="width:41.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except for percentages)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,288&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,778&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></div></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,007&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,470&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,537&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and Marketing Expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in sales and marketing expenses for the three months ended September 30, 2021 as compared to the three months ended September 30, 2020 was primarily due to increases in employee related costs, commissions and stock-based compensation of $2.0 million driven by increased headcount and higher revenues, higher consulting fees of $0.5 million associated with more surgeon training programs and surgeon consulting fees. As COVID-19 pandemic restrictions eased, we also experienced higher levels of travel, marketing, training activities, facilities and other related costs resulting in an increase of $2.2 million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in research and development expenses for the three months ended September 30, 2021 compared to the three months ended September 30, 2020 was primarily due to an increase of $0.3 million in employee related costs and stock-based compensation driven by increased headcount and an increase of $0.2 million due to clinical study and research and development activities. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The increase in general and administrative expenses for the three months ended September 30, 2021 compared to the three months ended September 30, 2020 was primarily due to an increase of $0.8 million in employee related costs and stock-based compensation driven by increased headcount, and an increase of $0.7 million in consulting, accounting and audit fees associated with&#160;SOX&#160;compliance&#160;requirements, partially offset by a decrease of $0.2 million related to the allocation of facilities and other related costs.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:15pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest and Other Income (Expense), Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:42.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.886%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,658)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,102)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,556)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest and other expense, net</span></div></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,673)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(799)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,874)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The decrease in interest income for the three months ended September 30, 2021 as compared to the three months ended September 30, 2020 was mainly due to lower interest earned on our investments in marketable securities, primarily as a result of lower interest rates.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The increase in interest expense for the three months ended September 30, 2021 as compared to the three months ended September 30, 2020 was primarily due to the loss on extinguishment of the Solar Term Loan of $1.8 million in the current period, partly offset by lower interest associated with the SVB Term Loan compared to the Solar Term Loan.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income (Expense), Net. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net decreased for the three months ended September 30, 2021 compared to the three months ended September 30, 2020 due to foreign currency fluctuations.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comparison of the Nine Months Ended September 30, 2021 and September 30, 2020 </span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue, Cost of Goods Sold, Gross Profit, and Gross Margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except for percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,053&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,627&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in revenue for the nine months ended September 30, 2021 as compared to the nine months ended September 30, 2020 comprised an $11.9 million increase in our U.S. revenue and an increase of $1.7 million in our international revenue, mainly due to an increase in case volumes and the impact of the COVID-19 pandemic. In March and April 2020, we saw a substantial worldwide reduction in case volumes due to the deferral of elective surgeries, which we believe to a certain extent were rescheduled and completed in the third quarter of 2020. Although we saw cases cancelled in January and February 2021 due to COVID-19, March case volumes benefited from an increase in rescheduled cases from November 2020 to February 2021. Revenue for the third quarter of 2021 was impacted due to the resurgence in the pandemic due to the Delta variant. We attribute case growth to higher sales force productivity, higher numbers of sales personnel, and increased active surgeons due to improved U.S. reimbursement coverage.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross Profit and Gross Margin.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Gross profit increased $13.3 million for the nine months ended September 30, 2021 as compared to the nine months ended September 30, 2020, mainly driven by higher revenue. The gross margin increased to 89% for the nine months ended September 30, 2021 as compared to 87% for the nine months ended September 30, 2020 primarily due to certain period costs charged directly to cost of operations of $0.2 million in the second quarter of 2020 as our operations were running at suboptimal capacity due to the COVID-19 pandemic, as well as lower inventory write-downs in the second quarter of 2021.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;padding-left:24.75pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:24.75pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:24.75pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:24.75pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:24.75pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:24.75pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:12pt;padding-left:24.75pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.722%"><tr><td style="width:1.0%"></td><td style="width:40.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except for percentages)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,033&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,359&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></div></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,608&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,312&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,296&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and Marketing Expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in sales and marketing expenses for the nine months ended September 30, 2021 as compared to the nine months ended September 30, 2020 was primarily due to increases in employee related costs, commissions and stock-based compensation of $7.8 million driven by increased headcount and higher revenues, higher consulting fees of $0.9 million associated with more surgeon training programs and surgeon consulting fees. As COVID-19 pandemic restrictions eased, we also experienced higher levels of travel, marketing, training activities, facilities and other related costs resulting in an increase of $5.0 million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in research and development expenses for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020 was primarily due to an increase of $1.3 million in employee related costs and stock-based compensation driven by increased headcount and an increase of $1.1 million in research and development expenses primarily due to clinical study and research and development activities. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The increase in general and administrative expenses for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was prim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arily due to an increase of $3.2 million in employee related costs and stock-based compensation driven by increased headcount, and an increase of $1.3 million in consulting, accounting and audit fees associated with&#160;SOX&#160;compliance&#160;requirements, partially offset by the decrease of $0.2 million related to the allocation of facilities and other related costs.</span></div><div style="margin-bottom:12pt;margin-top:15pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest and Other Income (Expense), Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"></td><td style="width:41.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except for percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(868)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,797)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,016)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1260)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest and other expense, net</span></div></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,356)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,022)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The decrease in interest income for the nine months ended September 30, 2021 as compared to the nine months ended September 30, 2020 was mainly due to lower interest earned on our investments in marketable securities, primarily as a result of lower interest rates.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Interest Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The decrease in interest expense for the nine months ended September 30, 2021 as compared to the nine months ended September 30, 2020 of $0.2 million was primarily due to $0.5 million of lower interest associated with the SVB Term Loan and Solar Term Loan in the first nine months of 2021 compared to the Pharmakon and Solar Term Loans in the first nine months of 2020, offset in part by the loss on extinguishment of the Solar Term Loan of $1.8 million in the current period compared to the loss on extinguishment of the Pharmakon Term Loan of $1.5 million in the third quarter of 2020.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income (Expense), Net. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net increased for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020 due to foreign currency fluctuations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:14pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_85"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, we had cash and marketable securities of $160.9 million compared to $196.4 million as of December 31, 2020. We have financed our operations through our public offerings, debt financing arrangements, and the sale of our products. As of September 30, 2021 and December 31, 2020, we had $34.9 million and $39.5 million, respectively,&#160;in outstanding debt.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, we had an accumulated deficit of $281.4 million. During the nine months ended September 30, 2021, we incurred a net loss of $42.1 million. During the years ended December 31, 2020 and 2019, we incurred a net loss of $43.7 million and $38.4 million, respectively, and expect to incur additional losses in the future. We have not achieved positive cash flow from operations to date.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon our current operating plan, we believe that our existing cash and marketable securities will enable us to fund our operating expenses and capital expenditure requirements through at least the next 12 months. However, the economic impact of the duration and severity of the COVID-19 pandemic, and our responses thereto (including such actions we have taken or may take in the future as disclosed elsewhere in this Report) pose risks and uncertainties in our future available capital resources. Further, we may face challenges and uncertainties and, as a result, need to raise additional capital as our available capital resources may be consumed more rapidly than currently expected due to, but not limited to, the following as a result of the COVID-19 pandemic or otherwise: (a)&#160;decreases in sales of our products and the uncertainty of future revenues from new products; (b)&#160;changes we may make to the business that affect ongoing operating expenses; (c)&#160;changes we may make in our business strategy; (d)&#160;regulatory developments affecting our existing products; (e)&#160;changes we may make in our research and development spending plans; and (f)&#160;other items affecting our forecasted level of expenditures and use of cash resources. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding debt as of September 30, 2021 is related to a term loan pursuant to the Loan and Security Agreement dated</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">August 12, 2021, entered into by us with Silicon Valley Bank (&#8220;SVB&#8221;). Pursuant the Loan and Security Agreement with SVB, SVB provided a term loan with an aggregate principal amount of $35.0 million to us. Prior to Loan and Security Agreement with SVB, our outstanding debt was related to a $40.0 million term loan (the &#8220;Solar Term Loan&#8221;) with Solar Capital Partners (&#8220;Solar&#8221;) entered into in May 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with the Loan and Security Agreement with SVB, we paid in full and terminated the Loan and Security Agreement with Solar, which we accounted for as debt extinguishment in accordance with the accounting standards. As of September 30, 2021 and December 31, 2020, there was no amount available that could be borrowed under the applicable credit facility. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Solar Term Loan bore interest at a rate per annum equal to 9.40% plus London Interbank Offered Rate (&#8220;LIBOR&#8221;), payable monthly in arrears. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the Loan and Security Agreement with Solar, we could voluntarily prepay the Solar Term Loan, in full or in part for a prepayment premium in an amount equal to 3.0% of the principal if prepaid in year one, 1.25% of the principal if prepaid in year two, and 0.50% of the principal if prepaid in year three or later. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We were also obligated to pay a final fee equal to $1.0 million or 2.5% of the aggregate principal amount of the Solar Term Loan, which was fully earned by Solar on the effective date of the Loan and Security Agreement with Solar. We paid in full and terminated the Solar Term Loan in August 2021, upon which date the final fee was due and payable. The final fee was included within the long-term borrowings and was accreted to interest expense using straight-line method over the life of the term loan.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The SVB Term Loan matures (the &#8220;Maturity Date&#8221;) on either (a) August 1, 2025 or (b) August 1, 2026 dependent on our achievement of a certain financial performance milestone as of December 31, 2022, as set forth in the Loan Agreement. Interest on the SVB Term Loan will be payable monthly at an annual rate set at the greater of (a) 5.75% and (b) prime rate as published in the Wall Street Journal plus 2.5%. Commencing on September 1, 2023, we will be required to make monthly principal amortization payments. We may elect to prepay the SVB Term Loan prior to the Maturity Date subject to a prepayment fee equal to 1% if the prepayment occurs prior to the second anniversary of the Effective Date and 0% if the prepayment occurs on or at any time after the second anniversary of the Effective Date. The SVB Term Loan is secured by substantially all our assets other than our intellectual property. We are also obligated to pay a final payment equal to $0.7 million or 2% of the aggregate principal amount of the SVB Term Loan, which was fully earned by SVB on the effective date of the Loan and Security Agreement with SVB. With respect to the SVB Term Loan, this final payment shall be due and payable on the earliest of (i) the maturity date, (ii) the full repayment of the loan, (iii) permitted prepayment and mandatory prepayment upon an acceleration as specified in the agreement or (iv) the termination of the agreement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The final payment was included within the long-term borrowings and is accreted to interest expense using straight-line method over the life of the term loan.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Loan Agreement includes affirmative and negative covenants applicable to us and certain of our foreign subsidiaries. The affirmative covenants include, among others, covenants requiring us to maintain our legal existence and governmental compliance, deliver certain financial reports, and maintain insurance coverage. The negative covenants include, among others, restrictions regarding transferring collateral, pledging our intellectual property to other parties, engaging in mergers or acquisitions, paying dividends or making other distributions, incurring indebtedness, transacting with affiliates, and entering into certain investments, in each case subject to certain exceptions.  As of September 30, 2021, we were in compliance with all debt covenants. Though there are uncertainties surrounding the impact of the COVID-19 pandemic that may impact our future revenue, we believe that we have sufficient cash and cash equivalents to meet the minimum liquidity requirements in the foreseeable succeeding periods. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contractual Obligations</span></div><div style="padding-left:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contractual obligations as of September 30, 2021:</span></div><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.972%"><tr><td style="width:1.0%"></td><td style="width:39.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.813%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.813%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.759%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payments Due By Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1 year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1-3 years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4-5 years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">More than 5 years</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal obligations and final fee on long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,778&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,502&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,251&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:24.305%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents the principal obligations and the final fee at maturities of our SVB Term Loan.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents the future interest obligations on our SVB Term Loan estimated using an interest rate of 5.75% as of September 30, 2021.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This compared to $59.2&#160;million of contractual obligations as of December 31, 2020 .</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the primary sources and uses of cash for each of the periods presented below:  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.222%"><tr><td style="width:1.0%"></td><td style="width:54.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.607%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by (used in):</span></div></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,819)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,780)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,039)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,903&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,089)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of exchange rate changes on cash and cash equivalents</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(375)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,561&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,279)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Used in Operating Activities  </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities for the nine months ended September 30, 2021 of $26.8 million resulted from cash outflows due to a net loss of $42.1 million, adjusted for $17.4 million of non-cash items, and cash outflows from net changes in operating assets and liabilities of $2.1 million. Net cash used in operating activities for the nine months ended September 30, 2020 of $22.8 million resulted from cash outflows due to a net loss of $34.7 million, adjusted for $11.7 million of non-cash items, partially offset by cash inflows from changes in operating assets and liabilities of $0.2 million. The increase in net loss, net of non-cash items for the nine months ended September 30, 2021 compared to the nine months ended September 30, 2020 was mainly due to higher operating expenses from the growth of the business. Net cash outflows from changes in operating assets and liabilities for the nine months ended September 30, 2021 were primarily due to higher inventory due to the timing of inventory build-up related to our iFuse-TORQ implants, and timing of vendor payments, partly offset primarily by timing of collections of accounts receivable. Cash inflows from changes in operating assets and liabilities for the nine months ended September 30, 2020 were primarily due to timing of prepayments of certain expenses, lower accounts receivable due to the timing of collections and lower inventory due to the timing of inventory build-up, partly offset by cash outflows due to decreases in operating liabilities due to timing of payments.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Provided by Investing Activities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities in the nine months ended September 30, 2021 was $36.2 million compared to $4.9 million in the nine months ended September 30, 2020. Net cash provided by investing activities for the nine months ended September 30, 2021 consisted of maturities of our marketable securities, net of purchases of $40.8 million, partially offset by purchases of property and equipment of $4.6 million primarily related to individual components in instrument sets as we anticipate increased case volumes, as well as capitalized costs related to the new lease in Santa Clara. Net cash provided by investing activities for the nine months ended September 30, 2020 consisted of maturities and sales of our marketable securities, net of purchases of $6.6 million, partially offset by purchases of property and equipment of $1.7 million.</span></div><div style="margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Provided by Financing Activities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in financing activities in the nine months ended September 30, 2021 of $2.7 million includes the paydown of our debt by $5.0 million and other payments of associated with refinancing of our debt of $6.6 million, partially offset by proceeds from the issuance of common stock under our stock-based incentive compensation plans of $3.9 million. This compares to the cash provided by financing activities for the nine months ended September 30, 2020 of $63.4 million which consisted of proceeds, net of underwriting discounts, commissions and offering costs of $63.0 million from our follow-on public offering during the first quarter of 2020 and proceeds from the issuance of common stock under our stock-based incentive compensation plans of $2.0 million, partially offset by payments associated with refinancing of our debt of $1.6 million.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_88"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies, Significant Judgments, and Use of Estimates</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported revenue generated, and expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our critical accounting policies and estimates are described in &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies and Estimates&#8221; in our Annual Report on Form 10-K filed with the SEC on March&#160;10, 2021. There had been no material changes to these accounting policies. See Note 2 of Notes to Condensed Consolidated Financial Statements (Unaudited) for related discussions on updates on recently issued accounting pronouncements. </span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_100"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no off-balance sheet arrangements that have, or are reasonably likely to have, a current or future effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources that is material to investors.</span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_103"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is affected by seasonal variations. For instance, we have historically experienced lower sales in the summer months and higher sales in the last quarter of the fiscal year. However, taken as a whole, seasonality does not have a material impact on our financial results.</span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_106"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">JOBS Act Accounting Election</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In April 2012, the JOBS Act was enacted. Section&#160;107(b) of the JOBS Act provides that an &#8220;emerging growth company&#8221; can take advantage of the extended transition period provided in Section&#160;7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. Thus, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this exemption and, therefore, are not be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. Beginning in 2022 we will no longer be an emerging growth company and therefore will no longer be able to avail ourselves of this exemption. </span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_109"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2 of Notes to Condensed Consolidated Financial Statements (Unaudited) for related discussions on updates  on recently issued accounting pronouncements not yet effective.</span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_112"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a &#8220;smaller reporting company,&#8221; we are not required to provide the information otherwise required by this Item.</span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_115"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit pursuant to the Securities and Exchange Act of 1934 is (i) recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of any system of internal control over financial reporting, including ours, is subject to inherent limitations, including the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate misconduct completely. Accordingly, any system of internal control over financial reporting, including ours, no matter how well designed and operated, can only provide reasonable, not absolute assurances. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business but cannot assure you that such improvements will be sufficient to provide us with effective internal control over financial reporting.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, our management, with the participation of our Chief Executive Officer (&#8220;CEO&#8221;) and our Chief Financial Officer (&#8220;CFO&#8221;), have evaluated our disclosure controls and procedures (as defined in Rules&#160;13a&#8209;15(e)&#160;and 15d&#8209;15(e)&#160;under the Securities Exchange Act of 1934). Based on that evaluation, our CEO and our CFO have concluded that, as of September 30, 2021, our disclosure controls and procedures were effective at the reasonable assurance level. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in internal control over financial reporting</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the quarter ended September 30, 2021, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. In response to the COVID-19 pandemic, certain of our employees still continued to work remotely during the quarter. Management took measures to ensure that our internal control over financial reporting remained unchanged during this period.</span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_118"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_121"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in various claims, complaints, investigations and legal actions that arise from time to time in the normal course of business, including commercial and employment matters. There are no matters pending that we currently believe are material. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:27pt"><span><br/></span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_124"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 1A. Risk Factors</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Investing in our common stock involves a high degree of risk. Investors should carefully consider the risks described below, as well as the other information in this Quarterly Report on Form 10-Q, including our condensed consolidated financial statements and the related notes and the section &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; before deciding whether to invest in our common stock. The occurrence of any of the events or developments described below could materially and adversely affect our business, financial condition, results of operations, and growth prospects. In such an event, the market price of our common stock could decline, and our stockholders may lose all or part of their investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business operations.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risk Factor Summary</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:14.5pt">We have incurred significant operating losses since inception, we expect to continue to incur operating losses in the future, and we may not be able to achieve or sustain future profitability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:14.5pt">Epidemic diseases, or the perception of their effects, may have (or, in the case of the COVID-19 pandemic, will continue to have during its duration) an adverse effect on our business, financial condition, results of operations, or cash flows;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:14.5pt">Prolonged inflation and supply chain disruptions could result in delayed product launches, lost revenue, higher costs and decreased profit margins;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:14.5pt">If hospitals, surgeons, and other healthcare providers are unable to obtain and maintain adequate or any coverage and reimbursement from third-party payors for procedures performed using our products, adoption of our products may be delayed,  it is unlikely that they will gain further acceptance, and the prices paid for our implants may decline</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.8pt">If healthcare payors reverse decisions to cover minimally invasive sacroiliac joint fusion exclusively when performed with iFuse and choose to reimburse for procedures performed with competitive products, our market share could decline, adversely affecting our revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:14.5pt">We may not be able to convince physicians that iFuse is an attractive alternative to our competitors&#8217; products and that our procedure is an attractive alternative to existing surgical and non-surgical treatments of the sacroiliac joint</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:14.5pt">Surgeons and payors may not find our clinical evidence to be compelling, which could limit our sales and revenue, and on-going and future research may prove our products to be less safe and effective than currently thought</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:13.8pt">Pricing pressure from our competitors, changes in third-party coverage and reimbursement, healthcare provider consolidation, payor consolidation and the presence of &#8220;physician-owned distributorships&#8221; may impact our ability to sell our product at prices necessary to support our current business strategies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:13.8pt">Practice trends or other factors, including the COVID-19 pandemic, may cause procedures to shift from the hospital environment to ambulatory surgical centers, or ASCs, where pressure on the prices of our products is generally more acute</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:14.5pt">We operate in a very competitive business environment and if we are unable to compete successfully against our existing or potential competitors, our sales and operating results may be adversely affected</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:13.8pt">We are highly dependent on revenue from the sale of a single family of products focused on procedures, the goal of which is to stabilize and fuse the sacroiliac joint. Reliance on a single family of products and single family of procedures could negatively affect our results of operations and financial condition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:13.8pt">If clinical experience with our iFuse Bedrock technique does not result in positive outcomes for patients, or if clinical trials involving the use of iFuse Bedrock fail to show meaningful patient benefit, sales of our iFuse implants could be adversely impacted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:14.5pt">If we are unable to maintain our network of direct sales representatives and third-party distributors, we may not be able to generate anticipated sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:14.5pt">We are dependent on a limited number of third-party suppliers, some of them single-source and some of them in single locations, for most of our products and components, and the loss of any of these suppliers, or their inability to provide us with an adequate supply of materials in a timely and cost-effective manner, could materially adversely affect our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:14.5pt">We, our suppliers, and our third-party manufacturers are subject to extensive governmental regulation both in the U.S. and abroad, and failure to comply with applicable requirements could cause our business to suffer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:13.8pt">We and our sales representatives must comply with U.S. federal and state fraud and abuse laws, including those relating to healthcare provider kickbacks and false claims for reimbursement, and other applicable federal and state healthcare laws, as well as equivalent foreign laws, and failure to comply could negatively affect our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;padding-left:14.5pt">If we or our licensors fail to adequately protect or enforce our intellectual property rights or secure rights to patents of others, the value of our intellectual property rights would diminish and our ability to successfully commercialize our products may be impaired</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Our Business and Our Industry</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We have incurred significant operating losses since inception, we expect to continue to incur operating losses in the future, and we may not be able to achieve or sustain future profitability.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have incurred net losses since our inception in 2008. For the nine months ended September 30, 2021, we had a net loss of $42.1 million. For the years ended December 31, 2020 and 2019, we had net losses of $43.7 million and $38.4 million, respectively. As of September 30, 2021, we had an accumulated deficit of $281.4 million. We have financed our operations primarily through the net proceeds of our public offerings of our common stock, private placements of equity securities, certain debt-related financing arrangements, and from sales of our products. We have devoted substantially all of our resources to research and development of our products, sales and marketing activities, investments in training and educating surgeons and other healthcare providers, and clinical and regulatory matters for our products. There can be no assurances that we will be able to generate sufficient revenue from our existing products or from any of our product candidates in development, and to transition to profitability and generate consistent positive cash flows, and even if we are able to do so, our ability to do so has been delayed by the COVID-19 pandemic. We expect that our operating expenses will continue to increase as we continue to build our commercial infrastructure, develop, enhance, and commercialize our existing and new products. As a result, we expect to continue to incur operating losses for the foreseeable future and may never achieve profitability. Furthermore, even if we do achieve profitability, we may not be able to sustain or increase profitability on an ongoing basis. If we do not achieve profitability, it will be more difficult for us to finance our business and accomplish our strategic objectives.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our expected future capital requirements may depend on many factors including expanding our surgeon base, the expansion of our sales force, and the timing and extent of spending on the development of our technology to increase our product offerings. We may need additional funding for our operations, but additional funds may not be available to us on acceptable terms on a timely basis, if at all. We may seek funds through borrowings or through additional rounds of financing, including private or public equity or debt offerings. If we raise additional funds by issuing equity securities, our stockholders may experience dilution. Any future debt financing into which we enter may impose upon us additional covenants that restrict our operations, including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our common stock, make certain investments, and engage in certain merger, consolidation or asset sale transactions. Any future debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders. Furthermore, we cannot be certain that additional funding will be available on acceptable terms, if at all. If we are unable to raise additional capital or generate sufficient cash from operations to adequately fund our operations, we will need to curtail planned activities to reduce costs, which will likely harm our ability to execute on our business plan and continue operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Epidemic diseases, or the perception of their effects, may have (or, in the case of the COVID-19 pandemic, will continue to have during its duration) an adverse effect on our business, financial condition, results of operations, or cash flows.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outbreaks of infectious diseases, such as COVID-19, and historically, the Ebola virus, Middle East Respiratory Syndrome, Severe Acute Respiratory Syndrome, or the H1N1 influenza virus, could divert medical resources and priorities towards the treatment of that disease. An outbreak of an infectious disease, or continued escalation of the outbreak of COVID-19 could also negatively affect hospital admission rates and the decision by patients to undergo elective surgery, which could decrease demand for procedures using our implants and cause other disruptions to our business. Business disruptions could include disruptions or restrictions on our ability to travel or to distribute our products, government orders suspending the performance of elective surgical procedures, inability of our customers to meet their financial commitments due to strain on the healthcare system, as well as temporary closures of our facilities or the facilities of our suppliers and their contract manufacturers, and a reduction in the business hours of hospitals and ambulatory surgery centers. Any disruption of our suppliers and their contract manufacturers or our customers would likely impact our sales and operating results. In addition, a significant outbreak of an infectious disease in the human population could result in a widespread health crisis that could adversely affect the economies and financial markets of many countries, resulting in an economic downturn that could affect demand for our products. Any of these events could negatively impact the number of procedures using our implants that are performed and have a material adverse effect on our business, financial condition, results of operations, or cash flows.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To date, COVID-19 has had, and we expect will continue to have, an adverse impact on our operations as a result of preventive and precautionary measures that we, other businesses, health systems and governments are taking. Due to these measures, we have experienced and expect to continue to experience significant and unpredictable reductions in the demand for our products, negative impact on hospital admission rates and delay in the decision by patients to undergo elective surgery, each of which has decreased and may continue to impact the demand for procedures using our implants. These developments and effects are expected to continue and may also significantly affect our business across the United States and other countries where COVID-19 has spread and may continue to spread. There are numerous uncertainties associated with this COVID-19 outbreak, including the number of individuals who will become infected, the effectiveness of vaccines or one or more therapies that mitigate the effect of the virus, the availability of vaccines and the vaccination rates in the U.S. and worldwide, the emergence of variants of the COVID-19 virus, the extent of the protective and preventative measures that have been put in place by both governmental entities and other businesses and those that may be put in place in the future, the effect that testing for COVID-19 and antibodies will enable relaxation of protective measures for a subset of the population, and numerous other uncertainties. We intend to continue to execute on our strategic plans and operational initiatives during the COVID-19 outbreak. However, the aforementioned uncertainties may result in delays or modifications to these plans and initiatives.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Existing travel restrictions, and the risk that countries may continue to close borders, impose prolonged quarantines, and further restrict travel, limit our ability to reach surgeons with our goal of increasing surgeon activity by providing education and support.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, the COVID-19 pandemic has adversely affected, and may continue to adversely affect, the economies and financial markets of many countries, which may result in a period of regional, national, and global economic slowdown or regional, national, or global recessions that could curtail or delay spending by hospitals and affect demand for our products as well as increase risk of customer defaults or delays in payments. These market disruptions could impair our ability to raise capital, should our business experience a prolonged period of reduced revenue requiring additional capital to sustain the business. COVID-19 and the current financial, economic, and capital markets environment, and future developments in these and other areas present material uncertainty and risk with respect to our performance, financial condition, results of operations, and cash flows. Due to the uncertain scope and duration of the pandemic and uncertain timing of global recovery and economic normalization, we are unable to estimate the long-term impacts on our operations and financial results. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The existence and further duration of the COVID-19 pandemic may also further exacerbate certain of the risks as described in this &#8220;Item 1A - Risk Factors&#8221; of this Quarterly Report on Form 10-Q.&#8221; </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Prolonged inflation and supply chain disruptions could result in delayed product launches, lost revenue, higher costs and decreased profit margins. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A majority of our products are manufactured and sold inside of the United States, which increases our exposure to domestic inflation and fuel price increases. Recent inflationary pressures have resulted in increased fuel, raw materials and other costs which, if they continue for a prolonged period, may adversely affect our results of operations. We have begun to experience shortages in certain raw materials and component inputs of our products, primarily surgical instruments, suppliers have been unable to meet delivery schedules due to excess demand and labor shortages, and lead times have lengthened throughout our supply chain. Our efforts to mitigate supply chain weaknesses may not be successful or may have unfavorable effects. For example, efforts to purchase raw materials in advance for product manufacturing may result in increased storage costs or excess supply. If our costs rise due to continuing significant inflationary pressures or supply chain disruptions, we may not be able to fully offset such higher costs through price increases. In addition, delays in obtaining materials, components or instruments from our suppliers could delay product launches or result in lost opportunities to sell our products due to their availability. Increased costs and decreased product availability due to supply chain issues could adversely impact our revenue and/or gross margin, and could thereby harm our business, financial condition, and results of operation.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If hospitals, surgeons, and other healthcare providers are unable to obtain and maintain adequate or any coverage and reimbursement from third-party payors for procedures performed using our products, adoption of our products may be delayed,  it is unlikely that they will gain further acceptance, and the prices paid for our implants may decline.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Maintaining and growing sales of our products depends on the availability of adequate coverage and reimbursement from third-party payors, including government programs such as Medicare and Medicaid, private insurance plans, and managed care programs. Hospitals, surgeons, and other healthcare providers that purchase or use medical devices generally rely on third-party payors to pay for all or part of the costs and fees associated with the procedures performed with these devices. When a procedure using our implants is performed, both the surgeon and the healthcare facility, either a hospital or ambulatory surgical center, submit claims for reimbursement to the healthcare payor. We may be unable to sell our products on a profitable basis if third-party payors deny coverage or reduce their current levels of payment, or if reimbursement levels are insufficient to support use of our products by healthcare facilities or to compensate surgeons for their time spent diagnosing patients and performing procedures using our products.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While all Medicare Administrative Contractors are regularly reimbursing for minimally invasive sacroiliac joint fusion, some private payors still have policies that treat the procedure as experimental or investigational and do not regularly reimburse for the procedure. Future action by the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) or third-party payors may further reduce the availability of payments to physicians, outpatient surgery centers, and/or hospitals for procedures using our products.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The healthcare industry in the United States has experienced a trend toward cost containment as government and private insurers seek to control healthcare costs. Payors are imposing lower payment rates and negotiating reduced contract rates with service providers and being increasingly selective about the technologies and procedures they chose to cover. Payors may adopt policies in the future restricting access to medical technologies like ours and/or the procedures performed using such technologies. Therefore, we cannot be certain that the procedures performed with each of our products will be reimbursed. There can be no guarantee that, should we introduce additional products in the future, payors will cover those products or the procedures in which they are used.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective January 1, 2020, the Medicare physician fee reimbursement for minimally invasive fusion with our iFuse implants, described as CPT Code 27279, increased by 27% to $920. Commercial payors generally set their physician fee reimbursement with reference to Medicare reimbursement rates.  Notwithstanding the increase in physican reimbursement associated with our procedure in 2020, we believe that some surgeons may continue to view the Medicare and commercial reimbursement amounts as insufficient for the procedure, given the work effort involved with the procedure, including the time to diagnose the patient and obtain prior authorization from the patient&#8217;s health insurer if necessary. We believe that some private payors apply their own coverage policies and criteria inconsistently, and surgeons may not be able to consistently have minimally invasive sacroiliac fusions approved and covered. The perception by physicians that the reimbursement for minimally invasive sacroiliac joint fusion is insufficient to compensate them for the work required, including diagnosis, documentation, obtaining payor approval for the procedure, and burden on their office staff, may negatively affect the number of procedures performed and may therefore adversely affect our revenues.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The American Medical Association (AMA) develops and maintains Current Procedural Terminology (CPT) codes that are used by third-party payors to determine the amount of reimbursement that a healthcare provider and facility will receive for a particular service. CPT codes are divided into three categories: Category I codes represent existing services or procedures that are widely used.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Category II codes are supplemental tracking codes, and Category III codes are temporary codes that represent new technologies, services, and procedures. A Category III code does not have a payment rate established and reimbursement is at the payor&#8217;s discretion. CPT Code 27279, which describes minimally-invasive surgical fusion of the sacroiliac joint performed with our iFuse implants, is a Category I CPT code. As the number of products and surgical procedures to address sacroiliac joint dysfunction has expanded and diversified, we are aware that certain medical societies have requested that the AMA create a Category III CPT code representing some of these unproven technologies. If either the current or future procedures performed with our products are determined to be best described by a Category III CPT code, or if the levels of reimbursement for, and consistency of coverage associated with, procedures performed with our medical devices, either under the existing Category I CPT Code or under any newly created Category III CPT Code, could decrease which could make our devices less attractive to healthcare professionals using our products. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Recent political, economic, and regulatory influences are subjecting the healthcare industry to fundamental changes that can impact coverage and reimbursement from third-party payors. We expect that the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2011, as currently enacted or as it may be amended in the future, and other healthcare reform measures that may be adopted in the future, could have a material adverse effect on our industry generally and on our ability to maintain or increase sales of our existing products.  CMS budget neutrality requirements may impose cuts to the Medicare physician fee schedule, which may be mitigated by acts of Congress or other changes to regulations. Other federal laws, known as budget sequestration, further reduce Medicare&#8217;s payments to providers by two percent through 2030. However, COVID-19 relief support legislation suspended the 2% Medicare reductions from May 1, 2020 through March 31, 2021, which was extended through December 31, 2021. These reductions may reduce reimbursement for procedures performed using our products, which could potentially negatively impact our revenue, and may reduce providers&#8217; revenues or profits, which could affect their ability to purchase new technologies. Both the federal and state governments in the U.S. and foreign governments continue to propose and pass new legislation and regulations designed to contain or reduce the cost of healthcare. Such legislation and regulations may result in decreased reimbursement for medical devices, which may further exacerbate industry-wide pressure to reduce the prices charged for </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">medical devices. This could harm our ability to market our products and generate sales, which could adversely affect our business, results of operations and financial condition.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Market acceptance of our products in foreign markets may depend, in part, upon the availability of coverage and reimbursement within prevailing healthcare payment systems. Reimbursement and healthcare payment systems in international markets vary significantly by country and include both government-sponsored healthcare and private insurance. We may not obtain additional international coverage and reimbursement approvals in a timely manner, if at all. Our failure to receive such approvals would negatively impact market acceptance of our products in the international markets in which those approvals are sought.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If healthcare payors reverse decisions to cover minimally invasive sacroiliac joint fusion exclusively when performed with iFuse and choose to reimburse for procedures performed with competitive products, our market share could decline, adversely affecting our revenues.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2021, more than 35 of the largest 65 U.S. payors that we track and target have issued positive coverage policies covering the patented triangular design of our iFuse implants and excluding coverage of other products that are intended to fuse the sacroiliac joint because of the clinical evidence supporting the use of iFuse and the lack of clinical evidence supporting the use of other products. We believe that payors have adopted these exclusive coverage decisions due to the strength of our clinical evidence and in part due to recommendations of specialty benefit managers and healthcare technology assessment organizations. Clinical trials of the type and size necessary to offer evidence of the safety and efficacy of competing products could be performed and could show that other products for sacroiliac joint fusion are as effective as, or more effective than, iFuse. Payors could also abandon their decisions to cover iFuse exclusively for other reasons.  If healthcare payors covering a significant number of covered lives reverse their policies of covering minimally invasive sacroiliac joint fusion exclusively when performed with the iFuse system, sales of our iFuse implants could decline or fail to grow, which could adversely affect our business, results of operations and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may not be able to convince physicians that iFuse is an attractive alternative to our competitors&#8217; products and that our procedure is an attractive alternative to existing surgical and non-surgical treatments of the sacroiliac joint.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Surgeons, in consultation with their patients, play the primary role in determining the course of treatment and, ultimately, any product that will be used in treatment. In order for us to sell our iFuse system successfully, we must demonstrate to surgeons through education and training that treatment with iFuse is beneficial, safe, and cost-effective for patients as compared to our competitors&#8217; products. If we are not successful in demonstrating the merits of iFuse to surgeons, their use of our products may decline, adversely affecting our revenues and profitability.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Historically, most spine surgeons did not include an evaluation of the sacroiliac joint in their diagnostic work-up because they did not have an adequate surgical procedure to perform for patients diagnosed with sacroiliac joint dysfunction. We believe that educating surgeons and other healthcare professionals about the clinical merits and patient benefits of iFuse is an important element of building our business. If we fail to effectively educate surgeons and other medical professionals, they may not include a sacroiliac joint evaluation as part of their diagnosis and, as a result, those patients may continue to receive unnecessary surgical procedures or only non-surgical treatment.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Surgeons may also hesitate to change their medical treatment practices for other reasons, including the following:</span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">       </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">lack of experience with minimally invasive procedures;</span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">       </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">perceived liability risks generally associated with the use of new products and procedures;</span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">       </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">costs associated with the purchase of new products; and </span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">       </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">time commitment that may be required for training.</span></div><div style="text-indent:49.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furthermore, we believe surgeons will not widely use iFuse unless they determine, based on experience, clinical data, and published peer-reviewed publications, that surgical intervention provides benefits or is an attractive alternative to non-surgical treatments of sacroiliac joint dysfunction. In addition, we believe support of our products relies heavily on long-term data showing their benefits. If we are unable to provide that data, surgeons may not use our products. In such circumstances, we may not achieve expected sales and may be unable to achieve profitability.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Many patients with sacroiliac joint dysfunction are cared for by pain physicians, who are generally trained as anesthesiologists or physical medicine and rehabilitation specialists. Pain physicians often offer a variety of non-surgical and surgical interventions to sacroiliac joint dysfunction patients, including, but not limited to, steroid injections, radiofrequency ablation of the nerves serving the sacroiliac joint and implantation of neurostimulation devices, allografts, and other products intended to treat the sacroiliac joint or the pain it can cause. Our professional education program seeks to teach pain physicians, and other health care providers, about the benefits of iFuse, in order to prompt these providers to refer their patients with sacroiliac joint dysfunction to surgeons who have been trained to perform the iFuse procedure. These providers may, however, prefer to continue to treat these patients with the interventions they offer because they feel these interventions are superior or because they have a financial interest in offering additional treatments </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to these patients. If we are unable to demonstrate to potential referring health care providers the comparative benefits of iFuse, and we are therefore unable to prompt sufficient numbers of these providers to refer their patients with sacroiliac joint dysfunction for treatment by surgeons trained to perform the iFuse procedure, sales of our iFuse implants could decline or fail to grow, which could adversely affect our business, results of operations and financial condition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Surgeons and payors may not find our clinical evidence to be compelling, which could limit our sales and revenue, and on-going and future research may prove our products to be less safe and effective than currently thought.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The products we currently market in the United States have either received premarket clearance under Section 510(k) of the United States. Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;), or are exempt from premarket review. Those marketed in the European Union (&#8220;EU&#8221;) have been the subject of a CE Certificate of Conformity. The 510(k) clearance process of the U.S. Food and Drug Administration (&#8220;FDA&#8221;) requires us to document that our product is &#8220;substantially equivalent&#8221; to another 510(k)-cleared product. The 510(k) process is shorter and typically requires the submission of less supporting documentation than other FDA approval processes, such as a premarket approval (&#8220;PMA&#8221;), and does not usually require pre-clinical or clinical studies. As a result, while there are a number of published studies relating to iFuse and minimally invasive sacroiliac joint surgery that support the safety and effectiveness of our products and the benefits they offer, our clinical studies may lack the size and scope of randomized controlled clinical trials required to support approval of a PMA. For these reasons, surgeons may be slow to adopt our products, third-party payors may be slow to provide coverage, and we may be subject to greater regulatory and product liability risks. Further, future patient studies or clinical experience may indicate that treatment with our products does not improve patient outcomes. Such results would slow the adoption of our products by surgeons, significantly reduce our ability to achieve expected sales, and could prevent us from achieving profitability. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Pricing pressure from our competitors, changes in third-party coverage and reimbursement, healthcare provider consolidation, payor consolidation and the presence of &#8220;physician-owned distributorships&#8221; may impact our ability to sell our product at prices necessary to support our current business strategies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If competitive forces drive down the prices we are able to charge for our product, our profit margins will shrink, which will adversely affect our ability to invest in and maintain and grow our market share. The sacroiliac joint fusion market has attracted numerous new companies and technologies. As a result of this increased competition, we believe there will be continuing increased pricing pressure, resulting in lower gross margins, with respect to our products.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Even to the extent our product and procedures using our product are currently covered and reimbursed by third-party private and public payors, adverse changes in coverage and reimbursement policies that affect our products, discounts, and number of implants used may also drive our prices and revenue down and harm our ability to market and sell our products.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Consolidation in the healthcare industry, including both third-party payors and healthcare providers, could lead to demands for price concessions or to the exclusion of some suppliers from certain of our markets, which could have an adverse effect on our business, results of operations, or financial condition. Because healthcare costs have risen significantly over the past several years, numerous initiatives and reforms initiated by legislators, regulators, and third-party payors to curb these costs have resulted in a consolidation trend in the healthcare industry to aggregate purchasing power. As the healthcare industry consolidates, competition to provide products and services to industry participants has become and will continue to become more intense. This in turn has resulted and will likely continue to result in greater pricing pressures and the exclusion of certain suppliers from important market segments as group purchasing organizations, independent delivery networks, and large single accounts continue to use their market power to consolidate purchasing decisions for hospitals. We expect that market demand, government regulation, third-party coverage, and reimbursement policies and societal pressures will continue to change the worldwide healthcare industry, resulting in further business consolidations and alliances among our customers, which may reduce competition, exert further downward pressure on the prices of our products, and adversely impact our business, results of operations, or financial condition. As we continue to expand into international markets, we will face similar risks relating to adverse changes in coverage and reimbursement procedures and policies in those markets. Physician-owned distributorships (&#8220;POD&#8221;) are medical device distributors that are owned, directly or indirectly, by physicians. These physicians profit from selling or arranging the sale of medical devices for use in procedures they perform on their own patients at hospitals that purchase the devices from the POD. We do not engage with PODs. The proliferation of PODs could result in increased pricing pressure on our products or harm our ability to sell our products to physicians who own or are affiliated with those distributorships and therefore choose to use competing products.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Practice trends or other factors, including the COVID-19 pandemic, may cause procedures to shift from the hospital environment to ambulatory surgical centers, or ASCs, where pressure on the prices of our products is generally more acute.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To protect health care professionals involved in surgical care and their patients, we anticipate that more outpatient eligible procedures will be performed in ASCs during the COVID-19 pandemic, and as its acuity declines and the healthcare system returns to a more normalized state.  We anticipate that this trend will nevertheless continue as a cost control measure with the healthcare system. Since patients do not stay overnight in ASCs and COVID-19 patients would not otherwise be treated in ASCs, it is likely that the ASC will be viewed as a safer site of service for patients and health care providers, where the risk of transmission of the novel coronavirus </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">can be more effectively controlled. In addition, ASC are generally more economically favorable site of service, and surgeons performing the procedures sometimes have ownership interests in the ASC. Because ASC facility fee reimbursement is typically less than facility fee reimbursement for hospitals and due to surgeons&#8217; economic interest in ASCs, we typically experience more pressure on the pricing of our products by ASCs than by hospitals, and the average price for which we sell our products to ASCs is less than the average prices we charge to hospitals. In addition, some surgeons may choose to use fewer implants due to their interest in the profitability of the ASC. An accelerated shift of procedures using our products to ASCs as a result of the COVID-19 pandemic could adversely impact the average selling prices of our products and our revenues could suffer as a result.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We operate in a very competitive business environment and if we are unable to compete successfully against our existing or potential competitors, our sales and operating results may be adversely affected.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our currently marketed products are, and any future products we commercialize will likely be, subject to intense competition. Our field is subject to rapid change and highly sensitive to the introduction of new products or other market activities of industry participants. Our ability to compete successfully will depend on our ability to develop proprietary products that reach the market in a timely manner, receive adequate coverage and reimbursement from third-party payors, and are safer, less invasive, and more effective than alternatives available for similar purposes as demonstrated in peer-reviewed clinical publications. Because of the size of the potential market, we anticipate that other companies will dedicate significant resources to developing competing products.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The number of competitors that we are aware of marketing sacroiliac joint fusion products in the United States has grown from zero to more than 20 since 2008. Some of our current and potential competitors are major medical device companies that have substantially greater financial, technical, and marketing resources than we do, and they may succeed in developing products that would render our products obsolete or noncompetitive. In addition, many of these competitors have significantly longer operating history and more established reputations than we do. Some of these companies sell a broad suite of products that can be used together in the operating room in order to facilitate surgery, such as surgical imaging, navigation and robotic systems, or a large number of implants intended to treat different conditions affecting the spine and pelvis.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The ability of these competitors to sell these products together or as part of larger purchasing arrangements may put us at a disadvantage. In addition, if these competitors use technology, contracts, or intellectual property measures to limit or eliminate the compatibility of their surgical imaging, navigation and robotic systems with our products, sales of our products could decline or fail to grow, which could adversely affect our business and results of operations. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the United States, we believe that our primary competitors marketing implantable devices currently are Medtronic plc and Globus Medical, Inc. In addition, a number of smaller companies selling allograft implants to a variety of physicians have collectively become a larger presence in our market. Our primary competitors in Europe are Globus Medical, Inc. and SIGNUS Medizintechnik GmbH. At any time, these or other industry participants may develop alternative treatments, products or procedures for the treatment of the sacroiliac joint that compete directly or indirectly with our products. They may also develop and patent processes or products earlier than we can, or obtain domestic and international regulatory clearances or approvals and CE Certificates of Conformity for competing products in the European Economic Area (&#8220;EEA&#8221;), more rapidly than we can, which could impair our ability to develop and commercialize similar processes or products. If alternative treatments are, or are perceived to be, superior to our products, sales of our products and our results of operations could be negatively affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">New participants have increasingly entered the medical device industry. Many of these new competitors specialize in a specific product or focus on a particular market segment, making it more difficult for us to increase our overall market position. The frequent introduction by competitors of products that are or claim to be superior to our current or planned future products may make it difficult to differentiate the benefits of our products over competing products. In addition, the entry of multiple new products and competitors may lead some of our competitors to employ pricing strategies that could adversely affect the pricing of our products and pricing in the market generally.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result, without the timely introduction of new products and enhancements, our products may become obsolete over time. If we are unable to develop innovative new products, maintain competitive pricing, and offer products that surgeons and other physicians perceive to be as reliable as those of our competitors, our market share or product margins could decrease, thereby harming our business.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are highly dependent on revenue from the sale of a single family of products focused on procedures, the goal of which is to stabilize and fuse the sacroiliac joint. Reliance on a single family of products and single family of procedures could negatively affect our results of operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Substantially all of our revenue comes from the sale of iFuse, iFuse-3D and iFuse-TORQ implants, and related tools and instruments. Therefore, we are dependent on widespread market adoption of iFuse and we will continue to be dependent on the success of this single product family for some time. There can be no assurance that iFuse will maintain a substantial degree of market acceptance among surgeons, patients or healthcare providers. Our failure to successfully grow the market for iFuse and increase our share within that market or any other event impeding our ability to sell iFuse, could adversely affect our results of operations, financial condition and continuing operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If clinical experience with our iFuse Bedrock technique does not result in positive outcomes for patients, or if clinical trials involving the use of iFuse Bedrock fail to show meaningful patient benefit, sales of our iFuse implants could be adversely impacted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2018, we introduced our iFuse Bedrock technique, in which spine surgeons place iFuse implants across the sacroiliac joint using a different surgical approach to treat sacroiliac joint dysfunction at the same time they are fusing multiple levels of the spine above and affixing those spinal fusion devices to the pelvis.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In April 2019, the FDA cleared promotion of iFuse Bedrock for a broader and more general purpose, to provide additional stability and immobilization of the sacroiliac joint in connection with a thoracolumbar fusion procedure.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To date, clinical experience with the iFuse Bedrock technique is limited and we have yet to complete a clinical trial to evaluate the iFuse Bedrock technique.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Surgeons do not know if the addition of iFuse implants to the implants used to fuse multiple levels of the lumbar spine will result in patient benefit.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If surgeons' clinical experience with iFuse Bedrock is not positive, or if our clinical trials do not show meaningful benefits to the patients undergoing this procedure, sale of our iFuse implants for this indication could be adversely impacted, which could negatively affect our operations and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If we are unable to maintain our network of direct sales representatives and third-party distributors, we may not be able to generate anticipated sales.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2021, our U.S. sales force consisted of 78 territory sales managers and 57 clinical support specialists directly employed by us, and 53 third-party distributors. As of September 30, 2021, our international sales force consisted of 20 sales representatives directly employed by us and 33 third-party distributors, which together have had sales in 37 countries through September 30, 2021. Our operating results are directly dependent upon the sales and marketing efforts of both our direct sales force and of our third-party distributors.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As we launch new products and increase our marketing efforts with respect to existing products, we will need to expand the reach of our marketing and sales networks. Our future success will depend largely on our ability to continue to hire, train, retain and motivate skilled direct sales representatives and third-party distributors with significant technical knowledge in various areas, such as spine health and treatment. New hires require training and take time to achieve full productivity. If we fail to train new hires adequately, or if we experience high turnover in our sales force in the future, we cannot be certain that new hires will become as productive as may be necessary to maintain or increase our sales. If a direct sales representative or third-party distributor were to depart and be retained by one of our competitors, we may be unable to prevent them from helping competitors solicit business from our existing customers, which could further adversely affect our sales. Because of the intense competition for their services, we may be unable to recruit or retain additional qualified third-party distributors or to hire additional direct sales representatives to work with us. Furthermore, we may not be able to enter into agreements with them on favorable or commercially reasonable terms, if at all. Failure to hire or retain qualified direct sales representatives or third-party distributors would prevent us from expanding our business and generating sales. If our direct sales representatives or third-party distributors fail to adequately promote, market and sell our products or decide to leave or cease to do business with us, our sales could significantly decrease.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we are unable to expand our sales and marketing capabilities domestically and internationally, we may not be able to effectively commercialize our products, which would adversely affect our business, results of operations, and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our business could suffer if we lose the services of key members of our senior management, key advisors or personnel.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are dependent upon the continued services of key members of our senior management and a limited number of key advisors and personnel. The loss of members of our senior management team, key advisors or personnel, or our inability to attract or retain other qualified personnel or advisors, could have a material adverse effect on our business, results of operations, and financial condition. We do not maintain &#8220;key person&#8221; insurance for any of our executives or employees. In addition, several of the members of our executive management team are not subject to non-competition agreements that restrict their ability to compete with us. Accordingly, the adverse effect resulting from the loss of certain executives could be compounded by our inability to prevent them from competing with us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> &#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If use of our products result in adverse events, this may require them to be taken off the market, require them to include safety warnings or otherwise limit their sales.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Unforeseen adverse events related to our products could arise either during clinical development or, if cleared, approved, or subject to CE Certificate of Conformity, after the product has been marketed. In clinical research, the most common adverse event related to our implant was leg pain resulting from misplacement. The most common adverse event for our implant procedure has been minor wound infections. Additional adverse effects from iFuse or any of our other products could arise either during clinical development or, if approved, cleared, or subject to CE Certificate of Conformity, after the product has been marketed.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we or others later identify adverse events caused by our products:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;sales of the product may decrease significantly, and we may not achieve the anticipated market share;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;regulatory authorities or our Notified Body may require changes to the labeling of our product. This may include the addition of labeling statements, specific warnings, and contraindications and issuing field alerts to physicians and patients;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we may be required to change instructions regarding the way the product is implanted or conduct additional clinical trials;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we may be subject to limitations on how we may promote the product;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;regulatory authorities may require us to temporarily or permanently take our approved product off the market or to conduct other field safety corrective actions;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we may be required to modify our product;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we may be subject to litigation fines or product liability claims; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;our reputation may suffer.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any of these events could prevent us from achieving or maintaining market acceptance of the affected product or could substantially increase commercialization costs and expenses, which in turn could delay or prevent us from generating significant revenue from the sale of our products.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Unfavorable media reports or other negative publicity concerning both alleged improper methods of tissue recovery from donors and disease transmission from donated tissue could limit widespread acceptance of some of our products.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We introduced iFuse Bone, an implantable bone product manufactured from sterilized recovered cadaveric bone tissue, to meet the demand of some of our surgeon customers to use implantable bone products to support and augment the patient's own bone tissue in orthopedic procedures. Unfavorable reports of improper or illegal tissue recovery practices, both in the United States and internationally, as well as incidents of improperly processed tissue leading to the transmission of disease, may affect the rate of future tissue donation and market acceptance of technologies incorporating human tissue. In addition, negative publicity could cause the families of potential donors to become reluctant to donate tissue to for-profit tissue processors. These reports could have a negative effect on sales of iFuse Bone.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Various factors outside our direct control may adversely affect manufacturing, sterilization, and distribution of our products.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The manufacture, sterilization, and distribution of our products is challenging. Changes that our suppliers may make outside the purview of our direct control can have an impact on our processes, quality of our products, and the successful delivery of products to our customers. Mistakes and mishandling are not uncommon and can affect supply and delivery. Some of these risks include:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;failure to complete sterilization on time or in compliance with the required regulatory standards;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;transportation and import and export risk;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;delays in analytical results or failure of analytical techniques that we depend on for quality control and release of products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;large-scale epidemics of communicable diseases such as COVID-19;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;supply chain disruptions, including those caused by material and labor supply shortages in the wake of COVID-19;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;natural disasters, labor disputes, financial distress, raw material availability, issues with facilities and equipment, or other forms of disruption to business operations affecting our manufacturers or suppliers; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;latent defects that may become apparent after products have been released and that may result in a recall or field safety corrective action with respect to such products.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If any of these risks were to materialize, our ability to provide our products to customers on a timely basis could be adversely impacted.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are dependent on a limited number of third-party suppliers, some of them single-source and some of them in single locations, for most of our products and components, and the loss of any of these suppliers, or their inability to provide us with an adequate supply of materials in a timely and cost-effective manner, could materially adversely affect our business.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We rely on third-party suppliers to manufacture and supply substantially all of our products. For us to be successful, our suppliers must be able to provide us with products and components in substantial quantities, in compliance with regulatory requirements, in accordance with agreed upon specifications, at acceptable prices, and on a timely basis. We do not have long-term supply contracts for some of our suppliers, and in some cases, even where we do have agreements in place, we purchase important parts of the iFuse Implant System from a single supplier. Therefore, we cannot assure investors that we will be able to obtain sufficient quantities of product in the future.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, future growth could strain the ability of our suppliers to deliver products, materials, and components. Suppliers often experience difficulties in scaling up production, including financial issues, or problems with production yields and quality control and assurance. For example, from time to time, we have experienced certain delays and may experience delays from our suppliers in the future.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We generally use a small number of suppliers for our instruments and currently rely on RMS for iFuse-3D implants and Orchid for iFuse implants. Our dependence on such a limited number of suppliers exposes us to risks, including, among other things:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;third-party contract manufacturers or suppliers may fail to comply with regulatory requirements or make errors in manufacturing that could negatively affect the safety or effectiveness of our products or cause delays in shipments of our products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;third-party contract manufacturers or suppliers may fail to maintain good manufacturing practices, leading to quality control problems or regulatory findings that could cause disruptions in their manufacturing processes and lead to delays in shipments of our products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we or our third-party manufacturers and suppliers may not be able to respond to unanticipated changes in customer orders, and if orders do not match forecasts, we or our suppliers may have excess or inadequate inventory of materials and components;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we or our third-party manufacturers and suppliers may be subject to price fluctuations due to a lack of long-term supply arrangements for key components;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we or our third-party manufacturers and suppliers may lose access to critical services, raw materials and components, or experience significant delays in obtaining them, resulting in an interruption in the manufacture, assembly and shipment of our systems;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we or our third-party manufacturers could experience plant closures due to local epidemics of communicable diseases, such as COVID-19, or local outbreaks of such diseases among their workforce, thereby shuttering a plant in which our products are manufactured;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we may experience delays in delivery by our third-party manufacturers and suppliers due to changes in demand from us or their other customers;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;fluctuations in demand for products that our third-party manufacturers and suppliers manufacture for others may affect their ability or willingness to deliver components to us in a timely manner;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;our third-party manufacturers and suppliers may wish to discontinue supplying components or services to us for risk management reasons;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we may not be able to find new or alternative components or reconfigure our system and manufacturing processes in a timely manner if the necessary components become unavailable; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;our third-party manufacturers and suppliers may encounter financial hardships unrelated to our demand, which could inhibit their ability to fulfill our orders and meet our requirements.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If any one or more of these risks materialize, it could significantly increase our costs and impact our ability to meet demand for our products and to launch new products. If we are unable to satisfy commercial demand for our system in a timely manner, our ability to generate revenue would be impaired, market acceptance of our products could be adversely affected, and customers may instead purchase or use our competitors&#8217; products. Additionally, we could be forced to seek alternative sources of supply.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, most of our supply and manufacturing agreements do not have minimum manufacturing or purchase obligations. As such, with many of our suppliers, we have no obligation to buy any given quantity of products, and the suppliers have no obligation to sell us or to manufacture for us any given quantity of components or products. As a result, our ability to purchase adequate quantities of components or our products may be limited and we may not be able to convince suppliers to make components and products available to us in some instances. Our suppliers may also encounter problems that limit their ability to supply components or manufacture products for us, including financial difficulties, damage to their manufacturing equipment or facilities, product discontinuations or adverse findings in quality audits. As a result, there is a risk that certain components could be discontinued and no longer available to us. We may be required to make significant &#8220;last time&#8221; purchases of component inventory that is being discontinued by the supplier to ensure supply continuity. If we fail to obtain sufficient quantities of high quality components to meet demand for our products in a timely manner or on terms acceptable to us, we would have to seek alternative sources of supply. Securing a replacement third-party manufacturer or supplier could be difficult. The introduction of new or alternative manufacturers or suppliers also may require design changes to our iFuse system that are subject to domestic and international regulatory clearances or approvals and the review of our Notified Body.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Because of the nature of our internal quality control requirements, regulatory requirements, and the custom and proprietary nature of the parts, we may not be able to quickly engage additional or replacement suppliers for many of our critical components. We may also be required to assess any potential new manufacturer&#8217;s compliance with all applicable regulations and guidelines, which could further impede our ability to manufacture our products in a timely manner. As a result, we could incur increased production costs, experience delays in deliveries of our products, suffer damage to our reputation, and experience an adverse effect on our business and financial results. Failure of any of our third-party suppliers to meet our product demand level would limit our ability to meet our sales commitments to our customers and could have a material adverse effect on our business.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We may also have difficulty obtaining similar components from other suppliers that are acceptable to the FDA, our Notified Body and the competent authorities in the countries of the EEA, or other foreign regulatory authorities, and the failure of our suppliers to comply with strictly enforced regulatory requirements could expose us to delays in obtaining clearances or approvals, regulatory action including warning letters, product recalls, termination of distribution, product seizures, civil, administrative, or criminal penalties and the suspension, variation, or withdrawal of our CE Certificates of Conformity. We could incur delays while we locate and engage qualified alternative suppliers, and we may be unable to engage alternative suppliers on favorable terms or at all. Any such disruption or increased expenses could harm our commercialization efforts and adversely affect our ability to generate sales.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, each of our third-party suppliers operates at a facility in a single location and substantially all of our inventory of component supplies and finished goods is held at these locations. A local outbreak of COVID-19 cases, vandalism, terrorism, or a natural or other disaster, such as an earthquake, fire, or flood, could damage or destroy equipment or our inventory of component supplies or finished products, cause substantial delays in our operations, result in the loss of key information, and cause us to incur additional expenses. Our insurance may not cover our losses in any particular case. In addition, regardless of the level of insurance coverage, damage to our or our suppliers&#8217; facilities could harm our business, financial condition, and operating results.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may encounter problems or delays in the assembly of our products or fail to meet certain regulatory requirements which could result in an adverse effect on our business and financial results.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">After the impacts of the COVID-19 pandemic subside, to become profitable we must assemble our products in adequate quantities in compliance with regulatory requirements and at an acceptable cost. Increasing our capacity to assemble and test our products will require us to improve internal efficiencies. We may encounter a number of difficulties in increasing our assembly and testing capacity, including:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;managing production yields;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;maintaining quality control and assurance;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;providing component and service availability;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;maintaining adequate control policies and procedures;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;hiring and retaining qualified personnel; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;complying with state, federal, and foreign regulations.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we are unable to satisfy commercial demand for our iFuse system due to our inability to assemble and test, our ability to generate revenue would be impaired, market acceptance of our products could be adversely affected and customers may instead purchase or use our competitors&#8217; products.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If we do not enhance and broaden our product offerings through our research and development efforts, we may be unable to compete effectively.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In order to increase our market share in the sacroiliac joint fusion and related markets, we must enhance and broaden our product offerings in response to customer demands and competitive pressures and technologies. We might not be able to successfully develop, obtain domestic and international regulatory clearances or approvals, or CE Certificates of Conformity for, or market new products, and our future products might not be accepted by the surgeons or the third-party payors who reimburse for many of the procedures performed with our products. The success of any new product offering or enhancement to an existing product will depend on numerous factors, including our ability to:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;properly identify and anticipate surgeon and patient needs;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;develop and introduce new products or product enhancements in a timely manner;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;adequately protect our intellectual property and avoid infringing upon the intellectual property rights of third parties;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;demonstrate the safety and effectiveness of new products; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;obtain the necessary domestic and international regulatory clearances or approvals and CE Certificates of Conformity for new products or product enhancements.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we do not develop and obtain domestic and international regulatory clearances or approvals and CE Certificates of Conformity for new products or product enhancements in time to meet market demand, or if there is insufficient demand for these products or enhancements, our business could be adversely affected. Our research and development efforts may require a substantial investment of time and resources before we are adequately able to determine the commercial viability of a new product, technology, material, or other innovation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In some cases, following a successful product development effort, we may need to invest substantial resources in surgical instrumentation and implant inventory, prior to launch of the product, and before we understand the demand for such product.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we overestimate the demand for such products and invest too heavily in inventory to support the product line, the additional revenue and product margins may not produce a positive return on such investments, which could cause our financial results to suffer. In addition, even if we are able to successfully develop enhancements or new generations of our products, these enhancements or new generations of products may not produce sales in excess of the costs of development and they may be quickly rendered obsolete by changing customer preferences or the introduction by our competitors of products embodying new technologies or features.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are required to maintain adequate levels of inventory, the failure of which could consume our resources and reduce our cash flows.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result of the need to maintain adequate levels of inventory, we are subject to the risk of inventory obsolescence. Many of our products come in sets, which feature components in a variety of sizes so that the implant or device may be chosen for size based on the patient&#8217;s needs. In order to market our products effectively, we often maintain and provide surgeons and hospitals with back-up products and products of different sizes. For each surgery, fewer than all of the components of the set are used, and therefore certain portions of the set may become obsolete before they can be used. In addition, as we introduce new implants and instruments with the same intended uses as existing products, the older products may fall out of favor with our customers, causing them to become obsolete. In the event that a substantial portion of our inventory becomes obsolete, it could have a material adverse effect on our earnings and cash flows due to the resulting costs associated with the inventory impairment charges and costs required to replace such inventory</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The size and future growth in the market for iFuse has not been established with precision and may be smaller than we estimate, possibly materially. In addition, we estimate cost savings to the economy and healthcare system as a result of the iFuse procedure based on our market research. If our estimates and projections overestimate the size of this market or these benefits and cost savings, our sales growth may be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are not aware of an independent third-party study that reliably reports the potential market size for iFuse or cost savings as a result of the iFuse procedure. Therefore, our estimates of the size and potential for future growth in the market for our iFuse products, cost savings to patients, the healthcare system and the economy overall from its use, and the number of people currently suffering from lower back pain who may benefit from and be amenable to our iFuse procedure, is based on a number of internal and third-party studies, surveys, reports, and estimates. While we believe these factors have historically provided and may continue to provide us with effective tools in estimating the total market for our iFuse products and procedures and health cost savings, these estimates may not be correct and the conditions supporting our estimates may change at any time, thereby reducing the predictive accuracy of these underlying factors. The actual incidence of lower back pain, and the actual demand for our products or competitive products, could differ materially from our projections if our assumptions and estimates are incorrect. As a result, our estimates of the size and future growth in the market for our iFuse products may prove to be incorrect. In addition, actual health cost savings to the healthcare system as a result of the iFuse procedure may materially differ from those we expect. If the actual number of people with lower back pain who would benefit from our iFuse products and the size and future growth in the market for iFuse products and related costs savings to the healthcare system is smaller than we have estimated, it may impair our projected sales growth and have an adverse impact on our business.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our results of operations could suffer if we are unable to manage our international business effectively.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Expansion into international markets is an element of our business strategy and involves risk. The sale and shipment of our products across international borders, as well as the purchase of components and products from international sources, subject us to extensive U.S. and foreign governmental trade, import, and export and customs regulations and laws. Compliance with these regulations and laws is costly and exposes us to penalties for non-compliance. Other laws and regulations that can significantly affect us include various anti-bribery laws, including the U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;), and the United Kingdom Bribery Act (&#8220;UKBA&#8221;), anti-boycott laws, anti-money laundering laws, and regulations relating to economic sanctions imposed by the U.S., including the Office of Foreign Asset Control of the U.S. Treasury. Any failure to comply with applicable legal and regulatory obligations in the U.S. or abroad could adversely affect us in a variety of ways that include, but are not limited to, significant criminal, civil and administrative penalties, including imprisonment of individuals, fines and penalties, denial of export privileges, seizure of shipments and restrictions on certain business activities. Also, the failure to comply with applicable legal and regulatory obligations could result in the disruption of our distribution and sales activities.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, some of the countries in which we sell or plan to sell our products are, to some degree, subject to various risks, including:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;exposure to different legal and regulatory standards;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;lack of stringent protection of intellectual property;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;inability of the local healthcare system to absorb prices for our product that would enable our business to become profitable in those markets;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;obstacles to obtaining domestic and foreign export, import, and other governmental approvals, permits, and licenses and compliance with foreign laws;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;potentially adverse tax consequences and the complexities of foreign value-added tax systems;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;adverse changes in tariffs and trade restrictions;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;limitations on the repatriation of earnings;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;difficulties in staffing and managing foreign operations;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;insufficient numbers of patients requiring procedures that use our products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;transportation delays and difficulties of managing international distribution channels;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;longer collection periods and difficulties in collecting receivables from foreign entities;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;increased financing costs;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;currency risks; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;political, social, and economic instability and increased security concerns.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These risks may limit or disrupt our expansion, restrict the movement of funds or result in the deprivation of contractual rights or the taking of property by nationalization or expropriation without fair compensation.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our successful conduct of our international business depends, in part, on our ability to develop and implement policies and strategies that are effective in anticipating and managing these and other risks in the countries in which we plan to do business. Failure to manage these and other risks may have a material adverse effect on our operations in any particular country and on our business as a whole.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">In the future our products may become obsolete, which would negatively affect operations and financial condition.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The medical device industry is characterized by rapid and significant change. There can be no assurance that other companies will not succeed in developing or marketing devices, and products that are more effective than our iFuse system or that would render the iFuse system obsolete or noncompetitive. Additionally, new surgical procedures, medications and other therapies could be developed that replace or reduce the importance of our product. Accordingly, our success will depend in part on our ability to respond quickly to changes in technology and the practice of medicine through the development and introduction of new products. Product development involves a high degree of risk and there can be no assurance that our new product development efforts will result in any commercially successful products.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If we experience significant disruptions in our information technology systems, our business, results of operations, and financial condition could be adversely affected.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The efficient operation of our business depends on our information technology systems. We rely on our information technology systems to effectively manage:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;sales and marketing, accounting, and financial functions;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;inventory management;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;engineering and product development tasks; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;our research and development data.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our information technology systems are vulnerable to damage or interruption from:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;earthquakes, fires, floods, and other natural disasters;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;terrorist attacks and attacks by computer viruses or hackers or breach of our cybersecurity;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;power losses; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;computer systems, or Internet, telecommunications, or data network failures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The failure of our information technology systems to perform as we anticipate or our failure to effectively implement new systems could disrupt our entire operation and could result in decreased sales, increased overhead costs, excess inventory and product shortages, and legal liability issues, all of which could have a material adverse effect on our reputation, business, results of operations, and financial condition.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, we accept payments for many of our sales through credit card transactions, which are handled through a third-party payment processor. As a result, we are subject to a number of risks related to credit card payments. As a result of these transactions, we pay interchange and other fees, which may increase over time and could require us to either increase the prices we charge for our products or experience an increase in our costs and expenses. In addition, as part of the payment processing process, we transmit our customers&#8217; credit card information to our third-party payment processor. We may in the future become subject to lawsuits or other proceedings for purportedly fraudulent transactions arising out of the actual or alleged theft of our customers&#8217; credit card information if the security of our third-party credit card payment processor is breached. We and our third-party credit card payment processor are also subject to payment card association operating rules, certification requirements and rules governing electronic funds transfers, which could change or be reinterpreted to make it difficult or impossible for us to comply. If we or our third-party credit card payment processor fail to comply with these rules or requirements, we may be subject to fines and higher transaction fees and lose our ability to accept credit card payments from our customers, and there may be an adverse impact on our business.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may seek to grow our business through acquisitions of or investments in new or complementary businesses, products or technologies, and the failure to manage acquisitions or investments, or the failure to integrate them with our existing business, could have a material adverse effect on us.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, we expect to consider opportunities to acquire or make investments in other technologies, products, and businesses that may enhance our capabilities, complement our current products, or expand the breadth of our markets or customer base. Potential and completed acquisitions and strategic investments involve numerous risks, including:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;problems assimilating the purchased technologies, products, or business operations;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;issues maintaining uniform standards, procedures, controls, and policies;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;unanticipated costs and liabilities associated with acquisitions;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;diversion of management&#8217;s attention from our core business;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;adverse effects on existing business relationships with suppliers and customers;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;risks associated with entering new markets in which we have limited or no experience;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;potential loss of key employees of acquired businesses; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;increased legal and accounting compliance costs.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have no current commitments with respect to any acquisition or investment. We do not know if we will be able to identify acquisitions we deem suitable, whether we will be able to successfully complete any such acquisitions on favorable terms or at all, or whether we will be able to successfully integrate any acquired business, product, or technology into our business or retain any key personnel, suppliers, or distributors. Our ability to successfully grow through acquisitions depends upon our ability to identify, negotiate, complete, and integrate suitable target businesses and to obtain any necessary financing. These efforts could be expensive and time consuming, and may disrupt our ongoing business and prevent management from focusing on our operations. If we are unable to successfully integrate any acquired businesses, products, or technologies effectively, our business, results of operations, and financial condition will be materially adversely affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may enter into collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships with third-parties that may not result in the development of commercially viable products or the generation of significant future revenue.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the ordinary course of our business, we may enter into collaborations, in-licensing arrangements, joint ventures, strategic alliances, partnerships, or other arrangements to develop products and to pursue new markets. Proposing, negotiating, and implementing collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships may be a lengthy and complex process. Other companies, including those with substantially greater financial, marketing, sales, technology, or other business resources, may compete with us for these opportunities or arrangements. We may not identify, secure, or complete any such transactions or arrangements in a timely manner, on a cost-effective basis, on acceptable terms or at all. We have limited institutional knowledge and experience with respect to these business development activities, and we may also not realize the anticipated benefits of any such transaction or arrangement. In particular, these collaborations may not result in the development of products that achieve commercial success or result in significant revenue and could be terminated prior to developing any products.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, we may not be in a position to exercise sole decision-making authority regarding the transaction or arrangement, which could create the potential risk of creating impasses on decisions, and our future collaborators may have economic or business interests or goals that are, or that may become, inconsistent with our business interests or goals. It is possible that conflicts may arise with our collaborators, such as conflicts concerning the achievement of performance milestones, or the interpretation of significant terms under any agreement, such as those related to financial obligations or the ownership or control of intellectual property developed during the collaboration. If any conflicts arise with any collaborators, they may act in their self-interest, which may be adverse to our best interest, and they may breach their obligations to us. In addition, we may have limited control over the amount and timing of resources that any future collaborators devote to our or their future products.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Disputes between us and our collaborators may result in litigation or arbitration which would increase our expenses and divert the attention of our management. Further, these transactions and arrangements will be contractual in nature and will generally be terminable under the terms of the applicable agreements and, in such event, we may not continue to have rights to the products relating to such transaction or arrangement or may need to purchase such rights at a premium. If we enter into in-bound intellectual property license agreements, we may not be able to fully protect the licensed intellectual property rights or maintain those licenses. Future licensors could retain the right to prosecute and defend the intellectual property rights licensed to us, in which case we would depend on the ability of our licensors to obtain, maintain and enforce intellectual property protection for the licensed intellectual property. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These licensors may determine not to pursue litigation against other companies or may pursue such litigation less aggressively than we would. Further, entering into such license agreements could impose various diligence, commercialization, royalty, or other obligations on us. Future licensors may allege that we have breached our license agreement with them, and accordingly seek to terminate our license, which could adversely affect our competitive business position and harm our business prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our term loan contains covenants that may restrict our business and financing activities.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On August 12, 2021, we entered into a Loan and Security Agreement with Silicon Valley Bank (&#8220;SVB&#8221;), pursuant to which we borrowed $35.0 million pursuant to a term loan (the &#8220;SVB Term Loan&#8221;). The Loan and Security Agreement with SVB contains customary events of default, including bankruptcy, the failure to make payments when due, the occurrence of a material impairment on SVB's security interest over the collateral, a material adverse change, the occurrence of a default under certain other indebtedness incurred by us or our subsidiaries, the rendering of certain types of judgments against us and our subsidiaries, the revocation of certain government approvals, violation of covenants, and incorrectness of representations and warranties in any material respect.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The SVB Term Loan is secured by substantially all our assets other than our intellectual property. The Loan and Security Agreement with SVB includes affirmative and negative covenants applicable to us and certain of our foreign subsidiaries. The affirmative covenants include, among others, covenants requiring us to maintain our legal existence and governmental compliance, deliver certain financial reports, and maintain insurance coverage. The negative covenants include, among others, restrictions regarding transferring collateral, pledging our intellectual property to other parties, engaging in mergers or acquisitions, paying dividends or making other distributions, incurring indebtedness, transacting with affiliates, and entering into certain investments, in each case subject to certain exceptions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The covenants in the SVB Term Loan, as well as any future financing agreements that we may enter into, may restrict our ability to finance our operations, engage in, expand, or otherwise pursue our business activities and strategies. Our ability to comply with these covenants may be affected by events beyond our control, and future breaches of any of these covenants could result in a default under our credit facility agreements. If not waived, future defaults could cause all of the outstanding indebtedness under our Loan and Security Agreement with SVB to become immediately due and payable.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not have or are unable to generate sufficient cash available to repay our debt obligations when they become due and payable, either upon maturity or in the event of a default, we may not be able to obtain additional debt or equity financing on favorable terms, if at all, which may negatively impact our ability to operate our business.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Our Legal and Regulatory Environment</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We, our suppliers, and our third-party manufacturers are subject to extensive governmental regulation both in the U.S. and abroad, and failure to comply with applicable requirements could cause our business to suffer.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The medical device industry is regulated extensively by governmental authorities, principally the FDA and corresponding state and foreign regulatory agencies. The FDA and other U.S. and foreign governmental agencies regulate, among other things, with respect to medical devices:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;design, development, and manufacturing;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;testing, labeling, content, and language of instructions for use and storage;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;clinical trials;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;product safety;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;marketing, sales, and distribution;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;premarket clearance and approval;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;conformity assessment procedures;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;record keeping procedures;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;advertising and promotion;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;compliance with good manufacturing practices requirements;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;recalls and field safety corrective actions;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;post-market surveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to recur, could lead to death or serious injury;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;post-market approval studies; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;product import and export.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The regulations to which we are subject are complex and have tended to become more stringent over time. Regulatory changes could result in restrictions on our ability to carry on or expand our operations, difficulties achieving new product clearances, higher than anticipated costs or lower than anticipated sales.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Before we can market or sell a new regulated product or make a significant modification to an existing product in the U.S., with only limited exceptions, we must obtain either clearance under Section&#160;510(k) of the FDCA for Class&#160;II devices or approval of a PMA application from the FDA for a Class&#160;III device. In the 510(k) clearance process, the FDA must determine that a proposed device is &#8220;substantially equivalent&#8221; to a device legally on the market, known as a &#8220;predicate&#8221; device, with respect to intended use, technology, and safety and effectiveness, in order to clear the proposed device for marketing. Clinical data is sometimes required to support substantial equivalence. The PMA pathway requires an applicant to demonstrate the safety and effectiveness of the device based, in part, on extensive data, including, but not limited to, technical, pre-clinical, clinical trial, manufacturing, and labeling data. The PMA process is typically required for devices that are deemed to pose the greatest risk, such as life-sustaining, life-supporting, or implantable devices. Products that are approved through a PMA application generally need FDA approval before they can be modified. Similarly, some modifications made to products cleared through a 510(k) may require a new 510(k). Both the 510(k) and PMA processes can be expensive and lengthy and require the payment of significant fees, unless exempt. The FDA&#8217;s 510(k) clearance process usually takes from three to 12 months, but may last longer. The process of obtaining a PMA is much more costly and uncertain than the 510(k) clearance process and generally takes from one to three years, or even longer, from the time the application is submitted to the FDA until an approval is obtained. The process of obtaining domestic and international regulatory clearances or approvals to market a medical device can be costly and time consuming, and we may not be able to obtain these clearances or approvals on a timely basis, if at all.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the U.S., our currently commercialized products have either received premarket clearance under Section&#160;510(k) of the FDCA or are exempt from premarket review. If the FDA requires us to go through a lengthier, more rigorous examination for future products or modifications to existing products than we had expected, our product introductions or modifications could be delayed or canceled, which could cause our sales to decline. In addition, the FDA may determine that future products will require the more costly, lengthy, and uncertain PMA process. Although we do not currently market any devices under PMA, the FDA may demand that we obtain a PMA prior to marketing certain of our future products. In addition, if the FDA disagrees with our determination that a product we currently market is subject to an exemption from premarket review, the FDA may require us to submit a 510(k) or PMA in order to continue marketing the product. Further, even with respect to those future products where a PMA is not required, we cannot assure investors that we will be able to obtain the 510(k) clearances with respect to those products.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The FDA can delay, limit or deny clearance or approval of a device for many reasons, including:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;we may not be able to demonstrate to the FDA&#8217;s satisfaction that our products are safe and effective for their intended uses;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the data from our pre-clinical studies and clinical trials may be insufficient to support clearance or approval, where required; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the manufacturing process or facilities we use may not meet applicable requirements.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, the FDA may change its clearance and approval policies, adopt additional regulations or revise existing regulations, or take other actions which may prevent or delay clearance or approval of our products under development or impact our ability to modify our currently approved or cleared products on a timely basis.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any delay in, or failure to receive or maintain, clearance or approval for our products under development could prevent us from generating revenue from these products or achieving profitability.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, even after we have obtained the proper regulatory clearance or approval to market a product, the FDA has the power to require us to conduct post-marketing studies. These studies can be very expensive and time consuming to conduct. Failure to comply with those studies in a timely manner could result in the revocation of the 510(k) clearance for a product that is subject to such a 522 Order and the recall or withdrawal of the product, which could prevent us from generating sales from that product in the U.S.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the EEA., a single regulatory approval process exists, and conformity with its requirements is required to affix a CE mark to our medical devices, without which they cannot be marketed or sold in the EEA.  To obtain a CE mark, defined products must meet minimum standards of performance, safety, and quality, and then, according to their classification, undergo a conformity assessment procedure. Except for low risk medical devices, a conformity assessment procedure requires the intervention of a third-party organization designated by the competent authorities of a EEA country, known as a Notified Body. The competent authorities of the E.U. countries separately regulate the clinical research for medical devices and the market surveillance of products once they are placed on the market. A new Medical Device Regulation was published by the E.U. in 2017 and became effective on May 26, 2021. Medical devices marketed in the EEA will require certification according to these new requirements, except that devices with valid CE certificates, issued pursuant to the Medical Device Directives before May 2020, can be placed on the market until May 2024. The new EU MDR includes significant additional premarket and post-market requirements. Penalties for regulatory non-compliance could be severe, including fines and revocation or suspension of a company&#8217;s business license, mandatory price reductions and criminal sanctions.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The FDA and other regulatory authorities, including foreign authorities, have broad enforcement powers. Regulatory enforcement or inquiries, or other increased scrutiny on us, could dissuade some surgeons from using our products and adversely affect our reputation and the perceived safety and effectiveness of our products.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Failure to comply with applicable regulations could jeopardize our ability to sell our products and result in enforcement actions such as:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;warning letters;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;fines;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;injunctions;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;civil penalties;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;termination of distribution;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;recalls or seizures of products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;delays in the introduction of products into the market;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;total or partial suspension of production;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;facility closures;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;refusal of the FDA or our Notified Body or other regulator to grant future clearances or approvals or to issue CE Certificates of Conformity;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;withdrawals, variation, or suspensions of current clearances or approvals and CE Certificates of Conformity, resulting in prohibitions on sales of our products; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;in the most serious cases, criminal penalties.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Adverse action by an applicable regulatory agency, our Notified Body or the FDA could result in inability to produce our products in a cost-effective and timely manner, or at all, decreased sales, higher prices, lower margins, additional unplanned costs or actions, damage to our reputation, and could have material adverse effect on our reputation, business, results of operations, and financial condition. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We and our sales representatives must comply with U.S. federal and state fraud and abuse laws, including those relating to healthcare provider kickbacks and false claims for reimbursement, and other applicable federal and state healthcare laws, as well as equivalent foreign laws, and failure to comply could negatively affect our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Healthcare providers, distributors and third-party payors play a primary role in the distribution, recommendation, ordering, and purchasing of any implant or other medical device for which we have or obtain marketing clearance or approval. Through our arrangements with customers and third-party payors, we are exposed to the risk that our employees, independent contractors, principal investigators, consultants, vendors, or third-party distributors may engage in fraudulent or other illegal activity. Misconduct by these parties could include, among other infractions or violations, intentional, reckless and/or negligent conduct or unauthorized activity that violates FDA regulations, manufacturing standards, federal and state healthcare fraud and abuse laws and regulations, laws that require the true, complete, and accurate reporting of financial information or data, other commercial or regulatory laws or requirements, and equivalent foreign rules. It is not always possible to identify and deter misconduct by our employees and other third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with such laws or regulations, and government authorities may conclude that our business practices do not comply with applicable fraud and abuse or other healthcare laws and regulations or guidance despite our good faith efforts to comply.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous U.S. federal and state laws pertaining to healthcare fraud and abuse, including anti-kickback and false claims laws. Our relationships and our distributors&#8217; relationships with surgeons, other healthcare professionals, and hospitals are subject to scrutiny under these laws. For example, we are subject to the federal health care Anti-Kickback Statute, the federal civil False Claims Act, the Health Insurance Portability and Accountability Act (&#8220;HIPAA&#8221;) and the federal Physician Payment Sunshine Act, each of which is described in detail in Item 1 Business - Healthcare Fraud and Abuse&#8221; and &#8220;-Data Privacy and Security Laws&#8221; in our Annual Report on Form 10-K filed with the SEC on March&#160;10, 2021.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain states also have enacted analogous state and foreign law equivalents of each of the above federal laws and certain states may also mandate implementation of corporate compliance programs, require compliance with the industry&#8217;s voluntary compliance guidelines, impose restrictions on device manufacturer marketing practices, and/or require tracking and reporting of gifts, compensation, and other remuneration to healthcare professionals and entities. Many of these state laws differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we or our employees are found to have violated any of the above laws we may be subject to significant administrative, civil and criminal penalties, including imprisonment, exclusion from participation in federal healthcare programs, such as Medicare, Medicaid, and equivalent foreign programs, significant fines, monetary penalties and damages, imposition of compliance obligations and monitoring, the curtailment or restructuring of our operations, and damage to our reputation.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have entered into consulting agreements and royalty agreements with physicians and healthcare executives, including some who are customers. We also engage in co-marketing arrangements with certain surgeons who use our products. In addition, prior to our IPO, a small number of our current customer surgeons acquired from us less than 1.0% of our current outstanding common stock, which they either purchased in an arm&#8217;s length transaction on terms identical to those offered to others or received from us as fair market value consideration for consulting services performed. While all of these transactions were structured to comply with applicable laws, including the federal Anti-Kickback Statute, state anti-kickback laws and other applicable laws, it is possible that regulatory agencies may view these transactions as prohibited arrangements that must be restructured, or discontinued, or for which we could be subject to significant penalties and criminal, civil and administrative liability. We would be materially and adversely affected if regulatory agencies interpret our financial relationships with surgeons who order our products to be in violation of applicable laws and we were unable to comply with such laws, which could subject us to, among other things, monetary penalties for non-compliance, the cost of which could be substantial.</span></div><div style="text-align:justify;text-indent:25pt"><span><br/></span></div><div style="text-align:justify;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Various state and federal regulatory and enforcement agencies continue actively to investigate violations of health care laws and regulations, and the U.S. Congress continues to strengthen the arsenal of enforcement tools. To enforce compliance with the federal laws, the U.S. Department of Justice has continued its scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. Dealing with investigations can be time- and resource-consuming and can divert management&#8217;s attention from the business. Additionally, if a healthcare company settles an investigation with the Department of Justice or other law enforcement agencies, it may need to agree to additional onerous compliance and reporting requirements as part of a consent decree, deferred or non-prosecution agreement, or corporate integrity agreement. Any such investigation or settlement could increase our costs or otherwise have an adverse effect on our business. Even if we are not determined to have violated these laws, government investigations into these issues typically require the expenditure of significant resources and generate negative publicity, which could harm our financial condition and divert resources and the attention of our management from operating our business.</span></div><div style="text-align:justify;text-indent:25pt"><span><br/></span></div><div style="text-align:justify;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The scope and enforcement of these laws is uncertain and subject to rapid change. The shifting compliance environment and the need to build and maintain robust and expandable systems and processes to comply with different compliance and/or reporting requirements in multiple jurisdictions increase the possibility that we may run afoul of one or more of the requirements or that federal </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">or state regulatory authorities might challenge our current or future activities under these laws. Additionally, we cannot predict the impact of any changes in these laws, whether or not retroactive.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our failure to adequately protect personal information in compliance with evolving legal requirements could harm our business.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect and store sensitive data, including legally protected personally identifiable information. We collect this kind of information for billing, reimbursement support, marketing purposes, post-marketing safety vigilance, servicing potential warranty claims and during the course of clinical trials. In doing so, we are subject to various federal, state and foreign laws that protect the confidentiality of certain patient health information, including patient medical records, and restrict the use and disclosure of patient health information by healthcare providers, such as HIPAA in the U.S. and regulations in the European Union (&#8220;EU&#8221;), which are described in detail in Item 1 Business - Data Privacy and Security Laws&#8221; in our Annual Report on Form 10-K filed with the SEC on March&#160;10, 2021.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The California Consumer Privacy Act (&#8220;CCPA&#8221;), which became effective on January 1, 2020, requires a broad range of businesses to honor the requests of California residents to access and require deletion of their personal information, opt out of certain personal information sharing, and receive detailed information about how their personal information is used and shared. The CCPA provides for civil penalties of up to $7,500 for intentional violations, and a private right of action for data breaches that allows private plaintiffs to seek the greater of actual damages or statutory damages of up to $750 per consumer per data breach.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These remedies are expected to increase data breach litigation. Although the CCPA includes exemptions for certain clinical trials data, and protected health information governed by HIPAA, the law may increase our compliance costs and potential liability with respect to other personal information we collect about California residents. Our compliance costs and potential liability with respect to personal information may also increase in response to other states adopting and considering initiative regarding protection of personal information. In March 2021, Virginia passed the Consumer Data Protection Act (&#8220;CDPA&#8221;) which will take effect on January 1, 2023. Virginia is the second state to pass comprehensive privacy litigation. Colorado passed the Colorado Privacy Act (&#8220;CPA&#8221;) on July 7, 2021 with enforcement to begin on July 1, 2023. While the CDPA and CPA emulate the GDPR and the CCPA in certain respects, the laws differ and compliance with one law does not equate to compliance with the other laws.  Several other states (including Washington, New York, and Minnesota) also are considering comprehensive privacy legislation that could further complicate and increase the cost of complying with various state privacy laws. If states pass a patchwork of privacy laws, this also could increase pressure on the U.S. Congress to harmonize privacy laws through federal legislation.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our failure to comply with applicable laws and regulations, or to protect such data, could result in enforcement actions against us, including fines, imprisonment of company officials and public censure, claims for damages by end-customers, and other affected individuals, and the imposition of integrity obligations and agency oversight, damage to our reputation, and loss of goodwill, any of which could harm our operations, financial performance, and business. Evolving and changing definitions of personal data and personal information, within the European Union, the U.S., and elsewhere, may limit or inhibit our ability to operate or expand our business, including limiting strategic partnerships that may involve the sharing of data. Moreover, if the relevant laws and regulations change, or are interpreted and applied in a manner that is inconsistent with our data practices or the operation of our products, or if we expand into new regions and are required to comply with new requirements, we may need to expend resources in order to change our business operations, data practices, or the manner in which our products operate. Even the perception of privacy concerns, whether or not valid, may harm our reputation and inhibit adoption of our products.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are subject to risks associated with our non-U.S. operations.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The FCPA prohibits companies and their intermediaries from making improper payments to foreign officials for the purpose of obtaining or retaining business. Other anti-corruption or anti-bribery laws, such as the UKBA, prohibit companies and their intermediaries from making improper payments for the purpose of obtaining or retaining business in foreign countries. The FCPA also imposes accounting standards and requirements on publicly traded U.S. corporations and their foreign affiliates, which are intended to prevent the diversion of corporate funds to the payment of bribes and other improper payments, and to prevent the establishment of slush funds from which such improper payments can be made. Because of the predominance of government-sponsored healthcare systems around the world, many of our customer relationships outside of the U.S. are with governmental entities and are therefore subject to such anti-bribery laws. Our internal control policies and procedures may not always protect us from reckless or criminal acts committed by our employees or agents. Violations of these laws, or allegations of such violations, could disrupt our operations, involve significant management distraction, and result in a material adverse effect on our business, results of operations, and financial condition. We also could suffer severe penalties, including criminal and civil penalties, disgorgement, and other remedial measures, including further changes or enhancements to our procedures, policies, and controls, as well as potential personnel changes and disciplinary actions.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furthermore, we are subject to anti-boycott laws, anti-money laundering laws, and the export controls and economic embargo rules and regulations of the U.S., including, but not limited to, the Export Administration Regulations and trade sanctions against embargoed countries, which are administered by the Office of Foreign Assets Control within the Department of the Treasury, as well as the laws and regulations administered by the Department of Commerce. These regulations limit our ability to market, sell, distribute, or otherwise transfer our products or technology to prohibited countries or persons. A determination that we have failed to </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">comply, whether knowingly or inadvertently, may result in substantial penalties, including fines and enforcement actions and civil and/or criminal sanctions, the disgorgement of profits, and the imposition of a court-appointed monitor, as well as the denial of export privileges, and may have an adverse effect on our reputation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Even if our products are approved by regulatory authorities or CE marked, if we, our contractors, or our suppliers fail to comply with ongoing FDA or other foreign regulatory requirements, or if we experience unanticipated problems with our products, these products could be subject to restrictions or withdrawal from the market.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For any product for which we obtain regulatory clearance or approval, or a CE Certificate of Conformity, the manufacturing processes, reporting requirements, post-approval clinical data, and promotional activities for such product will be subject to continued regulatory review, oversight and periodic inspections by the FDA, our Notified Body and other domestic and foreign regulatory bodies. In particular, we and our suppliers are required to comply with FDA&#8217;s Quality System Regulations (&#8220;QSR&#8221;) and International Standards Organization (&#8220;ISO&#8221;) regulations for the manufacture of our products and other regulations which cover the methods and documentation of the design, testing, production, control, quality assurance, labeling, packaging, storage, and shipping of any product for which we obtain regulatory clearance or approval, or a CE Certificate of Conformity.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The failure by us or one of our suppliers to comply with applicable statutes and regulations, or the failure to timely and adequately respond to any adverse inspectional observations or product safety issues, could result in, among other things, any of the following enforcement actions:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;untitled letters, warning letters, fines, injunctions, consent, and civil penalties;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;unanticipated expenditures to address or defend such actions;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;customer notifications for repair, replacement, refunds;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;recall, detention, or seizure of our products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;operating restrictions or partial suspension or total shutdown of production;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;refusing or delaying our requests for 510(k) clearance or premarket approval and conformity assessments of new products or modified products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;limitations on the intended uses for which the product may be marketed;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;operating restrictions;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;withdrawing 510(k) clearances or PMA approvals that have already been granted;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;suspension, variation or withdrawal of CE Certificates of Conformity;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;refusal to grant export approval for our products; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;criminal prosecution.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, we are required to conduct costly post-market testing and surveillance to monitor the safety or effectiveness of our products, and we must comply with medical device reporting requirements, including the reporting of adverse events and malfunctions related to our products. Later discovery of previously unknown problems with our products, including unanticipated adverse events or adverse events of unanticipated severity or frequency, manufacturing problems, or failure to comply with regulatory requirements such as QSR, may result in changes to labeling, restrictions on such products or manufacturing processes, withdrawal of the products from the market, voluntary or mandatory recalls, a requirement to repair, replace, or refund the cost of any medical device we manufacture or distribute, fines, suspension, variation, or withdrawal of regulatory approvals or CE Certificates of Conformity, product seizures, injunctions, or the imposition of civil, administrative, or criminal penalties which would adversely affect our business, operating results, and prospects.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If the FDA determines that our promotional materials, labeling, training or other marketing or educational activities constitute promotion of an unapproved use, it could request that we cease or modify our training or promotional materials or subject us to regulatory enforcement actions. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider our training or other promotional materials to constitute promotion of an unapproved use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false or fraudulent claims for payment of government funds. Any of these actions would harm our reputation and cause our product sales and profitability to suffer and may prevent us from generating revenue.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our employees, independent contractors, consultants, manufacturers, and third-party distributors may engage in misconduct or other improper activities, relating to regulatory standards and requirements. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are exposed to the risk that our employees, independent contractors, consultants, manufacturers, and third-party distributors may engage in fraudulent conduct or other illegal activity. Misconduct by these parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities to us that violates FDA regulations, including those laws requiring the reporting of true, complete and accurate information to the FDA, manufacturing standards, federal, state and foreign healthcare laws and regulations, data privacy laws and laws that require the true, complete and accurate reporting of financial information or data. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs, and other business arrangements. Misconduct by these parties could also involve the improper use of individually identifiable information which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil, criminal, and administrative penalties, including, without limitation, damages, fines, disgorgement of profits, imprisonment, exclusion from participation in government healthcare programs, such as Medicare and Medicaid, and the curtailment or restructuring of our operations.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may be subject to enforcement action, including fines, penalties or injunctions, if we are determined to be engaging in the off-label promotion of our products.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our promotional materials and training methods must comply with FDA and other applicable national and foreign laws and regulations, including the prohibition of the promotion of off-label use. Physicians may use our products off-label, as the FDA and equivalent third country authorities do not restrict or regulate a physician&#8217;s choice of treatment within the practice of medicine. In the U.S., the full indication for the iFuse Implant System is: &#8220;The iFuse Implant System is intended for sacroiliac fusion for the following conditions: (i) Sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. (ii) To augment immobilization and stabilization of the sacroiliac joint in skeletally mature patients undergoing sacropelvic fixation as part of a lumbar or thoracolumbar fusion. (iii) Acute, non-acute, and non-traumatic fractures involving the sacroiliac joint.&#8221; In the U.S., our marketing strategies must adhere to the above statements. In all other countries, the indication statement for the iFuse Implant System (including iFuse-3D) more broadly indicates that the device is indicated for sacroiliac joint fusion. The above-described potential limitation in indication statements in the U.S. does not apply in other geographies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe that the specific surgical procedures for which our products are marketed fall within the scope of the surgical applications that have been cleared by the FDA and our notified body. However, if the FDA or an equivalent third country authority determines that our promotional materials or training constitutes promotion of an off-label use, it could request that we modify our training or promotional materials, require us to stop promoting our products for those specific procedures until we obtain FDA or third country authority clearance or approval for them, or subject us to regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, injunction, seizure, civil fines, and criminal penalties. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider our promotional or training materials to constitute promotion of an unapproved use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false or fraudulent claims for payment of government fund. In that event, our reputation could be damaged and adoption of the products would be impaired. Although our policy is to refrain from statements that could be considered off-label promotion of our products, the FDA or another regulatory agency could disagree and conclude that we have engaged in off-label promotion. In addition, the off-label use of our products may increase the risk of injury to patients, and, in turn, the risk of product liability claims. Product liability claims are expensive to defend and could divert our management&#8217;s attention, result in substantial damage awards against us and harm our reputation.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are required to report certain malfunctions, deaths, and serious injuries associated with our products, which can result in voluntary corrective actions or agency enforcement actions.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under the FDA&#8217;s medical device reporting, regulations, and equivalent rules of other countries we are required to report to the FDA or a similar authority in such other country, any information that our product may have caused or contributed to a death or serious injury or in which our product malfunctioned and, if the malfunction were to recur, would likely cause or contribute to death or serious injury. In the EEA, we must report serious incidents and field safety corrective actions through the Commission&#8217;s electronic system on vigilance and post-market surveillance, which reports are transmitted to the competent authority of the Member State in which the incident occurred. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we fail to report these events to the FDA or applicable authority in another country within the required timeframes, or at all, FDA, or the applicable authority in the other country could take enforcement action against us. Any such adverse event involving our products or repeated product malfunctions may result in voluntary or involuntary corrective actions, such as recalls or customer notifications, or agency action, such as inspection or enforcement action. Any corrective action, whether voluntary or involuntary, as well as defending ourselves in a lawsuit, could divert managerial and financial resources, impair our ability to manufacture our products in a cost-effective and timely manner, and have an adverse effect on our reputation, results of operations, and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any adverse event involving our products, whether in the U.S. or abroad could result in future voluntary corrective actions, such as recalls, including corrections, or customer notifications, or agency action, such as inspection or enforcement actions. If malfunctions do occur, we may be unable to correct the malfunctions adequately or prevent further malfunctions, in which case we may need to cease manufacture and distribution of the affected products, initiate voluntary recalls, and redesign the products. Regulatory authorities may also take actions against us, such as ordering recalls, imposing fines, or seizing the affected products. Any corrective action, whether voluntary or involuntary, will require the dedication of our time and capital, distract management from operating our business, and may harm our reputation and financial results.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">A recall of our products, either voluntarily or at the direction of the FDA or another governmental authority, including foreign governmental authorities, or the discovery of serious safety issues or malfunctions with our products, can result in voluntary corrective actions or agency enforcement actions, which could have a significant adverse impact on us.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The FDA and similar foreign governmental authorities have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design or manufacture or in the event that a product poses an unacceptable risk to health. Manufacturers may, under their own initiative, recall a product if any material deficiency in a device is found.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the case of the FDA, the authority to require a recall must be based on an FDA finding that there is an unreasonable risk of substantial public harm. In addition, foreign governmental bodies have the authority to require the recall of our products in the event of material deficiencies or defects in design or manufacture. A government-mandated or voluntary recall by us or one of our third-party distributors could occur as a result of an unacceptable risk to health, component failures, manufacturing errors, design or labeling defects, or other deficiencies and issues. Recalls of any of our products would divert managerial and financial resources and have an adverse effect on our reputation, results of operations, and financial condition, which could impair our ability to produce our products in a cost-effective and timely manner in order to meet our customers&#8217; demands. We may also be required to bear other costs or take other actions that may have a negative impact on our future sales and our ability to generate profits.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The FDA requires that certain classifications of recalls be reported to FDA within 10 working days after the recall is initiated. Companies are required to maintain certain records of recalls, even if they are not reportable to the FDA. We may initiate voluntary recalls involving our products in the future that we determine do not require notification of the FDA. If the FDA disagrees with our determinations, they could require us to report those actions as recalls. A future recall announcement could harm our reputation with customers and negatively affect our sales. In addition, the FDA could take enforcement action for failing to report the recalls when they were conducted. Equivalent procedures and penalties have been established in other countries including EU Member States.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Modifications to our products may require new 510(k) clearances or premarket approvals and new conformity assessment by our Notified Body, or may require us to cease marketing or recall the modified products until clearances, approvals, or CE Certificates of Conformity are obtained.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any modification to a 510(k)-cleared device that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, design, or manufacture, requires a new 510(k) clearance or, possibly, a PMA. The FDA requires every manufacturer to make and document this determination in the first instance. A manufacturer may determine that a modification could not significantly affect safety or effectiveness and does not represent a major change in its intended use, so that no new 510(k) clearance is necessary. FDA may review any manufacturer&#8217;s decision and may not agree with our decisions regarding whether new clearances or approvals are necessary. The FDA may also on its own initiative determine that a new clearance or approval is required.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have modified some of our 510(k) cleared products and have determined based on our review of the applicable FDA guidance that in certain instances new 510(k) clearances or PMAs are not required. If the FDA disagrees with our determination and requires us to submit new 510(k) clearances or PMAs for modifications to our previously cleared products for which we have concluded that new clearances or approvals are unnecessary, we may be required to cease marketing or to recall the modified product until we obtain clearance or approval. In these circumstances, we may be subject to significant enforcement actions, regulatory fines, or penalties, which could require us to redesign our products and harm our operating results.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If a manufacturer determines that a modification to an FDA-cleared device could significantly affect its safety or effectiveness, or would constitute a major change in its intended use, then the manufacturer must file for a new 510(k) clearance or possibly a premarket approval application. Where we determine that modifications to our products require a new 510(k) clearance or premarket approval application, we may not be able to obtain those additional clearances or approvals for the modifications or additional </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">indications in a timely manner, or at all. FDA&#8217;s ongoing review of the 510(k) program may make it more difficult for us to make modifications to our previously cleared products, either by imposing more strict requirements on when a new 510(k) for a modification to a previously cleared product must be submitted, or applying more onerous review criteria to such submissions.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the EEA, we must inform the Notified Body that carried out the conformity assessment of the medical devices we market or sell in the EEA of any planned substantial changes to our quality system, manufacturing process, or changes to our devices which could affect compliance with the essential requirements or the devices&#8217; intended use. The Notified Body will then assess the changes and verify whether they affect the products&#8217; conformity with Essential Requirements and related applicable laws. There can be no assurances that the assessment will be favorable and that the Notified Body will attest to our compliance with the essential requirements, which will prevent us from selling our products in the EEA. Moreover, any substantial changes that take place in the coming years may impact the continuing effectiveness of our CE Certificates of Conformity that were issued on the basis of the Medical Device Directive.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">There is no guarantee that the FDA will grant 510(k) clearance or premarket approval of our future products or that our Notified Body will issue the required CE Certificate of Conformity, and failure to obtain necessary clearances or approvals for our future products would adversely affect our business prospects.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are in the process of developing our regulatory strategies for obtaining clearance or approval for future products. Some of them may require 510(k) clearance by the FDA or a new CE Certificate of Conformity. Other future products may require premarket approval. In addition, some of our new products may require clinical trials or significant clinical evidence to support regulatory approval and we may not successfully complete these clinical trials. Obtaining regulatory clearances or approvals and CE Certificates of Conformity can be a time-consuming process, and delays in obtaining required future regulatory clearances or approvals, and CE Certificates of Conformity would adversely affect our ability to introduce new or enhanced products in a timely manner, which in turn would adversely affect our business prospects. The FDA may not approve or clear these products or our Notified Body may not issue CE Certificate of Conformity for the indications that are necessary or desirable for successful commercialization. Indeed, the FDA may refuse our requests for 510(k) clearance or premarket approval of new products, new intended uses, or modifications to existing products and our Notified Body may refuse to issue new CE Certificates of Conformity. Failure to receive clearance, approval, or Certificates of Conformity for our new products would have an adverse effect on our ability to expand our business.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may fail to obtain or maintain foreign regulatory approvals to market our products in other countries.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We currently market our products internationally and intend to expand our international marketing. International jurisdictions require separate regulatory approvals and compliance with numerous and varying regulatory requirements. For example, we intend to continue to seek domestic and international regulatory clearance to market our primary products Asia, the Middle East and other key markets. The approval procedures vary among countries and may involve requirements for substantial additional testing, and the time required to obtain approval may differ from country to country and from that required to obtain FDA clearance or approval or to obtain CE Certificates of Conformity.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Clearance or approval by the FDA or obtaining a CE Certificate of Conformity does not ensure approval or certification by regulatory authorities in other countries or jurisdictions, and approval or certification by one foreign regulatory authority does not ensure approval or certification by regulatory authorities in other foreign countries or by the FDA. The foreign regulatory approval or certification process may include all of the risks associated with obtaining FDA clearance or approval, or a CE Certificate of Conformity for a medical device in the EEA, in addition to other risks. In addition, the time required to obtain foreign approval may differ from that required to obtain FDA clearance or approval, or a CE Certificate of Conformity in the EEA, and we may not obtain foreign regulatory approvals on a timely basis, if at all. We may not be able to file for regulatory approvals or certifications and may not receive necessary approvals to commercialize our products in any market. If we fail to receive necessary approvals or certifications to commercialize our products in foreign jurisdictions on a timely basis, or at all, our business, results of operations, and financial condition could be adversely affected.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Clinical trials necessary to support a De Novo 510(k) or PMA application or a conformity assessment procedure will be expensive and may require the enrollment of large numbers of patients, and suitable patients may be difficult to identify and recruit. Delays or failures in our clinical trials will prevent us from commercializing any modified or new products, or new indications for use for existing products, and will adversely affect our business, operating results and prospects.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Initiating and completing clinical trials necessary to support a De Novo 510(k) or PMA application for our possible future products or to support a conformity assessment procedure for a new CE Certificate of Conformity would be time consuming and expensive and the outcome uncertain. Moreover, the results of early clinical trials are not necessarily predictive of future results, and any product, or new indication for use, we advance into clinical trials may not have favorable results in later clinical trials.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Conducting successful clinical studies may require the enrollment of large numbers of patients, and suitable patients may be difficult to identify and recruit. Patient enrollment in clinical trials and completion of patient participation and follow-up depends on many factors, including the size of the patient population, the nature of the trial protocol, the attractiveness of, or the discomforts and risks associated with, the treatments received by enrolled subjects, the availability of appropriate clinical trial investigators and support staff,  the proximity of patients to clinical sites, and the ability to comply with the inclusion and exclusion criteria for participation in the clinical trial and patient compliance. Development of sufficient and appropriate clinical protocols to demonstrate safety and effectiveness are required and we may not adequately develop such protocols to support clearance and approval. Further, the FDA or our Notified Body may require us to submit data on a greater number of patients than we originally anticipated and/or for a longer follow-up period or change the data collection requirements or data analysis applicable to our clinical trials. Delays in patient enrollment or failure of patients to continue to participate in a clinical trial may cause an increase in costs and delays in the approval and attempted commercialization of our products or result in the failure of the clinical trial. For example, the COVID-19 pandemic has caused substantial delays in site initiation and patient enrollment in our SILVIA trial designed to assess the safety and efficacy of our Bedrock technique. In addition, despite considerable time and expense invested in our clinical trials, the FDA or our Notified Body may not consider our data adequate to demonstrate safety and effectiveness. Such increased costs and delays or failures could adversely affect our business, operating results and prospects.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our facility and our clinical investigational sites operate under procedures that govern the conduct and management of FDA-regulated clinical studies under 21 CFR Parts 50 and 812, and Good Clinical Practices. The FDA may conduct Bioresearch Monitoring inspections of us and/or our clinical sites to assess compliance with 21 CFR Parts 50 and 812, our procedures, and the clinical protocol. If the FDA were to find that we or our clinical investigators are not operating in compliance with applicable regulations, we could be subject to the above FDA enforcement action, as well as refusal to accept all or part of our data in support of our 510(k) or PMA, or we may need to conduct additional studies.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The results of our clinical trials may not support our product candidate claims or may result in the occurrence of adverse events.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Even if our clinical trials are completed as planned, or on a delayed basis, we cannot be certain that their results will support our product candidate claims or that the FDA, foreign authorities, or our Notified Body will agree with our conclusions regarding them. Success in pre-clinical studies and early clinical trials does not ensure that later clinical trials will be successful, and we cannot be sure that the later trials will replicate the results of prior trials and pre-clinical studies. The clinical trial process may fail to demonstrate that our product candidates are safe and effective for the proposed indicated uses, which could cause us to abandon a product candidate and may delay development of others. Any delay or termination of our clinical trials will delay the filing of our product submissions and, ultimately, our ability to commercialize our product candidates and generate revenue. It is also possible that patients enrolled in clinical trials will experience adverse events that are not currently part of the product candidate&#8217;s profile.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">U.S. legislative or FDA or foreign regulatory reforms may make it more difficult and costly for us to obtain regulatory clearances or approvals, or CE Certificates of Conformity for our product candidates and to manufacture, market, and distribute our products after approval is obtained.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, Congress introduces legislation that could significantly change the statutory provisions governing the regulatory approval, manufacture, and marketing of regulated products or the reimbursement thereof. In addition, FDA regulations and guidance are often revised or reinterpreted by the FDA in ways that may significantly affect our business and our products. Moreover, the new Medical Device Regulation entered into application on May 26, 2021. Any new regulations or revisions or reinterpretations of existing regulations may impose additional costs or lengthen review times of future products. It is impossible to predict whether legislative changes will be enacted or FDA regulations, guidance, or interpretations changed, and what the impact of such changes, if any, may be.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Leadership, personnel and structural changes within the FDA as well as recent federal election outcomes could result in significant legislative and regulatory reforms impacting the FDA's regulation of our products. Any change in the laws or regulations that govern the clearance and approval processes relating to our current and future products could make it more difficult and costly to obtain clearance or approval for new products, or to produce, market and distribute existing products. Significant delays in receiving clearance or approval, or the failure to receive clearance or approval for our new products would have an adverse effect on our ability to expand our business.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Another example can be found in the EEA. The Medical Devices Regulation (&#8220;MDR&#8221;) entered into application on May 26, 2021. MDR introduced substantial changes to the obligations with which medical device manufacturers must comply in the EEA. Examples of the changes which will be introduced by these regulations include the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;additional scrutiny during the conformity assessment procedure for high risk medical devices;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;strengthening of the clinical data requirements related to medical devices;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;strengthening of the designation and monitoring processes governing notified bodies;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the obligation for manufacturers and authorized representative to have a person responsible for regulatory compliance continuously at their disposal;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;authorized representatives held legally responsible and liable for defective products placed on the EU market;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;increased traceability of medical devices following the introduction of a Unique Device Identification (&#8220;UDI&#8221;), system;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;new rules governing the reprocessing of medical devices; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;increased transparency with the establishment of European database on medical devices (&#8220;EUDAMED&#8221;) III as information from several databases concerning economic operators, CE Certificates of Conformity, conformity assessment, clinical investigations, the UDI system, adverse event reporting and market surveillance would be available to the public.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Medical Device Regulation also substantially impacts clinical investigations of medical devices. Among other things, it imposes specific obligations concerning incapacitated subjects, minors, pregnant or breastfeeding women and clinical investigations in emergency situations. In addition to detailed provisions concerning the authorization and conduct of clinical investigations, the Regulation imposes on non-EU sponsors a responsibility to appoint a legal representative established in the EU and an obligation on EU Member States to ensure that systems for compensation for any damage suffered by a subject resulting from participation in a clinical investigation conducted on their territory are in place and places on sponsors and investigators the obligation to ensure they make use of these systems.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Transition from the regulation of our products under the Medical Device Directive, and implementing legislation in each EU Member State, to regulation under the Medical Devices Regulation has required and will continue to require a substantial transition effort by us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In addition, detail as to how certain aspects of the Medical Devices Regulation will be applied remains unclear. Failure to update our quality system and regulatory documentation could delay our transition to compliance with the Medical Devices Regulation and delay or prevent us from obtaining new CE Certificates of Conformity under the Regulation.  Transition from compliance with the Medical Device Directive to the Medical Devices Regulation could result in disruption to our business in the EEA which could adversely affect our business, results of operation and financial condition. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In addition, any changes to the membership of the European Union, such as the departure of the United Kingdom from the EU, may impact the regulatory requirements for the impacted countries and impair our business operations and our ability to market products in such countries. For example, pursuant to guidance issued by the UK Government as a result of the UK formally withdrawing from the European Union, the Medicines and Healthcare products Regulatory Agency (&#8220;MHRA&#8221;) became the standalone medicines and medical devices regulator for the UK as of January 1, 2021. A new mark referred to as &#8220;UKCA&#8221; (UK Conformity Assessed) has also been introduced and will replace the CE conformity mark. Although CE conformity marketing and certificates issued by Notified Bodies will continue to be recognized in the UK through June 2023, all medical devices must be registered with the MHRA as of January 1, 2021. Complying with this new regulatory framework will require us to invest in additional resources and could be expensive, time-consuming and disruptive to our existing operations in the UK.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may incur product liability losses, and insurance coverage may be inadequate or unavailable to cover these losses.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our business exposes us to potential product liability claims that are inherent in the testing, design, manufacture, and sale of surgical devices. Sacroiliac joint and other orthopedic spine surgeries involve significant risk of serious complications, including bleeding, nerve injury, paralysis, and even death. Surgeons may misuse or ineffectively use our products, which may result in unsatisfactory patient outcomes or patient injury. In addition, if longer-term patient results and experience indicate that our products or any component of a product cause tissue damage, motor impairment, or other adverse effects, we could be subject to significant liability. We could become the subject of product liability lawsuits alleging that component failures, manufacturing flaws, design defects, or inadequate disclosure of product-related risks or product-related information resulted in an unsafe condition or injury to patients. Product liability lawsuits and claims, safety alerts, or product recalls, regardless of their ultimate outcome, could have a material adverse effect on our business and reputation, our ability to attract and retain customers and our results of operations or financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Although we maintain third-party product liability insurance coverage, it is possible that claims against us may exceed the coverage limits of our insurance policies or cause us to record a self-insured loss. Even if any product liability loss is covered by an insurance policy, these policies typically have substantial retentions or deductibles that we are responsible for. Product liability claims in excess of applicable insurance coverage could have a material adverse effect on our business, results of operations, and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, any product liability claim brought against us, with or without merit, could result in an increase of our product liability insurance rates. Insurance coverage varies in cost and can be difficult to obtain, and we cannot guarantee that we will be able to obtain insurance coverage in the future on terms acceptable to us or at all.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are subject to environmental laws and regulations that can impose significant costs and expose us to potential financial liabilities.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The manufacture of certain of our products, including our implants and products, and the handling of materials used in the product testing process involve the use of biological, hazardous and/or radioactive materials and wastes. Our business and facilities and those of our suppliers are subject to foreign, federal, state, and local laws and regulations relating to the protection of human health and the environment, including those governing the use, manufacture, storage, handling, and disposal of, and exposure to, such materials and wastes. We own and operate certain x-ray equipment at our facilities which requires adoption of a radiation safety plan.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our failure to follow such safety plan or otherwise use this equipment properly could be hazardous to our employees and expose us to liability as the employer. In addition, under some environmental laws and regulations, we could be held responsible for costs relating to any contamination at our past or present facilities and at third-party waste disposal sites even if such contamination was not caused by us. A failure to comply with current or future environmental laws and regulations could result in severe fines or penalties. Any such expenses or liability could have a significant negative impact on our business, results of operations, and financial condition.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Certain of our products are derived from human tissue and are or could be subject to additional regulations and requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our iFuse Bone product is derived from human bone tissue, and as a result is subject to FDA and certain state regulations regarding human cells, tissues and cellular or tissue-based products, or HCT/Ps. To date, iFuse Bone is our only HCT/P product, and as a product regulated under Section 361 of the Public Health Service Act, we have not been required to file a 510(k) with respect to iFuse Bone. However, the FDA could require us to obtain a 510(k) clearance for future tissue products not regulated as 361 HCT/Ps. The process of obtaining a 510(k) clearance could take time and consume resources, and failing to receive such a clearance would render us unable to market and sell such products, which could have a material and adverse effect on our business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, procurement of certain human organs and tissue for transplantation is subject to the National Organ Transplant Act, or NOTA, which prohibits the transfer of certain human organs, including skin and related tissue, for valuable consideration, but permits the reasonable payment for costs associated with the removal, transportation, implantation, processing, preservation, quality control and storage of human tissue and skin. We reimburse tissue banks for their expenses associated with the recovery, storage and transportation of donated human tissue they provide to us for processing. We include in our pricing structure amounts paid to tissue banks to reimburse them for their expenses associated with the recovery and transportation of the tissue, in addition to certain costs associated with processing, preservation, quality control and storage of the tissue, marketing and medical education expenses and costs associated with development of tissue processing technologies. NOTA payment allowances may be interpreted to limit the amount of costs and expenses we can recover in our pricing for our products, thereby reducing our future revenue and profitability. If we were to be found to have violated NOTA&#8217;s prohibition on the sale or transfer of human tissue for valuable consideration, we would potentially be subject to criminal enforcement sanctions, which could materially and adversely affect our results of operations.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Our Intellectual Property</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If we or our licensors fail to adequately protect or enforce our intellectual property rights or secure rights to patents of others, the value of our intellectual property rights would diminish and our ability to successfully commercialize our products may be impaired.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We rely primarily on patent, copyright, trademark and trade secret laws, as well as confidentiality and nondisclosure agreements and other methods, to protect our proprietary technologies and know-how. As of September 30, 2021, we owned 43 issued U.S. patents and had 31 pending U.S. patent applications, and we owned 14 issued foreign patents and had 10 pending foreign patent applications. We have focused the majority of our foreign patent efforts in China, Europe, and Japan. Our current U.S. patents on iFuse, including the triangular shape, expire in November 2024. Competitors may market similar triangular shaped devices upon the expiration of the patents in late 2024. Our current U.S. patents on iFuse-3D, including the fenestrated design, expire in September 2035. Our foreign patents will expire between August 2025 and October 2031.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2021, we have 17 registered trademarks in the U.S. and have filed for 15 more. We have sought protection for at least 2 of these trademarks in 60 countries including the 27 European member countries of the Madrid Protocol.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have applied for patent protection relating to certain existing and proposed products and processes. While we generally apply for patents in those countries where we intend to make, have made, use, or sell our products, we may not accurately predict all of the countries where patent protection will ultimately be desirable. If we fail to timely file a patent application in any such country, we may be precluded from doing so at a later date. Furthermore, we cannot assure investors that any of our patent applications will be approved. The rights granted to us under our patents, including prospective rights sought in our pending patent applications, may not be meaningful or provide us with any commercial advantage. In addition, those rights could be opposed, contested, or circumvented by our competitors or be declared invalid or unenforceable in judicial or administrative proceedings. The failure of our patents to adequately protect our technology might make it easier for our competitors to offer the same or similar products or technologies. Competitors may be able to design around our patents or develop products that provide outcomes that are comparable to ours without infringing on our intellectual property rights. Due to differences between foreign and U.S. patent laws, our patented intellectual property rights may not receive the same degree of protection in foreign countries as they would in the U.S. Even if patents are granted outside the U.S., effective enforcement in those countries may not be available. Since most of our issued patents are for the U.S. only, we lack a corresponding scope of patent protection in other countries. In countries where we do not have significant patent protection, we may not be able to stop a competitor from marketing products in such countries that are the same as or similar to our products.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We rely on our trademarks, trade names and brand names to distinguish our products from the products of our competitors and have registered or applied to register many of these trademarks. We cannot assure investors that our trademark applications will be approved. Third parties may also oppose our trademark applications, or otherwise challenge our use of the trademarks. In the event that our trademarks are successfully challenged, we could be forced to rebrand our products, which could result in loss of brand recognition, and could require us to devote resources to advertising and marketing new brands. Further, we cannot assure investors that competitors will not infringe upon our trademarks, or that we will have adequate resources to enforce our trademarks.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also rely on trade secrets, know-how, and technology, which are not protected by patents, to maintain our competitive position. We try to protect this information by entering into confidentiality and intellectual property assignment agreements with parties that develop intellectual property for us and/or have access to it, such as our officers, employees, consultants, and advisors. However, in the event of unauthorized use or disclosure or other breaches of such agreements, we may not be provided with meaningful protection for our trade secrets or other proprietary information. In addition, our trade secrets may otherwise become known or be independently discovered by competitors. To the extent that our commercial partners, collaborators, employees, and consultants use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions. If any of our trade secrets, know-how or other technologies not protected by a patent were to be disclosed to or independently developed by a competitor, our business, financial condition, and results of operations could be materially adversely affected.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the future, we may enter into licensing agreements to maintain our competitive position. If we enter into in-bound intellectual property license agreements, we may not be able to fully protect the licensed intellectual property rights or maintain those licenses. Future licensors could retain the right to prosecute and defend the intellectual property rights licensed to us, in which case we would depend on the ability of our licensors to obtain, maintain and enforce intellectual property protection for the licensed intellectual property. These licensors may determine not to pursue litigation against other companies or may pursue such litigation less aggressively than we would. Further, entering into such license agreements could impose various diligence, commercialization, royalty, or other obligations on us. Future licensors may allege that we have breached our license agreement with them, and accordingly seek damages or to terminate our license, which could adversely affect our competitive business position and harm our business prospects.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If a competitor infringes upon one of our patents, trademarks, or other intellectual property rights, enforcing those patents, trademarks, and other rights may be difficult and time consuming. Even if successful, litigation to defend our patents and trademarks against challenges or to enforce our intellectual property rights could be expensive and time consuming and could divert management&#8217;s attention from managing our business. Moreover, we may not have sufficient resources to defend our patents or trademarks against challenges or to enforce our intellectual property rights. In addition, if third parties infringe any intellectual property that is not material to the products that we make, have made, use, or sell, it may be impractical for us to enforce this intellectual property against those third parties.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may be subject to damages resulting from claims that we, our employees, or our third-party distributors have wrongfully used or disclosed alleged trade secrets of our competitors or are in breach of non-competition or non-solicitation agreements with our competitors.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Many of our employees were previously employed at other medical device companies, including our competitors or potential competitors, in some cases until recently. Some of our third-party distributors sell, or in the past have sold, products of our competitors. We may be subject to claims that we, our employees, or our third-party distributors have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of these former employers or competitors. In addition, we have been and may in the future be subject to claims that we caused an employee to breach the terms of his or her non-competition or non-solicitation agreement. Even if we are successful in defending against these claims, litigation could result in substantial costs, divert the attention of management from our core business and harm our reputation. If our defense to those claims fails, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. There can be no assurance that this type of litigation will not occur, and any future litigation or the threat thereof may adversely affect our ability to hire additional direct sales representatives. A loss of key personnel or their work product could hamper or prevent our ability to commercialize product candidates, which could have an adverse effect on our business, results of operations, and financial condition.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The medical device industry is characterized by patent litigation and we could become subject to litigation that could be costly, result in the diversion of management&#8217;s time and efforts, require us to pay damages, and/or prevent us from developing or marketing our existing or future products.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our commercial success will depend in part on not infringing the patents or violating the other proprietary rights of third parties. Significant litigation regarding patent rights exists in our industry. Our competitors in both the U.S. and abroad, many of which have substantially greater resources and have made substantial investments in competing technologies, may have applied for or obtained or may in the future apply for and obtain, patents that will prevent, limit, or otherwise interfere with our ability to make and sell our products. We have conducted a limited review of patents issued to third parties. The large number of patents, the rapid rate of new patent issuances, the complexities of the technology involved, and the uncertainty of litigation increase the risk of management&#8217;s attention being diverted to patent litigation. Any litigation or claim against us, even those without merit, may cause us to incur substantial costs, and could place a significant strain on our financial resources, divert the attention of management from our core business, and harm our reputation. Further, as the number of participants in the medical device industry grows, the possibility of intellectual property infringement claims against us increases. If we are found to infringe the intellectual property rights of third parties, we could be required to pay substantial damages, including treble, or triple, damages if an infringement is found to be willful, and/or royalties and could be prevented from selling our products unless we obtain a license or are able to redesign our products to avoid infringement. Any such license may not be available on reasonable terms, if at all, and there can be no assurance that we would be able to redesign our products in a way that would not infringe the intellectual property rights of others. If we fail to obtain any required licenses or make any necessary changes to our products or technologies, we may have to withdraw existing products from the market or may be unable to commercialize one or more of our products, all of which could have a material adverse effect on our business, results of operations, and financial condition. If passed into law, patent reform legislation currently pending in the U.S. Congress could significantly change the risks associated with bringing or defending a patent infringement lawsuit. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, we generally indemnify our customers and third-party distributors with respect to infringement by our products of the proprietary rights of third parties. Third parties may assert infringement claims against our customers or third-party distributors. These claims may require us to initiate or defend protracted and costly litigation on behalf of our customers or third-party distributors, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages on behalf of our customers or third-party distributors or may be required to obtain licenses to intellectual property owned by such third parties. If we cannot obtain all necessary licenses on commercially reasonable terms, our customers and third-party distributors may be forced to stop using or selling our products.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Ownership of Our Common Stock</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The price of our common stock may be volatile, and the value of an investment in our common stock could decline.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Medical device stocks have historically experienced volatility, and the trading price of our common stock may fluctuate substantially. These fluctuations could cause our stockholders to lose all or part of their investment in our common stock. Factors that could cause fluctuations in the trading price of our common stock include the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the impact that the COVID-19 pandemic has on our business;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">actual or anticipated changes or fluctuations in our results of operations;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;results of our clinical trials and that of our competitors&#8217; products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;regulatory actions with respect to our products or our competitor&#8217;s products;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;announcements of new offerings, products, services or technologies, commercial relationships, acquisitions, or other events by us or our competitors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;price and volume fluctuations in the overall stock market from time to time; </span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;significant volatility in the market price and trading volume of healthcare companies, in general, and of companies in the medical device industry in particular;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;fluctuations in the trading volume of our shares or the size of our public float;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;negative publicity;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;whether our results of operations meet the expectations of securities analysts or investors or those expectations change;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;litigation involving us, our industry, or both;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;regulatory developments in the U.S., foreign countries, or both;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;lock-up releases and sales of large blocks of our common stock;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;additions or departures of key employees or scientific personnel; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;general economic conditions and trends.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, if the market for healthcare stocks or the stock market, in general, experience a further loss of investor confidence, the trading price of our common stock could decline for reasons unrelated to our business, results of operations, or financial condition. The trading price of our common stock might also decline in reaction to events that affect other companies in our industry even if these events do not directly affect us. In the past, following periods of volatility in the market price of a company&#8217;s securities, securities class action litigation has often been brought against that company. If our stock price is volatile, we may become the target of securities litigation. Securities litigation could result in substantial costs and divert our management&#8217;s attention and resources from our business. This could have a material adverse effect on our business, results of operations, and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our sales volumes and our operating results may fluctuate over the course of the year, which could affect the price of our common stock.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have experienced and continue to experience meaningful variability in our sales and gross profit from quarter to quarter, as well as within each quarter. Our sales and results of operations will be affected by numerous factors, including, among other things:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the impact that the COVID-19 pandemic has on our business;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">payor coverage and reimbursement;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the number of products sold in the quarter and our ability to drive increased sales of our products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">our ability to establish and maintain an effective and dedicated sales force;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">pricing pressure applicable to our products, including adverse third-party coverage and reimbursement outcomes;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">results of clinical research and trials on our existing products and products in development;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the mix of our products sold because profit margins differ amongst our products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">timing of new product offerings, acquisitions, licenses or other significant events by us or our competitors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the ability of our suppliers to timely provide us with an adequate supply of materials and components;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the evolving product offerings of our competitors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the demand for, and pricing of, our products and the products of our competitors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">factors that may affect the sale of our products, including seasonality and budgets of our customers;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">domestic and international regulatory clearances or approvals, or CE Certificates of Conformity, and legislative changes affecting the products we may offer or those of our competitors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">interruption in the manufacturing or distribution of our products;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the effect of competing technological, industry and market developments;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">our ability to expand the geographic reach of our sales and marketing efforts;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the costs of maintaining adequate insurance coverage, including product liability insurance;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the availability and cost of components and materials;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">the number of selling days in the quarter;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">fluctuation in foreign currency exchange rates; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">impairment and other special charges.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Some of the products we may seek to develop and introduce in the future will require FDA clearance or approval before commercialization in the U.S., and commercialization of such products outside of the U.S. would likely require additional regulatory approvals, or Certificates of Conformity and import licenses. As a result, it will be difficult for us to forecast demand for these products with any degree of certainty. In addition, we will be increasing our operating expenses as we expand our commercial capabilities. Accordingly, we may experience significant, unanticipated losses. If our quarterly or annual operating results fall below the expectations of investors or securities analysts, the price of our common stock could decline substantially. Furthermore, any quarterly or annual fluctuations in our operating results may, in turn, cause the price of our common stock to fluctuate substantially. Quarterly comparisons of our financial results may not always be meaningful and should not be relied upon as an indication of our future performance.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may be unable to utilize our federal and state net operating loss carryforwards to reduce our income taxes.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had net operating loss (&#8220;NOL&#8221;) carryforwards of $200.5 million and $165.0 million available to reduce future taxable income, if any, for U.S. federal income tax and state income tax purposes, respectively. If not utilized, our federal and state NOL carryforwards begin to expire in 2028 and 2021, respectively, subject to the recent California franchise tax law change affecting California state NOLs mentioned below. Portions of these NOL carryforwards could expire unused and be unavailable to offset future income tax liabilities. Under legislation enacted in 2017, as modified by legislation enacted in 2020, unused U.S. federal NOLs generated in tax years beginning after December 31, 2017</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">will not expire and may be carried forward indefinitely, but the deductibility of such federal NOLs in taxable years beginning after December 31, 2020, is limited to 80% of taxable income. At the state level, there may be periods during which the use of NOLs is suspended or otherwise limited. In addition, under Section 382 of the Code, and corresponding provisions of state law, if a corporation undergoes an &#8220;ownership change,&#8221; which generally occurs if the percentage of the corporation&#8217;s stock owned by 5% stockholders increases by more than 50% over a three-year period, the corporation&#8217;s ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset its post-change income may be limited. We updated our Section 382 ownership change analysis through December 31, 2020. The analysis determined that we have experienced Section 382 ownership changes in 2010 and 2020. A total of $1.4 million of our NOLs and tax credit carryforwards are subject to limitation as a result of the ownership change. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Assembly Bill 85 (AB 85) was signed into law by Governor Gavin Newsom on June 29, 2020. The legislation suspends the California NOL deductions for 2020, 2021, and 2022 for certain taxpayers and imposes a limitation of certain California Tax Credits for 2020, 2021, and 2022. The legislation disallows the use of California NOL deductions if the taxpayer recognizes business income and its adjusted gross income is greater than $1.0 million. The carryover periods for NOL deductions disallowed by this provision will be extended. Given that we expect to be at a loss position in the current year, the new legislation will not impact our current year provision. We will continue to monitor the possible California NOLs and credit limitation in future periods.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our charter documents and Delaware law could discourage takeover attempts and lead to management entrenchment.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that could delay or prevent a change in control of our company. These provisions could also make it difficult for stockholders to elect directors that are </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">not nominated by the current members of our board of directors or take other corporate actions, including effecting changes in our management. These provisions include:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;a classified board of directors with three-year staggered terms, which could delay the ability of stockholders to change the membership of a majority of our board of directors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the ability of our board of directors to issue shares of preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquiror;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the exclusive right of our board of directors to elect a director to fill a vacancy created by the expansion of our board of directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our board of directors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of our stockholders;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the requirement that a special meeting of stockholders may be called only by a majority vote of our entire board of directors, the chairman of our board of directors, or our chief executive officer, which could delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;the requirement for the affirmative vote of holders of at least 66&#160;2/3% of the voting power of all of the then-outstanding shares of the voting stock, voting together as a single class, to amend the provisions of our amended and restated certificate of incorporation relating to the management of our business or our amended and restated bylaws, which may inhibit the ability of an acquiror to effect such amendments to facilitate an unsolicited takeover attempt; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;advance notice procedures with which stockholders must comply to nominate candidates to our board of directors or to propose matters to be acted upon at a stockholders&#8217; meeting, which may discourage or deter a potential acquiror from conducting a solicitation of proxies to elect the acquiror&#8217;s own slate of directors or otherwise attempting to obtain control of us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, as a Delaware corporation, we are subject to Section&#160;203 of the Delaware General Corporation Law. These provisions may prohibit large stockholders, in particular those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A Delaware corporation may opt out of this provision by express provision in its original certificate of incorporation or by amendment to its certificate of incorporation or bylaws approved by its stockholders. However, we have not opted out of, and do not currently intend to opt out of, this provision.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These and other provisions in our amended and restated certificate of incorporation, amended and restated bylaws and Delaware law could make it more difficult for stockholders or potential acquirers to obtain control of our board of directors or initiate actions that are opposed by our then-current board of directors, including delay or impede a merger, tender offer, or proxy contest involving our company. The existence of these provisions could negatively affect the price of our common stock and limit opportunities for our stockholders to realize value in a corporate transaction.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware and the U.S. federal district courts are the exclusive forums for substantially all disputes between us and our stockholders, which restricts our stockholders&#8217; ability to bring a lawsuit against us or our directors, officers, or employees in jurisdictions other than Delaware and federal district courts.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding brought on our behalf; any action asserting a breach of a fiduciary duty; any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our amended and restated certificate of incorporation, or our amended and restated bylaws; or any action asserting a claim against us that is governed by the internal affairs doctrine. The provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act. This choice of forum provision may limit a stockholder's ability to bring a claim in a judicial forum that it finds favorable for these types of disputes with us or our directors, officers, or other employees.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our amended and restated certificate of incorporation also provides that the U.S. federal district courts are the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_127"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no sales of unregistered equity securities during the three months ended&#160;September 30, 2021.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no repurchases of shares or equity securities during the three months ended September 30, 2021.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Proceeds from our Initial Public Offering of Common Stock</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;16, 2018, our registration statement on Form S-1 (File No.&#160;333-227445) relating to our Initial Public Offering (&#8220;IPO&#8221;) of common stock became effective. The IPO closed on October&#160;16, 2018 at which time we issued 8,280,000 shares of our common stock at an initial offering price of $15.00 per share for gross proceeds of $124.2 million. We received net proceeds from the IPO of approximately $113.4 million, after deducting the underwriting discount of $8.7 million and other offering-related expenses of $2.1 million. None of the expenses associated with the IPO were paid to directors, officers, persons owning 10% or more of any class of equity securities, or to their associates,&#160;or to our affiliates. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no material change in the planned use of proceeds from the IPO from that described in the prospectus filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act on October&#160;16, 2018. As of September 30, 2021, approximately $104.1 million of the net proceeds had been used for general corporate purposes including cash used in operations and capital expenditures.</span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_130"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_133"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div id="ib00d06b2519f421eb73a3aa86da814ca_136"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On October 20, 2021, we entered into a Second Amendment to the Offer Letter Agreement and Severance Plan Participation Agreement (the &#8220;Second Amendment&#8221;) with Jeffery Dunn, our Executive Chairman. The Second Amendment to Mr. Dunn&#8217;s offer letter agreement provides that (1) Mr. Dunn will be entitled to receive the severance benefit set forth in Section 2 of the Participation Agreement only upon the occurrence of a Covered Termination occurring during the Change in Control Period and will not be entitled to receive the severance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">benefits set forth in Section 2 of the Participation Agreement upon the Closing of a Change in Control absent a Covered Termination within the Change in Control Period, and (2) The second prong of the &#8220;Good Reason&#8221; definition will be triggered if Mr. Dunn ceases to be, at any point during the Change in Control Period, the Chairman of the Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">or, following a Change in Control, the Chairman of the board of the successor entity or its ultimate parent entity, if any. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A copy of the Second Amendment to the Offer Letter Agreement and Severance Plan Participation Agreement is attached to this Quarterly Report on Form 10-Q as Exhibit 10.2.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_139"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.785%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.499%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.922%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporation&#160;By&#160;Reference</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SEC&#160;File&#160;No.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit/<br/>Reference</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date</span></td></tr><tr style="height:0pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1459839/000119312518303020/d641574dex31.htm">Amended and Restated Certificate of Incorporation.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-38701</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/19/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1459839/000119312518293978/d452987dex34.htm">Amended and Restated Bylaws.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-227445</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/5/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1459839/000119312518293978/d452987dex41.htm">Form of Common Stock Certificate of the Company.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-227445</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/5/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reference is made to Exhibits </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1459839/000119312518303020/d641574dex31.htm">3.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1459839/000119312518293978/d452987dex34.htm">3.2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sibn-ex101loanandsecuritya.htm">Loan and Security Agreement, dated August 12, 2021, between SI-BONE, Inc. and  Silicon Valley Bank</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sibn-ex101loanandsecuritya.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sibn-ex102secondamendmentt.htm">Second Amendment to the Offer Letter Agreement and Severance Plan Participation Agreement with Jeffery Dunn</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sibn-ex311_930202110xq.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sibn-ex312_930202110xq.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sibn-ex321_930202110xq.htm">Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;Furnished herewith.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 32.1 is being furnished and shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of that section, nor shall such exhibit be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="ib00d06b2519f421eb73a3aa86da814ca_142"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized, in Santa Clara, California, on November&#160;9, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.166%"><tr><td style="width:1.0%"></td><td style="width:5.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.126%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SI-BONE, Inc.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 9, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Laura A. Francis</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laura A. Francis</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Duly Authorized Officer and Principal Executive Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">) </span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SI-BONE, Inc.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 9, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Anshul Maheshwari</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anshul Maheshwari</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Duly Authorized Officer and Principal Financial and Accounting Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>sibn-ex101loanandsecuritya.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="icd7579ba879b4549a6769f17f340f8e7_38"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LOAN AND SECURITY AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> LOAN AND SECURITY AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (this &#8220;Agreement&#8221;) is dated as of the Effective Date between </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SILICON VALLEY BANK</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a California corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and the borrower listed on Schedule I hereto (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  The parties agree as follows&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">LOAN AND TERMS OF PAYMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Term Loan Advance.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Availability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the terms and conditions of this Agreement, on the Effective Date or soon thereafter as all conditions precedent to the making thereof have been met, Bank shall make one (1) term loan advance to Borrower in an original principal amount equal to the Term Loan Availability Amount (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Advance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  After repayment (in whole or in part), the Term Loan Advance may not be reborrowed.   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Repayment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Borrower shall repay the Term Loan Advance as set forth in Schedule I hereto.  All outstanding principal and accrued and unpaid interest under the Term Loan Advance, and all other outstanding Obligations with respect to such Term Loan Advance, are due and payable in full on the Term Loan Maturity Date. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Permitted Prepayment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Borrower shall have the option to prepay all, but not less than all, of the Term Loan Advance, provided Borrower (i) delivers written notice to Bank of its election to prepay the Term Loan Advance at least five (5) Business Days prior to such prepayment, and (ii) pays, on the date of such prepayment (A) the outstanding principal  plus accrued and unpaid interest with respect to the Term Loan Advance, (B) the applicable Prepayment Fee, if any, (C) the Final Payment, and (D) all other sums, if any, that shall have become due and payable with respect to the Term Loan Advance, including interest at the Default Rate with respect to any past due amounts.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Mandatory Prepayment Upon an Acceleration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the Term Loan Advance is accelerated by Bank following the occurrence and during the continuance of an Event of Default, Borrower shall immediately pay to Bank an amount equal to the sum of (i) all outstanding principal plus accrued and unpaid interest with respect to the Term Loan Advance, (ii) the applicable Prepayment Fee, if any (iii) the Final Payment, and (iv) all other sums, if any, that shall have become due and payable with respect to the Term Loan Advance, including interest at the Default Rate with respect to any past due amounts.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Payment of Interest on the Credit Extensions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Interest Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Interest on the outstanding principal amount of the Term Loan Advance is payable as set forth on Schedule I hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Interest Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt;text-decoration:underline">Term Loan Advance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to Section 1.2(c), the outstanding principal amount of the Term Loan Advance shall accrue interest as set forth on Schedule I hereto.  </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">All-In Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any terms in this Agreement to the contrary, if at any time the interest rate applicable to any Obligations is less than zero percent (0.0%), such interest rate shall be deemed to be zero percent (0.0%) for all purposes of this Agreement.</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Default Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Immediately upon the occurrence and during the continuance of an Event of Default, the outstanding Obligations shall bear interest at a rate per annum which is three percent (3.0%) above the rate that is otherwise applicable thereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Default Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), unless Bank otherwise elects, in its sole discretion, to impose a lesser increase or no increase.  Fees and expenses which are required to be paid by Borrower pursuant to the Loan Documents (including, without limitation, Bank Expenses) but are not paid when due shall bear interest until paid at a rate equal to the highest rate applicable to the Obligations.  Payment or acceptance of the increased interest rate provided in this Section 1.2(c) is not a permitted alternative to timely payment and shall not constitute a waiver of any Event of Default or otherwise prejudice or limit any rights or remedies of Bank.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Adjustment to Interest Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each change in the interest rate applicable to any amounts payable under the Loan Documents based on changes to the Prime Rate shall be effective on the effective date of any change to the Prime Rate and to the extent of such change. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Interest Computation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Interest shall be computed as set forth on Schedule I hereto.  In computing interest, the date of the making of any Credit Extension shall be included and the date of payment shall be excluded&#59; provided, however, that if any Credit Extension is repaid on the same day on which it is made, such day shall be included in computing interest on such Credit Extension.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Fees and Expenses.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Borrower shall pay to Bank&#58;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Prepayment Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Prepayment Fee, if and when due hereunder, which shall be fully earned and non-refundable as of the applicable prepayment date&#59; provided, however, if Borrower refinances the Term Loan Advance with another credit facility from Bank, Bank shall waive the Prepayment Fee&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Final Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Final Payment, when due hereunder, which shall be fully earned and non-refundable as of such date&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Bank Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All Bank Expenses incurred through and after the Effective Date, when due (or, if no stated due date, upon demand by Bank).  Borrower has paid to Bank a good faith deposit of Fifty Thousand Dollars ($50,000) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Good Faith Deposit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to initiate Bank&#8217;s due diligence review process.  The Good Faith Deposit will be applied to Bank Expenses as of the Effective Date.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise provided in this Agreement or in a separate writing by Bank, Borrower shall not be entitled to any credit, rebate, or repayment of any fees earned by Bank pursuant to this Agreement notwithstanding any termination of this Agreement or the suspension or termination of Bank&#8217;s obligation to make loans and advances hereunder.  Bank may deduct amounts owing by Borrower under the clauses of this Section 1.3 pursuant to the terms of Section 1.4(c). Bank shall provide Borrower written notice of deductions made pursuant to the terms of the clauses of this Section 1.3.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Payments&#59; Application of Payments&#59; Debit of Accounts.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All payments (including prepayments) to be made by Borrower under any Loan Document shall be made in immediately available funds in Dollars, without setoff, counterclaim, or deduction, before 12&#58;00 p.m. Pacific time on the date when due.  Payments of principal and&#47;or interest received after 12&#58;00 p.m. Pacific time are considered received at the opening of business on the next Business Day.  When a payment is due on a day that is not a Business Day, the payment shall be due the next Business Day, and additional fees or interest, as applicable, shall continue to accrue until paid.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"> Bank has the exclusive right  in its reasonable discretion to determine the order and manner in which all payments with respect to the Obligations may be applied.   Borrower shall have no right to specify the order or the accounts to which Bank shall allocate or apply any payments required to be made by Borrower to Bank or otherwise received by Bank under this Agreement when any such allocation or application is not specified elsewhere in this Agreement.</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Bank may debit the Designated Deposit Account (or if insufficient funds are contained therein, or if an Event of Default has occurred and is continuing, any of Borrower&#8217;s other accounts at Bank), for principal and interest payments or any other amounts Borrower owes Bank when as and when due under this Agreement.  These debits shall not constitute a set-off.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Change in Circumstances. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Increased Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If any Change in Law shall&#58; (i) impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement against assets of, deposits with or for the account of, or advances, loans or other credit extended or participated in by, Bank, (ii) subject Bank to any Taxes (other than (A) Indemnified Taxes, (B) Taxes described in clauses (b) through (d) of the definition of Excluded Taxes, and (C) Connection Income Taxes) on its loans, loan principal, letters of credit, commitment, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto, or (iii) impose on Bank any other condition, cost or expense (other than Taxes) affecting this Agreement or Credit Extensions made by Bank, and the result of any of the foregoing shall be to increase the cost to Bank of making, converting to, continuing or maintaining any Credit Extension (or of maintaining its obligation to make any such Credit Extension), or to reduce the amount of any sum received or receivable by Bank hereunder (whether of principal, interest or any other amount) then, upon written request of Bank, Borrower shall promptly pay to Bank such additional amount or amounts as will compensate Bank for such additional costs incurred or reduction suffered.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Capital Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If Bank determines that any Change in Law affecting Bank regarding capital or liquidity requirements, has or would have the effect of reducing the rate of return on Bank&#8217;s capital as a consequence of this Agreement, any term loan facility, or the Credit Extensions made by Bank to a level below that which Bank could have achieved but for such Change in Law (taking into consideration Bank&#8217;s policies with respect to capital adequacy and liquidity), then from time to time upon written request of Bank, Borrower shall promptly pay to Bank such additional amount or amounts as will compensate Bank for any such reduction suffered.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Delay in Requests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Failure or delay on the part of Bank to demand compensation pursuant to this Section 1.5 shall not constitute a waiver of Bank&#8217;s right to demand such compensation&#59; provided that Borrower compensate Bank pursuant to subsection (a) for any increased costs incurred or reductions suffered more than nine (9) months prior to the date that Bank notifies Borrower of the Change in Law giving rise to such increased costs or reductions (except that if the Change in Law giving rise to such increased costs or reductions is retroactive, then the nine (9) month period shall be extended to include the period of retroactive effect).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Taxes.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Payments Free of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any and all payments by or on account of any obligation of Borrower under any Loan Document shall be made without deduction or withholding for any Taxes, except as required by Applicable Law.  If any Applicable Law (as determined in the good faith discretion of Borrower) requires the deduction or withholding of any Tax from any such payment by Borrower, then (i)&#160;Borrower shall be entitled to make such deduction or withholding, (ii)&#160;Borrower shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with Applicable Law, and (iii) if such Tax is an Indemnified Tax, the sum payable by Borrower shall be increased as necessary so that after such deduction or withholding has been made (including such deductions and withholdings applicable to additional sums payable under this Section 1.6) Bank receives an amount equal to the sum it would have received had no such deduction or withholding been made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Payment of Other Taxes by Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Without limiting the provisions of subsection&#160;(a) above, Borrower shall timely pay any Other Taxes to the relevant Governmental Authority in accordance with Applicable Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Tax Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Without limiting the provisions of subsections (a) and (b) above, Borrower shall, and does hereby, indemnify Bank, within ten (10) days after demand therefor, for the full amount of </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this Section&#160;1.6) payable or paid by Bank or required to be withheld or deducted from a payment to Bank and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority.  A certificate as to the amount of such payment or liability delivered to Borrower by Bank shall be conclusive absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Evidence of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  As soon as practicable after any payment of Taxes by Borrower to a Governmental Authority pursuant to this Section&#160;1.6, Borrower shall deliver to Bank a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to Bank.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Status of Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If Bank (including any assignee or successor) is entitled to an exemption from or reduction of withholding tax with respect to payments made under any Loan Document, it shall deliver to Borrower, at the time or times reasonably requested by Borrower, such properly completed and executed documentation reasonably requested by Borrower as will permit such payments to be made without withholding or at a reduced rate of withholding.  In addition, Bank, if reasonably requested by Borrower, shall deliver such other documentation prescribed by Applicable Law or reasonably requested by Borrower as will enable Borrower to determine whether or not Bank is subject to backup withholding or information reporting requirements.  Without limiting the generality of the foregoing, Bank shall deliver whichever of IRS Form W-9, IRS Form W-8BEN-E, IRS Form W-8ECI or IRS Form W-8IMY is applicable, as well as any applicable supporting documentation or certifications.  If a payment made to Bank under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if Bank were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Internal  Revenue Code, as applicable), Bank shall deliver to Borrower at the time or times prescribed by law and at such time or times reasonably requested by Borrower such documentation prescribed by Applicable Law (including as prescribed by Section 1471(b)(3)(C)(i) of the Internal Revenue Code) and such additional documentation reasonably requested by Borrower as may be necessary for Borrower to comply with its obligations under FATCA and to determine that Bank has complied with its obligations under FATCA or to determine the amount, if any, to deduct and withhold from such payment.  Solely for purposes of the preceding sentence, &#8220;FATCA&#8221; shall include any amendments made to FATCA after the date of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt;text-decoration:underline">Treatment of Certain Refunds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If Bank determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified pursuant to this Section 1.6 (including by the payment of additional amounts pursuant to this Section 1.6), it shall pay to Borrower an amount equal to such refund (but only to the extent of indemnity payments made under this Section 1.6 with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of Bank and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund).  Borrower, upon the request of Bank, shall repay to Bank the amount paid over pursuant to this paragraph (f) (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) in the event that Bank is required to repay such refund to such Governmental Authority.  Notwithstanding anything to the contrary in this paragraph (f), in no event will Bank be required to pay any amount to Borrower pursuant to this paragraph (f) the payment of which would place Bank in a less favorable net after-Tax position than Bank would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid.  This paragraph (f) shall not be construed to require Bank to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to Borrower or any other Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Procedures for Borrowing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Subject to the prior satisfaction of all other applicable conditions to the making of the Term Loan Advance set forth in this Agreement (which must be satisfied no later than 12&#58;00 p.m. Pacific time on the applicable Funding Date), to obtain the Term Loan Advance, Borrower shall notify Bank (which notice shall be irrevocable) by 12&#58;00 p.m. Pacific time on the Funding Date of the Term Loan Advance.  Such notice shall be made </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by electronic mail or by telephone and, together with any such notification, Borrower shall deliver to Bank by electronic mail a completed Payment&#47;Advance Form executed by an Authorized Signer.  Bank may rely on any telephone notice given by a person whom Bank reasonably believes is an Authorized Signer.  Borrower will indemnify Bank for any loss Bank suffers due to such reasonable belief or reliance.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bank shall have received satisfactory evidence that the Board has approved that such Authorized Signer may provide such notices and request such Term Loan Advance (which requirement may be deemed satisfied by the prior delivery of Borrowing Resolutions or a secretary&#8217;s certificate that certifies as to such Board approval).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Bank shall credit proceeds of a Credit Extension to the Designated Deposit Account.  Bank may make the Term Loan Advance under this Agreement based on instructions from an Authorized Signer or without instructions if such Term Loan Advance is necessary to meet Obligations which have become due. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">CONDITIONS OF CREDIT EXTENSIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Conditions Precedent to Initial Credit Extension.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Bank&#8217;s obligation to make the initial Credit Extension is subject to the condition precedent that Bank shall have received, in form and substance satisfactory to Bank, such documents, and completion of such other matters, as Bank may reasonably deem necessary or appropriate, including, without limitation&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">duly executed Loan Documents&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">a duly executed Control Agreement with U.S. Bank&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">the Operating Documents of Borrower and its Subsidiaries and long-form good standing certificates of Borrower certified by the Secretary of State of the State of Delaware and the Secretary of State (or equivalent agency) of each other jurisdiction in which Borrower is qualified to conduct business, in each case as of a date no earlier than thirty (30) days prior to the Effective Date&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">a certificate duly executed by a Responsible Officer or secretary of Borrower with respect to Borrower&#8217;s (i) Operating Documents and (ii) Borrowing Resolutions&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">a duly executed payoff letter from Solar Capital&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">evidence that (i) the Liens securing Indebtedness owed by Borrower to Solar Capital will be terminated and (ii) the documents and&#47;or filings evidencing the perfection of such Liens, including without limitation any financing statements and&#47;or control agreements, have or will, concurrently with the initial Credit Extension, be terminated&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">certified copies, dated as of a recent date, of searches for financing statement filed in the central filing office of the State of Delaware, accompanied by written evidence (including any UCC termination statements) that the Liens indicated in any such financing statements either constitute Permitted Liens or have been or, in connection with the initial Credit Extension, will be terminated or released&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">a duly executed Perfection Certificate of Borrower&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">a duly executed landlord&#8217;s consent in favor of Bank for Borrower&#8217;s leased location at 471 El Camino Real, Suite 101, Santa Clara, CA 95050&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">a legal opinion of Borrower&#8217;s counsel dated as of the Effective Date&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:24.34pt">evidence satisfactory to Bank that the insurance policies and endorsements required by Section 5.8 hereof are in full force and effect, together with appropriate evidence showing lender loss payable and additional insured clauses or endorsements in favor of Bank&#59; and</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">payment of the fees and Bank Expenses then due as specified in Section 1.3 hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Conditions Precedent to all Credit Extensions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Bank&#8217;s obligation to make each Credit Extension, including the initial Credit Extension, is subject to the following conditions precedent&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">receipt of Borrower&#8217;s Credit Extension request and the related materials and documents as required by and in accordance with Section 1.7&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the representations and warranties in this Agreement shall be true and correct in all material respects as of the date of any Credit Extension request  and as of the Funding Date of each Credit Extension&#59; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof&#59; and provided, further that those representations and warranties expressly referring to a specific date shall be true and correct in all material respects as of such date, and no Default or Event of Default shall have occurred and be continuing or result from the Credit Extension.  Each Credit Extension is Borrower&#8217;s representation and warranty on that date that the representations and warranties in this Agreement remain true and correct in all material respects&#59; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof&#59; and provided, further that those representations and warranties expressly referring to a specific date shall be true and correct in all material respects as of such date&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">a Material Adverse Change shall not have occurred.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Covenant to Deliver.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Borrower shall deliver to Bank each item required to be delivered to Bank under this Agreement as a condition precedent to any Credit Extension.  A Credit Extension made prior to the receipt by Bank of any such item shall not constitute a waiver by Bank of Borrower&#8217;s obligation to deliver such item, and the making of any Credit Extension in the absence of a required item shall be in Bank&#8217;s sole discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">CREATION OF SECURITY INTEREST</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Grant of Security Interest.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Borrower hereby grants Bank, to secure the payment and performance in full of all of the Obligations, a continuing security interest in, and pledges to Bank, the Collateral, wherever located, whether now owned or hereafter acquired or arising, and all proceeds and products thereof.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Borrower acknowledges that it previously has entered, or may in the future enter, into Bank Services Agreements with Bank.  Regardless of the terms of any Bank Services Agreement, Borrower agrees that any amounts Borrower owes Bank thereunder shall be deemed to be Obligations hereunder and that it is the intent of Borrower and Bank to have all such Obligations secured by the first priority perfected security interest in the Collateral granted herein (subject to Permitted Liens).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Authorization to File Financing Statements.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Borrower hereby authorizes Bank to file financing statements covering the Collateral, without notice to Borrower, with all jurisdictions deemed necessary or appropriate by Bank to perfect or protect Bank&#8217;s interest or rights hereunder, including a notice that any disposition of the Collateral, by either Borrower or any other Person, in contravention of the terms of this Agreement shall be deemed to violate the rights of Bank under the Code.  Such financing statements may indicate the Collateral</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If this Agreement is terminated, Bank&#8217;s Lien in the Collateral shall continue until the Obligations (other than inchoate indemnity obligations) are repaid in full in cash.  Upon payment in full in cash of the Obligations (other than inchoate indemnity obligations) and at such time as Bank&#8217;s obligation to make Credit Extensions has terminated, Bank shall, at Borrower&#8217;s sole cost and expense, promptly terminate its security interest </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the Collateral and all rights therein shall automatically revert to Borrower, and Bank shall, upon request from Borrower and at Borrower&#8217;s sole cost and expense, promptly deliver to Borrower written evidence of the termination of such liens and any other documents reasonably necessary to terminate such liens.  In the event (a) all Obligations (other than inchoate indemnity obligations), except for Bank Services, are satisfied in full, and (b) this Agreement is terminated, Bank shall terminate the security interest granted herein upon Borrower providing cash collateral acceptable to Bank in its commercially reasonable discretion for Bank Services, if any.  In the event such Bank Services consist of outstanding Letters of Credit, Borrower shall provide to Bank cash collateral in an amount equal to at least (i) one hundred and five percent (105.0%) of the face amount of all such Letters of Credit denominated in Dollars and (ii) one hundred and fifteen percent (115.0%) of the Dollar Equivalent of the face amount of all such Letters of Credit denominated in a Foreign Currency, plus, in each case, all interest, fees, and costs due or estimated by Bank to become due in connection therewith, to secure all of the Obligations relating to such  Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrower represents and warrants as follows&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Due Organization, Authorization&#59; Power and Authority.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Borrower and each of its Subsidiaries are each duly existing and in good standing as a Registered Organization in their respective jurisdiction of formation and are qualified and licensed to do business and is in good standing in any other jurisdiction in which the conduct of their respective business or their ownership of property requires that they be qualified except where the failure to do so could not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">All information set forth on the Perfection Certificate pertaining to Borrower and each of its Subsidiaries is true and correct in all material respects (it being understood and agreed that Borrower may from time to time update certain information in the Perfection Certificate after the Effective Date to the extent permitted by one or more specific provisions in this Agreement and the Perfection Certificate shall be deemed to be updated to the extent such notice is provided to Bank of such permitted update).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The execution, delivery and performance by Borrower and each of its Subsidiaries of the Loan Documents to which it is a party have been duly authorized, and do not (i) conflict with any of Borrower&#8217;s or any such Subsidiary&#8217;s organizational documents, (ii) contravene, conflict with, constitute a default under or violate any material Applicable Law, (iii) contravene, conflict with or violate any applicable order, writ, judgment, injunction, decree, determination or award of any Governmental Authority by which Borrower or any of its Subsidiaries or any of their property or assets may be bound or affected, (iv) require any action by, filing, registration, or qualification with, or Governmental Approval from, any Governmental Authority (except such Governmental Approvals which have already been obtained and are in full force and effect), or (v) conflict with, contravene, constitute a default or breach under, or result in or permit the termination or acceleration of, any material agreement by which Borrower or any of its Subsidiaries is bound, or applicable consents or waivers have been obtained.  Neither Borrower nor any of its Subsidiaries are in default under any material agreement to which it is a party or by which it is bound in which the default could reasonably be expected to have a material adverse effect on Borrower&#8217;s or any of its Subsidiary&#8217;s business or operations (taken as a whole).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Collateral.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The security interest granted herein is and shall at all times continue to be a first priority perfected security interest in the Collateral (subject to Permitted Liens).  Borrower has good title to, rights in, and the power to transfer each item of the Collateral upon which it purports to grant a Lien hereunder, free and clear of any and all Liens except Permitted Liens.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Borrower has no Collateral Accounts at or with any bank or financial institution other than Bank or Bank&#8217;s Affiliates except for the Collateral Accounts described in the Perfection Certificate delivered to </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bank in connection herewith and which Borrower has taken such actions as are necessary to give Bank a perfected security interest therein, to the extent that perfection is required pursuant to the terms of Section 5.9(c).  The Accounts are bona fide, existing obligations of the Account Debtors.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The Collateral is not in the possession of any third party bailee (such as a warehouse) except as otherwise provided in the Perfection Certificate or as permitted pursuant to Section 6.2 (other than laptops and other portable electronic items used in the ordinary course of business).  None of the components of the Collateral shall be maintained at locations other than as provided in the Perfection Certificate or as permitted pursuant to Section 6.2 (other than laptops and other portable electronic items used in the ordinary course of business).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">All Inventory is in all material respects of good and marketable quality, free from material defects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Borrower owns, or possesses the right to use to the extent reasonably necessary in its business, all Intellectual Property, licenses and other intangible assets that are used in the conduct of its business operations as now operated, except to the extent that such failure to own or possess the right to use such asset would not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations, and no such asset, to the best knowledge of Borrower, conflicts with the  valid Intellectual Property, license, or intangible asset of any other Person to the extent that such conflict could reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">Except as noted on the Perfection Certificate (as updated from time to time in accordance with this Agreement) or for which notice has been given to Bank pursuant to and in accordance with Section 5.11(b), Borrower is not a party to, nor is it bound by, any Restricted License.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Reserved. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Litigation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other than as set forth on the Perfection Certificate delivered around the Effective Date, and as disclosed to Bank pursuant to Section 5.3, there are no actions, investigations or proceedings pending or, to the knowledge of any Responsible Officer, threatened in writing by or against Borrower or any of its Subsidiaries that could reasonably be expected to result in liability of more than, individually or in the aggregate, Seven Hundred Fifty Thousand Dollars ($750,000).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Financial Statements&#59; Financial Condition. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> All consolidated financial statements for Borrower and any of its Subsidiaries delivered to Bank by submission to the Financial Statement Repository or otherwise submitted to Bank fairly present in all material respects Borrower&#8217;s consolidated financial condition and Borrower&#8217;s consolidated results of operations as of the dates thereof and for the periods covered thereby, subject, in the case of unaudited financial statements, to normal year-end adjustments and the absence of footnote disclosures.  There has not been any material deterioration in Borrower&#8217;s consolidated financial condition since the date of the most recent financial statements submitted to the Financial Statement Repository or otherwise submitted to Bank.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Solvency.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The fair salable value of Borrower&#8217;s consolidated assets (including goodwill minus disposition costs) exceeds the fair value of Borrower&#8217;s liabilities&#59; Borrower is not left with unreasonably small capital after the transactions in this Agreement&#59; and Borrower and Borrower and each of its Subsidiaries (taken as a whole) are able to pay their debts (including trade debts) as they mature.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Regulatory Compliance.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Borrower is not an &#8220;investment company&#8221; or a company &#8220;controlled&#8221; by an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended.  Borrower is not engaged as one of its important activities in extending credit for margin stock (under Regulations X, T and U of the Federal Reserve Board of Governors).  Borrower and each of its Subsidiaries (a) have complied in all material respects with all Applicable Law, and (b) have not violated any Applicable Law the violation of which could reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations.  Borrower and each of its </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsidiaries have duly complied with, and their respective facilities, business, assets, property, leaseholds, real property and Equipment are in compliance with, Environmental Laws, except where the failure to do so could not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations&#59; there have been no outstanding citations, notices or orders of non-compliance issued to Borrower or any of its Subsidiaries or relating to their respective facilities, businesses, assets, property, leaseholds, real property or Equipment under such Environmental Laws  Borrower and each of its Subsidiaries have obtained all consents, approvals and authorizations of, made all declarations or filings with, and given all notices to, all Governmental Authorities that are necessary to continue their respective businesses as currently conducted, except where the failure to obtain or make or file the same would not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Subsidiaries&#59; Investments.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Borrower does not own any stock, partnership, or other ownership interest or other equity securities except for Permitted Investments.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Tax Returns and Payments&#59; Pension Contributions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Borrower and each of its Subsidiaries have timely filed, or submitted extensions for, all  required tax returns and reports, and Borrower and each of its Subsidiaries have timely paid, or submitted extensions for, all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower and each of its Subsidiaries except (i) to the extent such taxes are being contested in good faith by appropriate proceedings promptly instituted and diligently conducted, so long as such reserve or other appropriate provision, if any, as shall be required in conformity with GAAP shall have been made therefor, or (ii) if such taxes, assessments, deposits and contributions do not, individually or in the aggregate, exceed Fifty Thousand Dollars ($50,000).  Borrower is unaware of any claims or adjustments proposed for any of Borrower&#8217;s or any of its Subsidiary&#8217;s prior tax years which could result in additional taxes becoming due and payable by Borrower or any of its Subsidiaries in excess of Fifty Thousand Dollars ($50,000) in the aggregate.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Borrower and each of its Subsidiaries have paid all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms, and neither Borrower nor any of its Subsidiaries has withdrawn from participation in, and has not permitted partial or complete termination of, or permitted the occurrence of any other event with respect to, any such plan which could reasonably be expected to result in any material liability of Borrower or any of its Subsidiaries, including any liability to the Pension Benefit Guaranty Corporation or its successors or any other Governmental Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Full Disclosure. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No written representation, warranty or other statement of Borrower or any of its Subsidiaries in any report, certificate or written statement submitted to the Financial Statement Repository or otherwise submitted to Bank, as of the date such representation, warranty, or other statement was made, taken together with all such written reports, written certificates and written statements submitted to the Financial Statement Repository or otherwise submitted to Bank, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained in the reports, certificates or written statements not misleading in light of the circumstances under which they were made (it being recognized by Bank that the projections and forecasts provided by Borrower or any of its Subsidiaries in good faith and based upon reasonable assumptions are not viewed as facts and that actual results during the period or periods covered by such projections and forecasts may differ from the projected or forecasted results).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither Borrower nor any of its Subsidiaries is&#58; (a) in violation of any Sanctions&#59; or (b) a Sanctioned Person.  Neither Borrower nor any of its Subsidiaries, or, to Borrower&#8217;s knowledge, its directors, officers, employees, agents or Affiliates&#58; (i) conducts any business or engages in any transaction or dealing with any Sanctioned Person, including making or receiving any contribution of funds, goods or services to or for the benefit of any Sanctioned Person&#59; (ii) deals in, or otherwise engages in any transaction relating to, any property or interests in property blocked pursuant to any Sanctions&#59; (iii) engages in or conspires to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Sanctions&#59; or (iv) otherwise engages in any transaction that could cause Bank to violate any Sanctions.</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">AFFIRMATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrower shall do all of the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Use of Proceeds.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Cause the proceeds of the Credit Extensions to be used solely (a) as working capital, (b) to fund its general business purposes, or (c) repayment and payoff of Solar Capital and not for personal, family, household or agricultural purposes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Government Compliance.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Maintain its and all of its Subsidiaries&#8217; legal existence (except as permitted under Section 6.3 with respect to Subsidiaries only) and good standing in their respective jurisdictions of formation and maintain qualification in each jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations.  Borrower shall comply, and have each Subsidiary comply, in all material respects, with all material laws, ordinances and regulations to which it is subject.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Obtain all of the Governmental Approvals necessary for the performance by Borrower and each of its Subsidiaries of their obligations under the Loan Documents to which it is a party, including any grant of a security interest in the Collateral to Bank.  Borrower shall promptly provide copies of any such obtained Governmental Approvals to Bank upon Bank&#8217;s request.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Financial Statements, Reports. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Deliver to Bank by submitting to the Financial Statement Repository&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Quarterly Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  No later than forty-five (45) days after the last day of each of the first three fiscal quarters of Borrower&#8217;s fiscal year, a company prepared consolidated and consolidating balance sheet and income statement covering Borrower&#8217;s and each of its Subsidiary&#8217;s operations for such quarter in a form reasonably acceptable to Bank (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quarterly Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59; provided that year-end Quarterly Financial Statements shall be delivered no later than ninety (90) days after the last day of each fiscal year of Borrower&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Compliance Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Within forty-five (45) days after the last day of each of the first three fiscal quarters of Borrower (and no later than ninety (90) days after the last day of each fiscal year of Borrower), together with the statements set forth in Section 5.3(a), a duly completed Compliance Statement, confirming that as of the end of such month, Borrower was in full compliance with all of the terms and conditions of this Agreement, except as noted therein&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Annual Operating Budget and Financial Projections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Within thirty (30) days after the end of each fiscal year of Borrower, and within thirty (30) days of any material updates or amendments thereto, (i) annual operating budgets (including income statements, balance sheets and cash flow statements, by month) for the then-current fiscal year of Borrower, and (ii) annual financial projections for the then-current fiscal year (on a quarterly basis), in each case as approved by the Board, together with any material related business forecasts used in the preparation of such annual financial projections&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Annual Audited Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  As soon as available, and in any event within one hundred and eighty (180) days following the end of Borrower&#8217;s fiscal year, audited consolidated financial statements prepared under GAAP, consistently applied, together with an unqualified opinion on the financial statements from an independent certified public accounting firm reasonably acceptable to Bank&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">SEC Filings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event that Borrower or any of its Subsidiaries becomes subject to the reporting requirements under the Exchange Act within five (5) Business Days of filing, notification of the filing and copies of all periodic and other reports, proxy statements and other materials filed by Borrower and&#47;or any of its Subsidiaries or any Guarantor with the SEC, any Governmental Authority succeeding to any or all of the functions </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the SEC or with any national securities exchange, or distributed to its shareholders, as the case may be.  Documents required to be delivered pursuant to the terms hereof (to the extent any such documents are included in materials otherwise filed with the SEC) may be delivered electronically and if so delivered, shall be deemed to have been delivered on the date on which Borrower or any of its Subsidiaries posts such documents, or provides a link thereto, on Borrower&#8217;s or any of its Subsidiaries&#8217; website on the internet at Borrower&#8217;s or any of its Subsidiaries&#8217; website address&#59; provided, however, Borrower shall notify Bank in writing within five (5) Business Days (which may be by electronic mail) of the posting of any such documents&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt;text-decoration:underline">Security Holder and Subordinated Debt Holder Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Within five (5) Business Days of delivery, copies of all material statements, reports and notices made generally available to Borrower&#8217;s security holders or to any holders of Subordinated Debt (solely in their capacities as security holders or holders of Subordinated Debt and not in any other role)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Beneficial Ownership Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Prompt written notice of any changes to the beneficial ownership information set out in Section 14 of the Perfection Certificate.  Borrower understands and acknowledges that Bank relies on such true, accurate and up-to-date beneficial ownership information to meet Bank&#8217;s regulatory obligations to obtain, verify and record information about the beneficial owners of its legal entity customers&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Legal Action Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Prompt written notice upon becoming aware of any legal actions, investigations or proceedings pending or threatened in writing against Borrower or any of its Subsidiaries (not otherwise already disclosed on the Perfection Certificate delivered around the Effective Date) that could reasonably be expected to result in damages or costs to Borrower or any of its Subsidiaries of, individually or in the aggregate, Seven Hundred Fifty Thousand Dollars ($750,000) or more&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt;text-decoration:underline">Tort Claim Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If Borrower shall acquire a commercial tort claim with a value that could reasonably be expected to exceed Five Hundred Thousand Dollars ($500,000), Borrower shall promptly notify Bank in a writing signed by Borrower of the general details thereof and, if so requested by Bank, grant to Bank in such writing a security interest therein and in the proceeds thereof, all upon the terms of this Agreement, with such writing to be in form and substance reasonably satisfactory to Bank&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt;text-decoration:underline">Government Filings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Within five (5) Business Days after the same are sent by Borrower or received by Borrower, copies of all material correspondence, reports, documents and other filings by Borrower or any of its Subsidiaries with any Governmental Authority regarding compliance with or maintenance of Governmental Approvals or Applicable Law, in each case that could reasonably be expected to have a material effect on any of the Governmental Approvals material to the business of Borrower&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Registered Organization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If Borrower is not a Registered Organization as of the Effective Date but later becomes one, promptly notify Bank of such occurrence and provide Bank with Borrower&#8217;s organizational identification number&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt;text-decoration:underline">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Prompt written notice of the occurrence of a Default or Event of Default&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt;text-decoration:underline">Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Promptly, from time to time, such other financial information regarding Borrower or any of its Subsidiaries or compliance with the terms of any Loan Documents as reasonably requested by Bank.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any submission by Borrower of a Compliance Statement, or any other financial statement submitted to the Financial Statement Repository pursuant to this Section 5.3 or otherwise submitted to Bank shall be deemed to be a representation by Borrower that (i) as of the date of such Compliance Statement, or other financial statement, the information and calculations set forth therein are true and correct in all material respects, (ii) as of the end of the compliance period set forth in such submission, Borrower is in complete compliance with all required covenants except as noted in such Compliance Statement, or other financial statement, as applicable, except as noted in such </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance Statement or other financial statement, as applicable&#59;  (iii) as of the date of such submission, no Events of Default have occurred or are continuing, (iv) all representations and warranties other than any representations or warranties that are made as of a specific date in Section 4 remain true and correct in all material respects as of the date of such submission except as noted in such Compliance Statement, or other financial statement, as applicable, (v) as of the date of such submission, Borrower and each of its Subsidiaries has timely filed all required tax returns and reports, and Borrower has timely paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower except as otherwise permitted pursuant to the terms of Section 4.9, and (vi) as of the date of such submission, no Liens have been levied or claims made against Borrower or any of its Subsidiaries relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Bank.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Reserved.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Reserved.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Taxes&#59; Pensions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Timely file, and require each of its Subsidiaries to timely file (in each case, unless subject to a valid extension), all required  tax returns and reports and timely pay, and require each of its Subsidiaries to timely pay, or file extensions for, all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower and each of its Subsidiaries, except for (deferred payment of any taxes contested pursuant to the terms of Section 4.9(a) hereof, and shall deliver to Bank, on demand, appropriate certificates attesting to such payments, and pay, and require each of its Subsidiaries to pay, all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">To the extent Borrower or any of its Subsidiaries defers payment of any contested taxes in excess of Fifty Thousand Dollars ($50,000), (i) notify Bank in writing of the commencement of, and any material development in, the proceedings, and (ii) post bonds or take any other steps required to prevent the Governmental Authority levying such contested taxes from obtaining a Lien upon any of the Collateral that is other than a &#8220;Permitted Lien.&#8221;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Access to Collateral&#59; Books and Records. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At reasonable times, on three (3)) Business Days&#8217; notice (provided no notice is required if an Event of Default has occurred and is continuing), Bank, or its agents, shall have the right to inspect the Collateral and the right to audit and copy Borrower&#8217;s Books.  Such inspections and audits shall be conducted during Borrower&#8217;s business hours no more often than once every twelve (12) months, unless an Event of Default has occurred and is continuing, in which case such inspections and audits shall occur as often as Bank shall determine is necessary.  The foregoing inspections and audits shall be conducted at Borrower&#8217;s expense and the charge therefor shall be One Thousand Dollars ($1,000) per person per day (or such higher amount as shall represent Bank&#8217;s then-current standard charge for the same), plus reasonable out-of-pocket expenses.  In the event Borrower and Bank schedule an audit more than eight (8) days in advance, and Borrower cancels or seeks to or reschedules the audit with less than eight (8) days written notice to Bank, then (without limiting any of Bank&#8217;s rights or remedies) Borrower shall pay Bank a fee of Two Thousand Dollars ($2,000) plus any out-of-pocket expenses incurred by Bank to compensate Bank for the anticipated costs and expenses of the cancellation or rescheduling.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Insurance.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Keep its business and the Collateral insured for risks and in amounts standard for companies in Borrower&#8217;s industry and location and as Bank may reasonably request.  Insurance policies shall be in a form, with financially sound and reputable insurance companies that are not Affiliates of Borrower, and in amounts that are reasonably satisfactory to Bank.</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">All property policies shall have a lender&#8217;s loss payable endorsement showing Bank as lender loss payee.  All liability policies shall show, or have endorsements showing, Bank as an additional insured.  Bank shall be named as lender loss payee and&#47;or additional insured with respect to any such insurance providing coverage in respect of any Collateral. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Ensure that proceeds payable under any property policy are, at Bank&#8217;s option, payable to Bank on account of the Obligations.  Notwithstanding the foregoing, (a) so long as no Event of Default has occurred and is continuing, Borrower shall have the option of applying the proceeds of any casualty policy up to One Million  Dollars ($1,000,000) in the aggregate for all losses under all casualty policies in any one year, toward the replacement or repair of destroyed or damaged property&#59; provided that any such replaced or repaired property (i) shall be of equal or like value as the replaced or repaired Collateral and (ii) shall be deemed Collateral in which Bank has been granted a first priority security interest, and (b) after the occurrence and during the continuance of an Event of Default, all proceeds payable under such casualty policy shall, at the option of Bank, be payable to Bank on account of the Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">At Bank&#8217;s request, Borrower shall deliver certified copies of insurance policies and evidence of all premium payments.  Each provider of any such insurance required under this Section </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:line-through">5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5 shall agree, by endorsement upon the policy or policies issued by it or by independent instruments furnished to Bank, that it will give Bank twenty (20)&#160;days (or ten (10) days&#8217; prior written notice in the event of cancellation due to non-payment of premium) prior written notice before any such policy or policies shall be materially altered or canceled.  If Borrower fails to obtain insurance as required under this Section 5.8 or to pay any amount or furnish any required proof of payment to third persons and Bank, Bank may make all or part of such payment or obtain such insurance policies required in this Section 5.8, and take any action under the policies Bank deems prudent. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Accounts.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Maintain all of Borrower&#8217;s, any of its Subsidiaries&#8217;, and any Guarantor&#8217;s operating accounts, depository accounts and excess cash with Bank or Bank&#8217;s Affiliates, other than Borrower&#8217;s Foreign Subsidiaries may maintain accounts with third parties other than Bank, provided the aggregate value of such accounts is subject to the terms of Section 6.11 (collectively the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Permitted Foreign Subsidiary Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">In addition to the foregoing, Borrower, any Subsidiary of Borrower and any Guarantor, shall obtain any business credit card, Letter of Credit, FX Contract, and cash management services exclusively from Bank, except (i) third party credit cards, as permitted in the defined term &#8220;Permitted Indebtedness&#8221; part (g)&#59; (ii) Borrower&#8217;s Foreign Subsidiaries may maintain the foregoing bank services with third parties other than Bank, (iii) to the extent that Bank does not have such services in foreign locations, Borrower and its Subsidiaries may maintain the foregoing foreign banking services with third parties other than Bank, and (iv) Borrower may maintain and permit to exist online payment processors used in the ordinary course of business with third parties other than Bank.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">In addition to and without limiting the restrictions in (a), Borrower shall provide Bank five (5) days prior written notice before establishing any Collateral Account at or with any bank or financial institution other than Bank or Bank&#8217;s Affiliates.  For each Collateral Account that Borrower at any time maintains, Borrower shall cause the applicable bank or financial institution (other than Bank) at or with which any Collateral Account is maintained to execute and deliver a Control Agreement or other appropriate instrument with respect to such Collateral Account to perfect Bank&#8217;s Lien in such Collateral Account in accordance with the terms hereunder which Control Agreement may not be terminated without the prior written consent of Bank.  The provisions of the previous sentence shall not apply to (i) deposit accounts exclusively used for payroll, payroll taxes, and other employee wage and benefit payments to or for the benefit of Borrower&#8217;s employees and identified to Bank by Borrower as such, and (ii) the  Permitted Foreign Subsidiary Accounts.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Reserved.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Protection of Intellectual Property Rights.  </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">(i)  Use commercially reasonable efforts to protect, defend and maintain the validity and enforceability of Borrower&#8217;s and each Subsidiary&#8217;s Intellectual Property, except to the extent that such failure to do so would not reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations or that such Intellectual Property does not have material value&#59; (ii) promptly advise Bank in writing of infringements or any other event that could reasonably be expected to materially and adversely affect the value Borrower&#8217;s and each Subsidiary&#8217;s Intellectual Property that has material value&#59; and (iii) not allow any Intellectual Property material to Borrower&#8217;s or any Subsidiary&#8217;s business to be abandoned, forfeited or dedicated to the public without Bank&#8217;s written consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Provide written notice to Bank within thirty (30) days of entering or becoming bound by any Restricted License (other than over-the-counter software that is commercially available to the public).  Borrower shall take such commercially reasonable steps as Bank requests to obtain the consent of, or waiver by, any person whose consent or waiver is necessary for (i) any such Restricted License to be deemed &#8220;Collateral&#8221; and for Bank to have a security interest in it that might otherwise be restricted or prohibited by law or by the terms of any such Restricted License, whether now existing or entered into in the future, and (ii) Bank to have the ability in the event of a liquidation of any Collateral to dispose of such Collateral in accordance with Bank&#8217;s rights and remedies under this Agreement and the other Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Litigation Cooperation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  From the date hereof and continuing through the termination of this Agreement, make available to Bank, without expense to Bank, Borrower and its officers, employees and agents and Borrower&#8217;s books and records, to the extent that Bank may deem them reasonably necessary to prosecute or defend any third-party suit or proceeding instituted by or against Bank with respect to any Collateral or relating to Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Reserved.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Formation or Acquisition of Subsidiaries.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Notwithstanding and without limiting the negative covenants contained in Sections 6.3 and 6.7 hereof, at the time that Borrower or any Guarantor forms any Subsidiary or acquires any Subsidiary after the Effective Date (including, without limitation, pursuant to a Division), Borrower and such Guarantor shall (a) cause such new Subsidiary to provide to Bank a joinder to this Agreement to become a co-borrower hereunder or a guaranty to become a Guarantor hereunder (as determined by Bank in its sole discretion), together with documentation, all in form and substance satisfactory to Bank (including being sufficient to grant Bank a first priority Lien (subject to Permitted Liens) in and to the assets of such newly formed or acquired Subsidiary that constitute Collateral), (b) provide to Bank appropriate certificates and powers and financing statements, pledging (i) all of the direct or beneficial ownership interest in such new Subsidiary,  in form and substance reasonably satisfactory to Bank&#59; and (c) provide to Bank all other documentation in form and substance reasonably satisfactory to Bank, including one or more opinions of counsel satisfactory to Bank, which in its opinion is appropriate with respect to the execution and delivery of the applicable documentation referred to above.  Any document, agreement, or instrument executed or issued pursuant to this Section 5.14 shall be a Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Inventory&#59; Returns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Keep all Inventory in good and marketable condition, free from material defects.  Returns and allowances between Borrower and its Account Debtors shall follow Borrower&#8217;s customary practices as they exist at the Effective Date.  Borrower shall promptly notify Bank of all returns, recoveries, disputes and claims that involve more than Two Hundred Fifty Thousand Dollars ($250,000) (measured as to any single return, recovery, dispute or claim,  and not in the aggregate at such time).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Further Assurances.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Execute any further instruments and take such further action as Bank reasonably requests to perfect, protect, ensure the priority of or continue Bank&#8217;s Lien on the Collateral or to affect the purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  (a) Not, and not permit any of its Subsidiaries to, engage in any of the activities described in Section 4.11 in the future&#59; (b) not, and not permit any of its Subsidiaries to, become a Sanctioned Person&#59; (c) ensure that the proceeds of the Obligations are not used to violate any Sanctions&#59; and (d) deliver to Bank </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any certification or other evidence requested from time to time by Bank in its sole discretion, confirming each such Person&#8217;s compliance with this Section 5.17.  In addition, have implemented, and will consistently apply while this Agreement is in effect, reasonable procedures to ensure that the representations and warranties in Section 4.11 remain true and correct while this Agreement is in effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:80%">5.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:18.5pt">Post-Closing Obligations. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:24.91pt">As soon as possible, but in any event not later than the date that is fifteen (15) days after the Effective Date, Borrower shall deliver to Bank a duly executed landlord&#8217;s consent in favor of Bank for Borrower&#8217;s leased location at 2380-2390 Owen Street, Santa Clara, CA 95954.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:24.34pt">As soon as possible, but in any event not later than the date that is thirty (30) days after the Effective Date, Borrower shall deliver to Bank a duly executed bailee&#8217;s waiver in favor of Bank for the bailee location at 1125 W. Pinnacle Peak Road, Phoenix, AZ 85027, where Borrower maintains property with a third party.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">NEGATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrower shall not do any of the following without Bank&#8217;s prior written consent&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Dispositions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Convey, sell, lease, transfer, assign, or otherwise dispose of (including, without limitation, pursuant to a Division) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), or permit any of its Subsidiaries to Transfer, all or any part of its business or property, except for Transfers (a) of Inventory in the ordinary course of business&#59; (b) of worn-out, surplus or obsolete Equipment that is, in the reasonable judgment of Borrower, no longer economically practicable to maintain or useful in the ordinary course of business of Borrower&#59; (c) consisting of Permitted Liens and Permitted Investments&#59; (d) consisting of the sale or issuance of any stock, partnership, membership, or other ownership interest or other equity securities of Borrower permitted under Section 6.2 of this Agreement&#59; (e) consisting of Borrower&#8217;s or its Subsidiaries&#8217; use or transfer of money or Cash Equivalents in a manner that is not prohibited by the terms of this Agreement or the other Loan Documents, including without limitation cash returns or refunds of customer payments&#59; (f)&#160;of non-exclusive licenses for the use of the property of Borrower or its Subsidiaries in the ordinary course of business, and other licenses permitted pursuant to part (h) of the defined Permitted Liens&#59; (g) other Transfers not to exceed One Hundred Thousand Dollars ($100,000) in any twelve (12) month period&#59; and (h) other Transfers in which Borrower will receive cash proceeds in an amount equal to no less than seventy-five percent (75%) of such other Transfer consideration (fixed or contingent) paid or payable to Borrower or its Subsidiary.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the avoidance of doubt, none of (a) the sale of any Permitted Convertible Indebtedness, (b) the sale of any Warrant Transaction, (c) the purchase of any Bond Hedge Transaction or (d) the performance by Borrower of its obligations under any Permitted Convertible Indebtedness, any Warrant Transaction or any Bond Hedge Transaction (including the settlement or termination of any Bond Hedge Transaction or Warrant Transaction) shall constitute a Transfer.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Changes in Business, Management, Control, or Business Locations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  (a) Engage in or permit any of its Subsidiaries to engage in any business other than the businesses currently engaged in by Borrower and such Subsidiary, as applicable, or reasonably related thereto&#59; (b) liquidate or dissolve or permit any of its Subsidiaries to liquidate or dissolve (unless such Subsidiary&#8217;s assets are transferred to Borrower)&#59; (c) fail to provide notice to Bank of any Key Person departing from or ceasing to be employed by Borrower within seven (7) Business Days after such Key Person&#8217;s departure from Borrower&#59; (d) permit, allow or suffer to occur any Change in Control&#59; (e) without at least ten (10) days prior written notice to Bank, (i) add any new offices or business locations, including warehouses (unless such new offices or business locations contain less than Two Hundred Thousand Dollars ($200,000) in Borrower&#8217;s assets or property) or deliver any portion of the Collateral valued, individually or in the aggregate, in excess of Two Hundred Thousand Dollars ($200,000) to a bailee at a location other than to a bailee and at a location already disclosed in the Perfection Certificate, or (f) without at least twenty (20) days prior written notice to Bank (i) change its jurisdiction of organization, (ii) change its organizational structure or type, (iii) change its legal name, or, (iv) change any organizational number (if any) assigned by its jurisdiction of organization.  If Borrower intends to add any new offices or business locations, including warehouses, containing in excess of Two </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hundred Thousand Dollars ($200,000) of Borrower&#8217;s assets or property, then Borrower will cause the landlord of any such new offices or business locations, including warehouses, to execute and deliver a landlord consent in form and substance reasonably satisfactory to Bank.  If Borrower intends to deliver any portion of the Collateral valued, individually or in the aggregate, in excess of Two Hundred Thousand Dollars ($200,000) to a bailee, and Bank and such bailee are not already parties to a bailee agreement governing both the Collateral and the location to which Borrower intends to deliver the Collateral, then Borrower will  cause such bailee to execute and deliver a bailee agreement in form and substance reasonably satisfactory to Bank.  For the avoidance of doubt, no landlord or bailee waivers shall be required for or with respect to any foreign locations of Borrower or its Subsidiaries. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Mergers or Acquisitions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Merge or consolidate, or permit any of its Subsidiaries to merge or consolidate, with any other Person, or acquire, or permit any of its Subsidiaries to acquire, all or substantially all of the stock, partnership, membership, or other ownership interest or other equity securities or property of another Person (including, without limitation, by the formation of any Subsidiary or pursuant to a Division), except (i) if (a) Borrower has complied with the notice requirements applicable to prepayments hereunder, and (b) prior to or contemporaneously with the closing of such transaction, all Obligations are paid in full in cash, and all of Bank&#8217;s obligations to lend to Borrower under this Agreement are terminated, and&#47;or (iii) Permitted Acquisitions. A Subsidiary may merge or consolidate into another Subsidiary or into Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Indebtedness.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Create, incur, assume, or be liable for any Indebtedness, or permit any Subsidiary to do so, other than Permitted Indebtedness.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Encumbrance.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Create, incur, allow, or suffer to exist any Lien on any of its property, or assign or convey any right to receive income, including the sale of any Accounts, or permit any of its Subsidiaries to do so, in each case as to the foregoing except for Permitted Liens, permit any Collateral not to be subject to the first priority security interest granted herein, other than Permitted Liens, or enter into any agreement, document, instrument or other arrangement (except with or in favor of Bank) with any Person which directly or indirectly prohibits or has the effect of prohibiting Borrower or any Subsidiary from assigning, mortgaging, pledging, granting a security interest in or upon, or encumbering any of Borrower&#8217;s or any Subsidiary&#8217;s Intellectual Property, except as is otherwise permitted in Section 6.1 hereof and the definition of &#8220;Permitted Liens&#8221; herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Maintenance of Collateral Accounts.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Maintain any Collateral Account except pursuant to the terms of Section 5.9(c).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Distributions&#59; Investments.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  (a) Pay any dividends or make any distribution or payment or redeem, retire or purchase any stock, partnership, membership, or other ownership interest or other equity securities, provided that Borrower may (i) convert any of its convertible securities into other securities pursuant to the terms of such convertible securities or otherwise in exchange thereof, (ii) pay dividends solely in common stock or equity interests, (iii) repurchase the stock of former  employees, officers, directors or consultants pursuant to stock repurchase agreements or termination of employment or service or repurchases pursuant to rights of first refusal in Borrower&#8217;s bylaws, so long as an Event of Default does not exist at the time of any such repurchase and would not exist after giving effect to any such repurchase&#59; provided the aggregate amount of all such repurchases shall not exceed Five Hundred Thousand Dollars ($500,000) per fiscal year, (iv) pay cash distributions in lieu of issuing fractional shares&#59; provided the aggregate amount of all such payments shall not exceed Two Hundred Thousand Dollars ($200,000) per fiscal year , (v) distribute equity securities to former or current employees, officers, consultants or directors pursuant to the exercise of employee stock options approved by the Board, (vi) pay, in connection with any Permitted Acquisition by Borrower or any of its Subsidiaries, (A) the receipt or acceptance of the return to Borrower or any of its Subsidiaries of stock or equity interests of Borrower constituting a portion of the purchase price consideration in settlement of indemnification claims, or as a result of a purchase price adjustment (including earn-outs or similar obligations) and (B) payments or distributions to equity holders pursuant to appraisal rights required under requirements of law&#59; (vii) the distribution of rights pursuant to any shareholder rights plan or the redemption of such rights for nominal consideration in accordance with the terms of any shareholder rights plan, and (viii) for the avoidance of doubt, Subsidiaries of Borrower shall be permitted to, directly or indirectly, pay dividends or make distributions to other Subsidiaries or to Borrower, or (b) directly or indirectly make any </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment (including, without limitation, by the formation of any Subsidiary) other than Permitted Investments, or permit any of its Subsidiaries to do so.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, or anything to the contrary herein, and for the avoidance of doubt, this Section 6.7 shall not prohibit (i) the conversion by holders of (including any cash payment upon conversion), or required payment of any principal or premium on, or required payment of any interest with respect to, any Permitted Convertible Debt, in each case, in accordance with the terms of the indenture governing such Permitted Convertible Debt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that the preceding sentence shall only allow principal payments with respect to any repurchase in connection with the redemption of Permitted Convertible Debt upon satisfaction of a condition related to the stock price of the Borrower&#8217;s common stock if the Redemption Conditions are  satisfied in respect of such redemption&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided further </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that, to the extent both (a) the aggregate amount of cash payable upon conversion or redemption of any Permitted Convertible Debt (excluding any required payment of interest with respect to such Permitted Convertible Debt and excluding any payment of cash in lieu of a fractional share due upon conversion thereof) exceeds the aggregate principal amount thereof and (b) such conversion or redemption does not trigger or correspond to an exercise or early unwind or settlement of a corresponding portion of the Bond Hedge Transactions constituting Permitted Call Spread Agreements relating to such Permitted Convertible Debt (including, for the avoidance of doubt, the case where there is no Bond Hedge Transaction constituting a Permitted Call Spread Agreement relating to such Permitted Convertible Debt), the payment of such excess cash (any such payment, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Excess Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall not be permitted by this clause (i)&#59; and (ii) any required payment with respect to (including, for the avoidance of doubt, the payment of the relevant premium for the purchase thereof), or required early unwind or settlement of, any Permitted Call Spread Agreement, in each case, in accordance with the terms of the agreement governing such Permitted Call Spread Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that, to the extent cash is required to be paid under a Warrant Transaction as a result of the election of &#8220;cash settlement&#8221; (or substantially equivalent term) as the &#8220;settlement method&#8221; (or substantially equivalent term) thereunder by the Borrower (or its Affiliate) (including in connection with the exercise and&#47;or early unwind or settlement thereof), the payment of such cash shall not be permitted by this clause (ii).  Notwithstanding the foregoing, the Borrower may repurchase, exchange or induce the conversion of Permitted Convertible Debt by delivery of shares of the Borrower&#8217;s common stock and&#47;or a different series of Permitted Convertible Debt (which series (I) matures after, and does not require any scheduled amortization or other scheduled payments of principal prior to, the analogous date under the indenture governing the Permitted Convertible Debt that are so repurchased, exchanged or converted and (II) has terms, conditions and covenants that are commercially reasonable to the Borrower (as determined by the Borrower in good faith) (any such series of Permitted Convertible Debt, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Refinancing Convertible Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and&#47;or by payment of cash (x) in lieu of any fractional shares, (y) in respect of accrued and unpaid interest of such Permitted Convertible Debt and (z) additional cash in an amount that does not exceed the proceeds received by the Borrower from the substantially concurrent issuance of shares of the Borrower&#8217;s common stock and&#47;or a Refinancing Convertible Debt plus the net cash proceeds, if any, received by the Borrower pursuant to the related exercise or early unwind or termination of the related Permitted Call Spread Agreements pursuant to the immediately following proviso&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that, substantially concurrently with, or a commercially reasonable period of time before or after, the related settlement date for the Permitted Convertible Debt that is so repurchased, exchanged or converted, the Borrower shall (and, for the avoidance of doubt, shall be permitted under this Section 7.7 to) exercise or unwind or terminate early (whether in cash, shares or any combination thereof) the portion of the Permitted Call Spread Agreements, if any, corresponding to such Permitted Convertible Debt that is so repurchased, exchanged or converted.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Transactions with Affiliates.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Directly or indirectly enter into or permit to exist any material transaction with any Affiliate of Borrower, except for (a) transactions that are in the ordinary course of Borrower&#8217;s business, upon fair and reasonable terms that are no less favorable to Borrower than would be obtained in an arm&#8217;s length transaction with a non-affiliated Person&#59; (b) sales of Borrower&#8217;s equity securities to the then-existing investors of Borrower in connection with a bona fide equity financing by the Board so long as such sale shall not result in a violation of the Change of Control provision in Section 6.2, (c) debt financings from Borrower&#8217;s investors so long as all such Indebtedness shall constitute Subordinated Debt, (d) reasonable and customary compensation arrangements and benefit plans for officers, and other employees of Borrower approved by the Board, (e) reasonable and customary compensation arrangements for fees and costs paid to members of the Board in the ordinary course of </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business, and (f) Investments of the type described in and permitted under clauses (g) and&#47;or (h) of the definition of &#8220;Permitted Investments&#8221; herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Subordinated Debt.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Except as expressly permitted under the terms of the subordination, intercreditor, or other similar agreement to which any Subordinated Debt is subject&#58; (a) make or permit any payment on such Subordinated Debt&#59; (b) amend any provision in any document relating to such Subordinated Debt which would increase the amount thereof, or (c) provide for earlier or greater principal, interest, or other payments thereon, or adversely affect the subordination thereof to Obligations owed to Bank in contravention of the terms of such the subordination, intercreditor, or other similar agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Compliance.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  (a) Become an &#8220;investment company&#8221; or a company controlled by an &#8220;investment company&#8221;, under the Investment Company Act of 1940, as amended, or undertake as one of its important activities extending credit to purchase or carry margin stock (as defined in Regulation U of the Board of Governors of the Federal Reserve System), or use the proceeds of any Credit Extension for that purpose&#59; (b)(i) fail to meet the minimum funding requirements of ERISA, (ii) permit a Reportable Event or Prohibited Transaction, as defined in ERISA, to occur, (iii) fail to comply with the Federal Fair Labor Standards Act or (iv) violate any other law or regulation, if the foregoing subclauses (i) through (iv), individually or in the aggregate, could reasonably be expected to have a material adverse effect on Borrower&#8217;s business or operations, or permit any of its Subsidiaries to do so&#59; or (c) withdraw or permit any Subsidiary to withdraw from participation in, permit partial or complete termination of, or permit the occurrence of any other event with respect to, any present pension, profit sharing and deferred compensation plan which could reasonably be expected to result in any material liability of Borrower, including any material liability to the Pension Benefit Guaranty Corporation or its successors or any other Governmental Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Cash and Cash Equivalents held by Foreign Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The aggregate value of cash and Cash Equivalents held by all Foreign Subsidiaries of Borrower to exceed Two Million Five Hundred Thousand Dollars ($2,500,000) for more than five (5) Business Days in each calendar month.   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Value of Assets held by Foreign Subsidiaries.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate value of the assets owned by the Foreign Subsidiaries of Borrower shall not exceed twenty percent (20%) of the aggregate value of all assets owned by the Borrower and its Subsidiaries.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Redemption of Permitted Convertible Debt.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercise any redemption right with respect to any Permitted Convertible Debt upon satisfaction of a condition related to the stock price of the Borrower&#8217;s common stock, unless the Redemption Conditions are satisfied in respect of such redemption.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">EVENTS OF DEFAULT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any one of the following shall constitute an event of default (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under this Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Payment Default.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Borrower fails to (a) make any payment of principal or interest on any Credit Extension on its due date, or (b) pay any other Obligations within three (3) Business Days after such Obligations are due and payable (which three (3) Business Day cure period shall not apply to payments due on the Term Loan Maturity Date), in each unless such late payment is due to Bank&#8217;s failure to auto-debit such payment when sufficient funds were contained in the Designated Deposit Account (or if insufficient funds are contained therein, or if an Event of Default has occurred and is continuing, any of Borrower&#8217;s other accounts at Bank).  During the cure period, the failure to make or pay any payment specified under clause (b) hereunder is not an Event of Default (but no Credit Extension will be made during the cure period)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Covenant Default.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Borrower fails or neglects to perform any obligation in Section 5 (other than Sections 5.2 (Government Compliance), 5.12 (Litigation Cooperation), 5.15 (Inventory&#59; Returns) and 5.16 (Further Assurances)) or violates any covenant in Section 6&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Borrower fails or neglects to perform, keep, or observe any other term, provision, condition, covenant or agreement contained in this Agreement or any Loan Documents, and as to any default (other than those specified in this Section 7) under such other term, provision, condition, covenant or agreement that can be cured, has failed to cure the default within ten (10) days after the occurrence thereof&#59; provided, however, that if the default cannot by its nature be cured within the ten (10) day period or cannot after diligent attempts by Borrower be cured within such ten (10) day period, and such default is likely to be cured within a reasonable time, then Borrower shall have an additional period (which shall not in any case exceed thirty (30) days) to attempt to cure such default, and within such reasonable time period the failure to cure the default shall not be deemed an Event of Default (but no Credit Extensions shall be made during such cure period).  Cure periods provided under this section shall not apply to any covenants set forth in Section 7.2(a) above&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Material Adverse Change.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  A Material Adverse Change occurs&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Attachment&#59; Levy&#59; Restraint on Business.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">(i) The service of process seeking to attach, by trustee or similar process, any funds of Borrower or any Subsidiary with a value in excess of Two Hundred Thousand Dollars ($200,000), or (ii) a notice of lien or levy in an amount in excess of Two Hundred Thousand Dollars ($200,000), is filed against any of Borrower&#8217;s or any of its Subsidiaries&#8217; assets by any Governmental Authority, and the same under subclauses (i) and (ii) hereof are not, within fifteen (15) days after the occurrence thereof, discharged or stayed (whether through the posting of a bond or otherwise)&#59; provided, however, no Credit Extensions shall be made during any fifteen (15) day cure period&#59; or </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">(i) any material portion of Borrower&#8217;s or any of its Subsidiaries&#8217; assets with a value in excess of Two Hundred Thousand Dollars ($200,000), is attached, seized, levied on, or comes into possession of a trustee or receiver, or (ii) any court order enjoins, restrains, or prevents Borrower or any of its Subsidiaries from conducting all or any material part of its business&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Insolvency.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  (a) Borrower or Borrower and of its Subsidiaries (taken as a whole) is unable to pay its debts (including trade debts) as they become due or otherwise becomes insolvent&#59; (b) Borrower or any of its  Subsidiaries begins an Insolvency Proceeding&#59; or (c) an Insolvency Proceeding is begun against Borrower or any of its  Subsidiaries and is not dismissed or stayed within forty-five (45) days (but no Credit Extensions shall be made while any of the conditions described in clause (a) exist and&#47;or until any Insolvency Proceeding is dismissed)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Other Agreements.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  There is, under any agreement to which Borrower, any of Borrower&#8217;s Subsidiaries, or any Guarantor is a party with a third party or parties, (a) any default by Borrower (after applicable grace and&#47;or cure periods) resulting in a right by such third party or parties, whether or not exercised, to accelerate the maturity of any Indebtedness in an amount individually or in the aggregate in excess of Five Hundred Thousand Dollars ($500,000)&#59; or (b) any breach or default by Borrower, any of Borrower&#8217;s Subsidiaries, or Guarantor the result of which could reasonably be expected to have a material adverse effect on Borrower&#8217;s, any of Borrower&#8217;s Subsidiaries&#8217;, or any Guarantor&#8217;s business or operations (taken as a whole)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Judgments&#59; Penalties.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  One or more fines, penalties or final judgments, orders or decrees for the payment of money in an amount, individually or in the aggregate, of at least Five Hundred Thousand Dollars ($500,000)(not covered by independent third-party insurance as to which liability has been accepted by such insurance carrier) shall be rendered against Borrower or any of its Subsidiaries by any Governmental Authority, and the same are not, within ten (10) days after the entry, assessment or issuance thereof, discharged, satisfied or paid, or after execution thereof,  or stayed pending appeal, or such judgments are not discharged, satisfied or paid prior to the </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expiration of any such stay (provided that no Credit Extensions will be made prior to the discharge, satisfaction,  payment, or stay  of such fine, penalty, judgment, order or decree)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Misrepresentations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Borrower or any of its Subsidiaries or any Responsible Person acting for Borrower or any of its Subsidiaries knowingly makes any representation, warranty, or other statement now or later in this Agreement, any Loan Document or in any writing delivered to Bank or to induce Bank to enter this Agreement or any Loan Document, and such representation, warranty, or other statement is incorrect in any material respect when made (it being agreed and acknowledged by Bank that the projections and forecasts provided by Borrower or any of its Subsidiaries in good faith and based upon reasonable assumptions are not viewed as facts and that actual results during the period or periods covered by such projections and forecasts may differ from the projected or forecasted results)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Subordinated Debt.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  If&#58; (a) any document, instrument, or agreement evidencing any Subordinated Debt shall for any reason be revoked or invalidated or otherwise cease to be in full force and effect (other than in accordance with the terms of such document, instrument or agreement) or any Person (other than Bank)) shall be in breach thereof or contest in any manner the validity or enforceability thereof or deny that it has any further liability or obligation thereunder&#59; (b) a default or event of default (however defined) has occurred under any document, instrument, or agreement evidencing any Subordinated Debt, which default shall not have been cured or waived within any applicable grace period&#59; or (c) the Obligations shall for any reason be subordinated or shall not have the priority contemplated by the applicable subordination or intercreditor agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Lien Priority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  There is a material impairment in the perfection or priority of Bank&#8217;s security interest in the Collateral (unless such failure is caused by Bank&#8217;s gross negligence or willful misconduct)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Guaranty.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  (a) Any guaranty of any Obligations terminates or ceases for any reason to be in full force and effect (except due to termination in accordance with the terms of such guaranty)&#59; (b) any Guarantor does not perform any material obligation or covenant under any guaranty of the Obligations&#59; (c) any circumstance described in Sections 7.3, 7.4, 7.5, 7.6, 7.7, or 7.8 of this Agreement occurs with respect to any Guarantor (subject to the applicable cure and grace periods herein), (d) the death, liquidation, winding up, or termination of existence of any Guarantor&#59; or (e)a material impairment in the perfection or priority of Bank&#8217;s Lien in the collateral provided by Guarantor or in the value of such collateral &#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Governmental Approvals.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Any Governmental Approval shall have been (a) revoked, rescinded, suspended, modified in an adverse manner or not renewed in the ordinary course for a full term or (b) subject to any decision by a Governmental Authority that designates a hearing with respect to any applications for renewal of any of such Governmental Approval or that could result in the Governmental Authority taking any of the actions described in clause (a) above, and such decision or such revocation, rescission, suspension, modification or non-renewal (i) causes, or could reasonably be expected to cause, a Material Adverse Change, or (ii) materially and adversely affects the legal qualifications of Borrower or any of its Subsidiaries to hold such Governmental Approval in any applicable jurisdiction and such revocation, rescission, suspension, modification or non-renewal could reasonably be expected to materially and adversely affect the status of or legal qualifications of Borrower or any of its Subsidiaries to hold any Governmental Approval in any other jurisdiction that is material to the operation of Borrower&#8217;s business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">BANK&#8217;S RIGHTS AND REMEDIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Rights and Remedies.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Upon the occurrence and during the continuance of an Event of Default, Bank may, without notice or demand, do any or all of the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">declare all Obligations immediately due and payable (but if an Event of Default described in Section 7.5 occurs all Obligations are immediately due and payable without any action by Bank)&#59;</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">stop advancing money or extending credit for Borrower&#8217;s benefit under this Agreement or under any other agreement between Borrower and Bank&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">demand that Borrower (i) deposit cash with Bank in an amount equal to at least (A) one hundred and five percent (105.0%) of the aggregate face amount of any Letters of Credit denominated in Dollars remaining undrawn, and (B) one hundred and fifteen percent (115.0%) of the Dollar Equivalent of the aggregate face amount of any Letters of Credit denominated in a Foreign Currency remaining undrawn (plus, in each case, all interest, fees, and costs due or estimated by Bank to become due in connection therewith), to secure all of the Obligations relating to such Letters of Credit, as collateral security for the repayment of any future drawings under such Letters of Credit, and Borrower shall forthwith deposit and pay such amounts, and (ii) pay in advance all letter of credit fees scheduled to be paid or payable over the remaining term of any Letters of Credit&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">terminate any FX Contracts (it being understood and agreed that (i) Bank is not obligated to deliver the currency which Borrower has contracted to receive under any FX Contract, and Bank may cover its exposure for any FX Contracts by purchasing or selling currency in the interbank market as Bank deems appropriate&#59; (ii) Borrower shall be liable for all losses, damages, costs, margin obligations and expenses incurred by Bank arising from Borrower&#8217;s failure to satisfy its obligations under any FX Contract or the execution of any FX Contract&#59; and (iii) Bank shall not be liable to Borrower for any gain in value of a FX Contract that Bank may obtain in covering Borrower&#8217;s breach)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">verify the amount of, demand payment of and performance under, and collect any Accounts and General Intangibles, settle or adjust disputes and claims directly with Account Debtors for amounts on terms and in any order that Bank considers advisable, and notify any Person owing Borrower money of Bank&#8217;s security interest in such funds&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">make any payments and do any acts it considers necessary or reasonable to protect the Collateral and&#47;or its security interest in the Collateral.  Borrower shall assemble the Collateral if Bank requests and make it available as Bank designates.  Bank may enter premises where the Collateral is located, take and maintain possession of any part of the Collateral, and pay, purchase, contest, or compromise any Lien which appears to be prior or superior to its security interest and pay all expenses incurred. Borrower grants Bank a license to enter and occupy any of its premises, without charge, to exercise any of Bank&#8217;s rights or remedies&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">apply to the Obligations any (i) balances and deposits of Borrower it holds, or (ii) amount held by Bank owing to or for the credit or the account of Borrower&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">ship, reclaim, recover, store, finish, maintain, repair, prepare for sale, advertise for sale, and sell the Collateral.  For use solely upon the occurrence and during the continuation of an Event of Default, Bank is hereby granted a non-exclusive, royalty-free license or other right to use, without charge, Borrower&#8217;s labels, Patents, Copyrights, mask works, rights of use of any name, trade secrets, trade names, Trademarks, and advertising matter, or any similar property as it pertains to the Collateral, in completing production of, advertising for sale, and selling any Collateral and, in connection with Bank&#8217;s exercise of its rights under this Section 8.1, Borrower&#8217;s rights under all licenses and all franchise agreements inure to Bank&#8217;s benefit&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">place a &#8220;hold&#8221; on any account maintained with Bank and&#47;or deliver a notice of exclusive control, any entitlement order, or other directions or instructions pursuant to any Control Agreement or similar agreements providing control of any Collateral&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">demand and receive possession of Borrower&#8217;s Books&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">exercise all rights and remedies available to Bank under the Loan Documents or at law or equity, including all remedies provided under the Code or any Applicable Law (including disposal of the Collateral pursuant to the terms thereof).</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Power of Attorney.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrower hereby irrevocably appoints Bank as its true and lawful attorney-in-fact, (a) exercisable only following the occurrence and during the continuance of an Event of Default, to&#58; (i) endorse Borrower&#8217;s name on any checks, payment instruments, or other forms of payment or security&#59; (ii) sign Borrower&#8217;s name on any invoice or bill of lading for any Account or drafts against Account Debtors&#59; (iii) demand, collect, sue, and give releases to any Account Debtor for monies due, settle and adjust disputes and claims about the Accounts directly with Account Debtors, and compromise, prosecute, or defend any action, claim, case, or proceeding about any Collateral (including filing a claim or voting a claim in any bankruptcy case in Bank&#8217;s or Borrower&#8217;s name, as Bank chooses)&#59; (iv) make, settle, and adjust all claims under Borrower&#8217;s insurance policies&#59; (v) pay, contest or settle any Lien, charge, encumbrance, security interest, or other claim in or to the Collateral, or any judgment based thereon, or otherwise take any action to terminate or discharge the same&#59; and (vi) transfer the Collateral into the name of Bank or a third party as the Code permits&#59; and (b) regardless of whether an Event of Default has occurred, to sign Borrower&#8217;s name on any documents necessary to perfect or continue the perfection of Bank&#8217;s security interest in the Collateral.  Bank&#8217;s foregoing appointment as Borrower&#8217;s attorney in fact, and all of Bank&#8217;s rights and powers, coupled with an interest, are irrevocable until such time as all Obligations (other than inchoate indemnity obligations) have been paid in full in cash, Bank is under no further obligation to make Credit Extensions and the Loan Documents have been terminated. Bank shall not incur any liability in connection with or arising from the exercise of such power of attorney and shall have no obligation to exercise any of the foregoing rights and remedies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Protective Payments.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  If Borrower fails to obtain the insurance called for by Section 5.8 or fails to pay any premium thereon or fails to pay any other amount which Borrower is obligated to pay under this Agreement or any other Loan Document or which may be required to preserve the Collateral, Bank may obtain such insurance or make such payment, and all amounts so paid by Bank are Bank Expenses and immediately due and payable, bearing interest at the then highest rate applicable to the Obligations, and secured by the Collateral.  Bank will make reasonable efforts to provide Borrower with notice of Bank obtaining such insurance at the time it is obtained or within a reasonable time thereafter.  No payments by Bank are deemed an agreement to make similar payments in the future or Bank&#8217;s waiver of any Event of Default.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Application of Payments and Proceeds.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  If an Event of Default has occurred and is continuing, Bank shall have the right to apply in any order any funds in its possession, whether from Borrower account balances, payments, proceeds realized as the result of any collection of Accounts or other disposition of the Collateral, or otherwise, to the Obligations in such order as Bank shall determine in its sole discretion.  Any surplus shall be paid to Borrower or other Persons legally entitled thereto&#59; Borrower shall remain liable to Bank for any deficiency.  Following the occurrence and during the continuation of an Event of Default, if Bank, in its commercially reasonable discretion, directly or indirectly, enters into a deferred payment or other credit transaction with any purchaser at any sale of Collateral, Bank shall have the option, exercisable at any time, of either reducing the Obligations by the principal amount of the purchase price or deferring the reduction of the Obligations until the actual receipt by Bank of cash therefor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Bank&#8217;s Liability for Collateral.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   Bank&#8217;s sole duty with respect to the custody, safekeeping and physical preservation of the Collateral in its possession or under its control, under Section 9-207 of the Code or otherwise, shall be to deal with it in the same manner as Bank deals with its own property consisting of similar instruments or interests.   Borrower bears all risk of loss, damage or destruction of the Collateral.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">No Waiver&#59; Remedies Cumulative.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Bank&#8217;s failure, at any time or times, to require strict performance by Borrower of any provision of this Agreement or any other Loan Document shall not waive, affect, or diminish any right of Bank thereafter to demand strict performance and compliance herewith or therewith.  No waiver hereunder shall be effective unless signed by the party granting the waiver and then is only effective for the specific instance and purpose for which it is given.  Bank&#8217;s rights and remedies under this Agreement and the other Loan Documents are cumulative.  Bank has all rights and remedies provided under the Code, by law, or in equity.  Bank&#8217;s exercise of one right or remedy is not an election and shall not preclude Bank from exercising any other remedy under this Agreement or other remedy available at law or in equity, and Bank&#8217;s waiver of any Event of </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Default is not a continuing waiver.  Bank&#8217;s delay in exercising any remedy is not a waiver, election, or acquiescence.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">Demand Waiver.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Borrower waives demand, notice of default or dishonor, notice of payment and nonpayment, notice of any default, nonpayment at maturity, release, compromise, settlement, extension, or renewal of accounts, documents, instruments, chattel paper, and guarantees held by Bank on which Borrower is liable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">NOTICES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All notices, consents, requests, approvals, demands, or other communication by any party to this Agreement or any other Loan Document must be in writing and shall be deemed to have been validly served, given, or delivered&#58; (a) upon the earlier of actual receipt and three (3) Business Days after deposit in the U.S. mail, first class, registered or certified mail return receipt requested, with proper postage prepaid&#59; (b) upon transmission, when sent by electronic mail&#59; (c) one (1) Business Day after deposit with a reputable overnight courier with all charges prepaid&#59; or (d) when delivered, if hand-delivered by messenger, all of which shall be addressed to the party to be notified and sent to the address or email address indicated below&#59; provided that, for clause (b), if such notice, consent, request, approval, demand or other communication is not sent during the normal business hours of the recipient, it shall be deemed to have been sent at the opening of business on the next Business Day of the recipient.  Bank or Borrower may change its mailing or electronic mail address by giving the other party written notice thereof in accordance with the terms of this Section 9. </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to Borrower&#58;&#160;&#160;&#160;&#160;SI-Bone, Inc.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;471 El Camino Real, Suite 101 </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Santa Clara, CA 95050</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Attn&#58;  Laura Francis, CEO&#59; and</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Anshul Maheshwari, CFO</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Email&#58;  lfrancis&#64;si-bone.com&#59; and</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Anshul.Maheshwari&#64;si-bone.com</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with a copy to (which shall not constitute notice)&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cooley LLP</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;55 Hudson Yards</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;New York, New York, 10001-2157</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Attn&#58; Patrick Flanagan</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Email&#58; pflanagan&#64;cooley.com</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to Bank&#58;&#160;&#160;&#160;&#160;Silicon Valley Bank</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;505 Howard Street, Floor 3</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;San Francisco, CA 94105</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Attn&#58;  Mark Davis</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Email&#58;  mdavis&#64;svb.com</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with a copy to (which shall not constitute notice)&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DLA Piper LLP (US)</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;401 B Street, Suite 1700</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;San Diego, California 92101</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Attn&#58;  Matt Schwartz, Esq. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Email&#58;  matt.schwartz&#64;us.dlapiper.com </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">CHOICE OF LAW, VENUE AND JURY TRIAL WAIVER&#59; JUDICIAL REFERENCE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise expressly provided in any of the Loan Documents, California law governs the Loan Documents without regard to principles of conflicts of law that would require the application of the laws of another jurisdiction.  Borrower and Bank each irrevocably and unconditionally submit to the exclusive jurisdiction of the State and Federal courts in Santa Clara County, California&#59; provided, however, that nothing in this Agreement shall be deemed to operate to preclude Bank from bringing suit or taking other legal action in any other jurisdiction with respect to the Loan Documents or to realize on the Collateral or any other security for the Obligations, or to enforce a judgment or other court order in favor of Bank.  Borrower expressly, irrevocably and unconditionally submits and consents in advance to such jurisdiction in any action or suit commenced in any such court, and Borrower hereby irrevocably and unconditionally waives, to the fullest extent permitted by Applicable Law, any objection that it may have based upon lack of personal jurisdiction, improper venue, or forum non conveniens and hereby irrevocably and unconditionally consents to the granting of such legal or equitable relief as is deemed appropriate by such court.  Borrower hereby waives personal service of the summons, complaints, and other process issued in such action or suit and agrees that service of such summons, complaints, and other process may be made by registered or certified mail addressed to Borrower at the address set forth in, or subsequently provided by Borrower in accordance with, Section 9 of this Agreement and that service so made shall be deemed completed upon the earlier to occur of Borrower&#8217;s actual receipt thereof or three (3) days after deposit in the U.S. mails, proper postage prepaid.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, BORROWER AND BANK EACH WAIVES ITS RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS AGREEMENT, THE LOAN DOCUMENTS OR ANY CONTEMPLATED TRANSACTION UNDER THIS AGREEMENT, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER CLAIMS. THIS WAIVER IS A MATERIAL INDUCEMENT FOR THE PARTIES HERETO TO ENTER INTO THIS AGREEMENT.  EACH PARTY HERETO HAS REVIEWED THIS WAIVER WITH ITS COUNSEL.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WITHOUT INTENDING IN ANY WAY TO LIMIT THE PARTIES&#8217; AGREEMENT TO WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY, if the above waiver of the right to a trial by jury is not enforceable, the parties hereto agree that any and all disputes or controversies of any nature between them arising at any time shall be decided by a reference to a private judge, mutually selected by the parties (or, if they cannot agree, by the Presiding Judge of the Santa Clara County, California Superior Court) appointed in accordance with California Code of Civil Procedure Section 638 (or pursuant to comparable provisions of federal law if the dispute falls within the exclusive jurisdiction of the federal courts), sitting without a jury, in Santa Clara County, California&#59; and the parties hereby submit to the jurisdiction of such court.  The reference proceedings shall be conducted pursuant to and in accordance with the provisions of California Code of Civil Procedure Sections 638 through 645.1, inclusive.  The private judge shall have the power, among others, to grant provisional relief, including without limitation, entering temporary restraining orders, issuing preliminary and permanent injunctions and appointing receivers.  All such proceedings shall be closed to the public and confidential and all records relating thereto shall be permanently sealed.  If during the course of any dispute, a party desires to seek provisional relief, but a judge has not been appointed at that point pursuant to the judicial reference procedures, then such party may apply to the Santa Clara County, California Superior Court for such relief.  The proceeding before the private judge shall be conducted in the same manner as it would be before a court under the rules of evidence applicable to judicial proceedings.  The parties shall be entitled to discovery which shall be conducted in the same manner as it would be before a court under the rules of discovery applicable to judicial proceedings.  The private judge shall oversee discovery and may enforce all discovery rules and orders applicable to judicial proceedings in the same manner as a trial court judge.  The parties agree that the selected or appointed private judge shall have the power to decide all issues in the action or proceeding, whether of fact or of law, and shall report a statement of decision thereon pursuant to California Code of Civil Procedure Section 644(a).  Nothing in this paragraph shall limit the right of any party at any time to exercise self-help remedies, foreclose against collateral, or obtain provisional remedies.  The private judge shall also determine all issues relating to the applicability, interpretation, and enforceability of this paragraph.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Section 10 shall survive the termination of this Agreement and the repayment of all Obligations.</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">GENERAL PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Termination Prior to Term Loan Maturity Date&#59; Survival. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> All covenants, representations and warranties made in this Agreement shall continue in full force until this Agreement has terminated pursuant to its terms and all Obligations (other than inchoate indemnity obligations) have been satisfied.  So long as Borrower has satisfied the Obligations (other than inchoate indemnity obligations, and any other obligations which, by their terms, are to survive the termination of this Agreement and the repayment of all Obligations, and any Obligations under Bank Services Agreements that are cash collateralized in accordance with Section 3.1 of this Agreement), this Agreement may be terminated prior to the Term Loan Maturity Date by Borrower, effective three (3) Business Days after written notice of termination is given to Bank.  Those obligations that are expressly specified in this Agreement as surviving this Agreement&#8217;s termination and the repayment of all Obligations shall continue to survive notwithstanding this Agreement&#8217;s termination and the repayment of all Obligations. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Successors and Assigns.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  This Agreement binds and is for the benefit of the successors and permitted assigns of each party.  Borrower may not assign or transfer this Agreement or any rights or obligations under it without Bank&#8217;s prior written consent (which may be granted or withheld in Bank&#8217;s sole discretion) and any other attempted assignment or transfer by Borrower shall be null and void.  Bank has the right, without the consent of or notice to Borrower, to sell, transfer, assign, negotiate, or grant participation in all or any part of, or any interest in, Bank&#8217;s obligations, rights, and benefits under this Agreement and the other Loan Documents. Notwithstanding the foregoing, or anything to the contrary herein, so long as no Event of Default shall have occurred and is continuing, Bank shall not assign its interest in the Loan Documents to any Person who is (a) a competitor of Borrower, whether as an operating company or direct or indirect parent with voting control over such operating company, or (b) a vulture fund or distressed debt fund.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Indemnification. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">General Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Borrower shall indemnify, defend and hold Bank and its Affiliates and the partners, directors, officers, employees, agents, trustees, administrators, managers, advisors and representatives of Bank and its Affiliates (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnified Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) harmless against&#58; all losses, claims, damages, liabilities and related expenses (including Bank Expenses and the reasonable fees, charges and disbursements of any counsel for any Indemnified Person)  (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) arising out of, in connection with, or as a result of (i) the execution or delivery of this Agreement, any other Loan Document or any agreement or instrument contemplated hereby or thereby, the performance by the parties hereto of their respective obligations hereunder or thereunder or the consummation of the transactions contemplated hereby or thereby, (ii) any Credit Extension or the use or proposed use of the proceeds therefrom, (iii) any actual or alleged presence or release of hazardous materials on or from any property owned or operated by Borrower or any of its Subsidiaries, or any environmental liability related in any way to Borrower or any of its Subsidiaries, or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory, whether brought by a third party or by Borrower, and regardless of whether any Indemnified Person is a party thereto&#59; provided that such indemnity shall not, as to any Indemnified Person, be available to the extent that such losses, claims, damages, liabilities or related expenses are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Indemnified Person.  All amounts due under this Section 11.3 shall be payable promptly after demand therefor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Waiver of Consequential Damages, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  To the fullest extent permitted by Applicable Law, Borrower shall not assert, and hereby waives, any claim against any Indemnified Person, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) or any loss of profits arising out of, in connection with, or as a result of, this Agreement, any other Loan Document or any agreement or instrument contemplated hereby, the transactions contemplated hereby or thereby, any Credit Extension, or the use of the proceeds thereof.  No Indemnified Person shall be liable for any damages arising from the use by unintended recipients of any information or other materials distributed by it through telecommunications, electronic or other information transmission systems in connection with this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby.</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Section 11.3 shall survive the termination of this Agreement and the repayment of all Obligations until all statutes of limitation with respect to the Claims, losses, and expenses for which indemnity is given shall have run.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Time of Essence.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Time is of the essence for the performance of all Obligations in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Severability of Provisions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Each provision of this Agreement is severable from every other provision in determining the enforceability of any provision.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Amendments in Writing&#59; Waiver&#59; Integration.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  No purported amendment or modification of any Loan Document, or waiver, discharge or termination of any obligation under any Loan Document, shall be effective unless, and only to the extent, expressly set forth in a writing signed by each party hereto.  Without limiting the generality of the foregoing, no oral promise or statement, nor any action, inaction, delay, failure to require performance or course of conduct shall operate as, or evidence, an amendment, supplement or waiver or have any other effect on any Loan Document.  Any waiver granted shall be limited to the specific circumstance expressly described in it, and shall not apply to any subsequent or other circumstance, whether similar or dissimilar, or give rise to, or evidence, any obligation or commitment to grant any further waiver.  The Loan Documents represent the entire agreement about this subject matter and supersede prior negotiations or agreements.  All prior agreements, understandings, representations, warranties, and negotiations between the parties about the subject matter of the Loan Documents merge into the Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Counterparts.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  This Agreement may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one Agreement.  Delivery of an executed signature page of this Agreement by electronic mail transmission shall be effective as delivery of a manually executed counterpart hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Confidentiality.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Bank agrees to maintain the confidentiality of Information (as defined below), except that Information may be disclosed (a) to Bank&#8217;s Subsidiaries and Affiliates and their respective employees, directors, agents, attorneys, accountants and other professional advisors (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and, together with Bank, collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bank Entities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), provided that such Bank Entities are subject to the same confidentiality provisions herein&#59; (b) to prospective transferees, assignees, credit providers or purchasers of Bank&#8217;s interests under or in connection with this Agreement and their Representatives (provided, however, Bank shall use obtain any such prospective transferee&#8217;s, assignee&#8217;s, credit provider&#8217;s, purchaser&#8217;s or their Representatives&#8217; agreement to the terms of this provision or substantially similar terms)&#59; (c) as required by law, regulation, subpoena, or other order&#59; (d) to Bank&#8217;s regulators or as otherwise required or requested in connection with Bank&#8217;s examination or audit&#59; (e) in connection with the exercise of remedies under the Loan Documents or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder&#59; and (f) to third-party service providers of Bank so long as such service providers have executed a confidentiality agreement with Bank with terms no less restrictive than those contained herein.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all information received from Borrower and its agents regarding Borrower or its business, in each case other than information that is either&#58; (i) in the public domain or in Bank&#8217;s possession when disclosed to Bank, or becomes part of the public domain (other than as a result of its disclosure by Bank in violation of this Agreement) after disclosure to Bank&#59; or (ii) disclosed to Bank by a third party, if Bank does not know that the third party is prohibited from disclosing the information.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Electronic Execution of Documents.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature&#8221; and words of like import in any Loan Document shall be deemed to include electronic signatures, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity and enforceability as a manually executed signature or the use of a paper-based recordkeeping systems, as the case may be, to the extent and as provided for in any Applicable Law, including, without limitation, any state law based on the Uniform Electronic Transactions Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.5pt">Right of Setoff.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   Borrower hereby grants to Bank a Lien and a right of setoff as security for all Obligations to Bank, whether now existing or hereafter arising upon and against all deposits, credits, collateral and property, now or hereafter in the possession, custody, safekeeping or control of Bank or any entity under the control </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of Bank (including a subsidiary of Bank) or in transit to any of them, and other obligations owing to Bank or any such entity.  At any time after the occurrence and during the continuance of an Event of Default, without demand or notice, Bank may setoff the same or any part thereof and apply the same to any liability or Obligation of Borrower even though unmatured and regardless of the adequacy of any other collateral securing the Obligations.  ANY AND ALL RIGHTS TO REQUIRE BANK TO EXERCISE ITS RIGHTS OR REMEDIES WITH RESPECT TO ANY OTHER COLLATERAL WHICH SECURES THE OBLIGATIONS, PRIOR TO EXERCISING ITS RIGHT OF SETOFF WITH RESPECT TO SUCH DEPOSITS, CREDITS OR OTHER PROPERTY OF BORROWER, ARE HEREBY KNOWINGLY, VOLUNTARILY AND IRREVOCABLY WAIVED.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.5pt">Captions and Section References.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The headings used in this Agreement are for convenience only and shall not affect the interpretation of this Agreement.  Unless indicated otherwise, section references herein are to sections of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.5pt">Construction of Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The parties hereto mutually acknowledge that they and their attorneys have participated in the preparation and negotiation of this Agreement.  In cases of uncertainty this Agreement shall be construed without regard to which of the parties caused the uncertainty to exist.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.5pt">Relationship.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The relationship of the parties to this Agreement is determined solely by the provisions of this Agreement.  The parties do not intend to create any agency, partnership, joint venture, trust, fiduciary or other relationship with duties or incidents different from those of parties to an arm&#8217;s-length contract.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.5pt">Third Parties.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Nothing in this Agreement, whether express or implied, is intended to&#58; (a) confer any benefits, rights or remedies under or by reason of this Agreement on any Persons other than the express parties to it and their respective permitted successors and assigns&#59; (b) relieve or discharge the obligation or liability of any Person not an express party to this Agreement&#59; or (c) give any Person not an express party to this Agreement any right of subrogation or action against any party to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.5pt">Anti-Terrorism Law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Bank hereby notifies Borrower that, pursuant to the requirements of Anti-Terrorism Law, Bank may be required to obtain, verify and record information that identifies Borrower, which information may include the name and address of Borrower and other information that will allow Bank to identify Borrower in accordance with Anti-Terrorism Law. Borrower hereby agrees to take any action necessary to enable Bank to comply with the requirements of Anti-Terrorism Law. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">ACCOUNTING TERMS AND OTHER DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Accounting and Other Terms.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Accounting terms not defined in this Agreement shall be construed following GAAP, except for non-compliance with FAS 123R with respect to monthly financial statements. Calculations and determinations must be made following GAAP (except for (a) non-compliance with FAS 123R with respect to monthly financial statement), provided that if at any time any change in GAAP would affect the computation of any financial ratio or requirement set forth in any Loan Document, and either Borrower or Bank shall so request, Borrower and Bank shall negotiate in good faith to amend such ratio or requirement to preserve the original intent thereof in light of such change in GAAP&#59; provided, further, that, until so amended, (i) such ratio or requirement shall continue to be computed in accordance with GAAP prior to such change therein and (ii) Borrower shall provide Bank financial statements and other documents required under this Agreement or as reasonably requested hereunder setting forth a reconciliation between calculations of such ratio or requirement made before and after giving effect to such change in GAAP. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">As used in the Loan Documents&#58; (i) the words &#8220;shall&#8221; or &#8220;will&#8221; are mandatory, the word &#8220;may&#8221; is permissive, the word &#8220;or&#8221; is not exclusive, the words &#8220;includes&#8221; and &#8220;including&#8221; are not limiting, the singular includes the plural, and numbers denoting amounts that are set off in brackets are negative&#59; (ii) the term &#8220;continuing&#8221; in the context of an Event of Default means that the Event of Default has not been remedied (if capable </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of being remedied) or waived&#59; and (iii) whenever a representation or warranty is made to Borrower&#8217;s knowledge or awareness, to the &#8220;best of&#8221; Borrower&#8217;s knowledge, or with a similar qualification, knowledge or awareness means the actual knowledge, after reasonable investigation, of any Responsible Officer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">Definitions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in this Section 12.2.  All other terms contained in this Agreement, unless otherwise indicated, shall have the meaning provided by the Code to the extent such terms are defined therein.  As used in this Agreement, the following capitalized terms have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is, as to any Person, any &#8220;account&#8221; of such Person as &#8220;account&#8221; is defined in the Code with such additions to such term as may hereafter be made, and includes, without limitation, all accounts receivable and other sums owing to such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Account Debtor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any &#8220;account debtor&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is, with respect to any Person, each other Person that owns or controls directly or indirectly the Person, any Person that controls or is controlled by or is under common control with the Person, and each of that Person&#8217;s senior executive officers, directors, partners and, for any Person that is a limited liability company, that Person&#8217;s managers and members.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in the preamble hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Terrorism Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any law relating to terrorism or money-laundering, including Executive Order No. 13224 and the USA Patriot Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all  applicable provisions of constitutions, laws, statutes, ordinances, rules, treaties, regulations, permits, licenses, approvals, interpretations and orders of courts or Governmental Authorities and all orders and decrees of all courts and arbitrators.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Authorized Signer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any individual listed in Borrower&#8217;s Borrowing Resolution who is authorized to execute the Loan Documents, including making (and executing if applicable) any Credit Extension request, on behalf of Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in the preamble hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bank Entities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in Section 11.8. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bank Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; are all reasonable audit fees, costs and reasonable expenses (including reasonable, out-of-pocket and documented attorneys&#8217; fees and expenses) for preparing, amending, negotiating, administering, defending and enforcing the Loan Documents (including, without limitation, those incurred in connection with appeals or Insolvency Proceedings) or otherwise incurred with respect to Borrower or any Guarantor.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bank Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;  are any products, credit services, and&#47;or financial accommodations previously, now, or hereafter provided to Borrower or any of its Subsidiaries by Bank or any Bank Affiliate, including, without limitation, any letters of credit, cash management services (including, without limitation, merchant services, direct deposit of payroll, business credit cards, and check cashing services), interest rate swap arrangements, and foreign exchange services as any such products or services may be identified in Bank&#8217;s various agreements related thereto (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bank Services Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bank Services Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in the definition of Bank Services.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is Borrower&#8217;s board of directors or equivalent governing body.</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is set forth on Schedule I hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Borrower&#8217;s Books</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; are all Borrower&#8217;s books and records including ledgers, federal and state tax returns, records regarding Borrower&#8217;s assets or liabilities, the Collateral, business operations or financial condition, and all computer programs or storage or any equipment containing such information.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Borrowing Resolutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; are, with respect to any Person, those resolutions adopted by such Person&#8217;s board of directors (and, if required under the terms of such Person&#8217;s Operating Documents, stockholders) and delivered by such Person to Bank approving the Loan Documents to which such Person is a party and the transactions contemplated thereby, together with a certificate executed by its secretary on behalf of such Person certifying (a) such Person has the authority to execute, deliver, and perform its obligations under each of the Loan Documents to which it is a party, (b) that set forth as a part of or attached as an exhibit to such certificate is a true, correct, and complete copy of the applicable resolutions then in full force and effect authorizing and ratifying the execution, delivery, and performance by such Person of the Loan Documents to which it is a party, (c) the name(s) of the Person(s) authorized to execute the Loan Documents, including making (and executing if applicable) any Credit Extension request, on behalf of such Person, together with a sample of the true signature(s) of such Person(s), and (d) that Bank may conclusively rely on such certificate unless and until such Person shall have delivered to Bank a further certificate canceling or amending such prior certificate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is a day other than a Saturday, Sunday or other day on which commercial banks in the State of California are authorized or required by law to close, except that if any determination of a &#8220;Business Day&#8221; shall relate to an FX Contract, the term &#8220;Business Day&#8221; shall be a FX Business Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; are (a) marketable direct obligations issued or unconditionally guaranteed by the United States or any agency or any State thereof having maturities of not more than one (1) year from the date of acquisition&#59; (b) commercial paper maturing no more than one (1) year after its creation and having the highest rating from either Standard &#38; Poor&#8217;s Ratings Group or Moody&#8217;s Investors Service, Inc.&#59; (c) Bank&#8217;s certificates of deposit issued maturing no more than one (1) year after issue&#59; and (d) money market funds at least ninety-five percent (95.0%) of the assets of which constitute Cash Equivalents of the kinds described in clauses (a) through (c) of this definition.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (a) at any time, any &#8220;person&#8221; or &#8220;group&#8221; (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act), shall become, or obtain rights (whether by means of warrants, options or otherwise) to become, the &#8220;beneficial owner&#8221; (as defined in Rules 13(d)-3 and 13(d)5 under the Exchange Act), directly or indirectly, of forty-nine percent (49.0%) or more of the ordinary voting power for the election of directors, partners, managers and members, as applicable, of Borrower (determined on a fully diluted basis) other than by the sale of Borrower&#8217;s equity securities in a public offering or to venture capital or private equity investors so long as Borrower identifies to Bank the venture capital or private equity investors at least seven (7) Business Days prior to the closing of the transaction and provides to Bank a description of the material terms of the transaction&#59; (b) during any period of twelve (</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consecutive months, a majority of the members of the Board of Borrower cease to be composed of individuals (i)&#160;who were members of that board or equivalent governing body on the first (1st) day of such period, (ii)&#160;whose election or nomination to that board or equivalent governing body was approved by individuals referred to in clause (i)&#160;above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body or (iii)&#160;whose election or nomination to that board or other equivalent governing body was approved by individuals referred to in clauses (i)&#160;and (ii)&#160;above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body&#59; or (c) at any time, Borrower shall cease to own and control, of record and beneficially, directly or indirectly, one hundred percent (100.0%) of each class of outstanding stock, partnership, membership, or other ownership interest or other equity securities of each Subsidiary of Borrower free and clear of all Liens (except Permitted Liens and except dissolutions or transfers permitted pursuant to Sections 6.2 and 6.3 of this Agreement).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change in Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the occurrence, after the Effective Date, of&#58;  (a) the adoption or taking effect of any law, rule, regulation or treaty&#59; (b) any change in Applicable Law or in the administration, interpretation, </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">implementation or application thereof by any Governmental Authority&#59; or (c) the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) by any Governmental Authority&#59; provided that notwithstanding anything herein to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests, rules, guidelines or directives promulgated by Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a &#8220;Change in Law&#8221;, regardless of the date enacted, adopted or issued.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in Section 11.3.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is the Uniform Commercial Code, as the same may, from time to time, be enacted and in effect in the State of California&#59; provided, that, to the extent that the Code is used to define any term herein or in any Loan Document and such term is defined differently in different Articles or Divisions of the Code, the definition of such term contained in Article or Division 9 shall govern&#59; provided further, that in the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection, or priority of, or remedies with respect to, Bank&#8217;s Lien on any Collateral is governed by the Uniform Commercial Code in effect in a jurisdiction other than the State of California, the term &#8220;Code&#8221; shall mean the Uniform Commercial Code as enacted and in effect in such other jurisdiction solely for purposes of the provisions thereof relating to such attachment, perfection, priority, or remedies and for purposes of definitions relating to such provisions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; consists of all of Borrower&#8217;s right, title and interest in and to the following personal property&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">(i) all goods, Accounts (including health-care receivables), Equipment, Inventory, contract rights or rights to payment of money, leases, license agreements, franchise agreements, General Intangibles (except as provided below), commercial tort claims, documents, instruments (including any promissory notes), chattel paper (whether tangible or electronic), cash, deposit accounts, certificates of deposit, fixtures, letters of credit rights (whether or not the letter of credit is evidenced by a writing), securities, securities accounts, securities entitlements and all other investment property, supporting obligations, and financial assets, whether now owned or hereafter acquired, wherever located&#59; and (ii) all Borrower&#8217;s Books relating to the foregoing, and any and all claims, rights and interests in any of the above and all substitutions for, additions, attachments, accessories, accessions and improvements to and replacements, products, proceeds and insurance proceeds of any or all of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Notwithstanding the foregoing, the Collateral does not include any of the following (now existing or hereafter arising, owned or created)&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;any Intellectual Property&#59; provided, however, the Collateral shall include all Accounts and all proceeds of Intellectual Property.  If a judicial authority (including a U.S. Bankruptcy Court) would hold that a security interest in the underlying Intellectual Property is necessary to have a security interest in such Accounts and such property that are proceeds of Intellectual Property, then the Collateral shall automatically, and effective as of the Effective Date, include the Intellectual Property to the extent necessary to permit perfection of Bank&#8217;s security interest in such Accounts and such other property of Borrower that are proceeds of the Intellectual Property&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) &#160;&#160;&#160;&#160;any interest of Borrower as a lessee or sublessee under a real property lease or an Equipment lease if Borrower is prohibited by the terms of such lease from granting a security interest in such lease or under which such an assignment or Lien would cause a default to occur under such lease (but only to the extent that such prohibition is enforceable under all applicable laws including, without limitation, the Code)&#59; provided, however, that upon termination of such prohibition, such interest shall immediately become Collateral without any action by Borrower or Bank.</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Pursuant to the terms of a certain negative pledge arrangement with Bank, Borrower has agreed not to encumber any of its Intellectual Property in contravention of the terms of such pledge agreement without Bank&#8217;s prior written consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collateral Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any Deposit Account, Securities Account, or Commodity Account.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commodity Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any &#8220;commodity account&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compliance Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is that certain statement in the form attached hereto as Exhibit A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Connection Income Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Other Connection Taxes that are imposed on or measured by net income (however denominated) or that are franchise Taxes or branch profits Taxes.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is, for any Person, any direct or indirect liability of that Person for (a) any direct or indirect guaranty by such Person of any indebtedness, lease, dividend, letter of credit, credit card or other obligation of another, (b) any other obligation endorsed, co-made, discounted or sold with recourse by that Person, or for which that Person is directly or indirectly liable&#59; (c) any obligations for undrawn letters of credit for the account of that Person&#59; and (d) all obligations from any interest rate, currency or commodity swap agreement, interest rate cap or collar agreement, or other agreement or arrangement designated to protect a Person against fluctuation in interest rates, currency exchange rates or commodity prices&#59; but &#8220;Contingent Obligation&#8221; does not include endorsements in the ordinary course of business or any Permitted Call Spread Agreement(s).  The amount of a Contingent Obligation is the stated or determined amount of the primary obligation for which the Contingent Obligation is made or, if not determinable, the maximum reasonably anticipated liability for it determined by the Person in good faith&#59; but the amount may not exceed the maximum of the obligations under any guarantee or other support arrangement.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Control Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any control agreement entered into among the depository institution at which Borrower maintains a Deposit Account or the securities intermediary or commodity intermediary at which Borrower maintains a Securities Account or a Commodity Account, Borrower, and Bank pursuant to which Bank obtains control (within the meaning of the Code) over such Deposit Account, Securities Account, or Commodity Account.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Copyrights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; are any and all copyright rights, copyright applications, copyright registrations and like protections in each work of authorship and derivative work thereof, whether published or unpublished and whether or not the same also constitutes a trade secret.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any Letter of Credit, FX Contract, amount utilized for cash management services, Term Loan Advance, or any other extension of credit under the Loan Documents by Bank for Borrower&#8217;s benefit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is coined money and such other banknotes or other paper money as are authorized by law and circulate as a medium of exchange.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any event which with notice or passage of time or both, would constitute an Event of Default.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Default Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in Section 1.2(c).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deposit Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">deposit account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Designated Deposit Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is the deposit account with account number xxx-xxxx-9905, established  by Borrower with Bank for purposes of receiving Credit Extensions.</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Division</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, in reference to any Person which is an entity, the division of such Person into two (2) or more separate Persons, with the dividing Person either continuing or terminating its existence as part of such division, including, without limitation, as contemplated under Section 18-217 of the Delaware Limited Liability Company Act for limited liability companies formed under Delaware law, Section 17-220 of the Delaware Revised Uniform Limited Partnership Act for limited partnerships formed under Delaware law, or any analogous action taken pursuant to any other Applicable Law with respect to any corporation, limited liability company, partnership or other entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollar Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is, at any time, (a) with respect to any amount denominated in Dollars, such amount, and (b) with respect to any amount denominated in a Foreign Currency, the equivalent amount therefor in Dollars as determined by Bank at such time on the basis of the then-prevailing rate of exchange in San Francisco, California, for sales of the Foreign Currency for transfer to the country issuing such Foreign Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or use of the sign &#8220;$&#8221; means only lawful money of the United States and not any other currency, regardless of whether that currency uses the &#8220;$&#8221; sign to denote its currency or may be readily converted into lawful money of the United States.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean (a) Net Income, plus (b) to the extent deducted in the calculation of Net Income (i) Interest Expense, (ii) depreciation expense and amortization expense, (iii) income tax expense, and (iv) stock based compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is set forth on Schedule I hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any Applicable Law (including any permits, concessions, grants, franchises, licenses, agreements or governmental restrictions) relating to pollution or the protection of health, safety or the environment or the release of any materials into the environment (including those related to hazardous materials, air emissions, discharges to waste or public systems and health and safety matters).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equipment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is all &#8220;equipment&#8221; as defined in the Code with such additions to such term as may hereafter be made, and includes without limitation all machinery, fixtures, goods, vehicles (including motor vehicles and trailers), and any interest in any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is the Employee Retirement Income Security Act of 1974, as amended, and its regulations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in Section 7.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Excluded Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of the following Taxes imposed on or with respect to Bank or required to be withheld or deducted from a payment to Bank, (a) Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in each case, (i) imposed as a result of Bank being organized under the laws of, or having its principal office or its applicable lending office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii) that are Other Connection Taxes, (b) U.S. federal withholding Taxes imposed on amounts payable to or for the account of Bank with respect to an applicable interest in a Credit Extension pursuant to a law in effect on the date on which (i) Bank acquires such interest in the Credit Extensions or (ii) Bank changes its lending office, except in each case to the extent that, pursuant to Section&#160;1.6, amounts with respect to such Taxes were payable either to Bank&#8217;s assignor immediately before Bank became a party hereto or to Bank immediately before it changed its lending office, (c) Taxes attributable to Bank&#8217;s failure to comply with Section&#160;1.6(e) and&#47;or any reporting and delivery requirements, and (d) any withholding Taxes imposed under FATCA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Sections 1471 through 1474 of the Internal Revenue Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to comply with), any current or future regulations or official interpretations thereof, any agreements entered into pursuant to Section&#160;1471(b)(1) of the Internal Revenue Code and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities and implementing such Sections of the Internal Revenue Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Final Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is a payment (in addition to and not a substitution for the regular monthly payments of principal plus accrued interest) due on the earliest to occur of (a) the Term Loan Maturity Date, (b) the repayment of the Term Loan Advance in full, (c) as required pursuant to Section 1.1(c) or 1.1(d), or (d) the termination of this Agreement, in an amount equal to the original aggregate principle amount of the Term Loan Advance extended by Bank to Borrower multiplied by two percent (2.0%).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statement Repository</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is L43f1c&#64;svb.com or such other means of collecting information approved and designated by Bank after providing notice thereof to Borrower from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is the lawful money of a country other than the United States.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is a Subsidiary that is not an entity organized under the laws of the United States or any territory thereof or the District of Columbia.</font></div><div style="text-indent:18pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Funding Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any date on which a Credit Extension is made to or for the account of Borrower which shall be a Business Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FX Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any day when (a) Bank&#8217;s Foreign Exchange Department is conducting its normal business and (b) the Foreign Currency being purchased or sold by Borrower is available to Bank from the entity from which Bank shall buy or sell such Foreign Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FX Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any foreign exchange contract by and between Borrower and Bank under which Borrower commits to purchase from or sell to Bank a specific amount of Foreign Currency at a set price or on a specified date. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other Person as may be approved by a significant segment of the accounting profession, which are applicable to the circumstances as of the date of determination (except for with respect to unaudited financial statements for the absence of footnotes and subject to year-end audit adjustments).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Intangibles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is all &#8220;general intangibles&#8221; as defined in the Code in effect on the date hereof with such additions to such term as may hereafter be made, and includes without limitation, all Intellectual Property, claims, income and other tax refunds, security and other deposits, payment intangibles, contract rights, options to purchase or sell real or personal property, rights in all litigation presently or hereafter pending (whether in contract, tort or otherwise), insurance policies (including without limitation key man, property damage, and business interruption insurance), payments of insurance and rights to payment of any kind.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Good Faith Deposit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in Section 1.3.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any consent, authorization, approval, order, license, franchise, permit, certificate, accreditation, registration, filing or notice, of, issued by, from or to, or other act by or in respect of, any Governmental Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any nation or government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">legislative, judicial, taxing, regulatory or administrative functions of or pertaining to government, any securities exchange and any self-regulatory organization.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any Person providing a Guaranty in favor of Bank with respect to the Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guaranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any guarantee of all or any part of the Obligations, as the same may from time to time be amended, restated, modified or otherwise supplemented.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is (a) indebtedness for borrowed money or the deferred price of property or services, such as reimbursement and other obligations for surety bonds and letters of credit, (b) obligations evidenced by notes, bonds, debentures or similar instruments, (c) capital lease obligations, (d) Contingent Obligations and (e) other short- and long-term obligations under debt agreements, lines of credit and extensions of credit, provided, however, that in no event shall obligations under any Permitted Call Spread Agreement constitute Indebtedness.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnified Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in Section 11.3.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnified Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of Borrower under any Loan Document and (b) to the extent not otherwise described in clause (a), Other Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in Section 11.8.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insolvency Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any proceeding by or against any Person under the United States Bankruptcy Code, or any other bankruptcy or insolvency law, including assignments for the benefit of creditors, compositions, extensions generally with its creditors, or proceedings seeking reorganization, arrangement, receivership or other relief.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to any Person, all of such Person&#8217;s right, title, and interest in and to the following, whether now owned or hereafter acquired or created&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">its Copyrights, Trademarks and Patents&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">any and all trade secrets and trade secret rights, including, without limitation, any rights to unpatented inventions, know-how and operating manuals&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">licenses any and all source code&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">any and all design rights which may be available to such Person&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">any and all claims for damages by way of past, present and future infringement of any of the foregoing, with the right, but not the obligation, to sue for and collect such damages for said use or infringement of the Intellectual Property rights identified above&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">all amendments, renewals and extensions of any of the Copyrights, Trademarks or Patents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Internal Revenue Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the U.S. Internal Revenue Code of 1986, and the rules and regulations promulgated thereunder, each as amended or modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is all &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">inventory</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; as defined in the Code in effect on the date hereof with such additions to such term as may hereafter be made, and includes without limitation all merchandise, raw materials, parts, supplies, packing and shipping materials, work in process and finished products, including without limitation such inventory </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as is temporarily out of Borrower&#8217;s custody or possession or in transit and including any returned goods and any documents of title representing any of the above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any beneficial ownership interest in any Person (including stock, partnership, membership, or other ownership interest or other equity securities), and any loan, advance or capital contribution to any Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is each of Borrower&#8217;s (i) Chief Executive Officer, and (ii) Chief Financial Officer, as of the Effective Date.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is a standby or commercial letter of credit issued by Bank upon request of Borrower based upon an application, guarantee, indemnity, or similar agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is a claim, mortgage, deed of trust, levy, attachment charge, pledge, hypothecation, security interest or other encumbrance of any kind, whether voluntarily incurred or arising by operation of law or otherwise against any property.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; are, collectively, this Agreement and any schedules, exhibits, certificates, notices, and any other documents related to this Agreement, the Perfection Certificate, the Control Agreement, any Bank Services Agreement, any subordination agreement, any note, or notes or guaranties executed by Borrower or any Guarantor, landlord waivers and consents, bailee waivers and consents, and any other present or future agreement by Borrower and&#47;or any Guarantor with or for the benefit of Bank in connection with this Agreement or Bank Services, all as amended, restated, or otherwise modified in accordance with the terms thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material Adverse Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is (a) a material impairment in the perfection or priority of Bank&#8217;s Lien in the Collateral  or in the value of such Collateral&#59; (b) a material adverse change in the business, operations, or  condition (financial or otherwise) of Borrower&#59; or (c) a material impairment of the prospect of repayment of any portion of the Obligations when such Obligations are due. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, as calculated on a consolidated basis for Borrower and its Subsidiaries for any period as at any date of determination, the net profit (or loss), after provision for taxes, of Borrower and its Subsidiaries for such period taken as a single accounting period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; are Borrower&#8217;s obligations to pay when due any debts, principal, interest, fees, Bank Expenses, the Prepayment Fee (if applicable), the Final Payment, and other amounts Borrower owes Bank now or later, whether under this Agreement, or the other Loan Documents, or otherwise, including, without limitation, all obligations relating to Bank Services and interest accruing after Insolvency Proceedings begin and debts, liabilities, or obligations of Borrower assigned to Bank, and to perform Borrower&#8217;s duties under the Loan Documents (but in all cases excluding any equity interests of Bank and&#47;or its Affiliates in Borrower).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is the Office of Foreign Assets Control of the United States Department of the Treasury and any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; are, for any Person, such Person&#8217;s formation documents, as certified by the Secretary of State (or equivalent agency) of such Person&#8217;s jurisdiction of organization on a date that is no earlier than thirty (30) days prior to the Effective Date, and, (a) if such Person is a corporation, its bylaws in current form, (b) if such Person is a limited liability company, its limited liability company agreement (or similar agreement), and (c) if such Person is a partnership or limited partnership, its partnership agreement or limited partnership agreement (or similar agreement), each of the foregoing with all current amendments or modifications thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Connection Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to Bank, Taxes imposed as a result of a present or former connection between Bank and the jurisdiction imposing such Tax (other than connections arising from Bank having executed, delivered, become a party to, performed its obligations under, received payments under, received or </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Credit Extension or Loan Document).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all present or future stamp, court, documentary, intangible, recording, filing or similar Taxes that arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all patents, patent applications and like protections including without limitation improvements, divisions, continuations, renewals, reissues, extensions and continuations-in-part of the same.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payment&#47;Advance Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is that certain form in the form attached hereto as Exhibit B.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is set forth on Schedule I hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perfection Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is the Perfection Certificate delivered by Borrower in connection with this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Milestone</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Borrower&#8217;s delivery to Bank of evidence reasonably satisfactory to Bank in its commercially reasonable discretion, confirming that Borrower has achieved revenue (determined in accordance with GAAP) of at least Ninety Million Dollars ($90,000,000) for the trailing twelve (12) month period  ending on  December 31, 2022.   </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;Permitted Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Permitted Acquisitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an acquisition by Borrower or any Subsidiary of any Intellectual Property or all or substantially all of the assets of, all of the ownership interests in, or a business line, product line (including rights in respect of any medical device) or unit or division of another Person (including any foreign corporations) for cash consideration (including any purchase price adjustments, indemnity payments and earn-out obligations in connection therewith) up to Ten Million Dollars ($10,000,000) in any fiscal year (or such greater amount as may be agreed with the prior written consent of Bank)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, with respect to each such acquisition, each of the following conditions shall have been satisfied (or waived by Bank, acting in its good faith business discretion)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">no Event of Default shall have occurred and be continuing or would result from the consummation of the proposed acquisition and Bank has received evidence that Borrower is in compliance with all terms and conditions of this Agreement on a pro forma basis after giving effect to such acquisition, </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">such acquired Person or assets shall be in a similar line of business as is conducted by Borrower as of the Effective Date (or a line of business reasonably related thereto), </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">such acquisition shall not cause the focus or locations of Borrower&#8217;s and its Subsidiaries&#8217; operations (when taken as a whole) to be located outside of the United States,</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">such acquisition shall not constitute a hostile acquisition, </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">any Person acquired as a result of such acquisition shall become a secured Guarantor (or co-borrower) subject to the terms herein, within fifteen (15) Business Days of the consummation of such acquisition, </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">in connection with such acquisition, neither Borrower nor any of its subsidiaries (including for this purpose, the target of the acquisition) shall acquire or be subject to any Indebtedness or Liens that are not otherwise permitted hereunder&#59;</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Borrower shall provide Bank with written notice of the proposed acquisition at least five (5) Business Days prior to the anticipated signing, commitment, or closing date of the proposed acquisition, whichever occurs first&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Borrower shall provide to the Bank not later than five (5) Business Days after the execution thereof, a copy of the executed purchase agreement or similar agreement with respect to any such acquisition&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">such acquisition has been approved by the board of directors (or other equivalent legally governing body) of the Person to be acquired, </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">the entity or assets to be acquired in such acquisition shall not be subject to any Lien other (x) the first priority Liens granted in favor of Bank and (y) Permitted Liens&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">all transactions related to such acquisition shall be consummated in all material respects in accordance with applicable law&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Borrower shall provide to the Bank as soon as available but in any event not later than five (5) Business Days after the execution thereof, a copy of the executed purchase agreement or similar agreement with respect to any such acquisition.  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrower shall provide to the Bank as soon as available but in any event not later than five (5) Business Days after the execution thereof a certificate of a Responsible Officer of Borrower, in form and substance reasonably satisfactory to Bank, certifying that all of the requirements set forth in this definition have been satisfied or will be satisfied on or prior to the consummation of such acquisition.  Notwithstanding the foregoing and for the avoidance of doubt, in no event shall Borrower or any of its Subsidiaries assume any liabilities with respect to any acquisition, including without limitation, any Permitted Indebtedness, in excess of Fifteen Million Dollars ($15,000,000) in aggregate outstanding at any time for such Permitted Acquisitions.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Permitted Call Spread Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (a) any call option transaction (including, but not limited to, any bond hedge transaction or capped call transaction) pursuant to which the Borrower acquires an option requiring the counterparty thereto to deliver to the Borrower shares of common stock of the Borrower (or other securities or property following a merger event or other change of the common stock of the Borrower), the cash value thereof or a combination thereof from time to time upon exercise of such option entered into by the Borrower in connection with the issuance of Permitted Convertible Debt (such transaction, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bond Hedge Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and (b) any issued warrants to acquire common stock of the Borrower (or other securities or property following a merger event or other change of the common stock of the Borrower) (whether such warrant is settled in shares, cash or a combination thereof) issued by the Borrower in connection with the issuance of Permitted Convertible Debt and sold by Borrower substantially concurrently with any purchase by Borrower of a Bond Hedge Transaction and settled in (such transaction, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warrant Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that (i) the terms, conditions and covenants of each such call option transaction are customary for agreements of such type, as determined by the Board (or a committee thereof) in good faith, (ii) the purchase price for such Bond Hedge Transaction, less the proceeds received by the Borrower from the sale of any related Warrant Transaction, does not exceed the net proceeds received by the Borrower from the  issuance of the related Permitted Convertible Indebtedness at the time of such purchase, and (iii) in the case of clause (b) above, such warrants would be classified as an equity instrument in accordance with GAAP.</font></div><div style="padding-right:9pt"><font><br></font></div><div style="padding-right:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Permitted Convertible Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any unsecured notes issued by the Borrower that are convertible into a fixed number (subject to customary anti-dilution adjustments, &#8220;make-whole&#8221; increases and other customary changes thereto) of shares of common stock of the Borrower (or other securities or property following a merger event or other change of the common stock of the Borrower), cash or any combination thereof (with the amount of such cash or such combination determined by reference to the market price of such common stock or such other securities)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that such Indebtedness must satisfy each of the following conditions&#58; (i) both immediately prior to and after giving effect (including pro forma effect) to the issuance thereof, no Default or Event of Default </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall exist or result therefrom, (ii) such Indebtedness matures after, and does not require any scheduled   amortization or other scheduled or otherwise required payments of principal prior to, or have a scheduled maturity date earlier than, the date that is ninety one  (91) calendar days after the Term Loan Maturity Date and prior to that date, does not provide for or require any payments of principal or any other payments with the exception of semi-annual interest payments, obligations to settle conversions, redemption rights (which, for the avoidance of doubt, will be subject to Section 6.7)&#160; and customary obligations to offer to repurchase the notes upon the occurrence of a &#8220;fundamental change&#8221;, (iii) any cross-default or cross-acceleration event of default (each howsoever defined) provision contained therein that relates to indebtedness or other payment obligations of Borrower (or any of its Subsidiaries) (such indebtedness or other payment obligations, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cross-Default Reference Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) contains a cure period of at least thirty (30) calendar days (after written notice to the issuer of such Indebtedness by the trustee or to such issuer and such trustee by holders of at least 25% in aggregate principal amount of such Indebtedness then outstanding) before a default, event of default, acceleration or other event or condition under such Cross-Default Reference Obligation results in an event of default under such cross-default or cross-acceleration provision, (iv) the terms, conditions and covenants (other than pricing terms determined through a customary marketing process) of such Indebtedness must be customary for convertible Indebtedness of such type at the time of issuance (as determined by the Board, or a committee thereof, in good faith) and, (v) such Indebtedness is not guaranteed by any Subsidiary of the Borrower unless the Obligations are guaranteed by such Subsidiary on a secured basis. For the avoidance of doubt, and without limitation of the foregoing, Permitted Convertible Debt shall at all times be valued at the full stated principle amount thereof and shall not include any reduction or appreciation in value of the shares deliverable upon conversion thereof. </font></div><div style="padding-right:9pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Permitted Foreign Subsidiary Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in Section 5.9(a). </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Permitted Hedging Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any currency agreement, all rate swap transactions or other contract or arrangement designed solely to protect a Person against fluctuations in currency exchange rates and interest rate risk, and any confirmation executed in connection with any such agreement, contract, or arrangement, in each case, entered into by Borrower or any of its Subsidiaries solely to hedge or mitigate the risks of foreign exchange rate fluctuations and interest rate risk and not for any speculative or other purposes&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that such agreement, contract or arrangement shall comply in all respects with the hedging policies or guidelines as are approved by the Board or as are approved by Bank (such approval not to be unreasonably withheld, delayed or conditioned)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that all accrued and reasonably expected liabilities of Borrower or its Subsidiaries arising under Permitted Hedging Agreements shall not exceed One Million Dollars ($1,000,000) in the aggregate at any time. For the avoidance of doubt, no Permitted Call Spread Agreement shall constitute a Permitted Hedging Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br>&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Permitted Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is&#58;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Borrower&#8217;s Indebtedness to Bank under this Agreement, the other Loan Documents and under any other agreement with Bank&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Indebtedness existing on the Effective Date which is shown on the Perfection Certificate&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Subordinated Debt&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">unsecured Indebtedness to trade creditors incurred in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Indebtedness incurred as a result of endorsing negotiable instruments received in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">Indebtedness secured by Liens permitted under clauses (a) and (c) of the definition of &#8220;Permitted Liens&#8221; hereunder&#59; </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">other unsecured Indebtedness not otherwise permitted by Section 6.4 not exceeding Two Hundred Fifty Thousand Dollars ($250,000.00) in the aggregate outstanding at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Indebtedness with respect to credit cards maintained with American Express, not to exceed Five Hundred Thousand Dollars ($500,000) outstanding at any time&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Permitted Hedging Agreements&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">intercompany Indebtedness by and among Borrower and its Subsidiaries (subject to &#8220;Permitted Investments&#8221; part (g)(i)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Indebtedness in respect of letters of credit, bank guarantees and similar instruments issued for the account of Borrower and&#47;or its Subsidiaries in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) outstanding at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">advances or deposits received in the ordinary course of business from customers or vendors&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">Indebtedness in respect of netting services, overdraft protections, payment processing, automatic clearinghouse arrangements, arrangements in respect of pooled deposit or sweep accounts, check endorsement guarantees, and otherwise in connection with deposit accounts or cash management services and Indebtedness arising in connection with automated clearing house transfer of funds or the use of other payment processing services&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Indebtedness arising in connection with the financing of insurance premiums in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) outstanding at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Indebtedness in respect of performance bonds, bid bonds, appeal bonds, surety bonds, completion guarantees and similar obligations arising in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) in the aggregate outstanding at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Unsecured Indebtedness in connection with Permitted Acquisitions, not to exceed Fifteen Million Dollars ($15,000,000) in aggregate outstanding at any time&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Permitted Convertible Debt in aggregate principal amount not to exceed Two Hundred Fifty Million Dollars ($250,000,000) in principal amount at any time outstanding&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">Indebtedness of Borrower&#8217;s Subsidiaries in connection with the sale of Inventory by Borrower to its Subsidiaries in the ordinary course of business, which may from time to time be forgiven by Borrower&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.45pt">purchase price adjustments, indemnity payments and earn-out obligations in connection with any Permitted Acquisition (to the extent not in excess of the consideration limitations set forth in the definition thereof)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">extensions, refinancings, modifications, amendments and restatements of any items of Permitted Indebtedness (a) through (s) above, provided that the principal amount thereof is not increased or the terms thereof are not modified to impose more burdensome terms upon Borrower or its Subsidiary, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Permitted Investments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; are&#58;</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Investments (including, without limitation, Subsidiaries) existing on the Effective Date  which are shown on the Perfection Certificate&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">(i)&#160;Investments consisting of cash and Cash Equivalents, and (ii)&#160;any other Investments permitted by Borrower&#8217;s investment policy, as amended from time to time, provided that such investment policy (and any such amendment thereto) has been approved in writing by Bank, further provided that Bank hereby confirms approval of such investment policy delivered to Bank around the Effective Date&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of Borrower&#8217;s business&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Investments consisting of deposit and securities accounts (but only to the extent that Borrower or its Subsidiaries is permitted to maintain such accounts pursuant to Section 5.9 of this Agreement) in which Bank has a first priority perfected security interest (only if and to the extent required pursuant to Section 5.9 of this Agreement)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Investments accepted in connection with Transfers permitted by Section 6.1&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">Investments consisting of the creation of a Subsidiary for the purpose of consummating a merger transactions and Permitted Acquisitions permitted by Section 6.3 of this Agreement, which is otherwise a Permitted Investment&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Investments by Borrower in Subsidiaries that are not borrowers hereunder (or Guarantors), not to exceed (i) (x) Seven Million Five Hundred Thousand Dollars ($7,500,000) in the aggregate in any fiscal year&#59; and (y) Three Million Dollars ($3,000,000) in any fiscal quarter, plus (ii) the ongoing day-to-day operations of such Subsidiaries in the ordinary course of business, so long as such (part (ii)) Investments are (A) made on a cost-plus basis, or (B) otherwise in accordance with transfer pricing arrangements, or (C) are otherwise approved in advance in writing by Bank&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Investments by Borrower in any other co-borrower under this Agreement or Guarantor&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Investments consisting of (i) travel advances and employee relocation loans and other employee loans and advances in the ordinary course of business, and (ii) loans to employees, officers, directors, partners, managers and members relating to the purchase of equity securities of Borrower or its Subsidiaries pursuant to employee equity purchase plans or similar agreements approved by the Board&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Investments consisting of notes receivable of, or prepaid royalties and other credit extensions, to customers and suppliers who are not Affiliates, in the ordinary course of business&#59; provided that this paragraph (j) shall not apply to Investments of Borrower in any Subsidiary&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Cash investments of up to One Million Dollars ($1,000,000) per fiscal year, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">non-cash Investments in joint ventures or strategic alliances in the ordinary course of Borrower&#8217;s business consisting of the non-exclusive licensing of technology, the development of technology or the providing of technical support&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">any Permitted Call Spread Agreements&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Permitted Acquisitions&#59; </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Investments not to exceed Five Million Dollars ($5,000,000) per fiscal year to fund the expansion of Borrower and&#47;or its Subsidiaries in (i) Japan, and&#47;or (ii) any other jurisdiction as may be agreed by Bank (in its good faith business discretion) and Borrower&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">other Investments not otherwise enumerated in this defined term &#8220;Permitted Investments&#8221; not exceeding Five Hundred Thousand Dollars ($500,000) in the aggregate during any fiscal year.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Permitted Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; are&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Liens existing on the Effective Date which are shown on the Perfection Certificate or arising under this Agreement or the other Loan Documents&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Liens for taxes, fees, assessments or other government charges or levies, either (i) not due and payable or (ii) being contested in good faith and for which Borrower maintains adequate reserves on Borrower&#8217;s Books, provided that no notice of any such Lien has been filed or recorded under the Internal Revenue Code&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">purchase money Liens and equipment liens (i) on Equipment or software acquired or held by Borrower incurred for financing the acquisition of the Equipment or software securing no more than One Million Dollars ($1,000,000) in the aggregate amount outstanding, or (ii) existing on Equipment or software when acquired, if the Lien is confined to the property and improvements and the proceeds of the Equipment or software&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Liens of carriers, warehousemen, suppliers, or other Persons that are possessory in nature arising in the ordinary course of business so long as such Liens attach only to Inventory, securing liabilities in the aggregate amount not to exceed Two Hundred Fifty Thousand Dollars ($250,000), and which are not delinquent or remain payable without penalty or which are being contested in good faith and by appropriate proceedings which proceedings have the effect of preventing the forfeiture or sale of the property subject thereto&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Liens to secure payment of workers&#8217; compensation, employment insurance, old-age pensions, social security and other like obligations incurred in the ordinary course of business (other than Liens imposed by ERISA)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">Liens incurred in the extension, renewal or refinancing of the Indebtedness secured by Liens described in (a) through (c), but any extension, renewal or replacement Lien must be limited to the property encumbered by the existing Lien and the principal amount of the indebtedness may not increase&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">leases or subleases of real property granted in the ordinary course of Borrower&#8217;s business (or, if referring to another Person, in the ordinary course of such Person&#8217;s business), and leases, subleases, non-exclusive licenses or sublicenses of personal property (other than Intellectual Property) granted in the ordinary course of Borrower&#8217;s business (or, if referring to another Person, in the ordinary course of such Person&#8217;s business), if the leases, subleases, licenses and sublicenses do not prohibit granting Bank a security interest therein&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">(i) non-exclusive licenses of Intellectual Property granted to third parties in the ordinary course of business, (ii) licenses of Intellectual Property that could not reasonably be expected to result in a legal transfer of title of the licensed property that may be exclusive in respects of territory (as to discreet geographical areas inside and outside of the United States), and (iii) licenses existing on the Effective Date and disclosed on the Perfection Certificate&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">customary Liens of any bank in connection with statutory, common law and contractual rights of setoff and recoupment with respect to any deposit account or securities account of Borrower, provided that (i) Bank has a first priority perfected security interest in such account (if perfection is required pursuant to Section 5.9 of this Agreement), and (ii) such account is permitted to be maintained pursuant to Section 5.9 of this Agreement&#59; </font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Liens arising from attachments or judgments, orders, or decrees in circumstances not constituting an Event of Default under Sections  and 7.7&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">deposits under real property leases that are made in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) at any time&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">easements, rights-of-way, restrictions and other similar encumbrances affecting real property which, in the aggregate, are not substantial in amount, and which do not in any case materially detract from the value of the property subject thereto or materially interfere with the ordinary conduct of the business of the applicable Person&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">other Liens (not otherwise enumerated in this defined term) not exceeding One Hundred Thousand Dollars ($100,000) in the aggregate outstanding at any time&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Liens in respect of performance bonds, bid bonds, appeal bonds, surety bonds, completion guarantees and similar obligations arising in the ordinary course of business not to exceed Seven Hundred Fifty Thousand Dollars ($750,000) in the aggregate outstanding at any time&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Liens on cash and Cash Equivalents securing obligations under Permitted Hedging Agreements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any individual, sole proprietorship, partnership, limited liability company, joint venture, company, trust, unincorporated organization, association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prepayment Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is a fee due upon prepayment (whether voluntary or otherwise) of the Term Loan Advance in full equal to (i) one percent (1.00%) of the aggregate original principal amount of the Term Loan Advance made by Bank to Borrower hereunder, if such prepayment occurs prior to the second (2nd) anniversary of the Effective Date, (ii) zero percent (0.00%) of the aggregate original principal amount of the Term Loan Advance made by Bank to Borrower hereunder if such prepayment occurs on or at any time after the second (2nd) anniversary of the Effective Date but prior to the Term Loan Maturity Date&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prime Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is set forth on Schedule I hereto. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prime Rate Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is set forth on Schedule I hereto.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qualified Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the amount of the Borrower and its Subsidiaries cash and Cash Equivalents held with Bank and&#47;or Banks&#8217; Affiliates and&#47;or in accounts subject to a Control Agreement in favor of Bank&#59; </font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quarterly Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in Section 5.3(a).  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redemption Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to any redemption by the Borrower of any Permitted Convertible Debt, satisfaction of each of the following events&#58; (a) no Event of Default shall exist or result therefrom, (b) both immediately before and after such redemption, Borrower&#8217;s Qualified Cash shall be no less than the amount required to prepay the outstanding Obligations in full at the time of such redemption, including all outstanding principal of the Term Loans, the accrued and unpaid interest thereon, the Final Payment, and the Prepayment Fee (provided, however, for the avoidance of doubt no such prepayment is required at such time), and (c) both immediately before and after such redemption, Borrower&#8217;s Remaining Months Liquidity shall be no less than twelve (12). </font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registered Organization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any &#8220;registered organization&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remaining Months Liquidity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Qualified Cash divided by EBITDA (measured on a trailing twelve (12) month basis). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in Section 11.8.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Responsible Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any of the Chief Executive Officer, President, Chief Financial Officer, Chief Legal Officer, and Controller of Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted License</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any material license or other material agreement with respect to which Borrower is the licensee (a) that prohibits or otherwise restricts Borrower from granting a security interest in Borrower&#8217;s interest in such license or agreement or any other property, or (b) for which a default under or termination of could interfere with Bank&#8217;s right to sell any material Collateral.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sanctioned Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Person that&#58; (a) is listed on any Sanctions list maintained by OFAC or any similar Sanctions list maintained by any other Governmental Authority having jurisdiction over Borrower&#59; (b) is located, organized, or resident in any country, territory, or region that is the subject or target of Sanctions&#59; or (c) is fifty percent (50.0%) or more owned or controlled by one (1) or more Persons described in clauses (a) and (b) hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the economic sanctions laws, regulations, embargoes or restrictive measures administered, enacted or enforced by the United States government and any of its agencies, including, without limitation, OFAC and the U.S. State Department, or any other Governmental Authority having jurisdiction over Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is the Securities and Exchange Commission, any successor thereto, and any analogous Governmental Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is any &#8220;securities account&#8221; as defined in the Code with such additions to such term as may hereafter be made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Solar Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Solar Capital Ltd., as collateral agent and as a lender, and the other lenders party to that certain Loan and Security Agreement by and among such parties and Borrower, dated as of May 29, 2020, as amended and&#47;or restated).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subordinated Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is indebtedness incurred by Borrower or any of its Subsidiaries subordinated to all of Borrower&#8217;s or any of its Subsidiaries&#8217; now or hereafter indebtedness to Bank (pursuant to a subordination, intercreditor, or other similar agreement in form and substance satisfactory to Bank entered into between Bank and the other creditor), on terms acceptable to Bank. For the avoidance of doubt, Permitted Convertible Debt shall not constitute Subordinated Debt.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is, as to any Person, a corporation, partnership, limited liability company or other entity of which shares of stock, partnership, membership, or other ownership interest or other equity securities having ordinary voting power (other than stock, partnership, membership, or other ownership interest or other equity securities having such power only by reason of the happening of a contingency) to elect a majority of the board of directors or other managers of such corporation, partnership or other entity are at the time owned, or the management of which is otherwise controlled, directly or indirectly through one or more intermediaries, or both, by such Person.  Unless the context otherwise requires, each reference to a Subsidiary herein shall be a reference to a Subsidiary of Borrower or Guarantor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Advance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in Section 1.1(a) of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Amortization Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is set forth on Schedule I hereto.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Availability Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is set forth on Schedule I hereto.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is set forth on Schedule I hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trademarks</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to any Person, any trademark and servicemark rights, whether registered or not, applications to register and registrations of the same and like protections, and the entire goodwill of the business of such Person connected with and symbolized by such trademarks.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is defined in Section 6.1. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USA Patriot Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the &#8220;Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001&#8221; (Public Law 107-56, signed into law on October 26, 2001), as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature page follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</font></div><div><font><br></font></div><div><font><br></font></div></div></div><div id="icd7579ba879b4549a6769f17f340f8e7_41"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the parties hereto have caused this Agreement to be executed as of the Effective Date.</font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BORROWER&#58;</font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SI-BONE, INC. </font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58; &#47;s&#47; Anshul Maheshwari</font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Anshul Maheshwari</font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Chief Financial Officer</font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BANK&#58;</font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SILICON VALLEY BANK</font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58; &#47;s&#47; Mark Davis</font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Mark Davis</font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vice President</font></div><div style="margin-bottom:12pt;padding-left:252pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:84.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature Page to Loan and Security Agreement</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">295054968.4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">354271-000499&#34; &#34;&#34; 295054968.4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">354271-000499</font></div></div></div><div id="icd7579ba879b4549a6769f17f340f8e7_44"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SCHEDULE I</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LSA PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:32.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LSA Section</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LSA Provision</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1(a) &#8211; Term Loan &#8211; Availability</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Term Loan Advance must be in an amount equal to the Term Loan Availability Amount.  After repayment, the Term Loan Advance (or any portion thereof) may not be reborrowed.</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1(b) &#8211; Term Loan &#8211; Repayment</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing on the Term Loan Amortization Date, and continuing on each Payment Date thereafter until the Term Loan Advance is paid in full, Borrower shall repay the Term Loan Advance in (i) (a) twenty-four (24) equal monthly installments of principal if the Performance Milestone does not occur, or (b) thirty-six (36) equal monthly installments of principal if the Performance Milestone occurs, plus (ii) monthly payments of accrued interest in accordance with Section 1.2(a) at the rate set forth in Section 1.2(b)(i).   </font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2(a) &#8211; Interest Payments &#8211; Term Loan Advance</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on the outstanding principal amount of the Term Loan Advance is payable in arrears monthly (i) on each Payment Date commencing on the first Payment Date following the Funding Date of each such Term Loan Advance, (ii) on the date of any prepayment of the Term Loan Advance, and (iii) on the Term Loan Maturity Date.</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2(b)(i) &#8211; Interest Rate &#8211; Term Loan Advance</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding principal amount of the Term Loan Advance shall accrue interest at a floating rate per annum equal to the greater of (A) five and three quarters of one percent (5.75%) and (B) the Prime Rate plus the Prime Rate Margin, which interest shall be payable in accordance with Section 1.2(a).</font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2(e) &#8211; Interest Computation</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest shall be computed on the basis of the actual number of days elapsed and a 360-day year for any Credit Extension outstanding.</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.2 &#8211; &#8220;Borrower&#8221;</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> SI-BONE, INC.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a Delaware corporation.  </font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.2 &#8211; &#8220;Effective Date&#8221;</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is August 12, 2021.</font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.2 &#8211; &#8220;Payment Date&#8221;</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is the first (1st) calendar day of each month.</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.2 &#8211; &#8220;Prime Rate&#8221;</font></div></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prime Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is the rate of interest per annum from time to time published in the money rates section of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or any successor publication thereto as the &#8220;prime rate&#8221; then in effect&#59; provided that if such rate of interest, as set forth from time to time in the money rates section of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, becomes unavailable for any reason as determined by Bank, the &#8220;Prime Rate&#8221; shall mean the rate of interest per annum announced by Bank as its prime rate in effect at its principal office in the State of California (such Bank announced Prime Rate not being intended to be the lowest rate of interest charged by Bank in connection with extensions of credit to debtors)&#59; provided that, in the event such rate of interest is less than zero percent (0.0%) per annum, such rate shall be deemed to be zero percent (0.0%) per annum for purposes of this Agreement.</font></div></td></tr></table></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I-1</font></div><div style="text-align:right"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">295054968</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:111%">.4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">354271-000499&#34; &#34;&#34; 295054968</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:111%">.4</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:111%">354271-000499</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:32.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.2 &#8211; &#8220;Prime Rate Margin&#8221;</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prime Rate Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is two and one half of one percent (2.50%).  </font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 &#8211; &#8220;Term Loan Amortization Date&#8221;</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Amortization Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is September 1, 2023.   </font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 &#8211; &#8220;Term Loan Availability Amount&#8221;</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Availability Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is Thirty-Five Million Dollars ($35,000,000).  </font></div></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.2 &#8211; &#8220;Term Loan Maturity Date&#8221;</font></div></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is August 1, 2025&#59; provided, however, if Borrower achieves the Performance Milestone, then the Term Loan Maturity Date shall automatically, with no further action required by the parties hereto, be extended through August 1, 2026.   </font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:79.07pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I-2</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">295054968.4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">354271-000499&#34; &#34;&#34; 295054968.4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">354271-000499</font></div></div></div><div id="icd7579ba879b4549a6769f17f340f8e7_47"></div><hr style="page-break-after:always"><div style="min-height:47.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPLIANCE STATEMENT</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TO&#58;&#160;&#160;&#160;&#160;SILICON VALLEY BANK&#160;&#160;&#160;&#160;Date&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FROM&#58;&#160;&#160;&#160;&#160;SI-BONE, INC. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms and conditions of the Loan and Security Agreement between Borrower and Bank (as amended, modified, supplemented and&#47;or restated from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), Borrower is in complete compliance for the period ending _______________ with all required covenants except as noted below.  Attached are the required documents evidencing such compliance, setting forth calculations prepared in accordance with GAAP consistently applied from one period to the next except as explained in an accompanying letter or footnotes (and except for with respect to unaudited financial statements for the absence of footnotes and subject to year-end audit adjustments). Capitalized terms used but not otherwise defined herein shall have the meanings given them in the Agreement.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Please indicate compliance status by circling Yes&#47;No under &#8220;Complies&#8221; column.</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Reporting Covenants</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Required</font></td><td colspan="9" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Complies</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly Financial Statements with Compliance Statement</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly within 45 days and FYE within 90 days</font></td><td colspan="9" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes   No</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual financial statements (CPA Audited)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FYE within 180 days</font></td><td colspan="9" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes   No</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q, 10-K and 8-K</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within 5 Business Days after filing with SEC</font></td><td colspan="9" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes  No  N&#47;A</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board approved projections</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FYE within 30 days and within 30 days, as amended&#47;updated, in each case as approved by the Board</font></td><td colspan="9" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes   No</font></td></tr><tr><td colspan="9" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.1pt;padding-right:3.1pt"><font><br></font></div><div style="padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other Matters</font></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Have there been any material amendments to the Operating Documents of Borrower&#63; If yes, provide copies of any such amendments or changes with this Compliance Statement.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No</font></td></tr><tr style="height:17pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following are the exceptions with respect to the statements above&#58; (If no exceptions exist, state &#8220;No exceptions to note.&#8221;)</font></div><div style="height:76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">295054968.4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">354271-000499&#34; &#34;&#34; 295054968.4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">354271-000499</font></div></div></div><div id="icd7579ba879b4549a6769f17f340f8e7_50"></div><hr style="page-break-after:always"><div style="min-height:47.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-bottom:6pt;padding-right:-21pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LOAN PAYMENT&#47;ADVANCE REQUEST FORM</font></div><div style="margin-bottom:6pt;padding-right:-20.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Deadline for same day processing is Noon Pacific Time</font></div><div style="margin-bottom:12pt;padding-left:40.3pt;padding-right:-18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fax to&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; _____________________</font></div><div style="margin-bottom:6pt;padding-left:3.35pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loan Payment&#58;</font></div><div style="margin-bottom:6pt;padding-right:-6.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SI-BONE, INC. </font></div><div style="padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From Account #________________________________&#160;&#160;&#160;&#160;To Account ________________________________</font></div><div style="margin-bottom:6pt;padding-left:78.35pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Deposit Account #)&#160;&#160;&#160;&#160;(Loan Account #)</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal $____________________________________&#160;&#160;&#160;&#160;and&#47;or Interest $_____________________________</font></div><div style="padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Authorized Signature&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Phone Number&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Print Name&#47;Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div></td></tr></table></div><div style="padding-left:18pt;padding-right:-18pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:9.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loan Advance&#58;</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:-6.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Complete </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Outgoing Wire Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below if all or a portion of the funds from this loan advance are for an outgoing wire.</font></div><div style="padding-left:2.75pt;padding-right:-16.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From Account #________________________________&#160;&#160;&#160;&#160;To Account #__________________________________________</font></div><div style="margin-bottom:6pt;padding-left:73.65pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Loan Account #)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Deposit Account #)</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of Term Loan Advance $___________________________</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:1.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Borrower&#8217;s representations and warranties in the Loan and Security Agreement are true, correct and complete in all material respects on the date of the request for an advance&#59; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof&#59; and provided, further that those representations and warranties expressly referring to a specific date shall be true and correct in all material respects as of such date&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Authorized Signature&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Phone Number&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Print Name&#47;Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div></td></tr></table></div><div style="padding-left:18pt;padding-right:-18pt;text-align:justify"><font><br></font></div><div style="height:87.43pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">295054968.4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">354271-000499&#34; &#34;&#34; 295054968.4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:111%">354271-000499</font></div></div></div><hr style="page-break-after:always"><div style="min-height:47.64pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:3.35pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">outgoing wire request&#58;</font></div><div style="padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Complete only if all or a portion of funds from the loan advance above is to be wired.</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deadline for same day processing is noon, Pacific Time </font></div><div style="margin-top:6pt;padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beneficiary Name&#58; ____________________________&#160;&#160;&#160;&#160;Amount of Wire&#58; $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beneficiary Bank&#58; _____________________________&#160;&#160;&#160;&#160;Account Number&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">City and State&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beneficiary Bank Transit (ABA) #&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Beneficiary Bank Code (Swift, Sort, Chip, etc.)&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;padding-left:258.7pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(For International Wire Only)</font></div><div style="padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intermediary Bank&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Transit (ABA) #&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Further Credit to&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Special Instruction&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">By signing below, I (we) acknowledge and agree that my (our) funds transfer request shall be processed in accordance with and subject to the terms and conditions set forth in the agreements(s) covering funds transfer service(s), which agreements(s) were previously received and executed by me (us).</font></div><div style="padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Authorized Signature&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Signature (if required)&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Print Name&#47;Title&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Print Name&#47;Title&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:-15.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Telephone #&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Telephone #&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div></td></tr></table></div><div><font><br></font></div><div style="height:87.43pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-2</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">295054968.4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">354271-000499&#34; &#34;&#34; 295054968.4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">354271-000499</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>sibn-ex102secondamendmentt.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i009419811e5446f599cf1a469ef1677a_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">SECOND AMENDMENT  </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">OFFER LETTER AGREEMENT AND </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> SEVERANCE PLAN PARTICIPATION AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            This Second Amendment (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) to the Offer Letter Agreement by and between SI-BONE, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and Jeffrey Dunn (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), dated as of the 15th day of December, 2009 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Letter Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and the Participation Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Participation Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) under the SI-BONE, Inc. Severance Benefit Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Severance Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), as amended by the Amendment to Offer Letter and Severance Plan Participation Agreement, effective April 19, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">First Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), is entered into as of this 20th day of October, 2021, by and between the Company and the Executive, effective and contingent upon the earlier of May 1, 2021 and the date on which a new Chief Financial Officer is appointed and begins employment at the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  The Company and Executive are referred to herein as the &#8220;parties.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">RECITALS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, the Company and the Executive are parties to the Letter Agreement and to the Participation Agreement, as amended by the First Amendment&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, Section 9 of the Letter Agreement provides that the Letter Agreement may not be amended or modified, except by an express written agreement signed by both Executive and a duly authorized officer of the Company&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, Section 9(b) of the Severance Benefit Plan permits amendments to such plan provided that any such amendment will not be effective as to a particular employee who is or may be adversely impacted by such amendment or termination and has an effective Participation Agreement without the written consent of such employee&#59; and </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, the parties desire to amend each of the Letter Agreement and Participation Agreement to provide for the modifications set forth herein. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">NOW, THEREFORE, the parties agree that each of the Letter Agreement and the Participation Agreement, as amended, is hereby amended, automatically effective upon the Effective Date to reflect the following&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:8pt">Executive will be entitled to receive the severance benefit set forth in Section 2 of the Participation Agreement only upon the occurrence of a Covered Termination occurring during the Change in Control Period.  Executive will not be entitled to receive the severance benefits set forth in Section 2 of the Participation Agreement upon the Closing of a Change in Control absent a Covered Termination within the Change in Control Period. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:8pt">The second prong of the &#8220;Good Reason&#8221; definition will be triggered if Executive ceases to be, at any point during the Change in Control Period, the Chairman of the Board or, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">following a Change in Control, the Chairman of the board of the successor entity or its ultimate parent entity, if any. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:8pt">Except to the extent expressly amended hereby, the Letter Agreement, the Severance Plan and the Participation Agreement, as amended, shall remain in full force and effect in all respects.    </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#91;REMAINDER OF PAGE INTENTIONALLY LEFT BLANK&#93;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">IN WITNESS WHEREOF, this Amendment has been duly executed by the parties hereto as of the day and year first written above.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">                                                                        SI-BONE, Inc.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">                                                                        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">&#47;s&#47; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Timothy E. Davis, Jr.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">                                                                        Name&#58; Timothy E. Davis, Jr.</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Title&#58; Chairman of the Compensation Committee</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">                                                                        EXECUTIVE</font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">&#47;s&#47; Jeffrey W. Dunn </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">                                                                        Jeffrey W. Dunn </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>sibn-ex311_930202110xq.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5bb8003c9e5c44848e18188b92492a05_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Laura A. Francis, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Form 10-Q of SI-BONE, Inc.&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.74pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.74pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.74pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.138%"><tr><td style="width:1.0%"></td><td style="width:4.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Laura A. Francis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 9, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laura A. Francis</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>sibn-ex312_930202110xq.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i8ed53fd00e6342e3887b9103907da1c4_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:right"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Anshul Maheshwari, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Form 10-Q of SI-BONE, Inc.&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.74pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.74pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.74pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"><tr><td style="width:1.0%"></td><td style="width:5.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.366%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Anshul Maheshwari</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 9, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anshul Maheshwari</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>sibn-ex321_930202110xq.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="icdb3652d85294edd986bbb5a56648934_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350), Laura A. Francis, Chief Executive Officer of SI-BONE, Inc. (the &#8220;Company&#8221;), and Anshul Maheshwari, Chief Financial Officer of the Company, each hereby certify that, to the best of his or her knowledge&#58; </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Company&#8217;s Quarterly Report on Form 10-Q for the period ended September 30, 2021, to which this Certification is attached as Exhibit 32.1 (the &#8220;Periodic Report&#8221;), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act&#59; and </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.857%"><tr><td style="width:1.0%"></td><td style="width:4.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.305%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.566%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Laura A. Francis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 9, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laura A. Francis</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Anshul Maheshwari</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 9, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anshul Maheshwari</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of SI-BONE, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing. </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>sibn-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c8537e76-3d0d-41fe-8011-c02f9e3c1997,g:6717da7c-7375-4e6f-9fbf-fa93aabe50cb-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sibn="http://si-bone.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://si-bone.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sibn-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sibn-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sibn-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sibn-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://si-bone.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyandNatureofBusiness" roleURI="http://si-bone.com/role/TheCompanyandNatureofBusiness">
        <link:definition>2101101 - Disclosure - The Company and Nature of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheCompanyandNatureofBusinessDetails" roleURI="http://si-bone.com/role/TheCompanyandNatureofBusinessDetails">
        <link:definition>2402401 - Disclosure - The Company and Nature of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2406402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails" roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails">
        <link:definition>2407403 - Disclosure - Summary of Significant Accounting Policies - Revenue by Geography (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecurities" roleURI="http://si-bone.com/role/MarketableSecurities">
        <link:definition>2108103 - Disclosure - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesTables" roleURI="http://si-bone.com/role/MarketableSecuritiesTables">
        <link:definition>2309302 - Disclosure - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesDetails" roleURI="http://si-bone.com/role/MarketableSecuritiesDetails">
        <link:definition>2410404 - Disclosure - Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurement" roleURI="http://si-bone.com/role/FairValueMeasurement">
        <link:definition>2111104 - Disclosure - Fair Value Measurement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementTables" roleURI="http://si-bone.com/role/FairValueMeasurementTables">
        <link:definition>2312303 - Disclosure - Fair Value Measurement (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementDetails" roleURI="http://si-bone.com/role/FairValueMeasurementDetails">
        <link:definition>2413405 - Disclosure - Fair Value Measurement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponents" roleURI="http://si-bone.com/role/BalanceSheetComponents">
        <link:definition>2114105 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTables" roleURI="http://si-bone.com/role/BalanceSheetComponentsTables">
        <link:definition>2315304 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsPropertyandEquipmentNetDetails" roleURI="http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails">
        <link:definition>2416406 - Disclosure - Balance Sheet Components - Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsNarrativeDetails" roleURI="http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails">
        <link:definition>2417407 - Disclosure - Balance Sheet Components - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsAccruedLiabilitiesandOtherDetails" roleURI="http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails">
        <link:definition>2418408 - Disclosure - Balance Sheet Components - Accrued Liabilities and Other (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://si-bone.com/role/CommitmentsandContingencies">
        <link:definition>2119106 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://si-bone.com/role/CommitmentsandContingenciesTables">
        <link:definition>2320305 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>2421409 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails" roleURI="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails">
        <link:definition>2422410 - Disclosure - Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Borrowings" roleURI="http://si-bone.com/role/Borrowings">
        <link:definition>2123107 - Disclosure - Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsTables" roleURI="http://si-bone.com/role/BorrowingsTables">
        <link:definition>2324306 - Disclosure - Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsSummaryofBorrowingsDetails" roleURI="http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails">
        <link:definition>2425411 - Disclosure - Borrowings - Summary of Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsNarrativeDetails" roleURI="http://si-bone.com/role/BorrowingsNarrativeDetails">
        <link:definition>2426412 - Disclosure - Borrowings - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsDebtMaturityDetails" roleURI="http://si-bone.com/role/BorrowingsDebtMaturityDetails">
        <link:definition>2427413 - Disclosure - Borrowings - Debt Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentiveCompensationPlans" roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlans">
        <link:definition>2128108 - Disclosure - Stock-Based Incentive Compensation Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentiveCompensationPlansTables" roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables">
        <link:definition>2329307 - Disclosure - Stock-Based Incentive Compensation Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentiveCompensationPlansNarrativeDetails" roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails">
        <link:definition>2430414 - Disclosure - Stock-Based Incentive Compensation Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentiveCompensationPlansStockOptionActivityDetails" roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails">
        <link:definition>2431415 - Disclosure - Stock-Based Incentive Compensation Plans - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails" roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails">
        <link:definition>2432416 - Disclosure - Stock-Based Incentive Compensation Plans - Valuation Assumptions for Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails" roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails">
        <link:definition>2433417 - Disclosure - Stock-Based Incentive Compensation Plans - Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails" roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails">
        <link:definition>2434418 - Disclosure - Stock-Based Incentive Compensation Plans - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareofCommonStock" roleURI="http://si-bone.com/role/NetLossPerShareofCommonStock">
        <link:definition>2135109 - Disclosure - Net Loss Per Share of Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareofCommonStockTables" roleURI="http://si-bone.com/role/NetLossPerShareofCommonStockTables">
        <link:definition>2336308 - Disclosure - Net Loss Per Share of Common Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareofCommonStockComputationofEarningsPerShareDetails" roleURI="http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails">
        <link:definition>2437419 - Disclosure - Net Loss Per Share of Common Stock - Computation of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails" roleURI="http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails">
        <link:definition>2438420 - Disclosure - Net Loss Per Share of Common Stock - Antidilutive Common Stock Equivalents Excluded from Computation of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransaction" roleURI="http://si-bone.com/role/RelatedPartyTransaction">
        <link:definition>2139110 - Disclosure - Related Party Transaction</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionDetails" roleURI="http://si-bone.com/role/RelatedPartyTransactionDetails">
        <link:definition>2440421 - Disclosure - Related Party Transaction (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://si-bone.com/role/IncomeTaxes">
        <link:definition>2141111 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" abstract="false" name="MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_PrepaymentPenalty3148MonthsMember" abstract="true" name="PrepaymentPenalty3148MonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_ShareSubjectToRepurchaseMember" abstract="true" name="ShareSubjectToRepurchaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_SecondaryOfferingMember" abstract="true" name="SecondaryOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sibn_SocialSecurityTaxEmployerDeferralCARESAct" abstract="false" name="SocialSecurityTaxEmployerDeferralCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" abstract="false" name="AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod" abstract="false" name="DebtInstrumentPeriodicPaymentInterestOnlyPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering" abstract="false" name="SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sibn_SecondFollowOnPublicOfferingMember" abstract="true" name="SecondFollowOnPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_ProceedsFromSaleOfMarketableSecurities" abstract="false" name="ProceedsFromSaleOfMarketableSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_EmployeeStockPurchasePlanSharesMember" abstract="true" name="EmployeeStockPurchasePlanSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_A2018EmployeeStockPurchasePlanMember" abstract="true" name="A2018EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_RelatedPartyTransactionTermOfAgreement" abstract="false" name="RelatedPartyTransactionTermOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock" abstract="false" name="EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="sibn_MarketableSecuritiesFairValue" abstract="false" name="MarketableSecuritiesFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" abstract="false" name="DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_VestingOfEarlyExercisedStockOptions" abstract="false" name="VestingOfEarlyExercisedStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage" abstract="false" name="DebtInstrumentPrepaymentPremiumYearTwoPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sibn_CommonStockWarrantsMember" abstract="true" name="CommonStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage" abstract="false" name="DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sibn_MarketableSecuritiesAmortizedCost" abstract="false" name="MarketableSecuritiesAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_DebtPrepaymentPenaltyPeriodAxis" abstract="true" name="DebtPrepaymentPenaltyPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sibn_ComputerAndOfficeEquipmentMember" abstract="true" name="ComputerAndOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_PrepaymentPenalty24MonthsOnMember" abstract="true" name="PrepaymentPenalty24MonthsOnMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_VariableOptionOneMember" abstract="true" name="VariableOptionOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_ProceedsFromMaturityOfMarketableSecurities" abstract="false" name="ProceedsFromMaturityOfMarketableSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_FollowOnPublicOfferingMember" abstract="true" name="FollowOnPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_ConstructionInProgressSantaClaraLeaseMember" abstract="true" name="ConstructionInProgressSantaClaraLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sibn_DevelopmentAgreementMember" abstract="true" name="DevelopmentAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits" abstract="false" name="StockIssuedDuringPeriodSharesRestrictedStockUnits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" abstract="false" name="AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_PrepaymentPenalty124MonthsMember" abstract="true" name="PrepaymentPenalty124MonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_SVBTermLoanMember" abstract="true" name="SVBTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember" abstract="true" name="ConstructionInProgressSurgicalPlacementInstrumentSetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_FollowOnPublicOfferingAndSecondaryOfferingMember" abstract="true" name="FollowOnPublicOfferingAndSecondaryOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage" abstract="false" name="DebtInstrumentPrepaymentPremiumYearOnePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_PharmakonTermLoanMember" abstract="true" name="PharmakonTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_DebtInstrumentPrepaymentPenaltyPercentage" abstract="false" name="DebtInstrumentPrepaymentPenaltyPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sibn_PrepaymentPenalty4960MonthsMember" abstract="true" name="PrepaymentPenalty4960MonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_OperatingLeaseTermOfWrittenNoticeForTermination" abstract="false" name="OperatingLeaseTermOfWrittenNoticeForTermination" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:timeItemType"/>
  <xs:element id="sibn_SolarLoanAndSecurityAgreementMember" abstract="true" name="SolarLoanAndSecurityAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_DebtPrepaymentPenaltyPeriodDomain" abstract="true" name="DebtPrepaymentPenaltyPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement" abstract="false" name="DebtInstrumentPrepaymentAllowableIncrementsPerAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_AllocatedPublicOfferingCosts" abstract="false" name="AllocatedPublicOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour" abstract="false" name="OperatingLeasesFutureMinimumPaymentsDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>sibn-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c8537e76-3d0d-41fe-8011-c02f9e3c1997,g:6717da7c-7375-4e6f-9fbf-fa93aabe50cb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="sibn-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b9336744-ca31-4523-99dd-f83876876fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_4d4efc41-b501-496b-8325-8bb9f8c7564f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9336744-ca31-4523-99dd-f83876876fb4" xlink:to="loc_us-gaap_PreferredStockValue_4d4efc41-b501-496b-8325-8bb9f8c7564f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f57248e1-d0c6-4ffb-800a-c6e443a22039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9336744-ca31-4523-99dd-f83876876fb4" xlink:to="loc_us-gaap_CommonStockValue_f57248e1-d0c6-4ffb-800a-c6e443a22039" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_824f999e-466d-4b1d-b5e5-b42f47b80639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9336744-ca31-4523-99dd-f83876876fb4" xlink:to="loc_us-gaap_AdditionalPaidInCapital_824f999e-466d-4b1d-b5e5-b42f47b80639" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a3f5137c-3779-4c24-8a88-aa49fd0f7846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9336744-ca31-4523-99dd-f83876876fb4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a3f5137c-3779-4c24-8a88-aa49fd0f7846" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7b15d3ed-c10b-4bfe-a1d9-b37e2afc1c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b9336744-ca31-4523-99dd-f83876876fb4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7b15d3ed-c10b-4bfe-a1d9-b37e2afc1c9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c5a18e21-4c11-4759-a2f6-11ddf136b03d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_df0ad086-a6f6-4f94-8678-64150f8abf65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c5a18e21-4c11-4759-a2f6-11ddf136b03d" xlink:to="loc_us-gaap_LiabilitiesCurrent_df0ad086-a6f6-4f94-8678-64150f8abf65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_0a9401a7-69eb-470e-a584-68e8560ee4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c5a18e21-4c11-4759-a2f6-11ddf136b03d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_0a9401a7-69eb-470e-a584-68e8560ee4ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e5be79de-b2d1-48e3-96ba-0d39ad766f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c5a18e21-4c11-4759-a2f6-11ddf136b03d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e5be79de-b2d1-48e3-96ba-0d39ad766f0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ac1dba0e-3b8c-436e-9e6a-960057906af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8d00a3bf-d8a2-4cb0-9fdf-02523c846209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ac1dba0e-3b8c-436e-9e6a-960057906af5" xlink:to="loc_us-gaap_Liabilities_8d00a3bf-d8a2-4cb0-9fdf-02523c846209" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_4b041164-20c7-4c34-9e79-8b8b696eb0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ac1dba0e-3b8c-436e-9e6a-960057906af5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_4b041164-20c7-4c34-9e79-8b8b696eb0a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_65accbf7-240e-49ed-beec-a2123a627f20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ac1dba0e-3b8c-436e-9e6a-960057906af5" xlink:to="loc_us-gaap_StockholdersEquity_65accbf7-240e-49ed-beec-a2123a627f20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7d69a4ec-219e-4b80-991c-6f301974a68a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a968f151-b130-4d90-b73d-5621d7d88543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7d69a4ec-219e-4b80-991c-6f301974a68a" xlink:to="loc_us-gaap_AssetsCurrent_a968f151-b130-4d90-b73d-5621d7d88543" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4e488669-de7e-40fd-aaa7-3fcc5882bd83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7d69a4ec-219e-4b80-991c-6f301974a68a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4e488669-de7e-40fd-aaa7-3fcc5882bd83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d349642b-c5d6-499d-b4c1-22f0d06ee091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7d69a4ec-219e-4b80-991c-6f301974a68a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d349642b-c5d6-499d-b4c1-22f0d06ee091" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3089ab8d-e41c-4aad-8068-fe1f6669fd8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a5254044-44f8-4302-a705-f6b7260c4ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3089ab8d-e41c-4aad-8068-fe1f6669fd8e" xlink:to="loc_us-gaap_AccountsPayableCurrent_a5254044-44f8-4302-a705-f6b7260c4ac7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4b431097-7925-4763-8e6c-cfea33d1d797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3089ab8d-e41c-4aad-8068-fe1f6669fd8e" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4b431097-7925-4763-8e6c-cfea33d1d797" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3d5b386d-db3a-47f6-a5ba-e6b5ddf5c1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9f9b6998-c8f0-44ee-983d-5248c2add682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3d5b386d-db3a-47f6-a5ba-e6b5ddf5c1c1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9f9b6998-c8f0-44ee-983d-5248c2add682" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_89c95654-5883-4d48-8f4a-5c0084810cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3d5b386d-db3a-47f6-a5ba-e6b5ddf5c1c1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_89c95654-5883-4d48-8f4a-5c0084810cbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c0e1f12c-95e8-472f-8876-34ab9d999b04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3d5b386d-db3a-47f6-a5ba-e6b5ddf5c1c1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c0e1f12c-95e8-472f-8876-34ab9d999b04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9e1b009e-1558-4e2a-812d-a1bf6a482a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3d5b386d-db3a-47f6-a5ba-e6b5ddf5c1c1" xlink:to="loc_us-gaap_InventoryNet_9e1b009e-1558-4e2a-812d-a1bf6a482a83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_50c391d3-57a7-4d12-bbe1-88533bf5c472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3d5b386d-db3a-47f6-a5ba-e6b5ddf5c1c1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_50c391d3-57a7-4d12-bbe1-88533bf5c472" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="sibn-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_628bd05e-4a3d-42d3-b7ab-e9ed3000b151" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d03e1b6d-54e1-408c-a498-ac8b81f2be4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_628bd05e-4a3d-42d3-b7ab-e9ed3000b151" xlink:to="loc_us-gaap_GrossProfit_d03e1b6d-54e1-408c-a498-ac8b81f2be4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d011efe5-aab5-4b2f-ae48-6a19448cef70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_628bd05e-4a3d-42d3-b7ab-e9ed3000b151" xlink:to="loc_us-gaap_OperatingExpenses_d011efe5-aab5-4b2f-ae48-6a19448cef70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_bf76b0b5-7ee8-469e-9de5-0c79c965a949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cb032bbd-4b61-43d0-83cd-2b1a9fcfe40b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_bf76b0b5-7ee8-469e-9de5-0c79c965a949" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cb032bbd-4b61-43d0-83cd-2b1a9fcfe40b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a843b999-dd0f-4957-a65b-d2737a9dc2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_bf76b0b5-7ee8-469e-9de5-0c79c965a949" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a843b999-dd0f-4957-a65b-d2737a9dc2fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b3a583dd-08ad-4ec8-a99c-f1552d25c513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8936c9a9-480c-477c-9f71-89f9d8b92586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b3a583dd-08ad-4ec8-a99c-f1552d25c513" xlink:to="loc_us-gaap_NetIncomeLoss_8936c9a9-480c-477c-9f71-89f9d8b92586" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_b0f312d0-4dc3-45dc-99d8-7cdef2914b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b3a583dd-08ad-4ec8-a99c-f1552d25c513" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_b0f312d0-4dc3-45dc-99d8-7cdef2914b36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_e3083a3d-4397-4cf3-a7e0-5c9be6e6c828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b3a583dd-08ad-4ec8-a99c-f1552d25c513" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_e3083a3d-4397-4cf3-a7e0-5c9be6e6c828" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_340d7cde-5701-4b06-ad88-03747c09d29e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_213587cb-74db-4867-9072-a04c23410deb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_340d7cde-5701-4b06-ad88-03747c09d29e" xlink:to="loc_us-gaap_OperatingIncomeLoss_213587cb-74db-4867-9072-a04c23410deb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_deb3b937-ef2f-430d-ab46-bf10dfa246a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_340d7cde-5701-4b06-ad88-03747c09d29e" xlink:to="loc_us-gaap_InvestmentIncomeInterest_deb3b937-ef2f-430d-ab46-bf10dfa246a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_62b20707-0125-4fde-af0d-8340d1c5ef6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_340d7cde-5701-4b06-ad88-03747c09d29e" xlink:to="loc_us-gaap_InterestExpense_62b20707-0125-4fde-af0d-8340d1c5ef6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a2dc1467-eebd-414a-9a06-deb27399f285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_340d7cde-5701-4b06-ad88-03747c09d29e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a2dc1467-eebd-414a-9a06-deb27399f285" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_33da8d92-080f-4c3b-be99-7039fe1145dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_e6ce6020-75fe-4367-8bff-9a3e15eefd01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_33da8d92-080f-4c3b-be99-7039fe1145dd" xlink:to="loc_us-gaap_SellingAndMarketingExpense_e6ce6020-75fe-4367-8bff-9a3e15eefd01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6eab53d8-9ab3-49a6-b54b-9e9810c9662f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_33da8d92-080f-4c3b-be99-7039fe1145dd" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6eab53d8-9ab3-49a6-b54b-9e9810c9662f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_cbd421ec-affa-4f61-8f02-3b4ff68ae397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_33da8d92-080f-4c3b-be99-7039fe1145dd" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_cbd421ec-affa-4f61-8f02-3b4ff68ae397" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sibn-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5569a6f1-4166-472e-9687-852c07f58f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:to="loc_us-gaap_NetIncomeLoss_5569a6f1-4166-472e-9687-852c07f58f8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_04e4f119-8563-4934-ae4a-fff6e38fc677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:to="loc_us-gaap_ShareBasedCompensation_04e4f119-8563-4934-ae4a-fff6e38fc677" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_855ec3dc-51a0-4254-ad5a-ecfaed76faf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_855ec3dc-51a0-4254-ad5a-ecfaed76faf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_aaf07b39-4eac-40a5-ab55-a65c4a5e672b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_aaf07b39-4eac-40a5-ab55-a65c4a5e672b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_1d82e6b0-597f-40d4-80bc-5d207556df2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_1d82e6b0-597f-40d4-80bc-5d207556df2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesRealizedGainLoss_058be5a8-70dd-4575-b3ae-62410172f969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:to="loc_us-gaap_MarketableSecuritiesRealizedGainLoss_058be5a8-70dd-4575-b3ae-62410172f969" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_ac437a5c-13da-4d73-be18-79b6a7fc9802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_ac437a5c-13da-4d73-be18-79b6a7fc9802" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_db2659cd-04e8-4cb6-bb59-111e7be33c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_db2659cd-04e8-4cb6-bb59-111e7be33c5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_02ff417e-9f5e-4f73-a0b8-dbd5961eb358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_02ff417e-9f5e-4f73-a0b8-dbd5961eb358" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fd77c878-2080-4414-acc2-5a50100eb14c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fd77c878-2080-4414-acc2-5a50100eb14c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3811d1b2-5ed1-4350-88e5-2a17e68c6e87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3811d1b2-5ed1-4350-88e5-2a17e68c6e87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_03f4eaea-f7ca-448f-bec1-92b9f8b07354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_03f4eaea-f7ca-448f-bec1-92b9f8b07354" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2508cfd2-8da7-4ec3-90a7-32a08708d356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2508cfd2-8da7-4ec3-90a7-32a08708d356" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_57327f5a-41f0-4143-9433-eb7412bac74a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba4b6960-af05-489e-a34f-bf8fd4df102c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_57327f5a-41f0-4143-9433-eb7412bac74a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d5c577aa-8e45-4996-9709-b578ee35ca76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_512f6d93-ca86-4215-be82-284c5ff71763" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d5c577aa-8e45-4996-9709-b578ee35ca76" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_512f6d93-ca86-4215-be82-284c5ff71763" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_72c01334-5ce7-45b9-b2e1-f3dde5eb90a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d5c577aa-8e45-4996-9709-b578ee35ca76" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_72c01334-5ce7-45b9-b2e1-f3dde5eb90a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_d2e98443-2586-42f4-903e-5da0697c3840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d5c577aa-8e45-4996-9709-b578ee35ca76" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_d2e98443-2586-42f4-903e-5da0697c3840" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_bf7c9bf8-c7d3-4092-808e-45809482dd8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d5c577aa-8e45-4996-9709-b578ee35ca76" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_bf7c9bf8-c7d3-4092-808e-45809482dd8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_06b9661f-6001-4de5-b52a-e8fbfc713112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d5c577aa-8e45-4996-9709-b578ee35ca76" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_06b9661f-6001-4de5-b52a-e8fbfc713112" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_c43d9099-3d1b-45e1-aaa9-5d63be6acbde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d5c577aa-8e45-4996-9709-b578ee35ca76" xlink:to="loc_us-gaap_ProceedsFromStockPlans_c43d9099-3d1b-45e1-aaa9-5d63be6acbde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_38933cff-0d00-4e56-b3ba-75714d5a0032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d5c577aa-8e45-4996-9709-b578ee35ca76" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_38933cff-0d00-4e56-b3ba-75714d5a0032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de3cda9c-67b7-4de1-b856-e1c8d6fd3fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ProceedsFromMaturityOfMarketableSecurities_12c783a0-806f-4b5f-ada1-2391b025239e" xlink:href="sibn-20210930.xsd#sibn_ProceedsFromMaturityOfMarketableSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de3cda9c-67b7-4de1-b856-e1c8d6fd3fc6" xlink:to="loc_sibn_ProceedsFromMaturityOfMarketableSecurities_12c783a0-806f-4b5f-ada1-2391b025239e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ProceedsFromSaleOfMarketableSecurities_5ffda3fd-7d2c-44a2-b6eb-84028c172cb8" xlink:href="sibn-20210930.xsd#sibn_ProceedsFromSaleOfMarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de3cda9c-67b7-4de1-b856-e1c8d6fd3fc6" xlink:to="loc_sibn_ProceedsFromSaleOfMarketableSecurities_5ffda3fd-7d2c-44a2-b6eb-84028c172cb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_6b6cf3b4-d2e3-4a5c-b6ee-dcf8fd4338af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de3cda9c-67b7-4de1-b856-e1c8d6fd3fc6" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_6b6cf3b4-d2e3-4a5c-b6ee-dcf8fd4338af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_be985fc2-79fa-41d7-9cd4-6495376506c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de3cda9c-67b7-4de1-b856-e1c8d6fd3fc6" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_be985fc2-79fa-41d7-9cd4-6495376506c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_32d5ea9f-bc0a-4552-8d85-407ff5f2b7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92ee1a1b-a39f-494e-a56a-fb914b2fab30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_32d5ea9f-bc0a-4552-8d85-407ff5f2b7f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92ee1a1b-a39f-494e-a56a-fb914b2fab30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4067117b-7e64-4b82-8cfd-51a3831a2284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_32d5ea9f-bc0a-4552-8d85-407ff5f2b7f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4067117b-7e64-4b82-8cfd-51a3831a2284" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0547b188-389b-4093-922c-3f9fb95479d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_32d5ea9f-bc0a-4552-8d85-407ff5f2b7f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0547b188-389b-4093-922c-3f9fb95479d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2d20ce6d-22de-4f2c-aca9-9536667850f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_32d5ea9f-bc0a-4552-8d85-407ff5f2b7f4" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2d20ce6d-22de-4f2c-aca9-9536667850f8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/MarketableSecuritiesDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#MarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/MarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAmortizedCost_7632b1ed-a0ef-4fd9-b69d-b558f3e33f0b" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c57600de-40a7-466b-86d0-6ef0a3a83bb9" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sibn_MarketableSecuritiesAmortizedCost_7632b1ed-a0ef-4fd9-b69d-b558f3e33f0b" xlink:to="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c57600de-40a7-466b-86d0-6ef0a3a83bb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_be20e294-7f76-4987-846f-a77f689ba899" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sibn_MarketableSecuritiesAmortizedCost_7632b1ed-a0ef-4fd9-b69d-b558f3e33f0b" xlink:to="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_be20e294-7f76-4987-846f-a77f689ba899" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesFairValue_00306772-d30b-45d3-96a4-44803dc86d51" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sibn_MarketableSecuritiesAmortizedCost_7632b1ed-a0ef-4fd9-b69d-b558f3e33f0b" xlink:to="loc_sibn_MarketableSecuritiesFairValue_00306772-d30b-45d3-96a4-44803dc86d51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis_941dc016-6bd3-49f1-bc4b-3df81e6cd4b1" xlink:href="sibn-20210930.xsd#sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax_fa19c408-514f-46e1-ab5f-e1d4a4b40526" xlink:href="sibn-20210930.xsd#sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis_941dc016-6bd3-49f1-bc4b-3df81e6cd4b1" xlink:to="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax_fa19c408-514f-46e1-ab5f-e1d4a4b40526" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax_901b16c9-4ef4-4a9b-b063-bbf792f5ae06" xlink:href="sibn-20210930.xsd#sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis_941dc016-6bd3-49f1-bc4b-3df81e6cd4b1" xlink:to="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax_901b16c9-4ef4-4a9b-b063-bbf792f5ae06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_e2005a0f-fe42-4659-bf4c-abbf865f8b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis_941dc016-6bd3-49f1-bc4b-3df81e6cd4b1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_e2005a0f-fe42-4659-bf4c-abbf865f8b94" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#BalanceSheetComponentsPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9a389c93-908d-41e0-ab7a-744396e6169c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_d787e4bb-74c0-4484-8c20-3d1e5e8bb86f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_9a389c93-908d-41e0-ab7a-744396e6169c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_d787e4bb-74c0-4484-8c20-3d1e5e8bb86f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_838ef129-fff2-4fab-a70d-e3767500fe34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_9a389c93-908d-41e0-ab7a-744396e6169c" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_838ef129-fff2-4fab-a70d-e3767500fe34" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#BalanceSheetComponentsAccruedLiabilitiesandOtherDetails"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_5cbe1851-95c6-4670-a5b1-15ba22b42474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c09db265-d3af-4285-9567-17c31fa4501a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_5cbe1851-95c6-4670-a5b1-15ba22b42474" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c09db265-d3af-4285-9567-17c31fa4501a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_0efc2943-7f8b-4511-868c-da86166a2162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_5cbe1851-95c6-4670-a5b1-15ba22b42474" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_0efc2943-7f8b-4511-868c-da86166a2162" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3fab9dbd-258c-4bc0-a289-ba92bd6f22f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_5cbe1851-95c6-4670-a5b1-15ba22b42474" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3fab9dbd-258c-4bc0-a289-ba92bd6f22f6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_986c3d92-8961-463d-a809-18e6422bb698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_5f1b6807-3c86-401d-ab32-93ba53a566b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_986c3d92-8961-463d-a809-18e6422bb698" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_5f1b6807-3c86-401d-ab32-93ba53a566b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_5a6d5e3a-d0ef-4691-a1d8-d34046bfb7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_986c3d92-8961-463d-a809-18e6422bb698" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_5a6d5e3a-d0ef-4691-a1d8-d34046bfb7ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_82e967aa-1d6e-40b9-ac45-77b7a82daf39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_986c3d92-8961-463d-a809-18e6422bb698" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_82e967aa-1d6e-40b9-ac45-77b7a82daf39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_5686e431-103a-4ffa-99f6-9fe37c933114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_986c3d92-8961-463d-a809-18e6422bb698" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_5686e431-103a-4ffa-99f6-9fe37c933114" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_ce3d2369-c7be-47c3-98dc-0ae163e9bb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_986c3d92-8961-463d-a809-18e6422bb698" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_ce3d2369-c7be-47c3-98dc-0ae163e9bb5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour_62372900-46b1-48a6-806c-61c3d5538fb0" xlink:href="sibn-20210930.xsd#sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_986c3d92-8961-463d-a809-18e6422bb698" xlink:to="loc_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour_62372900-46b1-48a6-806c-61c3d5538fb0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#BorrowingsSummaryofBorrowingsDetails"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ff960258-67fb-4fa6-a4dd-524be27d5b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8449371e-487c-4da3-b866-0af7051ad980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ff960258-67fb-4fa6-a4dd-524be27d5b2b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8449371e-487c-4da3-b866-0af7051ad980" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_d20a4d1a-1127-479a-b647-9b6021ce2427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ff960258-67fb-4fa6-a4dd-524be27d5b2b" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_d20a4d1a-1127-479a-b647-9b6021ce2427" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_2e3ea210-d1da-40d1-9241-08cb19208b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ff960258-67fb-4fa6-a4dd-524be27d5b2b" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_2e3ea210-d1da-40d1-9241-08cb19208b89" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BorrowingsDebtMaturityDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#BorrowingsDebtMaturityDetails"/>
  <link:calculationLink xlink:role="http://si-bone.com/role/BorrowingsDebtMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_fe78594c-0893-4a73-9360-fad8d5a9d41a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_d16f3e72-13c7-40d4-8440-3332029f8302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fe78594c-0893-4a73-9360-fad8d5a9d41a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_d16f3e72-13c7-40d4-8440-3332029f8302" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_341c8666-b7ed-4ef8-9257-f7a2b195b3db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fe78594c-0893-4a73-9360-fad8d5a9d41a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_341c8666-b7ed-4ef8-9257-f7a2b195b3db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_88e788f2-2235-408e-a6db-4a63cab295d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fe78594c-0893-4a73-9360-fad8d5a9d41a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_88e788f2-2235-408e-a6db-4a63cab295d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_894590da-a96a-4a81-9fd3-1022a5a43080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fe78594c-0893-4a73-9360-fad8d5a9d41a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_894590da-a96a-4a81-9fd3-1022a5a43080" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_743b34df-638d-4a6e-bed2-6a18e159acd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fe78594c-0893-4a73-9360-fad8d5a9d41a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_743b34df-638d-4a6e-bed2-6a18e159acd7" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>sibn-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c8537e76-3d0d-41fe-8011-c02f9e3c1997,g:6717da7c-7375-4e6f-9fbf-fa93aabe50cb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="sibn-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="extended" id="i84b71d433d29468c97a66b99d2c81983_CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8010da09-632e-40d1-846f-9913689e19c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8010da09-632e-40d1-846f-9913689e19c5" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_9b9970e2-5ef4-45ac-a794-2b15a1d5263f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_SharesOutstanding_9b9970e2-5ef4-45ac-a794-2b15a1d5263f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3541d583-6d63-487e-96ce-1ab681b2b1df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockholdersEquity_3541d583-6d63-487e-96ce-1ab681b2b1df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_94f2834b-844c-4141-8b2f-8a92a7c7a443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_94f2834b-844c-4141-8b2f-8a92a7c7a443" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a5bbe37d-7668-4b6a-8630-fc91509b2ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a5bbe37d-7668-4b6a-8630-fc91509b2ff2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_675bb5b3-bba6-4b56-aa2f-5d732891e5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_675bb5b3-bba6-4b56-aa2f-5d732891e5e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_30db819e-7474-4a27-9ec1-52011e014975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_30db819e-7474-4a27-9ec1-52011e014975" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_83d5a480-49bc-4250-9858-c38902c3af5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_83d5a480-49bc-4250-9858-c38902c3af5f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2b9b94fd-413b-419a-9c53-d6ddedfc1f93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2b9b94fd-413b-419a-9c53-d6ddedfc1f93" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits_fdb039ae-d39c-47cd-a914-c36a09aaa10a" xlink:href="sibn-20210930.xsd#sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits_fdb039ae-d39c-47cd-a914-c36a09aaa10a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2655bbe1-7383-4a4b-b33f-5bef118062d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2655bbe1-7383-4a4b-b33f-5bef118062d4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions_0e0efa79-6792-436f-ba9c-1389d67887b2" xlink:href="sibn-20210930.xsd#sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions_0e0efa79-6792-436f-ba9c-1389d67887b2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_aa53cbe4-07f6-4be2-9f7d-2a4e735af9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_aa53cbe4-07f6-4be2-9f7d-2a4e735af9a6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_a09a9896-d035-4f1c-92f3-f44a21b8e9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_a09a9896-d035-4f1c-92f3-f44a21b8e9b3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fde19b3f-ed9b-45b2-b1a0-8868e48b3305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_NetIncomeLoss_fde19b3f-ed9b-45b2-b1a0-8868e48b3305" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_f2d17f01-635b-47d5-a2cd-d5d8f327cc24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3a12965c-4dae-4e24-b1c9-02a72774111f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_46c81fad-c609-40fb-8111-d875ce8b7ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8010da09-632e-40d1-846f-9913689e19c5" xlink:to="loc_us-gaap_StatementTable_46c81fad-c609-40fb-8111-d875ce8b7ce2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a0eab01e-bc45-4288-a2a2-d29ce6996af8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_46c81fad-c609-40fb-8111-d875ce8b7ce2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a0eab01e-bc45-4288-a2a2-d29ce6996af8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a0eab01e-bc45-4288-a2a2-d29ce6996af8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a0eab01e-bc45-4288-a2a2-d29ce6996af8" xlink:to="loc_us-gaap_EquityComponentDomain_a0eab01e-bc45-4288-a2a2-d29ce6996af8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f4f66e5d-1544-4d00-a07e-bbcdff43d7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a0eab01e-bc45-4288-a2a2-d29ce6996af8" xlink:to="loc_us-gaap_EquityComponentDomain_f4f66e5d-1544-4d00-a07e-bbcdff43d7ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_fc39f7a0-f3dc-4158-8cf5-e7727f34a850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f4f66e5d-1544-4d00-a07e-bbcdff43d7ab" xlink:to="loc_us-gaap_CommonStockMember_fc39f7a0-f3dc-4158-8cf5-e7727f34a850" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_98b4f9a9-a516-427f-a4a0-dc8cd2213acd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f4f66e5d-1544-4d00-a07e-bbcdff43d7ab" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_98b4f9a9-a516-427f-a4a0-dc8cd2213acd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e9b2a518-83dd-4736-837e-bc3285670076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f4f66e5d-1544-4d00-a07e-bbcdff43d7ab" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e9b2a518-83dd-4736-837e-bc3285670076" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6547e779-e50c-4bd3-a77d-064aaf7ba062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f4f66e5d-1544-4d00-a07e-bbcdff43d7ab" xlink:to="loc_us-gaap_RetainedEarningsMember_6547e779-e50c-4bd3-a77d-064aaf7ba062" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/TheCompanyandNatureofBusinessDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#TheCompanyandNatureofBusinessDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/TheCompanyandNatureofBusinessDetails" xlink:type="extended" id="i1557c676fc9246f3a65279fa6c9d628d_TheCompanyandNatureofBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_fee24c07-5e1b-4d70-8256-b8bfcbee9bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d1581698-66e0-4330-8e68-361593fb5a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fee24c07-5e1b-4d70-8256-b8bfcbee9bed" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d1581698-66e0-4330-8e68-361593fb5a7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering_7eb77735-6765-409a-b8ac-563cd02eae21" xlink:href="sibn-20210930.xsd#sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fee24c07-5e1b-4d70-8256-b8bfcbee9bed" xlink:to="loc_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering_7eb77735-6765-409a-b8ac-563cd02eae21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ce077023-e27b-4395-9ff1-200f3401ba8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fee24c07-5e1b-4d70-8256-b8bfcbee9bed" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ce077023-e27b-4395-9ff1-200f3401ba8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_dbaf1acb-7ac6-4a28-84db-e4e4cb86092b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fee24c07-5e1b-4d70-8256-b8bfcbee9bed" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_dbaf1acb-7ac6-4a28-84db-e4e4cb86092b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AllocatedPublicOfferingCosts_b7782fa2-6f73-46ef-988d-c4f64382abeb" xlink:href="sibn-20210930.xsd#sibn_AllocatedPublicOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fee24c07-5e1b-4d70-8256-b8bfcbee9bed" xlink:to="loc_sibn_AllocatedPublicOfferingCosts_b7782fa2-6f73-46ef-988d-c4f64382abeb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ab8f697f-97ba-42ee-842b-f205c3be00ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fee24c07-5e1b-4d70-8256-b8bfcbee9bed" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ab8f697f-97ba-42ee-842b-f205c3be00ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_06c88958-032d-47fd-8500-9bf58d54e55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ab8f697f-97ba-42ee-842b-f205c3be00ef" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_06c88958-032d-47fd-8500-9bf58d54e55a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_06c88958-032d-47fd-8500-9bf58d54e55a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_06c88958-032d-47fd-8500-9bf58d54e55a" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_06c88958-032d-47fd-8500-9bf58d54e55a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0a76ff34-8a18-42d7-ae61-405e504f1d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_06c88958-032d-47fd-8500-9bf58d54e55a" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0a76ff34-8a18-42d7-ae61-405e504f1d2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_FollowOnPublicOfferingMember_9355eca8-6fc6-4e94-a6de-8f515a2c68ca" xlink:href="sibn-20210930.xsd#sibn_FollowOnPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0a76ff34-8a18-42d7-ae61-405e504f1d2d" xlink:to="loc_sibn_FollowOnPublicOfferingMember_9355eca8-6fc6-4e94-a6de-8f515a2c68ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_FollowOnPublicOfferingAndSecondaryOfferingMember_de651efe-83df-4f93-a853-303e1730ded6" xlink:href="sibn-20210930.xsd#sibn_FollowOnPublicOfferingAndSecondaryOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0a76ff34-8a18-42d7-ae61-405e504f1d2d" xlink:to="loc_sibn_FollowOnPublicOfferingAndSecondaryOfferingMember_de651efe-83df-4f93-a853-303e1730ded6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_c5d32516-d8ec-4277-b188-a9893b83b653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0a76ff34-8a18-42d7-ae61-405e504f1d2d" xlink:to="loc_us-gaap_OverAllotmentOptionMember_c5d32516-d8ec-4277-b188-a9893b83b653" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SecondaryOfferingMember_5c280c5f-343a-44e7-be33-80f557c3eda5" xlink:href="sibn-20210930.xsd#sibn_SecondaryOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0a76ff34-8a18-42d7-ae61-405e504f1d2d" xlink:to="loc_sibn_SecondaryOfferingMember_5c280c5f-343a-44e7-be33-80f557c3eda5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SecondFollowOnPublicOfferingMember_961ed5fd-8049-459f-95bd-8c051ad33504" xlink:href="sibn-20210930.xsd#sibn_SecondFollowOnPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0a76ff34-8a18-42d7-ae61-405e504f1d2d" xlink:to="loc_sibn_SecondFollowOnPublicOfferingMember_961ed5fd-8049-459f-95bd-8c051ad33504" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails" xlink:type="extended" id="i36f73582750940a79c5bf83f999e415d_SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c8c58cc1-0848-4748-ad84-c1dbbcf463a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4cb1b62f-8858-4d6c-88b9-3a69fbbdacfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8c58cc1-0848-4748-ad84-c1dbbcf463a9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4cb1b62f-8858-4d6c-88b9-3a69fbbdacfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_17a0eba6-4209-4710-a979-3b85ba0688c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8c58cc1-0848-4748-ad84-c1dbbcf463a9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_17a0eba6-4209-4710-a979-3b85ba0688c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5f8a0e44-1735-43de-a79c-abcb2d05d6a5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17a0eba6-4209-4710-a979-3b85ba0688c3" xlink:to="loc_srt_StatementGeographicalAxis_5f8a0e44-1735-43de-a79c-abcb2d05d6a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5f8a0e44-1735-43de-a79c-abcb2d05d6a5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_5f8a0e44-1735-43de-a79c-abcb2d05d6a5" xlink:to="loc_srt_SegmentGeographicalDomain_5f8a0e44-1735-43de-a79c-abcb2d05d6a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d6df19d9-2586-44a7-8925-835b095cac60" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_5f8a0e44-1735-43de-a79c-abcb2d05d6a5" xlink:to="loc_srt_SegmentGeographicalDomain_d6df19d9-2586-44a7-8925-835b095cac60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b342ffdc-2472-4abe-932a-1e6e0e4d4f07" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d6df19d9-2586-44a7-8925-835b095cac60" xlink:to="loc_country_US_b342ffdc-2472-4abe-932a-1e6e0e4d4f07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_e3bbd38a-b9a7-4bc0-9298-450374b0c54f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d6df19d9-2586-44a7-8925-835b095cac60" xlink:to="loc_us-gaap_NonUsMember_e3bbd38a-b9a7-4bc0-9298-450374b0c54f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/MarketableSecuritiesDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#MarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/MarketableSecuritiesDetails" xlink:type="extended" id="i52b9badff99d449c8db701a63b57404d_MarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_9db3b046-8018-4209-98f5-c0bf57c88485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_9db3b046-8018-4209-98f5-c0bf57c88485" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_0ecf93a5-99a7-4687-ade2-f4fdbbacba8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_9db3b046-8018-4209-98f5-c0bf57c88485" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_0ecf93a5-99a7-4687-ade2-f4fdbbacba8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_62cdf541-41d6-4b3d-93dd-2c1d87c31e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_62cdf541-41d6-4b3d-93dd-2c1d87c31e1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis_0c3d3127-7054-4703-88b7-25a5fff72ca2" xlink:href="sibn-20210930.xsd#sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_62cdf541-41d6-4b3d-93dd-2c1d87c31e1c" xlink:to="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis_0c3d3127-7054-4703-88b7-25a5fff72ca2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax_7fb5b521-83b5-4129-aa24-f5911a008417" xlink:href="sibn-20210930.xsd#sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_62cdf541-41d6-4b3d-93dd-2c1d87c31e1c" xlink:to="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax_7fb5b521-83b5-4129-aa24-f5911a008417" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax_052c582c-1fea-4372-bee4-4d6a5e75cfaf" xlink:href="sibn-20210930.xsd#sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_62cdf541-41d6-4b3d-93dd-2c1d87c31e1c" xlink:to="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax_052c582c-1fea-4372-bee4-4d6a5e75cfaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_4026cd6d-2ed7-4862-b3d6-b690324410ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_62cdf541-41d6-4b3d-93dd-2c1d87c31e1c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_4026cd6d-2ed7-4862-b3d6-b690324410ee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAmortizedCost_ff511bc0-960d-4f53-8c60-a9654f1a1d80" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:to="loc_sibn_MarketableSecuritiesAmortizedCost_ff511bc0-960d-4f53-8c60-a9654f1a1d80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_92e2296d-3a6d-4431-bf37-aad497ffcf83" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:to="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_92e2296d-3a6d-4431-bf37-aad497ffcf83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_581e0b9f-c125-46d1-9311-2602296de4ab" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:to="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_581e0b9f-c125-46d1-9311-2602296de4ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesFairValue_81ecfb5e-69e8-453a-8ecf-80a1ca6efb05" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:to="loc_sibn_MarketableSecuritiesFairValue_81ecfb5e-69e8-453a-8ecf-80a1ca6efb05" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_9ce3ec31-1e1f-4a06-b1bf-92f7747ac57e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:to="loc_us-gaap_MarketableSecuritiesTable_9ce3ec31-1e1f-4a06-b1bf-92f7747ac57e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cb9fcda6-0992-4850-927f-a03717e3ca17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_9ce3ec31-1e1f-4a06-b1bf-92f7747ac57e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cb9fcda6-0992-4850-927f-a03717e3ca17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb9fcda6-0992-4850-927f-a03717e3ca17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cb9fcda6-0992-4850-927f-a03717e3ca17" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb9fcda6-0992-4850-927f-a03717e3ca17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1580d74-d90b-47db-b7b4-6d3ccbe8a718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cb9fcda6-0992-4850-927f-a03717e3ca17" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1580d74-d90b-47db-b7b4-6d3ccbe8a718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1e2a4d87-5670-4d83-862c-a90e7ccf1af4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1580d74-d90b-47db-b7b4-6d3ccbe8a718" xlink:to="loc_us-gaap_MoneyMarketFundsMember_1e2a4d87-5670-4d83-862c-a90e7ccf1af4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_235288b5-305e-4669-b14f-b766e3e453d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1580d74-d90b-47db-b7b4-6d3ccbe8a718" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_235288b5-305e-4669-b14f-b766e3e453d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_cf2cc3fc-7568-4fb3-806f-e5798b710eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1580d74-d90b-47db-b7b4-6d3ccbe8a718" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_cf2cc3fc-7568-4fb3-806f-e5798b710eb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_4882ce20-bc6d-4d45-8598-e50d5450276f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1580d74-d90b-47db-b7b4-6d3ccbe8a718" xlink:to="loc_us-gaap_CommercialPaperMember_4882ce20-bc6d-4d45-8598-e50d5450276f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/FairValueMeasurementDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#FairValueMeasurementDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/FairValueMeasurementDetails" xlink:type="extended" id="i23fac72dd66946309d388843b8218219_FairValueMeasurementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5ab56db2-af2e-484b-88f0-98fd37bddb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_e1d96596-b2ec-49c2-9b5d-2f5c5ac7a4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5ab56db2-af2e-484b-88f0-98fd37bddb1c" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_e1d96596-b2ec-49c2-9b5d-2f5c5ac7a4a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_f91f3229-bc97-4f4d-ba8c-5daa7e88b6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_e1d96596-b2ec-49c2-9b5d-2f5c5ac7a4a3" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_f91f3229-bc97-4f4d-ba8c-5daa7e88b6a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4d25434-509b-426e-9f35-24a0b1ddf8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5ab56db2-af2e-484b-88f0-98fd37bddb1c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4d25434-509b-426e-9f35-24a0b1ddf8bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_55110d07-fcb3-4c7d-ae5a-9910aa7fbe11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4d25434-509b-426e-9f35-24a0b1ddf8bf" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_55110d07-fcb3-4c7d-ae5a-9910aa7fbe11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_55110d07-fcb3-4c7d-ae5a-9910aa7fbe11_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_55110d07-fcb3-4c7d-ae5a-9910aa7fbe11" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_55110d07-fcb3-4c7d-ae5a-9910aa7fbe11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1a574c2c-8d6c-4410-be3c-1760c4cdec95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_55110d07-fcb3-4c7d-ae5a-9910aa7fbe11" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1a574c2c-8d6c-4410-be3c-1760c4cdec95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_99a4ceed-8713-4ad0-bdbe-f38ef7cc5c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1a574c2c-8d6c-4410-be3c-1760c4cdec95" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_99a4ceed-8713-4ad0-bdbe-f38ef7cc5c7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0745b177-2462-4ed5-be84-c9f8742fb3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4d25434-509b-426e-9f35-24a0b1ddf8bf" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0745b177-2462-4ed5-be84-c9f8742fb3ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0745b177-2462-4ed5-be84-c9f8742fb3ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0745b177-2462-4ed5-be84-c9f8742fb3ba" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0745b177-2462-4ed5-be84-c9f8742fb3ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_04824f31-da7e-404e-bb1a-edeec1deb78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0745b177-2462-4ed5-be84-c9f8742fb3ba" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_04824f31-da7e-404e-bb1a-edeec1deb78b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_bdbb2944-f386-411f-9e8d-294147044d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_04824f31-da7e-404e-bb1a-edeec1deb78b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_bdbb2944-f386-411f-9e8d-294147044d51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_232d571b-9fea-4e2e-8a1b-06bade55249b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_04824f31-da7e-404e-bb1a-edeec1deb78b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_232d571b-9fea-4e2e-8a1b-06bade55249b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8f84ae3c-c1c5-46d2-9cd2-5e0e0e7b3ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_04824f31-da7e-404e-bb1a-edeec1deb78b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8f84ae3c-c1c5-46d2-9cd2-5e0e0e7b3ef2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9c15ee26-eb9f-4bfe-927d-d198fcf73fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4d25434-509b-426e-9f35-24a0b1ddf8bf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9c15ee26-eb9f-4bfe-927d-d198fcf73fe2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c15ee26-eb9f-4bfe-927d-d198fcf73fe2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9c15ee26-eb9f-4bfe-927d-d198fcf73fe2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c15ee26-eb9f-4bfe-927d-d198fcf73fe2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c800d5d5-c61d-41a3-9828-3e9ee35b7842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9c15ee26-eb9f-4bfe-927d-d198fcf73fe2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c800d5d5-c61d-41a3-9828-3e9ee35b7842" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_0ecc33e1-379d-45fe-a6fa-2708c8ac9107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c800d5d5-c61d-41a3-9828-3e9ee35b7842" xlink:to="loc_us-gaap_MoneyMarketFundsMember_0ecc33e1-379d-45fe-a6fa-2708c8ac9107" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_5419a9c0-9bf1-4217-87b6-de5cf15607ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c800d5d5-c61d-41a3-9828-3e9ee35b7842" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_5419a9c0-9bf1-4217-87b6-de5cf15607ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_b9c0eb65-9459-4011-98c4-b229c6e69fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c800d5d5-c61d-41a3-9828-3e9ee35b7842" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_b9c0eb65-9459-4011-98c4-b229c6e69fc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_c2e69b1e-aa5d-46a8-b429-76a8a914e312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c800d5d5-c61d-41a3-9828-3e9ee35b7842" xlink:to="loc_us-gaap_CommercialPaperMember_c2e69b1e-aa5d-46a8-b429-76a8a914e312" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#BalanceSheetComponentsPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="extended" id="i5ac53eb9d6e0428588bccb96d21c63fc_BalanceSheetComponentsPropertyandEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_512151da-9deb-4d4f-bfc9-42f01e3c8eec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_5f7122c9-ef40-42f6-bf1a-bcda95e27803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_512151da-9deb-4d4f-bfc9-42f01e3c8eec" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_5f7122c9-ef40-42f6-bf1a-bcda95e27803" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_42d3fdfd-7a5d-4ff6-9557-fe9ef2f706d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_512151da-9deb-4d4f-bfc9-42f01e3c8eec" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_42d3fdfd-7a5d-4ff6-9557-fe9ef2f706d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f4d2d21d-1b32-4f46-a226-0353820233a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_512151da-9deb-4d4f-bfc9-42f01e3c8eec" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f4d2d21d-1b32-4f46-a226-0353820233a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_180c70aa-4c9d-427f-93b5-0aff1f52ac12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_512151da-9deb-4d4f-bfc9-42f01e3c8eec" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_180c70aa-4c9d-427f-93b5-0aff1f52ac12" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bc1e58db-8b97-4c29-8a04-a031477b48eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_180c70aa-4c9d-427f-93b5-0aff1f52ac12" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bc1e58db-8b97-4c29-8a04-a031477b48eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bc1e58db-8b97-4c29-8a04-a031477b48eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bc1e58db-8b97-4c29-8a04-a031477b48eb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bc1e58db-8b97-4c29-8a04-a031477b48eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59203f72-10e6-45d1-849b-b05e9d754668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bc1e58db-8b97-4c29-8a04-a031477b48eb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59203f72-10e6-45d1-849b-b05e9d754668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_2b4445d3-c765-4d2b-a6df-73bf736fcd40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59203f72-10e6-45d1-849b-b05e9d754668" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_2b4445d3-c765-4d2b-a6df-73bf736fcd40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_f062209c-e0ff-4e93-b7f3-d49eb5512332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59203f72-10e6-45d1-849b-b05e9d754668" xlink:to="loc_us-gaap_ConstructionInProgressMember_f062209c-e0ff-4e93-b7f3-d49eb5512332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember_01853a63-9bc1-4798-bc6b-cdf45bbef98e" xlink:href="sibn-20210930.xsd#sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConstructionInProgressMember_f062209c-e0ff-4e93-b7f3-d49eb5512332" xlink:to="loc_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember_01853a63-9bc1-4798-bc6b-cdf45bbef98e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ConstructionInProgressSantaClaraLeaseMember_5302ca54-2d06-4d5e-9bee-8d1d511ff7df" xlink:href="sibn-20210930.xsd#sibn_ConstructionInProgressSantaClaraLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConstructionInProgressMember_f062209c-e0ff-4e93-b7f3-d49eb5512332" xlink:to="loc_sibn_ConstructionInProgressSantaClaraLeaseMember_5302ca54-2d06-4d5e-9bee-8d1d511ff7df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ComputerAndOfficeEquipmentMember_4bbf5d46-8747-4dd2-9d8f-66cb8c2bbcd6" xlink:href="sibn-20210930.xsd#sibn_ComputerAndOfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59203f72-10e6-45d1-849b-b05e9d754668" xlink:to="loc_sibn_ComputerAndOfficeEquipmentMember_4bbf5d46-8747-4dd2-9d8f-66cb8c2bbcd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_0e045f3a-eae8-4665-bc20-9354c431e7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59203f72-10e6-45d1-849b-b05e9d754668" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_0e045f3a-eae8-4665-bc20-9354c431e7c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_edf52159-512d-4c3e-980a-5ce236638b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59203f72-10e6-45d1-849b-b05e9d754668" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_edf52159-512d-4c3e-980a-5ce236638b6e" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended" id="i657b0becef8f4c5484377b72b112a1ad_CommitmentsandContingenciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_OperatingLeaseTermOfWrittenNoticeForTermination_dce071eb-65a3-465e-aa62-368049583462" xlink:href="sibn-20210930.xsd#sibn_OperatingLeaseTermOfWrittenNoticeForTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_sibn_OperatingLeaseTermOfWrittenNoticeForTermination_dce071eb-65a3-465e-aa62-368049583462" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_61fcdc5a-8cf8-4ca5-8cb6-3e9d7dc54df0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_61fcdc5a-8cf8-4ca5-8cb6-3e9d7dc54df0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_bfa1690a-6efd-4ecc-a4dd-88e3999b8b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_us-gaap_PurchaseObligation_bfa1690a-6efd-4ecc-a4dd-88e3999b8b76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_8e9382fc-071e-4b2e-9eeb-c16913298e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_us-gaap_LitigationSettlementExpense_8e9382fc-071e-4b2e-9eeb-c16913298e66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_bb1dcb93-4d22-4f69-becb-634512d4fec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_us-gaap_LitigationReserve_bb1dcb93-4d22-4f69-becb-634512d4fec7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_5e4a344e-4e4b-4ee8-9d64-33d97661c5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_5e4a344e-4e4b-4ee8-9d64-33d97661c5bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend_de874d71-8705-427d-b7ed-806f9fa1e493" xlink:href="sibn-20210930.xsd#sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend_de874d71-8705-427d-b7ed-806f9fa1e493" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1_6558c765-15ef-4a5e-a602-157f3e401cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1_6558c765-15ef-4a5e-a602-157f3e401cd2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_2ad88137-ef5d-43d5-8043-558c0b72abd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_us-gaap_OtherCommitmentsTable_2ad88137-ef5d-43d5-8043-558c0b72abd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b24c7dbf-77e3-459b-8afc-53ef6e338bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_2ad88137-ef5d-43d5-8043-558c0b72abd0" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b24c7dbf-77e3-459b-8afc-53ef6e338bdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_b24c7dbf-77e3-459b-8afc-53ef6e338bdd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b24c7dbf-77e3-459b-8afc-53ef6e338bdd" xlink:to="loc_us-gaap_LossContingencyNatureDomain_b24c7dbf-77e3-459b-8afc-53ef6e338bdd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_aaccd4d0-3c4a-45e7-9a02-739270e1ea64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b24c7dbf-77e3-459b-8afc-53ef6e338bdd" xlink:to="loc_us-gaap_LossContingencyNatureDomain_aaccd4d0-3c4a-45e7-9a02-739270e1ea64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember_93e06163-63e0-4108-862b-5e21d7a270e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_aaccd4d0-3c4a-45e7-9a02-739270e1ea64" xlink:to="loc_us-gaap_IndemnificationGuaranteeMember_93e06163-63e0-4108-862b-5e21d7a270e5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/BorrowingsNarrativeDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#BorrowingsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/BorrowingsNarrativeDetails" xlink:type="extended" id="i1d8f9a048be44a918d088fc32a467915_BorrowingsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e13bc285-6252-4f56-975f-2045f16478bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e13bc285-6252-4f56-975f-2045f16478bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod_18b12b55-1ecb-45f7-b060-d5ac0818659d" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod_18b12b55-1ecb-45f7-b060-d5ac0818659d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ab3e1e81-a75b-4e7b-bd2d-583c4fa6ffe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ab3e1e81-a75b-4e7b-bd2d-583c4fa6ffe2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentPenaltyPercentage_caf0f2dc-d6f1-43bd-877b-3bde7b5d1c1a" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentPenaltyPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_DebtInstrumentPrepaymentPenaltyPercentage_caf0f2dc-d6f1-43bd-877b-3bde7b5d1c1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a9fe3c7d-6fbf-472a-9e65-db9c555ec448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a9fe3c7d-6fbf-472a-9e65-db9c555ec448" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_0cf11315-07e5-4151-84f3-0fbfe3d7704d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_0cf11315-07e5-4151-84f3-0fbfe3d7704d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_d7c674a0-332d-491f-8304-7af17a7b7ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_d7c674a0-332d-491f-8304-7af17a7b7ad9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_237a23d7-0aa5-4a31-bf15-51d520692186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_237a23d7-0aa5-4a31-bf15-51d520692186" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c9ffc83c-e8d6-41ce-a6ed-6dab9418dc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c9ffc83c-e8d6-41ce-a6ed-6dab9418dc8d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement_81b8a108-663d-42db-a74e-279d2522f3c2" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement_81b8a108-663d-42db-a74e-279d2522f3c2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage_9c0eb4ba-48bd-4014-972a-b141998130c2" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage_9c0eb4ba-48bd-4014-972a-b141998130c2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage_23389fa6-7aa4-4d17-a07c-4859333db97c" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage_23389fa6-7aa4-4d17-a07c-4859333db97c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage_902c44f5-0504-4a0e-a3d6-52192c1c6ccc" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage_902c44f5-0504-4a0e-a3d6-52192c1c6ccc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_7f7009c5-00ee-4016-b342-4299e0d72b47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_7f7009c5-00ee-4016-b342-4299e0d72b47" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal_74f24981-d7cc-472d-a9dc-4de281ea5b6c" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal_74f24981-d7cc-472d-a9dc-4de281ea5b6c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_26d98ae6-cb56-4680-9fd6-71ae9fc2e565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_26d98ae6-cb56-4680-9fd6-71ae9fc2e565" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SocialSecurityTaxEmployerDeferralCARESAct_dac097d3-7868-4f98-aa76-6692317fbd73" xlink:href="sibn-20210930.xsd#sibn_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_SocialSecurityTaxEmployerDeferralCARESAct_dac097d3-7868-4f98-aa76-6692317fbd73" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9b50143e-3e53-42d3-9545-eefbc0c37f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9b50143e-3e53-42d3-9545-eefbc0c37f4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9b50143e-3e53-42d3-9545-eefbc0c37f4e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9b50143e-3e53-42d3-9545-eefbc0c37f4e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9b50143e-3e53-42d3-9545-eefbc0c37f4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4ebea3e6-e5dd-47de-8f5c-c399708049b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9b50143e-3e53-42d3-9545-eefbc0c37f4e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4ebea3e6-e5dd-47de-8f5c-c399708049b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_b9107335-049d-47ef-a293-c332f568855b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4ebea3e6-e5dd-47de-8f5c-c399708049b5" xlink:to="loc_us-gaap_SecuredDebtMember_b9107335-049d-47ef-a293-c332f568855b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2f061418-461c-4339-865d-d3efdf6ef42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:to="loc_us-gaap_DebtInstrumentAxis_2f061418-461c-4339-865d-d3efdf6ef42d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2f061418-461c-4339-865d-d3efdf6ef42d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2f061418-461c-4339-865d-d3efdf6ef42d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2f061418-461c-4339-865d-d3efdf6ef42d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_991f48c2-dc61-46fc-b700-a77ce8711910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2f061418-461c-4339-865d-d3efdf6ef42d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_991f48c2-dc61-46fc-b700-a77ce8711910" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PharmakonTermLoanMember_b1505f35-9e00-47ed-8211-6c9fa1ed2ad1" xlink:href="sibn-20210930.xsd#sibn_PharmakonTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_991f48c2-dc61-46fc-b700-a77ce8711910" xlink:to="loc_sibn_PharmakonTermLoanMember_b1505f35-9e00-47ed-8211-6c9fa1ed2ad1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SolarLoanAndSecurityAgreementMember_5ceac5e3-5e3b-4f5b-8afa-a7edac7f36a3" xlink:href="sibn-20210930.xsd#sibn_SolarLoanAndSecurityAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_991f48c2-dc61-46fc-b700-a77ce8711910" xlink:to="loc_sibn_SolarLoanAndSecurityAgreementMember_5ceac5e3-5e3b-4f5b-8afa-a7edac7f36a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SVBTermLoanMember_c2162e3f-c4ed-4e2d-93df-ca190893805b" xlink:href="sibn-20210930.xsd#sibn_SVBTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_991f48c2-dc61-46fc-b700-a77ce8711910" xlink:to="loc_sibn_SVBTermLoanMember_c2162e3f-c4ed-4e2d-93df-ca190893805b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f2af75b5-c416-494c-b026-e58a3e04ebf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:to="loc_us-gaap_VariableRateAxis_f2af75b5-c416-494c-b026-e58a3e04ebf6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f2af75b5-c416-494c-b026-e58a3e04ebf6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f2af75b5-c416-494c-b026-e58a3e04ebf6" xlink:to="loc_us-gaap_VariableRateDomain_f2af75b5-c416-494c-b026-e58a3e04ebf6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e27166d3-55bd-47e8-b610-e76f035bacba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f2af75b5-c416-494c-b026-e58a3e04ebf6" xlink:to="loc_us-gaap_VariableRateDomain_e27166d3-55bd-47e8-b610-e76f035bacba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_VariableOptionOneMember_df82c543-7fe3-416b-bb09-31bf3e9c5629" xlink:href="sibn-20210930.xsd#sibn_VariableOptionOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_e27166d3-55bd-47e8-b610-e76f035bacba" xlink:to="loc_sibn_VariableOptionOneMember_df82c543-7fe3-416b-bb09-31bf3e9c5629" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_a92c8b28-837a-4300-97ac-900b25d03b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_e27166d3-55bd-47e8-b610-e76f035bacba" xlink:to="loc_us-gaap_PrimeRateMember_a92c8b28-837a-4300-97ac-900b25d03b5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7f437c52-4955-4cbd-a72d-956b1b0e0552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7f437c52-4955-4cbd-a72d-956b1b0e0552" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7f437c52-4955-4cbd-a72d-956b1b0e0552_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7f437c52-4955-4cbd-a72d-956b1b0e0552" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7f437c52-4955-4cbd-a72d-956b1b0e0552_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0c2fa69f-8061-4bd3-a0a9-955f21944a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7f437c52-4955-4cbd-a72d-956b1b0e0552" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0c2fa69f-8061-4bd3-a0a9-955f21944a94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_100ec43a-12f4-437b-a4b4-6fffbe3d3d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0c2fa69f-8061-4bd3-a0a9-955f21944a94" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_100ec43a-12f4-437b-a4b4-6fffbe3d3d7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f6b6d89d-372d-40a3-a70b-b1ce75a4c290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0c2fa69f-8061-4bd3-a0a9-955f21944a94" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f6b6d89d-372d-40a3-a70b-b1ce75a4c290" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtPrepaymentPenaltyPeriodAxis_457da9bc-5aa8-40b1-8568-61578abd5b3e" xlink:href="sibn-20210930.xsd#sibn_DebtPrepaymentPenaltyPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:to="loc_sibn_DebtPrepaymentPenaltyPeriodAxis_457da9bc-5aa8-40b1-8568-61578abd5b3e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtPrepaymentPenaltyPeriodDomain_457da9bc-5aa8-40b1-8568-61578abd5b3e_default" xlink:href="sibn-20210930.xsd#sibn_DebtPrepaymentPenaltyPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sibn_DebtPrepaymentPenaltyPeriodAxis_457da9bc-5aa8-40b1-8568-61578abd5b3e" xlink:to="loc_sibn_DebtPrepaymentPenaltyPeriodDomain_457da9bc-5aa8-40b1-8568-61578abd5b3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtPrepaymentPenaltyPeriodDomain_57c3e095-3bec-46a9-82fb-f8bd4ae9c3fc" xlink:href="sibn-20210930.xsd#sibn_DebtPrepaymentPenaltyPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sibn_DebtPrepaymentPenaltyPeriodAxis_457da9bc-5aa8-40b1-8568-61578abd5b3e" xlink:to="loc_sibn_DebtPrepaymentPenaltyPeriodDomain_57c3e095-3bec-46a9-82fb-f8bd4ae9c3fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PrepaymentPenalty124MonthsMember_1376e5ca-dcfe-4b9d-b28e-011d63586ddc" xlink:href="sibn-20210930.xsd#sibn_PrepaymentPenalty124MonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sibn_DebtPrepaymentPenaltyPeriodDomain_57c3e095-3bec-46a9-82fb-f8bd4ae9c3fc" xlink:to="loc_sibn_PrepaymentPenalty124MonthsMember_1376e5ca-dcfe-4b9d-b28e-011d63586ddc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PrepaymentPenalty24MonthsOnMember_fadfd6f6-04e6-43c2-836b-2704b05e8b0a" xlink:href="sibn-20210930.xsd#sibn_PrepaymentPenalty24MonthsOnMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sibn_DebtPrepaymentPenaltyPeriodDomain_57c3e095-3bec-46a9-82fb-f8bd4ae9c3fc" xlink:to="loc_sibn_PrepaymentPenalty24MonthsOnMember_fadfd6f6-04e6-43c2-836b-2704b05e8b0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PrepaymentPenalty3148MonthsMember_bceefc1b-78a3-4d29-9496-1d8e9fcce0b2" xlink:href="sibn-20210930.xsd#sibn_PrepaymentPenalty3148MonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sibn_DebtPrepaymentPenaltyPeriodDomain_57c3e095-3bec-46a9-82fb-f8bd4ae9c3fc" xlink:to="loc_sibn_PrepaymentPenalty3148MonthsMember_bceefc1b-78a3-4d29-9496-1d8e9fcce0b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PrepaymentPenalty4960MonthsMember_cb46241e-1e93-4d8a-91d7-8ccd1642f957" xlink:href="sibn-20210930.xsd#sibn_PrepaymentPenalty4960MonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sibn_DebtPrepaymentPenaltyPeriodDomain_57c3e095-3bec-46a9-82fb-f8bd4ae9c3fc" xlink:to="loc_sibn_PrepaymentPenalty4960MonthsMember_cb46241e-1e93-4d8a-91d7-8ccd1642f957" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#StockBasedIncentiveCompensationPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails" xlink:type="extended" id="ice4d7b830b134f30a9dd9241b338be10_StockBasedIncentiveCompensationPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_4f93da8a-40d9-4aca-ba5f-94b24f9f7c65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_4f93da8a-40d9-4aca-ba5f-94b24f9f7c65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_99a1a019-1a32-4163-9cd7-768e09018e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_99a1a019-1a32-4163-9cd7-768e09018e04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_29a0a228-cf1e-4ca2-bf91-608d2557aeea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_29a0a228-cf1e-4ca2-bf91-608d2557aeea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase_83ca8bf5-ebe6-4461-99ff-38fe5974ae45" xlink:href="sibn-20210930.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase_83ca8bf5-ebe6-4461-99ff-38fe5974ae45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_71746044-7560-47bf-8137-f1170b9ce23d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_71746044-7560-47bf-8137-f1170b9ce23d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_9b157b8c-43aa-430b-ad88-d32b915caf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_9b157b8c-43aa-430b-ad88-d32b915caf2c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval_5b767672-7c4e-4510-8739-0b8cc08c4701" xlink:href="sibn-20210930.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval_5b767672-7c4e-4510-8739-0b8cc08c4701" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_bed8715c-7a54-4de9-a3fd-5d6c40f35bbc" xlink:href="sibn-20210930.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_bed8715c-7a54-4de9-a3fd-5d6c40f35bbc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_d2d144fb-4d23-4ed8-80f8-159c7fe09332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_d2d144fb-4d23-4ed8-80f8-159c7fe09332" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_851e5538-74a4-404d-a417-8a2fd17ac440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_851e5538-74a4-404d-a417-8a2fd17ac440" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_1b21747d-26a3-4e63-befa-b69ff43b97ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_1b21747d-26a3-4e63-befa-b69ff43b97ba" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcc90e63-6f92-4f2e-843e-8eeeea97cde0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcc90e63-6f92-4f2e-843e-8eeeea97cde0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_503c4f9a-803a-4ffe-8080-b70856e4ff3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcc90e63-6f92-4f2e-843e-8eeeea97cde0" xlink:to="loc_us-gaap_PlanNameAxis_503c4f9a-803a-4ffe-8080-b70856e4ff3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_503c4f9a-803a-4ffe-8080-b70856e4ff3f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_503c4f9a-803a-4ffe-8080-b70856e4ff3f" xlink:to="loc_us-gaap_PlanNameDomain_503c4f9a-803a-4ffe-8080-b70856e4ff3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d97c8fd5-3743-496a-abd7-74d713a05895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_503c4f9a-803a-4ffe-8080-b70856e4ff3f" xlink:to="loc_us-gaap_PlanNameDomain_d97c8fd5-3743-496a-abd7-74d713a05895" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_A2018EmployeeStockPurchasePlanMember_e33062cf-9d22-4083-ad91-5f3344b01ad5" xlink:href="sibn-20210930.xsd#sibn_A2018EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d97c8fd5-3743-496a-abd7-74d713a05895" xlink:to="loc_sibn_A2018EmployeeStockPurchasePlanMember_e33062cf-9d22-4083-ad91-5f3344b01ad5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ca48cbe5-9c70-43de-af60-f96eb68be7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcc90e63-6f92-4f2e-843e-8eeeea97cde0" xlink:to="loc_us-gaap_AwardTypeAxis_ca48cbe5-9c70-43de-af60-f96eb68be7cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ca48cbe5-9c70-43de-af60-f96eb68be7cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ca48cbe5-9c70-43de-af60-f96eb68be7cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ca48cbe5-9c70-43de-af60-f96eb68be7cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ae30237-1fea-48c2-b1d9-eaaba75cf8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ca48cbe5-9c70-43de-af60-f96eb68be7cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ae30237-1fea-48c2-b1d9-eaaba75cf8d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_78fa45f3-71e8-4f05-a48c-82a99b6e948d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ae30237-1fea-48c2-b1d9-eaaba75cf8d3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_78fa45f3-71e8-4f05-a48c-82a99b6e948d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4fb68350-99a9-4756-bc94-30fb1570f529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ae30237-1fea-48c2-b1d9-eaaba75cf8d3" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4fb68350-99a9-4756-bc94-30fb1570f529" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails" xlink:type="extended" id="iafcce5f33624429d98a05e4c98921caf_StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_05250cd7-b116-41b6-aafe-aa09860a2313" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_05250cd7-b116-41b6-aafe-aa09860a2313" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_04d83cb0-1fff-4f9b-a8eb-f718f4e68c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_04d83cb0-1fff-4f9b-a8eb-f718f4e68c99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_459fa68d-1b6b-40b6-a637-799f15393e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_459fa68d-1b6b-40b6-a637-799f15393e7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_b666d342-5cb2-4126-afb9-2feed7e827c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_b666d342-5cb2-4126-afb9-2feed7e827c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_19b0deb4-72ce-49de-b10b-e2ae97d050ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_19b0deb4-72ce-49de-b10b-e2ae97d050ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_06b464ef-a24f-45ba-bea9-431b39d45c34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_06b464ef-a24f-45ba-bea9-431b39d45c34" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_b8c6fe91-2527-4c7c-a65b-5f517805b6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_b8c6fe91-2527-4c7c-a65b-5f517805b6a9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7a8370e0-f4e9-49df-9a35-3881d041d81a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7a8370e0-f4e9-49df-9a35-3881d041d81a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2cc138-037f-4298-924f-3d5bd391f6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_05250cd7-b116-41b6-aafe-aa09860a2313" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2cc138-037f-4298-924f-3d5bd391f6d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_796f9481-13da-4768-af6e-1ef3d881b3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2cc138-037f-4298-924f-3d5bd391f6d6" xlink:to="loc_us-gaap_AwardTypeAxis_796f9481-13da-4768-af6e-1ef3d881b3ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_796f9481-13da-4768-af6e-1ef3d881b3ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_796f9481-13da-4768-af6e-1ef3d881b3ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_796f9481-13da-4768-af6e-1ef3d881b3ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05e50100-85af-4f75-957f-6e53accb9770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_796f9481-13da-4768-af6e-1ef3d881b3ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05e50100-85af-4f75-957f-6e53accb9770" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_81553e65-03d8-4ec7-9c2f-bc32d11d9ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05e50100-85af-4f75-957f-6e53accb9770" xlink:to="loc_us-gaap_EmployeeStockOptionMember_81553e65-03d8-4ec7-9c2f-bc32d11d9ccf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_57077068-b637-43f9-aced-47c3b6bef565" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2cc138-037f-4298-924f-3d5bd391f6d6" xlink:to="loc_srt_RangeAxis_57077068-b637-43f9-aced-47c3b6bef565" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_57077068-b637-43f9-aced-47c3b6bef565_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_57077068-b637-43f9-aced-47c3b6bef565" xlink:to="loc_srt_RangeMember_57077068-b637-43f9-aced-47c3b6bef565_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6355b515-56d9-4105-9de3-b62e98a03af5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_57077068-b637-43f9-aced-47c3b6bef565" xlink:to="loc_srt_RangeMember_6355b515-56d9-4105-9de3-b62e98a03af5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6cde5460-cf71-40a4-b263-a6ca23a0bef2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6355b515-56d9-4105-9de3-b62e98a03af5" xlink:to="loc_srt_MinimumMember_6cde5460-cf71-40a4-b263-a6ca23a0bef2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ac93a66f-3831-459a-9b19-fb11ef308b1e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6355b515-56d9-4105-9de3-b62e98a03af5" xlink:to="loc_srt_MaximumMember_ac93a66f-3831-459a-9b19-fb11ef308b1e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails" xlink:type="extended" id="i13b8ec553f024fa9bbeb460fcad6182f_StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de3177c5-d107-4f5a-a4c2-87a877cdaa0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3849413a-9028-4d8f-97db-63ebdaa58149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de3177c5-d107-4f5a-a4c2-87a877cdaa0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3849413a-9028-4d8f-97db-63ebdaa58149" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cbec94d3-d7bb-4c5c-a7d1-c2a54e898256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3849413a-9028-4d8f-97db-63ebdaa58149" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cbec94d3-d7bb-4c5c-a7d1-c2a54e898256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a69c9f4b-3371-4cc2-bbc7-15ffb53b44e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3849413a-9028-4d8f-97db-63ebdaa58149" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a69c9f4b-3371-4cc2-bbc7-15ffb53b44e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c392147b-9799-4c51-aa16-51c295c209d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3849413a-9028-4d8f-97db-63ebdaa58149" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c392147b-9799-4c51-aa16-51c295c209d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f26460c5-d72a-48da-bb3f-3162b82f6195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3849413a-9028-4d8f-97db-63ebdaa58149" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f26460c5-d72a-48da-bb3f-3162b82f6195" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e7e596c5-2c00-498b-939d-f7ceb1b83473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3339999d-3a45-43f4-bf85-2ee218b8b0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de3177c5-d107-4f5a-a4c2-87a877cdaa0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3339999d-3a45-43f4-bf85-2ee218b8b0e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a48cefe5-b347-4f0f-a00a-e877a0df1aef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3339999d-3a45-43f4-bf85-2ee218b8b0e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a48cefe5-b347-4f0f-a00a-e877a0df1aef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1f32db86-a8b4-4571-9be8-2be062518fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3339999d-3a45-43f4-bf85-2ee218b8b0e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1f32db86-a8b4-4571-9be8-2be062518fb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_219e6a12-7b1a-4027-bc97-9141752f8545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3339999d-3a45-43f4-bf85-2ee218b8b0e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_219e6a12-7b1a-4027-bc97-9141752f8545" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a4495154-33c0-4fec-ad16-4391869e34a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3339999d-3a45-43f4-bf85-2ee218b8b0e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a4495154-33c0-4fec-ad16-4391869e34a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c5d9e31e-ed9f-41ae-8b05-0d2d212c5770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0daa54d2-413b-4a46-b112-287366f47930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de3177c5-d107-4f5a-a4c2-87a877cdaa0e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0daa54d2-413b-4a46-b112-287366f47930" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f1be6b86-1854-4f87-bf8e-0d6b9c4d33f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0daa54d2-413b-4a46-b112-287366f47930" xlink:to="loc_us-gaap_AwardTypeAxis_f1be6b86-1854-4f87-bf8e-0d6b9c4d33f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1be6b86-1854-4f87-bf8e-0d6b9c4d33f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f1be6b86-1854-4f87-bf8e-0d6b9c4d33f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1be6b86-1854-4f87-bf8e-0d6b9c4d33f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd7a0679-98c3-468f-a871-905808f3915e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f1be6b86-1854-4f87-bf8e-0d6b9c4d33f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd7a0679-98c3-468f-a871-905808f3915e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5bb651b3-9855-4d39-8fe3-3505002adb91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd7a0679-98c3-468f-a871-905808f3915e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5bb651b3-9855-4d39-8fe3-3505002adb91" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails" xlink:type="extended" id="ie5d86a9ed4db45c791ffdf9b39a91a57_StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c9e210-c5bd-43b7-aec9-1bf8fe85437d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_87929450-456f-4701-aaf4-af12845f03cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c9e210-c5bd-43b7-aec9-1bf8fe85437d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_87929450-456f-4701-aaf4-af12845f03cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c49eb0-3ee8-4bc9-8c49-dae554a5f158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c9e210-c5bd-43b7-aec9-1bf8fe85437d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c49eb0-3ee8-4bc9-8c49-dae554a5f158" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bd901361-bfb1-4b1a-89ef-f64396e8389f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c49eb0-3ee8-4bc9-8c49-dae554a5f158" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bd901361-bfb1-4b1a-89ef-f64396e8389f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bd901361-bfb1-4b1a-89ef-f64396e8389f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bd901361-bfb1-4b1a-89ef-f64396e8389f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bd901361-bfb1-4b1a-89ef-f64396e8389f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e7ac29c3-c588-48a7-aba9-af8389a2defa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bd901361-bfb1-4b1a-89ef-f64396e8389f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e7ac29c3-c588-48a7-aba9-af8389a2defa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c65c88b1-d579-4bbd-923c-4f0b6a34d584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e7ac29c3-c588-48a7-aba9-af8389a2defa" xlink:to="loc_us-gaap_CostOfSalesMember_c65c88b1-d579-4bbd-923c-4f0b6a34d584" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_f5920735-8c1c-4f0a-a7ab-ac38ff0b32ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e7ac29c3-c588-48a7-aba9-af8389a2defa" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_f5920735-8c1c-4f0a-a7ab-ac38ff0b32ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c068a31c-9f47-4795-ba22-38345b5f34a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e7ac29c3-c588-48a7-aba9-af8389a2defa" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c068a31c-9f47-4795-ba22-38345b5f34a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5e72cbc2-9ccd-4542-ab90-543227294654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e7ac29c3-c588-48a7-aba9-af8389a2defa" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5e72cbc2-9ccd-4542-ab90-543227294654" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails" xlink:type="extended" id="i23eb6fe5aced488cad1c3e13d0b6674b_NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1f10fa19-cd0f-4b67-a4c5-7c28c4ebe510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b2597e91-b771-4833-9335-2d3097549889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1f10fa19-cd0f-4b67-a4c5-7c28c4ebe510" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b2597e91-b771-4833-9335-2d3097549889" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fe90ae25-ca31-45b9-a2c6-7f0d4a68aa48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1f10fa19-cd0f-4b67-a4c5-7c28c4ebe510" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fe90ae25-ca31-45b9-a2c6-7f0d4a68aa48" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0637b2b4-072d-4e9d-92f6-482cb70c7874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fe90ae25-ca31-45b9-a2c6-7f0d4a68aa48" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0637b2b4-072d-4e9d-92f6-482cb70c7874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0637b2b4-072d-4e9d-92f6-482cb70c7874_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0637b2b4-072d-4e9d-92f6-482cb70c7874" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0637b2b4-072d-4e9d-92f6-482cb70c7874_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ddcd3b7-d1ad-4373-bac9-01a11ebb2b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0637b2b4-072d-4e9d-92f6-482cb70c7874" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ddcd3b7-d1ad-4373-bac9-01a11ebb2b4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_31b13b92-8ae9-4002-8dca-c6eded668e43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ddcd3b7-d1ad-4373-bac9-01a11ebb2b4a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_31b13b92-8ae9-4002-8dca-c6eded668e43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_12a3a83d-60f2-4265-b138-bc5ab07dd0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ddcd3b7-d1ad-4373-bac9-01a11ebb2b4a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_12a3a83d-60f2-4265-b138-bc5ab07dd0ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareSubjectToRepurchaseMember_19e2a3f0-44f8-43cc-b2e6-6760253b4689" xlink:href="sibn-20210930.xsd#sibn_ShareSubjectToRepurchaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ddcd3b7-d1ad-4373-bac9-01a11ebb2b4a" xlink:to="loc_sibn_ShareSubjectToRepurchaseMember_19e2a3f0-44f8-43cc-b2e6-6760253b4689" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_EmployeeStockPurchasePlanSharesMember_a32ef80e-ba41-48c4-9d2d-8dd408122296" xlink:href="sibn-20210930.xsd#sibn_EmployeeStockPurchasePlanSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ddcd3b7-d1ad-4373-bac9-01a11ebb2b4a" xlink:to="loc_sibn_EmployeeStockPurchasePlanSharesMember_a32ef80e-ba41-48c4-9d2d-8dd408122296" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_CommonStockWarrantsMember_2ac9907c-4e62-4fc9-a9d4-73f146223681" xlink:href="sibn-20210930.xsd#sibn_CommonStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ddcd3b7-d1ad-4373-bac9-01a11ebb2b4a" xlink:to="loc_sibn_CommonStockWarrantsMember_2ac9907c-4e62-4fc9-a9d4-73f146223681" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://si-bone.com/role/RelatedPartyTransactionDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#RelatedPartyTransactionDetails"/>
  <link:definitionLink xlink:role="http://si-bone.com/role/RelatedPartyTransactionDetails" xlink:type="extended" id="i27f25b0fe526442ba12a1cb9f6643d06_RelatedPartyTransactionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_39f89cdb-e187-4a3f-8b5f-b18a09c17410" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_e1dee89d-87a6-4d55-9c92-f3530e3b8ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_39f89cdb-e187-4a3f-8b5f-b18a09c17410" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_e1dee89d-87a6-4d55-9c92-f3530e3b8ebc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_3dcd2d56-14f7-449b-8800-4f85d0fd50ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_39f89cdb-e187-4a3f-8b5f-b18a09c17410" xlink:to="loc_us-gaap_DueToAffiliateCurrent_3dcd2d56-14f7-449b-8800-4f85d0fd50ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_RelatedPartyTransactionTermOfAgreement_0ff25e6e-9cbe-4375-8ece-b49c1aea6c78" xlink:href="sibn-20210930.xsd#sibn_RelatedPartyTransactionTermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_39f89cdb-e187-4a3f-8b5f-b18a09c17410" xlink:to="loc_sibn_RelatedPartyTransactionTermOfAgreement_0ff25e6e-9cbe-4375-8ece-b49c1aea6c78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f63d004f-3a41-4776-b174-6f04d228d4f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_39f89cdb-e187-4a3f-8b5f-b18a09c17410" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f63d004f-3a41-4776-b174-6f04d228d4f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7dfada8f-8572-472f-8285-0eda152c7467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f63d004f-3a41-4776-b174-6f04d228d4f6" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7dfada8f-8572-472f-8285-0eda152c7467" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7dfada8f-8572-472f-8285-0eda152c7467_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7dfada8f-8572-472f-8285-0eda152c7467" xlink:to="loc_us-gaap_RelatedPartyDomain_7dfada8f-8572-472f-8285-0eda152c7467_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7f0cda2a-aff9-4007-aac4-966f90774a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7dfada8f-8572-472f-8285-0eda152c7467" xlink:to="loc_us-gaap_RelatedPartyDomain_7f0cda2a-aff9-4007-aac4-966f90774a17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_e901d902-3e16-4976-96e3-19be4e8b0abc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_7f0cda2a-aff9-4007-aac4-966f90774a17" xlink:to="loc_srt_AffiliatedEntityMember_e901d902-3e16-4976-96e3-19be4e8b0abc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_bcc13b03-ea38-4344-9799-d2e40bc077c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f63d004f-3a41-4776-b174-6f04d228d4f6" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_bcc13b03-ea38-4344-9799-d2e40bc077c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_bcc13b03-ea38-4344-9799-d2e40bc077c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_bcc13b03-ea38-4344-9799-d2e40bc077c1" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_bcc13b03-ea38-4344-9799-d2e40bc077c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_ac5c9544-47ca-4b35-afa9-a67849c714cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_bcc13b03-ea38-4344-9799-d2e40bc077c1" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_ac5c9544-47ca-4b35-afa9-a67849c714cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DevelopmentAgreementMember_338ae50f-f365-46a0-ba18-d255d8e3fdd1" xlink:href="sibn-20210930.xsd#sibn_DevelopmentAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ac5c9544-47ca-4b35-afa9-a67849c714cb" xlink:to="loc_sibn_DevelopmentAgreementMember_338ae50f-f365-46a0-ba18-d255d8e3fdd1" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>sibn-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c8537e76-3d0d-41fe-8011-c02f9e3c1997,g:6717da7c-7375-4e6f-9fbf-fa93aabe50cb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_sibn_VestingOfEarlyExercisedStockOptions_9206e85e-3c59-4e46-9523-b611a9cf15c5_terseLabel_en-US" xlink:label="lab_sibn_VestingOfEarlyExercisedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of early exercised stock options</link:label>
    <link:label id="lab_sibn_VestingOfEarlyExercisedStockOptions_label_en-US" xlink:label="lab_sibn_VestingOfEarlyExercisedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Of Early Exercised Stock Options</link:label>
    <link:label id="lab_sibn_VestingOfEarlyExercisedStockOptions_documentation_en-US" xlink:label="lab_sibn_VestingOfEarlyExercisedStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of Early Exercised Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_VestingOfEarlyExercisedStockOptions" xlink:href="sibn-20210930.xsd#sibn_VestingOfEarlyExercisedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_VestingOfEarlyExercisedStockOptions" xlink:to="lab_sibn_VestingOfEarlyExercisedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f71aaee3-021e-4e9f-a472-20f80dca781d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_647a787d-eb59-420d-b5e2-342b1a17a291_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c9d1eb9-e0d7-4142-a7ff-311297df7fd7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_1b82728a-2ca3-4132-a131-e6ff4b9e2766_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_55f8df81-788d-4600-bc94-9d4a64ca0541_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c3735262-59f1-41d8-897f-7e82eb36767a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3ba8b799-20cf-4489-b773-7da3a09b8320_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_561c51c9-0258-4d48-b39b-b72865246e63_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_d602d84b-ed50-4566-99bf-33bb960d3147_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_4fea50d4-b574-443e-8713-7ba8418e7187_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_9e11d6f8-bb7f-4ecd-9b2b-fa70e22eacec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d894b605-b8e4-4da3-9c25-3187fbe1b7dc_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_0fa4bc4b-951b-40db-8974-46622b5754be_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_3646372f-a9db-4c42-b164-d4ee49d98348_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_6d88df06-4614-484f-bb2b-ecf69a3a17e3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Principal and Final Fee Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_e198fab6-0e5a-42b3-bfb4-97b5fa093f0e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_57f54c37-d1ac-491f-8bbd-e2e83eddc011_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_063e74c8-a99e-4391-99d7-c8cc2bb615de_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_3f9c5fcf-7364-4f57-a922-5e84c1d06e27_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5299926b-4a24-4ad7-b658-d8c712d01dc2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ca5b3cfe-4b90-404c-b4b4-4b89a39776bf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b96461f5-60bd-44d4-856a-d964b3c42287_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_9a7016d6-fbf4-4aa4-a30e-9433c8c427a7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_263566d9-51f9-4551-a10e-75266bc9c9f0_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_cf64ba92-6199-4278-ae02-9d0f1c8f9675_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursement charges expensed</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_bd5d120e-30f7-454f-9700-daa50eb72380_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DebtPrepaymentPenaltyPeriodDomain_2c645751-345b-467e-940c-c6f1a2118e07_terseLabel_en-US" xlink:label="lab_sibn_DebtPrepaymentPenaltyPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Prepayment Penalty, Period [Domain]</link:label>
    <link:label id="lab_sibn_DebtPrepaymentPenaltyPeriodDomain_label_en-US" xlink:label="lab_sibn_DebtPrepaymentPenaltyPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Prepayment Penalty, Period [Domain]</link:label>
    <link:label id="lab_sibn_DebtPrepaymentPenaltyPeriodDomain_documentation_en-US" xlink:label="lab_sibn_DebtPrepaymentPenaltyPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Debt, Prepayment Penalty, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtPrepaymentPenaltyPeriodDomain" xlink:href="sibn-20210930.xsd#sibn_DebtPrepaymentPenaltyPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DebtPrepaymentPenaltyPeriodDomain" xlink:to="lab_sibn_DebtPrepaymentPenaltyPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_8c2f205d-0259-4804-8dc8-02d9cb067ca3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (remaining three months)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_71cd6e62-3900-4246-bb59-b093a1f83d7c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_b7a358df-3363-490a-8fd9-beaec6f579af_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs to defend lawsuits or settle claims</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_22c31601-584f-4d1f-99d6-ce05fb1ed07f_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaturitiesOfLongTermDebtAbstract_96425efd-323d-447b-b907-514a97b6aa77_terseLabel_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future principal and final fee payments</link:label>
    <link:label id="lab_us-gaap_MaturitiesOfLongTermDebtAbstract_label_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Long-term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:to="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a1eb1cf3-9617-438d-9e27-6776a2590ffd_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock equivalents excluded from computation of diluted net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_a2834caf-d19d-4493-bd77-55ccfd32cd27_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_EmployeeStockPurchasePlanSharesMember_42ccbc10-a4f2-4b04-bec4-1f59e70751ab_verboseLabel_en-US" xlink:label="lab_sibn_EmployeeStockPurchasePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP purchase rights</link:label>
    <link:label id="lab_sibn_EmployeeStockPurchasePlanSharesMember_label_en-US" xlink:label="lab_sibn_EmployeeStockPurchasePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Shares [Member]</link:label>
    <link:label id="lab_sibn_EmployeeStockPurchasePlanSharesMember_documentation_en-US" xlink:label="lab_sibn_EmployeeStockPurchasePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_EmployeeStockPurchasePlanSharesMember" xlink:href="sibn-20210930.xsd#sibn_EmployeeStockPurchasePlanSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_EmployeeStockPurchasePlanSharesMember" xlink:to="lab_sibn_EmployeeStockPurchasePlanSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_1fb35d6a-3dc0-4459-b587-0cd80781060e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember_8fbaeaef-a1e5-4947-b42f-8db5d501ab83_terseLabel_en-US" xlink:label="lab_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress, surgical placement instrument set</link:label>
    <link:label id="lab_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember_label_en-US" xlink:label="lab_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Surgical Placement Instrument Set [Member]</link:label>
    <link:label id="lab_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember_documentation_en-US" xlink:label="lab_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Surgical Placement Instrument Set</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember" xlink:href="sibn-20210930.xsd#sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember" xlink:to="lab_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_04d7baba-87d2-4193-842d-f4c10be0620a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_707fcc9f-ba15-4d3d-b9d0-32b9918a0117_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2e8d7984-dc06-46a0-b751-edae1e0360d3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_8c9ae32a-2f6b-4b27-99db-a88801746495_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_a235e99a-09a1-4925-a7ed-a69f1f6493db_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_974fbd9f-0d37-4441-bfbb-48fe7b7fd9da_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_32fdfd64-f10d-40db-9931-ea250565127d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_913d8403-34dc-45a2-93c8-404699b8a131_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4ef33a61-7285-49e6-816b-6b5783f5dd1d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_c005d9d6-e01f-4870-82c8-fb252bc06aae_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_3be8645d-cc5d-4388-b6c1-76a1b6e64cd2_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_2c0ccde1-71ed-466a-ad72-6118efa1a155_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_319bec1a-ad86-4f6b-9c67-3a2dd9b6a0b5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_70fbe40d-7142-4c73-9dec-05d71841f244_terseLabel_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New lease, area (in square feet)</link:label>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_label_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of Real Estate Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfRealEstateProperty" xlink:to="lab_us-gaap_AreaOfRealEstateProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_53328726-9c9b-4c1a-93dc-ab13caa5a13e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis_92010554-1c39-41c5-8ae3-0a1c8056824f_totalLabel_en-US" xlink:label="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis_label_en-US" xlink:label="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Debt Securities, Current, Amortized Cost Basis</link:label>
    <link:label id="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis_documentation_en-US" xlink:label="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Debt Securities, Current, Amortized Cost Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" xlink:href="sibn-20210930.xsd#sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" xlink:to="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_4388ded8-080d-40f5-beec-901c693f756d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1e86558a-2b7a-47f3-8132-3f81f12c2421_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_98c2a4eb-089d-4d38-a4cc-68140d95f003_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_34eb6427-4687-42fd-8dd5-f4790abef8c9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_SocialSecurityTaxEmployerDeferralCARESAct_2c31f122-42f3-4de0-8a79-934531e2ee43_terseLabel_en-US" xlink:label="lab_sibn_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other</link:label>
    <link:label id="lab_sibn_SocialSecurityTaxEmployerDeferralCARESAct_label_en-US" xlink:label="lab_sibn_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:label id="lab_sibn_SocialSecurityTaxEmployerDeferralCARESAct_documentation_en-US" xlink:label="lab_sibn_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SocialSecurityTaxEmployerDeferralCARESAct" xlink:href="sibn-20210930.xsd#sibn_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_SocialSecurityTaxEmployerDeferralCARESAct" xlink:to="lab_sibn_SocialSecurityTaxEmployerDeferralCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_4f4794f3-dc45-43a4-b99a-fa9731a4e666_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_3e24dc1e-b592-4351-bb2a-1deea9a8f9a7_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_013fd1b2-4c74-43a7-9f55-4b9ac1354edf_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_0b3a9977-17a8-480b-b460-c923e7bcff58_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrimeRateMember_0de33359-c082-4004-8efe-354fa713995f_terseLabel_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:label id="lab_us-gaap_PrimeRateMember_label_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrimeRateMember" xlink:to="lab_us-gaap_PrimeRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_dc9e7e6c-8ab5-4b87-9ba6-30f9d0083464_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_1b6b9853-230c-4278-b84d-b8fdac82c7dd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f917083d-4271-466c-b8d4-6232fe3b22c5_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cba6404e-2cd7-4aa5-b19c-80d7b5bd1a56_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6f46e860-eae3-4397-adbe-752b070c32f3_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_24b35b57-1551-492c-8c8b-1cccea5f58df_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a7f214e4-053b-46ef-96c7-e027cdf155fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_3b9c31ba-4480-4b64-bb82-77ee52183e87_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_PrepaymentPenalty3148MonthsMember_aa3d9d61-aef7-44b8-a460-33c849147ae4_terseLabel_en-US" xlink:label="lab_sibn_PrepaymentPenalty3148MonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment Penalty, 31-48 Months</link:label>
    <link:label id="lab_sibn_PrepaymentPenalty3148MonthsMember_label_en-US" xlink:label="lab_sibn_PrepaymentPenalty3148MonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment Penalty, 31-48 Months [Member]</link:label>
    <link:label id="lab_sibn_PrepaymentPenalty3148MonthsMember_documentation_en-US" xlink:label="lab_sibn_PrepaymentPenalty3148MonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment Penalty, 31-48 Months [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PrepaymentPenalty3148MonthsMember" xlink:href="sibn-20210930.xsd#sibn_PrepaymentPenalty3148MonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_PrepaymentPenalty3148MonthsMember" xlink:to="lab_sibn_PrepaymentPenalty3148MonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_449e6009-9378-47cc-9de7-281a0ad749e9_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_7f4fc0da-6fd6-48ef-8b19-36cabec05eb6_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_54af3d9d-1ec5-4e15-9fe0-b23041a17638_verboseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract_d9ac87e8-ccc8-4e73-a35c-0063b5004f90_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract_98e47630-fe49-4df4-8222-e627b6c3127f_verboseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_f1bf76d7-c5fc-4249-b24e-059ea609dd62_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_878088d9-c9fb-4ff4-b3a0-1fb4f051ab8f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal outstanding and final fee</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_7ee81036-96da-4412-a8a7-f09b6dc308d0_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total principal and final fee payments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_8f1774ed-b92f-406f-932e-9a55ac3423ef_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_17136586-f2c4-4ae1-8240-5e66f0fcd18d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_da5ab70e-d56a-490f-9322-6f7e443923ed_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding debt, net of debt issuance costs and unaccreted value of final fee</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_e028ba51-0ede-4ad6-83c6-f975b9e6d922_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d022e476-68e6-4ba0-a7c8-c8e570c97918_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_ba276020-be82-44cd-a142-9038a937a625_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_26a0d2bc-9c9a-49d7-abcc-231c86bfd47e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_0cff423f-97a9-4055-a93e-d8c7aa295644_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal_01711e86-5f7b-4e72-a36b-c86242d85409_terseLabel_en-US" xlink:label="lab_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Final fee as percentage of aggregate principal amount (percent)</link:label>
    <link:label id="lab_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal_label_en-US" xlink:label="lab_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount As Percentage Of Aggregate Principal</link:label>
    <link:label id="lab_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal_documentation_en-US" xlink:label="lab_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount As Percentage Of Aggregate Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" xlink:to="lab_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_2d25edcb-f8a3-409a-845d-0e29cdf08dff_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_891f00bc-7b77-4681-b850-f3484f042bf6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_1794e2d4-3ea0-48fa-8459-016442f0c2ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income (expense), net:</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_fac947bf-13f2-433e-a8f6-b0e8dbfccbd0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a8e769d8-1671-48f5-b96e-19aa2de624d1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_74470d48-e107-457f-8cc6-d94c8872a23c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_7f5de077-3487-4d67-b2ca-940f12165a99_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_89afca5b-1153-4930-a223-828dd530d689_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_04c564f5-e5ca-4cf5-b0db-2ee325060be0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_49c89925-151a-450e-9527-bb5c5a607f39_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share of Common Stock</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_c7cedba5-9fdf-498a-8362-7d5e592d9454_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_281887d1-f7f4-4e66-8711-faa548b32da6_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ec072233-d654-4173-a4fa-9e517eb01cd4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options, net of shares withheld</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_0cb16a19-f1e8-434b-99b1-ab3740650d94_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_11a6517c-5fd3-471d-958e-b58887c762fc_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeaSpine</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_SecondFollowOnPublicOfferingMember_38786cba-df83-41ea-9382-0fa6f5e5700a_terseLabel_en-US" xlink:label="lab_sibn_SecondFollowOnPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second follow-on public offering</link:label>
    <link:label id="lab_sibn_SecondFollowOnPublicOfferingMember_label_en-US" xlink:label="lab_sibn_SecondFollowOnPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Follow On Public Offering [Member]</link:label>
    <link:label id="lab_sibn_SecondFollowOnPublicOfferingMember_documentation_en-US" xlink:label="lab_sibn_SecondFollowOnPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Follow On Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SecondFollowOnPublicOfferingMember" xlink:href="sibn-20210930.xsd#sibn_SecondFollowOnPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_SecondFollowOnPublicOfferingMember" xlink:to="lab_sibn_SecondFollowOnPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_83ad5642-62e6-49b9-a742-38f7d073e173_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9ac555d2-fc72-4ef7-8dda-323aa7e12cbb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_5c8897f0-a22e-4002-9eff-d3e7b5cf70cc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_00d602ef-0e61-4912-9d65-93bf4ab6b8a9_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_6f9b097b-7ca4-4452-8fce-44e64601752e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_f71aac6e-6828-4755-8e16-cf8bf0f471fb_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_aedade93-7d88-446e-ba27-3cd8eaef7e70_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_847da07b-337e-453c-a494-222381c0e736_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ConstructionInProgressSantaClaraLeaseMember_65b3f0ea-c158-4066-bef0-f0cee65878ec_terseLabel_en-US" xlink:label="lab_sibn_ConstructionInProgressSantaClaraLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress, Santa Clara lease</link:label>
    <link:label id="lab_sibn_ConstructionInProgressSantaClaraLeaseMember_label_en-US" xlink:label="lab_sibn_ConstructionInProgressSantaClaraLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Santa Clara Lease [Member]</link:label>
    <link:label id="lab_sibn_ConstructionInProgressSantaClaraLeaseMember_documentation_en-US" xlink:label="lab_sibn_ConstructionInProgressSantaClaraLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Santa Clara Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ConstructionInProgressSantaClaraLeaseMember" xlink:href="sibn-20210930.xsd#sibn_ConstructionInProgressSantaClaraLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ConstructionInProgressSantaClaraLeaseMember" xlink:to="lab_sibn_ConstructionInProgressSantaClaraLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e64a9c47-01ef-4220-9c7a-632ae2fa78d2_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_7ed71ee0-56c0-4696-a3f2-2c91262b6a45_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a032da4e-e26c-4337-a90b-fa3090f854f2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_505cf8e3-659b-4486-bfc8-0ea1a7aada36_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from public offering, net of underwriting discounts, commissions and offering costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_912f3010-23c1-4d33-8a1f-f6aed5f21308_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_4350b261-b672-4f0b-bf6d-e664ee9ef32e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_329b35d7-1c9e-4554-9e49-1ef86562a929_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_8c05551a-e4f1-4640-a5af-bd93a54acb01_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4303e98f-98a8-4fa6-ab2f-fa3600f4378f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Incentive Compensation Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_712fc63c-075d-499b-a6e9-512bcdebc2ea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_7f06b518-de06-4624-b1d0-bca8fefbee54_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2a31b0f6-b5eb-411e-a637-0c66ba2d4063_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from public offering, net of underwriting discounts, commissions and offering costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_cec5e820-a5ef-4fda-bc33-4fc930e95dfd_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_b9fd07bb-011f-4b73-a6fd-511c12b38e71_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional services</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_9abc4278-9d15-4b55-92ee-4b7d00913859_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value; 100,000,000 shares authorized; 33,450,995 and 32,583,220 shares issued and outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_eae5b1f1-09f0-4232-87ff-24bb04fa2c51_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c70acf02-d85d-4c7a-8f00-eec9e5ed633f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost, expected period for recognition (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_42450a32-7a9b-407a-acc9-67ee18f28e56_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_295746c2-caff-4030-a465-4d92dd62e7ba_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4b4ccbf2-d47d-4315-84d8-50b8c3a65fde_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_fec462bd-046c-4ed4-a7d0-c51d04a22984_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 6)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0defcae3-3125-4ec9-8287-b6481c41a618_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_04a459d0-eec4-4c5c-a677-049340537563_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DebtPrepaymentPenaltyPeriodAxis_71e029d7-da83-4ed6-b843-c60f18efb0a9_terseLabel_en-US" xlink:label="lab_sibn_DebtPrepaymentPenaltyPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Prepayment Penalty, Period [Axis]</link:label>
    <link:label id="lab_sibn_DebtPrepaymentPenaltyPeriodAxis_label_en-US" xlink:label="lab_sibn_DebtPrepaymentPenaltyPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Prepayment Penalty, Period [Axis]</link:label>
    <link:label id="lab_sibn_DebtPrepaymentPenaltyPeriodAxis_documentation_en-US" xlink:label="lab_sibn_DebtPrepaymentPenaltyPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Prepayment Penalty, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtPrepaymentPenaltyPeriodAxis" xlink:href="sibn-20210930.xsd#sibn_DebtPrepaymentPenaltyPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DebtPrepaymentPenaltyPeriodAxis" xlink:to="lab_sibn_DebtPrepaymentPenaltyPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_880e6692-704e-4654-bcfa-f8c6f9544b27_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_e5bec07d-ca99-4c57-86fa-fb73be7fcba8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_27af650f-4682-47d1-9f09-56745e3da6f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Valuation Assumptions Related to Stock Option Awards</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_cd9ed2b6-dd68-4bd4-826c-9e1dc558dfa9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_edc37156-527f-47b9-a9d1-7570427b294a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_cd95683c-4df4-4d68-ae1a-c25a088c5beb_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b8993aba-6935-4ee9-a48f-a9bb14f9d516_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1ceee7f4-9efa-45e9-af6f-356c9b702c5e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_MarketableSecuritiesFairValue_f35152d9-ab7e-4c2a-9ac3-2fb15d1ff38c_terseLabel_en-US" xlink:label="lab_sibn_MarketableSecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total marketable securities, Aggregate Fair Value</link:label>
    <link:label id="lab_sibn_MarketableSecuritiesFairValue_label_en-US" xlink:label="lab_sibn_MarketableSecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Fair Value</link:label>
    <link:label id="lab_sibn_MarketableSecuritiesFairValue_documentation_en-US" xlink:label="lab_sibn_MarketableSecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total aggregate fair value for marketable securities included in cash equivalents and investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesFairValue" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_MarketableSecuritiesFairValue" xlink:to="lab_sibn_MarketableSecuritiesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_0506cb3f-e826-4125-8f0e-cb811bf8b360_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Geography</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_4b403158-5804-4cb8-8240-b0a7f653678e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6c5b7c91-29a8-46f7-a1b5-83c146ecd565_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_dc1eb47f-bd8e-4dcc-a8b1-7d0e988eddf3_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from sale of stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_5bdcc790-2df0-47bd-9da3-b45fc0e592c0_terseLabel_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of purchase periods in offering interval</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_label_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_documentation_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:href="sibn-20210930.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:to="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5738e5c4-1ea2-4542-a8c8-a403032c9fe9_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_99923e09-0f1a-4e55-a0a4-8e834a59bef7_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_59230401-4b1a-47ee-b719-44a5ea19e774_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_d1611ed7-8c89-40ef-8bf8-7a9974d5d386_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f91472ad-89ec-47a5-893c-8ce04ba4baa0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_VariableOptionOneMember_9c62ce90-bc58-4a32-b8c6-8626e7533822_terseLabel_en-US" xlink:label="lab_sibn_VariableOptionOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread option</link:label>
    <link:label id="lab_sibn_VariableOptionOneMember_label_en-US" xlink:label="lab_sibn_VariableOptionOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Option One [Member]</link:label>
    <link:label id="lab_sibn_VariableOptionOneMember_documentation_en-US" xlink:label="lab_sibn_VariableOptionOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Option One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_VariableOptionOneMember" xlink:href="sibn-20210930.xsd#sibn_VariableOptionOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_VariableOptionOneMember" xlink:to="lab_sibn_VariableOptionOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_460ca1ed-e884-42a3-85c9-a9b8d86a0d1e_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_cd174e2a-8ec4-456f-b63e-7580ee7ca66c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_4bce55cc-7aab-45f8-87ff-c5f9677283bc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_71d1b368-0d15-4f9b-894d-e58d8ad1d04a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_992ab27b-a0d1-4cd9-8747-1aa4c2dfe602_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_4ab31206-80be-49bc-8dde-b2e568c1f616_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f747d483-b5c1-451d-8b56-0ad2ef427dff_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2fca25f8-a6ba-44f5-a828-7665681a04be_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement_4528b8dd-5102-4905-b8e0-4f553159be61_terseLabel_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowable prepayment increments per agreement</link:label>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement_label_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment, Allowable Increments Per Agreement</link:label>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement_documentation_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment, Allowable Increments Per Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement" xlink:to="lab_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ede2b37e-a31c-4edb-a9b6-db02f30bd353_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_41e07658-1485-4bc0-8266-902d32858bea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_c5e47ac6-476d-4abb-b993-192ee5621f75_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_b49f6e09-2630-42b3-8116-57e92e299a57_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e40e5369-1054-468b-937d-ba1cb6774486_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_5982f6f8-abf1-4e72-83d1-00f9ffcb511a_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_7d331dfe-884d-4506-97bf-290443bea679_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_ba35b36d-01b1-4c6d-9f63-c61b2b28b362_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_2de51945-232a-45b7-adbd-44d262d4c99b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Unit Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_cdb93fbc-e84e-4332-a674-f734007c6a72_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_735ab963-259d-4d4f-979b-417e2c0d2b74_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_9d43191d-575a-485d-884e-ce2874a8ee36_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_954e49e4-dbe7-4ecb-add8-f022783906a5_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_fdb7b6e5-80cb-43d3-8f4b-00bff1fe91f4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_841a23a6-8d3b-4b30-afec-74826686a1e7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_3bf29f2a-8646-495b-9f8c-6f19644bcabe_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_FollowOnPublicOfferingAndSecondaryOfferingMember_e3da6aaa-4ae0-4ad0-bf4d-da2c99cd0f09_terseLabel_en-US" xlink:label="lab_sibn_FollowOnPublicOfferingAndSecondaryOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First follow-on public offering and secondary offering</link:label>
    <link:label id="lab_sibn_FollowOnPublicOfferingAndSecondaryOfferingMember_label_en-US" xlink:label="lab_sibn_FollowOnPublicOfferingAndSecondaryOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow On Public Offering And Secondary Offering [Member]</link:label>
    <link:label id="lab_sibn_FollowOnPublicOfferingAndSecondaryOfferingMember_documentation_en-US" xlink:label="lab_sibn_FollowOnPublicOfferingAndSecondaryOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow On Public Offering And Secondary Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_FollowOnPublicOfferingAndSecondaryOfferingMember" xlink:href="sibn-20210930.xsd#sibn_FollowOnPublicOfferingAndSecondaryOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_FollowOnPublicOfferingAndSecondaryOfferingMember" xlink:to="lab_sibn_FollowOnPublicOfferingAndSecondaryOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_f886dc7d-6dfc-460a-8ffc-b9069cebc7bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of prepayment penalty and lender fees</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_24624d64-4f9c-4f94-bc66-14267e3152d4_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of prepayment penalty and lender fees</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_aea2ee7e-ca0c-4f73-becd-60f6a46c9d1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities and Other</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_954ea405-2f23-4606-9456-d6719ff63473_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d352b3cf-2896-4b31-8b0f-d56b06076572_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering_0416b250-1457-4115-b241-9b61ef0ffbee_terseLabel_en-US" xlink:label="lab_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares in transaction, including shares in secondary offering (in shares)</link:label>
    <link:label id="lab_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering_label_en-US" xlink:label="lab_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Number Of Shares Issued In Transaction, Including Shares In Secondary Offering</link:label>
    <link:label id="lab_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering_documentation_en-US" xlink:label="lab_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Number Of Shares Issued In Transaction, Including Shares In Secondary Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering" xlink:href="sibn-20210930.xsd#sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering" xlink:to="lab_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_41f356bb-7729-488a-b5d7-fcc740fe22ac_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_fde19405-558d-4b2a-8392-60c853757bb3_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity, beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_0b3c4bdd-d62f-4b4f-91cc-d8729254867b_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity, end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_3e7b88bf-570d-4c96-b931-6150d7bcf82f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_a8098396-8b9f-4929-aad6-c0701208ab6a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_d647c696-8747-4255-9080-12a99a1ddb79_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Future Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_40ef9b54-1274-4542-b222-6173e024382b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage_c9231fab-3c32-4515-8bc9-6613df33fe42_terseLabel_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment premium in year two (percent)</link:label>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage_label_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Premium Year Two, Percentage</link:label>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage_documentation_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Premium Year Two, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage" xlink:to="lab_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_fd6b82fc-e690-4cb1-aa02-cec7e53d9032_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_42e24abc-2c7b-4c5d-8d08-4f8e3ee110cc_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash information</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_91e92145-c610-455f-8583-addc79d86958_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_ac128a2d-6e93-490b-8fbe-812da54676d7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, minimum (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_d91b4811-8503-4dff-9f11-f5c54d24171f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_7b3743c4-5a37-4c1b-bdfd-e783873adce1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_fc1f602a-8522-4ada-a203-4fce4759b119_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_e4d8b45d-1d16-4b55-b95c-2305cb4d1ffa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, maximum (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_e8ed309f-a946-4558-b815-9223c9c4fda6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_86f3ea70-8d40-4bf4-88ec-2537e7ff9954_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1f03f4ad-a3f9-4170-8c9b-a87819db9e31_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_1c1f1fa1-0986-4fe3-bd83-34ef968acbac_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_bcd31dcc-24da-4a99-8227-5e479a6c350b_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_42a88aa1-978c-4439-994c-dc4b6a2b7b0c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7c7f3d44-f719-4f96-a0dc-3dd51c1daec6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock related to employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_d6d0aeff-27bb-49b7-a743-5f698f638468_terseLabel_en-US" xlink:label="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and related expenses for employee payroll deductions</link:label>
    <link:label id="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock_3780a014-7b92-4968-8b91-b6ebe32c41ba_terseLabel_en-US" xlink:label="lab_sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JOBS Act Accounting Election</link:label>
    <link:label id="lab_sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock_label_en-US" xlink:label="lab_sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company, Extended Transition Period Policy [Policy Text Block]</link:label>
    <link:label id="lab_sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company, Extended Transition Period Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock" xlink:href="sibn-20210930.xsd#sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock" xlink:to="lab_sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_9a0dc087-396b-4fc6-aa73-41cc848d98b1_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. treasury securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_8c6e5dc6-0c2d-4bd7-82c8-03c31dc6094a_verboseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. treasury securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_1d48a9c9-096e-4ba8-b115-35b2d03043a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_6593c386-1523-4521-b143-9774d2a16244_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DevelopmentAgreementMember_c74528ce-3f03-48d8-b93b-acf977fe2486_terseLabel_en-US" xlink:label="lab_sibn_DevelopmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint development agreement</link:label>
    <link:label id="lab_sibn_DevelopmentAgreementMember_label_en-US" xlink:label="lab_sibn_DevelopmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreement [Member]</link:label>
    <link:label id="lab_sibn_DevelopmentAgreementMember_documentation_en-US" xlink:label="lab_sibn_DevelopmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DevelopmentAgreementMember" xlink:href="sibn-20210930.xsd#sibn_DevelopmentAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DevelopmentAgreementMember" xlink:to="lab_sibn_DevelopmentAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_90f4d131-9f00-48a3-8416-f4ad22f03965_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_042146e9-2453-4383-a50a-a0a996b4a6a0_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_OperatingLeaseTermOfWrittenNoticeForTermination_2bf47fd3-77d3-40a0-a9b7-e288f3c10463_terseLabel_en-US" xlink:label="lab_sibn_OperatingLeaseTermOfWrittenNoticeForTermination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term of written notice for termination</link:label>
    <link:label id="lab_sibn_OperatingLeaseTermOfWrittenNoticeForTermination_label_en-US" xlink:label="lab_sibn_OperatingLeaseTermOfWrittenNoticeForTermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Term Of Written Notice For Termination</link:label>
    <link:label id="lab_sibn_OperatingLeaseTermOfWrittenNoticeForTermination_documentation_en-US" xlink:label="lab_sibn_OperatingLeaseTermOfWrittenNoticeForTermination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Term Of Written Notice For Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_OperatingLeaseTermOfWrittenNoticeForTermination" xlink:href="sibn-20210930.xsd#sibn_OperatingLeaseTermOfWrittenNoticeForTermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_OperatingLeaseTermOfWrittenNoticeForTermination" xlink:to="lab_sibn_OperatingLeaseTermOfWrittenNoticeForTermination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_bc21973c-282f-4188-9669-a0b46fef5080_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for doubtful accounts of $264 and $263, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_26819715-0ea1-4d53-9e50-f3266aade514_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt financing</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_19c1225c-de78-4f92-bd26-d2bf3164ba3e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_06d24a90-0704-49f1-99e8-e6b6ef0e07be_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_FollowOnPublicOfferingMember_5507cb41-4ccf-4a32-9acf-d8b0aaf0d473_terseLabel_en-US" xlink:label="lab_sibn_FollowOnPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First follow-on public offering</link:label>
    <link:label id="lab_sibn_FollowOnPublicOfferingMember_label_en-US" xlink:label="lab_sibn_FollowOnPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow On Public Offering [Member]</link:label>
    <link:label id="lab_sibn_FollowOnPublicOfferingMember_documentation_en-US" xlink:label="lab_sibn_FollowOnPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow On Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_FollowOnPublicOfferingMember" xlink:href="sibn-20210930.xsd#sibn_FollowOnPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_FollowOnPublicOfferingMember" xlink:to="lab_sibn_FollowOnPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_04087f83-2645-41ab-ab28-ef2f09220f89_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentPenaltyPercentage_85fb2a7f-469f-42fe-b585-f2e4d15df069_terseLabel_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentPenaltyPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt prepayment penalty percentage (percent)</link:label>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentPenaltyPercentage_label_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentPenaltyPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty Percentage</link:label>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentPenaltyPercentage_documentation_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentPenaltyPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentPenaltyPercentage" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentPenaltyPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DebtInstrumentPrepaymentPenaltyPercentage" xlink:to="lab_sibn_DebtInstrumentPrepaymentPenaltyPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_282f1a25-064f-44e4-b1c7-383b78946f30_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_61ba0a2a-14fa-4861-a426-bf92f4d3eb5d_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_139f0b9f-326b-4e18-a38a-910292518fb9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_9e422959-82b6-4ee6-bf46-1cf6e77982dc_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_37197313-d87e-4de6-b873-f3bf687c54e3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_75a65dd7-6b9f-44b9-975b-1681187576c7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_eaf30c4c-8f98-4dc8-ba66-8edb7a6937ea_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_818b97eb-57fd-4fd7-9376-a3e735563105_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_33668d01-7894-49f9-8c28-9d360bcc7dbe_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_63daa61a-ff3e-404c-85a5-58d237d218dc_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost, stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_aeb1a1da-6536-464a-b470-8d31537bfdbc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4cd074cd-3943-447d-8d3f-05e43fd2b7d3_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_2b10ac24-e22d-4546-b418-9542041e9c76_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_eeafaa74-299b-4fcd-bc73-2b035343e7c6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod_fdc0ce53-2396-4ba0-a2e1-db3a731e2ea1_terseLabel_en-US" xlink:label="lab_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt period payment, interest only period</link:label>
    <link:label id="lab_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod_label_en-US" xlink:label="lab_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Interest Only Period</link:label>
    <link:label id="lab_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod_documentation_en-US" xlink:label="lab_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Interest Only Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod" xlink:to="lab_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_058e474c-4276-40b1-be63-38d2f7ad0a88_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e1aaa38a-acf3-4a46-be35-f50913a5e7df_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_3f61b731-c681-4f49-a5e0-ff97d1accf02_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ProceedsFromMaturityOfMarketableSecurities_ce4ce66d-26fa-46a9-b4c7-7a9f313ba8dc_terseLabel_en-US" xlink:label="lab_sibn_ProceedsFromMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of marketable securities</link:label>
    <link:label id="lab_sibn_ProceedsFromMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_sibn_ProceedsFromMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Maturity Of Marketable Securities</link:label>
    <link:label id="lab_sibn_ProceedsFromMaturityOfMarketableSecurities_documentation_en-US" xlink:label="lab_sibn_ProceedsFromMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Maturity Of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ProceedsFromMaturityOfMarketableSecurities" xlink:href="sibn-20210930.xsd#sibn_ProceedsFromMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ProceedsFromMaturityOfMarketableSecurities" xlink:to="lab_sibn_ProceedsFromMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_78fb5934-1a2e-4f98-ad2c-7f38bc978fce_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_65c4949d-00fa-4bc6-86ad-d0daa8c76436_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_76097321-fcb2-47ba-9701-2238378b76df_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_c9f5cd97-67d0-454a-9756-10902fefdf39_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3559d0e1-77ef-4b5a-aa9f-a39c2d740ab6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_f8376150-04c4-45ed-a540-765acf96c283_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_7e323679-8f5c-4527-a09a-f38e4d594a15_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_09ba1ee6-1d4a-46b8-a88f-1d1b99a21e59_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding liability to SeaSpine</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_07e72e9e-5dcf-431c-ad0d-c863620da1d1_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities and Other</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_fbff84a8-8d50-48f2-9b3f-0826f50739ba_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_38c652af-9da5-4ecc-b0ba-69594bced082_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_aaa58cb1-8181-49e7-b93a-002197462584_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock as a percent of fair market value (percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_b62840b9-d960-484c-a947-c45a0fce00f3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_SVBTermLoanMember_b36d2da0-9ceb-440e-8cf6-b3b79ea17f72_terseLabel_en-US" xlink:label="lab_sibn_SVBTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SVB Term Loan</link:label>
    <link:label id="lab_sibn_SVBTermLoanMember_label_en-US" xlink:label="lab_sibn_SVBTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SVB Term Loan [Member]</link:label>
    <link:label id="lab_sibn_SVBTermLoanMember_documentation_en-US" xlink:label="lab_sibn_SVBTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SVB Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SVBTermLoanMember" xlink:href="sibn-20210930.xsd#sibn_SVBTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_SVBTermLoanMember" xlink:to="lab_sibn_SVBTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_533f469a-ab9c-413e-ac63-03c57918fe1b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_74e2886d-f73b-4062-83bc-ae798e54d180_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_9b84f47a-a0d8-411d-b635-7de7f4bb597a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval_ac04a0d9-5aa8-411e-818b-0aed2400d865_terseLabel_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase program offering period interval (in months)</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval_label_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period Interval</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval_documentation_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period Interval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" xlink:href="sibn-20210930.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" xlink:to="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_234ac76f-35e5-47f3-b60c-4e5f464c5717_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4946897c-b788-4b54-b2d0-a124044888fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d6003896-f246-4ae0-b8e2-c257fb3166fd_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_ebb93836-2070-46ec-b773-c24181632cca_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e93af519-cb56-48e0-b829-fd05cc59f9f4_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_A2018EmployeeStockPurchasePlanMember_5a8e94b2-fa0c-4e28-a3d4-a407500470f6_terseLabel_en-US" xlink:label="lab_sibn_A2018EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 ESPP</link:label>
    <link:label id="lab_sibn_A2018EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_sibn_A2018EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A2018 Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_sibn_A2018EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_sibn_A2018EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A2018 Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_A2018EmployeeStockPurchasePlanMember" xlink:href="sibn-20210930.xsd#sibn_A2018EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_A2018EmployeeStockPurchasePlanMember" xlink:to="lab_sibn_A2018EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ComputerAndOfficeEquipmentMember_f16c88d6-59fd-4fd3-9dfc-cddb275e07bd_terseLabel_en-US" xlink:label="lab_sibn_ComputerAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and office equipment</link:label>
    <link:label id="lab_sibn_ComputerAndOfficeEquipmentMember_label_en-US" xlink:label="lab_sibn_ComputerAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer And Office Equipment [Member]</link:label>
    <link:label id="lab_sibn_ComputerAndOfficeEquipmentMember_documentation_en-US" xlink:label="lab_sibn_ComputerAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer And Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ComputerAndOfficeEquipmentMember" xlink:href="sibn-20210930.xsd#sibn_ComputerAndOfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ComputerAndOfficeEquipmentMember" xlink:to="lab_sibn_ComputerAndOfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_71aa94e5-8962-453d-bee6-df767feaa2b1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from follow-on public offering, net of underwriting discounts, commissions and offering costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_6e9cc407-9894-4d85-8ed9-fce6f8687b2f_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_5c6267a4-6670-4213-a59f-dd808feeaa46_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_67ede7f7-6186-4ac0-9ea1-d227146e3b10_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_SolarLoanAndSecurityAgreementMember_c990ebd9-2008-464a-99e1-608a19b6f947_terseLabel_en-US" xlink:label="lab_sibn_SolarLoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Solar Term Loan</link:label>
    <link:label id="lab_sibn_SolarLoanAndSecurityAgreementMember_label_en-US" xlink:label="lab_sibn_SolarLoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Solar Loan and Security Agreement [Member]</link:label>
    <link:label id="lab_sibn_SolarLoanAndSecurityAgreementMember_documentation_en-US" xlink:label="lab_sibn_SolarLoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Solar Loan and Security Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SolarLoanAndSecurityAgreementMember" xlink:href="sibn-20210930.xsd#sibn_SolarLoanAndSecurityAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_SolarLoanAndSecurityAgreementMember" xlink:to="lab_sibn_SolarLoanAndSecurityAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_42627ef8-ec09-4121-8deb-8e5a5382a6ce_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_e28c4bd8-e37d-44ec-8931-6d52e78773ed_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_bcbff50d-1194-4d6a-9bbc-02752d36777b_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_5e0edb15-f9a9-44db-8855-1911262183bf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_PharmakonTermLoanMember_06555763-e3c4-4efc-9d2b-87e7a3fc91f9_terseLabel_en-US" xlink:label="lab_sibn_PharmakonTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmakon Term Loan</link:label>
    <link:label id="lab_sibn_PharmakonTermLoanMember_label_en-US" xlink:label="lab_sibn_PharmakonTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmakon Term Loan [Member]</link:label>
    <link:label id="lab_sibn_PharmakonTermLoanMember_documentation_en-US" xlink:label="lab_sibn_PharmakonTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmakon Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PharmakonTermLoanMember" xlink:href="sibn-20210930.xsd#sibn_PharmakonTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_PharmakonTermLoanMember" xlink:to="lab_sibn_PharmakonTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_PrepaymentPenalty124MonthsMember_599abe78-977d-4443-809b-265bd5bd3e57_terseLabel_en-US" xlink:label="lab_sibn_PrepaymentPenalty124MonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment Penalty, 1-24 Months</link:label>
    <link:label id="lab_sibn_PrepaymentPenalty124MonthsMember_label_en-US" xlink:label="lab_sibn_PrepaymentPenalty124MonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment Penalty, 1-24 Months [Member]</link:label>
    <link:label id="lab_sibn_PrepaymentPenalty124MonthsMember_documentation_en-US" xlink:label="lab_sibn_PrepaymentPenalty124MonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment Penalty, 1-24 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PrepaymentPenalty124MonthsMember" xlink:href="sibn-20210930.xsd#sibn_PrepaymentPenalty124MonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_PrepaymentPenalty124MonthsMember" xlink:to="lab_sibn_PrepaymentPenalty124MonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a98c012e-86da-4194-978c-f5c340082034_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_a6078089-82fc-46a5-a3aa-8b84e6d7830b_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_52870a31-2411-4506-a111-2c2bbe4a9f48_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_a1e6026b-cc2e-45a3-9540-e2f378a8dcc1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f023d28-3e73-4191-b133-9947dc14a054_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_875d0f49-b7e5-4dd6-aefb-d45bdf0bfdb9_verboseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1dd4ba03-63a2-4669-aff3-59c67b285b71_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_5e8e6da1-c4e0-443b-91ea-7f8c1e6e2cc9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b0a2ec95-b18c-40e6-b7ff-f8998a2b8ca4_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_b2d57e48-d164-461f-9680-762ef23afa73_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_1ede3078-facc-4c4b-8143-055284608cdb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaccreted value of final fee</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_56e7ddef-9512-4f86-93cf-c390bf163b04_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Final fee</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a26f4bf8-bb0d-42b8-a60b-d7b8b0bba65d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of common shares used to compute basic net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_fa01ce58-4c2c-49ce-a002-deff57f31c51_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_f0815b46-6952-4f65-98e4-3905e69de11a_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public offering price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax_ec4b5e9f-b9c9-44f9-a6c2-f94024e67055_terseLabel_en-US" xlink:label="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Debt Securities, Current, Accumulated Gross Unrealized Gain Before Tax</link:label>
    <link:label id="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Debt Securities, Current, Accumulated Gross Unrealized Gain Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="sibn-20210930.xsd#sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_16cb792b-58c6-4489-b6a9-2571fe2f12a3_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_91024146-e2ef-4e3d-8900-135cf8e665e9_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage_e13a3c3b-e838-40de-b1cb-06e3eca6d8d9_terseLabel_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment premium in year one (percent)</link:label>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage_label_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Premium Year One, Percentage</link:label>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage_documentation_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Premium Year One, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage" xlink:to="lab_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase_ff0850bb-dcd3-43bf-81f2-485271ab44fc_terseLabel_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early exercise of stock options, share subject to repurchase (in shares)</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase_label_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Early Exercise, Common Stock Subject To Repurchase</link:label>
    <link:label id="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase_documentation_en-US" xlink:label="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Early Exercise, Common Stock Subject To Repurchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" xlink:href="sibn-20210930.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" xlink:to="lab_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_74f2ea95-d0a3-4db6-8efc-c7a24408262c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_42b78f21-c5f0-4376-ad68-56ef558335cf_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_MarketableSecuritiesAmortizedCost_abff9279-769c-4d7f-a872-354dc0d9d5a2_totalLabel_en-US" xlink:label="lab_sibn_MarketableSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total marketable securities, Amortized Cost</link:label>
    <link:label id="lab_sibn_MarketableSecuritiesAmortizedCost_label_en-US" xlink:label="lab_sibn_MarketableSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Amortized Cost</link:label>
    <link:label id="lab_sibn_MarketableSecuritiesAmortizedCost_documentation_en-US" xlink:label="lab_sibn_MarketableSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total amortized cost for marketable securities included in cash equivalents and investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAmortizedCost" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_MarketableSecuritiesAmortizedCost" xlink:to="lab_sibn_MarketableSecuritiesAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_80280840-1a5b-46d7-a3b2-681d49ea5ee5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_PrepaymentPenalty24MonthsOnMember_926c710a-18e0-4919-aeae-04317ee2efc5_terseLabel_en-US" xlink:label="lab_sibn_PrepaymentPenalty24MonthsOnMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment Penalty, 24 Months On</link:label>
    <link:label id="lab_sibn_PrepaymentPenalty24MonthsOnMember_label_en-US" xlink:label="lab_sibn_PrepaymentPenalty24MonthsOnMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment Penalty, 24 Months On [Member]</link:label>
    <link:label id="lab_sibn_PrepaymentPenalty24MonthsOnMember_documentation_en-US" xlink:label="lab_sibn_PrepaymentPenalty24MonthsOnMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment Penalty, 24 Months On</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PrepaymentPenalty24MonthsOnMember" xlink:href="sibn-20210930.xsd#sibn_PrepaymentPenalty24MonthsOnMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_PrepaymentPenalty24MonthsOnMember" xlink:to="lab_sibn_PrepaymentPenalty24MonthsOnMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_7f197672-a961-40b0-8725-60c6020b14a5_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_a9cf2071-8760-430a-a233-23001702c4c9_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_a0caad2d-00ad-441b-bc5e-7af26112bfd2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ProceedsFromSaleOfMarketableSecurities_eb68425f-34ad-428e-8e33-30201e386aff_terseLabel_en-US" xlink:label="lab_sibn_ProceedsFromSaleOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of marketable securities</link:label>
    <link:label id="lab_sibn_ProceedsFromSaleOfMarketableSecurities_label_en-US" xlink:label="lab_sibn_ProceedsFromSaleOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Marketable Securities</link:label>
    <link:label id="lab_sibn_ProceedsFromSaleOfMarketableSecurities_documentation_en-US" xlink:label="lab_sibn_ProceedsFromSaleOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ProceedsFromSaleOfMarketableSecurities" xlink:href="sibn-20210930.xsd#sibn_ProceedsFromSaleOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ProceedsFromSaleOfMarketableSecurities" xlink:to="lab_sibn_ProceedsFromSaleOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_91c5361e-ed4a-4f11-b725-d8626fbbbee9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_f9c1b619-edf0-45cf-982a-c4f1992785dc_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_28adb213-f35e-49bf-9d95-4a4bee283942_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Marketable Securities Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_27df46db-5d06-4505-9717-f74070a8fd3c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_2bd223a8-e80f-4f05-9b68-cf5e4c05d4ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_e0a95d06-7e7b-43f1-b2db-baaf77ddc0f0_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTable" xlink:to="lab_us-gaap_MarketableSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_47154ce0-2308-488f-9925-f231cfb645a1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f5109d4f-3dc1-43eb-abe5-2ecaa69615fc_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_540f1789-c8ee-4d52-8113-af0b2245b4c0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2021</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_e6fb5173-170c-47a3-80ad-6e11a492e379_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax_e4c584f8-ba13-411b-aea4-827f7aa973b6_negatedTerseLabel_en-US" xlink:label="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Debt Securities, Current, Accumulated Gross Unrealized Loss Before Tax</link:label>
    <link:label id="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Debt Securities, Current, Accumulated Gross Unrealized Loss Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="sibn-20210930.xsd#sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_12ed58b9-8589-42b5-8f5d-8e3d41a6b2f6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_96796d21-ddd6-40ae-8cac-acf100b76192_terseLabel_en-US" xlink:label="lab_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total marketable securities, Unrealized Gains</link:label>
    <link:label id="lab_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:label id="lab_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_33233720-7cf3-4146-b395-f706c9b78a45_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1_1651dad0-738c-442f-bbbc-0dbf79a13d7d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optional lease renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_835f0048-b529-47e5-86bc-e84a372b3610_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_050d5ffe-5b2a-4cde-90bf-3dedd697d642_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_RelatedPartyTransactionTermOfAgreement_87d98f28-23ba-4691-a649-38153d872624_terseLabel_en-US" xlink:label="lab_sibn_RelatedPartyTransactionTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of product royalty sales period (in years)</link:label>
    <link:label id="lab_sibn_RelatedPartyTransactionTermOfAgreement_label_en-US" xlink:label="lab_sibn_RelatedPartyTransactionTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Term Of Agreement</link:label>
    <link:label id="lab_sibn_RelatedPartyTransactionTermOfAgreement_documentation_en-US" xlink:label="lab_sibn_RelatedPartyTransactionTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Term Of Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_RelatedPartyTransactionTermOfAgreement" xlink:href="sibn-20210930.xsd#sibn_RelatedPartyTransactionTermOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_RelatedPartyTransactionTermOfAgreement" xlink:to="lab_sibn_RelatedPartyTransactionTermOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_7f9812cc-426b-4735-9c58-188079fd3758_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4a6c3cc9-ea18-4e11-9634-1e1a002473a6_negatedTerseLabel_en-US" xlink:label="lab_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total marketable securities, Unrealized Losses</link:label>
    <link:label id="lab_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:label id="lab_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage_03e0ee5f-364e-4705-a60e-3df12df2cdee_terseLabel_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment premium in year three or later (percent)</link:label>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage_label_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Premium Year Three Or Later, Percentage</link:label>
    <link:label id="lab_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage_documentation_en-US" xlink:label="lab_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Premium Year Three Or Later, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage" xlink:to="lab_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3435e7ae-8336-4f63-86ca-ef5ab9626797_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_325c4dd7-f6c3-455c-b931-7532a2254e0b_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_583cdb8f-32c7-46ea-b273-0b505958e8c1_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_854f626e-7b71-460a-b82d-e162a48a20fd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend_d6b67459-10df-47e8-8b8c-cedf4ab4dbf4_terseLabel_en-US" xlink:label="lab_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease renewal, number of options to renew</link:label>
    <link:label id="lab_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend_label_en-US" xlink:label="lab_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Options To Extend</link:label>
    <link:label id="lab_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend_documentation_en-US" xlink:label="lab_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Options To Extend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend" xlink:href="sibn-20210930.xsd#sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend" xlink:to="lab_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_1e3a62bf-a2c1-4b69-b414-56f5519ae410_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Outstanding Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_7965df56-9358-42ae-a041-5ff9e76b643d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_ad5dd2cd-5c5a-4567-afa4-94358fe66bf1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt financing</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_06e60d0f-9d64-4bc7-b7d8-c1f4a5412372_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_c65e2b6e-729b-4877-886a-573de730bdd3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_28a2cf05-8ca0-40aa-92d1-4f9011daec1d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_fbd2ce01-442d-49b2-b50f-4dbc3e302427_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_6edbc80c-968d-4082-ae62-44013a4cb5fb_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_1b41be58-e61a-4620-ba0f-45ef90506118_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_bc9c4708-3675-45b3-87dc-f342b849acf1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Aggregate Future Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b08fdbeb-8d55-4553-992e-f2b5a6a4246c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d18f748a-68b1-4416-8cd9-41327eb56532_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_65ff5af0-36ae-4d70-8a4d-ef743c07dba9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits_83334332-4181-405a-b82e-f5498cea210c_terseLabel_en-US" xlink:label="lab_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon vesting of restricted stock units (in shares)</link:label>
    <link:label id="lab_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits_label_en-US" xlink:label="lab_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period Shares Restricted Stock Units</link:label>
    <link:label id="lab_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits_documentation_en-US" xlink:label="lab_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period Shares Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits" xlink:href="sibn-20210930.xsd#sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits" xlink:to="lab_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_c2e78729-9919-4a7f-bb0f-b25dee9d3d69_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_f952244f-b53c-42da-bed7-ecaa799a356b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bf2168f6-8af4-4b0e-8510-25575f0f6182_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_dc62399a-2b70-4f6d-acfa-ba2d04b2de08_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_bcd29f81-14f8-45ec-8e1e-bcb9d0f11964_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_e05189df-3308-491f-a629-692ff84d4719_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, minimum (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_8c27a82a-ef78-4e27-95c8-d8df44eab3d9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions_cbdde43b-e532-406d-b7e1-b6361f0ca725_terseLabel_en-US" xlink:label="lab_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of early exercised stock options</link:label>
    <link:label id="lab_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions_label_en-US" xlink:label="lab_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Share-based Compensation, Vesting Of Early Exercised Stock Options</link:label>
    <link:label id="lab_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions_documentation_en-US" xlink:label="lab_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Share-based Compensation, Vesting Of Early Exercised Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" xlink:href="sibn-20210930.xsd#sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" xlink:to="lab_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndemnificationGuaranteeMember_b2d05080-2e41-43e1-aff2-825f0087ce53_terseLabel_en-US" xlink:label="lab_us-gaap_IndemnificationGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Agreement</link:label>
    <link:label id="lab_us-gaap_IndemnificationGuaranteeMember_label_en-US" xlink:label="lab_us-gaap_IndemnificationGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndemnificationGuaranteeMember" xlink:to="lab_us-gaap_IndemnificationGuaranteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_584abdda-b2f7-4776-a087-60592f0073ea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (amortization) of discount on marketable securities</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_SecondaryOfferingMember_8ae6cb66-05a5-4a27-9228-ae89793e9d76_terseLabel_en-US" xlink:label="lab_sibn_SecondaryOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secondary offering by selling shareholders</link:label>
    <link:label id="lab_sibn_SecondaryOfferingMember_label_en-US" xlink:label="lab_sibn_SecondaryOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secondary Offering [Member]</link:label>
    <link:label id="lab_sibn_SecondaryOfferingMember_documentation_en-US" xlink:label="lab_sibn_SecondaryOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secondary Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SecondaryOfferingMember" xlink:href="sibn-20210930.xsd#sibn_SecondaryOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_SecondaryOfferingMember" xlink:to="lab_sibn_SecondaryOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_9a300ef1-c342-48ba-a88a-e1c698fc3572_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_0410ef67-6964-4553-95fc-b3d60b2fd565_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_88c452b9-50c8-492b-b4ef-2e8812404269_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale and disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_337eb92d-3e10-4cb6-8550-f4162ee8c565_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d2865087-c395-4382-a9eb-492828bb6898_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_d5148c9b-199d-4741-b02c-cf97a2c8c85d_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_518ca28d-e82f-4b32-b2d4-8f474c50c414_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_1fd2394b-0296-4849-a677-bc50ff0e94ab_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_0454f6e3-2863-4482-95d3-118717865c60_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, maximum (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_bb1383fb-2302-4042-b6c6-032247ba94c3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_148f82d5-4e84-4f0b-b632-31938de5e1f4_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_843cfb88-2a68-4d68-8938-d8d50ecfed68_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_05724714-ad58-44c5-999e-b12695a68ace_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options, net of shares withheld (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_20bd77c7-44aa-4165-a9a6-e292eea7d976_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_32ae01ff-4ccf-443c-bead-52c1ebd92a3b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of common shares used to compute diluted net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_fc6cd32a-f705-41d4-919a-d1ccfbd6526a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_c3eba5ea-ad41-43a4-8368-bec22d43fe96_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability associated with indemnifications</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_f7789525-cc85-4e21-818c-a1cf7177bab7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_c43e3ddd-185f-4f93-a54e-ffdc488b1e91_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriters option</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_f27074a3-0e86-40c4-a325-a7542dda3015_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_099505d0-57c6-437a-a073-547470a2dab7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_d5d209fe-beb3-4da4-a194-a7ead4f1617b_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e5dd6a38-6eae-44aa-821d-a6e7880313fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_69ae35b2-62d8-4eb0-8f20-12ff0dc91fd0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_8bd4eab1-a1f7-4970-ae02-6acc2271952f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Anti-dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_45427fed-368f-47c5-918b-ea624abb0004_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesRealizedGainLoss_e66d4368-ccc0-4b71-babd-9f31a923b1a0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized gain on marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:to="lab_us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_CommonStockWarrantsMember_b5dc6170-14ff-4851-bc71-08a88d83192f_terseLabel_en-US" xlink:label="lab_sibn_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock warrants</link:label>
    <link:label id="lab_sibn_CommonStockWarrantsMember_label_en-US" xlink:label="lab_sibn_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants [Member]</link:label>
    <link:label id="lab_sibn_CommonStockWarrantsMember_documentation_en-US" xlink:label="lab_sibn_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_CommonStockWarrantsMember" xlink:href="sibn-20210930.xsd#sibn_CommonStockWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_CommonStockWarrantsMember" xlink:to="lab_sibn_CommonStockWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_7eb3dfca-b028-4ddf-a351-591bf4b9084e_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase commitments related to inventory management and training materials</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_e98a2051-3d1c-4602-835c-e11a2a42d468_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1b5addd2-81ee-4995-b1c9-9ab3c39b8dba_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b1552829-55ec-4c05-b35e-f3f899fc5898_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_8a94e2de-106e-401c-b31e-9511510d61b2_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems" xlink:to="lab_us-gaap_MarketableSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_204bc137-970a-4979-9370-bfcf87c124b9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock related to employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_7e7d0c8f-ce09-4cfd-b405-58d1dda02ecd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_cecabdf8-2d5a-4678-b3ac-acd0cdb03747_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gain (loss) on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2b07ca5-961e-4d6c-8c2a-a41f1142a477_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3ff902b7-5203-4ce3-9123-d265bafb92b3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_7967d240-f16b-420a-bd1b-eb851b7ce148_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate during the period (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_55ecaed5-181d-48e4-b3b6-45e9b0765f20_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_cd706e98-3318-4bae-961f-90dd35d15642_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c759753e-8920-4c31-9985-1835b4f40829_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_e17ac8d7-b8dc-44f6-bb85-79ac8afb2cde_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour_f5de32da-1ce3-44b3-b044-912e4a7876cd_terseLabel_en-US" xlink:label="lab_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour_label_en-US" xlink:label="lab_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due After Year Four</link:label>
    <link:label id="lab_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour_documentation_en-US" xlink:label="lab_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour" xlink:href="sibn-20210930.xsd#sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour" xlink:to="lab_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_0baa5ca9-73c2-4714-a73f-61fb6c73627d_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_74ccc6cc-eb4f-40d3-b83b-05f5b84160d0_verboseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_ShareSubjectToRepurchaseMember_5cc31c88-eecf-4027-a271-d3ed82ee9bcb_terseLabel_en-US" xlink:label="lab_sibn_ShareSubjectToRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares subject to repurchase</link:label>
    <link:label id="lab_sibn_ShareSubjectToRepurchaseMember_label_en-US" xlink:label="lab_sibn_ShareSubjectToRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Subject To Repurchase [Member]</link:label>
    <link:label id="lab_sibn_ShareSubjectToRepurchaseMember_documentation_en-US" xlink:label="lab_sibn_ShareSubjectToRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Subject To Repurchase [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareSubjectToRepurchaseMember" xlink:href="sibn-20210930.xsd#sibn_ShareSubjectToRepurchaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_ShareSubjectToRepurchaseMember" xlink:to="lab_sibn_ShareSubjectToRepurchaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_061c31f1-5f0d-47d8-99a8-b74faafd79e7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_1c5a49c8-0cf7-4a0f-85df-0e00ec2a4417_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_82be5a50-9e7e-4743-810d-410309df42a2_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_de5b8b92-ba04-4f6c-b133-36fe238b1614_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_3bb358ba-608a-4028-be07-639202b85878_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_8e72cbcb-307b-4075-b87d-627d04b2d4f9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_cac454cf-afd8-4844-a65a-6da48d7d5ba7_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued Accounting Standards Not Yet Effective</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_2f2acca3-d1ec-4a01-93ae-7ca713bbd850_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Black-Scholes option-pricing model assumptions</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_77a5f9b9-eaea-4454-808c-7f71c2adc8c0_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_89fc523e-3e19-4cd1-8eae-9e4d19676159_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_b9b5e647-fa67-432c-80cf-f00384ab249a_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_AllocatedPublicOfferingCosts_318541d1-5da5-46f3-bae3-cad08467e95a_terseLabel_en-US" xlink:label="lab_sibn_AllocatedPublicOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated public offering costs</link:label>
    <link:label id="lab_sibn_AllocatedPublicOfferingCosts_label_en-US" xlink:label="lab_sibn_AllocatedPublicOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated Public Offering Costs</link:label>
    <link:label id="lab_sibn_AllocatedPublicOfferingCosts_documentation_en-US" xlink:label="lab_sibn_AllocatedPublicOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated Public Offering Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AllocatedPublicOfferingCosts" xlink:href="sibn-20210930.xsd#sibn_AllocatedPublicOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_AllocatedPublicOfferingCosts" xlink:to="lab_sibn_AllocatedPublicOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_93de81d2-faba-482d-a69b-63abe319b89f_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Company and Nature of Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_sibn_PrepaymentPenalty4960MonthsMember_469e8e2a-0979-430d-9e09-086b1f4d59c0_terseLabel_en-US" xlink:label="lab_sibn_PrepaymentPenalty4960MonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment Penalty, 49-60 Months</link:label>
    <link:label id="lab_sibn_PrepaymentPenalty4960MonthsMember_label_en-US" xlink:label="lab_sibn_PrepaymentPenalty4960MonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment Penalty, 49-60 Months [Member]</link:label>
    <link:label id="lab_sibn_PrepaymentPenalty4960MonthsMember_documentation_en-US" xlink:label="lab_sibn_PrepaymentPenalty4960MonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment Penalty, 49-60 Months [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PrepaymentPenalty4960MonthsMember" xlink:href="sibn-20210930.xsd#sibn_PrepaymentPenalty4960MonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sibn_PrepaymentPenalty4960MonthsMember" xlink:to="lab_sibn_PrepaymentPenalty4960MonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_6bc4311c-dc10-4046-9ac2-20d67b477207_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_88f226e7-7fd8-476f-8c25-c097e02f5de3_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>sibn-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c8537e76-3d0d-41fe-8011-c02f9e3c1997,g:6717da7c-7375-4e6f-9fbf-fa93aabe50cb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://si-bone.com/role/Cover" xlink:type="simple" xlink:href="sibn-20210930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3a695939-4ea7-41fd-af31-2e4cf2c273f4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_DocumentType_3a695939-4ea7-41fd-af31-2e4cf2c273f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_baffb40a-f661-48ce-a23d-781f70544908" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_DocumentQuarterlyReport_baffb40a-f661-48ce-a23d-781f70544908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_96586a3f-668c-4bb6-8149-c46326db4c2c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_DocumentPeriodEndDate_96586a3f-668c-4bb6-8149-c46326db4c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_512fe61a-b870-4e05-8044-4ce96e503622" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_DocumentTransitionReport_512fe61a-b870-4e05-8044-4ce96e503622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_92a49fa5-f104-4d0d-9d29-f594369c1fcf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityFileNumber_92a49fa5-f104-4d0d-9d29-f594369c1fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_ba37b60d-98ad-42aa-8c91-0935e5ca2b25" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityRegistrantName_ba37b60d-98ad-42aa-8c91-0935e5ca2b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2b58bc60-9430-4695-b4bb-0c6ef6f1a284" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2b58bc60-9430-4695-b4bb-0c6ef6f1a284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_701a01b0-7b2a-45a6-9b01-6755372d0e40" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityTaxIdentificationNumber_701a01b0-7b2a-45a6-9b01-6755372d0e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_52308487-59b3-45df-9293-21ccc75e3391" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityAddressAddressLine1_52308487-59b3-45df-9293-21ccc75e3391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_a9e97f9e-22d5-48f7-8b79-04b1685a4056" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityAddressAddressLine2_a9e97f9e-22d5-48f7-8b79-04b1685a4056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_783bd1e3-f015-4b11-942c-a436500d40a5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityAddressCityOrTown_783bd1e3-f015-4b11-942c-a436500d40a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_1ddf7769-37fe-43e2-b14e-a097246f7a75" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityAddressStateOrProvince_1ddf7769-37fe-43e2-b14e-a097246f7a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_fda0f2ec-da5d-44d2-9496-648e369be73c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityAddressPostalZipCode_fda0f2ec-da5d-44d2-9496-648e369be73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_33fb1ed0-ebed-49eb-bbc4-4e80a4eda310" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_CityAreaCode_33fb1ed0-ebed-49eb-bbc4-4e80a4eda310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1253317f-eee7-4daa-8882-e33bd1a430a0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_LocalPhoneNumber_1253317f-eee7-4daa-8882-e33bd1a430a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9517b913-265b-40cc-a3a0-23dea6601dd7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_Security12bTitle_9517b913-265b-40cc-a3a0-23dea6601dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3da573ea-e2ab-4d0e-b03b-e7e7865c634e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_TradingSymbol_3da573ea-e2ab-4d0e-b03b-e7e7865c634e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_67434569-4d89-4221-ab2f-53de56024baa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_SecurityExchangeName_67434569-4d89-4221-ab2f-53de56024baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_9d83e71f-6a45-4b1f-a18f-43f38ee170a7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityCurrentReportingStatus_9d83e71f-6a45-4b1f-a18f-43f38ee170a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5dad15a1-d478-4d8b-9f18-b7f4eed57445" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityInteractiveDataCurrent_5dad15a1-d478-4d8b-9f18-b7f4eed57445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_7dddb33b-6fb5-4ff4-9ba9-5ec02b134571" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityFilerCategory_7dddb33b-6fb5-4ff4-9ba9-5ec02b134571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_05e1bf5c-6072-47a5-b758-e67601ca9d85" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntitySmallBusiness_05e1bf5c-6072-47a5-b758-e67601ca9d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_cdb68523-6c76-449d-9736-8107fb3dc7d6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityEmergingGrowthCompany_cdb68523-6c76-449d-9736-8107fb3dc7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_018d857f-bd5a-47d1-b6ef-3fb0c7a922c4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityExTransitionPeriod_018d857f-bd5a-47d1-b6ef-3fb0c7a922c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_3fb976d8-79ba-4b5c-ae5e-8c3740493eb1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityShellCompany_3fb976d8-79ba-4b5c-ae5e-8c3740493eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_5bfbaabd-afba-4c98-977b-6edbc403768b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_5bfbaabd-afba-4c98-977b-6edbc403768b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8aeb7159-f2e6-4699-ac52-5fc78635c67c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_EntityCentralIndexKey_8aeb7159-f2e6-4699-ac52-5fc78635c67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f3ef3f89-108e-491c-ad9d-701856c57755" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_CurrentFiscalYearEndDate_f3ef3f89-108e-491c-ad9d-701856c57755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_c32ab889-4e94-4d3f-a123-858e3e9ea8c4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_DocumentFiscalYearFocus_c32ab889-4e94-4d3f-a123-858e3e9ea8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_2e583238-cae8-4c9f-925a-e065956d50d7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_DocumentFiscalPeriodFocus_2e583238-cae8-4c9f-925a-e065956d50d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1d4b9633-1f2d-40fe-854e-a5392280831e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e8f046d-550b-4254-9abd-a6c407e01e61" xlink:to="loc_dei_AmendmentFlag_1d4b9633-1f2d-40fe-854e-a5392280831e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="sibn-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_92ee2985-ddea-42c3-8258-8e0de34f410f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_55f2d869-7faf-455a-a831-92d1ca399cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_92ee2985-ddea-42c3-8258-8e0de34f410f" xlink:to="loc_us-gaap_AssetsAbstract_55f2d869-7faf-455a-a831-92d1ca399cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_95bdc8f5-2266-4d66-a79c-b47ad2bf0006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_55f2d869-7faf-455a-a831-92d1ca399cf8" xlink:to="loc_us-gaap_AssetsCurrentAbstract_95bdc8f5-2266-4d66-a79c-b47ad2bf0006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0aa69280-df29-4d15-a41e-d98ec8248b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_95bdc8f5-2266-4d66-a79c-b47ad2bf0006" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0aa69280-df29-4d15-a41e-d98ec8248b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_6e81f0b6-dffa-45d7-9812-02c9f7c3a98d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_95bdc8f5-2266-4d66-a79c-b47ad2bf0006" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_6e81f0b6-dffa-45d7-9812-02c9f7c3a98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5c97d5bc-6d47-4bf3-a511-0590bb7dd290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_95bdc8f5-2266-4d66-a79c-b47ad2bf0006" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_5c97d5bc-6d47-4bf3-a511-0590bb7dd290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c31b550a-1bda-4a8f-b6ed-a2c80028b22d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_95bdc8f5-2266-4d66-a79c-b47ad2bf0006" xlink:to="loc_us-gaap_InventoryNet_c31b550a-1bda-4a8f-b6ed-a2c80028b22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8bd005ad-b964-4fe4-a2f4-25b3368dacad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_95bdc8f5-2266-4d66-a79c-b47ad2bf0006" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8bd005ad-b964-4fe4-a2f4-25b3368dacad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a68c656a-c4dd-4127-b824-98040aaff961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_95bdc8f5-2266-4d66-a79c-b47ad2bf0006" xlink:to="loc_us-gaap_AssetsCurrent_a68c656a-c4dd-4127-b824-98040aaff961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_10b0bf61-5ed5-4d29-9c19-f8b2032c3343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_55f2d869-7faf-455a-a831-92d1ca399cf8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_10b0bf61-5ed5-4d29-9c19-f8b2032c3343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_591ea9af-a97e-4131-8fe6-978a8ba96108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_55f2d869-7faf-455a-a831-92d1ca399cf8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_591ea9af-a97e-4131-8fe6-978a8ba96108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d6ed1168-1345-423d-8cef-ae6f29573daa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_55f2d869-7faf-455a-a831-92d1ca399cf8" xlink:to="loc_us-gaap_Assets_d6ed1168-1345-423d-8cef-ae6f29573daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3a5f4b30-6008-4194-a5ad-3b12f35fafbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_92ee2985-ddea-42c3-8258-8e0de34f410f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3a5f4b30-6008-4194-a5ad-3b12f35fafbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_6b862bdd-a7a2-4f75-8118-d4b4b6ee2282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3a5f4b30-6008-4194-a5ad-3b12f35fafbe" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_6b862bdd-a7a2-4f75-8118-d4b4b6ee2282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a1b12a0f-7ba4-490c-85a0-35a11689d3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b862bdd-a7a2-4f75-8118-d4b4b6ee2282" xlink:to="loc_us-gaap_AccountsPayableCurrent_a1b12a0f-7ba4-490c-85a0-35a11689d3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_33aedf2b-dd88-47ae-bde2-4af75b0362d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b862bdd-a7a2-4f75-8118-d4b4b6ee2282" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_33aedf2b-dd88-47ae-bde2-4af75b0362d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8234e15c-ef46-46d5-8ddb-bd7d019bc5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b862bdd-a7a2-4f75-8118-d4b4b6ee2282" xlink:to="loc_us-gaap_LiabilitiesCurrent_8234e15c-ef46-46d5-8ddb-bd7d019bc5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3bb1791d-aa20-4c5a-ab01-c80e5cb065fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3a5f4b30-6008-4194-a5ad-3b12f35fafbe" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3bb1791d-aa20-4c5a-ab01-c80e5cb065fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b68bc7cb-f58d-4f1a-ad41-d3b246712c06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3a5f4b30-6008-4194-a5ad-3b12f35fafbe" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b68bc7cb-f58d-4f1a-ad41-d3b246712c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_db64a781-c976-4d61-bfbf-3396b4af5734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3a5f4b30-6008-4194-a5ad-3b12f35fafbe" xlink:to="loc_us-gaap_Liabilities_db64a781-c976-4d61-bfbf-3396b4af5734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_44d155c4-8620-4d95-a7eb-511e7c9f2292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3a5f4b30-6008-4194-a5ad-3b12f35fafbe" xlink:to="loc_us-gaap_CommitmentsAndContingencies_44d155c4-8620-4d95-a7eb-511e7c9f2292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_4003e865-d157-4328-a81c-776b0a6ab3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3a5f4b30-6008-4194-a5ad-3b12f35fafbe" xlink:to="loc_us-gaap_StockholdersEquityAbstract_4003e865-d157-4328-a81c-776b0a6ab3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_77b1e7fa-3d72-4e89-84d6-c5bbe0ae2ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4003e865-d157-4328-a81c-776b0a6ab3a9" xlink:to="loc_us-gaap_PreferredStockValue_77b1e7fa-3d72-4e89-84d6-c5bbe0ae2ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9c4f36cd-9212-4c04-b24c-3c9922736ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4003e865-d157-4328-a81c-776b0a6ab3a9" xlink:to="loc_us-gaap_CommonStockValue_9c4f36cd-9212-4c04-b24c-3c9922736ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_6d08dc90-8131-4ff4-a973-ae0ffc8a5637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4003e865-d157-4328-a81c-776b0a6ab3a9" xlink:to="loc_us-gaap_AdditionalPaidInCapital_6d08dc90-8131-4ff4-a973-ae0ffc8a5637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cd3d3a91-9fdf-4690-8801-8567c21c4398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4003e865-d157-4328-a81c-776b0a6ab3a9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cd3d3a91-9fdf-4690-8801-8567c21c4398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4b074feb-dec1-4cbd-89b6-0cff514d3e93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4003e865-d157-4328-a81c-776b0a6ab3a9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4b074feb-dec1-4cbd-89b6-0cff514d3e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_75a8f16d-af98-4d9f-b0a3-e0982e4971d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4003e865-d157-4328-a81c-776b0a6ab3a9" xlink:to="loc_us-gaap_StockholdersEquity_75a8f16d-af98-4d9f-b0a3-e0982e4971d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5ced8706-64a9-472e-8d18-b2668bb1c03f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3a5f4b30-6008-4194-a5ad-3b12f35fafbe" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5ced8706-64a9-472e-8d18-b2668bb1c03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="sibn-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_cf32b8ab-28c8-4b2a-8f29-31d7653b2ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f48369e2-710b-4896-9bc7-cc01c2bcac33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cf32b8ab-28c8-4b2a-8f29-31d7653b2ed4" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f48369e2-710b-4896-9bc7-cc01c2bcac33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7b5a13d4-b37d-4fb4-b274-d6b77f19e007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cf32b8ab-28c8-4b2a-8f29-31d7653b2ed4" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7b5a13d4-b37d-4fb4-b274-d6b77f19e007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b6fa226c-1ff9-4c63-9e36-1869a01b26a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cf32b8ab-28c8-4b2a-8f29-31d7653b2ed4" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b6fa226c-1ff9-4c63-9e36-1869a01b26a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_b3d9158f-5911-49f7-90b9-678ffbd0706d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cf32b8ab-28c8-4b2a-8f29-31d7653b2ed4" xlink:to="loc_us-gaap_PreferredStockSharesIssued_b3d9158f-5911-49f7-90b9-678ffbd0706d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_d22bf8a5-2e30-4feb-85c1-5424095bd0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cf32b8ab-28c8-4b2a-8f29-31d7653b2ed4" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_d22bf8a5-2e30-4feb-85c1-5424095bd0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a3457dc6-fa72-4ea7-ae8f-eccf40b42fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cf32b8ab-28c8-4b2a-8f29-31d7653b2ed4" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a3457dc6-fa72-4ea7-ae8f-eccf40b42fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_c2ad1882-0759-45f1-aaa5-45910e99509d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cf32b8ab-28c8-4b2a-8f29-31d7653b2ed4" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_c2ad1882-0759-45f1-aaa5-45910e99509d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3f9f8958-80fb-455d-8bc0-ee8fd89071df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cf32b8ab-28c8-4b2a-8f29-31d7653b2ed4" xlink:to="loc_us-gaap_CommonStockSharesIssued_3f9f8958-80fb-455d-8bc0-ee8fd89071df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_aa13e929-a9a9-4d69-9968-3f97d130e50d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cf32b8ab-28c8-4b2a-8f29-31d7653b2ed4" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_aa13e929-a9a9-4d69-9968-3f97d130e50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="sibn-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_a22a5c06-bcc0-4e51-baf6-9a0c80016e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_88a5c404-7eee-4db2-bfce-cb83ea29becd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a22a5c06-bcc0-4e51-baf6-9a0c80016e35" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_88a5c404-7eee-4db2-bfce-cb83ea29becd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_b65c8867-6a5d-4c24-a58f-df682580cc45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a22a5c06-bcc0-4e51-baf6-9a0c80016e35" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_b65c8867-6a5d-4c24-a58f-df682580cc45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_12913509-0375-4c18-b584-1885a5e191cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a22a5c06-bcc0-4e51-baf6-9a0c80016e35" xlink:to="loc_us-gaap_GrossProfit_12913509-0375-4c18-b584-1885a5e191cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_53b60bd4-52e4-4034-a7a7-df7408b9239e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a22a5c06-bcc0-4e51-baf6-9a0c80016e35" xlink:to="loc_us-gaap_OperatingExpensesAbstract_53b60bd4-52e4-4034-a7a7-df7408b9239e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_9b270582-82fa-4be2-9fec-2f8d2f12b48a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_53b60bd4-52e4-4034-a7a7-df7408b9239e" xlink:to="loc_us-gaap_SellingAndMarketingExpense_9b270582-82fa-4be2-9fec-2f8d2f12b48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_a459e734-d63c-4350-90a5-1c2f535dde19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_53b60bd4-52e4-4034-a7a7-df7408b9239e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_a459e734-d63c-4350-90a5-1c2f535dde19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_c6f683ee-fe4a-4b0c-9f05-246746c73266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_53b60bd4-52e4-4034-a7a7-df7408b9239e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_c6f683ee-fe4a-4b0c-9f05-246746c73266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9e09cfd6-ab9e-4a34-ad4a-729d42b34932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_53b60bd4-52e4-4034-a7a7-df7408b9239e" xlink:to="loc_us-gaap_OperatingExpenses_9e09cfd6-ab9e-4a34-ad4a-729d42b34932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_03e18641-61a1-456d-9015-604f19a2afa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a22a5c06-bcc0-4e51-baf6-9a0c80016e35" xlink:to="loc_us-gaap_OperatingIncomeLoss_03e18641-61a1-456d-9015-604f19a2afa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_f423889c-de23-4530-9fb4-178247be41cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a22a5c06-bcc0-4e51-baf6-9a0c80016e35" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_f423889c-de23-4530-9fb4-178247be41cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c7f96b45-d7d0-43de-8f86-7c9a55aa0328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_f423889c-de23-4530-9fb4-178247be41cf" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c7f96b45-d7d0-43de-8f86-7c9a55aa0328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_5726370e-3102-4b16-8eb5-31977f0fb101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_f423889c-de23-4530-9fb4-178247be41cf" xlink:to="loc_us-gaap_InterestExpense_5726370e-3102-4b16-8eb5-31977f0fb101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_df468418-d7be-4dc9-ad31-e289c70752bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_f423889c-de23-4530-9fb4-178247be41cf" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_df468418-d7be-4dc9-ad31-e289c70752bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b990aecd-9458-4f3c-8714-1db28acb87fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a22a5c06-bcc0-4e51-baf6-9a0c80016e35" xlink:to="loc_us-gaap_NetIncomeLoss_b990aecd-9458-4f3c-8714-1db28acb87fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d38de477-8192-4e3d-8851-c8b8c4c466f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a22a5c06-bcc0-4e51-baf6-9a0c80016e35" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d38de477-8192-4e3d-8851-c8b8c4c466f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_4e69e164-806e-4cd0-a460-24b12fba8254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d38de477-8192-4e3d-8851-c8b8c4c466f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_4e69e164-806e-4cd0-a460-24b12fba8254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_c89d8771-6d0c-4823-8652-9053a3bdcb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d38de477-8192-4e3d-8851-c8b8c4c466f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_c89d8771-6d0c-4823-8652-9053a3bdcb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_00b057fc-d7ef-43d3-84e8-ef59461e4c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a22a5c06-bcc0-4e51-baf6-9a0c80016e35" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_00b057fc-d7ef-43d3-84e8-ef59461e4c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_00a10a63-c4fd-4019-badf-bb7de9687ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a22a5c06-bcc0-4e51-baf6-9a0c80016e35" xlink:to="loc_us-gaap_EarningsPerShareBasic_00a10a63-c4fd-4019-badf-bb7de9687ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f330d590-57b8-4961-9a76-03acb687723d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a22a5c06-bcc0-4e51-baf6-9a0c80016e35" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f330d590-57b8-4961-9a76-03acb687723d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c49984c6-44a3-4ce8-83bf-affe21c28530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a22a5c06-bcc0-4e51-baf6-9a0c80016e35" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c49984c6-44a3-4ce8-83bf-affe21c28530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f172c2fe-5e94-4cec-85b8-d23c858df056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a22a5c06-bcc0-4e51-baf6-9a0c80016e35" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f172c2fe-5e94-4cec-85b8-d23c858df056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="sibn-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0120b5d3-93ac-4aeb-a62f-4a7a9eaf3d42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_46c81fad-c609-40fb-8111-d875ce8b7ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0120b5d3-93ac-4aeb-a62f-4a7a9eaf3d42" xlink:to="loc_us-gaap_StatementTable_46c81fad-c609-40fb-8111-d875ce8b7ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a0eab01e-bc45-4288-a2a2-d29ce6996af8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_46c81fad-c609-40fb-8111-d875ce8b7ce2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a0eab01e-bc45-4288-a2a2-d29ce6996af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f4f66e5d-1544-4d00-a07e-bbcdff43d7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a0eab01e-bc45-4288-a2a2-d29ce6996af8" xlink:to="loc_us-gaap_EquityComponentDomain_f4f66e5d-1544-4d00-a07e-bbcdff43d7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_fc39f7a0-f3dc-4158-8cf5-e7727f34a850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f4f66e5d-1544-4d00-a07e-bbcdff43d7ab" xlink:to="loc_us-gaap_CommonStockMember_fc39f7a0-f3dc-4158-8cf5-e7727f34a850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_98b4f9a9-a516-427f-a4a0-dc8cd2213acd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f4f66e5d-1544-4d00-a07e-bbcdff43d7ab" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_98b4f9a9-a516-427f-a4a0-dc8cd2213acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e9b2a518-83dd-4736-837e-bc3285670076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f4f66e5d-1544-4d00-a07e-bbcdff43d7ab" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e9b2a518-83dd-4736-837e-bc3285670076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6547e779-e50c-4bd3-a77d-064aaf7ba062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f4f66e5d-1544-4d00-a07e-bbcdff43d7ab" xlink:to="loc_us-gaap_RetainedEarningsMember_6547e779-e50c-4bd3-a77d-064aaf7ba062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8010da09-632e-40d1-846f-9913689e19c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_46c81fad-c609-40fb-8111-d875ce8b7ce2" xlink:to="loc_us-gaap_StatementLineItems_8010da09-632e-40d1-846f-9913689e19c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8010da09-632e-40d1-846f-9913689e19c5" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_9b9970e2-5ef4-45ac-a794-2b15a1d5263f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_SharesOutstanding_9b9970e2-5ef4-45ac-a794-2b15a1d5263f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3541d583-6d63-487e-96ce-1ab681b2b1df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockholdersEquity_3541d583-6d63-487e-96ce-1ab681b2b1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_94f2834b-844c-4141-8b2f-8a92a7c7a443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_94f2834b-844c-4141-8b2f-8a92a7c7a443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a5bbe37d-7668-4b6a-8630-fc91509b2ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a5bbe37d-7668-4b6a-8630-fc91509b2ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_675bb5b3-bba6-4b56-aa2f-5d732891e5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_675bb5b3-bba6-4b56-aa2f-5d732891e5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_30db819e-7474-4a27-9ec1-52011e014975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_30db819e-7474-4a27-9ec1-52011e014975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_83d5a480-49bc-4250-9858-c38902c3af5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_83d5a480-49bc-4250-9858-c38902c3af5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2b9b94fd-413b-419a-9c53-d6ddedfc1f93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2b9b94fd-413b-419a-9c53-d6ddedfc1f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits_fdb039ae-d39c-47cd-a914-c36a09aaa10a" xlink:href="sibn-20210930.xsd#sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits_fdb039ae-d39c-47cd-a914-c36a09aaa10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2655bbe1-7383-4a4b-b33f-5bef118062d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2655bbe1-7383-4a4b-b33f-5bef118062d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions_0e0efa79-6792-436f-ba9c-1389d67887b2" xlink:href="sibn-20210930.xsd#sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions_0e0efa79-6792-436f-ba9c-1389d67887b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_aa53cbe4-07f6-4be2-9f7d-2a4e735af9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_aa53cbe4-07f6-4be2-9f7d-2a4e735af9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_a09a9896-d035-4f1c-92f3-f44a21b8e9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_a09a9896-d035-4f1c-92f3-f44a21b8e9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fde19b3f-ed9b-45b2-b1a0-8868e48b3305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_NetIncomeLoss_fde19b3f-ed9b-45b2-b1a0-8868e48b3305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_f2d17f01-635b-47d5-a2cd-d5d8f327cc24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_SharesOutstanding_f2d17f01-635b-47d5-a2cd-d5d8f327cc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3a12965c-4dae-4e24-b1c9-02a72774111f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1be01176-cf30-400d-a630-c35e307c832a" xlink:to="loc_us-gaap_StockholdersEquity_3a12965c-4dae-4e24-b1c9-02a72774111f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sibn-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_12aa7041-a8e2-4b9d-af82-f2ead2a5661d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5bc262e0-c1da-4f51-ada3-74f59a80a863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_12aa7041-a8e2-4b9d-af82-f2ead2a5661d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5bc262e0-c1da-4f51-ada3-74f59a80a863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5229c7ce-236e-4a68-bd19-3901f2377116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5bc262e0-c1da-4f51-ada3-74f59a80a863" xlink:to="loc_us-gaap_NetIncomeLoss_5229c7ce-236e-4a68-bd19-3901f2377116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_021db424-26a9-4fe6-b48e-6b216646e5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5bc262e0-c1da-4f51-ada3-74f59a80a863" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_021db424-26a9-4fe6-b48e-6b216646e5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1ba7efb8-2f33-453d-8fec-697c2cd61c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_021db424-26a9-4fe6-b48e-6b216646e5f0" xlink:to="loc_us-gaap_ShareBasedCompensation_1ba7efb8-2f33-453d-8fec-697c2cd61c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f2ecfd43-2ef0-4135-acb8-9bac9616b886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_021db424-26a9-4fe6-b48e-6b216646e5f0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f2ecfd43-2ef0-4135-acb8-9bac9616b886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_b6a006e9-2ddc-4ec4-9102-402174d47b82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_021db424-26a9-4fe6-b48e-6b216646e5f0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_b6a006e9-2ddc-4ec4-9102-402174d47b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_72a30ca9-48dd-4c64-b041-e182ef7b5c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_021db424-26a9-4fe6-b48e-6b216646e5f0" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_72a30ca9-48dd-4c64-b041-e182ef7b5c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesRealizedGainLoss_c12b629f-77c6-42fb-b8e4-f3062b50306d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_021db424-26a9-4fe6-b48e-6b216646e5f0" xlink:to="loc_us-gaap_MarketableSecuritiesRealizedGainLoss_c12b629f-77c6-42fb-b8e4-f3062b50306d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_1ee85978-3250-4aca-b4b4-af6757d91827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_021db424-26a9-4fe6-b48e-6b216646e5f0" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_1ee85978-3250-4aca-b4b4-af6757d91827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fad8f114-34bd-40e4-b7a2-ff774714e2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_021db424-26a9-4fe6-b48e-6b216646e5f0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fad8f114-34bd-40e4-b7a2-ff774714e2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_3005c724-fb75-41d2-bbd7-7a973ca656a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_021db424-26a9-4fe6-b48e-6b216646e5f0" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_3005c724-fb75-41d2-bbd7-7a973ca656a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51beed75-e1c5-4b15-8a34-6ac36ac45367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5bc262e0-c1da-4f51-ada3-74f59a80a863" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51beed75-e1c5-4b15-8a34-6ac36ac45367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_129ef6a4-83b7-4fcf-8f77-e0fbac0c3d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51beed75-e1c5-4b15-8a34-6ac36ac45367" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_129ef6a4-83b7-4fcf-8f77-e0fbac0c3d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a78f8209-dc44-416d-a8b8-245cdb6b0308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51beed75-e1c5-4b15-8a34-6ac36ac45367" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a78f8209-dc44-416d-a8b8-245cdb6b0308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f0c9fb64-859b-49b6-a4a8-684d0b364b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51beed75-e1c5-4b15-8a34-6ac36ac45367" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f0c9fb64-859b-49b6-a4a8-684d0b364b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f1ea9a0f-f7c0-41a0-a01d-99189a3bcae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51beed75-e1c5-4b15-8a34-6ac36ac45367" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f1ea9a0f-f7c0-41a0-a01d-99189a3bcae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_e6b02ac5-b560-47f8-b6bf-fc781192ed19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51beed75-e1c5-4b15-8a34-6ac36ac45367" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_e6b02ac5-b560-47f8-b6bf-fc781192ed19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e6a94df7-ea15-4216-bd28-fa61e35ac283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5bc262e0-c1da-4f51-ada3-74f59a80a863" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e6a94df7-ea15-4216-bd28-fa61e35ac283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3ff74310-5197-4a14-b4ea-d214b61941da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_12aa7041-a8e2-4b9d-af82-f2ead2a5661d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3ff74310-5197-4a14-b4ea-d214b61941da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ProceedsFromMaturityOfMarketableSecurities_84dfcdf1-722e-4a37-a58b-a06901204f1e" xlink:href="sibn-20210930.xsd#sibn_ProceedsFromMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3ff74310-5197-4a14-b4ea-d214b61941da" xlink:to="loc_sibn_ProceedsFromMaturityOfMarketableSecurities_84dfcdf1-722e-4a37-a58b-a06901204f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ProceedsFromSaleOfMarketableSecurities_366e826e-2d2e-453d-9c23-c6e0f3baf7d8" xlink:href="sibn-20210930.xsd#sibn_ProceedsFromSaleOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3ff74310-5197-4a14-b4ea-d214b61941da" xlink:to="loc_sibn_ProceedsFromSaleOfMarketableSecurities_366e826e-2d2e-453d-9c23-c6e0f3baf7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_e17c428d-79d3-451e-8fa1-e44fd4eb7433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3ff74310-5197-4a14-b4ea-d214b61941da" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_e17c428d-79d3-451e-8fa1-e44fd4eb7433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c077bb84-6d94-4558-8663-9579b7cb8a65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3ff74310-5197-4a14-b4ea-d214b61941da" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c077bb84-6d94-4558-8663-9579b7cb8a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_979ed1ed-e552-4218-a3f4-851915a26b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3ff74310-5197-4a14-b4ea-d214b61941da" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_979ed1ed-e552-4218-a3f4-851915a26b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a123379-b36c-4cf2-8cc7-823d2d6b3040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_12aa7041-a8e2-4b9d-af82-f2ead2a5661d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a123379-b36c-4cf2-8cc7-823d2d6b3040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_bf7fb11a-46e7-435f-9109-c134b6596f55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a123379-b36c-4cf2-8cc7-823d2d6b3040" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_bf7fb11a-46e7-435f-9109-c134b6596f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_ebf9bc6c-9962-4a8a-8af3-94afbb153f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a123379-b36c-4cf2-8cc7-823d2d6b3040" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_ebf9bc6c-9962-4a8a-8af3-94afbb153f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_feb9b22f-56f3-4db3-83d6-36371db00960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a123379-b36c-4cf2-8cc7-823d2d6b3040" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_feb9b22f-56f3-4db3-83d6-36371db00960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f64790d8-ae04-49c8-812e-d6ba260a1bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a123379-b36c-4cf2-8cc7-823d2d6b3040" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f64790d8-ae04-49c8-812e-d6ba260a1bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_95b18f05-36ee-4cb5-8024-d2a28751c805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a123379-b36c-4cf2-8cc7-823d2d6b3040" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_95b18f05-36ee-4cb5-8024-d2a28751c805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_df8ce636-b9be-4cd9-b7b9-98859db15909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a123379-b36c-4cf2-8cc7-823d2d6b3040" xlink:to="loc_us-gaap_ProceedsFromStockPlans_df8ce636-b9be-4cd9-b7b9-98859db15909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_3c1cd5ed-ca37-484d-a5dd-2ac0013e539b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a123379-b36c-4cf2-8cc7-823d2d6b3040" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_3c1cd5ed-ca37-484d-a5dd-2ac0013e539b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c50a2024-bfbc-4fcd-8dca-a9cf24f7712f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a123379-b36c-4cf2-8cc7-823d2d6b3040" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c50a2024-bfbc-4fcd-8dca-a9cf24f7712f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_374a74a5-9578-4b06-8a9a-90389848cad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_12aa7041-a8e2-4b9d-af82-f2ead2a5661d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_374a74a5-9578-4b06-8a9a-90389848cad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a7c96359-a930-4b70-8e4c-f459c54a7fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_12aa7041-a8e2-4b9d-af82-f2ead2a5661d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a7c96359-a930-4b70-8e4c-f459c54a7fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_fee35721-2e43-489d-8f94-e49e5d722608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValueAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_12aa7041-a8e2-4b9d-af82-f2ead2a5661d" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_fee35721-2e43-489d-8f94-e49e5d722608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d7a03228-97f4-4720-a49c-96dc432f1ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_fee35721-2e43-489d-8f94-e49e5d722608" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d7a03228-97f4-4720-a49c-96dc432f1ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b0ed1d2f-ebae-4f66-9291-295b564df13e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_fee35721-2e43-489d-8f94-e49e5d722608" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b0ed1d2f-ebae-4f66-9291-295b564df13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_83cfc6ba-5cda-491b-8100-5b82905d57b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_12aa7041-a8e2-4b9d-af82-f2ead2a5661d" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_83cfc6ba-5cda-491b-8100-5b82905d57b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_VestingOfEarlyExercisedStockOptions_aea87b37-77e3-4c2f-b39d-82eb3ec49057" xlink:href="sibn-20210930.xsd#sibn_VestingOfEarlyExercisedStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_83cfc6ba-5cda-491b-8100-5b82905d57b1" xlink:to="loc_sibn_VestingOfEarlyExercisedStockOptions_aea87b37-77e3-4c2f-b39d-82eb3ec49057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8673ad5a-1a74-4510-a798-fdf7e7d1e69e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_83cfc6ba-5cda-491b-8100-5b82905d57b1" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8673ad5a-1a74-4510-a798-fdf7e7d1e69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/TheCompanyandNatureofBusiness" xlink:type="simple" xlink:href="sibn-20210930.xsd#TheCompanyandNatureofBusiness"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/TheCompanyandNatureofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fb410db9-b520-454a-bf41-cd1e74949b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_7bfc18ac-dd0b-4efd-a0b7-9943c77e4520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fb410db9-b520-454a-bf41-cd1e74949b2c" xlink:to="loc_us-gaap_NatureOfOperations_7bfc18ac-dd0b-4efd-a0b7-9943c77e4520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/TheCompanyandNatureofBusinessDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#TheCompanyandNatureofBusinessDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/TheCompanyandNatureofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7c7606b2-540c-408d-80ab-90813682c018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ab8f697f-97ba-42ee-842b-f205c3be00ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7c7606b2-540c-408d-80ab-90813682c018" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ab8f697f-97ba-42ee-842b-f205c3be00ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_06c88958-032d-47fd-8500-9bf58d54e55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ab8f697f-97ba-42ee-842b-f205c3be00ef" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_06c88958-032d-47fd-8500-9bf58d54e55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0a76ff34-8a18-42d7-ae61-405e504f1d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_06c88958-032d-47fd-8500-9bf58d54e55a" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0a76ff34-8a18-42d7-ae61-405e504f1d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_FollowOnPublicOfferingMember_9355eca8-6fc6-4e94-a6de-8f515a2c68ca" xlink:href="sibn-20210930.xsd#sibn_FollowOnPublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0a76ff34-8a18-42d7-ae61-405e504f1d2d" xlink:to="loc_sibn_FollowOnPublicOfferingMember_9355eca8-6fc6-4e94-a6de-8f515a2c68ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_FollowOnPublicOfferingAndSecondaryOfferingMember_de651efe-83df-4f93-a853-303e1730ded6" xlink:href="sibn-20210930.xsd#sibn_FollowOnPublicOfferingAndSecondaryOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0a76ff34-8a18-42d7-ae61-405e504f1d2d" xlink:to="loc_sibn_FollowOnPublicOfferingAndSecondaryOfferingMember_de651efe-83df-4f93-a853-303e1730ded6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_c5d32516-d8ec-4277-b188-a9893b83b653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0a76ff34-8a18-42d7-ae61-405e504f1d2d" xlink:to="loc_us-gaap_OverAllotmentOptionMember_c5d32516-d8ec-4277-b188-a9893b83b653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SecondaryOfferingMember_5c280c5f-343a-44e7-be33-80f557c3eda5" xlink:href="sibn-20210930.xsd#sibn_SecondaryOfferingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0a76ff34-8a18-42d7-ae61-405e504f1d2d" xlink:to="loc_sibn_SecondaryOfferingMember_5c280c5f-343a-44e7-be33-80f557c3eda5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SecondFollowOnPublicOfferingMember_961ed5fd-8049-459f-95bd-8c051ad33504" xlink:href="sibn-20210930.xsd#sibn_SecondFollowOnPublicOfferingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0a76ff34-8a18-42d7-ae61-405e504f1d2d" xlink:to="loc_sibn_SecondFollowOnPublicOfferingMember_961ed5fd-8049-459f-95bd-8c051ad33504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_fee24c07-5e1b-4d70-8256-b8bfcbee9bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ab8f697f-97ba-42ee-842b-f205c3be00ef" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_fee24c07-5e1b-4d70-8256-b8bfcbee9bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d1581698-66e0-4330-8e68-361593fb5a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fee24c07-5e1b-4d70-8256-b8bfcbee9bed" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d1581698-66e0-4330-8e68-361593fb5a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering_7eb77735-6765-409a-b8ac-563cd02eae21" xlink:href="sibn-20210930.xsd#sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fee24c07-5e1b-4d70-8256-b8bfcbee9bed" xlink:to="loc_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering_7eb77735-6765-409a-b8ac-563cd02eae21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ce077023-e27b-4395-9ff1-200f3401ba8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fee24c07-5e1b-4d70-8256-b8bfcbee9bed" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ce077023-e27b-4395-9ff1-200f3401ba8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_dbaf1acb-7ac6-4a28-84db-e4e4cb86092b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fee24c07-5e1b-4d70-8256-b8bfcbee9bed" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_dbaf1acb-7ac6-4a28-84db-e4e4cb86092b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AllocatedPublicOfferingCosts_b7782fa2-6f73-46ef-988d-c4f64382abeb" xlink:href="sibn-20210930.xsd#sibn_AllocatedPublicOfferingCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fee24c07-5e1b-4d70-8256-b8bfcbee9bed" xlink:to="loc_sibn_AllocatedPublicOfferingCosts_b7782fa2-6f73-46ef-988d-c4f64382abeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="sibn-20210930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fb5e3b10-e063-4ca9-bdb8-92877a7088e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_d7926e7f-2668-4350-8025-3ef9ba716bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fb5e3b10-e063-4ca9-bdb8-92877a7088e0" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_d7926e7f-2668-4350-8025-3ef9ba716bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="sibn-20210930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e49f88b0-5364-4b55-a50f-0e890f1d9593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_79c196c0-9400-446a-a98f-560a7bea0886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e49f88b0-5364-4b55-a50f-0e890f1d9593" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_79c196c0-9400-446a-a98f-560a7bea0886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_fdd471a2-d219-40ad-a477-6abb45f3e000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e49f88b0-5364-4b55-a50f-0e890f1d9593" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_fdd471a2-d219-40ad-a477-6abb45f3e000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a68c84e5-e92b-42e9-8b25-3d43476887b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e49f88b0-5364-4b55-a50f-0e890f1d9593" xlink:to="loc_us-gaap_UseOfEstimates_a68c84e5-e92b-42e9-8b25-3d43476887b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock_7046b5ac-38b3-4701-af17-cec3bf03f5d1" xlink:href="sibn-20210930.xsd#sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e49f88b0-5364-4b55-a50f-0e890f1d9593" xlink:to="loc_sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock_7046b5ac-38b3-4701-af17-cec3bf03f5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_402b60df-6dce-4ad7-80c0-54fb0c92c201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e49f88b0-5364-4b55-a50f-0e890f1d9593" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_402b60df-6dce-4ad7-80c0-54fb0c92c201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fa68ba7c-bcaa-40a6-9666-9f5861815604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e49f88b0-5364-4b55-a50f-0e890f1d9593" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fa68ba7c-bcaa-40a6-9666-9f5861815604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="sibn-20210930.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9aa92022-10ce-4f19-a7ff-2f585dee5f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_a8d7715e-599e-4f73-ba55-2b092dab3d74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9aa92022-10ce-4f19-a7ff-2f585dee5f67" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_a8d7715e-599e-4f73-ba55-2b092dab3d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7fdc5597-64e8-4b68-8630-d696ce57b66d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_1dfea7eb-de88-4915-9070-b8330ffbb2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7fdc5597-64e8-4b68-8630-d696ce57b66d" xlink:to="loc_us-gaap_NumberOfReportableSegments_1dfea7eb-de88-4915-9070-b8330ffbb2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_bdfa2e82-be72-48e7-83d1-6105d95c1d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7fdc5597-64e8-4b68-8630-d696ce57b66d" xlink:to="loc_us-gaap_NumberOfOperatingSegments_bdfa2e82-be72-48e7-83d1-6105d95c1d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e1910cb5-2c61-45b3-8801-dd7ffba05478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_17a0eba6-4209-4710-a979-3b85ba0688c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1910cb5-2c61-45b3-8801-dd7ffba05478" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_17a0eba6-4209-4710-a979-3b85ba0688c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5f8a0e44-1735-43de-a79c-abcb2d05d6a5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17a0eba6-4209-4710-a979-3b85ba0688c3" xlink:to="loc_srt_StatementGeographicalAxis_5f8a0e44-1735-43de-a79c-abcb2d05d6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d6df19d9-2586-44a7-8925-835b095cac60" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_5f8a0e44-1735-43de-a79c-abcb2d05d6a5" xlink:to="loc_srt_SegmentGeographicalDomain_d6df19d9-2586-44a7-8925-835b095cac60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b342ffdc-2472-4abe-932a-1e6e0e4d4f07" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d6df19d9-2586-44a7-8925-835b095cac60" xlink:to="loc_country_US_b342ffdc-2472-4abe-932a-1e6e0e4d4f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_e3bbd38a-b9a7-4bc0-9298-450374b0c54f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d6df19d9-2586-44a7-8925-835b095cac60" xlink:to="loc_us-gaap_NonUsMember_e3bbd38a-b9a7-4bc0-9298-450374b0c54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c8c58cc1-0848-4748-ad84-c1dbbcf463a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17a0eba6-4209-4710-a979-3b85ba0688c3" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_c8c58cc1-0848-4748-ad84-c1dbbcf463a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4cb1b62f-8858-4d6c-88b9-3a69fbbdacfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8c58cc1-0848-4748-ad84-c1dbbcf463a9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4cb1b62f-8858-4d6c-88b9-3a69fbbdacfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/MarketableSecurities" xlink:type="simple" xlink:href="sibn-20210930.xsd#MarketableSecurities"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/MarketableSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9243e1e1-e379-4925-a3d2-62e0016da883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_a2ee36c5-2cfc-41bf-a72c-2932f58be3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9243e1e1-e379-4925-a3d2-62e0016da883" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_a2ee36c5-2cfc-41bf-a72c-2932f58be3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/MarketableSecuritiesTables" xlink:type="simple" xlink:href="sibn-20210930.xsd#MarketableSecuritiesTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/MarketableSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a92bb168-f803-4c1b-99b0-cfbafa70fd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_b39a7679-61ab-473a-a596-a4badbea87a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a92bb168-f803-4c1b-99b0-cfbafa70fd1a" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_b39a7679-61ab-473a-a596-a4badbea87a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/MarketableSecuritiesDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#MarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/MarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c180265a-75b1-424e-8755-89c95d203399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_9ce3ec31-1e1f-4a06-b1bf-92f7747ac57e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c180265a-75b1-424e-8755-89c95d203399" xlink:to="loc_us-gaap_MarketableSecuritiesTable_9ce3ec31-1e1f-4a06-b1bf-92f7747ac57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cb9fcda6-0992-4850-927f-a03717e3ca17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_9ce3ec31-1e1f-4a06-b1bf-92f7747ac57e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cb9fcda6-0992-4850-927f-a03717e3ca17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1580d74-d90b-47db-b7b4-6d3ccbe8a718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cb9fcda6-0992-4850-927f-a03717e3ca17" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1580d74-d90b-47db-b7b4-6d3ccbe8a718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1e2a4d87-5670-4d83-862c-a90e7ccf1af4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1580d74-d90b-47db-b7b4-6d3ccbe8a718" xlink:to="loc_us-gaap_MoneyMarketFundsMember_1e2a4d87-5670-4d83-862c-a90e7ccf1af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_235288b5-305e-4669-b14f-b766e3e453d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1580d74-d90b-47db-b7b4-6d3ccbe8a718" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_235288b5-305e-4669-b14f-b766e3e453d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_cf2cc3fc-7568-4fb3-806f-e5798b710eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1580d74-d90b-47db-b7b4-6d3ccbe8a718" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_cf2cc3fc-7568-4fb3-806f-e5798b710eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_4882ce20-bc6d-4d45-8598-e50d5450276f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1580d74-d90b-47db-b7b4-6d3ccbe8a718" xlink:to="loc_us-gaap_CommercialPaperMember_4882ce20-bc6d-4d45-8598-e50d5450276f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_9ce3ec31-1e1f-4a06-b1bf-92f7747ac57e" xlink:to="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_9db3b046-8018-4209-98f5-c0bf57c88485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_9db3b046-8018-4209-98f5-c0bf57c88485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_0ecf93a5-99a7-4687-ade2-f4fdbbacba8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValueAbstract_9db3b046-8018-4209-98f5-c0bf57c88485" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_0ecf93a5-99a7-4687-ade2-f4fdbbacba8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_62cdf541-41d6-4b3d-93dd-2c1d87c31e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_62cdf541-41d6-4b3d-93dd-2c1d87c31e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis_0c3d3127-7054-4703-88b7-25a5fff72ca2" xlink:href="sibn-20210930.xsd#sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_62cdf541-41d6-4b3d-93dd-2c1d87c31e1c" xlink:to="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis_0c3d3127-7054-4703-88b7-25a5fff72ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax_7fb5b521-83b5-4129-aa24-f5911a008417" xlink:href="sibn-20210930.xsd#sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_62cdf541-41d6-4b3d-93dd-2c1d87c31e1c" xlink:to="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax_7fb5b521-83b5-4129-aa24-f5911a008417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax_052c582c-1fea-4372-bee4-4d6a5e75cfaf" xlink:href="sibn-20210930.xsd#sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_62cdf541-41d6-4b3d-93dd-2c1d87c31e1c" xlink:to="loc_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax_052c582c-1fea-4372-bee4-4d6a5e75cfaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_4026cd6d-2ed7-4862-b3d6-b690324410ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_62cdf541-41d6-4b3d-93dd-2c1d87c31e1c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_4026cd6d-2ed7-4862-b3d6-b690324410ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAmortizedCost_ff511bc0-960d-4f53-8c60-a9654f1a1d80" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:to="loc_sibn_MarketableSecuritiesAmortizedCost_ff511bc0-960d-4f53-8c60-a9654f1a1d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_92e2296d-3a6d-4431-bf37-aad497ffcf83" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:to="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_92e2296d-3a6d-4431-bf37-aad497ffcf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_581e0b9f-c125-46d1-9311-2602296de4ab" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:to="loc_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_581e0b9f-c125-46d1-9311-2602296de4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_MarketableSecuritiesFairValue_81ecfb5e-69e8-453a-8ecf-80a1ca6efb05" xlink:href="sibn-20210930.xsd#sibn_MarketableSecuritiesFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_ec4ff76a-a166-4414-941f-6644b547c19b" xlink:to="loc_sibn_MarketableSecuritiesFairValue_81ecfb5e-69e8-453a-8ecf-80a1ca6efb05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="sibn-20210930.xsd#FairValueMeasurement"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/FairValueMeasurement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2d0bd336-fda2-444b-8958-11750bcf3a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_8538ae1e-a6a7-43be-a30a-8ff719970fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2d0bd336-fda2-444b-8958-11750bcf3a4a" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_8538ae1e-a6a7-43be-a30a-8ff719970fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="sibn-20210930.xsd#FairValueMeasurementTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/FairValueMeasurementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f97d5db5-11cc-4b20-bd38-a87010f93ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_26f9fb08-84a5-48cf-a3b7-1446f00a4c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f97d5db5-11cc-4b20-bd38-a87010f93ba5" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_26f9fb08-84a5-48cf-a3b7-1446f00a4c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/FairValueMeasurementDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#FairValueMeasurementDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/FairValueMeasurementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2978715c-c876-44a3-88ee-43c8a8ecce3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4d25434-509b-426e-9f35-24a0b1ddf8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2978715c-c876-44a3-88ee-43c8a8ecce3e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4d25434-509b-426e-9f35-24a0b1ddf8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_55110d07-fcb3-4c7d-ae5a-9910aa7fbe11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4d25434-509b-426e-9f35-24a0b1ddf8bf" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_55110d07-fcb3-4c7d-ae5a-9910aa7fbe11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1a574c2c-8d6c-4410-be3c-1760c4cdec95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_55110d07-fcb3-4c7d-ae5a-9910aa7fbe11" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1a574c2c-8d6c-4410-be3c-1760c4cdec95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_99a4ceed-8713-4ad0-bdbe-f38ef7cc5c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1a574c2c-8d6c-4410-be3c-1760c4cdec95" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_99a4ceed-8713-4ad0-bdbe-f38ef7cc5c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0745b177-2462-4ed5-be84-c9f8742fb3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4d25434-509b-426e-9f35-24a0b1ddf8bf" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0745b177-2462-4ed5-be84-c9f8742fb3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_04824f31-da7e-404e-bb1a-edeec1deb78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0745b177-2462-4ed5-be84-c9f8742fb3ba" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_04824f31-da7e-404e-bb1a-edeec1deb78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_bdbb2944-f386-411f-9e8d-294147044d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_04824f31-da7e-404e-bb1a-edeec1deb78b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_bdbb2944-f386-411f-9e8d-294147044d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_232d571b-9fea-4e2e-8a1b-06bade55249b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_04824f31-da7e-404e-bb1a-edeec1deb78b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_232d571b-9fea-4e2e-8a1b-06bade55249b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8f84ae3c-c1c5-46d2-9cd2-5e0e0e7b3ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_04824f31-da7e-404e-bb1a-edeec1deb78b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8f84ae3c-c1c5-46d2-9cd2-5e0e0e7b3ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9c15ee26-eb9f-4bfe-927d-d198fcf73fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4d25434-509b-426e-9f35-24a0b1ddf8bf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9c15ee26-eb9f-4bfe-927d-d198fcf73fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c800d5d5-c61d-41a3-9828-3e9ee35b7842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9c15ee26-eb9f-4bfe-927d-d198fcf73fe2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c800d5d5-c61d-41a3-9828-3e9ee35b7842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_0ecc33e1-379d-45fe-a6fa-2708c8ac9107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c800d5d5-c61d-41a3-9828-3e9ee35b7842" xlink:to="loc_us-gaap_MoneyMarketFundsMember_0ecc33e1-379d-45fe-a6fa-2708c8ac9107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_5419a9c0-9bf1-4217-87b6-de5cf15607ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c800d5d5-c61d-41a3-9828-3e9ee35b7842" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_5419a9c0-9bf1-4217-87b6-de5cf15607ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_b9c0eb65-9459-4011-98c4-b229c6e69fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c800d5d5-c61d-41a3-9828-3e9ee35b7842" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_b9c0eb65-9459-4011-98c4-b229c6e69fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_c2e69b1e-aa5d-46a8-b429-76a8a914e312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c800d5d5-c61d-41a3-9828-3e9ee35b7842" xlink:to="loc_us-gaap_CommercialPaperMember_c2e69b1e-aa5d-46a8-b429-76a8a914e312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5ab56db2-af2e-484b-88f0-98fd37bddb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4d25434-509b-426e-9f35-24a0b1ddf8bf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5ab56db2-af2e-484b-88f0-98fd37bddb1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_e1d96596-b2ec-49c2-9b5d-2f5c5ac7a4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5ab56db2-af2e-484b-88f0-98fd37bddb1c" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_e1d96596-b2ec-49c2-9b5d-2f5c5ac7a4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_f91f3229-bc97-4f4d-ba8c-5daa7e88b6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_e1d96596-b2ec-49c2-9b5d-2f5c5ac7a4a3" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_f91f3229-bc97-4f4d-ba8c-5daa7e88b6a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponents" xlink:type="simple" xlink:href="sibn-20210930.xsd#BalanceSheetComponents"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BalanceSheetComponents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6557dbc2-1bca-4c49-8182-9e35c8d38906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_41e0bdcc-512d-47c1-9274-bf096cac4532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6557dbc2-1bca-4c49-8182-9e35c8d38906" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_41e0bdcc-512d-47c1-9274-bf096cac4532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsTables" xlink:type="simple" xlink:href="sibn-20210930.xsd#BalanceSheetComponentsTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c3a60fb6-b1db-45b7-852f-97e5e3bd9ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_bac657cd-e1d1-464d-8698-d770e035e009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c3a60fb6-b1db-45b7-852f-97e5e3bd9ae1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_bac657cd-e1d1-464d-8698-d770e035e009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_f074ad4f-9302-4fd4-803f-160d8e400dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c3a60fb6-b1db-45b7-852f-97e5e3bd9ae1" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_f074ad4f-9302-4fd4-803f-160d8e400dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#BalanceSheetComponentsPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d8386ef-94ea-48da-9058-c67f590f8258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_180c70aa-4c9d-427f-93b5-0aff1f52ac12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d8386ef-94ea-48da-9058-c67f590f8258" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_180c70aa-4c9d-427f-93b5-0aff1f52ac12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bc1e58db-8b97-4c29-8a04-a031477b48eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_180c70aa-4c9d-427f-93b5-0aff1f52ac12" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bc1e58db-8b97-4c29-8a04-a031477b48eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59203f72-10e6-45d1-849b-b05e9d754668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bc1e58db-8b97-4c29-8a04-a031477b48eb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59203f72-10e6-45d1-849b-b05e9d754668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_2b4445d3-c765-4d2b-a6df-73bf736fcd40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59203f72-10e6-45d1-849b-b05e9d754668" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_2b4445d3-c765-4d2b-a6df-73bf736fcd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_f062209c-e0ff-4e93-b7f3-d49eb5512332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59203f72-10e6-45d1-849b-b05e9d754668" xlink:to="loc_us-gaap_ConstructionInProgressMember_f062209c-e0ff-4e93-b7f3-d49eb5512332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember_01853a63-9bc1-4798-bc6b-cdf45bbef98e" xlink:href="sibn-20210930.xsd#sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConstructionInProgressMember_f062209c-e0ff-4e93-b7f3-d49eb5512332" xlink:to="loc_sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember_01853a63-9bc1-4798-bc6b-cdf45bbef98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ConstructionInProgressSantaClaraLeaseMember_5302ca54-2d06-4d5e-9bee-8d1d511ff7df" xlink:href="sibn-20210930.xsd#sibn_ConstructionInProgressSantaClaraLeaseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConstructionInProgressMember_f062209c-e0ff-4e93-b7f3-d49eb5512332" xlink:to="loc_sibn_ConstructionInProgressSantaClaraLeaseMember_5302ca54-2d06-4d5e-9bee-8d1d511ff7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ComputerAndOfficeEquipmentMember_4bbf5d46-8747-4dd2-9d8f-66cb8c2bbcd6" xlink:href="sibn-20210930.xsd#sibn_ComputerAndOfficeEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59203f72-10e6-45d1-849b-b05e9d754668" xlink:to="loc_sibn_ComputerAndOfficeEquipmentMember_4bbf5d46-8747-4dd2-9d8f-66cb8c2bbcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_0e045f3a-eae8-4665-bc20-9354c431e7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59203f72-10e6-45d1-849b-b05e9d754668" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_0e045f3a-eae8-4665-bc20-9354c431e7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_edf52159-512d-4c3e-980a-5ce236638b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_59203f72-10e6-45d1-849b-b05e9d754668" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_edf52159-512d-4c3e-980a-5ce236638b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_512151da-9deb-4d4f-bfc9-42f01e3c8eec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_180c70aa-4c9d-427f-93b5-0aff1f52ac12" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_512151da-9deb-4d4f-bfc9-42f01e3c8eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_5f7122c9-ef40-42f6-bf1a-bcda95e27803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_512151da-9deb-4d4f-bfc9-42f01e3c8eec" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_5f7122c9-ef40-42f6-bf1a-bcda95e27803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_42d3fdfd-7a5d-4ff6-9557-fe9ef2f706d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_512151da-9deb-4d4f-bfc9-42f01e3c8eec" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_42d3fdfd-7a5d-4ff6-9557-fe9ef2f706d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f4d2d21d-1b32-4f46-a226-0353820233a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_512151da-9deb-4d4f-bfc9-42f01e3c8eec" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f4d2d21d-1b32-4f46-a226-0353820233a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#BalanceSheetComponentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_851b0bfc-944b-478b-b9c0-73eabe203b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_3e720256-2298-4a72-ac2d-8813a5569f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_851b0bfc-944b-478b-b9c0-73eabe203b9b" xlink:to="loc_us-gaap_Depreciation_3e720256-2298-4a72-ac2d-8813a5569f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#BalanceSheetComponentsAccruedLiabilitiesandOtherDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8f0427ab-7bbf-46b7-8417-e71b275e5bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_334441e6-ea97-4c9d-b1fc-d9eae62513c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8f0427ab-7bbf-46b7-8417-e71b275e5bf1" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_334441e6-ea97-4c9d-b1fc-d9eae62513c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e8c6ff-d906-4f5f-b572-f08d4f807a84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_334441e6-ea97-4c9d-b1fc-d9eae62513c8" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e8c6ff-d906-4f5f-b572-f08d4f807a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_7bb96b60-86d0-4600-b2a5-ad8f3abc4916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_334441e6-ea97-4c9d-b1fc-d9eae62513c8" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_7bb96b60-86d0-4600-b2a5-ad8f3abc4916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8498206e-df05-4e96-951f-d55dc52e741b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_334441e6-ea97-4c9d-b1fc-d9eae62513c8" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8498206e-df05-4e96-951f-d55dc52e741b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_77fb7ccc-0d48-432a-81af-cdc370f61f39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_334441e6-ea97-4c9d-b1fc-d9eae62513c8" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_77fb7ccc-0d48-432a-81af-cdc370f61f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="sibn-20210930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e9cc64cd-371c-49e6-9dc1-765e56dc8b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e61c6745-f0c3-4c7f-a948-b4f786d01f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e9cc64cd-371c-49e6-9dc1-765e56dc8b1b" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e61c6745-f0c3-4c7f-a948-b4f786d01f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="sibn-20210930.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ea1a1bb5-6ef4-42e6-a5d4-0df93a0bd3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_ee2118db-2470-461e-ae1a-69a129c39f97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ea1a1bb5-6ef4-42e6-a5d4-0df93a0bd3b4" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_ee2118db-2470-461e-ae1a-69a129c39f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8e970141-b996-4af3-b20b-751c989a4741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_2ad88137-ef5d-43d5-8043-558c0b72abd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8e970141-b996-4af3-b20b-751c989a4741" xlink:to="loc_us-gaap_OtherCommitmentsTable_2ad88137-ef5d-43d5-8043-558c0b72abd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b24c7dbf-77e3-459b-8afc-53ef6e338bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_2ad88137-ef5d-43d5-8043-558c0b72abd0" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b24c7dbf-77e3-459b-8afc-53ef6e338bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_aaccd4d0-3c4a-45e7-9a02-739270e1ea64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b24c7dbf-77e3-459b-8afc-53ef6e338bdd" xlink:to="loc_us-gaap_LossContingencyNatureDomain_aaccd4d0-3c4a-45e7-9a02-739270e1ea64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember_93e06163-63e0-4108-862b-5e21d7a270e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_aaccd4d0-3c4a-45e7-9a02-739270e1ea64" xlink:to="loc_us-gaap_IndemnificationGuaranteeMember_93e06163-63e0-4108-862b-5e21d7a270e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_2ad88137-ef5d-43d5-8043-558c0b72abd0" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_OperatingLeaseTermOfWrittenNoticeForTermination_dce071eb-65a3-465e-aa62-368049583462" xlink:href="sibn-20210930.xsd#sibn_OperatingLeaseTermOfWrittenNoticeForTermination"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_sibn_OperatingLeaseTermOfWrittenNoticeForTermination_dce071eb-65a3-465e-aa62-368049583462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_61fcdc5a-8cf8-4ca5-8cb6-3e9d7dc54df0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_61fcdc5a-8cf8-4ca5-8cb6-3e9d7dc54df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_bfa1690a-6efd-4ecc-a4dd-88e3999b8b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_us-gaap_PurchaseObligation_bfa1690a-6efd-4ecc-a4dd-88e3999b8b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_8e9382fc-071e-4b2e-9eeb-c16913298e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_us-gaap_LitigationSettlementExpense_8e9382fc-071e-4b2e-9eeb-c16913298e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_bb1dcb93-4d22-4f69-becb-634512d4fec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_us-gaap_LitigationReserve_bb1dcb93-4d22-4f69-becb-634512d4fec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_5e4a344e-4e4b-4ee8-9d64-33d97661c5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_5e4a344e-4e4b-4ee8-9d64-33d97661c5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend_de874d71-8705-427d-b7ed-806f9fa1e493" xlink:href="sibn-20210930.xsd#sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend_de874d71-8705-427d-b7ed-806f9fa1e493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1_6558c765-15ef-4a5e-a602-157f3e401cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_3bc182cb-44d0-4654-bd29-f4b5582b32cd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1_6558c765-15ef-4a5e-a602-157f3e401cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_48e2f9c5-dda2-4085-a96b-c13b4e8969b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_e3f595e3-a982-4884-a33a-be0aeb127a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_48e2f9c5-dda2-4085-a96b-c13b4e8969b5" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_e3f595e3-a982-4884-a33a-be0aeb127a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_39b2efd4-b203-4b42-8b86-aa0aecc29590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_e3f595e3-a982-4884-a33a-be0aeb127a5d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_39b2efd4-b203-4b42-8b86-aa0aecc29590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1d26e049-779c-4676-8fed-54e38000ebc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_e3f595e3-a982-4884-a33a-be0aeb127a5d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1d26e049-779c-4676-8fed-54e38000ebc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_a5dbe92e-3817-4a79-902a-38f768341db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_e3f595e3-a982-4884-a33a-be0aeb127a5d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_a5dbe92e-3817-4a79-902a-38f768341db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_8138ab94-7885-4cbd-934d-3ceb40f9fbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_e3f595e3-a982-4884-a33a-be0aeb127a5d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_8138ab94-7885-4cbd-934d-3ceb40f9fbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_836aa805-b90b-4a87-a65c-afa7273a7e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_e3f595e3-a982-4884-a33a-be0aeb127a5d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_836aa805-b90b-4a87-a65c-afa7273a7e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour_b3328acf-dafe-4480-9212-8e43c5b635ee" xlink:href="sibn-20210930.xsd#sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_e3f595e3-a982-4884-a33a-be0aeb127a5d" xlink:to="loc_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour_b3328acf-dafe-4480-9212-8e43c5b635ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_ff4c9919-ace9-4a04-ba6e-b489ce4cc11f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_e3f595e3-a982-4884-a33a-be0aeb127a5d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_ff4c9919-ace9-4a04-ba6e-b489ce4cc11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/Borrowings" xlink:type="simple" xlink:href="sibn-20210930.xsd#Borrowings"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/Borrowings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c6c38210-0474-4f70-9565-a1735228e13c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_0e0496bb-5862-4a47-8014-a9e38630da53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c6c38210-0474-4f70-9565-a1735228e13c" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_0e0496bb-5862-4a47-8014-a9e38630da53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BorrowingsTables" xlink:type="simple" xlink:href="sibn-20210930.xsd#BorrowingsTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BorrowingsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f18db1a7-ae5b-4d8b-9315-e06f2fa89eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_994c98da-2e5f-4e50-9720-ca6a21ed4f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f18db1a7-ae5b-4d8b-9315-e06f2fa89eeb" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_994c98da-2e5f-4e50-9720-ca6a21ed4f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_cc62a135-2a90-4e54-ab36-e2c8846fcc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f18db1a7-ae5b-4d8b-9315-e06f2fa89eeb" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_cc62a135-2a90-4e54-ab36-e2c8846fcc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#BorrowingsSummaryofBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e43393c1-a4c8-4859-b911-4277a875dea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_64d18f49-4cb3-48d9-bd7e-8fc315ab1374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e43393c1-a4c8-4859-b911-4277a875dea3" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_64d18f49-4cb3-48d9-bd7e-8fc315ab1374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_de888e4d-7df1-48a4-b8cf-1b1349834ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e43393c1-a4c8-4859-b911-4277a875dea3" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_de888e4d-7df1-48a4-b8cf-1b1349834ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_47ac3c62-7da8-47d0-bc3b-58f0884774b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e43393c1-a4c8-4859-b911-4277a875dea3" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_47ac3c62-7da8-47d0-bc3b-58f0884774b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4fc6600e-1882-45b7-a438-70b55b992f12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e43393c1-a4c8-4859-b911-4277a875dea3" xlink:to="loc_us-gaap_LongTermDebt_4fc6600e-1882-45b7-a438-70b55b992f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_33d4ddf6-7be0-4947-8363-6b913a924aec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e43393c1-a4c8-4859-b911-4277a875dea3" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_33d4ddf6-7be0-4947-8363-6b913a924aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BorrowingsNarrativeDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#BorrowingsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BorrowingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8235bf94-8f19-46fb-b112-137238b85f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8235bf94-8f19-46fb-b112-137238b85f51" xlink:to="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9b50143e-3e53-42d3-9545-eefbc0c37f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9b50143e-3e53-42d3-9545-eefbc0c37f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4ebea3e6-e5dd-47de-8f5c-c399708049b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9b50143e-3e53-42d3-9545-eefbc0c37f4e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4ebea3e6-e5dd-47de-8f5c-c399708049b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_b9107335-049d-47ef-a293-c332f568855b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4ebea3e6-e5dd-47de-8f5c-c399708049b5" xlink:to="loc_us-gaap_SecuredDebtMember_b9107335-049d-47ef-a293-c332f568855b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2f061418-461c-4339-865d-d3efdf6ef42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:to="loc_us-gaap_DebtInstrumentAxis_2f061418-461c-4339-865d-d3efdf6ef42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_991f48c2-dc61-46fc-b700-a77ce8711910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2f061418-461c-4339-865d-d3efdf6ef42d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_991f48c2-dc61-46fc-b700-a77ce8711910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PharmakonTermLoanMember_b1505f35-9e00-47ed-8211-6c9fa1ed2ad1" xlink:href="sibn-20210930.xsd#sibn_PharmakonTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_991f48c2-dc61-46fc-b700-a77ce8711910" xlink:to="loc_sibn_PharmakonTermLoanMember_b1505f35-9e00-47ed-8211-6c9fa1ed2ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SolarLoanAndSecurityAgreementMember_5ceac5e3-5e3b-4f5b-8afa-a7edac7f36a3" xlink:href="sibn-20210930.xsd#sibn_SolarLoanAndSecurityAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_991f48c2-dc61-46fc-b700-a77ce8711910" xlink:to="loc_sibn_SolarLoanAndSecurityAgreementMember_5ceac5e3-5e3b-4f5b-8afa-a7edac7f36a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SVBTermLoanMember_c2162e3f-c4ed-4e2d-93df-ca190893805b" xlink:href="sibn-20210930.xsd#sibn_SVBTermLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_991f48c2-dc61-46fc-b700-a77ce8711910" xlink:to="loc_sibn_SVBTermLoanMember_c2162e3f-c4ed-4e2d-93df-ca190893805b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f2af75b5-c416-494c-b026-e58a3e04ebf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:to="loc_us-gaap_VariableRateAxis_f2af75b5-c416-494c-b026-e58a3e04ebf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e27166d3-55bd-47e8-b610-e76f035bacba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f2af75b5-c416-494c-b026-e58a3e04ebf6" xlink:to="loc_us-gaap_VariableRateDomain_e27166d3-55bd-47e8-b610-e76f035bacba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_VariableOptionOneMember_df82c543-7fe3-416b-bb09-31bf3e9c5629" xlink:href="sibn-20210930.xsd#sibn_VariableOptionOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_e27166d3-55bd-47e8-b610-e76f035bacba" xlink:to="loc_sibn_VariableOptionOneMember_df82c543-7fe3-416b-bb09-31bf3e9c5629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_a92c8b28-837a-4300-97ac-900b25d03b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_e27166d3-55bd-47e8-b610-e76f035bacba" xlink:to="loc_us-gaap_PrimeRateMember_a92c8b28-837a-4300-97ac-900b25d03b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7f437c52-4955-4cbd-a72d-956b1b0e0552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7f437c52-4955-4cbd-a72d-956b1b0e0552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0c2fa69f-8061-4bd3-a0a9-955f21944a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7f437c52-4955-4cbd-a72d-956b1b0e0552" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0c2fa69f-8061-4bd3-a0a9-955f21944a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_100ec43a-12f4-437b-a4b4-6fffbe3d3d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0c2fa69f-8061-4bd3-a0a9-955f21944a94" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_100ec43a-12f4-437b-a4b4-6fffbe3d3d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f6b6d89d-372d-40a3-a70b-b1ce75a4c290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0c2fa69f-8061-4bd3-a0a9-955f21944a94" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f6b6d89d-372d-40a3-a70b-b1ce75a4c290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtPrepaymentPenaltyPeriodAxis_457da9bc-5aa8-40b1-8568-61578abd5b3e" xlink:href="sibn-20210930.xsd#sibn_DebtPrepaymentPenaltyPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:to="loc_sibn_DebtPrepaymentPenaltyPeriodAxis_457da9bc-5aa8-40b1-8568-61578abd5b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtPrepaymentPenaltyPeriodDomain_57c3e095-3bec-46a9-82fb-f8bd4ae9c3fc" xlink:href="sibn-20210930.xsd#sibn_DebtPrepaymentPenaltyPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sibn_DebtPrepaymentPenaltyPeriodAxis_457da9bc-5aa8-40b1-8568-61578abd5b3e" xlink:to="loc_sibn_DebtPrepaymentPenaltyPeriodDomain_57c3e095-3bec-46a9-82fb-f8bd4ae9c3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PrepaymentPenalty124MonthsMember_1376e5ca-dcfe-4b9d-b28e-011d63586ddc" xlink:href="sibn-20210930.xsd#sibn_PrepaymentPenalty124MonthsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sibn_DebtPrepaymentPenaltyPeriodDomain_57c3e095-3bec-46a9-82fb-f8bd4ae9c3fc" xlink:to="loc_sibn_PrepaymentPenalty124MonthsMember_1376e5ca-dcfe-4b9d-b28e-011d63586ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PrepaymentPenalty24MonthsOnMember_fadfd6f6-04e6-43c2-836b-2704b05e8b0a" xlink:href="sibn-20210930.xsd#sibn_PrepaymentPenalty24MonthsOnMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sibn_DebtPrepaymentPenaltyPeriodDomain_57c3e095-3bec-46a9-82fb-f8bd4ae9c3fc" xlink:to="loc_sibn_PrepaymentPenalty24MonthsOnMember_fadfd6f6-04e6-43c2-836b-2704b05e8b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PrepaymentPenalty3148MonthsMember_bceefc1b-78a3-4d29-9496-1d8e9fcce0b2" xlink:href="sibn-20210930.xsd#sibn_PrepaymentPenalty3148MonthsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sibn_DebtPrepaymentPenaltyPeriodDomain_57c3e095-3bec-46a9-82fb-f8bd4ae9c3fc" xlink:to="loc_sibn_PrepaymentPenalty3148MonthsMember_bceefc1b-78a3-4d29-9496-1d8e9fcce0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_PrepaymentPenalty4960MonthsMember_cb46241e-1e93-4d8a-91d7-8ccd1642f957" xlink:href="sibn-20210930.xsd#sibn_PrepaymentPenalty4960MonthsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sibn_DebtPrepaymentPenaltyPeriodDomain_57c3e095-3bec-46a9-82fb-f8bd4ae9c3fc" xlink:to="loc_sibn_PrepaymentPenalty4960MonthsMember_cb46241e-1e93-4d8a-91d7-8ccd1642f957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed793b54-f828-4714-ad0b-67059f6c6f85" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e13bc285-6252-4f56-975f-2045f16478bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e13bc285-6252-4f56-975f-2045f16478bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod_18b12b55-1ecb-45f7-b060-d5ac0818659d" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod_18b12b55-1ecb-45f7-b060-d5ac0818659d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ab3e1e81-a75b-4e7b-bd2d-583c4fa6ffe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ab3e1e81-a75b-4e7b-bd2d-583c4fa6ffe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentPenaltyPercentage_caf0f2dc-d6f1-43bd-877b-3bde7b5d1c1a" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentPenaltyPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_DebtInstrumentPrepaymentPenaltyPercentage_caf0f2dc-d6f1-43bd-877b-3bde7b5d1c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a9fe3c7d-6fbf-472a-9e65-db9c555ec448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a9fe3c7d-6fbf-472a-9e65-db9c555ec448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_0cf11315-07e5-4151-84f3-0fbfe3d7704d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_0cf11315-07e5-4151-84f3-0fbfe3d7704d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_d7c674a0-332d-491f-8304-7af17a7b7ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_d7c674a0-332d-491f-8304-7af17a7b7ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_237a23d7-0aa5-4a31-bf15-51d520692186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_237a23d7-0aa5-4a31-bf15-51d520692186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c9ffc83c-e8d6-41ce-a6ed-6dab9418dc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c9ffc83c-e8d6-41ce-a6ed-6dab9418dc8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement_81b8a108-663d-42db-a74e-279d2522f3c2" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement_81b8a108-663d-42db-a74e-279d2522f3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage_9c0eb4ba-48bd-4014-972a-b141998130c2" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage_9c0eb4ba-48bd-4014-972a-b141998130c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage_23389fa6-7aa4-4d17-a07c-4859333db97c" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage_23389fa6-7aa4-4d17-a07c-4859333db97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage_902c44f5-0504-4a0e-a3d6-52192c1c6ccc" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage_902c44f5-0504-4a0e-a3d6-52192c1c6ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_7f7009c5-00ee-4016-b342-4299e0d72b47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_7f7009c5-00ee-4016-b342-4299e0d72b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal_74f24981-d7cc-472d-a9dc-4de281ea5b6c" xlink:href="sibn-20210930.xsd#sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal_74f24981-d7cc-472d-a9dc-4de281ea5b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_26d98ae6-cb56-4680-9fd6-71ae9fc2e565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_26d98ae6-cb56-4680-9fd6-71ae9fc2e565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_SocialSecurityTaxEmployerDeferralCARESAct_dac097d3-7868-4f98-aa76-6692317fbd73" xlink:href="sibn-20210930.xsd#sibn_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c897580f-bffc-4c28-be79-56f649d9790f" xlink:to="loc_sibn_SocialSecurityTaxEmployerDeferralCARESAct_dac097d3-7868-4f98-aa76-6692317fbd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/BorrowingsDebtMaturityDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#BorrowingsDebtMaturityDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/BorrowingsDebtMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_26dcda70-5188-45b3-9c43-2bdf9dcd970e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_5948f8f8-b202-4cbe-8c0f-6f3e94a85816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_26dcda70-5188-45b3-9c43-2bdf9dcd970e" xlink:to="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_5948f8f8-b202-4cbe-8c0f-6f3e94a85816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_6543985c-2555-44fb-aa49-c912c3cb923e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_5948f8f8-b202-4cbe-8c0f-6f3e94a85816" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_6543985c-2555-44fb-aa49-c912c3cb923e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_7ab5e55a-51db-4da9-a27d-0fcdb5160e38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_5948f8f8-b202-4cbe-8c0f-6f3e94a85816" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_7ab5e55a-51db-4da9-a27d-0fcdb5160e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_f92b89e6-0a37-44d4-a283-75ffd6f3e783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_5948f8f8-b202-4cbe-8c0f-6f3e94a85816" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_f92b89e6-0a37-44d4-a283-75ffd6f3e783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_828f5154-6f46-4078-a6bd-9e7103834e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_5948f8f8-b202-4cbe-8c0f-6f3e94a85816" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_828f5154-6f46-4078-a6bd-9e7103834e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0ea2bdf0-41b1-461a-a688-892ecb821959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_5948f8f8-b202-4cbe-8c0f-6f3e94a85816" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0ea2bdf0-41b1-461a-a688-892ecb821959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a420c7e0-9914-4589-b432-2a27f9b4f4b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_5948f8f8-b202-4cbe-8c0f-6f3e94a85816" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a420c7e0-9914-4589-b432-2a27f9b4f4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlans" xlink:type="simple" xlink:href="sibn-20210930.xsd#StockBasedIncentiveCompensationPlans"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e9004ada-cf88-4191-8c96-508a85c5c2a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4f6bacc9-56aa-4afb-97b0-9be376b9d516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e9004ada-cf88-4191-8c96-508a85c5c2a5" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4f6bacc9-56aa-4afb-97b0-9be376b9d516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables" xlink:type="simple" xlink:href="sibn-20210930.xsd#StockBasedIncentiveCompensationPlansTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_57537d7c-4eba-4e62-9e85-7f168b18a384" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_7a604095-2014-4c8c-8404-4ed7583afb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_57537d7c-4eba-4e62-9e85-7f168b18a384" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_7a604095-2014-4c8c-8404-4ed7583afb0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2b61ef0e-3a7c-4e9e-86db-442d083b5e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_57537d7c-4eba-4e62-9e85-7f168b18a384" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2b61ef0e-3a7c-4e9e-86db-442d083b5e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_22220046-2f01-42b9-bd7b-6c1ffe0f162f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_57537d7c-4eba-4e62-9e85-7f168b18a384" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_22220046-2f01-42b9-bd7b-6c1ffe0f162f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_03df4f7d-0c25-4374-a055-631ac68d8fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_57537d7c-4eba-4e62-9e85-7f168b18a384" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_03df4f7d-0c25-4374-a055-631ac68d8fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#StockBasedIncentiveCompensationPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6cbaead6-4a62-44bc-a5f9-ffa616a89a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcc90e63-6f92-4f2e-843e-8eeeea97cde0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6cbaead6-4a62-44bc-a5f9-ffa616a89a5b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcc90e63-6f92-4f2e-843e-8eeeea97cde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_503c4f9a-803a-4ffe-8080-b70856e4ff3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcc90e63-6f92-4f2e-843e-8eeeea97cde0" xlink:to="loc_us-gaap_PlanNameAxis_503c4f9a-803a-4ffe-8080-b70856e4ff3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d97c8fd5-3743-496a-abd7-74d713a05895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_503c4f9a-803a-4ffe-8080-b70856e4ff3f" xlink:to="loc_us-gaap_PlanNameDomain_d97c8fd5-3743-496a-abd7-74d713a05895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_A2018EmployeeStockPurchasePlanMember_e33062cf-9d22-4083-ad91-5f3344b01ad5" xlink:href="sibn-20210930.xsd#sibn_A2018EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d97c8fd5-3743-496a-abd7-74d713a05895" xlink:to="loc_sibn_A2018EmployeeStockPurchasePlanMember_e33062cf-9d22-4083-ad91-5f3344b01ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ca48cbe5-9c70-43de-af60-f96eb68be7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcc90e63-6f92-4f2e-843e-8eeeea97cde0" xlink:to="loc_us-gaap_AwardTypeAxis_ca48cbe5-9c70-43de-af60-f96eb68be7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ae30237-1fea-48c2-b1d9-eaaba75cf8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ca48cbe5-9c70-43de-af60-f96eb68be7cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ae30237-1fea-48c2-b1d9-eaaba75cf8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_78fa45f3-71e8-4f05-a48c-82a99b6e948d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ae30237-1fea-48c2-b1d9-eaaba75cf8d3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_78fa45f3-71e8-4f05-a48c-82a99b6e948d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4fb68350-99a9-4756-bc94-30fb1570f529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ae30237-1fea-48c2-b1d9-eaaba75cf8d3" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4fb68350-99a9-4756-bc94-30fb1570f529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcc90e63-6f92-4f2e-843e-8eeeea97cde0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_4f93da8a-40d9-4aca-ba5f-94b24f9f7c65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_4f93da8a-40d9-4aca-ba5f-94b24f9f7c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_99a1a019-1a32-4163-9cd7-768e09018e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_99a1a019-1a32-4163-9cd7-768e09018e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_29a0a228-cf1e-4ca2-bf91-608d2557aeea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_29a0a228-cf1e-4ca2-bf91-608d2557aeea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase_83ca8bf5-ebe6-4461-99ff-38fe5974ae45" xlink:href="sibn-20210930.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase_83ca8bf5-ebe6-4461-99ff-38fe5974ae45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_71746044-7560-47bf-8137-f1170b9ce23d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_71746044-7560-47bf-8137-f1170b9ce23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_9b157b8c-43aa-430b-ad88-d32b915caf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_9b157b8c-43aa-430b-ad88-d32b915caf2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval_5b767672-7c4e-4510-8739-0b8cc08c4701" xlink:href="sibn-20210930.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval_5b767672-7c4e-4510-8739-0b8cc08c4701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_bed8715c-7a54-4de9-a3fd-5d6c40f35bbc" xlink:href="sibn-20210930.xsd#sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_bed8715c-7a54-4de9-a3fd-5d6c40f35bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_d2d144fb-4d23-4ed8-80f8-159c7fe09332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_d2d144fb-4d23-4ed8-80f8-159c7fe09332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_851e5538-74a4-404d-a417-8a2fd17ac440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_851e5538-74a4-404d-a417-8a2fd17ac440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_1b21747d-26a3-4e63-befa-b69ff43b97ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e96a0069-fe26-437e-a720-d94833f29cbc" xlink:to="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_1b21747d-26a3-4e63-befa-b69ff43b97ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#StockBasedIncentiveCompensationPlansStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5dcc28f1-bcbb-424f-87d7-d92dee6eec18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c9cc2e1d-80a9-4f53-b19b-e383e907dd02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5dcc28f1-bcbb-424f-87d7-d92dee6eec18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c9cc2e1d-80a9-4f53-b19b-e383e907dd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ea252b29-d014-464f-96fd-f16b3eacfd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c9cc2e1d-80a9-4f53-b19b-e383e907dd02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ea252b29-d014-464f-96fd-f16b3eacfd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0143b5ae-fa1d-4b42-abb7-cdde269d713c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c9cc2e1d-80a9-4f53-b19b-e383e907dd02" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0143b5ae-fa1d-4b42-abb7-cdde269d713c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_8a8a7ec3-524a-4b13-88de-1acf07892f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c9cc2e1d-80a9-4f53-b19b-e383e907dd02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_8a8a7ec3-524a-4b13-88de-1acf07892f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ff72eb72-30a6-4e25-a227-06a0856abbb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c9cc2e1d-80a9-4f53-b19b-e383e907dd02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ff72eb72-30a6-4e25-a227-06a0856abbb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1355ed42-723b-4d6d-95a2-82dbcb7182ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5dcc28f1-bcbb-424f-87d7-d92dee6eec18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1355ed42-723b-4d6d-95a2-82dbcb7182ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_445fe621-4d8e-43f4-b9a4-8719ff5bd82f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1355ed42-723b-4d6d-95a2-82dbcb7182ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_445fe621-4d8e-43f4-b9a4-8719ff5bd82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9405776b-556d-4158-87ca-6e100cbd7ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1355ed42-723b-4d6d-95a2-82dbcb7182ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9405776b-556d-4158-87ca-6e100cbd7ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_37b70bcd-0ca0-4ce8-8211-36442ea39ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1355ed42-723b-4d6d-95a2-82dbcb7182ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_37b70bcd-0ca0-4ce8-8211-36442ea39ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5b8d3b96-c8bb-45b2-97f8-f1aeaa0255c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1355ed42-723b-4d6d-95a2-82dbcb7182ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5b8d3b96-c8bb-45b2-97f8-f1aeaa0255c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7b830470-8f4c-4801-af2d-b0065b5794f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2cc138-037f-4298-924f-3d5bd391f6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7b830470-8f4c-4801-af2d-b0065b5794f0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2cc138-037f-4298-924f-3d5bd391f6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_796f9481-13da-4768-af6e-1ef3d881b3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2cc138-037f-4298-924f-3d5bd391f6d6" xlink:to="loc_us-gaap_AwardTypeAxis_796f9481-13da-4768-af6e-1ef3d881b3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05e50100-85af-4f75-957f-6e53accb9770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_796f9481-13da-4768-af6e-1ef3d881b3ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05e50100-85af-4f75-957f-6e53accb9770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_81553e65-03d8-4ec7-9c2f-bc32d11d9ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05e50100-85af-4f75-957f-6e53accb9770" xlink:to="loc_us-gaap_EmployeeStockOptionMember_81553e65-03d8-4ec7-9c2f-bc32d11d9ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_57077068-b637-43f9-aced-47c3b6bef565" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2cc138-037f-4298-924f-3d5bd391f6d6" xlink:to="loc_srt_RangeAxis_57077068-b637-43f9-aced-47c3b6bef565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6355b515-56d9-4105-9de3-b62e98a03af5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_57077068-b637-43f9-aced-47c3b6bef565" xlink:to="loc_srt_RangeMember_6355b515-56d9-4105-9de3-b62e98a03af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6cde5460-cf71-40a4-b263-a6ca23a0bef2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6355b515-56d9-4105-9de3-b62e98a03af5" xlink:to="loc_srt_MinimumMember_6cde5460-cf71-40a4-b263-a6ca23a0bef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ac93a66f-3831-459a-9b19-fb11ef308b1e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6355b515-56d9-4105-9de3-b62e98a03af5" xlink:to="loc_srt_MaximumMember_ac93a66f-3831-459a-9b19-fb11ef308b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_05250cd7-b116-41b6-aafe-aa09860a2313" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2cc138-037f-4298-924f-3d5bd391f6d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_05250cd7-b116-41b6-aafe-aa09860a2313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_05250cd7-b116-41b6-aafe-aa09860a2313" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_04d83cb0-1fff-4f9b-a8eb-f718f4e68c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_04d83cb0-1fff-4f9b-a8eb-f718f4e68c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_459fa68d-1b6b-40b6-a637-799f15393e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_459fa68d-1b6b-40b6-a637-799f15393e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_b666d342-5cb2-4126-afb9-2feed7e827c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_b666d342-5cb2-4126-afb9-2feed7e827c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_19b0deb4-72ce-49de-b10b-e2ae97d050ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_19b0deb4-72ce-49de-b10b-e2ae97d050ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_06b464ef-a24f-45ba-bea9-431b39d45c34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_06b464ef-a24f-45ba-bea9-431b39d45c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_b8c6fe91-2527-4c7c-a65b-5f517805b6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_b8c6fe91-2527-4c7c-a65b-5f517805b6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7a8370e0-f4e9-49df-9a35-3881d041d81a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_53347824-2151-4a02-9d1f-116819b5c0b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7a8370e0-f4e9-49df-9a35-3881d041d81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cd830d2f-23d1-4c11-8a04-a2ac24e8ae49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0daa54d2-413b-4a46-b112-287366f47930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cd830d2f-23d1-4c11-8a04-a2ac24e8ae49" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0daa54d2-413b-4a46-b112-287366f47930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f1be6b86-1854-4f87-bf8e-0d6b9c4d33f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0daa54d2-413b-4a46-b112-287366f47930" xlink:to="loc_us-gaap_AwardTypeAxis_f1be6b86-1854-4f87-bf8e-0d6b9c4d33f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd7a0679-98c3-468f-a871-905808f3915e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f1be6b86-1854-4f87-bf8e-0d6b9c4d33f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd7a0679-98c3-468f-a871-905808f3915e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5bb651b3-9855-4d39-8fe3-3505002adb91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd7a0679-98c3-468f-a871-905808f3915e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5bb651b3-9855-4d39-8fe3-3505002adb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de3177c5-d107-4f5a-a4c2-87a877cdaa0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0daa54d2-413b-4a46-b112-287366f47930" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de3177c5-d107-4f5a-a4c2-87a877cdaa0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3849413a-9028-4d8f-97db-63ebdaa58149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de3177c5-d107-4f5a-a4c2-87a877cdaa0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3849413a-9028-4d8f-97db-63ebdaa58149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cbec94d3-d7bb-4c5c-a7d1-c2a54e898256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3849413a-9028-4d8f-97db-63ebdaa58149" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cbec94d3-d7bb-4c5c-a7d1-c2a54e898256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a69c9f4b-3371-4cc2-bbc7-15ffb53b44e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3849413a-9028-4d8f-97db-63ebdaa58149" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a69c9f4b-3371-4cc2-bbc7-15ffb53b44e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c392147b-9799-4c51-aa16-51c295c209d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3849413a-9028-4d8f-97db-63ebdaa58149" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c392147b-9799-4c51-aa16-51c295c209d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f26460c5-d72a-48da-bb3f-3162b82f6195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3849413a-9028-4d8f-97db-63ebdaa58149" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f26460c5-d72a-48da-bb3f-3162b82f6195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e7e596c5-2c00-498b-939d-f7ceb1b83473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3849413a-9028-4d8f-97db-63ebdaa58149" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e7e596c5-2c00-498b-939d-f7ceb1b83473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3339999d-3a45-43f4-bf85-2ee218b8b0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_de3177c5-d107-4f5a-a4c2-87a877cdaa0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3339999d-3a45-43f4-bf85-2ee218b8b0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a48cefe5-b347-4f0f-a00a-e877a0df1aef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3339999d-3a45-43f4-bf85-2ee218b8b0e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a48cefe5-b347-4f0f-a00a-e877a0df1aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1f32db86-a8b4-4571-9be8-2be062518fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3339999d-3a45-43f4-bf85-2ee218b8b0e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1f32db86-a8b4-4571-9be8-2be062518fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_219e6a12-7b1a-4027-bc97-9141752f8545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3339999d-3a45-43f4-bf85-2ee218b8b0e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_219e6a12-7b1a-4027-bc97-9141752f8545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a4495154-33c0-4fec-ad16-4391869e34a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3339999d-3a45-43f4-bf85-2ee218b8b0e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a4495154-33c0-4fec-ad16-4391869e34a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c5d9e31e-ed9f-41ae-8b05-0d2d212c5770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3339999d-3a45-43f4-bf85-2ee218b8b0e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c5d9e31e-ed9f-41ae-8b05-0d2d212c5770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a27ec8b1-1898-4c8c-baf4-36159d540bef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c49eb0-3ee8-4bc9-8c49-dae554a5f158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a27ec8b1-1898-4c8c-baf4-36159d540bef" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c49eb0-3ee8-4bc9-8c49-dae554a5f158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bd901361-bfb1-4b1a-89ef-f64396e8389f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c49eb0-3ee8-4bc9-8c49-dae554a5f158" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bd901361-bfb1-4b1a-89ef-f64396e8389f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e7ac29c3-c588-48a7-aba9-af8389a2defa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bd901361-bfb1-4b1a-89ef-f64396e8389f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e7ac29c3-c588-48a7-aba9-af8389a2defa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c65c88b1-d579-4bbd-923c-4f0b6a34d584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e7ac29c3-c588-48a7-aba9-af8389a2defa" xlink:to="loc_us-gaap_CostOfSalesMember_c65c88b1-d579-4bbd-923c-4f0b6a34d584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_f5920735-8c1c-4f0a-a7ab-ac38ff0b32ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e7ac29c3-c588-48a7-aba9-af8389a2defa" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_f5920735-8c1c-4f0a-a7ab-ac38ff0b32ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c068a31c-9f47-4795-ba22-38345b5f34a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e7ac29c3-c588-48a7-aba9-af8389a2defa" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c068a31c-9f47-4795-ba22-38345b5f34a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5e72cbc2-9ccd-4542-ab90-543227294654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e7ac29c3-c588-48a7-aba9-af8389a2defa" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5e72cbc2-9ccd-4542-ab90-543227294654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c9e210-c5bd-43b7-aec9-1bf8fe85437d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c49eb0-3ee8-4bc9-8c49-dae554a5f158" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c9e210-c5bd-43b7-aec9-1bf8fe85437d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_87929450-456f-4701-aaf4-af12845f03cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28c9e210-c5bd-43b7-aec9-1bf8fe85437d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_87929450-456f-4701-aaf4-af12845f03cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/NetLossPerShareofCommonStock" xlink:type="simple" xlink:href="sibn-20210930.xsd#NetLossPerShareofCommonStock"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/NetLossPerShareofCommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b6538144-4015-4670-ac77-5ddbb1ffa6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_f93adfad-b419-4627-a581-d5ca17632716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b6538144-4015-4670-ac77-5ddbb1ffa6d8" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_f93adfad-b419-4627-a581-d5ca17632716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/NetLossPerShareofCommonStockTables" xlink:type="simple" xlink:href="sibn-20210930.xsd#NetLossPerShareofCommonStockTables"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/NetLossPerShareofCommonStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8ed6fc6c-5a89-44c6-a615-041062a59b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9f02a80f-c976-4129-8a62-8cbf4b602147" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8ed6fc6c-5a89-44c6-a615-041062a59b8b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9f02a80f-c976-4129-8a62-8cbf4b602147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_a7e13462-13e1-41d1-891c-a9f1440a6dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8ed6fc6c-5a89-44c6-a615-041062a59b8b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_a7e13462-13e1-41d1-891c-a9f1440a6dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#NetLossPerShareofCommonStockComputationofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1aa6d004-0fb7-4f84-b8c5-b611735253d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f49fe986-04ac-41b4-a64c-9fac758e8a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1aa6d004-0fb7-4f84-b8c5-b611735253d8" xlink:to="loc_us-gaap_NetIncomeLoss_f49fe986-04ac-41b4-a64c-9fac758e8a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_42b7e8e5-ec83-42ee-99c6-091a1f86586a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1aa6d004-0fb7-4f84-b8c5-b611735253d8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_42b7e8e5-ec83-42ee-99c6-091a1f86586a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ca6f54eb-5636-4cc3-8f53-3c9850103ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1aa6d004-0fb7-4f84-b8c5-b611735253d8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ca6f54eb-5636-4cc3-8f53-3c9850103ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_62a69c31-b28d-4d26-a260-75f81c959e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1aa6d004-0fb7-4f84-b8c5-b611735253d8" xlink:to="loc_us-gaap_EarningsPerShareBasic_62a69c31-b28d-4d26-a260-75f81c959e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5eb6d97c-b97f-499c-b9f7-c57500737a64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1aa6d004-0fb7-4f84-b8c5-b611735253d8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5eb6d97c-b97f-499c-b9f7-c57500737a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_829b6c65-dfd7-4570-9804-1d494e672163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fe90ae25-ca31-45b9-a2c6-7f0d4a68aa48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_829b6c65-dfd7-4570-9804-1d494e672163" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fe90ae25-ca31-45b9-a2c6-7f0d4a68aa48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0637b2b4-072d-4e9d-92f6-482cb70c7874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fe90ae25-ca31-45b9-a2c6-7f0d4a68aa48" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0637b2b4-072d-4e9d-92f6-482cb70c7874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ddcd3b7-d1ad-4373-bac9-01a11ebb2b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0637b2b4-072d-4e9d-92f6-482cb70c7874" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ddcd3b7-d1ad-4373-bac9-01a11ebb2b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_31b13b92-8ae9-4002-8dca-c6eded668e43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ddcd3b7-d1ad-4373-bac9-01a11ebb2b4a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_31b13b92-8ae9-4002-8dca-c6eded668e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_12a3a83d-60f2-4265-b138-bc5ab07dd0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ddcd3b7-d1ad-4373-bac9-01a11ebb2b4a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_12a3a83d-60f2-4265-b138-bc5ab07dd0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_ShareSubjectToRepurchaseMember_19e2a3f0-44f8-43cc-b2e6-6760253b4689" xlink:href="sibn-20210930.xsd#sibn_ShareSubjectToRepurchaseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ddcd3b7-d1ad-4373-bac9-01a11ebb2b4a" xlink:to="loc_sibn_ShareSubjectToRepurchaseMember_19e2a3f0-44f8-43cc-b2e6-6760253b4689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_EmployeeStockPurchasePlanSharesMember_a32ef80e-ba41-48c4-9d2d-8dd408122296" xlink:href="sibn-20210930.xsd#sibn_EmployeeStockPurchasePlanSharesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ddcd3b7-d1ad-4373-bac9-01a11ebb2b4a" xlink:to="loc_sibn_EmployeeStockPurchasePlanSharesMember_a32ef80e-ba41-48c4-9d2d-8dd408122296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_CommonStockWarrantsMember_2ac9907c-4e62-4fc9-a9d4-73f146223681" xlink:href="sibn-20210930.xsd#sibn_CommonStockWarrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8ddcd3b7-d1ad-4373-bac9-01a11ebb2b4a" xlink:to="loc_sibn_CommonStockWarrantsMember_2ac9907c-4e62-4fc9-a9d4-73f146223681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1f10fa19-cd0f-4b67-a4c5-7c28c4ebe510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fe90ae25-ca31-45b9-a2c6-7f0d4a68aa48" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1f10fa19-cd0f-4b67-a4c5-7c28c4ebe510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b2597e91-b771-4833-9335-2d3097549889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1f10fa19-cd0f-4b67-a4c5-7c28c4ebe510" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b2597e91-b771-4833-9335-2d3097549889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/RelatedPartyTransaction" xlink:type="simple" xlink:href="sibn-20210930.xsd#RelatedPartyTransaction"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/RelatedPartyTransaction" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_f5ecd441-bda1-4b45-9cec-370495e6b4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_7a32319f-182c-4bc3-83b0-50232ddf507b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_f5ecd441-bda1-4b45-9cec-370495e6b4e5" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_7a32319f-182c-4bc3-83b0-50232ddf507b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/RelatedPartyTransactionDetails" xlink:type="simple" xlink:href="sibn-20210930.xsd#RelatedPartyTransactionDetails"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/RelatedPartyTransactionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_ddaee013-237d-40e9-9efd-bebc942b1ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f63d004f-3a41-4776-b174-6f04d228d4f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_ddaee013-237d-40e9-9efd-bebc942b1ca6" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f63d004f-3a41-4776-b174-6f04d228d4f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7dfada8f-8572-472f-8285-0eda152c7467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f63d004f-3a41-4776-b174-6f04d228d4f6" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7dfada8f-8572-472f-8285-0eda152c7467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7f0cda2a-aff9-4007-aac4-966f90774a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7dfada8f-8572-472f-8285-0eda152c7467" xlink:to="loc_us-gaap_RelatedPartyDomain_7f0cda2a-aff9-4007-aac4-966f90774a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_e901d902-3e16-4976-96e3-19be4e8b0abc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_7f0cda2a-aff9-4007-aac4-966f90774a17" xlink:to="loc_srt_AffiliatedEntityMember_e901d902-3e16-4976-96e3-19be4e8b0abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_bcc13b03-ea38-4344-9799-d2e40bc077c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f63d004f-3a41-4776-b174-6f04d228d4f6" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_bcc13b03-ea38-4344-9799-d2e40bc077c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_ac5c9544-47ca-4b35-afa9-a67849c714cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_bcc13b03-ea38-4344-9799-d2e40bc077c1" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_ac5c9544-47ca-4b35-afa9-a67849c714cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_DevelopmentAgreementMember_338ae50f-f365-46a0-ba18-d255d8e3fdd1" xlink:href="sibn-20210930.xsd#sibn_DevelopmentAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ac5c9544-47ca-4b35-afa9-a67849c714cb" xlink:to="loc_sibn_DevelopmentAgreementMember_338ae50f-f365-46a0-ba18-d255d8e3fdd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_39f89cdb-e187-4a3f-8b5f-b18a09c17410" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f63d004f-3a41-4776-b174-6f04d228d4f6" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_39f89cdb-e187-4a3f-8b5f-b18a09c17410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_e1dee89d-87a6-4d55-9c92-f3530e3b8ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_39f89cdb-e187-4a3f-8b5f-b18a09c17410" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_e1dee89d-87a6-4d55-9c92-f3530e3b8ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_3dcd2d56-14f7-449b-8800-4f85d0fd50ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_39f89cdb-e187-4a3f-8b5f-b18a09c17410" xlink:to="loc_us-gaap_DueToAffiliateCurrent_3dcd2d56-14f7-449b-8800-4f85d0fd50ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sibn_RelatedPartyTransactionTermOfAgreement_0ff25e6e-9cbe-4375-8ece-b49c1aea6c78" xlink:href="sibn-20210930.xsd#sibn_RelatedPartyTransactionTermOfAgreement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_39f89cdb-e187-4a3f-8b5f-b18a09c17410" xlink:to="loc_sibn_RelatedPartyTransactionTermOfAgreement_0ff25e6e-9cbe-4375-8ece-b49c1aea6c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://si-bone.com/role/IncomeTaxes" xlink:type="simple" xlink:href="sibn-20210930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://si-bone.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9f7ac3e6-77ec-4124-a5bd-94b43f4e6cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_b636c451-a8f7-415e-85eb-8a46902c2b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9f7ac3e6-77ec-4124-a5bd-94b43f4e6cef" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_b636c451-a8f7-415e-85eb-8a46902c2b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>sibn-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sibn="http://si-bone.com/20210930"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="sibn-20210930.xsd" xlink:type="simple"/>
    <context id="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i357c3dc213a54bb18148da0ae1debda3_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i9db2347a40b8493cbe05311630711796_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0cb4295888e44afca3a0e40aa138b826_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i419d7376a11a4f999760045756fc1697_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3c64a70df00648478c80144873723f9d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i00e5b99cc6f44c89bffc8842ab1cc43f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic2b9c3748b62489b87de37d50a5ee65e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6c0c789badb24a7a900f02455d94a596_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3478645a9bc24eaf82a0f884d4e7301f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6305ce423c24473be85c1772c0267e2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icb4574bb241d4e00bfb9eaee77d0f93e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1159e4f921fa4ba09c9b2b7bb7978816_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6b886e77773d4100b841947a370dbd45_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i44b3f6ddf6bd462b9a921c7660367222_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i40496ae85a1c42a5b586e6a69298a32f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6fdbf7f9eee94fd99865f6c845fc9e5c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic05d1aa069db477fb7428cb7052a36ba_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1bc41da9d91a4b3ebbf8a73d9351127d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i50c3adee274e4d9897c1e9b97580f092_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3b44971cd3d44f208027309c7bec414e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i012e884dcba141699671d533f8f9d6d5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i25d6449704a74361b824fbddaab1b298_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i92f4fbe9f6904a2a84b286559158e8ae_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie62877f00b8945bc828ba27d3c2bbdc8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9c273f41c79c4fbdb0d1230fd0559e14_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2093b54ed2e847d8acdb383a67170813_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0e87b080b86f4c85a1a6027779356588_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1b6779adb1074d70a27f1bd8c370bdd2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idf8d120fadaf4453aef93c87406ea34a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id07b214d4e3f413786721103a10a44e5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i98959cdb5f6c4fe6bbf1638730028292_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifa96cfe1e061452eab347a7417e00927_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i859739929cdc49feb9e1b5e371f5be77_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id6a7688791524893986b66bd6348be2b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iccb5bcce85274a778eab4af6eb1d355b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ief8c77e32bdc4fd0aff571107321d934_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0a812a4bda164222b3c7aea2c545528d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i21d4eb0fbe1b4f2082f7882f874778fc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2e3370ae52f94141aa28c7b6558b03f8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie8c36c532ca54066828971da81e190b9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4d59943d7b8c4788bf7ebb802bf66b71_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i89789d0c91fe4169839f59b9bd5ea2df_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2073aa5d83e1437fbb0649d1c506d3fe_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i37dff38285374aa6920e237cc777bdab_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i390582358ab4487fba346af76b925fb2_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i169c05e9512945e6a8746c4ef8542f10_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3b13a3cd460d43529a51830c587f1ae4_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i00aae33ac66f498b91c8304d0a3684e6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id5f4f5a94479403fa8baf12ad75427e3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2f8c0ef6b0b142b08f6da44a05bdb9e8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i29ed3ed441cb4fa78bb6e83cf96aedef_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id216b900385f40ddb4e3e20115d76dc5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7452925b0e5546ac8e3a5572be6ec889_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="idc576cf893e347489acff339085d0f95_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i610b8b3420f644baacc410f92061ab95_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8ff5e648858d44668dc102d8309e731c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i24f538cb702e4c0c8e346a1f3598951b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idbfd8a209c764a95b7ea7a91a7fc9474_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i245280170e0946e9aea8da85b267bfe2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i051e88f32e88449d8536056f5184fd50_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i81b69c135aa5478fb8c1e2ad5ddcee2c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i165ebc065905414c9459402dde0eea16_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia51f1dbf872743908801048a58b16c15_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2d612f341375492d8de3802bb7d01ce5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4ed0f6117ecf4e2cb1bee31260a098b5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia481f049459c472a9b4860fc2be9a142_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i426469690ff2417c9f81c8a4128839c6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i010b44ff2d3446fa8e15486e55a92e47_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic84bb4fdd42940249648de647e304e0a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i715926d08424490aabf690d9fa2f75e2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4d2b391980d14a2aaf03c702bc7ee2f8_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:FollowOnPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9010c1b3cf4c4b1a9c2136e170a13186_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:FollowOnPublicOfferingAndSecondaryOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i69d57d1462cc4484b5d209182af32f3f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i109df68e90ee490a9db47812746364dc_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:FollowOnPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib80c352eab074e7f8283e97c5bcd56d3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:SecondaryOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic20806741c494cdba90d292fbf08fc22_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:SecondFollowOnPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="iff1f8e32880046b2b07d08aa6eea7ef8_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i43f819d6ee994d6087b5510e48ec11a2_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:SecondFollowOnPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i7415c778d8224834a93c6630cef41f4e_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:SecondaryOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i278b0ccaf44c482899bd7ba4f716814d_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sibn:SecondaryOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ie659bc55581349eca6480acadb12d4f9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i976ed3cd496b4e58a4dc4becdbc4161b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if12a2b6dbfac4d1ab143dfbd3f951b36_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i46482b4e0b8440ce80cee026cd1125e8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1317afa536514c45b39738af99fef75c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5ff853edb14242bc858575b0953b7ca6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibd3e395480d74661ada50ae4fd7afc82_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iacd5d89692c34b9496302d55a55bc7ce_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i380833eacc394ce0bea4afe14c77beb8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if5b1f78d1cc14db3aff7642b38d0594b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0b457a33537545b79259df1751c27179_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8ec84971611b4b4b9fb02e3e0833ebe2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if0cb0da3346b4ba79a69c2838e5d4b76_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idac9e0269b454ee2a0357ade267691e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie171077119e94be4b547961f085b9ae7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i054dc78f1b714085a5838ba8d5780e3e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if50d4b24e0734d79ba8b9edd1e805e40_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i57ab096c74ac4847b7ee788ce1789d46_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id144f1a299a84ecbbb8e3d9cd71920cf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i433ab522b59a4aa783879f2118cf5b5a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i725fda3b69fb42b69214192df2b4307e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2cdbdee501ca4f0b85e078944f534f65_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i41b6362dacd34d9f88a9c8993387770b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iaf59194f545044df83f3f403416ed170_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i241fe256234a44b3b77f08e14eca6888_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i686c44112b5d4f3ba9a4d54da9d73cbf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i00577f535d504af0be68212884f55f8b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3ea729b060074c5899a64ea1337e293b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i102d310b7d67475fb03b9907bc7c3d46_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6d3079b6c3604eddb06b821bf1c2d0b7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie78d10f8420241fe8b24a9e42e1f528a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i27fdd2acd64a4b8d85de92ce53842683_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie0ab19ddd1d0461c9e0d4e27776d7d1f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i98e6ede9aecc414587ca1f1a67b50d01_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i987e7b13124e43d7b5ae40e6246e58cc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5e29646458c343d4b6be0890911f4d9c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3ecf8bebd1ef4e9ab058a08dfe87ac43_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i41f57a77065c4ecf98478986ebfac018_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0e6ed7e99cde4d7c92e1b6df344d0083_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibde2c8052a5648118d562a14a46b38fe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i80b10d0cb3ff49df8d232f17ea2522e9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a26c11caa9041ccaf5933b7b93b6d6c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i68990ae0b9c64420ab7d40fcde0e4612_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7b8c7b83b4a74dd6b717a704b99447b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ica53df319b9b4f6b8b770a1f538ab111_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3b60576a921b48b680618b3810b404bd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i66fdccee615a470db6971cc34c65e8c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e5ba73a05ed40299cc3f10f52f1b435_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icb844642c3174f18a5186ba1283f54e9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id53205439e8b4340b3ce102dd284cbde_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5b4f96fcd7e24f62a9e449453e2b6f9a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib6911b659231424280f48b741135ca13_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia33d55a979204b7f9ccc70abb78a1a48_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6360a4b99f2b445481090bd10f1bbeff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3a1f642004944d43b7569e23fd29e61c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i757d3032f8fc4a71b0a40a93905bf6dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id245cbf5f02e45a6bad677ee88cd874f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i24eb57cd3b86414f942f4026431cbebc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iea20d262a08e4a9686dd6fc4c64b6cbc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i737a4beebbff4635b25833b31ee0943e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6421c98b366e420ca30776333d1e2c0a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie875541c2b924f32a637a5864a311bb1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icca253489e02432f8f1edbe1cd8e4d4a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i20f42e5899834f1d97e11131b6de99de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i678091eb517f46e1b50ede7a3998b1b3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8864c9b1ec194188b89a16633da21be7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i78e300a956264748aa120a323a6cb2b5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ConstructionInProgressSurgicalPlacementInstrumentSetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iac1bec7b510c4ec2b6a53deea9267b72_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sibn:ConstructionInProgressSantaClaraLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i96d95d6a89cf4265bdd53a11781c3f3b_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="ieccec3c1ede24d35a58527aa4850247b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9791c5febf8a46f2885eb2f4b7f67d9e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0cb314875c314dbaa8fbacdb1b38b748_D20171001-20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:PharmakonTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-10-31</endDate>
        </period>
    </context>
    <context id="i76a103c32c444270af93260d49552321_I20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:PharmakonTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-31</instant>
        </period>
    </context>
    <context id="i38122eef897040fe8f70c368cf10c531_I20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:PharmakonTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sibn:DebtPrepaymentPenaltyPeriodAxis">sibn:PrepaymentPenalty3148MonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-31</instant>
        </period>
    </context>
    <context id="i61a838a9e8594bccb6b1be280637f067_I20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:PharmakonTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sibn:DebtPrepaymentPenaltyPeriodAxis">sibn:PrepaymentPenalty4960MonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-31</instant>
        </period>
    </context>
    <context id="id10385b30b3442289883167a68f5b983_I20200529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-29</instant>
        </period>
    </context>
    <context id="iba585a7740f44fc985da65b9dcbe6ac1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie50ee0dd6f3a424dbe678afcb26fe615_D20200529-20200529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">sibn:VariableOptionOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-29</startDate>
            <endDate>2020-05-29</endDate>
        </period>
    </context>
    <context id="i974cd92ce36a4cd597746c92af7a0c88_D20200529-20200529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-29</startDate>
            <endDate>2020-05-29</endDate>
        </period>
    </context>
    <context id="i33f72faa097e4cae973ab53d793b2746_I20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="ia2787e6887df4eadbb3510bc237985e9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i166abb90ea7347a7abf6019141e814f4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2011a05c7ea34cd28f12c592fe8857e3_D20210812-20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="i9064792f4ac4436e8f82e1ce978a4834_I20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sibn:DebtPrepaymentPenaltyPeriodAxis">sibn:PrepaymentPenalty124MonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="i0a17d4dc3afb45438117bbf39fc37e29_I20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SVBTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sibn:DebtPrepaymentPenaltyPeriodAxis">sibn:PrepaymentPenalty24MonthsOnMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="i843aa4772ef6448490b75f692b0f1072_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id34bef8ef9284847bf96f011100e54b4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2fcc266ce2fc436cacae32e6275aaae0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i16d63c9eb96e480599824e634ad5d531_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:SolarLoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5b5a42a702a94c05bf97ad13f96a9b57_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:PharmakonTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i523c84bcfc6d4d41a3fcb3cba85341bb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sibn:PharmakonTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i803e769cd5f448a08a337153cbee48f7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i95bf6c7ddfa44e2d8791432453dc5213_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i124ee46b86c74090ae66a0e1d2bb09bc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibc837735671140f3b29b3df351abc460_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i63d41e579cfd47938da6de7aa8a1649a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2386ac78016144aaa0d5030bad947246_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0544c913fcda445c9dc02da47fd8e3f3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i55b87ead255e4fb486d98dd4fd6bc105_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2557cc90be53464ba8c0545cd23e3d1e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i07d829ca6e82422aa5687003ba7c3973_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i89018ddd42954af7a9c4116beb0b2c43_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i628c4f2ee72e4e8e876d8acc49956b8b_D20200101-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i93c681895e154204b4fbed253a591a2f_D20200501-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id87cc2d1c9b043f287619c8da2816e8a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6e7f9f8af7df41879076b4ffe0b5ee6e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i640640c163644c5ea76e4fa756cfc106_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sibn:A2018EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib695fc1f6bb041edb51e55dea1b41799_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i91cd631ed91d4a67ac1fc657545f5f45_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if87f81e2cc0d49b29ee4c705174cb8c5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i960acef0c23e41da8c4a82a8f9881c4d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i77ae5cbb20b6488383046b736d749e54_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i994609a27d9e4161b8ab111b4129abd7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icb7dadad6be64748a0c1ae6be3e11291_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7ad191f36bb94c309b0048f07d23eca2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9cf34fb005a349d0af6d06e2e451cc1e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic8203731a1314feda1245f5c58a2e0b8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaf70a00d6a1245cda39d6c5734cbbedc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iad6ad9876dc54b99b44b939e6c69da80_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifbcd4bb50a164a709140bf9796c663bc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1fefa124b4804563b8e9ddcbdcb4d0b1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibdd8b69590ec442bb21d4bd6827a9b49_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i322ec7cf7cef4568a7a538070a8ff21e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id0bf7856168a4bbc8d608e2a53cbc8dc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3c468269d170486eb2b4e64a4513440d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i36d4c1a69b2b4a54b975f3d9b0099fc6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia72aa66ef16743e19faa81de6f8529b0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibc3c26de486d43ca9dd20ec5d101e9dc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i77acbbe553ec4a43a1af07135f846a82_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6b097d0adc3b46ba9ea4861ea981873d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9639632395d7474d8c63fe4431f760f8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3d7cc7784aab4de0a474421d3860f6ac_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:ShareSubjectToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i270de781b3674556993d7df5c50f4257_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:ShareSubjectToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic2d646eaf6f3487b995e90e7b3f9638d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:ShareSubjectToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i26c2606ec5ae4f489f0d680cc4f0ba15_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:ShareSubjectToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1310e619e2754e27ad6c1651d898e04e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:EmployeeStockPurchasePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i06fea0e7101e40dba2eb84ffe5da4f05_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:EmployeeStockPurchasePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie7aed40f2b6841ce8093e0bbc418e41e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:EmployeeStockPurchasePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iba3d79dab9b744f8a0b82ce2c0c46ba4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:EmployeeStockPurchasePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id8d65fa942e24ab2b39884d55f6a927d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7310fa50c10c46c8bbee63a8ff92f106_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id66e6a0d9d334aeca662f79c0d8aab8b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifad8a990e145427785bb494543f4b493_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sibn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i828e66a96b3b4c439de37f099c818aac_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaa0e01356bc64335a99cd3efce7ed726_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia2a91817bfc9420fbad12b231fb60c11_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i196e2035a7634702ac62a3f024b8006f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib8afc1805c1c46b7ab718de87f1939ab_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if6308366c8e94613b5653738e3f24c14_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459839</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">sibn:DevelopmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>sibn:segment</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="renewal_option">
        <measure>sibn:renewal_option</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="purchase_period">
        <measure>sibn:purchase_period</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80L2ZyYWc6MGNlNDc2NmQ5NGNjNDI0OThlMTAzYjg1MmE5ODNjMzgvdGFibGU6YzMwNmY0M2E4NWI4NGQyODliYWUxYzE1MDg5MGVlNWIvdGFibGVyYW5nZTpjMzA2ZjQzYTg1Yjg0ZDI4OWJhZTFjMTUwODkwZWU1Yl8xLTEtMS0xLTE_a472e842-4088-450d-8f13-158627f7c9cd">0001459839</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80L2ZyYWc6MGNlNDc2NmQ5NGNjNDI0OThlMTAzYjg1MmE5ODNjMzgvdGFibGU6YzMwNmY0M2E4NWI4NGQyODliYWUxYzE1MDg5MGVlNWIvdGFibGVyYW5nZTpjMzA2ZjQzYTg1Yjg0ZDI4OWJhZTFjMTUwODkwZWU1Yl8yLTEtMS0xLTE_831cee7f-b03f-4c1a-bbfa-e3d782495b96">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80L2ZyYWc6MGNlNDc2NmQ5NGNjNDI0OThlMTAzYjg1MmE5ODNjMzgvdGFibGU6YzMwNmY0M2E4NWI4NGQyODliYWUxYzE1MDg5MGVlNWIvdGFibGVyYW5nZTpjMzA2ZjQzYTg1Yjg0ZDI4OWJhZTFjMTUwODkwZWU1Yl8zLTEtMS0xLTE_d19964f2-f3f6-424d-9568-975adade52ec">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80L2ZyYWc6MGNlNDc2NmQ5NGNjNDI0OThlMTAzYjg1MmE5ODNjMzgvdGFibGU6YzMwNmY0M2E4NWI4NGQyODliYWUxYzE1MDg5MGVlNWIvdGFibGVyYW5nZTpjMzA2ZjQzYTg1Yjg0ZDI4OWJhZTFjMTUwODkwZWU1Yl80LTEtMS0xLTE_d019912c-acb3-404e-8ddd-f976478660a1">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80L2ZyYWc6MGNlNDc2NmQ5NGNjNDI0OThlMTAzYjg1MmE5ODNjMzgvdGFibGU6YzMwNmY0M2E4NWI4NGQyODliYWUxYzE1MDg5MGVlNWIvdGFibGVyYW5nZTpjMzA2ZjQzYTg1Yjg0ZDI4OWJhZTFjMTUwODkwZWU1Yl81LTEtMS0xLTE_5031cd4c-6bb5-4cad-9f47-db37e98f71d6">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTUx_450a79d3-5046-4729-b19f-3dec2647c7ed">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTUy_d49f1a8a-bb2a-4b18-8378-596f7b3e2c64">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMjk_4ae37e60-f483-40d1-9882-543ef8a5fe06">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTU1_a8e8a01f-7416-4129-ab73-bde9420598f9">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTUz_73f93b11-9929-42f9-a698-2b3da5ba3a17">001-38701</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTQ3_c41d6373-307e-4f7f-9549-5ae1d9cad9fa">SI-BONE,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6ZmQwN2NkMzJlYTAzNDEzNWJjNWU4ZjUwNDc3MGE0OGIvdGFibGVyYW5nZTpmZDA3Y2QzMmVhMDM0MTM1YmM1ZThmNTA0NzcwYTQ4Yl8wLTAtMS0xLTE_5817d817-f047-45e8-9891-8be44b7504cd">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6ZmQwN2NkMzJlYTAzNDEzNWJjNWU4ZjUwNDc3MGE0OGIvdGFibGVyYW5nZTpmZDA3Y2QzMmVhMDM0MTM1YmM1ZThmNTA0NzcwYTQ4Yl8wLTItMS0xLTE_477d2021-c69b-4574-8b3c-2142eb7b53bd">26-2216351</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6YjMwYmY1M2E0MTFkNDZmNzk5NjVhMzljZDY2YThkOTQvdGFibGVyYW5nZTpiMzBiZjUzYTQxMWQ0NmY3OTk2NWEzOWNkNjZhOGQ5NF8wLTAtMS0xLTEvdGV4dHJlZ2lvbjpkYzEwODkwZDJkNTE0NzgwODQzZjdlODg0NWIyOTcwOV80_82e82dba-97e6-4332-9b27-be4d7495f4c4">471 El Camino Real</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6YjMwYmY1M2E0MTFkNDZmNzk5NjVhMzljZDY2YThkOTQvdGFibGVyYW5nZTpiMzBiZjUzYTQxMWQ0NmY3OTk2NWEzOWNkNjZhOGQ5NF8wLTAtMS0xLTEvdGV4dHJlZ2lvbjpkYzEwODkwZDJkNTE0NzgwODQzZjdlODg0NWIyOTcwOV84_1728fd91-5f89-4629-acf5-cd64a4e741f5">Suite 101</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6YjMwYmY1M2E0MTFkNDZmNzk5NjVhMzljZDY2YThkOTQvdGFibGVyYW5nZTpiMzBiZjUzYTQxMWQ0NmY3OTk2NWEzOWNkNjZhOGQ5NF8wLTAtMS0xLTEvdGV4dHJlZ2lvbjpkYzEwODkwZDJkNTE0NzgwODQzZjdlODg0NWIyOTcwOV8xMg_8b53173f-d00a-4ccc-8704-250d08771d77">Santa Clara</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6YjMwYmY1M2E0MTFkNDZmNzk5NjVhMzljZDY2YThkOTQvdGFibGVyYW5nZTpiMzBiZjUzYTQxMWQ0NmY3OTk2NWEzOWNkNjZhOGQ5NF8wLTAtMS0xLTEvdGV4dHJlZ2lvbjpkYzEwODkwZDJkNTE0NzgwODQzZjdlODg0NWIyOTcwOV8xNg_984a4d04-4b10-450f-aca2-cd5d062068e2">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6YjMwYmY1M2E0MTFkNDZmNzk5NjVhMzljZDY2YThkOTQvdGFibGVyYW5nZTpiMzBiZjUzYTQxMWQ0NmY3OTk2NWEzOWNkNjZhOGQ5NF8wLTItMS0xLTE_561b47e0-ff25-405b-91b3-991c27702863">95050</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTQz_eb3e6a6b-34c5-43fe-a742-5ce24360fc75">408</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTQ0_1c074996-0d71-4b64-96ac-61d8a1e4816d">207-0700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6NDJkNWRlMTgxOWUxNDEzOWJmZTU3NTA5YzFkYzM5ZDIvdGFibGVyYW5nZTo0MmQ1ZGUxODE5ZTE0MTM5YmZlNTc1MDljMWRjMzlkMl8xLTAtMS0xLTE_2abf13c4-2df4-4712-9a07-9fa9b4eeac34">Common Stock, par value $0.0001&#160;per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6NDJkNWRlMTgxOWUxNDEzOWJmZTU3NTA5YzFkYzM5ZDIvdGFibGVyYW5nZTo0MmQ1ZGUxODE5ZTE0MTM5YmZlNTc1MDljMWRjMzlkMl8xLTEtMS0xLTE_9f4cd499-27d0-4b28-a5e6-9d9564cacbaf">SIBN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6NDJkNWRlMTgxOWUxNDEzOWJmZTU3NTA5YzFkYzM5ZDIvdGFibGVyYW5nZTo0MmQ1ZGUxODE5ZTE0MTM5YmZlNTc1MDljMWRjMzlkMl8xLTItMS0xLTE_d14cd898-4d11-4302-83a2-f48cea72a61a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTQ4_27151d8a-5a19-481e-8757-0f627eebfb28">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTQ5_5ae98c33-2324-4569-b99e-2bf142db457b">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6MGJmMjkzZTMzMTI3NDAzMjk5MDM2MzI1NTBiYmZiZWUvdGFibGVyYW5nZTowYmYyOTNlMzMxMjc0MDMyOTkwMzYzMjU1MGJiZmJlZV8wLTYtMS0xLTE_e71f5455-dcb4-45a2-b2c7-13a283662223">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6MGJmMjkzZTMzMTI3NDAzMjk5MDM2MzI1NTBiYmZiZWUvdGFibGVyYW5nZTowYmYyOTNlMzMxMjc0MDMyOTkwMzYzMjU1MGJiZmJlZV8xLTEtMS0xLTE_59da4ed7-9ac7-438f-bfaa-f6e4a81ef44b">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGFibGU6MGJmMjkzZTMzMTI3NDAzMjk5MDM2MzI1NTBiYmZiZWUvdGFibGVyYW5nZTowYmYyOTNlMzMxMjc0MDMyOTkwMzYzMjU1MGJiZmJlZV8xLTQtMS0xLTE_1fd8dd95-7a30-4172-a483-020b1e803c2d">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTQ1_9702a934-1dde-49b3-a28c-a7bb758fdd43">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTUw_dce29958-67df-4a91-92f6-be314d1d9c1b">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i357c3dc213a54bb18148da0ae1debda3_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xL2ZyYWc6M2M1MjAyNzQ2OTIxNDNkMGJkMTM2ZmNjNWNhMmE3NTAvdGV4dHJlZ2lvbjozYzUyMDI3NDY5MjE0M2QwYmQxMzZmY2M1Y2EyYTc1MF8yMTMx_0919da6a-0e3c-47ef-b368-fd01db974f89"
      unitRef="shares">33489778</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMy0xLTEtMS0x_6125483f-0b97-40c8-aa86-9b25ad05ffe3"
      unitRef="usd">59863000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMy0zLTEtMS0x_366b215b-a336-4bbc-b72e-b6ad8241401f"
      unitRef="usd">53581000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNC0xLTEtMS0x_2f79d5ce-bfea-40c3-a238-0bf777a10c90"
      unitRef="usd">100988000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNC0zLTEtMS0x_3878a403-8509-45fd-b90f-16651eb32fe7"
      unitRef="usd">142851000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNS0wLTEtMS0xL3RleHRyZWdpb246NmUxYTI0YjMxZGVkNGMwYzgwOTJhNTJlNmNhNWQ4ZDJfNjc_e718d135-5825-4d62-b9f0-eda07847a5d2"
      unitRef="usd">264000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNS0wLTEtMS0xL3RleHRyZWdpb246NmUxYTI0YjMxZGVkNGMwYzgwOTJhNTJlNmNhNWQ4ZDJfNzU_7309bdec-4a79-45e8-a8d6-176594fd71fe"
      unitRef="usd">263000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNS0xLTEtMS0x_bda90363-73b8-4534-a9d7-8cd809e2c8fa"
      unitRef="usd">12617000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNS0zLTEtMS0x_651b3628-b413-4ea3-8829-69052f6aa091"
      unitRef="usd">13611000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNi0xLTEtMS0x_388b88d8-eab8-4612-b574-b3c92e1de584"
      unitRef="usd">10246000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNi0zLTEtMS0x_1b5559a1-2fa5-46b4-af42-e85fd464808d"
      unitRef="usd">5633000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNy0xLTEtMS0x_5a68ee51-7a03-42e9-822f-823c05545903"
      unitRef="usd">1934000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfNy0zLTEtMS0x_b98a592b-85d2-4a8c-addf-04b5c7c50ae4"
      unitRef="usd">2565000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfOC0xLTEtMS0x_0456d4c0-6867-4381-94bf-a327b4a6c46a"
      unitRef="usd">185648000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfOC0zLTEtMS0x_fc198b8c-d23a-4d85-a3ff-8f39db3a1d8a"
      unitRef="usd">218241000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTAtMS0xLTEtMQ_37d3ab29-9ecc-4d06-8dff-50799df0a95e"
      unitRef="usd">7913000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTAtMy0xLTEtMQ_8a13b156-54c2-4159-bad4-6b448108ffbc"
      unitRef="usd">4527000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTEtMS0xLTEtMQ_4e9341fa-c868-447e-b554-f3ec46f0252e"
      unitRef="usd">405000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTEtMy0xLTEtMQ_32788204-d76d-4736-8e35-8ef586891b7f"
      unitRef="usd">374000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTItMS0xLTEtMQ_075b5cf0-02fa-4ad5-9054-dd484ad9ef86"
      unitRef="usd">193966000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTItMy0xLTEtMQ_04b4248c-e40f-440c-b163-72f2f33d43fa"
      unitRef="usd">223142000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTYtMS0xLTEtMQ_5d041a4f-58d4-47e6-b110-12f80b381de6"
      unitRef="usd">4139000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTYtMy0xLTEtMQ_7c6ce597-4525-4baf-a9f3-0a852dcd6454"
      unitRef="usd">3271000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTctMS0xLTEtMQ_e42e034b-ea72-4b9b-9b34-d498dd88b3d1"
      unitRef="usd">10425000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTctMy0xLTEtMQ_7ed6bddb-d1a2-4b42-8e60-ff0f61f26da7"
      unitRef="usd">10199000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTktMS0xLTEtMQ_56adb4f5-cbec-44cc-91a9-d5dcf8baef5b"
      unitRef="usd">14564000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMTktMy0xLTEtMQ_e8e6b696-44de-4680-83d4-2193f9ac58da"
      unitRef="usd">13470000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjAtMS0xLTEtMQ_8af95b54-7996-4878-9a19-02866abc70db"
      unitRef="usd">34922000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjAtMy0xLTEtMQ_bc316509-988a-40f5-95c9-785a33bf4d61"
      unitRef="usd">39455000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjEtMS0xLTEtMQ_bd13b237-d1d4-42cd-ace7-153b94963c95"
      unitRef="usd">862000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjEtMy0xLTEtMQ_ed18dde6-2af4-4df6-b38a-6ae374a5c19e"
      unitRef="usd">854000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjItMS0xLTEtMQ_0ae3f1f6-f758-4c18-ac73-11b767f855da"
      unitRef="usd">50348000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjItMy0xLTEtMQ_aec1664a-4754-472e-9bd7-85f9069fe038"
      unitRef="usd">53779000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjQtMS0xLTEtMQ_231780e4-c959-40fa-bc8e-3d06146a51f2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjQtMy0xLTEtMQ_45a04c61-db89-4a6c-911d-4b9667f4b181"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzIy_015365ba-1025-4c9b-8d8d-69beb77a23f6"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzIy_c88fb6d9-d134-49b1-883b-2ed0e97242ed"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzM2_bed9710b-4bb0-49a9-9bff-f2bf7913fd6e"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzM2_e0c75e12-530b-431f-95de-7ba2cae06493"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzU4_220f036c-0c60-4bc3-b4ea-ceb3929d9d08"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzU4_2a081aca-e5fa-44e0-bd46-6c634f66b9ca"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzU4_4ee18b6a-db97-42d4-95b9-69965fb8e09a"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMC0xLTEtMS90ZXh0cmVnaW9uOmU1YjdkYmZiZjQwNTQ3ZmZhZTZkN2FiYWNlOWI2NGZlXzU4_c8f35244-a555-4efd-b2f5-c00df0cbf66f"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMS0xLTEtMQ_ea379a9b-0417-442b-ab7c-50625e03ffd2"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjctMy0xLTEtMQ_389606e6-b09e-4c72-b8e3-a7fee07f708b"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzE5_4ee57d0f-be78-4329-839a-4c78da748244"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzE5_8227ed57-ddef-463a-8236-21af9b10ae84"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzMz_332d7c04-ae99-43e6-99ff-99d03bc6e5af"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzMz_d2552b64-ad80-4b76-9b9a-17d25d235a3e"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzU1_4277f255-8324-4f09-bef8-f06701269133"
      unitRef="shares">33450995</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzU1_5b964c5f-b18a-4777-8481-4144ffcd4bb9"
      unitRef="shares">33450995</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzYy_a822d292-0723-40b4-a6a3-411d1b858cef"
      unitRef="shares">32583220</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMC0xLTEtMS90ZXh0cmVnaW9uOmE5YzU0NzczNzNjNzQwZjA4YTZlYjVjNjgwNDQyM2I1XzYy_b284481e-a475-49aa-8b97-29f841cfcc29"
      unitRef="shares">32583220</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMS0xLTEtMQ_27da2c77-08d2-4e0d-bc2d-a4596f5da7cd"
      unitRef="usd">3000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjgtMy0xLTEtMQ_52bff8da-2e64-43d1-a49f-c8d0a1845d48"
      unitRef="usd">3000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjktMS0xLTEtMQ_44ce7c50-707b-4d6f-bf32-592ad99ca369"
      unitRef="usd">424561000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMjktMy0xLTEtMQ_63925fbd-de9a-4e08-be6c-f0ef49dafd21"
      unitRef="usd">408113000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzAtMS0xLTEtMQ_4dbec0d6-99e0-41ba-beb3-ec163f15ca64"
      unitRef="usd">426000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzAtMy0xLTEtMQ_db6b3f53-7539-4e6c-ba37-78d367f1bc3c"
      unitRef="usd">524000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzEtMS0xLTEtMQ_1a7dfee4-d31a-42d7-83cb-bce8f5117d63"
      unitRef="usd">-281372000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzEtMy0xLTEtMQ_8346094a-4237-448c-a7bb-972a9591e7fa"
      unitRef="usd">-239277000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzItMS0xLTEtMQ_d9c9323d-56b6-4ee3-bdad-2830415e4fb2"
      unitRef="usd">143618000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzItMy0xLTEtMQ_36ffaf3e-67e7-415c-b3e7-425433a39a20"
      unitRef="usd">169363000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzMtMS0xLTEtMQ_30b545f2-cde1-4965-9324-046c73b0e87a"
      unitRef="usd">193966000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xNi9mcmFnOmE3NjY5NGU0ZmVhYTRjNzJiZGE2OTM0MTBkZmUxMWQ3L3RhYmxlOjAwZDAxZDUxYjE3YjQyZWRhYzZjM2NjMTAwMjgwZmM4L3RhYmxlcmFuZ2U6MDBkMDFkNTFiMTdiNDJlZGFjNmMzY2MxMDAyODBmYzhfMzMtMy0xLTEtMQ_3fd3f028-1535-4fa6-be30-a387bea81ec7"
      unitRef="usd">223142000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMi0xLTEtMS0x_354eee5c-34f3-4735-b942-1755d7f6e962"
      unitRef="usd">22286000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMi0zLTEtMS0x_70e26977-9a46-4cd4-ab22-7cbfdecc88b8"
      unitRef="usd">20373000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMi01LTEtMS0x_b59513d8-5a7e-4d17-91cf-bd5af0a77326"
      unitRef="usd">64922000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMi03LTEtMS0x_76a19540-fe75-4a83-bbd8-9d2395587a34"
      unitRef="usd">51243000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMy0xLTEtMS0x_1eec18ce-2f19-4a37-a23c-81bc87f21d36"
      unitRef="usd">2478000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMy0zLTEtMS0x_1f3893bf-8142-4e1a-b8dc-d5d9dbfbd6f7"
      unitRef="usd">2578000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMy01LTEtMS0x_b0022467-2807-4f6c-8111-e0ebf5af34b5"
      unitRef="usd">7053000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMy03LTEtMS0x_f32ea8c4-c9c7-4237-9a70-8f22f2f26e2e"
      unitRef="usd">6627000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNC0xLTEtMS0x_0a552328-ed8d-4350-941e-23f9d6b73fda"
      unitRef="usd">19808000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNC0zLTEtMS0x_266584c3-5aad-4d40-906b-c48a80f6c2f3"
      unitRef="usd">17795000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNC01LTEtMS0x_2b822025-3e65-4d1e-8dd3-3a0e847d05e0"
      unitRef="usd">57869000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNC03LTEtMS0x_40b0ab65-8d95-449c-89f1-4eaebb416351"
      unitRef="usd">44616000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNi0xLTEtMS0x_b93383c1-293a-4b38-991b-4a0389271a84"
      unitRef="usd">23525000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNi0zLTEtMS0x_4be1578a-915d-455d-9bda-ced1ad8bfc17"
      unitRef="usd">18772000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNi01LTEtMS0x_1b70b1b3-dc8f-4a4c-b2b1-3c9d7a2664f4"
      unitRef="usd">67531000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNi03LTEtMS0x_99d58524-1b6e-4637-8cb9-73d4e3079766"
      unitRef="usd">53808000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNy0xLTEtMS0x_58ddaa65-a9f5-4e86-aff0-053dcd985ed9"
      unitRef="usd">3288000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNy0zLTEtMS0x_afd3829b-b7b1-414e-98a4-84e5a6fbc844"
      unitRef="usd">2778000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNy01LTEtMS0x_7297c102-3f50-4511-b7ad-f7c3eb6979fb"
      unitRef="usd">9392000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfNy03LTEtMS0x_9024b298-7c7e-4e95-8ae3-7fbe267dac61"
      unitRef="usd">7033000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOC0xLTEtMS0x_16c798bf-f651-456b-a3d4-317e101341f7"
      unitRef="usd">6194000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOC0zLTEtMS0x_d028fbf9-6e68-4545-a21b-1578ed4365d8"
      unitRef="usd">4920000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOC01LTEtMS0x_cfdc5bf6-c7b0-4d62-9971-b97b1016c36d"
      unitRef="usd">18685000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOC03LTEtMS0x_c2240925-70e4-4f9b-9267-6d646bd29d85"
      unitRef="usd">14471000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOS0xLTEtMS0x_a8c616fb-9b88-413d-a033-2fef403c6394"
      unitRef="usd">33007000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOS0zLTEtMS0x_5a195e7a-a621-4dea-ac2a-55d7435642cd"
      unitRef="usd">26470000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOS01LTEtMS0x_94c8dedf-681d-42b5-9c12-e9afc19b6803"
      unitRef="usd">95608000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfOS03LTEtMS0x_b7c28bac-4838-49ce-976c-5dea41a7b114"
      unitRef="usd">75312000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTAtMS0xLTEtMQ_98a82284-2108-4b31-9b68-97e1021b38c7"
      unitRef="usd">-13199000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTAtMy0xLTEtMQ_e530959b-6a28-45a9-8740-18373d922fc0"
      unitRef="usd">-8675000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTAtNS0xLTEtMQ_29f2a152-6e78-4736-8cf6-0d61f9c0a9c2"
      unitRef="usd">-37739000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTAtNy0xLTEtMQ_d3eb544f-00e3-40ed-9c54-700a87d51d0e"
      unitRef="usd">-30696000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTItMS0xLTEtMQ_3445e2be-ec70-4c5b-8fed-be47540443dd"
      unitRef="usd">44000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTItMy0xLTEtMQ_fd5a31f9-a48c-4b8a-a1fc-b90d4785fc82"
      unitRef="usd">192000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTItNS0xLTEtMQ_5f0236f7-66bc-46f5-812e-b5ed319cf1fa"
      unitRef="usd">151000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTItNy0xLTEtMQ_01be217f-9e53-44f8-a078-e35c4037efc9"
      unitRef="usd">1019000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTMtMS0xLTEtMQ_957eb324-4531-4e70-b5fa-8a15588b5838"
      unitRef="usd">2658000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTMtMy0xLTEtMQ_a15e313a-778f-41d8-8dc8-1523e3a78714"
      unitRef="usd">1102000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTMtNS0xLTEtMQ_d0833abb-03e3-4a6a-87c2-cd7620fb5e09"
      unitRef="usd">4797000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTMtNy0xLTEtMQ_81707ada-08d1-4d85-b3d0-f02dc2651159"
      unitRef="usd">5016000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTQtMS0xLTEtMQ_7222cad0-5f1f-4d6c-ab90-98f825ccb7c7"
      unitRef="usd">-59000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTQtMy0xLTEtMQ_a062ff79-8fdd-4716-a2ec-12160e35ec25"
      unitRef="usd">111000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTQtNS0xLTEtMQ_4dae9daa-b579-45e9-a09a-345eb316c8b1"
      unitRef="usd">290000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTQtNy0xLTEtMQ_85f1e63a-5cc9-4b77-b686-7f8a47b65acb"
      unitRef="usd">-25000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTUtMS0xLTEtMQ_e516ab9a-9131-4f56-9c34-1bb58a705c80"
      unitRef="usd">-15872000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTUtMy0xLTEtMQ_e1550665-98b5-4de3-abe6-7a1dc2a9d78a"
      unitRef="usd">-9474000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTUtNS0xLTEtMQ_08164429-95a6-4154-8ecd-82dc44c1c91e"
      unitRef="usd">-42095000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTUtNy0xLTEtMQ_f4d84f3c-dfc6-4181-a23a-6554267e7769"
      unitRef="usd">-34718000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTctMS0xLTEtMQ_93986fc6-c8dc-4ba9-9d1b-582a589defdd"
      unitRef="usd">-23000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTctMy0xLTEtMQ_87dce1c7-37dd-4fbc-b0f6-124adb01f2fa"
      unitRef="usd">-33000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTctNS0xLTEtMQ_5d6995b1-2c4a-4392-aa8b-7a83bc92ad22"
      unitRef="usd">-103000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTctNy0xLTEtMQ_91e451f9-16fd-4e9c-bce9-d0fdbe67dd9b"
      unitRef="usd">-23000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTgtMS0xLTEtMQ_a6c0b822-7b97-4023-ae7b-84429c74453d"
      unitRef="usd">-11000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTgtMy0xLTEtMQ_050e7dc1-b5b2-498d-8107-459c2e5e9694"
      unitRef="usd">-147000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTgtNS0xLTEtMQ_476ed4fc-1e48-4dc7-a176-3f5a9010f4ea"
      unitRef="usd">5000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTgtNy0xLTEtMQ_44575ba8-63cc-4d6e-919f-870c5d2ff2ef"
      unitRef="usd">-11000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTktMS0xLTEtMQ_7a30a54b-53fd-48d5-ac4b-f1f3e49f7cb4"
      unitRef="usd">-15906000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTktMy0xLTEtMQ_6400fdc1-31a2-4ccc-b2bb-fc17e6cd1aea"
      unitRef="usd">-9654000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTktNS0xLTEtMQ_1a24904e-307c-4979-99ac-8cd78f6822ed"
      unitRef="usd">-42193000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMTktNy0xLTEtMQ_1c55c1cc-6fcd-48b4-acf9-dfaf411ffb54"
      unitRef="usd">-34752000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtMS0xLTEtMQ_391491d9-cbdf-4860-9a39-472d0bb22b38"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtMS0xLTEtMQ_4c9d128f-e587-4193-9cc3-20f1eee19670"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtMy0xLTEtMQ_38a6c922-224f-448f-8a2c-5ca149be9733"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtMy0xLTEtMQ_e13fcdef-c6ae-4da9-8a6a-5d36784d3bc1"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtNS0xLTEtMQ_6fbb9a08-b8cc-4a83-a104-23ba74001e66"
      unitRef="usdPerShare">-1.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtNS0xLTEtMQ_f5a373d5-10dd-49b0-9f66-978c7bb073ab"
      unitRef="usdPerShare">-1.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtNy0xLTEtMQ_67038e76-2eb2-4a12-b7a3-f412abd646d1"
      unitRef="usdPerShare">-1.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjEtNy0xLTEtMQ_a4ee5fdc-802a-459e-ab47-7d5cb73d7a67"
      unitRef="usdPerShare">-1.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtMS0xLTEtMQ_2e1276ab-9ad9-488a-8b47-c9c3959826da"
      unitRef="shares">33340093</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtMS0xLTEtMQ_48c5097a-d00d-4b8a-8e48-34430a959d87"
      unitRef="shares">33340093</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtMy0xLTEtMQ_04c64e22-6ec9-42a1-9deb-4cad34d5e622"
      unitRef="shares">28713418</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtMy0xLTEtMQ_65958481-fb18-469c-afdf-cf61e3af0122"
      unitRef="shares">28713418</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtNS0xLTEtMQ_3b649b20-8d52-4e34-95d8-d59643b102d3"
      unitRef="shares">33005904</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtNS0xLTEtMQ_ad8419fb-5079-4db6-92f4-baed044f7398"
      unitRef="shares">33005904</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtNy0xLTEtMQ_61a9f38c-6cc2-4c95-99ad-abda11534c0a"
      unitRef="shares">28155561</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8xOS9mcmFnOjFjMzZlMDVjYTQ1NzRhMjE5M2Y1MjQwOTgxNjgyMmUxL3RhYmxlOjlhMGNhMjljNDk0ZDQ2NGRiN2Q1MTBlODBkMDNlNTJlL3RhYmxlcmFuZ2U6OWEwY2EyOWM0OTRkNDY0ZGI3ZDUxMGU4MGQwM2U1MmVfMjMtNy0xLTEtMQ_9b48a954-a5c3-45fe-8999-ba20092a72c8"
      unitRef="shares">28155561</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i00e5b99cc6f44c89bffc8842ab1cc43f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMi0yLTEtMS0x_45422655-2e32-49d8-a457-930ce51f0d68"
      unitRef="shares">32583220</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i00e5b99cc6f44c89bffc8842ab1cc43f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMi00LTEtMS0x_cac3032f-7caf-457c-ba14-021d81d40a2a"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic2b9c3748b62489b87de37d50a5ee65e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMi02LTEtMS0x_67a47429-d1a4-4f37-80e4-3fc77a24b536"
      unitRef="usd">408113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6c0c789badb24a7a900f02455d94a596_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMi04LTEtMS0x_136bca5b-9d81-4047-9b84-eac43afd28ea"
      unitRef="usd">524000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3478645a9bc24eaf82a0f884d4e7301f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMi0xMC0xLTEtMQ_ea776422-a4aa-49f5-a88c-8d79280a9bb1"
      unitRef="usd">-239277000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMi0xMi0xLTEtMQ_fe0274d8-ca58-46a7-9fb0-cfb85d116161"
      unitRef="usd">169363000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="id6305ce423c24473be85c1772c0267e2_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMy0yLTEtMS0x_c2965b46-0d74-4d7b-9af8-e38b45430da2"
      unitRef="shares">93975</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="icb4574bb241d4e00bfb9eaee77d0f93e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMy02LTEtMS0x_63fb51ad-795a-4481-8cc9-5519e27b81af"
      unitRef="usd">601000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i1159e4f921fa4ba09c9b2b7bb7978816_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMy0xMi0xLTEtMQ_f93d188a-20df-4ec5-82f1-51789b69c901"
      unitRef="usd">601000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits
      contextRef="id6305ce423c24473be85c1772c0267e2_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNC0yLTEtMS0x_28a1b2ea-cd31-483c-9bb1-d3f0719f1cfc"
      unitRef="shares">131339</sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icb4574bb241d4e00bfb9eaee77d0f93e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNS02LTEtMS0x_2ba6cb54-4c7d-4dc6-8436-195e6e059605"
      unitRef="usd">4030000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1159e4f921fa4ba09c9b2b7bb7978816_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNS0xMi0xLTEtMQ_e623f9d5-11e0-4fdd-983a-d262fb4f5a4a"
      unitRef="usd">4030000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
      contextRef="icb4574bb241d4e00bfb9eaee77d0f93e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNi02LTEtMS0x_7ec5e871-f2b9-4308-958a-3d731813becb"
      unitRef="usd">9000</sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions>
    <sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
      contextRef="i1159e4f921fa4ba09c9b2b7bb7978816_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNi0xMi0xLTEtMQ_881ef045-5940-470e-8e12-47ae35fc4540"
      unitRef="usd">9000</sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6b886e77773d4100b841947a370dbd45_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNy04LTEtMS0x_6ffe9dff-868d-41d5-84ae-168241e6ec4a"
      unitRef="usd">-115000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i1159e4f921fa4ba09c9b2b7bb7978816_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNy0xMi0xLTEtMQ_8cfa636f-d325-46dd-872d-728223ac98f0"
      unitRef="usd">-115000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6b886e77773d4100b841947a370dbd45_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfOC04LTEtMS0x_2969c351-59c9-4fc3-a521-01965dc52bdf"
      unitRef="usd">21000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i1159e4f921fa4ba09c9b2b7bb7978816_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfOC0xMi0xLTEtMQ_44a793fa-b61d-4454-b6c7-c5de8a0119e2"
      unitRef="usd">21000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i44b3f6ddf6bd462b9a921c7660367222_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfOS0xMC0xLTEtMQ_1301be42-124b-480d-8fde-0437c3be7f6d"
      unitRef="usd">-12242000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1159e4f921fa4ba09c9b2b7bb7978816_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfOS0xMi0xLTEtMQ_6bb9f8be-d984-4b55-9449-119d49bcdf27"
      unitRef="usd">-12242000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i40496ae85a1c42a5b586e6a69298a32f_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTAtMi0xLTEtMQ_8f4e5d0e-ca9c-4789-8910-0bf0e1fcf311"
      unitRef="shares">32808534</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i40496ae85a1c42a5b586e6a69298a32f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTAtNC0xLTEtMQ_acff3dab-32a7-4a97-a432-c6dcc7f55831"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6fdbf7f9eee94fd99865f6c845fc9e5c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTAtNi0xLTEtMQ_e56ea169-74d5-4b67-8f17-84595c32d1e7"
      unitRef="usd">412753000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic05d1aa069db477fb7428cb7052a36ba_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTAtOC0xLTEtMQ_ebb27259-c321-4e88-9cca-794dd3ba06b8"
      unitRef="usd">430000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1bc41da9d91a4b3ebbf8a73d9351127d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTAtMTAtMS0xLTE_b7c0461a-929e-4fd4-9775-e372f1439846"
      unitRef="usd">-251519000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i50c3adee274e4d9897c1e9b97580f092_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTAtMTItMS0xLTE_cb9043ea-4427-4a86-827a-563f489f05b4"
      unitRef="usd">161667000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3b44971cd3d44f208027309c7bec414e_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTEtMi0xLTEtMQ_2c034017-000f-4291-8e95-bc891498929f"
      unitRef="shares">140917</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i012e884dcba141699671d533f8f9d6d5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTEtNi0xLTEtMQ_51bf1181-60bd-44d8-8555-42021655893e"
      unitRef="usd">650000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i25d6449704a74361b824fbddaab1b298_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTEtMTItMS0xLTE_a2d9b403-4150-4379-bb20-46130c2de106"
      unitRef="usd">650000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i3b44971cd3d44f208027309c7bec414e_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTItMi0xLTEtMQ_e85acc8e-8c1f-446e-8812-38e3661d4fc5"
      unitRef="shares">104861</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i012e884dcba141699671d533f8f9d6d5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTItNi0xLTEtMQ_aceed5b3-cd5c-4b8e-b5c8-070a4cd86404"
      unitRef="usd">1566000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i25d6449704a74361b824fbddaab1b298_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTItMTItMS0xLTE_7be9e259-0eac-48ef-8aed-1f518612251c"
      unitRef="usd">1566000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits
      contextRef="i3b44971cd3d44f208027309c7bec414e_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTMtMi0xLTEtMQ_f05a46ac-410e-4f38-b277-b2a0678ecd1c"
      unitRef="shares">181958</sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i012e884dcba141699671d533f8f9d6d5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTQtNi0xLTEtMQ_ca23935d-c3e7-4483-ab6f-2f2ade3943cf"
      unitRef="usd">4257000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i25d6449704a74361b824fbddaab1b298_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTQtMTItMS0xLTE_39215b03-c197-496b-85df-8223d425ca0c"
      unitRef="usd">4257000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
      contextRef="i012e884dcba141699671d533f8f9d6d5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTUtNi0xLTEtMQ_8c9097aa-4304-4fcc-b85c-16b2a60dfbc5"
      unitRef="usd">9000</sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions>
    <sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
      contextRef="i25d6449704a74361b824fbddaab1b298_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTUtMTItMS0xLTE_f35e32f7-ede8-4d8e-bfb6-364ec687cebc"
      unitRef="usd">9000</sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i92f4fbe9f6904a2a84b286559158e8ae_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTYtOC0xLTEtMQ_f429748c-4e07-44fa-b1ee-34478d57f7e1"
      unitRef="usd">35000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i25d6449704a74361b824fbddaab1b298_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTYtMTItMS0xLTE_c3a5ea58-23c3-4fd3-96e2-c22aa5a84d0f"
      unitRef="usd">35000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i92f4fbe9f6904a2a84b286559158e8ae_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTctOC0xLTEtMQ_bfad061f-2912-4cfb-8cec-ed4ea0119c01"
      unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i25d6449704a74361b824fbddaab1b298_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTctMTItMS0xLTE_a29d2953-1c82-40bb-9cf1-4795e2d56334"
      unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="ie62877f00b8945bc828ba27d3c2bbdc8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTgtMTAtMS0xLTE_d47cf183-468a-4a1f-a045-d2fb4a5a2715"
      unitRef="usd">-13981000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i25d6449704a74361b824fbddaab1b298_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTgtMTItMS0xLTE_c11fa765-3bca-4f9d-b0e2-3d50c6eb4651"
      unitRef="usd">-13981000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i9c273f41c79c4fbdb0d1230fd0559e14_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTktMi0xLTEtMQ_9574577a-8a4d-4de6-928e-7369f620b573"
      unitRef="shares">33236270</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i9c273f41c79c4fbdb0d1230fd0559e14_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTktNC0xLTEtMQ_945216ac-e07b-4648-81ac-d05819af21ed"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2093b54ed2e847d8acdb383a67170813_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTktNi0xLTEtMQ_42b9efcf-d306-4c5d-85f6-b8251f4169f8"
      unitRef="usd">419235000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0e87b080b86f4c85a1a6027779356588_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTktOC0xLTEtMQ_445b358d-652e-4ea3-8ecd-b966940e056b"
      unitRef="usd">460000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1b6779adb1074d70a27f1bd8c370bdd2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTktMTAtMS0xLTE_396b8ddd-ea94-4074-88fd-90550a03b8dc"
      unitRef="usd">-265500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idf8d120fadaf4453aef93c87406ea34a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMTktMTItMS0xLTE_21790c3d-5086-454e-a9f9-17aae43a2125"
      unitRef="usd">154198000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="id07b214d4e3f413786721103a10a44e5_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjAtMi0xLTEtOTI3NA_746127ce-13b6-47bb-88f9-58bb541f7f53"
      unitRef="shares">82109</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i98959cdb5f6c4fe6bbf1638730028292_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjAtNi0xLTEtOTI5MA_87e45729-a674-4de9-b32d-2da9cded94f4"
      unitRef="usd">1076000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjAtMTItMS0xLTExMTkx_a2f2607e-2aa9-4618-bc1b-5e368a80b863"
      unitRef="usd">1076000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits
      contextRef="id07b214d4e3f413786721103a10a44e5_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjEtMi0xLTEtOTI4MQ_5eea1b22-48e4-4b11-b530-10ee5faa1f80"
      unitRef="shares">132616</sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i98959cdb5f6c4fe6bbf1638730028292_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjItNi0xLTEtOTI5OA_e6027c09-4c84-4026-8525-3fc9e7cc61f4"
      unitRef="usd">4241000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjItMTItMS0xLTExMjA0_a1e8a4ca-4635-4fc3-b85d-6d3e263c9c1c"
      unitRef="usd">4241000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
      contextRef="i98959cdb5f6c4fe6bbf1638730028292_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjMtNi0xLTEtOTMwNQ_cefa069d-a50e-4e59-a9ab-babe7ba24976"
      unitRef="usd">9000</sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions>
    <sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjMtMTItMS0xLTExMjA2_7c37d1aa-2f59-4637-839a-0ed45d500587"
      unitRef="usd">9000</sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ifa96cfe1e061452eab347a7417e00927_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjQtOC0xLTEtOTMxMw_80e0a2ca-a17a-4b1f-9bd1-110585ca1b6e"
      unitRef="usd">-23000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjQtMTItMS0xLTExMjA4_41c3cff3-2bd4-4eca-ad44-a6af2188d8e4"
      unitRef="usd">-23000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ifa96cfe1e061452eab347a7417e00927_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjUtOC0xLTEtOTMxMw_9dafff72-55ac-4137-bc1a-2e1dfcb22570"
      unitRef="usd">-11000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjUtMTItMS0xLTExMjEw_1b1b2d37-2613-41ff-8d70-cb518de4159a"
      unitRef="usd">-11000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i859739929cdc49feb9e1b5e371f5be77_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjYtMTAtMS0xLTkzMjE_7fb8100f-80f8-4135-b116-16e58801289a"
      unitRef="usd">-15872000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjYtMTItMS0xLTExMjEw_97cb3f3d-609f-40ec-855b-43b7d19ee207"
      unitRef="usd">-15872000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="id6a7688791524893986b66bd6348be2b_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjctMi0xLTEtNDYx_53190c20-679c-47f5-af85-20af947e7d7e"
      unitRef="shares">33450995</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id6a7688791524893986b66bd6348be2b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjctNC0xLTEtNDYx_5ed0c011-a6be-4109-a304-c76a473a795b"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iccb5bcce85274a778eab4af6eb1d355b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjctNi0xLTEtNDYx_0d0de86b-e985-4a9f-97f6-ab9aa0fb71f1"
      unitRef="usd">424561000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief8c77e32bdc4fd0aff571107321d934_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjctOC0xLTEtNDYx_31df67ff-cb86-47c8-827c-32ac54995f67"
      unitRef="usd">426000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0a812a4bda164222b3c7aea2c545528d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjctMTAtMS0xLTQ2MQ_20f41ed3-12b8-4bcc-9eec-23f7568764b6"
      unitRef="usd">-281372000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMjctMTItMS0xLTQ2MQ_568f1ce7-e9c9-4300-9df0-3b16a2ed54b7"
      unitRef="usd">143618000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i21d4eb0fbe1b4f2082f7882f874778fc_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzgtMi0xLTEtMQ_3e44c484-99fa-46df-8b53-dd36fd2f86d7"
      unitRef="shares">25163803</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i21d4eb0fbe1b4f2082f7882f874778fc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzgtNC0xLTEtMQ_d67cbc3a-333c-4073-af64-7f72d26f589d"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2e3370ae52f94141aa28c7b6558b03f8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzgtNi0xLTEtMQ_cee62935-26c7-4d81-b583-2faa58b45b43"
      unitRef="usd">258121000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie8c36c532ca54066828971da81e190b9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzgtOC0xLTEtMQ_73060499-c8aa-44b3-aa69-2f3db5ba739e"
      unitRef="usd">464000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4d59943d7b8c4788bf7ebb802bf66b71_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzgtMTAtMS0xLTE_48f6de5c-b176-4b8d-a9fa-32d0a9edb971"
      unitRef="usd">-195580000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i89789d0c91fe4169839f59b9bd5ea2df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzgtMTItMS0xLTE_3dd89f7e-bb27-4087-b890-67c8f8b51208"
      unitRef="usd">63008000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i2073aa5d83e1437fbb0649d1c506d3fe_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzktMi0xLTEtMQ_392169c1-1bf5-4016-b49d-6f9f2a5d5d21"
      unitRef="shares">3135053</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i37dff38285374aa6920e237cc777bdab_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzktNi0xLTEtMQ_14eaf39c-c19d-4315-8812-e56ad0768bf2"
      unitRef="usd">62978000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i390582358ab4487fba346af76b925fb2_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfMzktMTItMS0xLTE_78fb429f-337a-49c1-9bba-e9f12c9fe557"
      unitRef="usd">62978000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i2073aa5d83e1437fbb0649d1c506d3fe_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDAtMi0xLTEtMQ_ee16b926-ad34-4cdc-8d0d-ff2a0e93f870"
      unitRef="shares">43334</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i37dff38285374aa6920e237cc777bdab_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDAtNi0xLTEtMQ_6d8c0117-9992-4282-9281-ff2bf0145e23"
      unitRef="usd">174000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i390582358ab4487fba346af76b925fb2_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDAtMTItMS0xLTE_75fe1d38-7f4d-42f6-9078-6ccb08406645"
      unitRef="usd">174000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits
      contextRef="i2073aa5d83e1437fbb0649d1c506d3fe_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDEtMi0xLTEtMQ_75676609-ddac-4369-9100-9908f182b5aa"
      unitRef="shares">63938</sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i37dff38285374aa6920e237cc777bdab_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDItNi0xLTEtMQ_da2143ff-32a7-44f6-9f68-3c23b953354b"
      unitRef="usd">2622000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i390582358ab4487fba346af76b925fb2_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDItMTItMS0xLTE_201892f4-9631-4d39-8b7a-6a9a0311e697"
      unitRef="usd">2622000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
      contextRef="i37dff38285374aa6920e237cc777bdab_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDMtNi0xLTEtMQ_07f856ad-6b86-431a-a922-273dc017a4d0"
      unitRef="usd">27000</sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions>
    <sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
      contextRef="i390582358ab4487fba346af76b925fb2_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDMtMTItMS0xLTE_e11ebe42-c714-40be-b720-d9c4e03d2f86"
      unitRef="usd">27000</sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i169c05e9512945e6a8746c4ef8542f10_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDQtOC0xLTEtMQ_8291d1a6-f400-431c-9bcc-b4d3f6d212bf"
      unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i390582358ab4487fba346af76b925fb2_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDQtMTItMS0xLTE_9d98b57a-d706-4d94-bd6c-267ef2df84f2"
      unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i169c05e9512945e6a8746c4ef8542f10_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDUtOC0xLTEtMQ_55c6cd2d-b3f8-47fb-b037-666ffbe8bd7e"
      unitRef="usd">221000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i390582358ab4487fba346af76b925fb2_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDUtMTItMS0xLTE_1e4f8375-5c78-4092-b25b-ff1fdcfc823f"
      unitRef="usd">221000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i3b13a3cd460d43529a51830c587f1ae4_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDYtMTAtMS0xLTE_e3d0c44c-657e-4f1d-a5b7-c73dc490f22d"
      unitRef="usd">-12772000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i390582358ab4487fba346af76b925fb2_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDYtMTItMS0xLTE_57285d4f-f1d0-44b0-be97-62bb2e7ad579"
      unitRef="usd">-12772000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i00aae33ac66f498b91c8304d0a3684e6_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDctMi0xLTEtMQ_0f69376f-5e65-4fe5-949e-b5bd648d9af7"
      unitRef="shares">28406128</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i00aae33ac66f498b91c8304d0a3684e6_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDctNC0xLTEtMQ_a1612313-bb54-4c4d-b447-4cd40f40b777"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id5f4f5a94479403fa8baf12ad75427e3_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDctNi0xLTEtMQ_33733c84-fb1f-479c-b74c-7a32573e31bc"
      unitRef="usd">323922000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2f8c0ef6b0b142b08f6da44a05bdb9e8_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDctOC0xLTEtMQ_41cc8ba7-ba4b-42c5-b8f8-3d99f9e7c53a"
      unitRef="usd">697000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i29ed3ed441cb4fa78bb6e83cf96aedef_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDctMTAtMS0xLTE_c9b418e6-fc60-4466-8e04-232ea5dc6e89"
      unitRef="usd">-208352000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id216b900385f40ddb4e3e20115d76dc5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDctMTItMS0xLTE_3597bda6-7892-401e-a2b9-497443ccfc91"
      unitRef="usd">116270000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7452925b0e5546ac8e3a5572be6ec889_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDgtMi0xLTEtMQ_3fa945b6-4257-4019-b836-063e78eac60b"
      unitRef="shares">46608</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="idc576cf893e347489acff339085d0f95_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDgtNi0xLTEtMQ_24845afe-654e-4ada-9737-2818fa423fa3"
      unitRef="usd">185000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDgtMTItMS0xLTE_fd546cd3-3939-478e-a324-80550a59024c"
      unitRef="usd">185000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i7452925b0e5546ac8e3a5572be6ec889_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDktMi0xLTEtMQ_8aa6238a-003f-441e-aa9c-8ad5cf603e39"
      unitRef="shares">74685</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="idc576cf893e347489acff339085d0f95_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDktNi0xLTEtMQ_a6a6ad8e-2abd-4ce8-8a2a-59f4223899b4"
      unitRef="usd">991000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNDktMTItMS0xLTE_0474f231-e41e-4500-948e-8d7e789ae8e9"
      unitRef="usd">991000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits
      contextRef="i7452925b0e5546ac8e3a5572be6ec889_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTAtMi0xLTEtMQ_fc0fac99-5b8d-494a-bcd2-0b451bbd785b"
      unitRef="shares">85030</sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="idc576cf893e347489acff339085d0f95_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTEtNi0xLTEtMQ_f0f31162-8087-4692-9f8f-5221776aa6bb"
      unitRef="usd">2955000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTEtMTItMS0xLTE_6643bacd-3d51-4b73-af61-571c3ff312b9"
      unitRef="usd">2955000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
      contextRef="idc576cf893e347489acff339085d0f95_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTItNi0xLTEtMQ_a7a9ab0b-edb1-4cd9-85a5-57147f125849"
      unitRef="usd">26000</sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions>
    <sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
      contextRef="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTItMTItMS0xLTE_23055ceb-8c02-4e87-b189-0cba57d56277"
      unitRef="usd">26000</sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i610b8b3420f644baacc410f92061ab95_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTMtOC0xLTEtMQ_12ff7410-fc35-4184-8100-d549508509b6"
      unitRef="usd">-2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTMtMTItMS0xLTE_580af263-2f49-4130-a276-46b2faaf975d"
      unitRef="usd">-2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i610b8b3420f644baacc410f92061ab95_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTQtOC0xLTEtMQ_e4d0632f-1d39-45bb-b97b-caee804f7443"
      unitRef="usd">-85000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTQtMTItMS0xLTE_2875569a-8b9c-430c-8898-20d01c213193"
      unitRef="usd">-85000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i8ff5e648858d44668dc102d8309e731c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTUtMTAtMS0xLTE_e864d1f1-0631-47f7-bf3a-bcd69fa397da"
      unitRef="usd">-12472000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iff0294a2d0d34296a74f6b92a3347c7e_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTUtMTItMS0xLTE_ce9b5d47-6ef8-4b30-99ed-a7c5cf96a51d"
      unitRef="usd">-12472000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i24f538cb702e4c0c8e346a1f3598951b_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTYtMi0xLTEtMQ_90186739-e74d-43f3-91b1-206dd680d7e2"
      unitRef="shares">28612451</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i24f538cb702e4c0c8e346a1f3598951b_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTYtNC0xLTEtMQ_ef967805-e846-4668-bb06-7131f7175d01"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idbfd8a209c764a95b7ea7a91a7fc9474_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTYtNi0xLTEtMQ_4653d3c3-216e-4777-8542-5c5f088b5b14"
      unitRef="usd">328079000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i245280170e0946e9aea8da85b267bfe2_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTYtOC0xLTEtMQ_63f955fd-b524-4afb-a02f-626f374ffa54"
      unitRef="usd">610000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i051e88f32e88449d8536056f5184fd50_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTYtMTAtMS0xLTE_37a76779-6eb1-421c-8f86-ce00cdeca2ce"
      unitRef="usd">-220824000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i81b69c135aa5478fb8c1e2ad5ddcee2c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTYtMTItMS0xLTE_b1e638dd-69f5-4711-a15a-5fd4f3213f7d"
      unitRef="usd">107868000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i165ebc065905414c9459402dde0eea16_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTQtMi0xLTEtMzA5_51787b97-93ed-409b-80f4-58d19a003094"
      unitRef="shares">137392</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia51f1dbf872743908801048a58b16c15_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTQtNi0xLTEtMzM5_6b6fdfe6-2415-4ff6-80de-e56be19e07a1"
      unitRef="usd">628000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTQtMTItMS0xLTM4OA_29de5a0e-3487-46ae-9a34-a5b569613867"
      unitRef="usd">628000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits
      contextRef="i165ebc065905414c9459402dde0eea16_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTYtMi0xLTEtMzI0_ef658bcc-026c-4e5b-8d9e-2c3bbb634fa7"
      unitRef="shares">88734</sibn:StockIssuedDuringPeriodSharesRestrictedStockUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia51f1dbf872743908801048a58b16c15_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTctNi0xLTEtMzQx_6f896929-abaa-44c7-8f27-a799bc905f19"
      unitRef="usd">3180000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTctMTItMS0xLTM5OQ_1e95b493-a512-452e-bdba-794edfdb7c83"
      unitRef="usd">3180000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
      contextRef="ia51f1dbf872743908801048a58b16c15_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTgtNi0xLTEtMzUy_6a038865-f29a-4e47-bb01-49934ec57035"
      unitRef="usd">9000</sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions>
    <sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTgtMTItMS0xLTQwNw_ce909bfa-e832-4243-9d6f-d69082e95a64"
      unitRef="usd">9000</sibn:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i2d612f341375492d8de3802bb7d01ce5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTktOC0xLTEtMzU4_cc6e7a61-4ada-4a74-807c-fcfb46feb20e"
      unitRef="usd">-33000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNTktMTItMS0xLTQxOA_3f897b06-5bb6-4d27-b7fc-1d605dbb20d1"
      unitRef="usd">-33000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i2d612f341375492d8de3802bb7d01ce5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjAtOC0xLTEtMzcy_d48d32ce-8067-41fe-afaf-0643b4c23ea6"
      unitRef="usd">-147000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjAtMTItMS0xLTQzMQ_7a6e9276-0e0d-402c-bea8-df6d7596a603"
      unitRef="usd">-147000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i4ed0f6117ecf4e2cb1bee31260a098b5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjEtMTAtMS0xLTM4NQ_569faac7-be89-472b-a3ec-e1712491331c"
      unitRef="usd">-9474000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjEtMTItMS0xLTQzOA_5fd7a767-aaa0-490d-a544-2b80228c948f"
      unitRef="usd">-9474000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="ia481f049459c472a9b4860fc2be9a142_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjItMi0xLTEtNDQ5_85c42b69-defb-4f21-9049-b95b2c8786b0"
      unitRef="shares">28838577</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia481f049459c472a9b4860fc2be9a142_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjItNC0xLTEtNDQ5_26b47fb9-33fd-4388-9257-4e3be5815e34"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i426469690ff2417c9f81c8a4128839c6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjItNi0xLTEtNDQ5_3b20d2bd-34c3-4b4a-846d-0fc0f23d20d2"
      unitRef="usd">331896000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i010b44ff2d3446fa8e15486e55a92e47_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjItOC0xLTEtNDQ5_67a495cb-b4c4-4ad5-ba41-21f89d6f71c2"
      unitRef="usd">430000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic84bb4fdd42940249648de647e304e0a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjItMTAtMS0xLTQ0OQ_0246317c-af8c-4c62-adb7-c3731f62e437"
      unitRef="usd">-230298000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i715926d08424490aabf690d9fa2f75e2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yMi9mcmFnOmM5NTQ1ZWUzNTU5MzRkYTlhMWI4NjllMzBkZjdjZjEyL3RhYmxlOjVkZjg4OWExMGM2YTQ5OTZiNjQwYzQzYTlkOGJkODZiL3RhYmxlcmFuZ2U6NWRmODg5YTEwYzZhNDk5NmI2NDBjNDNhOWQ4YmQ4NmJfNjItMTItMS0xLTQ0OQ_d02df379-0226-45b5-9e0d-a6892e1825b4"
      unitRef="usd">102031000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMy0xLTEtMS0x_35c965b0-1621-4e60-a33c-d671488e8491"
      unitRef="usd">-42095000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMy0zLTEtMS0x_3f2bb278-dc55-401b-9ce2-3b70710d0d81"
      unitRef="usd">-34718000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNS0xLTEtMS0x_69f58b65-6485-4913-a3a3-7a76b610ce18"
      unitRef="usd">12528000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNS0zLTEtMS0x_da4975f5-c844-40ee-aa20-e923d9d843db"
      unitRef="usd">8757000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNi0xLTEtMS0x_6d68eb8f-9063-43b7-bf80-d3be6b35addd"
      unitRef="usd">1436000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNi0zLTEtMS0x_6d44f238-3652-4218-b66b-753da7d47444"
      unitRef="usd">786000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNy0xLTEtMS0x_0a7d5517-edcf-4138-960f-57d4899c2d10"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNy0zLTEtMS0x_e850501b-c444-481e-8343-d2cec0c67b5a"
      unitRef="usd">235000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfOC0xLTEtMS0x_1d53e937-d569-4ffb-bd4b-d609a7d880e7"
      unitRef="usd">-1056000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfOC0zLTEtMS0x_6b2ad2d1-ce71-4a9c-8067-72632c14feca"
      unitRef="usd">16000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:MarketableSecuritiesRealizedGainLoss
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfOS0xLTEtMS0x_ca0d63be-268a-4179-bd2a-7f450fb4cc7e"
      unitRef="usd">0</us-gaap:MarketableSecuritiesRealizedGainLoss>
    <us-gaap:MarketableSecuritiesRealizedGainLoss
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfOS0zLTEtMS0x_437152dc-23cd-44b9-ae3b-2f3531e50515"
      unitRef="usd">43000</us-gaap:MarketableSecuritiesRealizedGainLoss>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTAtMS0xLTEtMQ_46f30a3d-f292-4fa9-b811-2901f8e0fdfd"
      unitRef="usd">234000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTAtMy0xLTEtMQ_3b94ed6c-a246-44e4-90f6-84a94de70204"
      unitRef="usd">204000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTEtMS0xLTEtMQ_32fb416e-dfe4-49fb-bb40-fed2b281c489"
      unitRef="usd">-1848000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTEtMy0xLTEtMQ_b3c0de99-b108-470b-a835-b9a3dda93511"
      unitRef="usd">-1534000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTItMS0xLTEtMQ_c1112d83-563e-4c41-913f-89c7e09a63c5"
      unitRef="usd">-304000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTItMy0xLTEtMQ_07445e1a-fbe2-4e88-81b7-12c0f1ca4f56"
      unitRef="usd">-248000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTQtMS0xLTEtMQ_f2574cdb-27e9-4a74-9885-3372d234ab1d"
      unitRef="usd">-1060000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTQtMy0xLTEtMQ_faada87e-7468-4235-bc0b-c8cc4e6b951f"
      unitRef="usd">-63000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTUtMS0xLTEtMQ_7d151a2e-d447-4999-86bf-d81fd6cf14e3"
      unitRef="usd">4545000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTUtMy0xLTEtMQ_27005a46-0e87-4423-8a44-58cf82ba7abf"
      unitRef="usd">-337000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTYtMS0xLTEtMQ_73aaec4c-9bbe-4e84-902b-d271041b83e2"
      unitRef="usd">-610000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTYtMy0xLTEtMQ_e810fa36-f435-4d68-b09b-e9ca9dfd62ef"
      unitRef="usd">-1489000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTctMS0xLTEtMQ_a70c6208-2c7e-4d66-b64d-507fe90ce232"
      unitRef="usd">425000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTctMy0xLTEtMQ_839a34f7-6f95-4c88-9f7b-381b9d2d7f6b"
      unitRef="usd">416000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTgtMS0xLTEtMQ_a75a646d-eb29-46f3-8c4b-f12c3ef00382"
      unitRef="usd">320000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTgtMy0xLTEtMQ_3635e757-97e5-4b09-9e38-0481063e43bb"
      unitRef="usd">-2072000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTktMS0xLTEtMQ_c3ab24d8-d03e-409c-8a4b-5a8da88ec9fc"
      unitRef="usd">-26819000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMTktMy0xLTEtMQ_f92c9739-ccfe-4222-a826-0c23089d9e24"
      unitRef="usd">-22780000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <sibn:ProceedsFromMaturityOfMarketableSecurities
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjEtMS0xLTEtMQ_999edc64-3492-4a4a-9b43-afba186ed243"
      unitRef="usd">107494000</sibn:ProceedsFromMaturityOfMarketableSecurities>
    <sibn:ProceedsFromMaturityOfMarketableSecurities
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjEtMy0xLTEtMQ_6f56e3b8-1948-4e58-8e2c-abbe331a3eb8"
      unitRef="usd">63200000</sibn:ProceedsFromMaturityOfMarketableSecurities>
    <sibn:ProceedsFromSaleOfMarketableSecurities
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjItMS0xLTEtMQ_ad4343a9-cfd0-48cd-bbfd-32cfccddb050"
      unitRef="usd">0</sibn:ProceedsFromSaleOfMarketableSecurities>
    <sibn:ProceedsFromSaleOfMarketableSecurities
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjItMy0xLTEtMQ_85618402-4ba1-456e-971c-5e69954fd006"
      unitRef="usd">12592000</sibn:ProceedsFromSaleOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjMtMS0xLTEtMQ_fe0bdab8-dab9-41ca-bbfb-e1156b461802"
      unitRef="usd">66678000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjMtMy0xLTEtMQ_852b6fc7-b282-49f0-9368-bb94671bde27"
      unitRef="usd">69145000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjQtMS0xLTEtMQ_a9540654-1617-477b-a00e-a87decf62e17"
      unitRef="usd">4614000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjQtMy0xLTEtMQ_292d2a83-5ed0-48ef-afb3-aaa65d5e75bd"
      unitRef="usd">1744000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjUtMS0xLTEtMQ_a0429255-02fb-43d5-b4e7-9363de48e81b"
      unitRef="usd">36202000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjUtMy0xLTEtMQ_4dec5612-58ca-437a-857d-9d3f0085f440"
      unitRef="usd">4903000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjctMS0xLTEtMQ_7fe17282-95d3-440d-a251-49f196abfe76"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjctMy0xLTEtMQ_1f2bde5a-6bf0-484c-b71c-208990619c86"
      unitRef="usd">62978000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjgtMS0xLTEtMQ_0fa85d2c-dd1a-4683-a8cc-4dd3f6aef26a"
      unitRef="usd">35000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjgtMy0xLTEtMQ_d0df410a-b66b-4c86-a1d1-02215130f649"
      unitRef="usd">45297000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjktMS0xLTEtMQ_e306f011-f500-40af-9b61-e4a40f1d9b13"
      unitRef="usd">41000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMjktMy0xLTEtMQ_8a33d560-a547-4ee2-85f2-af29183d42cb"
      unitRef="usd">45297000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzAtMS0xLTEtMQ_ca6878f1-ff83-4c0d-a05a-2eecb85c4e03"
      unitRef="usd">111000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzAtMy0xLTEtMQ_3300d1df-754c-44af-9bb0-363a9a277832"
      unitRef="usd">750000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzEtMS0xLTEtMQ_00cde4f2-0a60-40de-9358-75f7c4f47c8a"
      unitRef="usd">508000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzEtMy0xLTEtMQ_5f45950e-7207-4504-b7cc-61f8366a04d8"
      unitRef="usd">843000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzItMS0xLTEtMQ_45a60bd5-48b7-4844-9ca0-d6604e928428"
      unitRef="usd">1566000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzItMy0xLTEtMQ_a7574ef8-9d15-46bc-9a13-81a24c8c142d"
      unitRef="usd">991000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzMtMS0xLTEtMQ_de149ad4-9e23-4d86-b43b-1345cbfabe3b"
      unitRef="usd">2327000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzMtMy0xLTEtMQ_371ff197-9579-461c-aa85-5107786ec14d"
      unitRef="usd">987000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzYtMS0xLTEtMQ_7e768b4d-7056-4789-82b5-af9afa47f9be"
      unitRef="usd">-2726000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzYtMy0xLTEtMQ_c0d53c82-4c61-46b6-bdbd-d84402fd79f2"
      unitRef="usd">63363000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzctMS0xLTEtMQ_7e4999d0-f49d-414b-ad46-d94fef36c4d8"
      unitRef="usd">-375000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzctMy0xLTEtMQ_2d8c66fe-670f-47bb-af7a-ac1ae109eb51"
      unitRef="usd">75000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzgtMS0xLTEtMQ_56759390-de4c-4291-b8e8-191d98dc15da"
      unitRef="usd">6282000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfMzgtMy0xLTEtMQ_adc39722-659c-4425-9e82-9a3c2049963a"
      unitRef="usd">45561000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDAtMS0xLTEtMQ_825c342b-992c-4205-aa4b-6d03357a1763"
      unitRef="usd">53581000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i89789d0c91fe4169839f59b9bd5ea2df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDAtMy0xLTEtMQ_d5b90d4e-7aaf-4047-86b5-c7eb7ef718cd"
      unitRef="usd">10435000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDEtMS0xLTEtMQ_ad8cf144-2bb3-4736-b069-ff2ad959fc9c"
      unitRef="usd">59863000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i715926d08424490aabf690d9fa2f75e2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDEtMy0xLTEtMQ_25c1672d-af71-4818-8189-ca876e46e10b"
      unitRef="usd">55996000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <sibn:VestingOfEarlyExercisedStockOptions
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDYtMS0xLTEtMQ_4d13b123-9e66-4227-acd6-1c86efc16ade"
      unitRef="usd">27000</sibn:VestingOfEarlyExercisedStockOptions>
    <sibn:VestingOfEarlyExercisedStockOptions
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDYtMy0xLTEtMQ_08d1a743-4e99-465b-83e4-ae5ee274fa9f"
      unitRef="usd">62000</sibn:VestingOfEarlyExercisedStockOptions>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDctMS0xLTEtMQ_4964cb1d-6daf-4de4-9ec0-7a83dfb11f92"
      unitRef="usd">474000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8yNS9mcmFnOjM1YzgyNDdmMjQ0MjQ2MTE5NGNlYzk1NmI4YmQyOTI3L3RhYmxlOjgxMTY2ZjNlNGRiNjQwMjhiYjE0YjM2Zjg3YWMyZTg2L3RhYmxlcmFuZ2U6ODExNjZmM2U0ZGI2NDAyOGJiMTRiMzZmODdhYzJlODZfNDctMy0xLTEtMQ_9f1a105d-efb0-4748-a381-7110378aea71"
      unitRef="usd">256000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:NatureOfOperations
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfNDI0Mw_fbbdf7db-6e13-4313-8c2b-0f4f1223df25">The Company and Nature of Business&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SI-BONE, Inc. (the &#x201c;Company&#x201d;) was incorporated in the state of Delaware on March&#160;18, 2008 and is headquartered in Santa Clara, California. The Company is a medical device company that has pioneered a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of the most common types of sacroiliac joint disorders that cause lower back pain. The Company introduced its primary product, the iFuse Implant System, or iFuse, in 2009 in the U.S., in 2010 in certain countries in the European Union, and in 2015 in certain countries in the rest of the world.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2020, the Company received $63.0 million of net proceeds from its first follow-on public offering of 4,300,000 shares of the Company's common stock, of which 2,490,053 shares were offered and sold by the Company, and the exercise of underwriter's option to purchase from the Company an additional 645,000 shares of the Company's common stock, at a public offering price of $21.50 per share. The total public offering costs incurred in connection with the follow-on offering were allocated based on the gross proceeds received by the Company and the other selling shareholders on a pro-rated basis. Public offering cost of $0.4 million allocated to selling of shares by the Company was charged against the gross proceeds received from the follow-on offering. Public offering costs of $0.2 million allocated to selling of shares by the selling shareholders was recognized as transaction costs within general and administrative expenses on the consolidated statements of operations in the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the Company received $71.6&#160;million of net proceeds from its second follow-on public offering of shares of the Company's common stock, of which 3,000,000 shares were offered and sold by the Company, and the exercise of underwriter's option to purchase from the Company an additional 478,507 shares of the Company's common stock, at a public offering price of $22.00 per share. In addition to the shares sold by the Company in this second follow-on offering, the selling stockholder sold 190,053 shares of the Company's common stock previously held by the selling stockholder at a price to the public of $22.00 per share. The Company did not receive any proceeds from the sale by the selling stockholder.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;The Company is subject to continuing risk and uncertainties as a result of the COVID-19 pandemic, and is closely monitoring the impact of the pandemic on all aspects of its business, including the impacts on its customers, patients that would benefit from procedures involving the Company's products, employees, suppliers, vendors, business partners and distribution channels. Economies worldwide continue to be negatively impacted by the COVID-19 pandemic, in particular with recurrent outbreaks and mutations of the virus, despite advances in vaccines, and the Company anticipates these disruptions will continue. While the Company has not experienced material disruptions to its supply chain to date, certain of its third-party suppliers have faced delays, product shortages and rising costs resulting from disruptions in the global supply chain, primarily related to the instruments. As a result, the Company is continuing to work closely with its manufacturing partners and suppliers, as well as determining alternative sourcing strategies to enable the Company to source key components and maintain appropriate inventory levels to meet customer demand. As such the Company's future results of operations and liquidity could be adversely impacted by a variety of factors related to the COVID-19 pandemic, including those discussed in the section entitled "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended December 31, 2020.  As of the date of issuance of these condensed consolidated financial statements, the extent to which the COVID-19 pandemic may materially impact the Company's financial condition, liquidity, or results of operations remains uncertain</us-gaap:NatureOfOperations>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i4d2b391980d14a2aaf03c702bc7ee2f8_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfNjg3_dca8de9d-bc94-402f-973c-a802495f7c4e"
      unitRef="usd">63000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <sibn:SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering
      contextRef="i9010c1b3cf4c4b1a9c2136e170a13186_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfNzUw_795bc94a-64c7-43ee-9ff9-0ff7634941e1"
      unitRef="shares">4300000</sibn:SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i4d2b391980d14a2aaf03c702bc7ee2f8_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfODAw_241ccf89-7eb4-4ee9-8670-39a1406a197a"
      unitRef="shares">2490053</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i69d57d1462cc4484b5d209182af32f3f_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfOTMy_8fefa565-dbfe-4541-8adc-f5aa0d11f0a9"
      unitRef="shares">645000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i109df68e90ee490a9db47812746364dc_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMTAwMw_09184647-344b-4be0-afd0-73d41cc45460"
      unitRef="usdPerShare">21.50</us-gaap:SaleOfStockPricePerShare>
    <sibn:AllocatedPublicOfferingCosts
      contextRef="i4d2b391980d14a2aaf03c702bc7ee2f8_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMTI0OA_bacb2f00-42b3-4cd3-9171-f977eba8432f"
      unitRef="usd">400000</sibn:AllocatedPublicOfferingCosts>
    <sibn:AllocatedPublicOfferingCosts
      contextRef="ib80c352eab074e7f8283e97c5bcd56d3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMTM5OQ_e9b8fc56-2dc6-4d81-88e4-5d495415a377"
      unitRef="usd">200000</sibn:AllocatedPublicOfferingCosts>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ic20806741c494cdba90d292fbf08fc22_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMTY0NQ_83c766c3-d2a1-4fe9-8600-3cd024231cea"
      unitRef="usd">71600000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ic20806741c494cdba90d292fbf08fc22_D20201001-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMTc1Ng_80b5c89c-e9e4-4b88-a2b2-54b7a86bb4f7"
      unitRef="shares">3000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="iff1f8e32880046b2b07d08aa6eea7ef8_D20201001-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMTg4OA_ed5bcf94-5e53-4a26-a2b4-5c247c09156a"
      unitRef="shares">478507</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i43f819d6ee994d6087b5510e48ec11a2_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMTk1OQ_d2e71f29-66e7-459e-a6cd-374110d74b59"
      unitRef="usdPerShare">22.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i7415c778d8224834a93c6630cef41f4e_D20201001-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMjA4Mw_a115582d-b1a0-4612-b54a-7c81d2e86a24"
      unitRef="shares">190053</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i278b0ccaf44c482899bd7ba4f716814d_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zMS9mcmFnOjZiZDlhZGQ5Y2UxYjRmYWViNDFjYjI1MWU5MGFmMTgyL3RleHRyZWdpb246NmJkOWFkZDljZTFiNGZhZWI0MWNiMjUxZTkwYWYxODJfMjE5NA_929931a4-a644-477f-a778-04e44dd0537b"
      unitRef="usdPerShare">22.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNjE_d6f71096-96ff-4cf1-8c0d-a23ffefee714">Summary of Significant Accounting Policies&lt;div style="margin-bottom:12pt;margin-top:9pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;) and applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all of the information required by GAAP for complete financial statements. These unaudited interim condensed consolidated financial statements have been prepared on the same basis as the Company&#x2019;s annual financial statements and, in the opinion of management, reflect all adjustments that are necessary for a fair statement of the Company&#x2019;s consolidated financial information. The results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any other interim period or for any other future year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements should be read in conjunction with the audited financial statements and related notes thereto for the year ended December 31, 2020 contained in the Company&#x2019;s Annual Report on Form 10-K filed with the SEC on March 10, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are based on historical experience, where applicable and other assumptions believed to be reasonable by the management. Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s significant accounting policies are disclosed in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2020. There have been no material changes to these accounting policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;JOBS Act Accounting Election&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As an emerging growth company under the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), the Company has been eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. The Company has elected to take advantage of the extended transition period for adopting new or revised accounting standards that have different effective dates for public and private companies. As a result, these condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On June 30, 2021, the Company&#x2019;s public float exceeded $700&#160;million and as such the Company will be deemed to be a large accelerated filer under Rule 12b-2 of the Exchange Act, commencing with the Company&#x2019;s Annual Report on Form 10-K for the 2021 fiscal year. The Company will retain its current filer status until the end of 2021. As a large accelerated filer, the Company will no longer qualify as an emerging growth company nor be eligible to rely on the benefits afforded to emerging growth companies under the JOBS Act.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages and operates as one reportable segment. The Company derives substantially all of its revenue from sales to customers in the U.S. Revenue by geography is based on billing address of the customer. No single country outside the U.S.  accounts for more than 10% of the total revenue during the periods presented. Long-lived assets held outside the U.S. are immaterial. The table below summarizes the Company's revenue by geography:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.086%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Effective&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-02, Leases (Topic 842), which requires that lessee's recognize a right-of-use asset and a lease liability for all leases with lease terms greater than twelve months in the balance sheet.&#160;A lease liability is a lessee's obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset is an asset that represents the lessee&#x2019;s right to use, or control use of, a specified asset for the lease term for all leases (with the exception of short-term leases) at the adoption date. In July 2018, the FASB issued&#160;ASU&#160;2018-10 and&#160;ASU 2018-11, which provides clarification on the narrow aspects of the guidance and provide an additional transition method to adopt the new leases standard. The new transition method allows an entity to recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. In March 2019, the FASB issued&#160;ASU 2019-01, which provides clarification on implementation issues associated with adopting&#160;ASU 2016-02.&#160;The new leases standard must be adopted using a modified retrospective transition method and allows for the application of the new guidance at the beginning of the earliest comparative period presented or at the adoption date. In November 2019, the FASB issued ASU 2019-10, which revised the mandatory effective dates of the new leases standard. Further, due to the impact of the COVID-19, in June 2020, the FASB issued ASU 2020-05 to further defer the effective date for one year for entities in the &#x201c;all other&#x201d; categories. For public companies, the new guidance became effective for fiscal years, and for interim periods within those fiscal years, beginning after December&#160;15, 2018. For all other entities, the new guidance is now effective for fiscal years beginning after December&#160;15, 2021 and interim periods within fiscal years beginning after December 15, 2022. Early adoption is still permitted for any interim or annual financial statements not yet issued.  The Company expects to disclose the adoption of this standard for the fiscal year ending December 31, 2021. The Company is currently evaluating the impact of this standard on its consolidated financial statements including the timing of its adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (1) whether a contract is or contains a lease, (2) the classification of existing leases, and (3) whether previously capitalized initial direct costs would qualify for capitalization under ASC 842. The Company expects that the adoption of this new standard will have a material impact on its balance sheet. The most significant impact would be the recognition of operating lease right-of-use assets and liability. The standard is not expected to have a material impact to the Company's consolidated statements of income and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued&#160;ASU 2016-13,&#160;Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. FASB issued ASU 2019-05 in May 2019, ASU 2019-08 and ASU 2019-11 in November 2019 for codification improvements of Topic 326. The new standard revises the accounting requirements related to the measurement of credit losses and will require organizations to measure all expected credit losses for financial assets based on historical experience, current conditions and reasonable and supportable forecasts about collectability. Assets must be presented in the financial statements at the net amount expected to be collected.&#160;In November 2019, the FASB issued ASU 2019-10,&#160;which defers the effective date of&#160;ASU 2016-13&#160;for public companies that are eligible to be smaller reporting companies and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.&#160;In February 2020, the FASB issued ASU 2020-02, which provides guidance regarding methodologies, documentation, and internal controls related to expected credit losses. The Company is currently evaluating the impact of this standard on its consolidated financial statements but does not expect the standard will have a material impact on the Company's consolidated financial statements. The Company expects to disclose the adoption of this standard for the fiscal year ending December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the FASB issued&#160;ASU&#160;2021-04&#160;&#x201c;Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014; Stock Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815- 40) Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#x201d; which clarifies and reduces diversity in an issuer&#x2019;s accounting for modifications or exchanges of freestanding equity-classified written call options that remain equity classified after modification or exchange. An entity should measure the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as follows: i) for a modification or an exchange that is a part of or directly related to a modification or an exchange of an existing debt instrument or line-of-credit or revolving-debt arrangements (hereinafter, referred to as a &#x201c;debt&#x201d; or &#x201c;debt instrument&#x201d;), as the difference between the fair value of the modified or exchanged written call option and the fair value of that written call option immediately before it is modified or exchanged; ii) for all other modifications or exchanges, as the excess, if any, of the fair value of the modified or exchanged written call option over the fair value of that written call option immediately before it is modified or exchanged. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. The Company is currently evaluating the impact of this update on its consolidated financial statements. While the Company does not expect the adoption of ASU 2021-04 to materially impact the Company's consolidated financial statements and related disclosures because it does not currently anticipate modifications to its outstanding equity-classified written call options, the impact on the Company's consolidated financial statements and disclosures will depend on the facts and circumstances of any specific future transactions.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNTY_4b6ff75f-21f3-461e-9ffc-a62983894956">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;) and applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all of the information required by GAAP for complete financial statements.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNTc_ed5eaec3-a979-4327-9b99-6139b497514e">These unaudited interim condensed consolidated financial statements have been prepared on the same basis as the Company&#x2019;s annual financial statements and, in the opinion of management, reflect all adjustments that are necessary for a fair statement of the Company&#x2019;s consolidated financial information. The results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any other interim period or for any other future year.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNTg_f103ff6e-5a31-4df6-a7a9-521609cb4edd">Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are based on historical experience, where applicable and other assumptions believed to be reasonable by the management. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <sibn:EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNjM_4616d7f0-e207-4ee6-9e36-1496e6ea7dcf">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;JOBS Act Accounting Election&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As an emerging growth company under the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), the Company has been eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. The Company has elected to take advantage of the extended transition period for adopting new or revised accounting standards that have different effective dates for public and private companies. As a result, these condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On June 30, 2021, the Company&#x2019;s public float exceeded $700&#160;million and as such the Company will be deemed to be a large accelerated filer under Rule 12b-2 of the Exchange Act, commencing with the Company&#x2019;s Annual Report on Form 10-K for the 2021 fiscal year. The Company will retain its current filer status until the end of 2021. As a large accelerated filer, the Company will no longer qualify as an emerging growth company nor be eligible to rely on the benefits afforded to emerging growth companies under the JOBS Act.&lt;/span&gt;&lt;/div&gt;</sibn:EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNTk_5607564d-9a1f-45e4-b095-8b385e46f451">SegmentsThe Company manages and operates as one reportable segment. The Company derives substantially all of its revenue from sales to customers in the U.S. Revenue by geography is based on billing address of the customer.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMzg0OQ_35598f75-33c7-4f3b-8953-6409139b36bc"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMzg0OQ_c3b35009-d259-4958-b7f0-6ece9e22238c"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNjA_4ac52d2f-eff8-4dd9-bc8a-56543de54235">The table below summarizes the Company's revenue by geography:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.086%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie659bc55581349eca6480acadb12d4f9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfMy0xLTEtMS0x_dfc7b507-211d-4795-b12d-6fed7ea2b9bb"
      unitRef="usd">20392000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i976ed3cd496b4e58a4dc4becdbc4161b_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfMy0zLTEtMS0x_66e33f76-bbf2-4f9e-8519-9f9733091f31"
      unitRef="usd">18924000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if12a2b6dbfac4d1ab143dfbd3f951b36_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfMy01LTEtMS0x_08ab8037-bb0a-4f38-8ad7-456dee5f5465"
      unitRef="usd">59391000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46482b4e0b8440ce80cee026cd1125e8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfMy02LTEtMS0x_1053b6a1-540e-42be-86e1-e281a686b971"
      unitRef="usd">47442000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1317afa536514c45b39738af99fef75c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNC0xLTEtMS0x_4555aa33-1f3c-42db-9783-32a911de4172"
      unitRef="usd">1894000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ff853edb14242bc858575b0953b7ca6_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNC0zLTEtMS0x_9d3d2be6-9b39-42c7-8834-8c25bbb021c2"
      unitRef="usd">1449000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd3e395480d74661ada50ae4fd7afc82_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNC01LTEtMS0x_b5c7eaa2-a0d7-45a7-aa8c-0bc4dfa71f14"
      unitRef="usd">5531000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacd5d89692c34b9496302d55a55bc7ce_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNC02LTEtMS0x_f54bd98a-5a2e-41a2-a6d6-ac340fbf2356"
      unitRef="usd">3801000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNS0xLTEtMS0x_af778005-c0cc-44ff-bdef-0f7199ba8a36"
      unitRef="usd">22286000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNS0zLTEtMS0x_1908fbbc-f257-49b9-8bbb-5c92061e3961"
      unitRef="usd">20373000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNS01LTEtMS0x_af86df93-68ae-40cd-a5ab-40fdcc771f95"
      unitRef="usd">64922000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RhYmxlOmMyNThkNzE5MzMwNDQ3MmY5ZGU3N2Y4N2MyMGI2NDQ5L3RhYmxlcmFuZ2U6YzI1OGQ3MTkzMzA0NDcyZjlkZTc3Zjg3YzIwYjY0NDlfNS02LTEtMS0x_d1121878-09c0-4a5f-b141-8a0d76ff11d3"
      unitRef="usd">51243000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNC9mcmFnOjk5MGJkYjJmYTQ0ODQwYjQ5NDY2NDc5MTg4NzFlYWI4L3RleHRyZWdpb246OTkwYmRiMmZhNDQ4NDBiNDk0NjY0NzkxODg3MWVhYjhfMTEwNjQ_a887c5fb-7e97-479b-9806-8a015a227dcd">&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Effective&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-02, Leases (Topic 842), which requires that lessee's recognize a right-of-use asset and a lease liability for all leases with lease terms greater than twelve months in the balance sheet.&#160;A lease liability is a lessee's obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset is an asset that represents the lessee&#x2019;s right to use, or control use of, a specified asset for the lease term for all leases (with the exception of short-term leases) at the adoption date. In July 2018, the FASB issued&#160;ASU&#160;2018-10 and&#160;ASU 2018-11, which provides clarification on the narrow aspects of the guidance and provide an additional transition method to adopt the new leases standard. The new transition method allows an entity to recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. In March 2019, the FASB issued&#160;ASU 2019-01, which provides clarification on implementation issues associated with adopting&#160;ASU 2016-02.&#160;The new leases standard must be adopted using a modified retrospective transition method and allows for the application of the new guidance at the beginning of the earliest comparative period presented or at the adoption date. In November 2019, the FASB issued ASU 2019-10, which revised the mandatory effective dates of the new leases standard. Further, due to the impact of the COVID-19, in June 2020, the FASB issued ASU 2020-05 to further defer the effective date for one year for entities in the &#x201c;all other&#x201d; categories. For public companies, the new guidance became effective for fiscal years, and for interim periods within those fiscal years, beginning after December&#160;15, 2018. For all other entities, the new guidance is now effective for fiscal years beginning after December&#160;15, 2021 and interim periods within fiscal years beginning after December 15, 2022. Early adoption is still permitted for any interim or annual financial statements not yet issued.  The Company expects to disclose the adoption of this standard for the fiscal year ending December 31, 2021. The Company is currently evaluating the impact of this standard on its consolidated financial statements including the timing of its adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (1) whether a contract is or contains a lease, (2) the classification of existing leases, and (3) whether previously capitalized initial direct costs would qualify for capitalization under ASC 842. The Company expects that the adoption of this new standard will have a material impact on its balance sheet. The most significant impact would be the recognition of operating lease right-of-use assets and liability. The standard is not expected to have a material impact to the Company's consolidated statements of income and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued&#160;ASU 2016-13,&#160;Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. FASB issued ASU 2019-05 in May 2019, ASU 2019-08 and ASU 2019-11 in November 2019 for codification improvements of Topic 326. The new standard revises the accounting requirements related to the measurement of credit losses and will require organizations to measure all expected credit losses for financial assets based on historical experience, current conditions and reasonable and supportable forecasts about collectability. Assets must be presented in the financial statements at the net amount expected to be collected.&#160;In November 2019, the FASB issued ASU 2019-10,&#160;which defers the effective date of&#160;ASU 2016-13&#160;for public companies that are eligible to be smaller reporting companies and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.&#160;In February 2020, the FASB issued ASU 2020-02, which provides guidance regarding methodologies, documentation, and internal controls related to expected credit losses. The Company is currently evaluating the impact of this standard on its consolidated financial statements but does not expect the standard will have a material impact on the Company's consolidated financial statements. The Company expects to disclose the adoption of this standard for the fiscal year ending December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the FASB issued&#160;ASU&#160;2021-04&#160;&#x201c;Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014; Stock Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815- 40) Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#x201d; which clarifies and reduces diversity in an issuer&#x2019;s accounting for modifications or exchanges of freestanding equity-classified written call options that remain equity classified after modification or exchange. An entity should measure the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as follows: i) for a modification or an exchange that is a part of or directly related to a modification or an exchange of an existing debt instrument or line-of-credit or revolving-debt arrangements (hereinafter, referred to as a &#x201c;debt&#x201d; or &#x201c;debt instrument&#x201d;), as the difference between the fair value of the modified or exchanged written call option and the fair value of that written call option immediately before it is modified or exchanged; ii) for all other modifications or exchanges, as the excess, if any, of the fair value of the modified or exchanged written call option over the fair value of that written call option immediately before it is modified or exchanged. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. The Company is currently evaluating the impact of this update on its consolidated financial statements. While the Company does not expect the adoption of ASU 2021-04 to materially impact the Company's consolidated financial statements and related disclosures because it does not currently anticipate modifications to its outstanding equity-classified written call options, the impact on the Company's consolidated financial statements and disclosures will depend on the facts and circumstances of any specific future transactions.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RleHRyZWdpb246Y2UyNGVmZTc2ZTIyNDY1OGE5NjViYWYzNGRmYWI2YzhfMTIyMw_d45118fb-e9cc-42b4-92bb-72cd264d1076">Marketable Securities&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company's marketable securities were available-for-sale and were classified based on their maturities. Marketable securities with remaining maturities at the date of purchase of three months or less are classified as cash equivalents. Short-term investments are securities that original maturity or remaining maturity is greater than three months and not more than twelve months. Long-term investments are securities for which the original maturity or remaining maturity is greater than twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the marketable securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;   &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.242%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.242%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:15pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized gains and losses on available-for-sale securities are recorded in accumulated other comprehensive income (loss) on the condensed consolidated balance sheets. The Company evaluates its investments to assess whether those in unrealized loss positions are other-than-temporarily impaired. The Company considers impairments to be other-than-temporary if it is related to deterioration in credit risk or if it is likely the Company will sell the securities before the recovery of their cost basis. The Company did not identify any of its marketable securities as other-than-temporarily impaired as of September 30, 2021 or December 31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RleHRyZWdpb246Y2UyNGVmZTc2ZTIyNDY1OGE5NjViYWYzNGRmYWI2YzhfMTIyMg_7ea4082e-36b3-4bd6-aab4-70f45114ffca">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the marketable securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;   &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.242%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.242%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i380833eacc394ce0bea4afe14c77beb8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMy0xLTEtMS0x_243e93f4-9bc7-4b31-829a-284843523928"
      unitRef="usd">54218000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i380833eacc394ce0bea4afe14c77beb8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMy03LTEtMS0x_c294c74a-646d-4e09-a50e-59c2306cf8ed"
      unitRef="usd">54218000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfNS0xLTEtMS0x_ca97db6f-aeaf-4394-8137-69a4d87778b8"
      unitRef="usd">54218000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfNS03LTEtMS0x_c45c9f4e-c324-450d-9f44-1bbc7617eedc"
      unitRef="usd">54218000</us-gaap:CashEquivalentsAtCarryingValue>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis
      contextRef="if5b1f78d1cc14db3aff7642b38d0594b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfNy0xLTEtMS0x_8d7dae84-a902-4a63-8d6a-a2c08f4e203a"
      unitRef="usd">52140000</sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if5b1f78d1cc14db3aff7642b38d0594b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfNy0zLTEtMS0x_3ad2d805-e37d-4a1b-bf7e-8e0c1282012e"
      unitRef="usd">3000</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if5b1f78d1cc14db3aff7642b38d0594b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfNy01LTEtMS0x_a0864f5e-3d08-4a67-8c17-385c824cb009"
      unitRef="usd">0</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="if5b1f78d1cc14db3aff7642b38d0594b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfNy03LTEtMS0x_eee9dea4-e172-493d-b43c-8adf16cb32b5"
      unitRef="usd">52143000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis
      contextRef="i0b457a33537545b79259df1751c27179_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOC0xLTEtMS0x_c24a998f-3c09-45d4-bc91-e70d8621ac64"
      unitRef="usd">15373000</sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0b457a33537545b79259df1751c27179_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOC0zLTEtMS0x_78268b09-ad40-4131-a856-adde692bec30"
      unitRef="usd">0</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0b457a33537545b79259df1751c27179_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOC01LTEtMS0x_4392113b-a66a-4e5e-b50f-c5a45abf0644"
      unitRef="usd">3000</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i0b457a33537545b79259df1751c27179_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOC03LTEtMS0x_ecb61980-7af6-494a-8363-521a10426196"
      unitRef="usd">15370000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis
      contextRef="i8ec84971611b4b4b9fb02e3e0833ebe2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOS0xLTEtMS0x_ec08b662-b6b4-4787-b0d2-ad4ec38e2829"
      unitRef="usd">33475000</sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8ec84971611b4b4b9fb02e3e0833ebe2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOS0zLTEtMS0x_dcdafa72-0ad2-41ad-976d-9bb2b9d9d460"
      unitRef="usd">0</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8ec84971611b4b4b9fb02e3e0833ebe2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOS01LTEtMS0x_058249bf-8b9a-4b68-9b0b-399056b28d4a"
      unitRef="usd">0</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8ec84971611b4b4b9fb02e3e0833ebe2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfOS03LTEtMS0x_de15c2ec-8ef3-45f0-ae14-a0a793133e69"
      unitRef="usd">33475000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTAtMS0xLTEtMQ_fd152a77-464c-4367-b287-441f511e3d65"
      unitRef="usd">100988000</sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTAtMy0xLTEtMQ_ca483538-46db-40f2-b61c-f19353f86430"
      unitRef="usd">3000</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTAtNS0xLTEtMQ_32586f36-dab5-4e01-9a97-c4d37080adfd"
      unitRef="usd">3000</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTAtNy0xLTEtMQ_a6c7a0a6-55f4-4494-a57b-1c66ee499ac2"
      unitRef="usd">100988000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <sibn:MarketableSecuritiesAmortizedCost
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTQtMS0xLTEtMQ_f41ec146-415b-4a41-b5da-66a10e632d19"
      unitRef="usd">155206000</sibn:MarketableSecuritiesAmortizedCost>
    <sibn:MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTQtMy0xLTEtMQ_47f3662e-2ec4-4fba-8fd8-904fda8e430c"
      unitRef="usd">3000</sibn:MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <sibn:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTQtNS0xLTEtMQ_7168712e-d12b-490c-8518-4aa2521aeffa"
      unitRef="usd">3000</sibn:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <sibn:MarketableSecuritiesFairValue
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjdmOTY0NjZlMTZmYjQ5MzI5N2ViM2I0YTUzZGM1OWNlL3RhYmxlcmFuZ2U6N2Y5NjQ2NmUxNmZiNDkzMjk3ZWIzYjRhNTNkYzU5Y2VfMTQtNy0xLTEtMQ_7b882b12-96b2-4a76-a8a3-8c75faeddd3a"
      unitRef="usd">155206000</sibn:MarketableSecuritiesFairValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="if0cb0da3346b4ba79a69c2838e5d4b76_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMy0xLTEtMS0x_8528f6be-d6c9-478b-8e7d-3414dce71eff"
      unitRef="usd">45948000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="if0cb0da3346b4ba79a69c2838e5d4b76_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMy03LTEtMS0x_c353266c-cad7-4d69-8f66-4d43c7b9385c"
      unitRef="usd">45948000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="idac9e0269b454ee2a0357ade267691e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNC0xLTEtMS0x_9d16f3ce-e638-45a0-a6e8-54bcd46e95d8"
      unitRef="usd">1400000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="idac9e0269b454ee2a0357ade267691e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNC03LTEtMS0x_04d2cd3f-330b-4959-902c-84b519dd4a8b"
      unitRef="usd">1400000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNS0xLTEtMS0x_197a2139-1f4a-4efc-aa24-c5ce103248ed"
      unitRef="usd">47348000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNS03LTEtMS0x_e9686df7-9ad8-4655-a1ff-2d24b3c1e39c"
      unitRef="usd">47348000</us-gaap:CashEquivalentsAtCarryingValue>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis
      contextRef="ie171077119e94be4b547961f085b9ae7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNy0xLTEtMS0x_704e9b7f-a656-4ce2-a1df-2ed88005674f"
      unitRef="usd">74779000</sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie171077119e94be4b547961f085b9ae7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNy0zLTEtMS0x_5382311b-e0d1-4d6f-8bf2-017576b8ccb8"
      unitRef="usd">4000</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie171077119e94be4b547961f085b9ae7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNy01LTEtMS0x_fadc1bce-3bb5-4795-a2b7-b6a89b56d945"
      unitRef="usd">7000</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ie171077119e94be4b547961f085b9ae7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfNy03LTEtMS0x_ac037569-1f62-450a-a309-23ebce41a965"
      unitRef="usd">74776000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis
      contextRef="i054dc78f1b714085a5838ba8d5780e3e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOC0xLTEtMS0x_d09ebdb8-bad7-4bc5-b204-02e0972acf40"
      unitRef="usd">8940000</sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i054dc78f1b714085a5838ba8d5780e3e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOC0zLTEtMS0x_4f4faee4-d42e-42b4-ac00-8e1b2e5525aa"
      unitRef="usd">4000</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i054dc78f1b714085a5838ba8d5780e3e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOC01LTEtMS0x_52f9d9ac-5bbf-4421-ac3d-94983eaaa4b8"
      unitRef="usd">6000</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i054dc78f1b714085a5838ba8d5780e3e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOC03LTEtMS0x_b6a1d176-5209-4b9d-bfb3-29992dae435d"
      unitRef="usd">8938000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis
      contextRef="idac9e0269b454ee2a0357ade267691e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOS0xLTEtMS0x_8ed23a1d-9c30-4940-91b9-1891f521ec07"
      unitRef="usd">59137000</sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idac9e0269b454ee2a0357ade267691e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOS0zLTEtMS0x_5301addf-eb12-4a1b-b46e-5e67da2c8f04"
      unitRef="usd">0</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idac9e0269b454ee2a0357ade267691e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOS01LTEtMS0x_884facaa-6eff-495a-b328-1646bdd97995"
      unitRef="usd">0</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="idac9e0269b454ee2a0357ade267691e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfOS03LTEtMS0x_59a5a393-8f16-49a3-b7df-3ff463141e58"
      unitRef="usd">59137000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTAtMS0xLTEtMQ_b08f3348-32a2-42cd-b5f4-eb60c5017995"
      unitRef="usd">142856000</sibn:AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTAtMy0xLTEtMQ_23af7d99-497a-4d51-9f02-be1e4f547309"
      unitRef="usd">8000</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax>
    <sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTAtNS0xLTEtMQ_a937723c-2762-4d25-bea9-5a0cf71e0cce"
      unitRef="usd">13000</sibn:AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTAtNy0xLTEtMQ_237fc2c3-7ea9-4f80-b874-b60a5cba3dbc"
      unitRef="usd">142851000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <sibn:MarketableSecuritiesAmortizedCost
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTQtMS0xLTEtMQ_647163fc-1d09-4eb7-ada9-e5f586c978a0"
      unitRef="usd">190204000</sibn:MarketableSecuritiesAmortizedCost>
    <sibn:MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTQtMy0xLTEtMQ_6bfe07c8-358a-4930-9d6e-e537f32ca5ef"
      unitRef="usd">8000</sibn:MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <sibn:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTQtNS0xLTEtMQ_a1534996-2aff-4203-9d64-4676bd623f40"
      unitRef="usd">13000</sibn:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <sibn:MarketableSecuritiesFairValue
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV8zNy9mcmFnOmNlMjRlZmU3NmUyMjQ2NThhOTY1YmFmMzRkZmFiNmM4L3RhYmxlOjQ0NGM2OGY4ZGU3YzRlMzZiMTI4OTMyM2IyYmE4YjZkL3RhYmxlcmFuZ2U6NDQ0YzY4ZjhkZTdjNGUzNmIxMjg5MzIzYjJiYThiNmRfMTQtNy0xLTEtMQ_4bc66c45-18f9-424e-9509-578e5bf34334"
      unitRef="usd">190199000</sibn:MarketableSecuritiesFairValue>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RleHRyZWdpb246YTAyOTg1YmEyNDEzNDFmMjlhYjExYzEyZDk0MGVmZDFfODA1_fca39770-2fe0-40fd-9482-eb753d7595c7">Fair Value Measurement&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Carrying amounts of certain of the Company&#x2019;s financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities and market interest rates, if applicable. The carrying value of the Company&#x2019;s long-term debt also approximates fair value based on management&#x2019;s estimation that a current interest rate would not differ materially from the stated rate. There were no other financial assets or liabilities that required fair value hierarchy measurements and disclosures for the periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the fair value of the Company&#x2019;s marketable securities measured at fair value on a recurring basis based on the three-tier fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RleHRyZWdpb246YTAyOTg1YmEyNDEzNDFmMjlhYjExYzEyZDk0MGVmZDFfODA0_d5fb21db-1584-40e2-84e3-a2ecbbcfc12f">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the fair value of the Company&#x2019;s marketable securities measured at fair value on a recurring basis based on the three-tier fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="if50d4b24e0734d79ba8b9edd1e805e40_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNC0xLTEtMS0x_b7ffd7d1-601c-4506-82d7-0613cc1e29b2"
      unitRef="usd">54218000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i57ab096c74ac4847b7ee788ce1789d46_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNC0zLTEtMS0x_e12df0f2-f118-4fcf-860e-244d5d52976a"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id144f1a299a84ecbbb8e3d9cd71920cf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNC01LTEtMS0x_b7785442-6035-4638-8067-c164efca727e"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i433ab522b59a4aa783879f2118cf5b5a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNC03LTEtMS0x_b9e3d38c-19a2-481d-a2a5-b05decf6b31c"
      unitRef="usd">54218000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i725fda3b69fb42b69214192df2b4307e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNS0xLTEtMS0x_44501589-fe07-4794-9988-fb5edcdaf4fe"
      unitRef="usd">52143000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i2cdbdee501ca4f0b85e078944f534f65_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNS0zLTEtMS0x_8895fb8e-22f4-4b08-9175-72ee0c15f643"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i41b6362dacd34d9f88a9c8993387770b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNS01LTEtMS0x_9f2e331d-bc41-4846-bf9f-fd6aed02974b"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="iaf59194f545044df83f3f403416ed170_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNS03LTEtMS0x_7d0eb627-0f4b-4f35-90e9-3a94d893b907"
      unitRef="usd">52143000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i241fe256234a44b3b77f08e14eca6888_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNi0xLTEtMS0x_50cc8ae8-2c8b-4282-ac52-bd6c860d5f6f"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i686c44112b5d4f3ba9a4d54da9d73cbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNi0zLTEtMS0x_4480999a-8b5a-4742-918d-5aa8c1a6848e"
      unitRef="usd">15370000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i00577f535d504af0be68212884f55f8b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNi01LTEtMS0x_debd7bce-02da-45d7-a3d6-210ba8514cb4"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3ea729b060074c5899a64ea1337e293b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNi03LTEtMS0x_4b5e7e1a-06e0-4eca-b2d4-f3cdfd273115"
      unitRef="usd">15370000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i102d310b7d67475fb03b9907bc7c3d46_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNy0xLTEtMS0x_fef71ad0-645a-4842-997d-096e0990fc2c"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6d3079b6c3604eddb06b821bf1c2d0b7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNy0zLTEtMS0x_d4e3ae00-befb-4e3f-bea4-bd6c80231bd2"
      unitRef="usd">33475000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ie78d10f8420241fe8b24a9e42e1f528a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNy01LTEtMS0x_70c4221c-5daf-42ba-a8b0-21cd142aea56"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i27fdd2acd64a4b8d85de92ce53842683_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfNy03LTEtMS0x_abe1475f-306f-45e0-81af-579331a00212"
      unitRef="usd">33475000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ie0ab19ddd1d0461c9e0d4e27776d7d1f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfOC0xLTEtMS0x_10adbedc-b663-49b3-adbb-8a7d00febf9d"
      unitRef="usd">106361000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i98e6ede9aecc414587ca1f1a67b50d01_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfOC0zLTEtMS0x_3913c711-def1-49fc-ba02-82b76f557661"
      unitRef="usd">48845000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i987e7b13124e43d7b5ae40e6246e58cc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfOC01LTEtMS0x_5bba6f38-caae-44c8-9ac9-b8a68d59db32"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i5e29646458c343d4b6be0890911f4d9c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfOC03LTEtMS0x_2f30b3a5-c40d-4a0f-aaec-e0183410beae"
      unitRef="usd">155206000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3ecf8bebd1ef4e9ab058a08dfe87ac43_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTQtMS0xLTEtMQ_c7fa3900-e6dc-4f86-91c6-9713608fe7c3"
      unitRef="usd">45948000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i41f57a77065c4ecf98478986ebfac018_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTQtMy0xLTEtMQ_fb39e479-26f8-4349-a5a1-d6beb547d8f1"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0e6ed7e99cde4d7c92e1b6df344d0083_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTQtNS0xLTEtMQ_926a2a69-7103-4456-957f-ce442e0d3450"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ibde2c8052a5648118d562a14a46b38fe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTQtNy0xLTEtMQ_63a0505c-da50-4f4b-a03c-22befea53b0d"
      unitRef="usd">45948000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i80b10d0cb3ff49df8d232f17ea2522e9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTUtMS0xLTEtMQ_b0d28e7c-adc2-4ce1-961a-c9221dd7d7df"
      unitRef="usd">74776000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i7a26c11caa9041ccaf5933b7b93b6d6c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTUtMy0xLTEtMQ_5b5dcfc9-d1e0-4cc7-9b3b-3afe56bae6f7"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i68990ae0b9c64420ab7d40fcde0e4612_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTUtNS0xLTEtMQ_7a8e02a4-4478-4f87-aa51-a9e0180d0c21"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i7b8c7b83b4a74dd6b717a704b99447b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTUtNy0xLTEtMQ_66ed69b4-4164-434a-8502-ebe7d83a761d"
      unitRef="usd">74776000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ica53df319b9b4f6b8b770a1f538ab111_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTYtMS0xLTEtMQ_45a3f05d-9b7c-4a5f-965f-a006871560f5"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3b60576a921b48b680618b3810b404bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTYtMy0xLTEtMQ_abc8299f-57eb-456f-a720-656d5e36f9cd"
      unitRef="usd">8938000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i66fdccee615a470db6971cc34c65e8c9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTYtNS0xLTEtMQ_afd7c4a9-d2c0-41f0-8464-c27604fb924e"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6e5ba73a05ed40299cc3f10f52f1b435_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTYtNy0xLTEtMQ_0e5e11b3-ac58-4bf7-ba79-b098daea5396"
      unitRef="usd">8938000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="icb844642c3174f18a5186ba1283f54e9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTctMS0xLTEtMQ_2e6560d2-57b8-4c69-b743-2389551dcd57"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id53205439e8b4340b3ce102dd284cbde_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTctMy0xLTEtMQ_1f50f766-a9d3-479c-ab7e-a42f2a35bc4b"
      unitRef="usd">60537000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i5b4f96fcd7e24f62a9e449453e2b6f9a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTctNS0xLTEtMQ_7216ae65-7fa9-4d74-8910-823d362e281a"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ib6911b659231424280f48b741135ca13_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTctNy0xLTEtMQ_e8527f2f-e2b4-4681-a66e-e7ead68580f8"
      unitRef="usd">60537000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ia33d55a979204b7f9ccc70abb78a1a48_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTgtMS0xLTEtMQ_0d7596d6-3f02-497b-9b98-3f219a1b248b"
      unitRef="usd">120724000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6360a4b99f2b445481090bd10f1bbeff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTgtMy0xLTEtMQ_ed049a08-fb18-41cb-8dc0-41ebc46ea95e"
      unitRef="usd">69475000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3a1f642004944d43b7569e23fd29e61c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTgtNS0xLTEtMQ_652565db-f9c0-41d9-8aba-4aa30199cb63"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i757d3032f8fc4a71b0a40a93905bf6dc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80MC9mcmFnOmEwMjk4NWJhMjQxMzQxZjI5YWIxMWMxMmQ5NDBlZmQxL3RhYmxlOjQ4MWUwM2QwMTBhYzRkMTE5NjNmZDU5NTVjZGE1MWQ1L3RhYmxlcmFuZ2U6NDgxZTAzZDAxMGFjNGQxMTk2M2ZkNTk1NWNkYTUxZDVfMTgtNy0xLTEtMQ_603031cb-8923-4f07-92b5-82f82ad8d984"
      unitRef="usd">190199000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfNDg4_99c86472-8185-449d-ba1d-5905a9580f27">Balance Sheet Components&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2021 and December 31, 2020, inventory consisted entirely of finished goods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment, net:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and office equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Construction in progress consists of cost of individual components of a custom instrument set used for surgical placement of the Company&#x2019;s products that have not yet been placed into service of $2.8 million and construction costs related to the new lease in Santa Clara of $0.1 million. Depreciation expense was $0.6 million and $0.3 million for the three months ended September 30, 2021 and 2020, respectively, and $1.4 million and $0.8 million for the nine months ended September 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Liabilities and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Accrued professional services &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfNDg5_ca8aa6cd-f5d8-42e3-8d3e-6a3667c0a8ae">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment, net:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and office equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id245cbf5f02e45a6bad677ee88cd874f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfMi0xLTEtMS0x_bc648991-279a-407f-955b-047264f5976d"
      unitRef="usd">9650000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i24eb57cd3b86414f942f4026431cbebc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfMi0zLTEtMS0x_df8e20d2-e731-4b42-b777-52d935eb4484"
      unitRef="usd">6342000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iea20d262a08e4a9686dd6fc4c64b6cbc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfMy0xLTEtMS0x_9083e29e-fa53-44a9-a6d0-cb364b4e851b"
      unitRef="usd">2906000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i737a4beebbff4635b25833b31ee0943e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfMy0zLTEtMS0x_456b3861-870b-470e-b784-d50c405fe387"
      unitRef="usd">1692000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6421c98b366e420ca30776333d1e2c0a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNC0xLTEtMS0x_1bea646e-7ee8-4f47-98ba-631b8339eb54"
      unitRef="usd">878000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie875541c2b924f32a637a5864a311bb1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNC0zLTEtMS0x_268820d2-c726-43ba-aa73-5efb096e9900"
      unitRef="usd">714000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="icca253489e02432f8f1edbe1cd8e4d4a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNS0xLTEtMS0x_e4e51762-db27-4611-a0ce-9e6cee563848"
      unitRef="usd">503000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i20f42e5899834f1d97e11131b6de99de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNS0zLTEtMS0x_0040f6f4-3a7a-4edf-93a0-7a3f4d13bab0"
      unitRef="usd">503000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i678091eb517f46e1b50ede7a3998b1b3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNi0xLTEtMS0x_804148d4-7142-4f4c-b4e2-2784e5406a2f"
      unitRef="usd">310000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8864c9b1ec194188b89a16633da21be7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNi0zLTEtMS0x_9661d291-c715-43f7-8955-ba7619f6d10a"
      unitRef="usd">233000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNy0xLTEtMS0x_7b4fd809-5ef6-49e3-9755-a72ce3a44bc7"
      unitRef="usd">14247000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfNy0zLTEtMS0x_1d8cc6b6-f486-4f70-bdfc-6a5d6f62b842"
      unitRef="usd">9484000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfOC0xLTEtMS0x_69c07fae-a156-480c-b545-bd8d3d957e66"
      unitRef="usd">6334000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfOC0zLTEtMS0x_f64c5647-70e3-432d-af99-95c5e27d1020"
      unitRef="usd">4957000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfOS0xLTEtMS0x_c11acf19-93e5-4071-8f3e-b06042aaca36"
      unitRef="usd">7913000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjA0MjZkMGFmN2IzZDQ0OWQ4ZWUxM2VmNTFhZjc3YWU0L3RhYmxlcmFuZ2U6MDQyNmQwYWY3YjNkNDQ5ZDhlZTEzZWY1MWFmNzdhZTRfOS0zLTEtMS0x_89abaf73-590a-4bf0-adb5-4dc2ff43b251"
      unitRef="usd">4527000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i78e300a956264748aa120a323a6cb2b5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfMTA5OTUxMTYyODkzNw_445412d2-4ded-4298-9c5c-d68601b0961e"
      unitRef="usd">2800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iac1bec7b510c4ec2b6a53deea9267b72_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfMTA5OTUxMTYyODk1OA_733363d0-2842-4c35-b223-92cf3e827ab9"
      unitRef="usd">100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:Depreciation
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfMTA5OTUxMTYyODI3Mg_93109fa9-2b01-49ee-9161-e587e013fefa"
      unitRef="usd">600000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfMzY3_b43c96ad-ec6d-4b10-8d2e-b951759fb90c"
      unitRef="usd">300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfNDEw_4272ba67-0d53-418d-9e8c-1f68cc109f8a"
      unitRef="usd">1400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfNDE3_5b8f6aac-66d5-4a61-a3e2-3f067d9982d8"
      unitRef="usd">800000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RleHRyZWdpb246YTg4Zjk4MDlkMjBkNGI4MmFkZmY0ZTAwYzIwYTVkYjhfNDkx_caa7a641-9eb8-495c-8d24-bfec4d24a836">&lt;div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Liabilities and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Accrued professional services &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfMi0xLTEtMS0x_a6af9552-149d-4f88-814a-c3e470a748cd"
      unitRef="usd">8501000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfMi0zLTEtMS0x_321afa9c-0e66-47f1-9c23-f13596185bca"
      unitRef="usd">9175000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfNC0xLTEtMS0x_a99c5f16-504d-4c35-9ec6-b691001fbf76"
      unitRef="usd">719000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfNC0zLTEtMS0x_a76896f5-84a5-48d4-9cb1-bae690dab5a1"
      unitRef="usd">511000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfNS0xLTEtMS0x_0d6ab78a-57a4-4d46-ac44-36e59fe7548e"
      unitRef="usd">1205000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfNS0zLTEtMS0x_29ee294d-ef1e-49d4-b59a-1563724a4daa"
      unitRef="usd">513000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfNi0xLTEtMS0x_7c759b00-7fa7-4f9d-813b-59b719229500"
      unitRef="usd">10425000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80My9mcmFnOmE4OGY5ODA5ZDIwZDRiODJhZGZmNGUwMGMyMGE1ZGI4L3RhYmxlOjkyODM4OGYxYmM4NzRiOWVhOTcwNWI0ODUwNTY2ZmEwL3RhYmxlcmFuZ2U6OTI4Mzg4ZjFiYzg3NGI5ZWE5NzA1YjQ4NTA1NjZmYTBfNi0zLTEtMS0x_46f3765f-44a7-4dee-bd6d-2f5e8aef56b8"
      unitRef="usd">10199000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMjk1NQ_10ac1054-2840-4a21-82a5-12dbe801fa4b">Commitments and Contingencies&lt;div style="margin-top:9pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a non-cancelable operating lease for an office building space, located in Santa Clara, California which expires in May 2025. The Company also has non-cancelable operating leases for its office building spaces in Gallarate, Italy and Knaresborough, United Kingdom, which expire in August 2027 and December 2025, respectively. Effective April 30, 2021, the Company terminated its office lease in Mannheim, Germany, and commenced a new lease that can be terminated at any time with six months written notice to the landlord. Further, the Company also leases vehicles under operating lease arrangements for certain of its personnel in Europe which expire at various times throughout 2021 to 2025. In August 2021, the Company signed a new lease for 19,534 square feet of research and development and warehouse space in Santa Clara, California. The term of the new lease will commence on November 1, 2021 and will terminate on October 31, 2026, with an option to renew for one additional three year term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense is recorded over the lease terms on a straight-line basis. Rent expenses charged to operations under operating leases were $0.3 million for the three months ended September 30, 2021 and 2020, and $0.9 million for the nine months ended September 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;           The table below summarizes aggregate future minimum lease payments under all leases as of September 30, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchase Commitments and Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company has certain purchase commitments related to its inventory management and training materials with certain suppliers wherein the Company is required to provide forecasts and purchase certain amounts included in such forecasts. The contractual obligations represent future cash commitments and liabilities under agreements with third parties and exclude orders for goods and services entered into in the normal course of business that are not enforceable or legally binding. These outstanding commitments amounted to $1.3 million and $0.3 million as of September 30, 2021 and December 31, 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company&#x2019;s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. No liability associated with such indemnifications has been recorded to date.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <sibn:OperatingLeaseTermOfWrittenNoticeForTermination
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMzg0ODI5MDcwMDMwNg_80fbd1f3-141b-42db-992b-34b217330dd2">six months</sibn:OperatingLeaseTermOfWrittenNoticeForTermination>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="i96d95d6a89cf4265bdd53a11781c3f3b_I20210831"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMzg0ODI5MDcwMTk4Nw_fe3e8a80-89b9-4419-af19-8b6675f6f1b4"
      unitRef="sqft">19534</us-gaap:AreaOfRealEstateProperty>
    <sibn:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend
      contextRef="i96d95d6a89cf4265bdd53a11781c3f3b_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMzg0ODI5MDcwMTk5NA_7343204f-8bb7-4be7-a364-f2f2997e87cd"
      unitRef="renewal_option">1</sibn:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1
      contextRef="i96d95d6a89cf4265bdd53a11781c3f3b_I20210831"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMzg0ODI5MDcwMjAyMQ_7e5c219a-4179-481e-abe2-f83ff859aaec">P3Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMTA5OTUxMTYzMDg3MA_8043f6a5-d334-41f7-847f-84e835e9f88a"
      unitRef="usd">300000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMTA5OTUxMTYzMDgyNA_b70c75fe-367b-46eb-920a-4c96ef884b5f"
      unitRef="usd">900000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMjk1Ng_4de55f52-d585-4b9f-85cb-7eb2553c2db4">The table below summarizes aggregate future minimum lease payments under all leases as of September 30, 2021: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RhYmxlOjhiNDZkOWRjMTFlYTQ2Y2Q5MTJkYTIyNTNlNTQwNzRiL3RhYmxlcmFuZ2U6OGI0NmQ5ZGMxMWVhNDZjZDkxMmRhMjI1M2U1NDA3NGJfMS0xLTEtMS0x_4eaed362-79de-4381-8424-7b34b36ae357"
      unitRef="usd">378000</us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RhYmxlOjhiNDZkOWRjMTFlYTQ2Y2Q5MTJkYTIyNTNlNTQwNzRiL3RhYmxlcmFuZ2U6OGI0NmQ5ZGMxMWVhNDZjZDkxMmRhMjI1M2U1NDA3NGJfMi0xLTEtMS0x_99610a05-38e4-4b43-b3dd-f72b2d26c1ab"
      unitRef="usd">1641000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RhYmxlOjhiNDZkOWRjMTFlYTQ2Y2Q5MTJkYTIyNTNlNTQwNzRiL3RhYmxlcmFuZ2U6OGI0NmQ5ZGMxMWVhNDZjZDkxMmRhMjI1M2U1NDA3NGJfMy0xLTEtMS0x_d2430c10-a3e4-460a-bf0a-87d12179400d"
      unitRef="usd">1559000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RhYmxlOjhiNDZkOWRjMTFlYTQ2Y2Q5MTJkYTIyNTNlNTQwNzRiL3RhYmxlcmFuZ2U6OGI0NmQ5ZGMxMWVhNDZjZDkxMmRhMjI1M2U1NDA3NGJfNC0xLTEtMS0x_bba09c35-09e3-449d-90ae-89371eadc490"
      unitRef="usd">1510000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RhYmxlOjhiNDZkOWRjMTFlYTQ2Y2Q5MTJkYTIyNTNlNTQwNzRiL3RhYmxlcmFuZ2U6OGI0NmQ5ZGMxMWVhNDZjZDkxMmRhMjI1M2U1NDA3NGJfNS0xLTEtMS0x_298534eb-76dd-445c-b1fb-e182ed183ddd"
      unitRef="usd">987000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <sibn:OperatingLeasesFutureMinimumPaymentsDueAfterYearFour
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RhYmxlOjhiNDZkOWRjMTFlYTQ2Y2Q5MTJkYTIyNTNlNTQwNzRiL3RhYmxlcmFuZ2U6OGI0NmQ5ZGMxMWVhNDZjZDkxMmRhMjI1M2U1NDA3NGJfNi0xLTEtMS0x_a9364966-7635-4ccf-a0e6-0cdf36e6376d"
      unitRef="usd">540000</sibn:OperatingLeasesFutureMinimumPaymentsDueAfterYearFour>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RhYmxlOjhiNDZkOWRjMTFlYTQ2Y2Q5MTJkYTIyNTNlNTQwNzRiL3RhYmxlcmFuZ2U6OGI0NmQ5ZGMxMWVhNDZjZDkxMmRhMjI1M2U1NDA3NGJfNy0xLTEtMS0x_407a3e3e-64f5-45ca-9cc0-14439c3cc344"
      unitRef="usd">6615000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:PurchaseObligation
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMTYyNw_40a469aa-5a08-4117-9bdd-8e72a4d10d8d"
      unitRef="usd">1300000</us-gaap:PurchaseObligation>
    <us-gaap:PurchaseObligation
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMTYzNA_5f46cda9-b3d6-4e65-8e14-0d89ce9c0009"
      unitRef="usd">300000</us-gaap:PurchaseObligation>
    <us-gaap:LitigationSettlementExpense
      contextRef="ieccec3c1ede24d35a58527aa4850247b_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMjc3OQ_ab71f70b-47a1-402a-867f-758a41ddc716"
      unitRef="usd">0</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationReserve
      contextRef="i9791c5febf8a46f2885eb2f4b7f67d9e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80Ni9mcmFnOmIyMGZlZWI0ZTliYjQxNjU4MDUxYjg4OTI2ZTI1ZTcxL3RleHRyZWdpb246YjIwZmVlYjRlOWJiNDE2NTgwNTFiODg5MjZlMjVlNzFfMjg3OQ_6f446a10-aba2-4938-93d4-08721a9e14ba"
      unitRef="usd">0</us-gaap:LitigationReserve>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQwNA_280c8171-8335-4b7e-a405-ed4d458107f2">Borrowings&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Term Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the outstanding borrowings from the term loan described below, as of the dates presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.583%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal outstanding and final fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unaccreted value of final fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(671)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(884)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding debt, net of debt issuance costs and unaccreted value of final fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Classified as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In October 2017, the Company entered into a term loan with Biopharma Credit Investments IV Sub LP (&#x201c;Pharmakon&#x201d;) in for total loan proceeds of $40.0&#160;million (the &#x201c;Pharmakon Term Loan&#x201d;). The Pharmakon Term Loan included an interest-only period for 35 months through September 2020 and then equal quarterly principal payments plus interest through December 2022. The &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Pharmakon Term Loan carried a fixed interest rate of 11.5% and allowed for early prepayment. The prepayment penalty fee was equal to the remaining interest due if prepaid within the first 30 months, a 2% penalty for months 31-48, and a 1% penalty for months 49-60. The Company paid in full and terminated the Pharmakon Term Loan in May 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The outstanding debt as of December 31, 2020 is related to a term loan pursuant to the Loan and Security Agreement dated May 29, 2020, entered into by the Company with Solar Capital Partners (&#x201c;Solar&#x201d;). Pursuant to the Loan and Security Agreement, Solar provided an aggregate principal amount of $40.0&#160;million term loan (the &#x201c;Solar Term Loan&#x201d;). The total debt issuance costs of $0.8&#160;million associated with the Solar Term Loan were recorded in the condensed consolidated balance sheet as a direct deduction from the carrying amount of the loan, and are amortized as a component of interest expense using straight-line method over the life of the term loan.  In accordance with the Loan and Security Agreement with Solar, the Company paid in full and terminated the Pharmakon Term Loan, which was accounted for as debt extinguishment in accordance with the accounting standards. The Company recognized the unamortized debt issuance costs of $0.7&#160;million and the prepayment penalty and lender fees of $0.8&#160;million related to Pharmakon Term Loan as a loss on debt extinguishment. The costs and fees are reflected as interest expense in the consolidated statement of operations for the year ended December 31, 2020. The Solar Term Loan bore interest at a rate per annum equal to 9.40% plus London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), payable monthly in arrears. LIBOR means the greater of (i) 0.33% or (ii) one-month LIBOR (or a comparable replacement rate to be determined by the collateral agent if the LIBOR is no longer available), which rate shall reset monthly. The Solar Term Loan included an interest-only period of 36 months through June 2023, and then repaid in equal monthly principal payments plus interest through  June 1, 2025. Pursuant to the Loan and Security Agreement with Solar, the Company could voluntarily prepay the Solar Term Loan, in full or in part, but only in increments of $10.0&#160;million, for a prepayment premium in an amount equal to 3.0% of the principal if prepaid in year one, 1.25% of the principal if prepaid in year two, and 0.50% of the principal if prepaid in year three or later. The Solar Term Loan was secured by substantially all of the Company&#x2019;s assets.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:line-through"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company was also obligated to pay a final fee equal to $1.0&#160;million or 2.5% of the aggregate principal amount of the Solar Term Loan, which was fully earned by Solar on the effective date of the Loan and Security Agreement with Solar. With respect to the Solar Term Loan, this final fee shall be due and payable on the earliest of (i) the maturity date, (ii) the acceleration of the loan balance or (iii) its full prepayment, refinancing, substitution or replacement. The final fee was included within the long-term borrowings and was accreted to interest expense using straight-line method over the life of the term loan. The Company paid in full and terminated the Solar Term Loan in August 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The outstanding debt as of September 30, 2021 is related to a term loan pursuant to the Loan and Security Agreement dated August 12, 2021 (the &#x201c;Effective Date&#x201d;), entered into by the Company with Silicon Valley Bank (&#x201c;SVB&#x201d;). Pursuant the agreement, SVB provided an aggregate principal amount of $35.0&#160;million to the Company (the &#x201c;SVB Term Loan&#x201d;). The Company used the proceeds of the SVB Term Loan to repay in full and terminate the Solar Term Loan, which was accounted for as debt extinguishment in accordance with the accounting standards. The Company recognized the unamortized debt issuance costs and unaccreted value of final fee of $1.3&#160;million and the prepayment penalty and lender fees of $0.5&#160;million related to Solar Term Loan as a loss on debt extinguishment. The costs and fees are reflected as interest expense in the condensed consolidated statement of operations for the three and nine months ended September 30, 2021. The total debt issuance costs of $0.1&#160;million associated with the SVB Term Loan were recorded in the condensed consolidated balance sheet as a direct deduction from the carrying amount of the loan, and are amortized as a component of interest expense using straight-line method over the life of the term loan. The SVB Term Loan matures (the &#x201c;Maturity Date&#x201d;) on either (a) August 1, 2025 or (b) August 1, 2026 dependent on the Company&#x2019;s achievement of a certain financial performance milestone as of December 31, 2022, as set forth in the Loan Agreement. Interest on the SVB Term Loan is payable monthly at an annual rate set at the greater of (a) 5.75% and (b) prime rate as published in the Wall Street Journal plus 2.5%. Commencing on September 1, 2023, the Company will be required to make monthly principal amortization payments. The Company may elect to prepay the SVB Term Loan prior to the Maturity Date subject to a prepayment fee equal to 1% if  the prepayment occurs prior to the second anniversary of the Effective Date and &#x2014;% if the prepayment occurs on or at any time after the second anniversary of the Effective Date. The SVB Term Loan is secured by substantially all the Company's assets other than the Company's intellectual property. The Company is also obligated to pay a final payment equal to $0.7&#160;million or 2% of the aggregate principal amount of the SVB Term Loan, which is considered fully earned by SVB on the effective date of the Loan and Security Agreement with SVB. This final payment shall be due and payable on the earliest of (i) the maturity date, (ii) the full repayment of the loan, (iii) permitted prepayment and mandatory prepayment upon an acceleration as specified in the agreement or (iv) the termination of the agreement.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The final payment is included within the long-term borrowings and is accreted to interest expense using straight-line method over the life of the term loan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The effective interest rate related to the SVB Term Loan and Solar Term Loan (excluding the write-down of unamortized debt issuance costs and prepayment penalty related to the Solar Term Loan) was 8.5% for both the three and nine months ended September 30, 2021. The effective interest rate related to the Solar Term Loan and Pharmakon Term Loan (excluding the write-down of unamortized debt issuance costs and prepayment penalty related to the Pharmakon Term Loan) was 10.8% and 11.6% for the three and nine months ended September 30, 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;         The table below summarizes the future principal and final fee payments under the SVB Term Loan as of September 30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total principal and final fee payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Loan Agreement includes affirmative and negative covenants applicable to the Company and certain of its foreign subsidiaries. The affirmative covenants include, among others, covenants requiring the Company to maintain its legal existence and governmental compliance, deliver certain financial reports, and maintain insurance coverage. The negative covenants include, among others, restrictions regarding transferring collateral, pledging the Company's intellectual property to other parties, engaging in mergers or acquisitions, paying dividends or making other distributions, incurring indebtedness, transacting with affiliates, and entering into certain investments, in each case subject to certain exceptions. As of September 30, 2021, the Company was in compliance with all debt covenants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;CARES Act&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On March 27, 2020, the U.S. federal government enacted the &#x201c;Coronavirus Aid, Relief and Economic Security (CARES) Act,&#x201d; which, among other things, allowed employers to defer the deposit and payment of an employer's share of social security taxes through December 31, 2020. The Company recorded a total liability of $1.0 million related to the deferral of the social security taxes of which $0.5 million is included in each accrued liabilities and other and other long-term liabilities in the condensed consolidated balance sheets as of September 30, 2021 and December 31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTc5OA_b26a7bc4-56f8-4449-809b-4f588b79530d">&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the outstanding borrowings from the term loan described below, as of the dates presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.583%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal outstanding and final fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unaccreted value of final fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(671)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(884)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding debt, net of debt issuance costs and unaccreted value of final fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Classified as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfMi0xLTEtMS0x_53643730-38c7-4846-b73c-6129493b2ad9"
      unitRef="usd">35700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfMi0zLTEtMS0x_b1c9bc4e-fe1f-4302-984e-fe203f4b5a88"
      unitRef="usd">41000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfMy0xLTEtMS0x_b97b2430-79cb-491e-b36e-d371f2cc0215"
      unitRef="usd">107000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfMy0zLTEtMS0x_56b22748-f8b6-4e82-85a0-5c212e802e35"
      unitRef="usd">661000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfNC0xLTEtMS0x_684c2e25-4c11-499e-bc24-de0668dd84f1"
      unitRef="usd">671000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfNC0zLTEtMS0x_6260a078-b3f6-4401-acec-6743b9566b26"
      unitRef="usd">884000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:LongTermDebt
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfNS0xLTEtMS0x_0bde597e-3486-47f9-b1c1-5d49f9086a63"
      unitRef="usd">34922000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfNS0zLTEtMS0x_be9729c7-b20b-4986-8086-480ea84d47ac"
      unitRef="usd">39455000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfOC0xLTEtMS0x_934d5cdf-654b-41a5-acb9-6077c09dfb38"
      unitRef="usd">34922000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjBhZDhmMzcxZmJmMTQyYTRiNDU2MzUwYjE4ZTQzM2E2L3RhYmxlcmFuZ2U6MGFkOGYzNzFmYmYxNDJhNGI0NTYzNTBiMThlNDMzYTZfOC0zLTEtMS0x_8cda8be9-3c36-4383-a9ab-660fd819f286"
      unitRef="usd">39455000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i0cb314875c314dbaa8fbacdb1b38b748_D20171001-20171031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0Mzg4NA_b9cc9062-fea8-40e0-80f0-998b51a51719"
      unitRef="usd">40000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <sibn:DebtInstrumentPeriodicPaymentInterestOnlyPeriod
      contextRef="i0cb314875c314dbaa8fbacdb1b38b748_D20171001-20171031"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0Mzk3OA_4aac58bd-795c-4b11-98d8-1ecbee0406a3">P35M</sibn:DebtInstrumentPeriodicPaymentInterestOnlyPeriod>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i76a103c32c444270af93260d49552321_I20171031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NDE0Mw_866dea3a-0c66-4025-b3bf-f8151eb41a89"
      unitRef="number">0.115</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <sibn:DebtInstrumentPrepaymentPenaltyPercentage
      contextRef="i38122eef897040fe8f70c368cf10c531_I20171031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NDI4OQ_db9144fd-fb12-49b2-a14d-9a7d8ac999e6"
      unitRef="number">0.02</sibn:DebtInstrumentPrepaymentPenaltyPercentage>
    <sibn:DebtInstrumentPrepaymentPenaltyPercentage
      contextRef="i61a838a9e8594bccb6b1be280637f067_I20171031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NDMyNQ_edca78d7-eec9-4ea5-893a-a4a9a885e04f"
      unitRef="number">0.01</sibn:DebtInstrumentPrepaymentPenaltyPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id10385b30b3442289883167a68f5b983_I20200529"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NjExOA_35adeeea-dd60-4353-8400-4340c49590ae"
      unitRef="usd">40000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="id10385b30b3442289883167a68f5b983_I20200529"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NjE5MA_527493c6-61f2-4abe-b481-f9d43552ac15"
      unitRef="usd">800000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="iba585a7740f44fc985da65b9dcbe6ac1_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NjczMg_60bb0503-9e41-4ed9-abd9-b4ea6222f16a"
      unitRef="usd">700000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="iba585a7740f44fc985da65b9dcbe6ac1_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0Njc4Mg_d64ab544-6c23-4077-86cf-854b15c2230b"
      unitRef="usd">800000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id10385b30b3442289883167a68f5b983_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NzAzNw_ac54f51c-ff0b-491e-b74d-90a14e7916f7"
      unitRef="number">0.0940</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ie50ee0dd6f3a424dbe678afcb26fe615_D20200529-20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NzE0Ng_0eb9e959-d694-4c6d-b083-5b98a04ec49c"
      unitRef="number">0.0033</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <sibn:DebtInstrumentPeriodicPaymentInterestOnlyPeriod
      contextRef="i974cd92ce36a4cd597746c92af7a0c88_D20200529-20200529"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NzQyMQ_c2c9b57a-62c6-42ff-9a6b-4297bfbc18c5">P36M</sibn:DebtInstrumentPeriodicPaymentInterestOnlyPeriod>
    <sibn:DebtInstrumentPrepaymentAllowableIncrementsPerAgreement
      contextRef="id10385b30b3442289883167a68f5b983_I20200529"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NzY4MA_d198c2c8-6225-4ad7-948c-4534a68a4ed5"
      unitRef="usd">10000000</sibn:DebtInstrumentPrepaymentAllowableIncrementsPerAgreement>
    <sibn:DebtInstrumentPrepaymentPremiumYearOnePercentage
      contextRef="id10385b30b3442289883167a68f5b983_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NzczMg_3a845e7b-9ddb-4494-bf13-f9fa8e0c9e63"
      unitRef="number">0.030</sibn:DebtInstrumentPrepaymentPremiumYearOnePercentage>
    <sibn:DebtInstrumentPrepaymentPremiumYearTwoPercentage
      contextRef="id10385b30b3442289883167a68f5b983_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0Nzc3Nw_4898d507-3dbe-4b1c-84ab-6642f6e9e7ff"
      unitRef="number">0.0125</sibn:DebtInstrumentPrepaymentPremiumYearTwoPercentage>
    <sibn:DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage
      contextRef="id10385b30b3442289883167a68f5b983_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0NzgyNg_127f13cd-deba-4bcd-b38c-c21ad4de5089"
      unitRef="number">0.0050</sibn:DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="id10385b30b3442289883167a68f5b983_I20200529"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0ODE0MQ_a6dd3940-b465-4c25-a507-8b3119679bcd"
      unitRef="usd">1000000</us-gaap:DebtInstrumentFeeAmount>
    <sibn:DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal
      contextRef="id10385b30b3442289883167a68f5b983_I20200529"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0ODE0OA_488b1e54-abeb-4d98-adc7-0bc1d0639b70"
      unitRef="number">0.025</sibn:DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i33f72faa097e4cae973ab53d793b2746_I20210812"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjM3MQ_32ced9ed-cfb2-4e7e-b043-9d45672c95f0"
      unitRef="usd">35000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="ia2787e6887df4eadbb3510bc237985e9_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjM5MQ_5f9c699f-f05f-4128-881f-00f4f1d9fa72"
      unitRef="usd">1300000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i166abb90ea7347a7abf6019141e814f4_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjM5MQ_adcd6e88-cb64-4e4a-b881-739c230f6aca"
      unitRef="usd">1300000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="ia2787e6887df4eadbb3510bc237985e9_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQxMQ_a178f793-fc2f-4a84-95cc-b077bafbe670"
      unitRef="usd">500000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i166abb90ea7347a7abf6019141e814f4_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQxMQ_ac090db8-0088-46b0-b513-5278f1ade607"
      unitRef="usd">500000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i33f72faa097e4cae973ab53d793b2746_I20210812"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQzMA_212d79e9-1bfc-4482-8bcf-b96a9ac201b1"
      unitRef="usd">100000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i33f72faa097e4cae973ab53d793b2746_I20210812"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQ0NA_d49faf60-d1c8-4a26-9046-908bdd1431f9"
      unitRef="number">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2011a05c7ea34cd28f12c592fe8857e3_D20210812-20210812"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQ1MQ_ab9b0bc2-9f32-49d9-b8f9-c0ffbd2a61a8"
      unitRef="number">0.025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <sibn:DebtInstrumentPrepaymentPenaltyPercentage
      contextRef="i9064792f4ac4436e8f82e1ce978a4834_I20210812"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQ1Nw_c2eefd0d-5103-4c9c-a2e1-4a36dd58f14e"
      unitRef="number">0.01</sibn:DebtInstrumentPrepaymentPenaltyPercentage>
    <sibn:DebtInstrumentPrepaymentPenaltyPercentage
      contextRef="i0a17d4dc3afb45438117bbf39fc37e29_I20210812"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjQ2MQ_f4a4a11f-ca48-49d0-a8b9-8cdff1c26f58"
      unitRef="number">0</sibn:DebtInstrumentPrepaymentPenaltyPercentage>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i33f72faa097e4cae973ab53d793b2746_I20210812"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMzg0ODI5MDczMjM1MQ_329fdc39-8be9-499a-8a55-3b02eff9423e"
      unitRef="usd">700000</us-gaap:DebtInstrumentFeeAmount>
    <sibn:DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal
      contextRef="i33f72faa097e4cae973ab53d793b2746_I20210812"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY0MDIxNw_16bfad3c-3e85-42a7-9939-5211166150fa"
      unitRef="number">0.02</sibn:DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i843aa4772ef6448490b75f692b0f1072_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDUyNw_a28f4e3d-8f5d-47d7-8a6e-af1eb86583ef"
      unitRef="number">0.085</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i166abb90ea7347a7abf6019141e814f4_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDUyNw_e4ebd7b4-142c-47ef-88eb-1efee5a4c49c"
      unitRef="number">0.085</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="id34bef8ef9284847bf96f011100e54b4_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDUyNw_ec398794-cd20-4232-9231-f819c64b4ac2"
      unitRef="number">0.085</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ia2787e6887df4eadbb3510bc237985e9_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDUyNw_ed94cabb-5ea9-4904-9b8b-2afd3be902ec"
      unitRef="number">0.085</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i2fcc266ce2fc436cacae32e6275aaae0_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDUwMg_265b246c-83b7-441b-a179-521064bade0d"
      unitRef="number">0.108</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i16d63c9eb96e480599824e634ad5d531_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDUwMg_a5d81fd1-c8bd-4076-8411-5f72985ed424"
      unitRef="number">0.108</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i5b5a42a702a94c05bf97ad13f96a9b57_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDQ5NQ_197f4351-9f88-4fac-b4a2-c0dbdc4ecc93"
      unitRef="number">0.116</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i523c84bcfc6d4d41a3fcb3cba85341bb_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfMTA5OTUxMTY1NDQ5NQ_b51d21f7-6605-4e81-bcfd-cdd20e089b53"
      unitRef="number">0.116</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTgwMA_9d3a0669-350d-48d5-a818-e550e3a6dca3">The table below summarizes the future principal and final fee payments under the SVB Term Loan as of September 30, 2021:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total principal and final fee payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjQxMWU4OGI1YjAxOTRjNzNhNjdjNTg0ZTQ5MGVlM2EyL3RhYmxlcmFuZ2U6NDExZTg4YjViMDE5NGM3M2E2N2M1ODRlNDkwZWUzYTJfMS0xLTEtMS0x_c54c0eed-1cf3-46c0-95d1-1c36aea40ff5"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjQxMWU4OGI1YjAxOTRjNzNhNjdjNTg0ZTQ5MGVlM2EyL3RhYmxlcmFuZ2U6NDExZTg4YjViMDE5NGM3M2E2N2M1ODRlNDkwZWUzYTJfMi0xLTEtMS0x_612e203d-4e64-4a95-b7e0-b21df5c9fbf9"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjQxMWU4OGI1YjAxOTRjNzNhNjdjNTg0ZTQ5MGVlM2EyL3RhYmxlcmFuZ2U6NDExZTg4YjViMDE5NGM3M2E2N2M1ODRlNDkwZWUzYTJfMy0xLTEtMS0x_45cc2943-fc0a-426e-a1a9-7e3ee5122f04"
      unitRef="usd">7292000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjQxMWU4OGI1YjAxOTRjNzNhNjdjNTg0ZTQ5MGVlM2EyL3RhYmxlcmFuZ2U6NDExZTg4YjViMDE5NGM3M2E2N2M1ODRlNDkwZWUzYTJfNC0xLTEtMS0x_d5a08f14-45e1-4852-afda-31bed58ec47b"
      unitRef="usd">17500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjQxMWU4OGI1YjAxOTRjNzNhNjdjNTg0ZTQ5MGVlM2EyL3RhYmxlcmFuZ2U6NDExZTg4YjViMDE5NGM3M2E2N2M1ODRlNDkwZWUzYTJfNS0xLTEtMS0x_f7cf653c-14cf-46ad-a462-c268619f4018"
      unitRef="usd">10908000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RhYmxlOjQxMWU4OGI1YjAxOTRjNzNhNjdjNTg0ZTQ5MGVlM2EyL3RhYmxlcmFuZ2U6NDExZTg4YjViMDE5NGM3M2E2N2M1ODRlNDkwZWUzYTJfNy0xLTEtMS0x_db5b7218-e252-4a43-bc00-9424fd8f1835"
      unitRef="usd">35700000</us-gaap:DebtInstrumentCarryingAmount>
    <sibn:SocialSecurityTaxEmployerDeferralCARESAct
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTU4NA_023d8034-eab1-4024-9aa3-7ee34bc9d8c6"
      unitRef="usd">1000000</sibn:SocialSecurityTaxEmployerDeferralCARESAct>
    <sibn:SocialSecurityTaxEmployerDeferralCARESAct
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTU4NA_bda0c518-32e2-4cd8-9c4f-266d01280b57"
      unitRef="usd">1000000</sibn:SocialSecurityTaxEmployerDeferralCARESAct>
    <sibn:SocialSecurityTaxEmployerDeferralCARESAct
      contextRef="i803e769cd5f448a08a337153cbee48f7_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTY0OQ_195f6b8a-b560-46c9-a601-73ba58b79a90"
      unitRef="usd">500000</sibn:SocialSecurityTaxEmployerDeferralCARESAct>
    <sibn:SocialSecurityTaxEmployerDeferralCARESAct
      contextRef="i95bf6c7ddfa44e2d8791432453dc5213_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTY0OQ_69482178-d3a7-4e18-a341-d57a42ea145b"
      unitRef="usd">500000</sibn:SocialSecurityTaxEmployerDeferralCARESAct>
    <sibn:SocialSecurityTaxEmployerDeferralCARESAct
      contextRef="i124ee46b86c74090ae66a0e1d2bb09bc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTY0OQ_a02c893f-e2f6-4c6a-9e14-4f4411e29747"
      unitRef="usd">500000</sibn:SocialSecurityTaxEmployerDeferralCARESAct>
    <sibn:SocialSecurityTaxEmployerDeferralCARESAct
      contextRef="ibc837735671140f3b29b3df351abc460_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV80OS9mcmFnOjlhNWM4MDUxODQ0ZTRhMTJhZDU4MTdlZDk5YzY0MGE3L3RleHRyZWdpb246OWE1YzgwNTE4NDRlNGExMmFkNTgxN2VkOTljNjQwYTdfNTY0OQ_e84df552-062f-4433-b22b-d7dc614de007"
      unitRef="usd">500000</sibn:SocialSecurityTaxEmployerDeferralCARESAct>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMzE5Ng_8a61b2e2-bc9e-4474-88bf-618d0aadcd81">Stock-Based Incentive Compensation Plans &lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the stock option activity for the nine months ended September 30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:72pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted- &lt;br/&gt;Average &lt;br/&gt;Exercise &lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,405,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.54&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1pt;padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317,001)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.34&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.78&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,063,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2021, the unrecognized compensation cost related to stock options was $1.7 million, which is expected to be recognized over a period of approximately 1.2 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no stock options granted during the three months ended September 30, 2020 and nine months ended September 30, 2021. The table below summarizes the weighted average grant date fair value per share and the assumptions used to estimate the grant date fair value using the Black-Scholes option-pricing model of the stock options granted in the nine months ended September 30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.416%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.37&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.56%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.64%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Early Exercise of Unvested Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Early exercises of stock options under the Company's 2008 Stock Option Plan are subject to a right of repurchase by the Company of any unvested shares. The repurchase rights lapse over the original vesting period of the options. The Company accounts for the cash received in consideration for the early exercised options as a liability included in accrued liabilities, which is then reclassified to stockholders&#x2019; equity as the options vest. As of September 30, 2021, the Company had no shares subject to repurchase. As of December 31, 2020, the Company had a total of 5,836 shares of common stock subject to repurchase under the 2008 Stock Option Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes restricted stock units activity for the nine months ended September 30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.915%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165,295&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$20.07&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049,699&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.56&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(445,913)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.19&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171,872)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.84&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597,209&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.48&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2021, the unrecognized compensation cost related to the restricted stock units was $34.4 million, which is expected to be recognized over a period of approximately 2.9 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s 2018 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;) allows eligible employees to purchase shares of the Company's common stock through payroll deductions at the price equal to 85% of the lesser of the fair market value of the stock as of the first date or the ending date of each six month offering period. The offering period generally commences in May and November. On March 26, 2020, the Company's Compensation Committee approved the amendment of the terms of future offerings under the ESPP which, among other things, increased the maximum number of shares that may be purchased on any single purchase date, provided for automatic enrollment in a new offering, and provided that the offering which commenced in May 2020 be twelve months in duration and consist of two purchase periods. The current offering period under the ESPP began on May 17, 2021 and the related purchase will occur on November 15, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the ESPP shares is estimated using the Black-Scholes option pricing model, which is being amortized over the requisite service period. The Company issued 104,861 shares and 74,685 shares under the ESPP, representing approximately $1.6 million and $1.0&#160;million in employee contributions, for nine months ended September 30, 2021 and September 30, 2020, respectively. As of September 30, 2021 and December 31, 2020, total accumulated ESPP related employee payroll deductions amounted to $0.7 million and $0.4 million, respectively, which were included within accrued compensation and related expenses in the condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the detail of stock-based compensation expense amounts included in the condensed consolidated statements of operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.083%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.253%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMzIwMg_f75fff88-2f6e-4a17-900c-0aeaf5e9a690">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the stock option activity for the nine months ended September 30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:72pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted- &lt;br/&gt;Average &lt;br/&gt;Exercise &lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,405,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.54&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1pt;padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317,001)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.34&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.78&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,063,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfMS0yLTEtMS0x_56eb8530-3cfb-4d6a-a10f-ced1ef81c425"
      unitRef="shares">2405957</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfMS00LTEtMS0x_f0c85f70-7330-46ff-b07f-70bd0de16427"
      unitRef="usdPerShare">8.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfMy0yLTEtMS0x_d15aca93-f163-4fa4-b807-691d75d61168"
      unitRef="shares">317001</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfMy00LTEtMS0x_0b81fa89-aae0-45c8-b56b-afbb9f932bc9"
      unitRef="usdPerShare">7.34</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfNC0yLTEtMS0x_e5ba4d84-6850-461a-bf93-79a296cd219d"
      unitRef="shares">25217</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfNC00LTEtMS0x_ca8b1d56-0add-434f-af28-5a02f65827d5"
      unitRef="usdPerShare">15.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfNS0yLTEtMS0x_c469ab37-d6fa-4145-b2e7-d631911d962b"
      unitRef="shares">2063739</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjUxMTJjYTNlZjNjMjQzNjg4MjE1ZDFiNjQ1MGJlNjNhL3RhYmxlcmFuZ2U6NTExMmNhM2VmM2MyNDM2ODgyMTVkMWI2NDUwYmU2M2FfNS00LTEtMS0x_271a1c7d-7340-4568-9a57-daa33ae886f1"
      unitRef="usdPerShare">10.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjEw_f229f9e8-8c4a-4a53-b57c-8d460d76de12"
      unitRef="usd">1700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i63d41e579cfd47938da6de7aa8a1649a_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjgw_d9a05f38-e699-4f8c-8903-4829b0a8097e">P1Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjk2_52e19e5c-5980-4c21-a72f-a30443c9e9b1"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjk2_9b616c0f-4d6c-4357-b9bd-c7ec1cbaa193"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMzE5Nw_06e4b3b9-da26-41f5-9876-391a036dcd55">The table below summarizes the weighted average grant date fair value per share and the assumptions used to estimate the grant date fair value using the Black-Scholes option-pricing model of the stock options granted in the nine months ended September 30, 2020:&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.416%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.37&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.56%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.64%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfMi0xMy0xLTEtMQ_e0e19d9f-22a9-4a3b-8a18-7067c218a928"
      unitRef="usdPerShare">8.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i2386ac78016144aaa0d5030bad947246_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfMy0xMy0xLTEtMQ_19d4a87d-aeb1-41f7-9d1d-08b1a69a4944">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i0544c913fcda445c9dc02da47fd8e3f3_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfMy0xNS0xLTEtMQ_d7d7f817-535c-438c-bb24-efb6ceb23f22">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i55b87ead255e4fb486d98dd4fd6bc105_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfNC0xMy0xLTEtMQ_6c6c3f50-745e-4777-b31e-acc3bbe1cd3f"
      unitRef="number">0.467</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i55b87ead255e4fb486d98dd4fd6bc105_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfNC0xNS0xLTEtMQ_f238fdbe-9988-4e71-a0cc-0f6583c8b449"
      unitRef="number">0.472</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i55b87ead255e4fb486d98dd4fd6bc105_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfNS0xMy0xLTEtMQ_0f82aa85-2e14-4dbc-a658-aeb29931a21c"
      unitRef="number">0.0156</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i55b87ead255e4fb486d98dd4fd6bc105_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfNS0xNS0xLTEtMQ_057d9616-f32e-4fd6-a766-96fd89e1bfb4"
      unitRef="number">0.0164</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i55b87ead255e4fb486d98dd4fd6bc105_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjgwMTFmYjZlYmY2MzRlOTRiMGUzNWIyYjk1N2I0MTQzL3RhYmxlcmFuZ2U6ODAxMWZiNmViZjYzNGU5NGIwZTM1YjJiOTU3YjQxNDNfNi0xMy0xLTEtMQ_949f642b-8b73-4615-9c41-6fcc8fe06a48"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase
      contextRef="i9db2347a40b8493cbe05311630711796_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMzg0ODI5MDcwMDc3OQ_7859704b-32e8-4278-b856-bca1a32180f8"
      unitRef="shares">0</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase
      contextRef="i0cb4295888e44afca3a0e40aa138b826_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMTE2Ng_2071eb34-812d-4d64-8cbc-edd8167f3575"
      unitRef="shares">5836</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMzE5OA_303f6b9e-6ec0-4db5-a34b-ec2b67551e47">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes restricted stock units activity for the nine months ended September 30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.915%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165,295&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$20.07&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049,699&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.56&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(445,913)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.19&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171,872)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.84&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597,209&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.48&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i2557cc90be53464ba8c0545cd23e3d1e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfMS0yLTEtMS0x_f78f9aa1-708a-4fc7-a23c-e7d647b8c6aa"
      unitRef="shares">1165295</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i2557cc90be53464ba8c0545cd23e3d1e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfMS00LTEtMS0x_46b924b2-1b87-4f50-829c-421c0fffe97e"
      unitRef="usdPerShare">20.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfMi0yLTEtMS0x_c4109105-1202-4321-808f-68aedd236fbd"
      unitRef="shares">1049699</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfMi00LTEtMS0x_832dc463-ba6e-44a3-9199-4a38ca729b48"
      unitRef="usdPerShare">29.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfMy0yLTEtMS0x_05d592a4-686e-4976-98c7-efa9e421ffa3"
      unitRef="shares">445913</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfMy00LTEtMS0x_e7b99f60-f338-4356-bee9-38deb12710b0"
      unitRef="usdPerShare">21.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfNC0yLTEtMS0x_ef965ccc-cbd5-4ab5-94d6-9fdbab5b1819"
      unitRef="shares">171872</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfNC00LTEtMS0x_efa3a2f8-4a3d-4216-8589-849829b80b1f"
      unitRef="usdPerShare">24.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i07d829ca6e82422aa5687003ba7c3973_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfNS0yLTEtMS0x_1961e7ff-6ecc-41d8-b270-01f1dcbf09f7"
      unitRef="shares">1597209</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i07d829ca6e82422aa5687003ba7c3973_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjQ0NTFjMDZmZDZmYTQzMDk5Yjg5NmY5YzU2MzRiZDgwL3RhYmxlcmFuZ2U6NDQ1MWMwNmZkNmZhNDMwOTliODk2ZjljNTYzNGJkODBfNS00LTEtMS0x_e97ade85-2796-4e3b-aabb-56120f412fd0"
      unitRef="usdPerShare">25.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i07d829ca6e82422aa5687003ba7c3973_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMTQ2MA_5cb0b3b2-454b-4d85-87dd-37a03d00336a"
      unitRef="usd">34400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="if6c78e0d0a03487b8f7edf5f6fa52280_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMTUzMA_29dd6b88-fdb5-4eb3-a1f8-fa5397ff4a0f">P2Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i89018ddd42954af7a9c4116beb0b2c43_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMTc0OA_e54c7bf9-822a-446c-aded-d6f1a3ab9140"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval
      contextRef="i628c4f2ee72e4e8e876d8acc49956b8b_D20200101-20200430"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMzg0ODI5MDcwMDg0Ng_7ba44a1e-6e47-4901-9d56-de532441b588">P6M</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval
      contextRef="i93c681895e154204b4fbed253a591a2f_D20200501-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjI5Nw_0f59c18d-905e-4a28-86a4-c89882637b23">P12M</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval>
    <sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods
      contextRef="i93c681895e154204b4fbed253a591a2f_D20200501-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjMyNw_62705785-78f7-4a40-835c-48797e02d73c"
      unitRef="purchase_period">2</sibn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i89018ddd42954af7a9c4116beb0b2c43_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjY0Mw_40801cf7-2174-4d03-8bff-3d8e857e682e"
      unitRef="shares">104861</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="id87cc2d1c9b043f287619c8da2816e8a_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjY1Nw_6ee12162-5c58-4c41-8cdf-014855f117f3"
      unitRef="shares">74685</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i89018ddd42954af7a9c4116beb0b2c43_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjcxMA_3f0fb5f1-b18d-4f0e-99c9-ebf8534f41ea"
      unitRef="usd">1600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="id87cc2d1c9b043f287619c8da2816e8a_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjcxNw_bcbdbe4c-3a4d-4047-9a07-4352762bb776"
      unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent
      contextRef="i6e7f9f8af7df41879076b4ffe0b5ee6e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjg4MQ_68c60033-89c2-4f35-a894-ca1fd434fcc4"
      unitRef="usd">700000</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent
      contextRef="i640640c163644c5ea76e4fa756cfc106_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMjg4OA_8eab607a-a2db-4765-876b-16d18b038e0e"
      unitRef="usd">400000</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RleHRyZWdpb246Yzg0NGM0Y2IzZDBlNDAxNGE5YWFjMzYyY2E1MzIyODhfMzE5OQ_f20e33ca-2edb-48a8-8717-5282b35119f9">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the detail of stock-based compensation expense amounts included in the condensed consolidated statements of operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.083%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.253%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib695fc1f6bb041edb51e55dea1b41799_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfMy0yLTEtMS0x_27fd6321-14d2-4783-b2f7-978d8434cd73"
      unitRef="usd">128000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i91cd631ed91d4a67ac1fc657545f5f45_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfMy00LTEtMS0x_c70cfc4a-5107-49e9-9eec-752f0ff9f911"
      unitRef="usd">87000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if87f81e2cc0d49b29ee4c705174cb8c5_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfMy02LTEtMS0x_11530e6b-7b21-4b09-8685-b250e7798a93"
      unitRef="usd">432000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i960acef0c23e41da8c4a82a8f9881c4d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfMy04LTEtMS0x_16b53fd2-2380-40c1-b3ed-42b2fd06921f"
      unitRef="usd">243000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i77ae5cbb20b6488383046b736d749e54_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNC0yLTEtMS0x_30b78c0c-925d-4d9e-a369-f5bed6319bc1"
      unitRef="usd">2153000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i994609a27d9e4161b8ab111b4129abd7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNC00LTEtMS0x_b958ee5a-457f-4ad3-9a3c-835236c57c07"
      unitRef="usd">1488000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icb7dadad6be64748a0c1ae6be3e11291_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNC02LTEtMS0x_52ed6469-22e5-485b-a4f9-dc3fa2bcbbc3"
      unitRef="usd">6177000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7ad191f36bb94c309b0048f07d23eca2_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNC04LTEtMS0x_674f8186-7d7b-4299-89ef-38ab6a9ddab6"
      unitRef="usd">3976000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9cf34fb005a349d0af6d06e2e451cc1e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNS0yLTEtMS0x_f33b0669-4f98-4fa9-bb60-cab5c1ae86eb"
      unitRef="usd">434000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic8203731a1314feda1245f5c58a2e0b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNS00LTEtMS0x_d9e631c8-c298-4f7d-9a6f-f6cd2d104feb"
      unitRef="usd">299000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaf70a00d6a1245cda39d6c5734cbbedc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNS02LTEtMS0x_1a9eb766-a2d3-4c5a-ae6a-0d7d2ab58395"
      unitRef="usd">1257000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iad6ad9876dc54b99b44b939e6c69da80_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNS04LTEtMS0x_47761a5c-24fe-4a61-bd65-c4ea860d5d33"
      unitRef="usd">827000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifbcd4bb50a164a709140bf9796c663bc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNi0yLTEtMS0x_50fd85a4-e8f2-4c81-bff6-2f98153b94d3"
      unitRef="usd">1526000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1fefa124b4804563b8e9ddcbdcb4d0b1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNi00LTEtMS0x_e8dd9c88-1386-46c1-a89e-ae241d06eafd"
      unitRef="usd">1306000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibdd8b69590ec442bb21d4bd6827a9b49_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNi02LTEtMS0x_c417347d-463c-4b05-abec-1a08668cc2b7"
      unitRef="usd">4662000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i322ec7cf7cef4568a7a538070a8ff21e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNi04LTEtMS0x_1b448808-c6ce-46fe-9c0a-0d8c434ab3a4"
      unitRef="usd">3711000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNy0yLTEtMS0x_80bcd2d5-d6e4-48a4-a0c4-5c4566a6a135"
      unitRef="usd">4241000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNy00LTEtMS0x_16c6cac6-2b47-4dec-b05c-8fb86480589f"
      unitRef="usd">3180000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNy02LTEtMS0x_5b74e05b-f0bd-4617-8cad-518741ba0299"
      unitRef="usd">12528000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81Mi9mcmFnOmM4NDRjNGNiM2QwZTQwMTRhOWFhYzM2MmNhNTMyMjg4L3RhYmxlOjkyZDkxNDBkM2IwNzRmMmU5NmE4MGEzMTA2MDg1YTU1L3RhYmxlcmFuZ2U6OTJkOTE0MGQzYjA3NGYyZTk2YTgwYTMxMDYwODVhNTVfNy04LTEtMS0x_fe06febf-2bdf-4e19-83ae-60eaf55cd13d"
      unitRef="usd">8757000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RleHRyZWdpb246NTdkOTUyZWRmMzEyNDM0ODkzNDVkYTRhMTE2M2Q1MjRfNjI3_04f3144b-a5ca-4093-824c-2e29a14ee2bd">Net Loss Per Share of Common Stock&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the computation of basic and diluted net loss per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands, except share and per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,474)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares used to compute basic and diluted net loss per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,340,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,713,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,005,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,155,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because the Company has reported a net loss in all periods presented, outstanding stock options, restricted stock units, shares subject to repurchase, ESPP purchase rights and common stock warrants are anti-dilutive and therefore diluted net loss per common share is the same as basic net loss per common share for the periods presented. The following anti-dilutive common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;            &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,063,739&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,504,349&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,063,739&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,504,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597,209&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,173&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597,209&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares subject to repurchase&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,784&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP purchase rights&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,070&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,950&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,070&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,813,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,019,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,813,140&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,019,378&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RleHRyZWdpb246NTdkOTUyZWRmMzEyNDM0ODkzNDVkYTRhMTE2M2Q1MjRfNjI4_2f6d7df8-d0c5-45b6-b2cb-3bdfa0806259">&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the computation of basic and diluted net loss per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands, except share and per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,474)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares used to compute basic and diluted net loss per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,340,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,713,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,005,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,155,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfMy0xLTEtMS0x_ba164d8d-8ae7-442c-9b0c-bd524775d027"
      unitRef="usd">-15872000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfMy0zLTEtMS0x_e32f40cf-64d8-420d-9dcf-f4b22e5c49ff"
      unitRef="usd">-9474000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfMy01LTEtMS0x_6e8e93af-07c7-4c76-a312-ad70659f5bd5"
      unitRef="usd">-42095000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfMy03LTEtMS0x_b2fed48c-f526-4cd1-8095-77d264afe4a2"
      unitRef="usd">-34718000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS0xLTEtMS0x_766cca22-3e06-43c0-8dd8-a05b396564aa"
      unitRef="shares">33340093</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS0xLTEtMS0x_c69378d1-8288-43d6-aba1-db685e44964e"
      unitRef="shares">33340093</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS0zLTEtMS0x_8ec35982-3ad7-45be-9dd3-a4a3267e7b0a"
      unitRef="shares">28713418</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS0zLTEtMS0x_9f7e37be-cb83-453d-be09-715e606bf7c3"
      unitRef="shares">28713418</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS01LTEtMS0x_6f48a73e-ee22-439d-92b0-003f47b8ad3b"
      unitRef="shares">33005904</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS01LTEtMS0x_79efd023-4e46-46f5-abfd-c1bc0b0e948a"
      unitRef="shares">33005904</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS03LTEtMS0x_493d1fe0-e08b-4a75-bf60-d97a53db606a"
      unitRef="shares">28155561</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNS03LTEtMS0x_d9c740d7-40c8-4947-9518-409fac8e3724"
      unitRef="shares">28155561</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy0xLTEtMS0x_8c1fa5de-1411-4cae-b770-f2cc7e5f33e4"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy0xLTEtMS0x_adb8f738-02bc-40e6-9d07-11414c83b370"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy0zLTEtMS0x_06d0e723-1635-4831-9083-799cb703c2ae"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy0zLTEtMS0x_c3f1b00c-d983-4646-b9ca-2082b293c40c"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy01LTEtMS0x_1ae656a8-3cf5-475c-abe7-a8793f985c7e"
      unitRef="usdPerShare">-1.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy01LTEtMS0x_7c707a75-6c0d-4e7f-83fc-cdc8ed20e03c"
      unitRef="usdPerShare">-1.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy03LTEtMS0x_33cac9dc-c743-45f8-a66c-330ae5d39bca"
      unitRef="usdPerShare">-1.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOjk4NzhkNTRkMDExNTRkNWFiMGIyYmY4MWJjMWI5ZGM3L3RhYmxlcmFuZ2U6OTg3OGQ1NGQwMTE1NGQ1YWIwYjJiZjgxYmMxYjlkYzdfNy03LTEtMS0x_c044c48e-21dd-400b-8ec5-043989a6fc9e"
      unitRef="usdPerShare">-1.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RleHRyZWdpb246NTdkOTUyZWRmMzEyNDM0ODkzNDVkYTRhMTE2M2Q1MjRfNjI5_afc1ee33-6ecb-4595-9112-c5a9a950f5d6">The following anti-dilutive common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented:&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;            &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,063,739&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,504,349&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,063,739&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,504,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597,209&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,173&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597,209&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares subject to repurchase&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,784&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP purchase rights&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,070&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,950&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,070&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,813,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,019,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,813,140&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,019,378&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id0bf7856168a4bbc8d608e2a53cbc8dc_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMi0xLTEtMS0x_8e038bc0-885d-4a7b-9fa0-a96bf1deb780"
      unitRef="shares">2063739</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3c468269d170486eb2b4e64a4513440d_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMi0zLTEtMS0x_6286ecf3-1a10-42e9-aced-c4a4f782839f"
      unitRef="shares">2504349</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i36d4c1a69b2b4a54b975f3d9b0099fc6_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMi01LTEtMS0x_e8dd5773-02c6-4b69-a6b6-d7a748a2c7ea"
      unitRef="shares">2063739</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia72aa66ef16743e19faa81de6f8529b0_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMi03LTEtMS0x_a71902a0-981b-403d-88d3-a12886ebcfa1"
      unitRef="shares">2504349</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibc3c26de486d43ca9dd20ec5d101e9dc_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMy0xLTEtMS0x_c676b9cc-dbf6-4733-8849-fe5adc35becb"
      unitRef="shares">1597209</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i77acbbe553ec4a43a1af07135f846a82_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMy0zLTEtMS0x_8da0c34e-2792-4c81-a86b-ef825483da25"
      unitRef="shares">1250173</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6b097d0adc3b46ba9ea4861ea981873d_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMy01LTEtMS0x_cd6606ab-af44-416f-b1a0-2d49fead882b"
      unitRef="shares">1597209</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9639632395d7474d8c63fe4431f760f8_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfMy03LTEtMS0x_c0c320e1-7783-405c-bfa5-067e610c1a33"
      unitRef="shares">1250173</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3d7cc7784aab4de0a474421d3860f6ac_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNC0xLTEtMS0x_04d6767d-adf6-4f08-b515-aa0a9f7f687b"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i270de781b3674556993d7df5c50f4257_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNC0zLTEtMS0x_fd355f7a-a675-46f4-a123-0fb3b1b73d15"
      unitRef="shares">7784</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic2d646eaf6f3487b995e90e7b3f9638d_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNC01LTEtMS0x_70a13f18-c89c-42ef-9d39-62734f397632"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i26c2606ec5ae4f489f0d680cc4f0ba15_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNC03LTEtMS0x_bdece395-0970-4307-bcf3-fa52ebebb136"
      unitRef="shares">7784</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1310e619e2754e27ad6c1651d898e04e_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNS0xLTEtMS0x_a272e9f5-b1b7-4cab-b9a1-e475e71eef02"
      unitRef="shares">34070</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i06fea0e7101e40dba2eb84ffe5da4f05_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNS0zLTEtMS0x_a90e5af9-ea71-45cd-869a-7dca02e8cb61"
      unitRef="shares">138950</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie7aed40f2b6841ce8093e0bbc418e41e_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNS01LTEtMS0x_93b64930-9544-4a30-ba78-6a747fcafde3"
      unitRef="shares">34070</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iba3d79dab9b744f8a0b82ce2c0c46ba4_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNS03LTEtMS0x_c523e03d-75b9-463a-b71c-910ba68b0a85"
      unitRef="shares">138950</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id8d65fa942e24ab2b39884d55f6a927d_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNi0xLTEtMS0x_e30c7682-b2c2-4178-8c24-d1121a1d0304"
      unitRef="shares">118122</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7310fa50c10c46c8bbee63a8ff92f106_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNi0zLTEtMS0x_e8e084e3-4113-4550-bc3b-7c2ff9e5c0e8"
      unitRef="shares">118122</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id66e6a0d9d334aeca662f79c0d8aab8b_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNi01LTEtMS0x_2c8d57c1-5619-4a99-9797-4a1bb63eb5e1"
      unitRef="shares">118122</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ifad8a990e145427785bb494543f4b493_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNi03LTEtMS0x_b2bb4ab9-d498-4cfb-8a19-bd762c231c0b"
      unitRef="shares">118122</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNy0xLTEtMS0x_8958cb35-74ae-488e-b127-dd2047c66315"
      unitRef="shares">3813140</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i419d7376a11a4f999760045756fc1697_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNy0zLTEtMS0x_20ee0b60-8349-44c1-9f3a-1190e611f182"
      unitRef="shares">4019378</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNy01LTEtMS0x_e03f833d-1175-4b75-85b9-f444c035aa4c"
      unitRef="shares">3813140</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3c64a70df00648478c80144873723f9d_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81NS9mcmFnOjU3ZDk1MmVkZjMxMjQzNDg5MzQ1ZGE0YTExNjNkNTI0L3RhYmxlOmY1YmFhNGIwNjAwNjQ0OGI4MjA1NDI3ZGVjNzFmZWY3L3RhYmxlcmFuZ2U6ZjViYWE0YjA2MDA2NDQ4YjgyMDU0MjdkZWM3MWZlZjdfNy03LTEtMS0x_dc5c945b-0fe2-4289-a4a8-205459187908"
      unitRef="shares">4019378</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMjQ2NA_2c819f15-3d77-4878-a5a9-1c2f96b77d25">Related Party Transaction &lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 24, 2020, the Company entered into a joint development agreement (the &#x201c;Development Agreement&#x201d;) with SeaSpine Orthopedics Corporation (&#x201c;SeaSpine&#x201d;) to develop a next generation device for sacropelvic fixation. Mr. Keith Valentine, who serves as the President, Chief Executive Officer and a member of the board of directors of SeaSpine, also serves as a member of the Company's Board of Directors since August 2015. On April 27, 2021, Addendum No.1 to the Development Agreement was entered into by and between the Company and SeaSpine to extend certain obligations as described under the Development Agreement to a consultant of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the development plan, SeaSpine shall use reasonable efforts to assist in the development of the potential product offering, including licensing certain existing intellectual property to be incorporated into such product. Under the terms of the&#160;Development Agreement, the Company agreed to make monthly payments to SeaSpine to reimburse for full time resources employed by SeaSpine responsible to conduct the development activities. For the three months ended September 30, 2021 and 2020, the Company expensed $5,000 and $40,000, respectively, of the reimbursement charges from SeaSpine. For the nine months ended September 30, 2021 and 2020, the Company expensed $29,000 and $86,000, respectively, of the reimbursement charges from SeaSpine. The reimbursement charges were recorded within research and development expense in the condensed consolidated statements of operations. There were no outstanding liabilities to SeaSpine as of September 30, 2021 and December 31, 2020.&lt;/span&gt;&lt;/div&gt;Certain intellectual property developed pursuant to the project plan will be owned by the Company, certain intellectual property developed pursuant to the project plan will be owned by SeaSpine, and other intellectual property developed pursuant to the project plan will be jointly owned by SeaSpine and the Company. The Company also agreed to provide SeaSpine a royalty-free, worldwide, perpetual, non-exclusive license of certain of the Company's intellectual property incorporated into the product to be developed. The Company also agreed to pay SeaSpine a product royalty, in an amount specified in the Development Agreement, for each resulting product sold for a period of 10 years beginning on the initial market launch. The term of the Development Agreement shall continue until the expiration of all royalty terms, unless earlier terminated by either party, as provided for by the Development Agreement.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i828e66a96b3b4c439de37f099c818aac_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMTA5OTUxMTYzMDI2MA_ae245e8c-1147-4a67-97ce-fb3f9a06ac63"
      unitRef="usd">5000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="iaa0e01356bc64335a99cd3efce7ed726_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMTA5OTUxMTYzMDI0Ng_fb740c3d-78ac-4e6d-ad60-6b14619ff901"
      unitRef="usd">40000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="ia2a91817bfc9420fbad12b231fb60c11_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMTI4Ng_ebbb25da-3289-4726-b206-62073ca66370"
      unitRef="usd">29000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i196e2035a7634702ac62a3f024b8006f_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMTI5Mw_a4d00fd3-a887-4442-82b5-09a395005c60"
      unitRef="usd">86000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:DueToAffiliateCurrent
      contextRef="ib8afc1805c1c46b7ab718de87f1939ab_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMTUwMg_cb3b823c-9c70-4306-95bc-25bdd0c8b5a2"
      unitRef="usd">0</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="if6308366c8e94613b5653738e3f24c14_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMTUwMg_f28cdef9-9369-4658-bc58-2d6f9399197c"
      unitRef="usd">0</us-gaap:DueToAffiliateCurrent>
    <sibn:RelatedPartyTransactionTermOfAgreement
      contextRef="ia2a91817bfc9420fbad12b231fb60c11_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV81OC9mcmFnOjNjZjk3MTE4M2MxNDRmNjY4NDBlOGJlMjA5NzM5NjlmL3RleHRyZWdpb246M2NmOTcxMTgzYzE0NGY2Njg0MGU4YmUyMDk3Mzk2OWZfMjIzNg_97679650-0946-4976-a7c2-f086309e69dd">P10Y</sibn:RelatedPartyTransactionTermOfAgreement>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i9a78e483637447919ecdf70d22fc1496_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmIwMGQwNmIyNTE5ZjQyMWViNzNhM2FhODZkYTgxNGNhL3NlYzpiMDBkMDZiMjUxOWY0MjFlYjczYTNhYTg2ZGE4MTRjYV82MS9mcmFnOmZjYTNmNjE3Mjg1ODQzMmRiZWRlYjRmYmRmMDcyNzc4L3RleHRyZWdpb246ZmNhM2Y2MTcyODU4NDMyZGJlZGViNGZiZGYwNzI3NzhfMTE0MA_f2f3c581-76a1-423c-9be3-a4a3d5187277">Income TaxesIn determining quarterly provisions for income taxes, the Company uses the annual estimated effective tax rate applied to the actual year-to-date profit or loss, adjusted for discrete items arising in that quarter. The Company updates its estimate of its annual effective tax rate at the end of each quarterly period. The estimate takes into account annual forecasted income (loss) before income taxes, the geographic mix of income (loss) before income taxes and any significant permanent tax items. The Company did not have provision for income taxes for the three and nine months ended September 30, 2021 and 2020. The Company continues to maintain a full valuation allowance against its net deferred tax assets due to the uncertainty surrounding realization of such assets. The Company accounts for the uncertainty in income taxes by utilizing a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of any uncertain tax positions that have been taken or are expected to be taken on an income tax return. There had been no changes in the estimated uncertain tax benefits recorded as of December 31, 2020.</us-gaap:IncomeTaxDisclosureTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393394224408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SI-BONE,&#160;INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-2216351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">471 El Camino Real<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Santa Clara<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">207-0700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001&#160;per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SIBN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,489,778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001459839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393390147656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 59,863<span></span>
</td>
<td class="nump">$ 53,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">100,988<span></span>
</td>
<td class="nump">142,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts of $264 and $263, respectively</a></td>
<td class="nump">12,617<span></span>
</td>
<td class="nump">13,611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">10,246<span></span>
</td>
<td class="nump">5,633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,934<span></span>
</td>
<td class="nump">2,565<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">185,648<span></span>
</td>
<td class="nump">218,241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">7,913<span></span>
</td>
<td class="nump">4,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">405<span></span>
</td>
<td class="nump">374<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">193,966<span></span>
</td>
<td class="nump">223,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">4,139<span></span>
</td>
<td class="nump">3,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities and other</a></td>
<td class="nump">10,425<span></span>
</td>
<td class="nump">10,199<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">14,564<span></span>
</td>
<td class="nump">13,470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term borrowings</a></td>
<td class="nump">34,922<span></span>
</td>
<td class="nump">39,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">862<span></span>
</td>
<td class="nump">854<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">50,348<span></span>
</td>
<td class="nump">53,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 6)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS&#8217; EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 100,000,000 shares authorized; 33,450,995 and 32,583,220 shares issued and outstanding, respectively</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">424,561<span></span>
</td>
<td class="nump">408,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">426<span></span>
</td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(281,372)<span></span>
</td>
<td class="num">(239,277)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">143,618<span></span>
</td>
<td class="nump">169,363<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 193,966<span></span>
</td>
<td class="nump">$ 223,142<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393390024072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 264<span></span>
</td>
<td class="nump">$ 263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (in shares)</a></td>
<td class="nump">33,450,995<span></span>
</td>
<td class="nump">32,583,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="nump">33,450,995<span></span>
</td>
<td class="nump">32,583,220<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393388241368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 22,286<span></span>
</td>
<td class="nump">$ 20,373<span></span>
</td>
<td class="nump">$ 64,922<span></span>
</td>
<td class="nump">$ 51,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">2,478<span></span>
</td>
<td class="nump">2,578<span></span>
</td>
<td class="nump">7,053<span></span>
</td>
<td class="nump">6,627<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">19,808<span></span>
</td>
<td class="nump">17,795<span></span>
</td>
<td class="nump">57,869<span></span>
</td>
<td class="nump">44,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">23,525<span></span>
</td>
<td class="nump">18,772<span></span>
</td>
<td class="nump">67,531<span></span>
</td>
<td class="nump">53,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">3,288<span></span>
</td>
<td class="nump">2,778<span></span>
</td>
<td class="nump">9,392<span></span>
</td>
<td class="nump">7,033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">6,194<span></span>
</td>
<td class="nump">4,920<span></span>
</td>
<td class="nump">18,685<span></span>
</td>
<td class="nump">14,471<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">33,007<span></span>
</td>
<td class="nump">26,470<span></span>
</td>
<td class="nump">95,608<span></span>
</td>
<td class="nump">75,312<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(13,199)<span></span>
</td>
<td class="num">(8,675)<span></span>
</td>
<td class="num">(37,739)<span></span>
</td>
<td class="num">(30,696)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Interest and other income (expense), net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2,658)<span></span>
</td>
<td class="num">(1,102)<span></span>
</td>
<td class="num">(4,797)<span></span>
</td>
<td class="num">(5,016)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(59)<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">290<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(15,872)<span></span>
</td>
<td class="num">(9,474)<span></span>
</td>
<td class="num">(42,095)<span></span>
</td>
<td class="num">(34,718)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (15,906)<span></span>
</td>
<td class="num">$ (9,654)<span></span>
</td>
<td class="num">$ (42,193)<span></span>
</td>
<td class="num">$ (34,752)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in usd per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (1.28)<span></span>
</td>
<td class="num">$ (1.23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in usd per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (1.28)<span></span>
</td>
<td class="num">$ (1.23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares used to compute basic net loss per share (in shares)</a></td>
<td class="nump">33,340,093<span></span>
</td>
<td class="nump">28,713,418<span></span>
</td>
<td class="nump">33,005,904<span></span>
</td>
<td class="nump">28,155,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of common shares used to compute diluted net loss per share (in shares)</a></td>
<td class="nump">33,340,093<span></span>
</td>
<td class="nump">28,713,418<span></span>
</td>
<td class="nump">33,005,904<span></span>
</td>
<td class="nump">28,155,561<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393388661960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Stockholders' equity, beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,163,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, beginning of period at Dec. 31, 2019</a></td>
<td class="nump">$ 63,008<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 258,121<span></span>
</td>
<td class="nump">$ 464<span></span>
</td>
<td class="num">$ (195,580)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock from public offering, net of underwriting discounts, commissions and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,135,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock from public offering, net of underwriting discounts, commissions and offering costs</a></td>
<td class="nump">62,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld</a></td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits', window );">Issuance of common stock upon vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">2,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions', window );">Vesting of early exercised stock options</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized gain (loss) on marketable securities</a></td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(12,772)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,772)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Stockholders' equity, end of period (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,406,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, end of period at Mar. 31, 2020</a></td>
<td class="nump">116,270<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">323,922<span></span>
</td>
<td class="nump">697<span></span>
</td>
<td class="num">(208,352)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Stockholders' equity, beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,163,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, beginning of period at Dec. 31, 2019</a></td>
<td class="nump">63,008<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">258,121<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="num">(195,580)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized gain (loss) on marketable securities</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(34,718)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Stockholders' equity, end of period (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,838,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, end of period at Sep. 30, 2020</a></td>
<td class="nump">102,031<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">331,896<span></span>
</td>
<td class="nump">430<span></span>
</td>
<td class="num">(230,298)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Stockholders' equity, beginning of period (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,406,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, beginning of period at Mar. 31, 2020</a></td>
<td class="nump">116,270<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">323,922<span></span>
</td>
<td class="nump">697<span></span>
</td>
<td class="num">(208,352)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld</a></td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock related to employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock related to employee stock purchase plan</a></td>
<td class="nump">991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits', window );">Issuance of common stock upon vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">2,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions', window );">Vesting of early exercised stock options</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized gain (loss) on marketable securities</a></td>
<td class="num">(85)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(12,472)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,472)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Stockholders' equity, end of period (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,612,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, end of period at Jun. 30, 2020</a></td>
<td class="nump">107,868<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">328,079<span></span>
</td>
<td class="nump">610<span></span>
</td>
<td class="num">(220,824)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld</a></td>
<td class="nump">628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits', window );">Issuance of common stock upon vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions', window );">Vesting of early exercised stock options</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="num">(33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized gain (loss) on marketable securities</a></td>
<td class="num">(147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(9,474)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,474)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Stockholders' equity, end of period (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,838,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, end of period at Sep. 30, 2020</a></td>
<td class="nump">102,031<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">331,896<span></span>
</td>
<td class="nump">430<span></span>
</td>
<td class="num">(230,298)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Stockholders' equity, beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,583,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, beginning of period at Dec. 31, 2020</a></td>
<td class="nump">169,363<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">408,113<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="num">(239,277)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld</a></td>
<td class="nump">601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits', window );">Issuance of common stock upon vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">4,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions', window );">Vesting of early exercised stock options</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized gain (loss) on marketable securities</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(12,242)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,242)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Stockholders' equity, end of period (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,808,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, end of period at Mar. 31, 2021</a></td>
<td class="nump">161,667<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">412,753<span></span>
</td>
<td class="nump">430<span></span>
</td>
<td class="num">(251,519)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Stockholders' equity, beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,583,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, beginning of period at Dec. 31, 2020</a></td>
<td class="nump">$ 169,363<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">408,113<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="num">(239,277)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld (in shares)</a></td>
<td class="nump">317,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="num">$ (103)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized gain (loss) on marketable securities</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(42,095)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Stockholders' equity, end of period (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,450,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, end of period at Sep. 30, 2021</a></td>
<td class="nump">143,618<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">424,561<span></span>
</td>
<td class="nump">426<span></span>
</td>
<td class="num">(281,372)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Stockholders' equity, beginning of period (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,808,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, beginning of period at Mar. 31, 2021</a></td>
<td class="nump">161,667<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">412,753<span></span>
</td>
<td class="nump">430<span></span>
</td>
<td class="num">(251,519)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld</a></td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock related to employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock related to employee stock purchase plan</a></td>
<td class="nump">1,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits', window );">Issuance of common stock upon vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">4,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions', window );">Vesting of early exercised stock options</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized gain (loss) on marketable securities</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(13,981)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,981)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Stockholders' equity, end of period (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,236,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, end of period at Jun. 30, 2021</a></td>
<td class="nump">154,198<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">419,235<span></span>
</td>
<td class="nump">460<span></span>
</td>
<td class="num">(265,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, net of shares withheld</a></td>
<td class="nump">1,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits', window );">Issuance of common stock upon vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">4,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions', window );">Vesting of early exercised stock options</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized gain (loss) on marketable securities</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(15,872)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,872)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Stockholders' equity, end of period (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,450,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity, end of period at Sep. 30, 2021</a></td>
<td class="nump">$ 143,618<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 424,561<span></span>
</td>
<td class="nump">$ 426<span></span>
</td>
<td class="num">$ (281,372)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital, Share-based Compensation, Vesting Of Early Exercised Stock Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Shares Restricted Stock Units</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393389020680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (42,095)<span></span>
</td>
<td class="num">$ (34,718)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">12,528<span></span>
</td>
<td class="nump">8,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,436<span></span>
</td>
<td class="nump">786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion (amortization) of discount on marketable securities</a></td>
<td class="nump">1,056<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesRealizedGainLoss', window );">Realized gain on marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">1,848<span></span>
</td>
<td class="nump">1,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on sale and disposal of property and equipment</a></td>
<td class="nump">304<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">1,060<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(4,545)<span></span>
</td>
<td class="nump">337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">610<span></span>
</td>
<td class="nump">1,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">425<span></span>
</td>
<td class="nump">416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities and other</a></td>
<td class="nump">320<span></span>
</td>
<td class="num">(2,072)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(26,819)<span></span>
</td>
<td class="num">(22,780)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_ProceedsFromMaturityOfMarketableSecurities', window );">Maturities of marketable securities</a></td>
<td class="nump">107,494<span></span>
</td>
<td class="nump">63,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_ProceedsFromSaleOfMarketableSecurities', window );">Sales of marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(66,678)<span></span>
</td>
<td class="num">(69,145)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(4,614)<span></span>
</td>
<td class="num">(1,744)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">36,202<span></span>
</td>
<td class="nump">4,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from follow-on public offering, net of underwriting discounts, commissions and offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">62,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from debt financing</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">45,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of debt financing</a></td>
<td class="num">(41,000)<span></span>
</td>
<td class="num">(45,297)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt issuance costs</a></td>
<td class="num">(111)<span></span>
</td>
<td class="num">(750)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments of prepayment penalty and lender fees</a></td>
<td class="num">(508)<span></span>
</td>
<td class="num">(843)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">1,566<span></span>
</td>
<td class="nump">991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of stock options</a></td>
<td class="nump">2,327<span></span>
</td>
<td class="nump">987<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(2,726)<span></span>
</td>
<td class="nump">63,363<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(375)<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">6,282<span></span>
</td>
<td class="nump">45,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash and cash equivalents at</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of period</a></td>
<td class="nump">53,581<span></span>
</td>
<td class="nump">10,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of period</a></td>
<td class="nump">59,863<span></span>
</td>
<td class="nump">55,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of non-cash information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_VestingOfEarlyExercisedStockOptions', window );">Vesting of early exercised stock options</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Unpaid purchases of property and equipment</a></td>
<td class="nump">$ 474<span></span>
</td>
<td class="nump">$ 256<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_ProceedsFromMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Maturity Of Marketable Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_ProceedsFromMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_ProceedsFromSaleOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Marketable Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_ProceedsFromSaleOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_VestingOfEarlyExercisedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vesting of Early Exercised Stock Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_VestingOfEarlyExercisedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393387203368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and Nature of Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">The Company and Nature of Business</a></td>
<td class="text">The Company and Nature of Business<div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SI-BONE, Inc. (the &#8220;Company&#8221;) was incorporated in the state of Delaware on March&#160;18, 2008 and is headquartered in Santa Clara, California. The Company is a medical device company that has pioneered a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of the most common types of sacroiliac joint disorders that cause lower back pain. The Company introduced its primary product, the iFuse Implant System, or iFuse, in 2009 in the U.S., in 2010 in certain countries in the European Union, and in 2015 in certain countries in the rest of the world.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, the Company received $63.0 million of net proceeds from its first follow-on public offering of 4,300,000 shares of the Company's common stock, of which 2,490,053 shares were offered and sold by the Company, and the exercise of underwriter's option to purchase from the Company an additional 645,000 shares of the Company's common stock, at a public offering price of $21.50 per share. The total public offering costs incurred in connection with the follow-on offering were allocated based on the gross proceeds received by the Company and the other selling shareholders on a pro-rated basis. Public offering cost of $0.4 million allocated to selling of shares by the Company was charged against the gross proceeds received from the follow-on offering. Public offering costs of $0.2 million allocated to selling of shares by the selling shareholders was recognized as transaction costs within general and administrative expenses on the consolidated statements of operations in the year ended December 31, 2020.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company received $71.6&#160;million of net proceeds from its second follow-on public offering of shares of the Company's common stock, of which 3,000,000 shares were offered and sold by the Company, and the exercise of underwriter's option to purchase from the Company an additional 478,507 shares of the Company's common stock, at a public offering price of $22.00 per share. In addition to the shares sold by the Company in this second follow-on offering, the selling stockholder sold 190,053 shares of the Company's common stock previously held by the selling stockholder at a price to the public of $22.00 per share. The Company did not receive any proceeds from the sale by the selling stockholder.  </span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div>The Company is subject to continuing risk and uncertainties as a result of the COVID-19 pandemic, and is closely monitoring the impact of the pandemic on all aspects of its business, including the impacts on its customers, patients that would benefit from procedures involving the Company's products, employees, suppliers, vendors, business partners and distribution channels. Economies worldwide continue to be negatively impacted by the COVID-19 pandemic, in particular with recurrent outbreaks and mutations of the virus, despite advances in vaccines, and the Company anticipates these disruptions will continue. While the Company has not experienced material disruptions to its supply chain to date, certain of its third-party suppliers have faced delays, product shortages and rising costs resulting from disruptions in the global supply chain, primarily related to the instruments. As a result, the Company is continuing to work closely with its manufacturing partners and suppliers, as well as determining alternative sourcing strategies to enable the Company to source key components and maintain appropriate inventory levels to meet customer demand. As such the Company's future results of operations and liquidity could be adversely impacted by a variety of factors related to the COVID-19 pandemic, including those discussed in the section entitled "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended December 31, 2020.  As of the date of issuance of these condensed consolidated financial statements, the extent to which the COVID-19 pandemic may materially impact the Company's financial condition, liquidity, or results of operations remains uncertain<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393385771992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:12pt;margin-top:9pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all of the information required by GAAP for complete financial statements. These unaudited interim condensed consolidated financial statements have been prepared on the same basis as the Company&#8217;s annual financial statements and, in the opinion of management, reflect all adjustments that are necessary for a fair statement of the Company&#8217;s consolidated financial information. The results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any other interim period or for any other future year. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements should be read in conjunction with the audited financial statements and related notes thereto for the year ended December 31, 2020 contained in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 10, 2021.</span></div><div style="margin-top:9pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are based on historical experience, where applicable and other assumptions believed to be reasonable by the management. Actual results could differ from those estimates. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s significant accounting policies are disclosed in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020. There have been no material changes to these accounting policies.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">JOBS Act Accounting Election</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an emerging growth company under the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), the Company has been eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. The Company has elected to take advantage of the extended transition period for adopting new or revised accounting standards that have different effective dates for public and private companies. As a result, these condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 30, 2021, the Company&#8217;s public float exceeded $700&#160;million and as such the Company will be deemed to be a large accelerated filer under Rule 12b-2 of the Exchange Act, commencing with the Company&#8217;s Annual Report on Form 10-K for the 2021 fiscal year. The Company will retain its current filer status until the end of 2021. As a large accelerated filer, the Company will no longer qualify as an emerging growth company nor be eligible to rely on the benefits afforded to emerging growth companies under the JOBS Act.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages and operates as one reportable segment. The Company derives substantially all of its revenue from sales to customers in the U.S. Revenue by geography is based on billing address of the customer. No single country outside the U.S.  accounts for more than 10% of the total revenue during the periods presented. Long-lived assets held outside the U.S. are immaterial. The table below summarizes the Company's revenue by geography:</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"><tr><td style="width:1.0%"/><td style="width:46.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.086%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.605%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,286&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,373&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,922&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,243&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Effective</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-02, Leases (Topic 842), which requires that lessee's recognize a right-of-use asset and a lease liability for all leases with lease terms greater than twelve months in the balance sheet.&#160;A lease liability is a lessee's obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset is an asset that represents the lessee&#8217;s right to use, or control use of, a specified asset for the lease term for all leases (with the exception of short-term leases) at the adoption date. In July 2018, the FASB issued&#160;ASU&#160;2018-10 and&#160;ASU 2018-11, which provides clarification on the narrow aspects of the guidance and provide an additional transition method to adopt the new leases standard. The new transition method allows an entity to recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. In March 2019, the FASB issued&#160;ASU 2019-01, which provides clarification on implementation issues associated with adopting&#160;ASU 2016-02.&#160;The new leases standard must be adopted using a modified retrospective transition method and allows for the application of the new guidance at the beginning of the earliest comparative period presented or at the adoption date. In November 2019, the FASB issued ASU 2019-10, which revised the mandatory effective dates of the new leases standard. Further, due to the impact of the COVID-19, in June 2020, the FASB issued ASU 2020-05 to further defer the effective date for one year for entities in the &#8220;all other&#8221; categories. For public companies, the new guidance became effective for fiscal years, and for interim periods within those fiscal years, beginning after December&#160;15, 2018. For all other entities, the new guidance is now effective for fiscal years beginning after December&#160;15, 2021 and interim periods within fiscal years beginning after December 15, 2022. Early adoption is still permitted for any interim or annual financial statements not yet issued.  The Company expects to disclose the adoption of this standard for the fiscal year ending December 31, 2021. The Company is currently evaluating the impact of this standard on its consolidated financial statements including the timing of its adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (1) whether a contract is or contains a lease, (2) the classification of existing leases, and (3) whether previously capitalized initial direct costs would qualify for capitalization under ASC 842. The Company expects that the adoption of this new standard will have a material impact on its balance sheet. The most significant impact would be the recognition of operating lease right-of-use assets and liability. The standard is not expected to have a material impact to the Company's consolidated statements of income and cash flows.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued&#160;ASU 2016-13,&#160;Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. FASB issued ASU 2019-05 in May 2019, ASU 2019-08 and ASU 2019-11 in November 2019 for codification improvements of Topic 326. The new standard revises the accounting requirements related to the measurement of credit losses and will require organizations to measure all expected credit losses for financial assets based on historical experience, current conditions and reasonable and supportable forecasts about collectability. Assets must be presented in the financial statements at the net amount expected to be collected.&#160;In November 2019, the FASB issued ASU 2019-10,&#160;which defers the effective date of&#160;ASU 2016-13&#160;for public companies that are eligible to be smaller reporting companies and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.&#160;In February 2020, the FASB issued ASU 2020-02, which provides guidance regarding methodologies, documentation, and internal controls related to expected credit losses. The Company is currently evaluating the impact of this standard on its consolidated financial statements but does not expect the standard will have a material impact on the Company's consolidated financial statements. The Company expects to disclose the adoption of this standard for the fiscal year ending December 31, 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the FASB issued&#160;ASU&#160;2021-04&#160;&#8220;Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212; Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815- 40) Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#8221; which clarifies and reduces diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options that remain equity classified after modification or exchange. An entity should measure the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as follows: i) for a modification or an exchange that is a part of or directly related to a modification or an exchange of an existing debt instrument or line-of-credit or revolving-debt arrangements (hereinafter, referred to as a &#8220;debt&#8221; or &#8220;debt instrument&#8221;), as the difference between the fair value of the modified or exchanged written call option and the fair value of that written call option immediately before it is modified or exchanged; ii) for all other modifications or exchanges, as the excess, if any, of the fair value of the modified or exchanged written call option over the fair value of that written call option immediately before it is modified or exchanged. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. The Company is currently evaluating the impact of this update on its consolidated financial statements. While the Company does not expect the adoption of ASU 2021-04 to materially impact the Company's consolidated financial statements and related disclosures because it does not currently anticipate modifications to its outstanding equity-classified written call options, the impact on the Company's consolidated financial statements and disclosures will depend on the facts and circumstances of any specific future transactions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393385598584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Marketable Securities</a></td>
<td class="text">Marketable Securities<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company's marketable securities were available-for-sale and were classified based on their maturities. Marketable securities with remaining maturities at the date of purchase of three months or less are classified as cash equivalents. Short-term investments are securities that original maturity or remaining maturity is greater than three months and not more than twelve months. Long-term investments are securities for which the original maturity or remaining maturity is greater than twelve months.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the marketable securities:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"><tr><td style="width:1.0%"/><td style="width:36.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.242%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.242%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.486%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,218&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,218&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,206&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,206&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"><tr><td style="width:1.0%"/><td style="width:36.620%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.084%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.029%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,779&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,776&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,851&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,204&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,199&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:15pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gains and losses on available-for-sale securities are recorded in accumulated other comprehensive income (loss) on the condensed consolidated balance sheets. The Company evaluates its investments to assess whether those in unrealized loss positions are other-than-temporarily impaired. The Company considers impairments to be other-than-temporary if it is related to deterioration in credit risk or if it is likely the Company will sell the securities before the recovery of their cost basis. The Company did not identify any of its marketable securities as other-than-temporarily impaired as of September 30, 2021 or December 31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393387185304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurement</a></td>
<td class="text">Fair Value Measurement<div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carrying amounts of certain of the Company&#8217;s financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities and market interest rates, if applicable. The carrying value of the Company&#8217;s long-term debt also approximates fair value based on management&#8217;s estimation that a current interest rate would not differ materially from the stated rate. There were no other financial assets or liabilities that required fair value hierarchy measurements and disclosures for the periods presented. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the fair value of the Company&#8217;s marketable securities measured at fair value on a recurring basis based on the three-tier fair value hierarchy:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.888%"><tr><td style="width:1.0%"/><td style="width:45.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,370&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,370&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,361&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,845&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,206&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,724&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,475&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,199&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393387221928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text">Balance Sheet Components<div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021 and December 31, 2020, inventory consisted entirely of finished goods.</span></div><div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"/><td style="width:66.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,692&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,247&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,484&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,913&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,527&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction in progress consists of cost of individual components of a custom instrument set used for surgical placement of the Company&#8217;s products that have not yet been placed into service of $2.8 million and construction costs related to the new lease in Santa Clara of $0.1 million. Depreciation expense was $0.6 million and $0.3 million for the three months ended September 30, 2021 and 2020, respectively, and $1.4 million and $0.8 million for the nine months ended September 30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"/><td style="width:66.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and related expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accrued professional services </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,425&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,199&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393385422472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:9pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a non-cancelable operating lease for an office building space, located in Santa Clara, California which expires in May 2025. The Company also has non-cancelable operating leases for its office building spaces in Gallarate, Italy and Knaresborough, United Kingdom, which expire in August 2027 and December 2025, respectively. Effective April 30, 2021, the Company terminated its office lease in Mannheim, Germany, and commenced a new lease that can be terminated at any time with six months written notice to the landlord. Further, the Company also leases vehicles under operating lease arrangements for certain of its personnel in Europe which expire at various times throughout 2021 to 2025. In August 2021, the Company signed a new lease for 19,534 square feet of research and development and warehouse space in Santa Clara, California. The term of the new lease will commence on November 1, 2021 and will terminate on October 31, 2026, with an option to renew for one additional three year term. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense is recorded over the lease terms on a straight-line basis. Rent expenses charged to operations under operating leases were $0.3 million for the three months ended September 30, 2021 and 2020, and $0.9 million for the nine months ended September 30, 2021 and 2020, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">           The table below summarizes aggregate future minimum lease payments under all leases as of September 30, 2021: </span></div><div><span><br/></span></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.722%"><tr><td style="width:1.0%"/><td style="width:81.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.231%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,641&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments and Obligations</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has certain purchase commitments related to its inventory management and training materials with certain suppliers wherein the Company is required to provide forecasts and purchase certain amounts included in such forecasts. The contractual obligations represent future cash commitments and liabilities under agreements with third parties and exclude orders for goods and services entered into in the normal course of business that are not enforceable or legally binding. These outstanding commitments amounted to $1.3 million and $0.3 million as of September 30, 2021 and December 31, 2020, respectively. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company&#8217;s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. No liability associated with such indemnifications has been recorded to date.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393387208632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings</a></td>
<td class="text">Borrowings<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding borrowings from the term loan described below, as of the dates presented:</span></div><div style="margin-bottom:12pt;margin-top:9pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.583%"><tr><td style="width:1.0%"/><td style="width:66.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.558%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.405%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal outstanding and final fee</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(661)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unaccreted value of final fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(671)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(884)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding debt, net of debt issuance costs and unaccreted value of final fee</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,922&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,455&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classified as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term borrowings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,922&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,455&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2017, the Company entered into a term loan with Biopharma Credit Investments IV Sub LP (&#8220;Pharmakon&#8221;) in for total loan proceeds of $40.0&#160;million (the &#8220;Pharmakon Term Loan&#8221;). The Pharmakon Term Loan included an interest-only period for 35 months through September 2020 and then equal quarterly principal payments plus interest through December 2022. The </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pharmakon Term Loan carried a fixed interest rate of 11.5% and allowed for early prepayment. The prepayment penalty fee was equal to the remaining interest due if prepaid within the first 30 months, a 2% penalty for months 31-48, and a 1% penalty for months 49-60. The Company paid in full and terminated the Pharmakon Term Loan in May 2020.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The outstanding debt as of December 31, 2020 is related to a term loan pursuant to the Loan and Security Agreement dated May 29, 2020, entered into by the Company with Solar Capital Partners (&#8220;Solar&#8221;). Pursuant to the Loan and Security Agreement, Solar provided an aggregate principal amount of $40.0&#160;million term loan (the &#8220;Solar Term Loan&#8221;). The total debt issuance costs of $0.8&#160;million associated with the Solar Term Loan were recorded in the condensed consolidated balance sheet as a direct deduction from the carrying amount of the loan, and are amortized as a component of interest expense using straight-line method over the life of the term loan.  In accordance with the Loan and Security Agreement with Solar, the Company paid in full and terminated the Pharmakon Term Loan, which was accounted for as debt extinguishment in accordance with the accounting standards. The Company recognized the unamortized debt issuance costs of $0.7&#160;million and the prepayment penalty and lender fees of $0.8&#160;million related to Pharmakon Term Loan as a loss on debt extinguishment. The costs and fees are reflected as interest expense in the consolidated statement of operations for the year ended December 31, 2020. The Solar Term Loan bore interest at a rate per annum equal to 9.40% plus London Interbank Offered Rate (&#8220;LIBOR&#8221;), payable monthly in arrears. LIBOR means the greater of (i) 0.33% or (ii) one-month LIBOR (or a comparable replacement rate to be determined by the collateral agent if the LIBOR is no longer available), which rate shall reset monthly. The Solar Term Loan included an interest-only period of 36 months through June 2023, and then repaid in equal monthly principal payments plus interest through  June 1, 2025. Pursuant to the Loan and Security Agreement with Solar, the Company could voluntarily prepay the Solar Term Loan, in full or in part, but only in increments of $10.0&#160;million, for a prepayment premium in an amount equal to 3.0% of the principal if prepaid in year one, 1.25% of the principal if prepaid in year two, and 0.50% of the principal if prepaid in year three or later. The Solar Term Loan was secured by substantially all of the Company&#8217;s assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:line-through"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company was also obligated to pay a final fee equal to $1.0&#160;million or 2.5% of the aggregate principal amount of the Solar Term Loan, which was fully earned by Solar on the effective date of the Loan and Security Agreement with Solar. With respect to the Solar Term Loan, this final fee shall be due and payable on the earliest of (i) the maturity date, (ii) the acceleration of the loan balance or (iii) its full prepayment, refinancing, substitution or replacement. The final fee was included within the long-term borrowings and was accreted to interest expense using straight-line method over the life of the term loan. The Company paid in full and terminated the Solar Term Loan in August 2021. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The outstanding debt as of September 30, 2021 is related to a term loan pursuant to the Loan and Security Agreement dated August 12, 2021 (the &#8220;Effective Date&#8221;), entered into by the Company with Silicon Valley Bank (&#8220;SVB&#8221;). Pursuant the agreement, SVB provided an aggregate principal amount of $35.0&#160;million to the Company (the &#8220;SVB Term Loan&#8221;). The Company used the proceeds of the SVB Term Loan to repay in full and terminate the Solar Term Loan, which was accounted for as debt extinguishment in accordance with the accounting standards. The Company recognized the unamortized debt issuance costs and unaccreted value of final fee of $1.3&#160;million and the prepayment penalty and lender fees of $0.5&#160;million related to Solar Term Loan as a loss on debt extinguishment. The costs and fees are reflected as interest expense in the condensed consolidated statement of operations for the three and nine months ended September 30, 2021. The total debt issuance costs of $0.1&#160;million associated with the SVB Term Loan were recorded in the condensed consolidated balance sheet as a direct deduction from the carrying amount of the loan, and are amortized as a component of interest expense using straight-line method over the life of the term loan. The SVB Term Loan matures (the &#8220;Maturity Date&#8221;) on either (a) August 1, 2025 or (b) August 1, 2026 dependent on the Company&#8217;s achievement of a certain financial performance milestone as of December 31, 2022, as set forth in the Loan Agreement. Interest on the SVB Term Loan is payable monthly at an annual rate set at the greater of (a) 5.75% and (b) prime rate as published in the Wall Street Journal plus 2.5%. Commencing on September 1, 2023, the Company will be required to make monthly principal amortization payments. The Company may elect to prepay the SVB Term Loan prior to the Maturity Date subject to a prepayment fee equal to 1% if  the prepayment occurs prior to the second anniversary of the Effective Date and &#8212;% if the prepayment occurs on or at any time after the second anniversary of the Effective Date. The SVB Term Loan is secured by substantially all the Company's assets other than the Company's intellectual property. The Company is also obligated to pay a final payment equal to $0.7&#160;million or 2% of the aggregate principal amount of the SVB Term Loan, which is considered fully earned by SVB on the effective date of the Loan and Security Agreement with SVB. This final payment shall be due and payable on the earliest of (i) the maturity date, (ii) the full repayment of the loan, (iii) permitted prepayment and mandatory prepayment upon an acceleration as specified in the agreement or (iv) the termination of the agreement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The final payment is included within the long-term borrowings and is accreted to interest expense using straight-line method over the life of the term loan.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The effective interest rate related to the SVB Term Loan and Solar Term Loan (excluding the write-down of unamortized debt issuance costs and prepayment penalty related to the Solar Term Loan) was 8.5% for both the three and nine months ended September 30, 2021. The effective interest rate related to the Solar Term Loan and Pharmakon Term Loan (excluding the write-down of unamortized debt issuance costs and prepayment penalty related to the Pharmakon Term Loan) was 10.8% and 11.6% for the three and nine months ended September 30, 2020, respectively. </span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">         The table below summarizes the future principal and final fee payments under the SVB Term Loan as of September 30, 2021:</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"><tr><td style="width:1.0%"/><td style="width:84.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.888%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal and final fee payments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,700&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Loan Agreement includes affirmative and negative covenants applicable to the Company and certain of its foreign subsidiaries. The affirmative covenants include, among others, covenants requiring the Company to maintain its legal existence and governmental compliance, deliver certain financial reports, and maintain insurance coverage. The negative covenants include, among others, restrictions regarding transferring collateral, pledging the Company's intellectual property to other parties, engaging in mergers or acquisitions, paying dividends or making other distributions, incurring indebtedness, transacting with affiliates, and entering into certain investments, in each case subject to certain exceptions. As of September 30, 2021, the Company was in compliance with all debt covenants. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">CARES Act</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 27, 2020, the U.S. federal government enacted the &#8220;Coronavirus Aid, Relief and Economic Security (CARES) Act,&#8221; which, among other things, allowed employers to defer the deposit and payment of an employer's share of social security taxes through December 31, 2020. The Company recorded a total liability of $1.0 million related to the deferral of the social security taxes of which $0.5 million is included in each accrued liabilities and other and other long-term liabilities in the condensed consolidated balance sheets as of September 30, 2021 and December 31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393387171272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Compensation Plans<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Incentive Compensation Plans</a></td>
<td class="text">Stock-Based Incentive Compensation Plans <div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the stock option activity for the nine months ended September 30, 2021:</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"><tr><td style="width:1.0%"/><td style="width:62.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of <br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted- <br/>Average <br/>Exercise <br/>Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,405,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.54</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317,001)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.34</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.78</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,063,739&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, the unrecognized compensation cost related to stock options was $1.7 million, which is expected to be recognized over a period of approximately 1.2 years.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no stock options granted during the three months ended September 30, 2020 and nine months ended September 30, 2021. The table below summarizes the weighted average grant date fair value per share and the assumptions used to estimate the grant date fair value using the Black-Scholes option-pricing model of the stock options granted in the nine months ended September 30, 2020:</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.416%"><tr><td style="width:1.0%"/><td style="width:43.673%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.049%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value per share</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.37</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.56%</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Early Exercise of Unvested Stock Options</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Early exercises of stock options under the Company's 2008 Stock Option Plan are subject to a right of repurchase by the Company of any unvested shares. The repurchase rights lapse over the original vesting period of the options. The Company accounts for the cash received in consideration for the early exercised options as a liability included in accrued liabilities, which is then reclassified to stockholders&#8217; equity as the options vest. As of September 30, 2021, the Company had no shares subject to repurchase. As of December 31, 2020, the Company had a total of 5,836 shares of common stock subject to repurchase under the 2008 Stock Option Plan.</span></div><div style="margin-top:18pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes restricted stock units activity for the nine months ended September 30, 2021:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.666%"><tr><td style="width:1.0%"/><td style="width:60.915%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.931%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165,295</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20.07</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049,699</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.56</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445,913)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.19</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171,872)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.84</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597,209</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.48</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, the unrecognized compensation cost related to the restricted stock units was $34.4 million, which is expected to be recognized over a period of approximately 2.9 years.</span></div><div style="margin-top:18pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2018 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) allows eligible employees to purchase shares of the Company's common stock through payroll deductions at the price equal to 85% of the lesser of the fair market value of the stock as of the first date or the ending date of each six month offering period. The offering period generally commences in May and November. On March 26, 2020, the Company's Compensation Committee approved the amendment of the terms of future offerings under the ESPP which, among other things, increased the maximum number of shares that may be purchased on any single purchase date, provided for automatic enrollment in a new offering, and provided that the offering which commenced in May 2020 be twelve months in duration and consist of two purchase periods. The current offering period under the ESPP began on May 17, 2021 and the related purchase will occur on November 15, 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the ESPP shares is estimated using the Black-Scholes option pricing model, which is being amortized over the requisite service period. The Company issued 104,861 shares and 74,685 shares under the ESPP, representing approximately $1.6 million and $1.0&#160;million in employee contributions, for nine months ended September 30, 2021 and September 30, 2020, respectively. As of September 30, 2021 and December 31, 2020, total accumulated ESPP related employee payroll deductions amounted to $0.7 million and $0.4 million, respectively, which were included within accrued compensation and related expenses in the condensed consolidated balance sheets. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the detail of stock-based compensation expense amounts included in the condensed consolidated statements of operations:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.083%"><tr><td style="width:1.0%"/><td style="width:46.253%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,241&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,180&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,528&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,757&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393387228616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share of Common Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share of Common Stock</a></td>
<td class="text">Net Loss Per Share of Common Stock<div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the computation of basic and diluted net loss per share:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,095)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used to compute basic and diluted net loss per share</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,340,093&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,713,418&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,005,904&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,155,561&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.28)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.23)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the Company has reported a net loss in all periods presented, outstanding stock options, restricted stock units, shares subject to repurchase, ESPP purchase rights and common stock warrants are anti-dilutive and therefore diluted net loss per common share is the same as basic net loss per common share for the periods presented. The following anti-dilutive common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented:</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">            </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,063,739</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,504,349</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,063,739</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,504,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597,209</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,173</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597,209</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares subject to repurchase</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,784</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP purchase rights</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,070</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,950</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,070</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock warrants</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,122</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,122</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,122</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813,140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,019,378&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813,140</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,019,378</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393387771384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transaction<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transaction</a></td>
<td class="text">Related Party Transaction <div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2020, the Company entered into a joint development agreement (the &#8220;Development Agreement&#8221;) with SeaSpine Orthopedics Corporation (&#8220;SeaSpine&#8221;) to develop a next generation device for sacropelvic fixation. Mr. Keith Valentine, who serves as the President, Chief Executive Officer and a member of the board of directors of SeaSpine, also serves as a member of the Company's Board of Directors since August 2015. On April 27, 2021, Addendum No.1 to the Development Agreement was entered into by and between the Company and SeaSpine to extend certain obligations as described under the Development Agreement to a consultant of the Company.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the development plan, SeaSpine shall use reasonable efforts to assist in the development of the potential product offering, including licensing certain existing intellectual property to be incorporated into such product. Under the terms of the&#160;Development Agreement, the Company agreed to make monthly payments to SeaSpine to reimburse for full time resources employed by SeaSpine responsible to conduct the development activities. For the three months ended September 30, 2021 and 2020, the Company expensed $5,000 and $40,000, respectively, of the reimbursement charges from SeaSpine. For the nine months ended September 30, 2021 and 2020, the Company expensed $29,000 and $86,000, respectively, of the reimbursement charges from SeaSpine. The reimbursement charges were recorded within research and development expense in the condensed consolidated statements of operations. There were no outstanding liabilities to SeaSpine as of September 30, 2021 and December 31, 2020.</span></div>Certain intellectual property developed pursuant to the project plan will be owned by the Company, certain intellectual property developed pursuant to the project plan will be owned by SeaSpine, and other intellectual property developed pursuant to the project plan will be jointly owned by SeaSpine and the Company. The Company also agreed to provide SeaSpine a royalty-free, worldwide, perpetual, non-exclusive license of certain of the Company's intellectual property incorporated into the product to be developed. The Company also agreed to pay SeaSpine a product royalty, in an amount specified in the Development Agreement, for each resulting product sold for a period of 10 years beginning on the initial market launch. The term of the Development Agreement shall continue until the expiration of all royalty terms, unless earlier terminated by either party, as provided for by the Development Agreement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393387124680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income TaxesIn determining quarterly provisions for income taxes, the Company uses the annual estimated effective tax rate applied to the actual year-to-date profit or loss, adjusted for discrete items arising in that quarter. The Company updates its estimate of its annual effective tax rate at the end of each quarterly period. The estimate takes into account annual forecasted income (loss) before income taxes, the geographic mix of income (loss) before income taxes and any significant permanent tax items. The Company did not have provision for income taxes for the three and nine months ended September 30, 2021 and 2020. The Company continues to maintain a full valuation allowance against its net deferred tax assets due to the uncertainty surrounding realization of such assets. The Company accounts for the uncertainty in income taxes by utilizing a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of any uncertain tax positions that have been taken or are expected to be taken on an income tax return. There had been no changes in the estimated uncertain tax benefits recorded as of December 31, 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393385469208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all of the information required by GAAP for complete financial statements.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">These unaudited interim condensed consolidated financial statements have been prepared on the same basis as the Company&#8217;s annual financial statements and, in the opinion of management, reflect all adjustments that are necessary for a fair statement of the Company&#8217;s consolidated financial information. The results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any other interim period or for any other future year.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are based on historical experience, where applicable and other assumptions believed to be reasonable by the management. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock', window );">JOBS Act Accounting Election</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">JOBS Act Accounting Election</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an emerging growth company under the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), the Company has been eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. The Company has elected to take advantage of the extended transition period for adopting new or revised accounting standards that have different effective dates for public and private companies. As a result, these condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 30, 2021, the Company&#8217;s public float exceeded $700&#160;million and as such the Company will be deemed to be a large accelerated filer under Rule 12b-2 of the Exchange Act, commencing with the Company&#8217;s Annual Report on Form 10-K for the 2021 fiscal year. The Company will retain its current filer status until the end of 2021. As a large accelerated filer, the Company will no longer qualify as an emerging growth company nor be eligible to rely on the benefits afforded to emerging growth companies under the JOBS Act.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text">SegmentsThe Company manages and operates as one reportable segment. The Company derives substantially all of its revenue from sales to customers in the U.S. Revenue by geography is based on billing address of the customer.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards Not Yet Effective</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Effective</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-02, Leases (Topic 842), which requires that lessee's recognize a right-of-use asset and a lease liability for all leases with lease terms greater than twelve months in the balance sheet.&#160;A lease liability is a lessee's obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset is an asset that represents the lessee&#8217;s right to use, or control use of, a specified asset for the lease term for all leases (with the exception of short-term leases) at the adoption date. In July 2018, the FASB issued&#160;ASU&#160;2018-10 and&#160;ASU 2018-11, which provides clarification on the narrow aspects of the guidance and provide an additional transition method to adopt the new leases standard. The new transition method allows an entity to recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. In March 2019, the FASB issued&#160;ASU 2019-01, which provides clarification on implementation issues associated with adopting&#160;ASU 2016-02.&#160;The new leases standard must be adopted using a modified retrospective transition method and allows for the application of the new guidance at the beginning of the earliest comparative period presented or at the adoption date. In November 2019, the FASB issued ASU 2019-10, which revised the mandatory effective dates of the new leases standard. Further, due to the impact of the COVID-19, in June 2020, the FASB issued ASU 2020-05 to further defer the effective date for one year for entities in the &#8220;all other&#8221; categories. For public companies, the new guidance became effective for fiscal years, and for interim periods within those fiscal years, beginning after December&#160;15, 2018. For all other entities, the new guidance is now effective for fiscal years beginning after December&#160;15, 2021 and interim periods within fiscal years beginning after December 15, 2022. Early adoption is still permitted for any interim or annual financial statements not yet issued.  The Company expects to disclose the adoption of this standard for the fiscal year ending December 31, 2021. The Company is currently evaluating the impact of this standard on its consolidated financial statements including the timing of its adoption. The Company anticipates electing several practical expedients that permit the Company not to reassess (1) whether a contract is or contains a lease, (2) the classification of existing leases, and (3) whether previously capitalized initial direct costs would qualify for capitalization under ASC 842. The Company expects that the adoption of this new standard will have a material impact on its balance sheet. The most significant impact would be the recognition of operating lease right-of-use assets and liability. The standard is not expected to have a material impact to the Company's consolidated statements of income and cash flows.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued&#160;ASU 2016-13,&#160;Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. FASB issued ASU 2019-05 in May 2019, ASU 2019-08 and ASU 2019-11 in November 2019 for codification improvements of Topic 326. The new standard revises the accounting requirements related to the measurement of credit losses and will require organizations to measure all expected credit losses for financial assets based on historical experience, current conditions and reasonable and supportable forecasts about collectability. Assets must be presented in the financial statements at the net amount expected to be collected.&#160;In November 2019, the FASB issued ASU 2019-10,&#160;which defers the effective date of&#160;ASU 2016-13&#160;for public companies that are eligible to be smaller reporting companies and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.&#160;In February 2020, the FASB issued ASU 2020-02, which provides guidance regarding methodologies, documentation, and internal controls related to expected credit losses. The Company is currently evaluating the impact of this standard on its consolidated financial statements but does not expect the standard will have a material impact on the Company's consolidated financial statements. The Company expects to disclose the adoption of this standard for the fiscal year ending December 31, 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the FASB issued&#160;ASU&#160;2021-04&#160;&#8220;Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212; Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815- 40) Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#8221; which clarifies and reduces diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options that remain equity classified after modification or exchange. An entity should measure the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as follows: i) for a modification or an exchange that is a part of or directly related to a modification or an exchange of an existing debt instrument or line-of-credit or revolving-debt arrangements (hereinafter, referred to as a &#8220;debt&#8221; or &#8220;debt instrument&#8221;), as the difference between the fair value of the modified or exchanged written call option and the fair value of that written call option immediately before it is modified or exchanged; ii) for all other modifications or exchanges, as the excess, if any, of the fair value of the modified or exchanged written call option over the fair value of that written call option immediately before it is modified or exchanged. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. The Company is currently evaluating the impact of this update on its consolidated financial statements. While the Company does not expect the adoption of ASU 2021-04 to materially impact the Company's consolidated financial statements and related disclosures because it does not currently anticipate modifications to its outstanding equity-classified written call options, the impact on the Company's consolidated financial statements and disclosures will depend on the facts and circumstances of any specific future transactions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Emerging Growth Company, Extended Transition Period Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393387094120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Revenue by Geography</a></td>
<td class="text">The table below summarizes the Company's revenue by geography:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"><tr><td style="width:1.0%"/><td style="width:46.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.086%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.605%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,286&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,373&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,922&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,243&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393385370008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the marketable securities:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"><tr><td style="width:1.0%"/><td style="width:36.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.242%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.242%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.486%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,218&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,218&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,206&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,206&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"><tr><td style="width:1.0%"/><td style="width:36.620%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.084%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.029%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,779&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,776&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,851&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,204&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,199&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393388594936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Marketable Securities Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the fair value of the Company&#8217;s marketable securities measured at fair value on a recurring basis based on the three-tier fair value hierarchy:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.888%"><tr><td style="width:1.0%"/><td style="width:45.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,370&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,370&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,361&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,845&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,206&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,724&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,475&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,199&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393387176824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"/><td style="width:66.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,692&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,247&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,484&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,913&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,527&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities and Other</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.916%"><tr><td style="width:1.0%"/><td style="width:66.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and related expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accrued professional services </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,425&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,199&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393479509656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Aggregate Future Minimum Lease Payments</a></td>
<td class="text">The table below summarizes aggregate future minimum lease payments under all leases as of September 30, 2021: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.722%"><tr><td style="width:1.0%"/><td style="width:81.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.231%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,641&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393387228056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Outstanding Borrowings</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding borrowings from the term loan described below, as of the dates presented:</span></div><div style="margin-bottom:12pt;margin-top:9pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.583%"><tr><td style="width:1.0%"/><td style="width:66.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.558%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.405%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal outstanding and final fee</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(661)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unaccreted value of final fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(671)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(884)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding debt, net of debt issuance costs and unaccreted value of final fee</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,922&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,455&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Classified as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term borrowings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,922&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,455&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Future Principal and Final Fee Payments</a></td>
<td class="text">The table below summarizes the future principal and final fee payments under the SVB Term Loan as of September 30, 2021:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.388%"><tr><td style="width:1.0%"/><td style="width:84.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.888%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal and final fee payments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,700&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393393446648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Compensation Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the stock option activity for the nine months ended September 30, 2021:</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.444%"><tr><td style="width:1.0%"/><td style="width:62.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of <br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted- <br/>Average <br/>Exercise <br/>Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,405,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.54</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317,001)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.34</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.78</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,063,739&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Valuation Assumptions Related to Stock Option Awards</a></td>
<td class="text">The table below summarizes the weighted average grant date fair value per share and the assumptions used to estimate the grant date fair value using the Black-Scholes option-pricing model of the stock options granted in the nine months ended September 30, 2020:<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.416%"><tr><td style="width:1.0%"/><td style="width:43.673%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.049%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value per share</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.37</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.56%</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Restricted Stock Unit Activity</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes restricted stock units activity for the nine months ended September 30, 2021:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.666%"><tr><td style="width:1.0%"/><td style="width:60.915%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.931%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165,295</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20.07</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049,699</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.56</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445,913)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.19</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171,872)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.84</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597,209</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.48</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Stock-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the detail of stock-based compensation expense amounts included in the condensed consolidated statements of operations:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.083%"><tr><td style="width:1.0%"/><td style="width:46.253%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,241&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,180&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,528&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,757&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393387485960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share of Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Net Loss per Share</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the computation of basic and diluted net loss per share:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,095)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used to compute basic and diluted net loss per share</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,340,093&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,713,418&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,005,904&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,155,561&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.28)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.23)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Anti-dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss per Share</a></td>
<td class="text">The following anti-dilutive common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented:<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">            </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,063,739</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,504,349</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,063,739</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,504,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597,209</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,173</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597,209</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares subject to repurchase</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,784</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP purchase rights</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,070</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,950</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,070</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock warrants</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,122</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,122</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,122</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813,140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,019,378&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813,140</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,019,378</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393389532024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and Nature of Business (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=sibn_FollowOnPublicOfferingMember', window );">First follow-on public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds from sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,490,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Public offering price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AllocatedPublicOfferingCosts', window );">Allocated public offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=sibn_FollowOnPublicOfferingAndSecondaryOfferingMember', window );">First follow-on public offering and secondary offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering', window );">Number of shares in transaction, including shares in secondary offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Underwriters option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued (in shares)</a></td>
<td class="nump">478,507<span></span>
</td>
<td class="nump">645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=sibn_SecondaryOfferingMember', window );">Secondary offering by selling shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued (in shares)</a></td>
<td class="nump">190,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Public offering price (in dollars per share)</a></td>
<td class="nump">$ 22.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AllocatedPublicOfferingCosts', window );">Allocated public offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=sibn_SecondFollowOnPublicOfferingMember', window );">Second follow-on public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds from sale of stock</a></td>
<td class="nump">$ 71.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued (in shares)</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Public offering price (in dollars per share)</a></td>
<td class="nump">$ 22.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_AllocatedPublicOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allocated Public Offering Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_AllocatedPublicOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Number Of Shares Issued In Transaction, Including Shares In Secondary Offering</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=sibn_FollowOnPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=sibn_FollowOnPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=sibn_FollowOnPublicOfferingAndSecondaryOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=sibn_FollowOnPublicOfferingAndSecondaryOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=sibn_SecondaryOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=sibn_SecondaryOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=sibn_SecondFollowOnPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=sibn_SecondFollowOnPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393385388840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393389910456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Revenue by Geography (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 22,286<span></span>
</td>
<td class="nump">$ 20,373<span></span>
</td>
<td class="nump">$ 64,922<span></span>
</td>
<td class="nump">$ 51,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">20,392<span></span>
</td>
<td class="nump">18,924<span></span>
</td>
<td class="nump">59,391<span></span>
</td>
<td class="nump">47,442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 1,894<span></span>
</td>
<td class="nump">$ 1,449<span></span>
</td>
<td class="nump">$ 5,531<span></span>
</td>
<td class="nump">$ 3,801<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393389278152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Carrying Value</a></td>
<td class="nump">$ 54,218<span></span>
</td>
<td class="nump">$ 47,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">100,988<span></span>
</td>
<td class="nump">142,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Aggregate Fair Value</a></td>
<td class="nump">100,988<span></span>
</td>
<td class="nump">142,851<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_MarketableSecuritiesAmortizedCost', window );">Total marketable securities, Amortized Cost</a></td>
<td class="nump">155,206<span></span>
</td>
<td class="nump">190,204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Total marketable securities, Unrealized Gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Total marketable securities, Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_MarketableSecuritiesFairValue', window );">Total marketable securities, Aggregate Fair Value</a></td>
<td class="nump">155,206<span></span>
</td>
<td class="nump">190,199<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Carrying Value</a></td>
<td class="nump">54,218<span></span>
</td>
<td class="nump">45,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">52,140<span></span>
</td>
<td class="nump">74,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Aggregate Fair Value</a></td>
<td class="nump">52,143<span></span>
</td>
<td class="nump">74,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">15,373<span></span>
</td>
<td class="nump">8,940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Aggregate Fair Value</a></td>
<td class="nump">15,370<span></span>
</td>
<td class="nump">8,938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">33,475<span></span>
</td>
<td class="nump">59,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Aggregate Fair Value</a></td>
<td class="nump">$ 33,475<span></span>
</td>
<td class="nump">$ 59,137<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available For Sale Debt Securities, Current, Accumulated Gross Unrealized Gain Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available For Sale Debt Securities, Current, Accumulated Gross Unrealized Loss Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available For Sale Debt Securities, Current, Amortized Cost Basis</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Accumulated Gross Unrealized Gain, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Accumulated Gross Unrealized Loss, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_MarketableSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amortized cost for marketable securities included in cash equivalents and investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_MarketableSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_MarketableSecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total aggregate fair value for marketable securities included in cash equivalents and investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_MarketableSecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393390048552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement (Details) - Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">$ 155,206<span></span>
</td>
<td class="nump">$ 190,199<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">54,218<span></span>
</td>
<td class="nump">45,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">52,143<span></span>
</td>
<td class="nump">74,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">15,370<span></span>
</td>
<td class="nump">8,938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">33,475<span></span>
</td>
<td class="nump">60,537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">106,361<span></span>
</td>
<td class="nump">120,724<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">54,218<span></span>
</td>
<td class="nump">45,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;1 | U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">52,143<span></span>
</td>
<td class="nump">74,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;1 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">48,845<span></span>
</td>
<td class="nump">69,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;2 | U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;2 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">15,370<span></span>
</td>
<td class="nump">8,938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">33,475<span></span>
</td>
<td class="nump">60,537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3 | U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393387872248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 14,247<span></span>
</td>
<td class="nump">$ 9,484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="num">(6,334)<span></span>
</td>
<td class="num">(4,957)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">7,913<span></span>
</td>
<td class="nump">4,527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">9,650<span></span>
</td>
<td class="nump">6,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">2,906<span></span>
</td>
<td class="nump">1,692<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember', window );">Construction in progress, surgical placement instrument set</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ConstructionInProgressSantaClaraLeaseMember', window );">Construction in progress, Santa Clara lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ComputerAndOfficeEquipmentMember', window );">Computer and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">878<span></span>
</td>
<td class="nump">714<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">503<span></span>
</td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 310<span></span>
</td>
<td class="nump">$ 233<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ConstructionInProgressSantaClaraLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ConstructionInProgressSantaClaraLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ComputerAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sibn_ComputerAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393392680056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393392684376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Accrued Liabilities and Other (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities and Other</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and related expenses</a></td>
<td class="nump">$ 8,501<span></span>
</td>
<td class="nump">$ 9,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional services</a></td>
<td class="nump">719<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Others</a></td>
<td class="nump">1,205<span></span>
</td>
<td class="nump">513<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities and other</a></td>
<td class="nump">$ 10,425<span></span>
</td>
<td class="nump">$ 10,199<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393389136680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>ft&#178; </div>
<div>renewal_option</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_OperatingLeaseTermOfWrittenNoticeForTermination', window );">Operating lease, term of written notice for termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">six months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Purchase commitments related to inventory management and training materials</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">New lease, area (in square feet) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend', window );">Lease renewal, number of options to renew | renewal_option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1', window );">Optional lease renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember', window );">Indemnification Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Costs to defend lawsuits or settle claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Liability associated with indemnifications</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Options To Extend</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_OperatingLeaseTermOfWrittenNoticeForTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Term Of Written Notice For Termination</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_OperatingLeaseTermOfWrittenNoticeForTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:timeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal for lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393392704360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract', window );"><strong>Aggregate Future Minimum Lease Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="nump">$ 378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2022</a></td>
<td class="nump">1,641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2023</a></td>
<td class="nump">1,559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2024</a></td>
<td class="nump">1,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2025</a></td>
<td class="nump">987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">540<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">$ 6,615<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Leases, Future Minimum Payments, Due After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393392641192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Summary of Borrowings (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding and final fee</a></td>
<td class="nump">$ 35,700<span></span>
</td>
<td class="nump">$ 41,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Less: Unamortized debt issuance costs</a></td>
<td class="num">(107)<span></span>
</td>
<td class="num">(661)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Unaccreted value of final fee</a></td>
<td class="num">(671)<span></span>
</td>
<td class="num">(884)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding debt, net of debt issuance costs and unaccreted value of final fee</a></td>
<td class="nump">34,922<span></span>
</td>
<td class="nump">39,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term borrowings</a></td>
<td class="nump">$ 34,922<span></span>
</td>
<td class="nump">$ 39,455<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393382000056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 12, 2021</div></th>
<th class="th"><div>May 29, 2020</div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from debt financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="nump">$ 45,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments of prepayment penalty and lender fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="nump">$ 843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Final fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_SocialSecurityTaxEmployerDeferralCARESAct', window );">Accrued liabilities and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_SocialSecurityTaxEmployerDeferralCARESAct', window );">Accrued liabilities and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_SocialSecurityTaxEmployerDeferralCARESAct', window );">Accrued liabilities and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term loan | Pharmakon Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from debt financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod', window );">Debt period payment, interest only period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">35 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate during the period (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term loan | Pharmakon Term Loan | Prepayment Penalty, 31-48 Months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_DebtInstrumentPrepaymentPenaltyPercentage', window );">Debt prepayment penalty percentage (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term loan | Pharmakon Term Loan | Prepayment Penalty, 49-60 Months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_DebtInstrumentPrepaymentPenaltyPercentage', window );">Debt prepayment penalty percentage (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term loan | Solar Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod', window );">Debt period payment, interest only period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments of prepayment penalty and lender fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement', window );">Allowable prepayment increments per agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage', window );">Prepayment premium in year one (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage', window );">Prepayment premium in year two (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage', window );">Prepayment premium in year three or later (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Final fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal', window );">Final fee as percentage of aggregate principal amount (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate during the period (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.80%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="nump">10.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term loan | Solar Term Loan | Basis spread option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term loan | SVB Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate (percent)</a></td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments of prepayment penalty and lender fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Final fee</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal', window );">Final fee as percentage of aggregate principal amount (percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate during the period (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term loan | SVB Term Loan | Prepayment Penalty, 1-24 Months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_DebtInstrumentPrepaymentPenaltyPercentage', window );">Debt prepayment penalty percentage (percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term loan | SVB Term Loan | Prepayment Penalty, 24 Months On</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_DebtInstrumentPrepaymentPenaltyPercentage', window );">Debt prepayment penalty percentage (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term loan | SVB Term Loan | Prime Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Fee Amount As Percentage Of Aggregate Principal</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Interest Only Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment, Allowable Increments Per Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtInstrumentPrepaymentPenaltyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Penalty Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtInstrumentPrepaymentPenaltyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Premium Year One, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Premium Year Three Or Later, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Premium Year Two, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_SocialSecurityTaxEmployerDeferralCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Social Security Tax, Employer, Deferral, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_SocialSecurityTaxEmployerDeferralCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sibn_PharmakonTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sibn_PharmakonTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtPrepaymentPenaltyPeriodAxis=sibn_PrepaymentPenalty3148MonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtPrepaymentPenaltyPeriodAxis=sibn_PrepaymentPenalty3148MonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtPrepaymentPenaltyPeriodAxis=sibn_PrepaymentPenalty4960MonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtPrepaymentPenaltyPeriodAxis=sibn_PrepaymentPenalty4960MonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sibn_SolarLoanAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sibn_SolarLoanAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=sibn_VariableOptionOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=sibn_VariableOptionOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sibn_SVBTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sibn_SVBTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtPrepaymentPenaltyPeriodAxis=sibn_PrepaymentPenalty124MonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtPrepaymentPenaltyPeriodAxis=sibn_PrepaymentPenalty124MonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_DebtPrepaymentPenaltyPeriodAxis=sibn_PrepaymentPenalty24MonthsOnMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_DebtPrepaymentPenaltyPeriodAxis=sibn_PrepaymentPenalty24MonthsOnMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393384334488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Debt Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Future principal and final fee payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2021 (remaining three months)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">7,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">17,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">10,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total principal and final fee payments</a></td>
<td class="nump">$ 35,700<span></span>
</td>
<td class="nump">$ 41,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturitiesOfLongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturitiesOfLongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393389197336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Compensation Plans - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>purchase_period </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost, stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase', window );">Early exercise of stock options, share subject to repurchase (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,836<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock related to employee stock purchase plan</a></td>
<td class="nump">$ 1,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, expected period for recognition (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, expected period for recognition (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sibn_A2018EmployeeStockPurchasePlanMember', window );">2018 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock as a percent of fair market value (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval', window );">Employee stock purchase program offering period interval (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods', window );">Number of purchase periods in offering interval | purchase_period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock related to employee stock purchase plan (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,861<span></span>
</td>
<td class="nump">74,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock related to employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and related expenses for employee payroll deductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period Interval</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Early Exercise, Common Stock Subject To Repurchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred for employer-related costs classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherEmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sibn_A2018EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sibn_A2018EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393385415016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Compensation Plans - Stock Option Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning of period (in shares) | shares</a></td>
<td class="nump">2,405,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(317,001)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Canceled and forfeited (in shares) | shares</a></td>
<td class="num">(25,217)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, end of period (in shares) | shares</a></td>
<td class="nump">2,063,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">7.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled and forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">15.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393479395416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Compensation Plans - Valuation Assumptions for Stock Options (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Black-Scholes option-pricing model assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value per share (in dollars per share)</a></td>
<td class="nump">$ 8.37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Black-Scholes option-pricing model assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum (percent)</a></td>
<td class="nump">46.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum (percent)</a></td>
<td class="nump">47.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum (percent)</a></td>
<td class="nump">1.56%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum (percent)</a></td>
<td class="nump">1.64%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Black-Scholes option-pricing model assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Black-Scholes option-pricing model assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393389583064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Compensation Plans - Restricted Stock Units Activity (Details) - Restricted Stock Units<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning of period (in shares) | shares</a></td>
<td class="nump">1,165,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">1,049,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(445,913)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares) | shares</a></td>
<td class="num">(171,872)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, end of period (in shares) | shares</a></td>
<td class="nump">1,597,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 20.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">29.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">21.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">24.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 25.48<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393389154232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Incentive Compensation Plans - Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 4,241<span></span>
</td>
<td class="nump">$ 3,180<span></span>
</td>
<td class="nump">$ 12,528<span></span>
</td>
<td class="nump">$ 8,757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">432<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">2,153<span></span>
</td>
<td class="nump">1,488<span></span>
</td>
<td class="nump">6,177<span></span>
</td>
<td class="nump">3,976<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">434<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
<td class="nump">827<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1,526<span></span>
</td>
<td class="nump">$ 1,306<span></span>
</td>
<td class="nump">$ 4,662<span></span>
</td>
<td class="nump">$ 3,711<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393469124632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share of Common Stock - Computation of Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (15,872)<span></span>
</td>
<td class="num">$ (13,981)<span></span>
</td>
<td class="num">$ (12,242)<span></span>
</td>
<td class="num">$ (9,474)<span></span>
</td>
<td class="num">$ (12,472)<span></span>
</td>
<td class="num">$ (12,772)<span></span>
</td>
<td class="num">$ (42,095)<span></span>
</td>
<td class="num">$ (34,718)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares used to compute basic net loss per share (in shares)</a></td>
<td class="nump">33,340,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,713,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,005,904<span></span>
</td>
<td class="nump">28,155,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of common shares used to compute diluted net loss per share (in shares)</a></td>
<td class="nump">33,340,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,713,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,005,904<span></span>
</td>
<td class="nump">28,155,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in usd per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.28)<span></span>
</td>
<td class="num">$ (1.23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in usd per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.28)<span></span>
</td>
<td class="num">$ (1.23)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393388920008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share of Common Stock - Antidilutive Common Stock Equivalents Excluded from Computation of Earnings Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock equivalents excluded from computation of diluted net loss per share (in shares)</a></td>
<td class="nump">3,813,140<span></span>
</td>
<td class="nump">4,019,378<span></span>
</td>
<td class="nump">3,813,140<span></span>
</td>
<td class="nump">4,019,378<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock equivalents excluded from computation of diluted net loss per share (in shares)</a></td>
<td class="nump">2,063,739<span></span>
</td>
<td class="nump">2,504,349<span></span>
</td>
<td class="nump">2,063,739<span></span>
</td>
<td class="nump">2,504,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock equivalents excluded from computation of diluted net loss per share (in shares)</a></td>
<td class="nump">1,597,209<span></span>
</td>
<td class="nump">1,250,173<span></span>
</td>
<td class="nump">1,597,209<span></span>
</td>
<td class="nump">1,250,173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_ShareSubjectToRepurchaseMember', window );">Shares subject to repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock equivalents excluded from computation of diluted net loss per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,784<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,784<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_EmployeeStockPurchasePlanSharesMember', window );">ESPP purchase rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock equivalents excluded from computation of diluted net loss per share (in shares)</a></td>
<td class="nump">34,070<span></span>
</td>
<td class="nump">138,950<span></span>
</td>
<td class="nump">34,070<span></span>
</td>
<td class="nump">138,950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_CommonStockWarrantsMember', window );">Common stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock equivalents excluded from computation of diluted net loss per share (in shares)</a></td>
<td class="nump">118,122<span></span>
</td>
<td class="nump">118,122<span></span>
</td>
<td class="nump">118,122<span></span>
</td>
<td class="nump">118,122<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_ShareSubjectToRepurchaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_ShareSubjectToRepurchaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_EmployeeStockPurchasePlanSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_EmployeeStockPurchasePlanSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sibn_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140393478336696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transaction (Details) - SeaSpine - Joint development agreement - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Reimbursement charges expensed</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="nump">$ 86,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Outstanding liability to SeaSpine</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sibn_RelatedPartyTransactionTermOfAgreement', window );">Term of product royalty sales period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sibn_RelatedPartyTransactionTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Term Of Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sibn_RelatedPartyTransactionTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sibn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=sibn_DevelopmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=sibn_DevelopmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>60
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ME+)ELLW5 W_YPAI"]007/)?U7_328/$(+;92\:()UC,HLG+W/_G9"+$7H//
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MG>4/ =$(,\20XY+GFM5\GUOEQ_"''-AV>_TAUV3FQ[I+/<0?;KZ,]P8=\(>
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MK@DFO=/;_7 U,,4^3T-Y3RN!CDW8P$.,HM2TZ1N=S[$!5:F*L'UM #IN.C9
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M:D-M%<^T0]FL]-%AIK!'$SK-M*QE^FNN SY#J=Q %E1,YQ&;V=J9@CU[^#C
M\<AJIE0<!9'=9E&/,G*BO.*0BU/!V@Q79(AM9%6+/Y-0(Q,J)>$(J2D4Q:$=
M:-P#C9U +U@&R?*N1OQ)FY+;L,7&LMX(F"F!26 'EO3 $B>P\S2M>&.^M_NV
M>X?D"F5"I7);U C> F?]XC6[ W]4/-U6EG!LM4A,"WO!V,*FT-R?L+#O#9G9
M<ZKRG;-<_ %_O6<Z,%Z!N9O897J+R)R2"<A[9.*[K;]G\L;BVD6$4EM6I!SB
M3M5VO+[%$>@8L47(HQ.(\8 8.Q%_T8D(P/(GG72V0JUUQMIAMX+%ID?$=)P=
M;%(!F8([<(I/CH*K&#B!3A#@TZ6$.XVXK'3VK)^;%_SW5I1:%ZL.Q$!'/,/@
MIA"F$Z3@#W3E4S<MKEEQS]4HURO%@28T[ERP.Y$?S/O^0$-^<"@CZ*!7FH&X
M>-#A8S5)8 GTT @;4RJ<BIJ!FGPW-WTN'F"?9/5LQ67RS)P&=,SA%C%")MC(
M'^C(=_/1;<5+)K)=EF]W2-9K7G5;9D5L\DWH&X:T,5><3  >:,EW\U*_V25[
MGMQIDW8H-NQI$9I,Z0,Y^8?9:<M?./E@4BM6DUD(-FQIH1_L1=B.%@\$A-T$
M='-,<69#C2WD@L/83T; K7(XBKT)Y ,/8?]5M;> "%/'U]YXH _LIH^OK.YX
M6"?@HPD:6]C!BV@R3L$6N1#V?\H^ XU@-XTL@3Y>B=@D@[$;6D2@;DZFW'!@
M#.SN<&ZW5;IFZK6 J>E;81A&8Z*VRB4^G:A#\< [V,T[+V ?3\W89)@Y#7W#
M,RQB?D0G"@P\<!%V<U$?\X#X04!CCNZ>CPB?#KN%A$)HI\?833&:>!,TB@>R
MPM&K@GXE"B@[CP_Z@62PFV1N*YERGNV6D3FL.8>BK-S>Y2*%[5[Q"I9]WW2W
ML/G;(N/5HW95P+)K0M1[W8=NH#B&6KEC@6[@=*&,#_=4%I$0)]%$W88'ZL)N
MZGJI=%/8]P:V0K4P5^!Y!EQ3C : UPZ7#-Q%#C5/4 &T'Q]V?8@3+K'U0[Z)
MURKG #Q0%G&W3K=CN(?;)F)V1'/?]\>(+5)1,$$A9& ^XF:^?;QEM;,V@CJ1
MY5V>R[EV?+3B]FQ!3'*;!]XX/]NDXJE.E>Q]G',SX$MW[FT-RNBHU!V6_F#4
MAB[BFS*7SYQW#\LNLZ,R9]:O,L3"A$$X_FA@D4H2?T*Q@2W) ;9\H1C4E5"\
M\RH5JE&N54"6ND&W;XI)AYC@: S=E$KBJ1 8&).X&=/*/6^[XO/=$?F\4\%"
MC3C"AOEMK1R9ZN;(P*#$S:#7D,73)N_SI[1I=A$4S1#&7>,+OM4HJ2.DN=#E
MP ,49,5$E%L:0!*-^Q6+5#11PI"!48F[_=,;(HJTXMK9Q6MQ6]I '(]K 8L4
M#8)P*@P&CB;QX6+ !A6QVE$$D($/B9L/+_B]* KMC3H! F_+S&H%D]\"$L1&
MDK9]9J13'T/I0(/438/735GAP$=-/@N2>"\*NB,"BUB0)!,-,1U8C[H;M>6V
M+'.NF8/E36F42[6MFE15R&+>;)XHVM-*XQ/XRS4'YJ)NYOJ[JV5UA+(J?^X3
M9'8X/5*3C8SD:)$))YH@.O 5=?/5SZ+Y$%/^OZ:BFWS_B(=&XY;"(H2#\0XO
M]HX:-[RZ;TY@%6I*VO:HKG_:G_*>-V>;H^<7_L?+]JQVF*8].O[**@@M!>7#
M"J;T/D1@R:H]C6UO:EDV!YIWLJ[EIKE<<P9$K07@_4K*>G>C%^C/Q,_^ U!+
M P04    " !5@6E3PYE("V@%   +#@  &    'AL+W=O<FMS:&5E=',O<VAE
M970W+GAM;,576V_;-A3^*X17[ *XLGQ+TC8)T*0MEH>V0;UL#\,>&.K8XB*1
M*DG5S7[]OD-*2M*ZWHH5V(ME4CS?^<Z=.MY:=^-+HB ^UI7Q)Z,RA.;I9.)5
M2;7TF6W(X,W:NEH&+-UFXAM'LHA"=369Y?G!I);:C$Z/X]ZE.SVV;:BTH4LG
M?%O7TMV>466W)Z/IJ-]XIS=EX(W)Z7$C-[2B<-5<.JPF TJA:S)>6R,<K4]&
MSZ=/SQ9\/A[X5=/6W_LOV))K:V]X<5&<C'(F1!6IP @2CP]T3E7%0*#QOL,<
M#2I9\/[_'OU5M!VV7$M/Y[;Z31>A/!D=C41!:]E6X9W=_DR=/4O&4[;R\5=L
MN[/Y2*C6!UMWPF!0:Y.>\F/GAW\C,.L$9I%W4A19OI!!GAX[NQ6.3P.-_T13
MHS3(:<-!606'MQIRX?27DL2YK1MI;H4TA7@C0^M(V+4X:SW.>G\\"=##IR>J
MPSQ+F+,O8#X1KZT)I1<O34'%0_D)^ TD9SW)L]E>P!4UF9CG8S'+9],]>//!
MZ'G$FW\![ZW;2*/_DIP78YAOO*UT(5.:P F7CCR9D#;@BE?:2*.TK,0*FX2<
M#%[\_OS:!X>L^F,/H\7 :!$9+;YI&/XKIEA=/#Y[^^;E6%P8E8D? R2^_^YH
M-LN?=8)Q-7WVD]A*+[11UC76P04%%H*/>W8(8[Z@2FXEXQOQ6CI5BND1!RP_
MBLJU%R5ZQOM6ND NR:\D?"S.*^DDHB KC1YCM,S$?>80E**F0BNXOZ /6I%0
MW;M0RB!*,&L0*(JP4C3.-DY30(OA@M&UK"K F _2H_[1?=PF8NFZJ4! ^%N/
MD(I@Q;KUE(R2REE=::G$GU;C#(B)@)X7./1L+9^JK0],I8;%X;8ASR\^$RVT
MMZX@YQ-;)5D)6B%Q-U$WHD'C_,1B$YPM6L5.0I[!&&Z7;!<VPSCJUJ\8YJ(S
M815-& NPC"_&[%VX_DD?I:MLE76;TYR?BER0_+0MM&GR_<F7+=Q'TH@K$XLC
MQB[*+??*H6(&QZ /5T6&G(JKM79XU06>CZ"(\V1%;[$C18A-(1X=S+,<4:NJ
MKO(,QA(,5T2%%VMGZ^B2!+FV%?SX& >;]KK2"N?7Y+39L.!B/,_S<9[GPI?(
M2M]SZU3^X/O(H<.JFS&_WI8:63L;+YY <#GO!1$I2M"<7G 'FD4AKF_OPR4_
M\09])*>TCR71HOVYK=.P&_IL$]L)\JQI41Z8),F@\*!,A2P*S0>1H0>+Y5=8
M@.22GWD"R:,BET>S:;;,18,01+B4<L$&Z/E42"&Q8[6WKJM498WIQNA6AS+%
M=7#_(!A=A7*S*K8(GI8%]P,^OG'6^[M8#B%_Z,C!CQ8_H(IIS<"1<@F_<QUQ
MDV:@QZ[7HGTF+G<8$0W/L\6047?<$(8>G*LV>?@3+MSS$"BWX<!OD/9 W&?*
M$,[/7;.;G^\(SKZ2X$ZW,%M0L1M,-B:,AN.D\3*%+:GCX"&<&S+D$'AVMBRX
M2?(DX^L1\A?7/4^^#YL:AB,P_=WT R?T"1='Y- $;DDZ03ST,0X4U=<(X7P:
MQW8>^\%;%2QO[FL!A]/LX)];@(>E8+^W!WQEY<^YV.X7W/]7^8O#H_$R/_Q&
ME3_+\@>5?W&GBTG%C$J*=AB88JMW>+Q7-7Z8D\PIY62"FSYLIWMM 6M,>-MZ
M3.R2[KCL D]61RL[(P87[+#Y_H M="&,#7W."=Y[F&'I$E#1'OV9>*?]C8_A
MOS+=7 R8B+MN@Y-[%_2:T%#X,\2G*9KNZL/N\*7S/%WP[XZGSR3<K3;H1**B
M-43S[' Y$BY]>J1%L$V\[E_;@(^'^)=O7N3X -ZOK0W]@A4,WW^G?P-02P,$
M%     @ 58%I4RU&RMM+$   N3   !@   !X;"]W;W)K<VAE971S+W-H965T
M."YX;6R]6VUSVS82_BL87^_.GI%D2983YW7&=IUK>DV3B9IV;F[N T5"$BXD
MH0*D%?77W[.[ $G)DA.GUWZ))1%8[/L^NV">KZW[Z)=:5^I3D9?^Q=&RJE9/
M3T]]NM1%X@=VI4L\F5M7)!6^NL6I7SF=9+RIR$_'P^&CTR(QY='+Y_S;._?R
MN:VKW)3ZG5.^+HK$;:YT;M<OCD9'\8?W9K&LZ(?3E\]7R4)/=?5A]<[AVVE#
M)3.%+KVQI7)Z_N+H<O3T:D+K><'/1J]]Y[,B26;6?J0OK[,71T-B2.<ZK8A"
M@C^W^EKG.1$"&[\&FD?-D;2Q^SE2?\6R0Y99XO6US7\Q6;5\<71QI#(]3^J\
M>F_7W^D@SSG12VWN^5^UEK63LR.5UKZR1=@,#@I3RM_D4]!#9\/%\,"&<=@P
M9K[E(.;RVZ1*7CYW=JT<K08U^L"B\FXP9THRRK1R>&JPKWHY%6,H.U=3LRC-
MW*1)6:G+-+5U69ERH=[9W*1&^^>G%<ZC7:=IH'TEM,<':#]1;VQ9+;VZ*3.=
M;>\_!9\-L^/([-7X7H)3O1JHLV%/C8?CT3WTSAKASYC>V0%Z>Z14_[Z<^<K!
M6?YSSP&3YH )'S#Y0[3[_Z*MKA)O/"U\Y[37995(0)09?C!E:E:YYL?7MO38
MD\GSGY8:09/:8I64&Z)7ETF=F4IG*K6P:.GE4]B"+W-3)B"7Y,KC#(W8K;Q:
M)K=:S;0N%;+&*G%89THF[#*LUG#X:JD6NM0NR?,-/=$KHI:TDJQ:-K&W F,?
M2F9D2N<P[Y>%=M" .O[;7R[&X^&S#X/I0/WC\O(=?Q\].V%YD]4*.DEFN5:N
M)G+TH].+.F>9F1*1G^JT=J8R8<7-IW29E L-#16%\9R1XD'3F^OF"%!*7$8<
MF[("/T5')1#>.I)FH"Z]6FE7F(I$J*%*AT.M#SSU5*I=A7RJYM96I64!G;+@
MRW7HF5)2,O%2+9-*0;6JI)](BT[_6AO2]6RC&E5T;-%:D$@+*SU1$5L&?((*
MJ6*6Y&PFJ1$)J^A;G>IB!G;.1AR,0U#V0AC"(,W"%YPM>'_'9S[C*9"!!:$E
M:E;C@X7H4 !D3?,Z ZT\CQ;JBM\5EN7$(T6.FVM0VG?6@+P;"F]=.AKL=[JV
M%??T24&:H["#8NB7:XDC<I71XV?D5F4-:OL54<(6P='MRI0D(\0NDA)UDI;T
MJ!Y286.-)-E_42AD:^L),)'WE"!(&8F:)\:U9T0M[G)U0.:.LEES.-ZC[+$O
M !^X$#QT$E&MEDYK=J8224L54@4T50%$%H);?"<D\N"X5<.R@>>9,D.<4L6.
MK,8C*PN5*_UI!?&)R7#F1B>.CJ#@VW7/$3DYJZ'<A#B*Y@;SQF9WG\_KJG9"
M=7 W$S[$2?S2UGE&/!-H(K-BSW_K4E ))[]NF!QR".S.^1!)",2DABIVQ<>"
MN\&) RF?2.;=9_9+<<;WG*+(APGQJ-&P_T_PDV-?PR:R'3U_D[ATB06BWH'Z
MX-E.-[XR!6=D4ID$A80H'NZ53-1!WF6JC1S3IJL0U[[C^63^(OD(!VB.XJ3E
M@2I7XH42 O,YA8<X#DE%!:6@>L).B_4ZZ#4WR<SD;:[/C$]SZ\GZ6$BJ@\7I
MY$-[FJ+!>2M\/FC&0QPY?:O+6J*&G!O>Y56&(@1W:_=P,627'72430%$T)33
MS]( -%(IS)F.,QK9NZ?6Y##=^D<'B:]WE3?3N=&4OR7,X++>EKQ^)N6@-07J
M6%K57-DD,E-V],Q ]2[F?ZIJC:D&GT4J/^UQ3M_9T\4$<0])'XSV=1[^!2'$
M.0#GM!F_)#^D' *J @XX-55<5O:P.5#?O[V:DLJZ@M_$[N22O$-!KVY!OR\
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M.EUVPK0O9=5^Q;?.#SV!:7A$(.X$8H^[->11OA1.7%\:O0+#W*2-%_ZJ7IK
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MR<$T4E%E)(/28/[4/@.5.1K;G6]MSP\J(C4+0LIEUF#K'>+-D<(K.6MX:"2
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MC)Q(O S]:+F$USY-P>B;3W1V[F6CP57D[O,_6(?'TV7W9GA>WKV\* 4[^A*
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MZX\^0;1:[8D8 TFXC&80A[-EXBGI+$5S6*JJ.)'U!+F8+V >9_ !Z=372I3
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M]]Q_8MO1EK6P\JTNOZC"[<XGRPD4<B/:TGW4^W_(SIXY\<MU:?D7]GYO.IM
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M=;(>X'RZ^*4-XAV&Q:H[7R^XLI'F"+$>4[]9A*VLL4!*C F9)S%5+>'@+^+
M^?HK!I(R*X0/M(@>@F1Q#\J@>TX&8WRIE',8( X\P30/'"BAX(-!9Q.U6S9P
MT[K6'-4;-S$*H<^Y !EHU%WC,GVCC0'A-QZE;2<"SW6J:BNH!TCHXNEV&)@*
M[<),[6.-J5ES,Z.)ICRNLTL#(,T580ZAD6CQ'(G6Y>AV"CF;02T#:CPW]XH'
M[+:!D(6ZL=]]\?3.+GIG,]2@9FXOR]L!\? CCI7>I<27^YSUWMN/4M8'LVN;
M>6N,=_%IJ+_QZ%INL5:T%X_3OT>8?C3LP6$0L<?J!YTC<Z+I\P)/ N,A=31A
M=0%F45T$"#&ZZ;+XP1 ))T/D"'+6D@&RTL8=@<8KC#W7(K0"'=^H],9IWS=#
MA1,O07>4!LM%W"M&1F=IL%C.^Y537P74#>E<6//(<HIE>.Q8]-C(G' A&A8P
M@CW*4/008=<MPT3 2?64]L9,OQ]U22E+^(M#4'EX>*Y@\OMF!)X(<.!IJ];'
MFF/5!W[0^CZ$JV@>\[C_+#J>NKSYT;A7C'7LP\CGJ&'JVBLJY&'R.NE3Q&]0
MZ([6/3SQ$*C17[65OBITJ0K>MA8E-5S@ZQRLB/$I_@2BOAU.N@#[D:V03JAR
M&*V[&XX3W3I].F?8DS'R$?VPR3N^&^%PZ:8;6NUK5(C.#B<'G.^///Y,S8?Y
MX>D%2]2M17?AJ>6M]@BQU0@)@)(Q)A G2_Q=XLD?TEF"OTDZ@QM1=MGO^P\E
M=Q+$\QD.&NER"8L@SC*8!:ML02.>9/RG[87$>.J&(3"=I3@ X?$^2.89+!,<
MD'Q/X9VBJ%2MZ Z(;T]P@$D6^#N+%H %MTB0>Q;'I%60I/0_"^)EQ KC5M8Y
MR)#O?=='T]&5727-EB\FJ4]C//SMW; ZW'U>^BN_XW9_<8JM#8\E>%J1&R3%
ME)Y/_ &F?W&ZX0O M7;8!OAQ)P6"!&W [QNM7?]" H8;X8O_ E!+ P04
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MGJWMV=(T7DG-:TNNJ2IA]^>LS/9T-!_U!S=R4_IP,#U;UF+#M^P_U6N+W71
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M71Y(K'J)>#=_]R.JTY=TR^*V!E.ZMK[$?,AEYF#6UL:*2.YEA]4+#NI@TC$
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MZ74E%!99:+( 3-*0Z\O\%D@95F '#>! ?5;1AJSZ6V0JT[J>WX1HVLC$/8\
M?>\0=3O#=T%2\O$>H&AV* 3+?/+M\\\MD'>F^YR3L.ISXQ,OT"[:+59[2'J<
M\7)3,^\5FBP\(TBT6\>"4'R5 V4%)KGH>1>DF%6<!BA/YQPI1#1(1_X/('E+
M0=L3@8P>/)KMX=2#BFXI5ZRD62!JHV8WE,EP)"0\4L1N 6MK*GS.8@[A;+%F
MH=6FF,?B?06O1'&+56RPM9X&*O/"@"/U.5.*3/'W)Z,1&KZBX-Z5DRLZYVRY
MYIUW^)V$S!7XBME"BD+:!;<)L+P-6L*G$"P?@&?%>#(;3J+]$Y)&& Q(' B9
MD=1),9L\7WAD\H'=FO(=M<AB/!K^*Q5;KJESI'&LXQ*YYI?,N54<-)JR5FO9
M53RC9$I$#>F^\!Y*:7+.-(-S[)!Q<%\_E1&%@716_ :>]7Q%JMR34@#7&3WT
M MXJ>$F ;3,T17-B&<4-F-RK?6<T]A-42#3[\N]YRK_G>S/F5"W8$;?EVJ_;
MV3>&KR:^,GJH%BIJ%2L>QX_S6]<-Z5L+\LT9)8%&^W[1]P2DIEA2.1\Z2<B<
M I%'&\IVO2/AC0]A+:K<0IF%E?42,,]U975& 0$URSRWE-V# T=J^U3[-*GV
MZ5X%?0 PK!K(\!8%&:?V:M(T9;F?D%S^C<[K.H;\-D/\&>>(MX@U-;,MH7;4
MLL?>X=^D++B5S*7!O]0<O[F87J;N6.\Y_6/-8"KNNYA^3-OHZ.%H,A _ IO0
M<.AG-"&9.'\T.2*4HY&H$F[D5 N[.Z6^(W_(S*+2OU.BLC0S&YKYL$6"9V3G
M4QU6@VH">*$_@4\5_C3.2WX-('KI$'8*G%*<(;";.U7<II8B^-=:QXP<<N\(
MS5DE<FF0DQ>ACP]8UV^HY2J4 *L=J8O].G \$"7^M:')DXQB2:W4!5.C]SR(
MMT5NS3G)?V:%(?#\I,CWAIZSE("9 K'6TJG<65>--04](RH&.,2A^]%SK?)
M-2;F3F^;:CU,^9[*4!U;!K=$!ACR!K_PR$\%5$ &6$5^<DR^^4-;L%^>![^$
MJR47FW[D7X;C$:NA>QY'ET&5O=4Y.,F0WGD6Z7GP)JRDI5B6)%B38G_1:C^R
M\E"""; J\YR1#&*B!VM*!33,*9MY3U4_:"#B&)_CZ(?[>Z$P<^<K" (&GL,%
MHG/JK"UY<G6KAAX1])IOQF#<L:N*G"=Z);<>5 RA)]1*^BUY;FP_YTG=K.EW
MTD)C4.#3G:I^.AQ]A6HUC63*.)+T)"C].X.$0J[+7I% 8*!-T=]I:4-]HH2\
MC$5H%\W3.%0D8C+W+@EIK6%#4E+;HN0J*3KZ;<#(T2NCY3K[-Z$^HQ"S<B.Z
ME1;=E&LB%.03@U)#B/F)VTZG_LG<^EG!%[0]'G6YSR/(T*N!DK'W &)?BGO^
M]Z:UU 4,T'VJZ#6PE,RZN<S[7]Z^'A)#.N!,&OKM8F\R&H[.B-#<$Z:KBP!,
MUMEB?5/EYVD)/;";ZV[,&\H!UW@B%8J"@&W4 DTO0=\WYGX#,[AOLYG*: K6
M<4#G]4"C\^-/^G9]&N-K #-$S>WZELX%Y)RJ0IKUC,\&G'(\?TF ).$6#C4-
M.^_V</BETVAX5>6[V'\0)03<-9QYU;FH)I<AD-N-KN.,*A[(C[OGB-0FK;C^
MD+.L8SL_0&.\%N8Q:CU"V!-U+^YCK/;$VCEP6S]+IQX \JE;6;2RB5.7OM_W
M3S.A=_AB/^A'U9%<H\N0'AC&IZ3:9X>0;*9K#E-_A4A=+N"I!>6:+H72;"?7
M72_OS;#6@Y""N4)0%09D/1P?T1C(SWQ\V2;AM(M5'%7 =8#B<'+D(6Z!_;V\
M/<?9VC%;/G?X2#D\[:C7E(5,ZZ#03-:Z0?/S.T^Q-:%TF-12<<J, _=W/#6*
M#1*/ZN,6?Z#O8RZF5X3Q=KC)<C.#1HM11"6K<5/&$P+4 T)M/#T.)O86W0!K
M=%@)-H7K75&&'9[QF0KC.2[#\>PP=HXJV@*[U@>)*W]4XE3[\$AS9)AQ!]\A
M00>-?+?ADSU/)*>KD!$]7,FD6U+C?^<">.(DGD#]_1KS>#@^'?30_MO*-;9E
MTL,KP$[XWH_&]0#YZ>3QT3/QSJ/2.-5?7TG=^S:"QSL@Q1G5@7=R%:IA]\-Y
M']:A&HYIX5KM#'= >>?'T)^E%5$YB>L.6R1S^*+JX7!O-+,V44.G+N.LB[QF
M7?#,"UYXP8G;,(=@"@C !0K5[^&F@G"_W\Z5(GG!.A%?#J+Z@E-]:0P<IQTT
MT]+^-'_GF>:\].C:.O7>. :EDB)5SDQ+.PO*2LEO+_S!$7=UN";4[-UW>Z3D
M)LS UUR=AV>%GQU^(PQBC.&V@0RZ'.Y<NC\1W#+O[(]BP)6CVU1E>T/5;D_
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M@6_^XP-@"K\3/3--8TK^N%0R5Y86X'=ZR3,^T 'I)?E7_P=02P,$%     @
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M@S1TC[MI30\G*KN!OE=2FO/"!IB>XLV_4$L#!!0    ( %6!:5/+0^,.HP(
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M MV%$:?=AZ(/M#2VV$BBEJ3BM%_?(25K[< QTH>^2,,AY\SA7#2:[85\4B6
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MB3@L'-\YWOC.]K$N;KC+>4;V=$/U;78C8>36+!%+*5=,<"3I;N%<^I_6>%@
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M2UDP]J0G=\G <G1&D$,LM016CPV,(<^UDLKC;R5JU3$U<7^\4_]BBE?%++"
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M2? >W N]683Z 7"Q []]KVBI'Y^Z G_JP+=W1&'*Y#L=]W5[!]Z^>0?> %J
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M*4?>E4<*6-(U-P]R\P':>BXL7RZY=D^R:7T#C^1K;635@C&#BHGF3;=M'_8
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MS"6.-CE"^\7DH$CWY/WQ$4W(K8%"_^EQ,&P=#)V#X3$'.["'5FP)!^PZI\2
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M9K+*O@7V$RU:UW:>A39-S T;\]4 :3>8^Y40^F-B.]GX'2K^ %!+ P04
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MW*_V(W^]G_<;''[.Q\7<M^ ]2+TB8^TB8^W,GM-H[T&1ZSA1<@DZK<C/SS"
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M2$ F6$;IL>(3!RD3L6&'&4P[!IEUM,PZIOZYD:1:"0-)W#3MVAY*4FNU@S?
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MW]872BRRUYP>A%(BRC[.@227Z0#X?BJ$>KY(WYPJ7D$\_1]02P,$%     @
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M4<?YB(A#\--LC-Z_^U!#Z\9N9<;2THHC5U2PNMB,3Z?B-%.YM5NY2D5EI2Y
M=OB8^0#'>R323/@KR-@_4R9"'C3JFYS^D;:?NM'6_;_XX!9;>SG1*==HQQCO
M-!G7AL[F9HWNK<PK6)#)DD$I46B^0;OSIG1CAJ_65 3H]Y_ )'I0+)9_6 BY
M)2'7$'(;"#TE@OE\F81_@R=_EY'/I?J(I-Y4$$_U4&U@<O.>,:^KZ\L(]QS(
MCI<:4MV25-=*:K;K%"WARRA@]Q[VISP0']!7U!C>F]QV=X=112?G;)NQ1]@K
M"7M6PK=41!O$7IGP0\D07^Q_MX\Y6^@JYG]!H4>*0Z^P3?U3==UY1ZR[_8YW
M(.UX4H.T7BFM9Y7V(&5&H9IH49 ?,61&KDVPB.JP@!@6IQ'?,%:\*96E4&[J
M"DGO.&>ZWH&2\?&DP0#7:^F76OHGY-7/=<F\9V]0VAM\'ZL9.U4/X'S3>F:O
M*60@O,LW7 0M,RH09I9.Q@VC0M;5A\D;SK&!(H+BO))B@@*ZL7UIO-/<8*OM
M1R:5" WU/(Q/P-AJFE2FR7<2QJI,X,[_&4:[<Y)#$7:V@23NFX&L"@[^EHI3
M2_>XQG1<MZG(X*K*8'N9(0[NH]O9=&K3594 ['TG651MW=B^=T_+C1A6SO$.
M3B6B.H'T44&_7-!0P(%$/,,Y^X5&&92FXFU]%MF=][OGCO.#34>U;6/[OGW;
M5%\$A^8@!NX+6 ;)<KL:0N@7!"@PRR!/X=IV]PVW7H&M/8O8H9C48O?U5V4&
M#ZS6/F?QG D=HDIZWB_K,UNIOI3]%1WTU;4*!D>M JE?4:2J/L1> +ZU63BU
M%YH4/';)8\?M>WB_B;BOF==SO7ZW06A5C8B]&OT'7=&D<+G7%GF.<ZBH9I;3
MM!>2J@828A5TY?LB.]R0:1*4@G3%2223IM24TE*Z$3R*$)R8,[_IC'!7^-[E
M[!X*F]1,.CY(M'>N1V(FEN:J3 +K+%'Y*:P<+:_CKLPEU,'X-;X8XYKQ";ZX
MSR_;*O/YW=\G*I8A'$<BM@!7SGD/DDKDUVGY@^*IN9R9<Z5X;'ZN& V8T!/@
M_8)SM7W0#LI+S=$_4$L#!!0    ( %6!:5.=[VXE 0,  %$)   9    >&PO
M=V]R:W-H965T<R]S:&5E=#0Q+GAM;*6676_:,!2&_XH5[:*56O)%"%2 !+33
M>M$5%6V]-LF!6'7LS#;02OOQLYT0LO&QEG)!;,?G/<\Y/K'=WW#Q(C, A5YS
MRN3 R90J;EQ7)AGD6+9X 4R_67"18Z6[8NG*0@!.K5%.W<#S.FZ."7.&?3LV
M%<,^7RE*&$P%DJL\Q^)M#)1O!H[O; >>R#)39L =]@N\A!FH'\54Z)Y;JZ0D
M!R8)9TC 8N",_)NQ'Q@#.^,G@8ULM)$)9<[YB^G<IP/',T1 (5%& NO'&B9
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M<AWZL>?YAT$Z-4CG),@$Z^JDFD,G"^G=: %$?8"JLT\51(%_)#MQ#16_?_5
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M. ,  ) *   9    >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;*667V_:,!#
MO\HIVL,FK20."9 )D$KW]V%;5;3NV20'6'5L9IO22?OPLYTTL)&PEKTDMN.[
M^]W9=[GQ3JH[O48T\%!RH2?!VIC-FS#4^1I+JGMR@\)^64I54F.G:A7JC4):
M>*&2AW$4#<*2,A%,QW[M6DW'<FLX$WBM0&_+DJJ?,^1R-PE(\+APPU9KXQ;"
MZ7A#5SA'\VUSK>PL;+04K$2AF12@<#D)+LF;&4F<@-]QRW"G#\;@7%E(>><F
MGXI)$#DBY)@;IX+:USU>(>=.D^7X42L-&IM.\'#\J/V]=]XZLZ :KR3_S@JS
MG@2C  I<TBTW-W+W$6N'4J<OEUS[)^SJO5$ ^58;6=;"EJ!DHGK3ASH0!P+]
M+H&X%H@]=V7(4[ZEAD['2NY N=U6FQMX5[VTA6/"G<K<*/N563DSG1N9WUW,
MK%\%?!(Y"A<DN)*E/79-?>"N.14:+N &M5$L-W:GEX)O@AD-ERZNS/R$EV_1
M4,;UJ\Z]X]!89&<XS&N\6847=^!E\%D*L];P3A18_"D?6E<;?^-'?V?Q285S
MW/2@'[V&.(K)"PA!KZE"73U/Z.\W\>Q[_?T._5^VY0(5R"7,_Z4R:50F7F72
MH?+KUFA#1<'$ZC4L<,6$L$-G8H.*R0)>,E&[\0I^09LK560J,ZDWX[+U?DK(
M((VS=!S>M_"E#5]ZDN^#HL(=]%,QTF.,*,D&6=:.,6@P!B<Q;NV5>P;%X(CB
M(DG2C/3;*88-Q? DQ16U2<0MASTPL$5SB>PY5,-C*C(DHV'<3C5JJ$9/OT)H
MR9Y_>4;'IY9FPSCJ.+6L(<M.YLMW7S9MA"[O4=G? /C;!+:6(;RG3,$MY5L\
MD44DVE>ZZ/_SJ)"<4Z7=4A4,%Y5]G6BM8)79T4%HXJ@7#=L#0PXJ,WER7IV#
M51?^Z) KZZ6##JYXSQ4_-='.P8I;L$B/=-PCLB^\I']NYIV#V6_!3'JCI -S
M7\S),ZKY<2J>@YH<W[^TEXS^(@T/FH02U<JW0AIRN16FZA>:U:;=NJR:C/WV
MJE?[3)7-'@T<EU8TZ@UM65!5^U--C-SXEF,AC6U@_'!M6T94;H/]OI32/$Z<
M@:8)G?X&4$L#!!0    ( %6!:5-FI0VJHP,  )8.   9    >&PO=V]R:W-H
M965T<R]S:&5E=#0T+GAM;,U736_C-A#]*X2PAUU@$XGZ=F ;B#_:!N@"1MQM
M#XL]T-;8$B*1+DG'R;\O22FR+"E"T,TAEYBDWCS.S)N0G/&)\0>1 DCT5.14
M3*Q4RL.-;8MM"@41U^P 5'W9,5X0J:9\;XL#!Y(8HR*W7<<)[8)DU)J.S=J*
M3\?L*/.,PHHC<2P*PI]GD+/3Q,+6R\)]MD^E7K"GXP/9PQKD]\.*JYE=LR19
M 51DC"(.NXEUBV^6.-0&!O%W!B?1&",=RH:Q!SVY2R:6HSV"'+924Q#U\PAS
MR'/-I/SXMR*UZCVU87/\POZ;"5X%LR$"YBS_)TMD.K%B"R6P(\=<WK/3'U %
M%&B^+<N%^8M.%=:QT/8H)"LJ8^5!D='RESQ5B6@8*)Y^ [<R<-L&_BL&7F7@
MO74'OS+PW[I#4!F8T.TR=I.X!9%D.N;LA+A&*S8],-DWUBI?&=6%LI9<?<V4
MG9RN)=L^7,U4JA-T1[= M6YHS@I5B8(8+5<YH0)=H2;T K!\TF- GQ<@29:+
M+PK\?;U GS]]09]01M%?*3L*0A,QMJ7R6>]L;RO_9J5_[BO^>>@;HS(5:$D3
M2'KL%\/VHP%[6^6J3IC[DK"9.TBXAL,U\IROR'5<W.//_.WF3E\XO[;[\G_O
M?I$,KZX>S_!YK_&EA,/5IEL2MYP3N@=UHDBT>49-W(H\F^7;$^$)^O&GHD1W
M$@KQ<\ AOW;(-P[Y@^5<;K1M.@1EC?858,D8&D9]KCY.?==7R7ULJMH%>3AV
M+D&++@B[@1M?HI9=5!P%40VZB#NHXPX&XYXS(1';H3UCB4""Y4.E'M:DX<=0
M-ZH=BMY=W9(QN-"DI<B\BXFCEK1=B.^Y+6&[&-?W^G6-ZXCCX8A)#@*IHU.=
M^?P!9$;W WD<U:RCCR$L=L[7D//NTE:4%PG'@=<2MP>%_;A5 HL>5(BC5A4L
M>U#>* K[-<:-.Q@/!G\/ @C?ID;H!![5\^V@DSV46?=,[GX0L<^W!O;>7VRO
MYS_0;VO=!;FC45OJ+D@=TQVINZC8?>64QN?K"0_?3[\#!4YR(S1)U'LN$Y(3
M_>8:2NSY%L#!!]'Z?(?@\/VU#KL7:>"&;;%[4)X3MM7NHOPP;!_=/2@OPK@E
MM]UX9Q? ]Z;!$2JL(Y7EHZE>K9NH6],ZM-9G^&:.>]87NNDR[_HS?=FQ?2-\
MGZEG> X[M95S':E"X&435$XD.YA7_H9)U3.88:H:1^ :H+[O&),O$[U!W8I.
M_P-02P,$%     @ 58%I4]D')!JP P  PPT  !D   !X;"]W;W)K<VAE971S
M+W-H965T-#4N>&ULM5?+;N,V%/T50IC%!$BLMR4'MH$D=F(/.D4P;CJ+H@O:
MHBTA$JF25#S]^UY*LB(KM*!.T8W-QSE'E^?R.3TR_BIB0B3ZD:54S(Q8ROS6
M-,4N)AD6(Y83"CU[QC,LH<H/IL@YP5%)RE+3L:RQF>&$&O-IV?;,YU-6R#2A
MY)DC4609YG_?DY0=9X9MG!J^)8=8J@9S/LWQ@6R(?,F?.=3,1B5*,D)%PBCB
M9#\S[NS;=:CP)>#WA!Q%JXS42+:,O:K*.IH9E@J(I&0GE0*&OS?R0-)4"4$8
M?]6:1O-)16R73^J/Y=AA+%LLR -+OR>1C&=&:*"(['&1RF_LN"+U>'REMV.I
M*'_1L<9:!MH50K*L)D,$64*K?_RC]J%% !T]P:D)3I?@72"X-<$=2O!J@C>4
MX-<$?RAA7!/&0PE!30B&NA36A'#H%R8U85).ARI_9?(76.+YE+,CX@H-:JI0
MSJ"2#3E/J)KK&\FA-P&>G/\*R^D7)@1Z)AQM8LP)8GOTP+(,9N)&LMTKNE'5
MO)"XG)W0N\2<)O30YGQ>$(F35%P!^F6S0)\_7:%/R$1"]0J44/1"$RFNH1'*
MO\6L$)A&8FI*&(.*Q-S5\=Y7\3H7XG715T9E+-"21B32\%?]_$D/WP3O&@.=
MDX'W3J_@AN0CY%K7R+$<6Q//0S_]2T%[Z8M^^E?,@6Y?I"^'!V]IZ(_#@]?1
MGX8'KZ.O_IOSZY\>^]E$<)N5Y)9Z[@4]S:KXXVXK)(?]_,\>?:_1]TI]KV>E
MIK!2=6NF8HY+ICK=WN8WMA\&SM1\:T]%'<R=A/8Y;*&#.8[745MJ8!,O\,Y1
MCUHQKQO:DQ86=&$K#<QSK(E_#EMK8*X7V&$#.\N WV3 [\W ]_+D)-$-?B,<
M+@*(%MD6D@U;XJ[:,.OMKA D0I*I5M@WB3J-DQVB=0)1#AQ1;9O)B7.E2VL5
MCM\:ANNZGF5-W$XJ/@*=,+!=KS7BRC^=HF7Y$ZN3MK5.T?9]?VSK/1PW'H[_
M'P^C)(6_Z"=<' ]U\2/P@HLZ1:V+.L4^%X/&Q6#07O!NPG4]R907A8C>.[26
M5.IA>WU8(Z\SS*46Y79<6VE0]LCI:*WU*%=O0]C8$/YK&T[S9)@1X2 CM*@/
M1FA0&B/TJ*X19NM&EQ%^*)\# A9#065U)#6MS8OCKKQH=]KO[=LG6].^@A=*
M]:!XEZ^>-W J'Q(J4$KV\"EK%,#TY=63H:I(EI?WR2V3<#LMBS&\L@A7 .C?
M,R9/%?6!YMTV_P=02P,$%     @ 58%I4[J[3.K4 P  6A(  !D   !X;"]W
M;W)K<VAE971S+W-H965T-#8N>&ULS5A1CZ,V$/XK%D]W4KM@( %62:3=A.I.
MNJNBC=H^5'WP$B=Q%VS.-IOMOZ]M" 22)=S="R\)F)EO9CY_,+9G1\9?Q %C
M"=ZRE(JY=9 RO[=MD1QPAL0=RS%53W:,9TBJ6[ZW1<XQVAJG++5=QYG:&2+4
M6LS,V)HO9JR0*:%XS8$HL@SQ_QYQRHYS"UJG@2>R/T@]8"]F.=KC#99_Y&NN
M[NP:94LR3 5A%'"\FUL/\#Z&D78P%G\2?!1GUT"7\LS8B[[YO)U;CLX(ISB1
M&@*IOU>\Q&FJD50>WRI0JXZI'<^O3^B_F>)5,<](X"5+_R);>9A;H06V>(>*
M5#ZQXR=<%331> E+A?D%Q\K6L4!2",FRREEED!%:_J.WBH@S!X5SW<&M'-RN
M@_^.@U<Y>$,C^)6#/S3"I'(PI=ME[8:X%9)H,>/L"+BV5FCZPK!OO!5?A&JA
M;"173XGRDXO?E1:_,"' &G.P.2". =N!)<LR-8L;R9(7\"MXH))L25KH.6T_
MB[\5Y!6EF$H!XK<D+;9X"W:<9=HL+R0R:E"(,>*4T/UYG \K+!%)Q4<50>@1
M,;.E*DDG9B=5^H]E^NX[Z7O@*Z/RH()3%?F*_ZK?/^KQMQ65-9_NB<]'MQ=P
M@_,[X#F_ -=QX95\EL/=G6OE_%ST^(>CM\CP:G%Y!L][!Z^EFPU."DXDP=^O
ME+^_*&#P6>),_-.3EE^GY9NT_'?2JA0LC(+QF8)Q*Z^DG9<I1#VCZHU)]1N3
MJ_Q$J61"*P5_O";A,IN)R49_N%\77@@]Z"N*7\^E<6GG.S#R@K!MMQJ(%]_&
M:]$WJ>F;]-)7OODLU\2(GNF8UGC3,:DDJ-,*1J62X&*V7&?J!5[44<D5NXGC
M>W[';C40+[Z-UZ(OK.D+>^E[PD)RDF@N2@H+2F2?7*(:.!J37*#3=%)G5(*I
MTCF?.3B) M?I*N::H9IC&'@=R0Q%C <@MDD\6X[ _H^+J5>M6Y__54M)()E:
MC>8%3PYJ,=@W2VX3P!V5?)I>";UQR<>[F,-N0[IB$@2AWU7-3:#X%E";LJ:/
MP_Y&'F_6:W!2!^!Z3]#WA8%-AX.348FD:95P.BZ13"_7&KX37 CET@QZ831Q
MNE(9!!??AFO3U[1T^!T]_8@X1[1?,4VW@^&H%--T2QB-2S'1Y=S!$+IN5S+#
M[%8#[>+;=B6!]ME>.<-\;PXIA*J_H++<V=2C]4'(@]G^=\8?X?T27AE?Z8,3
MLS=OX,M3EZ^([PD5(,4[%<JY"U2RO#S(*&\DR\U._9E)M>\WEP>,MIAK _5\
MQY@\W>@ ]7'2XG]02P,$%     @ 58%I4ZO>2"?D @  I@@  !D   !X;"]W
M;W)K<VAE971S+W-H965T-#<N>&ULI5;?;]HP$/Y7K&@/K;0V(?Q8BP"I$- Z
MK1HJ[?8P[<$D!['JV)GM0/GO=TY"1DN:,?6%V)?ON[OO?/@RV$KUI&, 0YX3
M+O30B8U)^ZZKPQ@2JB]E"@+?K*1*J,&M6KLZ54"CG)1PU_>\GIM0)IS1(+?-
MU6@@,\.9@+DB.DL2JG9CX'([=%K.WG#/UK&Q!G<T2.D:%F >T[G"G5MYB5@"
M0C,IB(+5T+EI]6<]B\\!WQEL]<&:6"5+*9_LYC8:.IY-"#B$QGJ@^-C !#BW
MCC"-WZ5/IPIIB8?KO?=9KAVU+*F&B>0_6&3BH7/ED A6-./F7FX_0ZFG:_V%
MDNO\EVQ+K.>0,--&)B49,TB8*)[TN:S# 0']U!/\DN"_)G3>(+1+0OO4")V2
MT#DU0K<D=$\E]$I"?IAN4:R\T@$U=#10<DN41:,WN\B/*V=C@9FPC;4P"M\R
MY)G1/7!J(")SJLR./"@J-"W._"P 0QG7Y^2"+( N4F3B\HMDPN#9;; G4^PP
M0^A: >2K"_*X",C9A_.!:S W&\$-RSS&11[^&WFTR9T4)M9D*B*(:OA!,_^Z
M@>]B3:K"^/O"C/U&APM(+TG;^TA\SV_5Y#,YG>[5R7E?].G[HL^:Z0&$2&_5
MT5_4LETU63OWU_[O)OOYU7;5K8%$_VH(U*D"=?) G3<#L629*5VT8QA3M09-
MX!FO85W;5>/"7R_W9R_AS:CK>:AY<WC4QZ".=X0*CE'^]1%J>HRZZAVB7NCN
M5KJ[C;J_948;*B(FUH0SNF2<8:&-K/ZX==*[1YF\5O1/Q*P)\4))KU+2:U3R
M "HA<D52):,L-$3)'>6H15..)YF"8C(B9TR0'5"EZRZ:H#E RRNH==WF'MRC
M"6#OV(FG22@S88INKZS54+W)9\DK^[C5G[1J[$&K/RUFYE_WQ02_PU9E0A,.
M*PSE77["RJIB*A8;(]/\%E]*@S,A7\;X(0'* O#]2DJSW]@ U:?)Z ]02P,$
M%     @ 58%I4[@2 P@; P  ,!(   T   !X;"]S='EL97,N>&ULW5A1;]HP
M$/XKD3M-K30U0-J4K("T(56:M$V5VH>]588X8,FQ,\=TT%\_GQT"I3[$^K"5
M!='8]_F^^WQWJ2,&M5D)=C=GS$3+4LAZ2.;&5!_CN)[.64GK<U4Q:9%"Z9(:
M.]6SN*XTHWD-3J6(>YU.&I>42S(:R$5Y4YHZFJJ%-$-RT9HB?_N2#TDWO2"1
MIQNKG W)P^G[GPMEKM]%_G[RX>2D\W!VO6L_=< 9B8.DEP>0GG?LA3([%*-/
M#Z/?1XY17QU$O8?9$<=-[D>#0LE-"1+B#38R+5GT2,60C*G@$\W!JZ E%RMO
M[H%AJH32D;&UMU*Z8*F?/-SU,VB+AJ?D4FD7VT?P?R?-\AU@/0.!7(A68(]X
MPVA046.8EC=VXA8[XPLH:L;WJ\HJG&FZZO8NR<;!W6R0B=(YTVV8+EF;1@/!
M"I"C^6P.=Z.J&$!C5&D'.:<S):G3L/9H!I9VRH2X@V?F1_&,>UELU;0#%97M
MT IJAI[&3X!_F\US;].^CC>J^*,RGQ=V.]+-H5?8K68%7[KYLF@%8.Q=G)U6
ME5A]$GPF2^8W?W# T8"N_:*YTOS)1H-6F5H#TR1Z9-KPZ;;EEZ;5/5N:=3LM
M"UQS[P@U_]T\SYADFHIMT;;WWW*67ZTXN?I7DMU_E5W!08W-0?C615X>@\CT
M&$0>04\FV9O4&#='X];Y^^ST;:T1O.4,R7=XGQ*;H-%DP87ALIG->9XS^>(0
MMO2&3NSK\#-^NSYG!5T(<]^"0[(9?V,Y7Y19N^H6$M&LVHR_PO:Z:?N*96-Q
MF;,ER\?-5,\F;AC9@8W:7."PB]RX*XQ@/AX+(X!A<3 %F(_WPN+\3_OIH_OQ
M&*:M'T3ZJ$\?]?%>(63L/EB<L$]FK_!.LRQ)TA3+Z'@<5##&\I:F\ VS8=K
M XL#D?XLUWBU\0[9WP=83?=U"+93O!.QG>*Y!B2<-_#(LG"UL3C@@54!ZQV(
M'XX#/17V21*H*J8->X)Q),LP!'HQW*-IBF0GA4^X/MA3DB19%D8 "RM($@R!
MIQ%', 6@ 4.2Q)V#.^=1O#ZGXLUO1*/?4$L#!!0    ( %6!:5.7BKL<P
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MQ;5]96O-L0W[V-4'I#R21A8)=K%J@:WYKW!04-I(A_1&$":DE#C2R.:@,?U
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M*^JM!'HKZJT$>BOJK01Z&^IM!'H;ZFT$>AOJ;01Z6^^PA$!O0[V-0&]#O8U
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( %6!:5/6#H 7[@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( %6!
M:5.97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ 58%I4P3'N?!@!0  FA8  !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( %6!
M:5-@=CK^L04   ,5   8              " @:,-  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    " !5@6E3OF&)Y2$#  !3"@  &
M        @(&*$P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ 58%I4XKG?7=1!@  U!D  !@              ("!X18  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( %6!:5.7Y*(FLPL  %E/   8
M              " @6@=  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    " !5@6E3LCR<NX('   ?'P  &               @(%1*0  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ 58%I4\.92 MH!0
M"PX  !@              ("!"3$  'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( %6!:5,M1LK;2Q   +DP   8              " @:<V
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !5@6E3Z7Y(
MV0@%  #7#   &               @($H1P  >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ 58%I4YO/AZX\!   7@H  !D
M ("!9DP  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " !5
M@6E32)^F_"X$  !7"0  &0              @('94   >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( %6!:5/_C4L,E0<  $$2   9
M          " @3Y5  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#
M%     @ 58%I4Z556SS=#   E"@  !D              ("!"ET  'AL+W=O
M<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " !5@6E33^EWRYD(   =
M%@  &0              @($>:@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM
M;%!+ 0(4 Q0    ( %6!:5.-"B\?Y@,  ,L)   9              " @>YR
M  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ 58%I4]_B
MLTV3!   \ H  !D              ("!"W<  'AL+W=O<FMS:&5E=',O<VAE
M970Q-BYX;6Q02P$"% ,4    " !5@6E30-8/FN #  #,"   &0
M    @('5>P  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M %6!:5/I]^K(< \  # O   9              " @>Q_  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ 58%I4YC^E6*L @  I@4  !D
M             ("!DX\  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    " !5@6E3\*->N'(#  !C"   &0              @(%VD@  >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( %6!:5-!=7JR4P,
M !L(   9              " @1^6  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ 58%I4V3M^6A> P  E@<  !D              ("!
MJ9D  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " !5@6E3
MRT/C#J,"  "1!0  &0              @($^G0  >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( %6!:5-['/V?@ ,  "$(   9
M      " @1B@  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ 58%I4^>.S)@?!0  CPP  !D              ("!SZ,  'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " !5@6E3?Z%IX, #  !:"0
M&0              @($EJ0  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( %6!:5/4/>HG% 0  #$0   9              " @1RM  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ 58%I4P\7UH,I
M @  ] 0  !D              ("!9[$  'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    " !5@6E3Q<3VN@@#  #Q"0  &0
M@(''LP  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( %6!
M:5,$O>=?C 0  ,L5   9              " @0:W  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ 58%I4_P$(L?:!   6AX  !D
M         ("!R;L  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    " !5@6E3GVR)FL$#  "\#P  &0              @(':P   >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( %6!:5,HVX(<D (  ,@&
M   9              " @=+$  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ 58%I4^6V^WYV @  A 8  !D              ("!F<<
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " !5@6E3O]HN
M*]T#  !1#   &0              @(%&R@  >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    ( %6!:5/=[&R#: (  ),&   9
M  " @5K.  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
M58%I4PE/]+BV @  70<  !D              ("!^=   'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    " !5@6E373=B4 P'  ".*   &0
M            @('FTP  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( %6!:5/XR\.5<0(  +H&   9              " @2G;  !X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ 58%I4Y=XDG8@!0
MX!0  !D              ("!T=T  'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    " !5@6E3G>]N)0$#  !1"0  &0              @($H
MXP  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( %6!:5/A
MH]2=3@,  (\+   9              " @6#F  !X;"]W;W)K<VAE971S+W-H
M965T-#(N>&UL4$L! A0#%     @ 58%I4]GT@;LX P  D H  !D
M     ("!Y>D  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %6!:5.X$@,(&P,  # 2   -              "
M 3O\  !X;"]S='EL97,N>&UL4$L! A0#%     @ 58%I4Y>*NQS     $P(
M  L              ( !@?\  %]R96QS+RYR96QS4$L! A0#%     @ 58%I
M4Z<_4VWS P  O1\   \              ( !:@ ! 'AL+W=O<FMB;V]K+GAM
M;%!+ 0(4 Q0    ( %6!:5.Y(]HWL@$  %0<   :              "  8H$
M 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( %6!:5-E
MX9FUMP$  &4<   3              "  70& 0!;0V]N=&5N=%]4>7!E<UTN
9>&UL4$L%!@     W #< ^ X  %P( 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>233</ContextCount>
  <ElementCount>314</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>55</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - The Company and Nature of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/TheCompanyandNatureofBusiness</Role>
      <ShortName>The Company and Nature of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/MarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - Fair Value Measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/FairValueMeasurement</Role>
      <ShortName>Fair Value Measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2114105 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2119106 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2123107 - Disclosure - Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/Borrowings</Role>
      <ShortName>Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2128108 - Disclosure - Stock-Based Incentive Compensation Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/StockBasedIncentiveCompensationPlans</Role>
      <ShortName>Stock-Based Incentive Compensation Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2135109 - Disclosure - Net Loss Per Share of Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/NetLossPerShareofCommonStock</Role>
      <ShortName>Net Loss Per Share of Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2139110 - Disclosure - Related Party Transaction</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/RelatedPartyTransaction</Role>
      <ShortName>Related Party Transaction</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2141111 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://si-bone.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/MarketableSecuritiesTables</Role>
      <ShortName>Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/MarketableSecurities</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2312303 - Disclosure - Fair Value Measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/FairValueMeasurementTables</Role>
      <ShortName>Fair Value Measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/FairValueMeasurement</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2315304 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/BalanceSheetComponents</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2320305 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/CommitmentsandContingencies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2324306 - Disclosure - Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BorrowingsTables</Role>
      <ShortName>Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/Borrowings</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2329307 - Disclosure - Stock-Based Incentive Compensation Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables</Role>
      <ShortName>Stock-Based Incentive Compensation Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/StockBasedIncentiveCompensationPlans</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2336308 - Disclosure - Net Loss Per Share of Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/NetLossPerShareofCommonStockTables</Role>
      <ShortName>Net Loss Per Share of Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://si-bone.com/role/NetLossPerShareofCommonStock</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - The Company and Nature of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/TheCompanyandNatureofBusinessDetails</Role>
      <ShortName>The Company and Nature of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://si-bone.com/role/TheCompanyandNatureofBusiness</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Summary of Significant Accounting Policies - Revenue by Geography (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Revenue by Geography (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/MarketableSecuritiesDetails</Role>
      <ShortName>Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://si-bone.com/role/MarketableSecuritiesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - Fair Value Measurement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/FairValueMeasurementDetails</Role>
      <ShortName>Fair Value Measurement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://si-bone.com/role/FairValueMeasurementTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2416406 - Disclosure - Balance Sheet Components - Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails</Role>
      <ShortName>Balance Sheet Components - Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2417407 - Disclosure - Balance Sheet Components - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails</Role>
      <ShortName>Balance Sheet Components - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - Balance Sheet Components - Accrued Liabilities and Other (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails</Role>
      <ShortName>Balance Sheet Components - Accrued Liabilities and Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2421409 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2422410 - Disclosure - Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2425411 - Disclosure - Borrowings - Summary of Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails</Role>
      <ShortName>Borrowings - Summary of Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2426412 - Disclosure - Borrowings - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BorrowingsNarrativeDetails</Role>
      <ShortName>Borrowings - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2427413 - Disclosure - Borrowings - Debt Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/BorrowingsDebtMaturityDetails</Role>
      <ShortName>Borrowings - Debt Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2430414 - Disclosure - Stock-Based Incentive Compensation Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails</Role>
      <ShortName>Stock-Based Incentive Compensation Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2431415 - Disclosure - Stock-Based Incentive Compensation Plans - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Incentive Compensation Plans - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2432416 - Disclosure - Stock-Based Incentive Compensation Plans - Valuation Assumptions for Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails</Role>
      <ShortName>Stock-Based Incentive Compensation Plans - Valuation Assumptions for Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2433417 - Disclosure - Stock-Based Incentive Compensation Plans - Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Stock-Based Incentive Compensation Plans - Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - Stock-Based Incentive Compensation Plans - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Incentive Compensation Plans - Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2437419 - Disclosure - Net Loss Per Share of Common Stock - Computation of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails</Role>
      <ShortName>Net Loss Per Share of Common Stock - Computation of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - Net Loss Per Share of Common Stock - Antidilutive Common Stock Equivalents Excluded from Computation of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails</Role>
      <ShortName>Net Loss Per Share of Common Stock - Antidilutive Common Stock Equivalents Excluded from Computation of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="sibn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2440421 - Disclosure - Related Party Transaction (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://si-bone.com/role/RelatedPartyTransactionDetails</Role>
      <ShortName>Related Party Transaction (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://si-bone.com/role/RelatedPartyTransaction</ParentRole>
      <Position>47</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="sibn-20210930.htm">sibn-20210930.htm</File>
    <File>sibn-20210930.xsd</File>
    <File>sibn-20210930_cal.xml</File>
    <File>sibn-20210930_def.xml</File>
    <File>sibn-20210930_lab.xml</File>
    <File>sibn-20210930_pre.xml</File>
    <File>sibn-ex101loanandsecuritya.htm</File>
    <File>sibn-ex102secondamendmentt.htm</File>
    <File>sibn-ex311_930202110xq.htm</File>
    <File>sibn-ex312_930202110xq.htm</File>
    <File>sibn-ex321_930202110xq.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2021</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>65
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sibn-20210930.htm": {
   "axisCustom": 1,
   "axisStandard": 19,
   "contextCount": 233,
   "dts": {
    "calculationLink": {
     "local": [
      "sibn-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "sibn-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sibn-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sibn-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sibn-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sibn-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 405,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 5
   },
   "keyCustom": 30,
   "keyStandard": 284,
   "memberCustom": 20,
   "memberStandard": 33,
   "nsprefix": "sibn",
   "nsuri": "http://si-bone.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://si-bone.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - Fair Value Measurement",
     "role": "http://si-bone.com/role/FairValueMeasurement",
     "shortName": "Fair Value Measurement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114105 - Disclosure - Balance Sheet Components",
     "role": "http://si-bone.com/role/BalanceSheetComponents",
     "shortName": "Balance Sheet Components",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119106 - Disclosure - Commitments and Contingencies",
     "role": "http://si-bone.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123107 - Disclosure - Borrowings",
     "role": "http://si-bone.com/role/Borrowings",
     "shortName": "Borrowings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128108 - Disclosure - Stock-Based Incentive Compensation Plans",
     "role": "http://si-bone.com/role/StockBasedIncentiveCompensationPlans",
     "shortName": "Stock-Based Incentive Compensation Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135109 - Disclosure - Net Loss Per Share of Common Stock",
     "role": "http://si-bone.com/role/NetLossPerShareofCommonStock",
     "shortName": "Net Loss Per Share of Common Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139110 - Disclosure - Related Party Transaction",
     "role": "http://si-bone.com/role/RelatedPartyTransaction",
     "shortName": "Related Party Transaction",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141111 - Disclosure - Income Taxes",
     "role": "http://si-bone.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Marketable Securities (Tables)",
     "role": "http://si-bone.com/role/MarketableSecuritiesTables",
     "shortName": "Marketable Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312303 - Disclosure - Fair Value Measurement (Tables)",
     "role": "http://si-bone.com/role/FairValueMeasurementTables",
     "shortName": "Fair Value Measurement (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315304 - Disclosure - Balance Sheet Components (Tables)",
     "role": "http://si-bone.com/role/BalanceSheetComponentsTables",
     "shortName": "Balance Sheet Components (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320305 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://si-bone.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324306 - Disclosure - Borrowings (Tables)",
     "role": "http://si-bone.com/role/BorrowingsTables",
     "shortName": "Borrowings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329307 - Disclosure - Stock-Based Incentive Compensation Plans (Tables)",
     "role": "http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables",
     "shortName": "Stock-Based Incentive Compensation Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336308 - Disclosure - Net Loss Per Share of Common Stock (Tables)",
     "role": "http://si-bone.com/role/NetLossPerShareofCommonStockTables",
     "shortName": "Net Loss Per Share of Common Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i4d2b391980d14a2aaf03c702bc7ee2f8_D20200101-20200331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - The Company and Nature of Business (Details)",
     "role": "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails",
     "shortName": "The Company and Nature of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i4d2b391980d14a2aaf03c702bc7ee2f8_D20200101-20200331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Summary of Significant Accounting Policies - Revenue by Geography (Details)",
     "role": "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails",
     "shortName": "Summary of Significant Accounting Policies - Revenue by Geography (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "ie659bc55581349eca6480acadb12d4f9_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Marketable Securities (Details)",
     "role": "http://si-bone.com/role/MarketableSecuritiesDetails",
     "shortName": "Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i5e29646458c343d4b6be0890911f4d9c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413405 - Disclosure - Fair Value Measurement (Details)",
     "role": "http://si-bone.com/role/FairValueMeasurementDetails",
     "shortName": "Fair Value Measurement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i5e29646458c343d4b6be0890911f4d9c_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416406 - Disclosure - Balance Sheet Components - Property and Equipment, Net (Details)",
     "role": "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails",
     "shortName": "Balance Sheet Components - Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417407 - Disclosure - Balance Sheet Components - Narrative (Details)",
     "role": "http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails",
     "shortName": "Balance Sheet Components - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - Balance Sheet Components - Accrued Liabilities and Other (Details)",
     "role": "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails",
     "shortName": "Balance Sheet Components - Accrued Liabilities and Other (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sibn:OperatingLeaseTermOfWrittenNoticeForTermination",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421409 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "role": "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sibn:OperatingLeaseTermOfWrittenNoticeForTermination",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422410 - Disclosure - Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details)",
     "role": "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails",
     "shortName": "Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425411 - Disclosure - Borrowings - Summary of Borrowings (Details)",
     "role": "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails",
     "shortName": "Borrowings - Summary of Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426412 - Disclosure - Borrowings - Narrative (Details)",
     "role": "http://si-bone.com/role/BorrowingsNarrativeDetails",
     "shortName": "Borrowings - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "sibn:SocialSecurityTaxEmployerDeferralCARESAct",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i0cb4295888e44afca3a0e40aa138b826_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "sibn:SocialSecurityTaxEmployerDeferralCARESAct",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427413 - Disclosure - Borrowings - Debt Maturity (Details)",
     "role": "http://si-bone.com/role/BorrowingsDebtMaturityDetails",
     "shortName": "Borrowings - Debt Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "role": "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430414 - Disclosure - Stock-Based Incentive Compensation Plans - Narrative (Details)",
     "role": "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
     "shortName": "Stock-Based Incentive Compensation Plans - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9db2347a40b8493cbe05311630711796_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i0cb4295888e44afca3a0e40aa138b826_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431415 - Disclosure - Stock-Based Incentive Compensation Plans - Stock Option Activity (Details)",
     "role": "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails",
     "shortName": "Stock-Based Incentive Compensation Plans - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i0cb4295888e44afca3a0e40aa138b826_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i3c64a70df00648478c80144873723f9d_D20200101-20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432416 - Disclosure - Stock-Based Incentive Compensation Plans - Valuation Assumptions for Stock Options (Details)",
     "role": "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails",
     "shortName": "Stock-Based Incentive Compensation Plans - Valuation Assumptions for Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i3c64a70df00648478c80144873723f9d_D20200101-20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i2557cc90be53464ba8c0545cd23e3d1e_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433417 - Disclosure - Stock-Based Incentive Compensation Plans - Restricted Stock Units Activity (Details)",
     "role": "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails",
     "shortName": "Stock-Based Incentive Compensation Plans - Restricted Stock Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i2557cc90be53464ba8c0545cd23e3d1e_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - Stock-Based Incentive Compensation Plans - Stock-Based Compensation Expense (Details)",
     "role": "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails",
     "shortName": "Stock-Based Incentive Compensation Plans - Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437419 - Disclosure - Net Loss Per Share of Common Stock - Computation of Earnings Per Share (Details)",
     "role": "http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails",
     "shortName": "Net Loss Per Share of Common Stock - Computation of Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - Net Loss Per Share of Common Stock - Antidilutive Common Stock Equivalents Excluded from Computation of Earnings Per Share (Details)",
     "role": "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails",
     "shortName": "Net Loss Per Share of Common Stock - Antidilutive Common Stock Equivalents Excluded from Computation of Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "ia9968dcf42a44a24bd7482e443d5b426_D20210701-20210930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i828e66a96b3b4c439de37f099c818aac_D20210701-20210930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440421 - Disclosure - Related Party Transaction (Details)",
     "role": "http://si-bone.com/role/RelatedPartyTransactionDetails",
     "shortName": "Related Party Transaction (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i828e66a96b3b4c439de37f099c818aac_D20210701-20210930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i21d4eb0fbe1b4f2082f7882f874778fc_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY",
     "role": "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i2073aa5d83e1437fbb0649d1c506d3fe_D20200101-20200331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - The Company and Nature of Business",
     "role": "http://si-bone.com/role/TheCompanyandNatureofBusiness",
     "shortName": "The Company and Nature of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://si-bone.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Marketable Securities",
     "role": "http://si-bone.com/role/MarketableSecurities",
     "shortName": "Marketable Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sibn-20210930.htm",
      "contextRef": "i9a78e483637447919ecdf70d22fc1496_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 55,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://si-bone.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "sibn_A2018EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A2018 Employee Stock Purchase Plan [Member]",
        "label": "A2018 Employee Stock Purchase Plan [Member]",
        "terseLabel": "2018 ESPP"
       }
      }
     },
     "localname": "A2018EmployeeStockPurchasePlanMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Additional Paid In Capital, Share-based Compensation, Vesting Of Early Exercised Stock Options",
        "label": "Adjustments To Additional Paid In Capital, Share-based Compensation, Vesting Of Early Exercised Stock Options",
        "terseLabel": "Vesting of early exercised stock options"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_AllocatedPublicOfferingCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocated Public Offering Costs",
        "label": "Allocated Public Offering Costs",
        "terseLabel": "Allocated public offering costs"
       }
      }
     },
     "localname": "AllocatedPublicOfferingCosts",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/MarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Debt Securities, Current, Accumulated Gross Unrealized Gain Before Tax",
        "label": "Available For Sale Debt Securities, Current, Accumulated Gross Unrealized Gain Before Tax",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/MarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Debt Securities, Current, Accumulated Gross Unrealized Loss Before Tax",
        "label": "Available For Sale Debt Securities, Current, Accumulated Gross Unrealized Loss Before Tax",
        "negatedTerseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/MarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Debt Securities, Current, Amortized Cost Basis",
        "label": "Available For Sale Debt Securities, Current, Amortized Cost Basis",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_CommonStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Warrants [Member]",
        "label": "Common Stock Warrants [Member]",
        "terseLabel": "Common stock warrants"
       }
      }
     },
     "localname": "CommonStockWarrantsMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_ComputerAndOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer And Office Equipment [Member]",
        "label": "Computer And Office Equipment [Member]",
        "terseLabel": "Computer and office equipment"
       }
      }
     },
     "localname": "ComputerAndOfficeEquipmentMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_ConstructionInProgressSantaClaraLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Construction in Progress, Santa Clara Lease",
        "label": "Construction in Progress, Santa Clara Lease [Member]",
        "terseLabel": "Construction in progress, Santa Clara lease"
       }
      }
     },
     "localname": "ConstructionInProgressSantaClaraLeaseMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_ConstructionInProgressSurgicalPlacementInstrumentSetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Construction in Progress, Surgical Placement Instrument Set",
        "label": "Construction in Progress, Surgical Placement Instrument Set [Member]",
        "terseLabel": "Construction in progress, surgical placement instrument set"
       }
      }
     },
     "localname": "ConstructionInProgressSurgicalPlacementInstrumentSetMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Fee Amount As Percentage Of Aggregate Principal",
        "label": "Debt Instrument, Fee Amount As Percentage Of Aggregate Principal",
        "terseLabel": "Final fee as percentage of aggregate principal amount (percent)"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmountAsPercentageOfAggregatePrincipal",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sibn_DebtInstrumentPeriodicPaymentInterestOnlyPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment, Interest Only Period",
        "label": "Debt Instrument, Periodic Payment, Interest Only Period",
        "terseLabel": "Debt period payment, interest only period"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentInterestOnlyPeriod",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sibn_DebtInstrumentPrepaymentAllowableIncrementsPerAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment, Allowable Increments Per Agreement",
        "label": "Debt Instrument, Prepayment, Allowable Increments Per Agreement",
        "terseLabel": "Allowable prepayment increments per agreement"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentAllowableIncrementsPerAgreement",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_DebtInstrumentPrepaymentPenaltyPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Penalty Percentage",
        "label": "Debt Instrument, Prepayment Penalty Percentage",
        "terseLabel": "Debt prepayment penalty percentage (percent)"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPenaltyPercentage",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sibn_DebtInstrumentPrepaymentPremiumYearOnePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Premium Year One, Percentage",
        "label": "Debt Instrument, Prepayment Premium Year One, Percentage",
        "terseLabel": "Prepayment premium in year one (percent)"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPremiumYearOnePercentage",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sibn_DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Premium Year Three Or Later, Percentage",
        "label": "Debt Instrument, Prepayment Premium Year Three Or Later, Percentage",
        "terseLabel": "Prepayment premium in year three or later (percent)"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPremiumYearThreeOrLaterPercentage",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sibn_DebtInstrumentPrepaymentPremiumYearTwoPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Premium Year Two, Percentage",
        "label": "Debt Instrument, Prepayment Premium Year Two, Percentage",
        "terseLabel": "Prepayment premium in year two (percent)"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPremiumYearTwoPercentage",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sibn_DebtPrepaymentPenaltyPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt, Prepayment Penalty, Period [Axis]",
        "label": "Debt, Prepayment Penalty, Period [Axis]",
        "terseLabel": "Debt, Prepayment Penalty, Period [Axis]"
       }
      }
     },
     "localname": "DebtPrepaymentPenaltyPeriodAxis",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sibn_DebtPrepaymentPenaltyPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Debt, Prepayment Penalty, Period [Axis]",
        "label": "Debt, Prepayment Penalty, Period [Domain]",
        "terseLabel": "Debt, Prepayment Penalty, Period [Domain]"
       }
      }
     },
     "localname": "DebtPrepaymentPenaltyPeriodDomain",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_DevelopmentAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development Agreement",
        "label": "Development Agreement [Member]",
        "terseLabel": "Joint development agreement"
       }
      }
     },
     "localname": "DevelopmentAgreementMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Growth Company, Extended Transition Period Policy [Policy Text Block]",
        "label": "Emerging Growth Company, Extended Transition Period Policy [Policy Text Block]",
        "terseLabel": "JOBS Act Accounting Election"
       }
      }
     },
     "localname": "EmergingGrowthCompanyExtendedTransitionPeriodPolicyPolicyTextBlock",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sibn_EmployeeStockPurchasePlanSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan Shares [Member]",
        "label": "Employee Stock Purchase Plan Shares [Member]",
        "verboseLabel": "ESPP purchase rights"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanSharesMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_FollowOnPublicOfferingAndSecondaryOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Follow On Public Offering And Secondary Offering",
        "label": "Follow On Public Offering And Secondary Offering [Member]",
        "terseLabel": "First follow-on public offering and secondary offering"
       }
      }
     },
     "localname": "FollowOnPublicOfferingAndSecondaryOfferingMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_FollowOnPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Follow On Public Offering",
        "label": "Follow On Public Offering [Member]",
        "terseLabel": "First follow-on public offering"
       }
      }
     },
     "localname": "FollowOnPublicOfferingMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Options To Extend",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Options To Extend",
        "terseLabel": "Lease renewal, number of options to renew"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedNumberOfOptionsToExtend",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sibn_MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/MarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "sibn_MarketableSecuritiesAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Accumulated Gross Unrealized Gain, Before Tax",
        "label": "Marketable Securities, Accumulated Gross Unrealized Gain, Before Tax",
        "terseLabel": "Total marketable securities, Unrealized Gains"
       }
      }
     },
     "localname": "MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/MarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "sibn_MarketableSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Accumulated Gross Unrealized Loss, Before Tax",
        "label": "Marketable Securities, Accumulated Gross Unrealized Loss, Before Tax",
        "negatedTerseLabel": "Total marketable securities, Unrealized Losses"
       }
      }
     },
     "localname": "MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_MarketableSecuritiesAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/MarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amortized cost for marketable securities included in cash equivalents and investments.",
        "label": "Marketable Securities, Amortized Cost",
        "totalLabel": "Total marketable securities, Amortized Cost"
       }
      }
     },
     "localname": "MarketableSecuritiesAmortizedCost",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_MarketableSecuritiesFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/MarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "sibn_MarketableSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total aggregate fair value for marketable securities included in cash equivalents and investments.",
        "label": "Marketable Securities, Fair Value",
        "terseLabel": "Total marketable securities, Aggregate Fair Value"
       }
      }
     },
     "localname": "MarketableSecuritiesFairValue",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_OperatingLeaseTermOfWrittenNoticeForTermination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Term Of Written Notice For Termination",
        "label": "Operating Lease, Term Of Written Notice For Termination",
        "terseLabel": "Operating lease, term of written notice for termination"
       }
      }
     },
     "localname": "OperatingLeaseTermOfWrittenNoticeForTermination",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "timeItemType"
    },
    "sibn_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Leases, Future Minimum Payments, Due After Year Four",
        "label": "Operating Leases, Future Minimum Payments, Due After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueAfterYearFour",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_PharmakonTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmakon Term Loan [Member]",
        "label": "Pharmakon Term Loan [Member]",
        "terseLabel": "Pharmakon Term Loan"
       }
      }
     },
     "localname": "PharmakonTermLoanMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_PrepaymentPenalty124MonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayment Penalty, 1-24 Months",
        "label": "Prepayment Penalty, 1-24 Months [Member]",
        "terseLabel": "Prepayment Penalty, 1-24 Months"
       }
      }
     },
     "localname": "PrepaymentPenalty124MonthsMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_PrepaymentPenalty24MonthsOnMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayment Penalty, 24 Months On",
        "label": "Prepayment Penalty, 24 Months On [Member]",
        "terseLabel": "Prepayment Penalty, 24 Months On"
       }
      }
     },
     "localname": "PrepaymentPenalty24MonthsOnMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_PrepaymentPenalty3148MonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayment Penalty, 31-48 Months [Member]",
        "label": "Prepayment Penalty, 31-48 Months [Member]",
        "terseLabel": "Prepayment Penalty, 31-48 Months"
       }
      }
     },
     "localname": "PrepaymentPenalty3148MonthsMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_PrepaymentPenalty4960MonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayment Penalty, 49-60 Months [Member]",
        "label": "Prepayment Penalty, 49-60 Months [Member]",
        "terseLabel": "Prepayment Penalty, 49-60 Months"
       }
      }
     },
     "localname": "PrepaymentPenalty4960MonthsMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_ProceedsFromMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Maturity Of Marketable Securities",
        "label": "Proceeds From Maturity Of Marketable Securities",
        "terseLabel": "Maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromMaturityOfMarketableSecurities",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_ProceedsFromSaleOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Sale Of Marketable Securities",
        "label": "Proceeds From Sale Of Marketable Securities",
        "terseLabel": "Sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfMarketableSecurities",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_RelatedPartyTransactionTermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transaction, Term Of Agreement",
        "label": "Related Party Transaction, Term Of Agreement",
        "terseLabel": "Term of product royalty sales period (in years)"
       }
      }
     },
     "localname": "RelatedPartyTransactionTermOfAgreement",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sibn_SVBTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SVB Term Loan",
        "label": "SVB Term Loan [Member]",
        "terseLabel": "SVB Term Loan"
       }
      }
     },
     "localname": "SVBTermLoanMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Number Of Shares Issued In Transaction, Including Shares In Secondary Offering",
        "label": "Sale Of Stock, Number Of Shares Issued In Transaction, Including Shares In Secondary Offering",
        "terseLabel": "Number of shares in transaction, including shares in secondary offering (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransactionIncludingSharesInSecondaryOffering",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sibn_SecondFollowOnPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second Follow On Public Offering",
        "label": "Second Follow On Public Offering [Member]",
        "terseLabel": "Second follow-on public offering"
       }
      }
     },
     "localname": "SecondFollowOnPublicOfferingMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_SecondaryOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secondary Offering",
        "label": "Secondary Offering [Member]",
        "terseLabel": "Secondary offering by selling shareholders"
       }
      }
     },
     "localname": "SecondaryOfferingMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods",
        "terseLabel": "Number of purchase periods in offering interval"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period Interval",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period Interval",
        "terseLabel": "Employee stock purchase program offering period interval (in months)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriodInterval",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sibn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Early Exercise, Common Stock Subject To Repurchase",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Early Exercise, Common Stock Subject To Repurchase",
        "terseLabel": "Early exercise of stock options, share subject to repurchase (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sibn_ShareSubjectToRepurchaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Subject To Repurchase [Member]",
        "label": "Share Subject To Repurchase [Member]",
        "terseLabel": "Shares subject to repurchase"
       }
      }
     },
     "localname": "ShareSubjectToRepurchaseMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_SocialSecurityTaxEmployerDeferralCARESAct": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Social Security Tax, Employer, Deferral, CARES Act",
        "label": "Social Security Tax, Employer, Deferral, CARES Act",
        "terseLabel": "Accrued liabilities and other"
       }
      }
     },
     "localname": "SocialSecurityTaxEmployerDeferralCARESAct",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sibn_SolarLoanAndSecurityAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Solar Loan and Security Agreement",
        "label": "Solar Loan and Security Agreement [Member]",
        "terseLabel": "Solar Term Loan"
       }
      }
     },
     "localname": "SolarLoanAndSecurityAgreementMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_StockIssuedDuringPeriodSharesRestrictedStockUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period Shares Restricted Stock Units",
        "label": "Stock Issued During Period Shares Restricted Stock Units",
        "terseLabel": "Issuance of common stock upon vesting of restricted stock units (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockUnits",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "sibn_VariableOptionOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Option One",
        "label": "Variable Option One [Member]",
        "terseLabel": "Basis spread option"
       }
      }
     },
     "localname": "VariableOptionOneMember",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sibn_VestingOfEarlyExercisedStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting of Early Exercised Stock Options",
        "label": "Vesting Of Early Exercised Stock Options",
        "terseLabel": "Vesting of early exercised stock options"
       }
      }
     },
     "localname": "VestingOfEarlyExercisedStockOptions",
     "nsuri": "http://si-bone.com/20210930",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r284",
      "r379",
      "r380",
      "r382",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "SeaSpine"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r224",
      "r259",
      "r286",
      "r287",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r418",
      "r458",
      "r460",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r224",
      "r259",
      "r286",
      "r287",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r418",
      "r458",
      "r460",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r224",
      "r259",
      "r276",
      "r286",
      "r287",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r418",
      "r458",
      "r460",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r224",
      "r259",
      "r276",
      "r286",
      "r287",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r418",
      "r458",
      "r460",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r156",
      "r157",
      "r268",
      "r270",
      "r459",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r156",
      "r157",
      "r268",
      "r270",
      "r459",
      "r470",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.",
        "label": "Accounts Payable and Accrued Liabilities [Member]",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r32",
      "r387"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r18",
      "r160",
      "r161"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for doubtful accounts of $264 and $263, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedTerseLabel": "Accretion (amortization) of discount on marketable securities"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities and other",
        "totalLabel": "Accrued liabilities and other"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued Liabilities and Other"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r34"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional services"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r30",
      "r188"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r21",
      "r46",
      "r47",
      "r48",
      "r450",
      "r465",
      "r466"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r45",
      "r48",
      "r54",
      "r55",
      "r56",
      "r96",
      "r97",
      "r98",
      "r341",
      "r461",
      "r462",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r19",
      "r318",
      "r387"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r96",
      "r97",
      "r98",
      "r315",
      "r316",
      "r317",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r288",
      "r290",
      "r321",
      "r322"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r290",
      "r311",
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r25",
      "r162",
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r63",
      "r79",
      "r244",
      "r369"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Common stock equivalents excluded from computation of diluted net loss per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of a real estate property.",
        "label": "Area of Real Estate Property",
        "terseLabel": "New lease, area (in square feet)"
       }
      }
     },
     "localname": "AreaOfRealEstateProperty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r90",
      "r138",
      "r147",
      "r153",
      "r172",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r337",
      "r342",
      "r358",
      "r385",
      "r387",
      "r434",
      "r448"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r43",
      "r90",
      "r172",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r337",
      "r342",
      "r358",
      "r385",
      "r387"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r165",
      "r181"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://si-bone.com/role/MarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "sibn_AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Short-term investments",
        "verboseLabel": "Aggregate Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r291",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r344",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r82",
      "r83",
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Unpaid purchases of property and equipment"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r28",
      "r81"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r76",
      "r81",
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "End of period",
        "periodStartLabel": "Beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r76",
      "r359"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r28"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Equivalents, at Carrying Value [Abstract]",
        "terseLabel": "Cash and cash equivalents at",
        "verboseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper",
        "verboseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails",
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r40",
      "r195",
      "r438",
      "r454"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 6)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r202",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r96",
      "r97",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r17",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r17",
      "r387"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value; 100,000,000 shares authorized; 33,450,995 and 32,583,220 shares issued and outstanding, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r50",
      "r52",
      "r53",
      "r59",
      "r440",
      "r456"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r87",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r277",
      "r285",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds",
        "verboseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails",
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r65",
      "r420"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r88",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r238",
      "r245",
      "r246",
      "r248",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/Borrowings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r89",
      "r94",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r228",
      "r234",
      "r235",
      "r236",
      "r237",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r251",
      "r252",
      "r253",
      "r254",
      "r370",
      "r435",
      "r436",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r15",
      "r249",
      "r436",
      "r447"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Principal outstanding and final fee",
        "totalLabel": "Total principal and final fee payments"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails",
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r221",
      "r251",
      "r252",
      "r368",
      "r370",
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "negatedTerseLabel": "Unaccreted value of final fee",
        "terseLabel": "Final fee"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails",
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r36",
      "r241",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Effective interest rate during the period (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r36",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Fixed interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r38",
      "r89",
      "r94",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r228",
      "r234",
      "r235",
      "r236",
      "r237",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r251",
      "r252",
      "r253",
      "r254",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r38",
      "r89",
      "r94",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r228",
      "r234",
      "r235",
      "r236",
      "r237",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r247",
      "r251",
      "r252",
      "r253",
      "r254",
      "r262",
      "r263",
      "r264",
      "r265",
      "r367",
      "r368",
      "r370",
      "r371",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r31",
      "r234",
      "r369"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedLabel": "Less: Unamortized debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r79",
      "r186"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r79",
      "r137"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Incentive Compensation Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DueToAffiliateCurrent": {
     "auth_ref": [
      "r12",
      "r92",
      "r380",
      "r468"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Affiliate, Current",
        "terseLabel": "Outstanding liability to SeaSpine"
       }
      }
     },
     "localname": "DueToAffiliateCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r60",
      "r101",
      "r102",
      "r103",
      "r104",
      "r105",
      "r109",
      "r111",
      "r113",
      "r114",
      "r115",
      "r119",
      "r120",
      "r348",
      "r349",
      "r441",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share, basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r60",
      "r101",
      "r102",
      "r103",
      "r104",
      "r105",
      "r111",
      "r113",
      "r114",
      "r115",
      "r119",
      "r120",
      "r348",
      "r349",
      "r441",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share, diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share of Common Stock"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r359"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation cost, expected period for recognition (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r312"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r312"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost, stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options",
        "verboseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r54",
      "r55",
      "r56",
      "r96",
      "r97",
      "r98",
      "r100",
      "r106",
      "r108",
      "r122",
      "r173",
      "r261",
      "r266",
      "r315",
      "r316",
      "r317",
      "r328",
      "r329",
      "r347",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r461",
      "r462",
      "r463",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r350",
      "r351",
      "r352",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r236",
      "r251",
      "r252",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r351",
      "r391",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r350",
      "r351",
      "r353",
      "r354",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r236",
      "r277",
      "r278",
      "r283",
      "r285",
      "r351",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r236",
      "r251",
      "r252",
      "r277",
      "r278",
      "r283",
      "r285",
      "r351",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r236",
      "r251",
      "r252",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r351",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r236",
      "r251",
      "r252",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r391",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r355",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r166",
      "r167",
      "r169",
      "r170",
      "r171",
      "r175",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r185",
      "r247",
      "r260",
      "r346",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails",
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "verboseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Loss on sale and disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r79",
      "r255",
      "r256"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r64",
      "r90",
      "r138",
      "r146",
      "r149",
      "r152",
      "r154",
      "r172",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r358"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r190",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r91",
      "r325",
      "r326",
      "r327",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndemnificationGuaranteeMember": {
     "auth_ref": [
      "r203",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor.",
        "label": "Indemnification Agreement [Member]",
        "terseLabel": "Indemnification Agreement"
       }
      }
     },
     "localname": "IndemnificationGuaranteeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r57",
      "r136",
      "r366",
      "r369",
      "r442"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r42",
      "r387"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r67",
      "r135"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r168",
      "r433",
      "r444",
      "r469",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/MarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal for lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Renewal Term",
        "terseLabel": "Optional lease renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r33",
      "r90",
      "r148",
      "r172",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r338",
      "r342",
      "r343",
      "r358",
      "r385",
      "r386"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r24",
      "r90",
      "r172",
      "r358",
      "r387",
      "r437",
      "r452"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r35",
      "r90",
      "r172",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r338",
      "r342",
      "r343",
      "r358",
      "r385",
      "r386",
      "r387"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r40",
      "r195"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Liability associated with indemnifications"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Costs to defend lawsuits or settle claims"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r15",
      "r235",
      "r250",
      "r251",
      "r252",
      "r436",
      "r449"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Outstanding debt, net of debt issuance costs and unaccreted value of final fee"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r94",
      "r208",
      "r240"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r94",
      "r208",
      "r240"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r94",
      "r208",
      "r240"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r94",
      "r208",
      "r240"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2021 (remaining three months)"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term borrowings"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsSummaryofBorrowingsDetails",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r38",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r204",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r204",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Marketable Securities [Line Items]",
        "terseLabel": "Marketable Securities [Line Items]"
       }
      }
     },
     "localname": "MarketableSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesRealizedGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).",
        "label": "Marketable Securities, Realized Gain (Loss)",
        "negatedTerseLabel": "Realized gain on marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in marketable security.",
        "label": "Marketable Securities [Table]",
        "terseLabel": "Marketable Securities [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/MarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MaturitiesOfLongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Long-term Debt [Abstract]",
        "terseLabel": "Future principal and final fee payments"
       }
      }
     },
     "localname": "MaturitiesOfLongTermDebtAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsDebtMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds",
        "verboseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails",
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r123",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "The Company and Nature of Business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r76",
      "r77",
      "r80"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r49",
      "r51",
      "r56",
      "r58",
      "r80",
      "r90",
      "r99",
      "r101",
      "r102",
      "r103",
      "r104",
      "r107",
      "r108",
      "r112",
      "r138",
      "r146",
      "r149",
      "r152",
      "r154",
      "r172",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r349",
      "r358",
      "r439",
      "r455"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Standards Not Yet Effective"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash information"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r138",
      "r146",
      "r149",
      "r152",
      "r154"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r372",
      "r374"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases, Future Minimum Payments Due",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Aggregate Future Minimum Lease Payments"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r372",
      "r374"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r372",
      "r374"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r372",
      "r374"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r372",
      "r374"
     ],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesAggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases, Rent Expense, Net",
        "terseLabel": "Rent expense"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r34"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsAccruedLiabilitiesandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r335",
      "r336",
      "r340"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Unrealized gain (loss) on marketable securities",
        "verboseLabel": "Net unrealized gain (loss) on marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r335",
      "r336",
      "r340"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Changes in foreign currency translation",
        "verboseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherEmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred for employer-related costs classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Other Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and related expenses for employee payroll deductions"
       }
      }
     },
     "localname": "OtherEmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Interest and other income (expense), net:"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Underwriters option"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedTerseLabel": "Payments of prepayment penalty and lender fees",
        "terseLabel": "Payments of prepayment penalty and lender fees"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payments of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r291",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r16",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r16",
      "r387"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r26",
      "r27"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate [Member]"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from follow-on public offering, net of underwriting discounts, commissions and offering costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from debt financing"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r71",
      "r314"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from the exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from issuance of common stock under employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r30",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r29",
      "r187"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "verboseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r10",
      "r11",
      "r189",
      "r387",
      "r445",
      "r453"
     ],
     "calculation": {
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r10",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Schedule of Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r10",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r62",
      "r176"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Bad debt expense"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "terseLabel": "Purchase commitments related to inventory management and training materials"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r284",
      "r379",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r284",
      "r379",
      "r380",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r379"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Reimbursement charges expensed"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r284",
      "r379",
      "r382",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r377",
      "r378",
      "r380",
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransaction"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayments of debt financing"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r324",
      "r419",
      "r484"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units",
        "verboseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r20",
      "r266",
      "r318",
      "r387",
      "r451",
      "r464",
      "r466"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r96",
      "r97",
      "r98",
      "r100",
      "r106",
      "r108",
      "r173",
      "r315",
      "r316",
      "r317",
      "r328",
      "r329",
      "r347",
      "r461",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r133",
      "r134",
      "r145",
      "r150",
      "r151",
      "r155",
      "r156",
      "r159",
      "r267",
      "r268",
      "r420"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesRevenuebyGeographyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Geography"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Net proceeds from sale of stock"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares issued (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Public offering price (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities and Other"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockAntidilutiveCommonStockEquivalentsExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Anti-dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r38",
      "r94",
      "r251",
      "r253",
      "r262",
      "r263",
      "r264",
      "r265",
      "r367",
      "r368",
      "r371",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Outstanding Borrowings"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Computation of Basic and Diluted Net Loss per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/NetLossPerShareofCommonStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r350",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Schedule of Aggregate Future Minimum Lease Payments"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Future Principal and Final Fee Payments"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r30",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r381",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r299",
      "r304",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock-Based Compensation"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r291",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Unit Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r293",
      "r304",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Valuation Assumptions Related to Stock Option Awards"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Term loan"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Canceled and forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Canceled and forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding, end of period (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "terseLabel": "Black-Scholes option-pricing model assumptions"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, maximum (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, minimum (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, maximum (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, minimum (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockBasedCompensationExpenseDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Canceled and forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled and forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Stock options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value per share (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r295",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, end of period (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r289",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansRestrictedStockUnitsActivityDetails",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r308",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansValuationAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock as a percent of fair market value (percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Stockholders' equity, end of period (in shares)",
        "periodStartLabel": "Stockholders' equity, beginning of period (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r86",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r41",
      "r54",
      "r55",
      "r56",
      "r96",
      "r97",
      "r98",
      "r100",
      "r106",
      "r108",
      "r122",
      "r173",
      "r261",
      "r266",
      "r315",
      "r316",
      "r317",
      "r328",
      "r329",
      "r347",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r461",
      "r462",
      "r463",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r96",
      "r97",
      "r98",
      "r122",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r16",
      "r17",
      "r261",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock related to employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r16",
      "r17",
      "r261",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock from public offering, net of underwriting discounts, commissions and offering costs (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r16",
      "r17",
      "r261",
      "r266",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "verboseLabel": "Issuance of common stock upon exercise of stock options, net of shares withheld (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r16",
      "r17",
      "r261",
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock related to employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY",
      "http://si-bone.com/role/StockBasedIncentiveCompensationPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r16",
      "r17",
      "r261",
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock from public offering, net of underwriting discounts, commissions and offering costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r41",
      "r261",
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options, net of shares withheld"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r17",
      "r22",
      "r23",
      "r90",
      "r163",
      "r172",
      "r358",
      "r387"
     ],
     "calculation": {
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Stockholders' equity, end of period",
        "periodStartLabel": "Stockholders' equity, beginning of period",
        "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/TheCompanyandNatureofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Components"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BalanceSheetComponents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r166",
      "r167",
      "r169",
      "r170",
      "r171",
      "r247",
      "r260",
      "r346",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails",
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r93",
      "r277",
      "r285",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. treasury securities",
        "verboseLabel": "U.S. treasury securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/FairValueMeasurementDetails",
      "http://si-bone.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r110",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average number of common shares used to compute diluted net loss per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r109",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average number of common shares used to compute basic net loss per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://si-bone.com/role/NetLossPerShareofCommonStockComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://si-bone.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123389529&loc=d3e10037-110241"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123408193&loc=d3e13051-110250"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r485": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r486": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r487": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r488": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r489": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r490": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r491": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r492": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r493": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r494": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r495": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r496": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r497": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r498": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r499": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>66
<FILENAME>0001459839-21-000061-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001459839-21-000061-xbrl.zip
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M1UNMS=/Z^X^GC=;F>6-WG>\??3RO?_F<-RX:AW6R<;BUMG^\MWMPUGC?./Q
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MQ,8.Q@\NX5XD>47,2$8%MHJP:+TWQF(+CO0$P)V)?M,D0C\%'86&KB-&,4O
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M;^8 4L&I=&"TP-@R^%='BTB@H51W-I"Y *C5"D4J\;>!GID18")R%OFT[X,
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M/:@]"^;:1NR(!SZ_#.*.T]U<$'<DQ UIT3^*BD&M*>97EC"C R,!1T[4+$Q
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M*W!EB<=.6Q#N2$ !8.V4-T1AL+UFAH*2*23,^&,3$63448%I]I%A)362 I1
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M3IDPDXK<L]*O;&;9RIVR'5M7;P=>'$0M4!R].(;7S[XB4!G>").A0%W&9(#
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M8;KT9K,76K7DQ)K;CMDD)IH6$#\#Q!N70\?E5J15:MI/ 3Z:/<A+U?6PDEK
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MB3-%E2Z3E Z\7:)V;Y#.!WK'N7Y)W]I&OTA-; $TKVIY_$$B7CDH%^Y4\VH
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M)BC0/FAB(O,ZV6R>L:ZDJD5!H64GH1\]A%?C=%4(+PW"4P\K^U&.2Z;!(>6
MT69?2S,#TA#!DK26&)HAS#.$:USW/F"X,_B4-_AP]+6&<N_5@CB70V:=2C?S
MT$UOQF+@.BL$'31$6RP&2;.W)A2"X]ZP2$,4&DN<MIL-]A;%<VJ8=ATMA@K9
MVT-V:B%0)X0PE@)+5F3(NFSD)V00M4@!)6JBP\:FZ$J^<$U*^R*P:V @/!_%
MC[;7]'^+@_&%L<'^0IWGK0R(1^&_K,2 .)73]HF8M@9AO\AHJQ%-=6-N05*S
ME7/"2AVCH* LR6X,BP8T8RG_X)X(@<(0GNV*KN&7X\ U$/%@@+P2LZ(">>E
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MR"E@"<&92@'W0P%[4S. F<0L%0QD5)D"%)>@?9) @J3)>&*-9QN;7'45KV9
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MK;FWVRBF!;.S53'=,2?-%-HIPG54$E@L)U<M9>"4Y9"0,NN"1!GHK133RK9
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MJF*J8JIBJF*J8GIT8JK)^>L$UYC=X.Q)*^.CCW$PML4:K%GV&G"L8JIB:E]
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M+)%H[G"8^FPOI_,&3S7X/@_]OM\Z#[[O'^SPO:VW"B5ERD>@W&4&5LX5$\F
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M",:H4M):Z=S&)NL:44M=UHT0*F]7,54QK6?RM:K7]56OLTE<*9%G% 3@05!
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M]*&8Z]V9ZXPV1"VPR-MAGN=@A"81:<89"M1'C[U43MC<A/#R)OTS"46L.6T
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MO)1(QP+M*$6.GQ3O6"B=NMT+I7KJCT'50OTY"[X0EH(C(HE"7"F'+,816:U
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M#+\F^^E/[L1)&?"ZG.EYFE[1\A#_P?CLK!MS)23;K7KZ=?O#\: ZO0TSAZK
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M__H8QK)\;9K!:<]OMG[*E;S_O_]'4XI_;2:]^HW\^G/KJQWFX_O]P5E_4+&
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M:F:!AM?G#N;;2)S&T4F_*C1?O<JTRT(S(9.^$76YV?S!Y>_"_/6_UG7OP8A
MD:JR]C-%]^/3<<U?4=V!8:[G;M/N)]>R[F5=FFAJU8VKZ5 :[2!_-M7F2=?9
M-)W]:N+K!J0P@>;JF:\^1O@&\]O)7:OS"!O*D.^3*VT/^X THTG_TTGGC84'
M9&QHC.QP^6RV3N'UJX8*^?NY^7AE2!;,-M0*"R\_Z%=RS>TJELQY;SKO$ZUN
M6I1,='8BR)DZC)HF X#VU5Q/FHO80;<3AZ-))X[JB<T<3^OI9@.[4N7W^E_J
M\G-+)[\UG??<''8"CW4#CZ:;&=RI/[C4GV/^+2ZIX]OQ(#=A:;?".$Z4"&1F
M_:P[\_Y_=EZC/*!.TS$CASJN&A[%"(M\HU3?N!5B:KHK+ ZKFF]P^>I65_F7
M2NMS0X9&/YL5HZJ^G&_5K!LMD$T\[@^J_BEO^Y?[Q[0OR\Q%GWMAST:0GS?7
M^6)8]XK/?UWLR5PO$W5%I6&\\)69"E3^T;135ZVS1+0K&*H'.7V+Z6LN&68G
MMX?_^IUAWNB1N9EU+USU(C>Z7:NY$]ULO0&U/I\I:R<K3^[9 ;<][8PFS:]S
M\>S) ZM?K^XKGOO5G%?K5%:;S=9" >ZZHW955'O21FW16"JE[,Q!P,1LY][K
MR@[<B\6^.].>)O""\8OMCJNZZY=,8/YI_:87RK6=>3J])EA7%]SNG#9(4;4E
MF<+M_'!RN7'?.:LLMNID5/4;BE_B .Y\5D6>)HT00V?65:F6PT)/E3S#U=IA
MJT!AZR?R<^Z96#=(K-?W_'+P7LUR#^O#<,8\?J(_UW7(N_#].3!/\.S.L!I6
M#2.UT?S$9G<_RX#4'P]A0L&/J,CYMZH/7B>74@>1#O*RY?M#&/W7JL7BI.%+
M%N/T*[:)R^:^+-L'KS(CW%RN)B<7P70BL6Q74ZE536:J7DUVUBAO(N):HHO4
MKGK8*0QSH>%?\XVODZ[C=2_+:H&>/+L_J=[?D*/+_&RQZ^9Y_:CI2#NU?4P;
MRX,8KQAW@]6SDMH+.CFGB5GI>@".-9'Q=GB2NQE]O=@$\!:NWB.[,LV:-'5C
MKN K$A'6KO\R\W1V>D-P=:N)0J^ ;8,E_;L_G'-&&)4__]+:K<EXQ;1@/A>O
MS+V5EMUP<_GJ#<MC)[.L\V:9GWV@*PG-EGF2+UP@!;695.2FL4K0AD&^8B+J
MZ:AG3'.J7#5;J+V N99?"YW:JA!ITT,MV\#BB_OZQ;OUB^?1-EVBJCL G!S#
M"ER;;X7AS=>KU6^JTXLWJ9>XR?0U)G)=!]A)+ZK<*ZU3/RT/9J[%:_YU.#Z;
MMGN QP 'R+AC77^<O]G-&#NUPNWZP1-".2-L#1E9W@1WPO-'3?O;!<.MFK)U
MZYYT#8]=C>35WZF97D6CALMX5#]=4O/Z#VD)-YKUUIMOG@4C'9Z"C.)@KH'?
M[#L-26[XRSS/ZJ]()]ISZ^*-B=9L[N:"%M]GH/228S+E6(-X#+:0!U"[ (!3
MQ]7+A+X?3QV5]HQ"94>O\8D7S&.Y/C\@Q7#CO($4YU>,ZL8W7?:^LWPL>]X5
M*_#]$+6[6IOR_L_CK4PUR$]:"WXOA$$)PKS^I7%[WDR\]3]@7@Y.LLDV2Q*5
M^.<VS)FK6GD2^NONW()06^N;O[.:C3O#DUI5?CH8NU'U9:XP$OG[69"Q-ZR^
MU-RG=3#J^\\+GTR>J8C^N;:)U['J8EFUR<F__V\,QY7G7MUBLF]=.7%OJC#&
M--*T_Q7^! O%Z'QN/)H(U.+XYSHN.YBU+YRM3UEQ7C5]1Q=?%3Z8-$:L%K^W
M@Q@K?:OZQ5:/0J\:%@M:_=<@.RR]UJL,9OMU^]*)4UG#11.^B)/E)(Q];ET.
M+SL85J&]W.BQEN%LJ'9QJ*<7AQCGAYCFAQCK(?K9$+\V0_05WLYW@8=%N&J\
M6D_@W%=JJ)U_ZOQ#866;QI.&)Q5SG2S*L[6DB@%=ND4.1$W:3E87K#[V^:$/
M5QY[;LB6^E5TYI=6Y^?:T?SN,*O'5?'7L]P@-Q/R0>-U  #/@??U;]N;>3L!
M3 U$/R%V^>K*W('6-]A?]U+M=[_ Y:BZW X&^5:-^>5^W0"I^6W;<"4LY8-F
M''FLC<6'QJ*S.L(-Y_XZ]_!9]UY;LX%)]]DJRC'ZFEOX5BAK.X-67G"FS6^G
M,;&Y&5XNM*S[R^X!<[OL\L[I*4P"S"Q,L8N9:,$"EJ6P](F_MCH344XIQ=4F
M,WW-'$<>PJ^=+)KS]N2E;O.:0,0&]_>>]7)I069A$A&H%\1QO2%2<;"%0$]%
MDB<QL!M'?B;<BOP8M[H,#SG^>5ZOY;/!G\VBJ-TJ,/T]E/.9\U3QCMJRTFAY
M!+"1V.PQ/TR>FCF]*77:;/UUTNG&A:#),B8U3V8:<IG7Z7HCI^93,+2)0[X:
MG6I6F!J1&@HUSCM=.5:9HP6=.78WFX=9E.B""&!,^=US7[;5EI?VPH2N3 NK
M]Y@??\4Z0SRK&@)/P,@W%_K. %AV'J&OU\,\]<W^DF^E\:A:F'*8OLZTNABE
MN-0AK.0 ?2<'B/Q@#E!^M2I)PF$<L'14$),X)=$I9IFU6@:K"??V(\OY'25Q
M: V'NTZ)0U/%>^A)8/?>AW*G!XY0M04[W.EEGVR[%W;MX'.LPDZU#W(0 ;^K
M91T^;#R9PX&=I/*.AJ^G\+DV64KG39;2Z5YW]].?W0^G[]G>Z?OSW4_OZ-[A
MR<G^X1$Y.GU[NOOMS\\?3M]V]DYW+V4I'='WYWN__^?TPZ&G'PYAG*^/R/[O
M;\3>I_]TCOXZ^K;W^Y^G1W_MT*-O.4MIYWSWZ\? !2$Z.11-/I1+'4>&.H<4
M]8%*'@A6\F*/2AF)PBZ8$#CE)F*K%8TX&6ETXD+RBTE-,^FT9H*YMO7DU2J^
M-"ONVD%=95%+ ^SJT8(8VW7KVT5.<#J;P>%T!EM?8P[T?K&=;OX$ 8%%N4%N
M'27.G\WQD&E\%VX,W!O(5'.7S=;N\IOG+(':CZQ"=],O3&*P$T)Y-AX #QTV
MY#(WQVM2>++3EC?#[.)(P+VHMD0R5P**6;/#@UF>2F=FW]57Y\94.0K]00>6
M?F!$S9#.:U_PPD K,KN87S0_MCQ%F>;-FO4NI!\U37BO&T]V&>HP1I4)\J,#
M6WCR31:!:U3V"INY1TR>J=#,P%\TL!Y_5-%RK&E$3#J&N,ME;"R@J\(I0RY/
MR=L;9'_.YSNN+VA=TX5X*7S]LDJJY_J^>JLUY6T/WK182ODC38N9W!3R'GK@
MLDU D7OH TPY+8.]A\'B34-_N#?S]P=[L\;-M^TF2,FE:Y]$P\"%MK>M2ZTQ
M2T?;RU.V?9HWR7-JTZO^<+0FO6U7/4&XWE/\O@>LM$X?^SWO'I5)OM])KI.9
MRBS?!UH<'^>L$W!0W^:=IO_DG:8[A=BYE>?YS-H+[V.[V^_%\\97:25XE]+,
M]J6T/F(::\:B]9X9[B-VX+S;% GW2KGH],>=.RC*\\H.3][,@E[;HU=V,#B'
MR:S@:7WJ2OQ8O*2N*_$IG,+G>._3A^[NX8?3?+QV]]N.V*/_Z>S2'7QT^/[;
MA]]WR?Y?>]V+=27VZ)'8R\\X??_WWNF'?+SVV^ZGS^S#7SO?CC[]>;)WN/?Y
MZ-M[<43_L]BNEG(6#4L<&><5XHX1I*FQB&JN.1.4&:HWM@1O4Z+7OKE1:?[X
MK#&I2=HK6E>TKFA=T;IGK76%?SUG_L6F_,M3D)GB%DDN ^(1&V0%CD@83QF6
M/ND8UI!_7>/2KE^)KJ=RY1UUPZSQFVY2L>88_NI"-L-MFF->&4QZYDU]3'"4
M<65Y;CYLF'<1"T:(9%@1HHPL"\!Z+0 +C1V\-2HXF9"--B$.2SC2A"DDC>5!
M*Z6TNS,'?"4[>4(=]9Z5X?^8OU%$6T1;1%N6Z[)<W\=R/>>O<>%-XA%Y1CGB
M @<$OW)$G/-*$A5C\$]JN6X<C@N'D BOS/J.0D^KW./ZM[W-W<L(G^0([\@K
M7FM/^/WFP69K-*A.NY_/I?K>QB-^W@MI$HXDI0/QGO#@F$U)24X=TP$+P]VM
M%M)AQ_5^V9Z<#WG;'QS @IE/3,V2]%_5QURGV74YN>ZW7.ZT+*^K+*_SV]$Z
MJ&"CYL@:3!&WDB$=I$66>JQAV:6865A>:9MPO/9=;$L7^4<P[96MUS>%:F/X
M?= ?#F<YACF/\[>J<,):=2YY&B8]ZZ;';*!!8X$B4P%,FCCDDHI(1^P)U103
M&C>V;MVTI%CS<[3F^84Z=?Z. 7V+@_Y=6GE.)"Y6_H-6/M?'#6O)DXB(!:SS
MPJV0]D0AIH77E'N'L9D&P(JM%UN_573KHLW/['VI]1>S7LVL9^&N&*,)T7(4
MB0(^;EA CC./M V)2.\8=:+AX^NT@K^$C/M7_<%9?Y"/:;C^DG3[&R'235._
MGC0B8<>%LHP)I@073ADJ#&BO$L13190I88*G $O[K^8WS2FWQNB$F,<&<1$X
M<MX0%!4.6E)B?:Y90L0==NA>HTS.8MIW:]KWXUB4\,$M3'T6/E":2NUR6F3@
M&''""+):2/@U1&FHBQZ$>U>.1;'U![;UGQ[$V$NT8"V,>A8MX,Q00IA#5DJ+
M>!01.8$3\L)R85W"DO-E,<&?BR6OJR6O"R$O(8('L>6Y$(%WDAB-D;))(FZX
M1;D<&A) PPGF%#Z4#1>_]9;=PYU@>!8I!:_ZIZ=Q4%5 /K-G<5!2":Z")!V]
MYD8128CC\/\F.4PCB]7)*A=IB1$\"5R:3ZR/'FLG)45..HZXT@HY'&CV(\!G
MT)%J:H!CL#978HU"EV5#8BU-N\0(UL[49S&"X(--5E&$+1@X)S8@HR3\XQQU
M)IC Y=W%"(JM%ULOH8,'MO59Z  +3;EQ"6EG+.).:C!S[! S!@OIJ [<%ELO
MMGX[REZB" ]BUK,H0HA$>!H]TC$QQ$7"R$;"D<56&49 I'(=V?H=)1H\F>/Z
MRUL-W";WX,85()\?@MWK0< 2='BH<BZ'VQ6$55#V[F,*1%"K%.*2>\295 A(
M"?S*21*$1!:DV-@"76D;?5<575:IHOI4MD *+OP +I3(Q)K@P?D4#[SEF@FF
M 0^"0QRG') D'B5BX,])2Y[S%^XJ2ZD@P?HCP2HY#^L !25P<1LHV)M1 T:%
MEHE)%*P3N=8;0<8:A3P/3&&-;4CA3K(>"@JL/PJLBY]0(AT/A ,S2F"E5Q9;
MB81('!P#PY$5RB'BI8R1&V,]?7(N0JD(^3@5(==OP$_ERC*QZUW#=*T#H8?]
M4=6L=$EOQONI[_3<2G*O]O*%R]TXYKNLG>Q"B+=0MY6HV[N%Z"XGT1,N$2?"
M(6XY04X$BZ2T!$?):" F)[N*-L7R2=1_NZ-]Z0)R!>3N-FJU%,=*O/I^$&[F
MG'*5F)0T(AH].*?)6:13T,A@GH+5D3/L[ZY<3\&V@FUK\-8/'I)?#=Q*!/XV
MX#87@5=$:D4 W *A0-\,]D@+DNL569K/*\64[.TB\ 77"JZMSUNOO6.:.PR7
MBN0_A&HSRJ:<UM01BHQTN6BJDLAJRY#V2B0;0PBY:.I3<DJO*$HNOE.4?/56
MWGGL# 88^N,<P/N!GN#EF7?QS/L5=KGTZDG_1X7&\-_0^;+U3_AG\I53.SCN
M].::W5_NO9YE4P>^%P0/S^_:LV'\9?+#KY,=@DZO6I^J+_VZ^("<]7P!#ZKG
MU1__^K431B>_:+DIJ,J+6K.UT#RX_I1L5NO=!?BJ/V-R4]*K/\:;Y,K/OG=;
MPC8%EC]TV^\_DG+^X@<KI;J'P6)]+X/%U-SHMM=LC%V?)D,N7;N$>]?V^3 \
MU%R@H6HI#7T=?3QU<=!BI-T"&HD7V,9M9V7IXG-MDL-ZS]ATPZ:5=VRN/%^Q
MXJO?? IGR'_A5L]GBF?AE58.'E]]B*5,\IU,<@YB?:>;29GE6Z#%\?$@'N=2
ML-F?;E4.]9U"[-S"\WQF[:=.KS4ZZ8_A%F'X\RKS]2SJ!^_V>_&\R6!II?&2
M$L*KO.USBP(^ZX[Q"7N'@V6,2\>=5<9*XZEF.HK G:IC?9A01DH'PN_'^][A
MO=]WZ?[O1_S#[^_9T;<_N[O?X+F'.WS_</=\E^Z<'YV^X4>?/GR^%.][_0X?
M?8/O?3KY_.$P?-K[_?TW>,>_=S\=YYCAMZ-/_^H<'9[ \_Y,NPLMD@352;J(
M@O0FUS5R2$<5$..$!Q\5 ;W=V.*B;?@Z=8R_HR,#!9.>$B;]6,/;HG5%ZXK6
M%:U[6EI7^-=SYE]S':"98%1*C[P-"O$@#0(^)N$GSKQR)G>\6D/^=<,0P%-
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M]':UABE%F4=4Y3S?0 6@@#5(6.R3(A&#P(-K\#/-76L8>#8PL"R!0KVC\4A
M,.D3J.2I9TAE]>=)8^2TX@A"!"N\LRPX/XH1R'/Q#&[8"ADU680GB=>C2/W)
MZ4_6$UM/[//ZY"^4+[3?Z=O6L =5U4SV2EZ,:0*185.W.2V&7T33^GN:A-J%
M^ZGF]5-;N[7'MI#']GYR5U=R121+'I&0\S:C4\@&\-VB2$)+;Y2V&#PV@U<I
M7K2PXGY4Y7$.DVN,JS'N83>KYL)8O4W],  W#DFE2Q$KKQ$3VB)N&$8FR @
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MN)LNL'BC?-Z-=OA[_+A#H B[[0_9V^W"HI<52?M9&%XP8N/#()*C)#A$A.:
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MV#+*K/2..O&8AV_R>8+EG9D"=_8WQ.X^@.G^P?GNYM<?C;/#W/N&T$ ![V)
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M%?UR,)8/):*8$(E29'=!P+M/25G^ZJ9]E 6YR&M.\9I3_.709-><XC6G^"_
M*5Z=1M*)'-.;$E6?XC1N9$/SWG=L]\:YIJ-]QN'&4>^G*&R?]\GLRV+I?93<
MDJV3TU;G/,8/E91->'!O!MWNKY,F]_5\=W,G?^_[P<D.;_R [WSZ]WAWWY\U
M/FWCW<V/9XW] _KY9.ML]N1U=Q]\_Q\Y'GC;//AQQ" 6$)\_;8G&CPUR\.4]
M;^QOD,87B SV7T]SAUMIDQ&"(I*;HO&D-=*$6^19Y I;Q;4/*^MZ5>#+F\?/
MODRV1J5?%)4>)16D1J5[1J5Q/@BCQ"9K/,)12L15(LAXRE B3!A)M'"Y":)9
M)4HL$2K=X J.(FX8;+P>R![KDPO[KJG\YVZ%54\!&5=EKHS\V--N)\5>#\3&
MMD:Y%+WBR@#RNN*).5/S3(HG'L7;NU0>D>?_GXGI?QMKW+P+;DY1G%ICO$A$
M(H%YJ!(!3/02.6E@K4ER2>5T8;)HY_9; L&#^G(SM[Q3A=.+4-*[.S^UDCZ<
MDHZ=&ZND-C()I+D5J&0H,MX1Y&R4!@?KA"4KZX+\=,!UCTKZZ[LVSWE;KCS"
MNK3G]HO7?"[;)E6Y")>/G6NXO -<3I9 X2"M4]HB 0N(>. 26<\Y8C(*DZ(2
M7,?<1(+B98H%Z[KM)?5J:C6]3S6=(&XW,5(#44=,)")NP*MQPEA$A&2*<LN#
MM=FK>49$;@O'(#=]KZY>?+P)^F6 [[&8:6I _'E G#Q94UX)XS!&*EF%>#(!
M:<(<@A<5,11L6>YD0? JIS_MN-R[^CSQ9DX-I#60+I$'60/IXP/I1!=!F9B2
M(N7.G2J72$;D@@R()A&UC4E(ITL@)>:^]K6?'DBGR\8KUKZIW/EYQ>03J<.7
MDNJ&^KG^/Z[[Q_KEC.-2),%:!2QSL;U)G)+H% ,EL5H&JPGW%I9BY?IR[\<@
M1)R?WBW7B@<N+GC3.3EI]LL&1QOM\*:<^:/8]J#CF\V>;W5Z@^[2%!@TFB,M
MWP8M_MSZ#-KY>;_5!$W[WOCRD>]L?OQ^\.6(@U;2S_O;Y/.^_WZIP. +H,+)
MOW"/#ZW=3W\U&YM;M+%_!!K^%I#B2.Q\^=S:^?)OJ_'C;=KY\I4TWA\2;#W!
M@N=*5(RXI01I:@4B-+BH,4F6NPJ606ICV,B@2EV,7&BI 7IY9-R9H$@N4^+@
MWP9,9TL2)M:AS#V<6HG+6C)3?3*I,=42W7S_Z?%ZAIG!EJ6@ Q<@5R0*+H5U
M1$FE39A;-#%4CNF$_64KD=@]C5V;Y[(H^WKU;D/P8):=WV%_3+%0'%L0F0+$
M WG;]K%55DIT+IZZ*HW/14\PS&'[4S=HMO**%3!V'U<+T.TRTW6Z@'ZU> //
M#]]L-VUQ=MSTQSD5MMF%QX /[MCSG&TMUHK)P8![T2E'=/UX>N6 FB7-Q)P1
ME3=X9UMY%'T8WS8L]GFI%_^W;>'^8*DZ@Z/CU>(C>$8P[O\+WPR=D]6I4>9K
M; R.8.WR.%7Y]8M<\3SRF9JN8BNEZH]BX[3;;%WDWJ].,EH48'9.FNUJNL;C
MOR @V+'M-BP5C.4=?!"^L#JD,3@!Y<X4%W:"L* DPX!9*ER<O"Z\6-X))*8X
M:_:/'\H(])JN_>I"/TKUV(=1[*9/W6:_']N-#MCR^+;3W1^.K2P_?%DFX,<1
M.(#;8F?3G^UL[IPUC@XU3BZ0Q!#AQ"$.1@ 90QT"D*5$,89#H"OKO>;W87'A
M+'H79]7L9@*4+#I#&HL6B F 1U@KW@ZZ>3]W6NQ*Q1KJSK<(8MZ"7\#) UF>
MU77;[5HP'94QR7KFP2FSS7;)]0(OP<=[G78[MK*\;@TR(\6TXH#\?;/=9F?0
M*V4PD[:4^M89]*NJ2!ARI?K;DRHVHR@]@,X9><^#N3*XZ?TW]6>WB60P(DBK
M3:9?D,*%()@%"Z:)9XFYX3:1GHYN\&+!33?:W?0AVM96KP_J-V+HN(AM\$L6
M^?VOO'%VF"*#J$1CI(TS$+(0@VPF\--.2B623,1QB%;,JIA#,5ST_CL T"Y2
MC"4]$(!NM%V0MHR+(0+V=DH&E/+O,_ADKDF)E2&XQB)5=B>CYHAS:"QG9\U6
MZP)R"Q"R1N[BF7&?3-3UEI^Z@-W\L5W?[TQ4$LG5"GZSX3PMA14$'^)>N,^U
MDEQ^Q+8.JR_=BTQO-]Y.234X#CY+]AD@1B^VIQ ]TZC'.(WKY0_ \X/8?S,R
M10!(\+"[:;<<9F^_L_4=8"G4@E\)OFAD$AK.*.8))-U!F.ZB0I9)CA)-U!@5
MM<J5!)UVO"SUV2?N5TF8UYKO!<1A=OW#H#NS_B-0NZT(?*@D-=MW\I)7^\O&
M^<[[0Q6%I\18Q(D"F(,8"%D7*4J:I:2%L3;ZE?6*4^0<,.R29<]@LE;\$A'&
MAXS((\JD9B;=\GE[*!2 I!5_PM"%A4?N9>RT,,*NS5= ^6J%L[UF;ZV8O$ZO
M\,<P!15UU]!K >"9[\;TBK,(5F-YF9JFM:N7'W2K>LY)VLRG9NEX=+4:4S?]
MV-D\8CL;N6<A2](*%!CCH%NY'1I7@*D\:B:B25K;!^+S>0):EUI(%A:2<["T
M3F$/KF1$3"J(JF2$J(IFWE1O9 0)X4ZD+"27=\,?D-AE[F[T]7O.0Y@>8FEF
MK_CSM-,K/8%794$QW&?(,C$\[)GXUG!O'H^_8EVOTQKTK_[*A$V1\^K.G\A\
M$'YI:JZ>M\F?Q]UQ:?Y11 ZBLZ\0;,"3O+*M,WO>6_EC^OGAX8=W%AR&=M4\
M/?[$S-^.W-M&KW<;6ZO%=N/--:["L@RWL;N_M5?L[Q9O=D&A&WM;F_FWO=V_
MMS<W]N&/M]N-C<:;[8V_B[U]>&%GJ[&_5_SVL6T'(>_,_;[X$UXM(',WNF^W
M<?TT2E",_WDTCJBW@]SG>J?9;IX,3K*YL:U_['FY%_2VTYTQ1TM%'_4DISM'
MASQ$(9*@* @M(,0SX)@([Y"*C@K!/ V.7SK=B40GRV*,*O%@P%, @Z4X")WU
M22@W>[I3[E24^^ NMCIG16]P K@-DM0K[-%1-Q[E_8=4KAQ8LW+IAN[UZ7#M
MACZR;;5&WK$M*9HO6[97Q?7'1;>U8%.'.HJ6@<C\HZ:;)N.QV9ND65.4WH6]
M29,U(1^ $$FN478[AJ9;TM4L49'J?(J9 PB/L_.5P[E)@IX%>(R>!97.PY/H
M+,,:ST]3^A!/;+,*W=-<DJJ:BN(7S3J[KY+I&7=DRG<9>2T74@:^33/'RQE:
MEB;Q[(Y.RS#Q[!@<E,]?=S]]^+*S#_?8?T\/Z'NQL_\7C"F/M]%J[,/8?WQH
M7DH\>[>-&R?OQ>=W.]_A>8[A.E\^;W[]OG/RX7CGRS;9H1])8W.#-=[]E78F
M*X]XM#$P29$R(2+.-$&:4XZ48]PQ:2,3:F6=J<L$JDM;TO!L !.4@MZBH/'7
MKGEZG+K%6P#+YB N6QKKLT"3R7H 8R3!%@O$((*%X(DSY%@(*"GJ:*#2$^MR
M':/D"Q9^/[L6VT^$)ZPND'X.0+/=WC_K9,>E5V/-(EAS/H$U@7*&/<&9\!VP
M1F*+7((?6@5"84%!8$+&&B%^.F.^]EWF80VO?9?E@I1\&%J#RJ*@,D4NY9S%
M)E-*89,[:F>^4(-M1-HP1:(-GAM<@@K!M0/S$* B:@=F&7992D!YVQET:SQ9
M&$\FMU>HT8+QZ)"2$ 9Q+CQR)#D4B:8Q$ W!$3@I1B_:\K5V46Y6K?WCV(UE
MJD#MJ/PD=,RI#+D2-S;RC&?8R/!1(\<BR#%%6FZ8Y$9*0 YP1[CW"5D<)<(^
M)":C9( H*^N"/T,_9%&*\IH)X?$FJ(:\!XC-:A1<! 4G-WDX5I9%%I'D"5!0
M>(N,]Q@1SAG$:=XSSE?6Y:HD]T6,MVRT")=23F_HH%:V3+NVA=JR563_,^CZ
MXYS<-%OTONM@=JJ:@-ND#2Y5T001<\JR1X67IZ,G]A-//-'&/%=E-MO?X.5.
M][R 8=BJ?+.<E5Q5T<YY- !2,"R K:HJ;73QWN#TM-6,77@Y.\!E0LIX&&7I
MQG\'S6YUI]-NYULSE)68T=O><.+'XQM>TYZ II2#\JU!J"K#>P-_//Y>57Z7
M)36KW\"VBLYX]>"6I[G,#YY@F-4&WSF>>OI\V]9$U\)A?MM1-PX+5\MG[!\W
MNS \V[WH;!B_ER,J2J6LREN/.IU0O7G!=E_F"97#SK-;S4@[PWPN"QQTX4D[
MJ7"#'JQ@KU>58><2Q7:G#U^%:_I85:UWBU8\LJW6>>&:93)3^=CYZX-^KV^K
M_*:IQRHGKIKKA5H'W\UZ+5:Q,E*\L9Z]X J$@_/&&9@;RZ6Q%@F+-<K<&,@X
M"-QU5-3R0'#0^4SANM*414M,[LC85*_TW5?Z1V/C4"0N?; FGT]+Q*,4L,B$
M(UAAXZ/Q8!C,#45(5V7<3C-+C+H0SK)+W"T+]R9S1]>6R;)OPZA.VLT$KDZ>
MNE^B$'+2II=FI5=9E1+^;3?;F*F'GJ9?&-H>L%;-M@7;?MGZK!6@K+V!!5M9
M,4',,#A,DRI<W"S"&\>=%AB^8]L]:<&%JFJWTH+VJD+UYHDK[Y8O,/[BV)YF
MX]GJ]'(V>6^04FDQ,RU+V^>\F%"X\[E?/5_-C^4SA42%=L,B^?/LJH!I[D7?
MC?U5^,3I>>G^KL+7^MD9@(MW,K5%GL'8:L7*<3@=,B[ JZG;'#YWX5NV>9*'
M4%XX^P&HO'EUMZ%NC<@SAM/SO_\_38GZ$QX_^N,V",C1^26:@%Z\O&)CKP/<
MI:/8AB OVWP8U6G,0ZPN<F*_EYGYIYW\,."(#:U]OO#0S;E(UY]<,UCS5L@4
M+Y..V(G]&H=.SW#-IP:1/9$0A^0$5>& MYD6H=G/GF*G]2U7T^8I&KHO)_8\
MW^(D+X ] A^NUY\1G/+/:IRK('U]$)QOE<MS'OOPW=@NO[WVRVEM]L1G',(K
MU[\4KNR.!U@H#^YXY5A6+#_=B;D>KN4T-=#XTN?7762T/I/^[\6%;;<)R^SR
M'6ROTQY*;3.7Q=G^H)=U:.CF9H,TOD/6K>$-5H=:!M=L3]TD7SM[K*G;.2GI
M+]*@!>:M![H<!KX_(M+(KBY$"5GP?TEA6,!;B]Y'SSR)(5(>F+!""ZJLY5I@
MRI6;6YMU-6W'J]3\'@/Z$;N=2Y0-L$25J[87^_U6*8_#4N&7R\CQQ;/=]X?6
M*9(4=@@")((XIA9IJ1)20EM.0O"*R)7U=N>2Z]8?VS+?R<$N:&B(*>;8TY[U
M!B6!5]:G/.$C.)V(RV\R%VN+B))1AGB1HDLP:IFHUB(ZFKA32:I@XOP0[TX2
M]"%FB'C)<G.4Y48FSJ7-&6/.4@1AM4:&!?#YM:+$&G#_G5U9;UR6FPO0!#CN
M]3J^60I$:1O*79 9B>B5J%):T N:C"QI\*W;%)3?EJ?4W,!32NB3$96J!R<J
MW8RNOWR,I+M[0\'^TCIN?-HI!7EW\ST(]X?CG?V_CC]O@G#OA];GS:_BX =<
MZ]T6FQ7LW4];Y.!'%N0MWMC\T&J\V_J^<_+V:R./B_[[=7>_]:7QY?W9P7Z8
M)*WYL0.O06!+-?::*((TR^>&3D5D.18H!AZXT 2K=(GMDSB>))-&2NRYP,X$
M9Z5DE!DN :'$;/WJZTZWVSD#S^$N5*0WWVR&BC0RRPV126C%HS9:FQ2M]HH3
MJ0R^GHITB8/C3+)4_-VQ[4MS]BB%X5F!ML'K[ Y*T_52-:BQ[\7NQJ&CTBKG
M.1(R:<0Y-TAC QX&2)UVR@@&@C:C!;<_@[F-1_S PGFC0YPZK5:IT\/*](F:
M]'+'8F*#VUVH?Q4Y]$<1=0ND&7R5GN\V7=XOR,7MJ\-]LORA; %[Q? H((97
M-T43UTSGU(D6DW,G^-$KS;59$YK=I=)<RC4CZ?U7FO,U(?2=+GO]>T*)AQ@L
M&*K[+(N_LM/81++*U''OC0>ZRUU]?GDO>H'Z^I<V69=VZ!>IUK]QTLSLI-TJ
M7V"Y9ZQ*J'C)% ?_=)MMWSS-I]L3]C!OYJ5F9O9,,=:D!S7IP?TEF$U[Z6]L
MMWL.,[E1GC,L35;9'7WV85;9:WC_^&3GA__^^>2ODYW]]^<'^Q^:C<V/=.?'
MQ[.#+UO\\_[['SMTB\YFE>V\>_MU]]W!C\:/MR<')P??&YM_'3=RIED^XMU_
MW=S9/VXU-G=@S)^GRY0%DYPIAA&#,!)QS25RBGDD"36PE([:8%;6F5@%'%RB
MQ/Q'2K>M$6F9GFW9FG_5B'1_B#3N_^6(-\[SB%(D"7&&*3*Z_)-BEK@35NN5
M=4Y6\5(ATL\VEUUZAR\3I[\J/H(*=&!$/V+N4.#Z1;.7,S1\K(Z1[E2R.&<F
MGDG=T6]/4+.X&5/,YW9OP<V&>7^3IWV2,;D&G%L SF1BO3/*90(%I(QWB!L2
MD6,RHL 42=1[6!61&PY>+DS\_=9 ,U_9G[+G:JV9]]YKOM;,>]',L2L@I*-4
M<8V2=CDS55.DA<4H]Z*@46,:&6BFE)<9E)Y$,W_Y/9_*N[K;3W <?$Y^!+_A
MFVT-RD3/*W>*?G&F@Z=Q&R:#E;<QUG'*PN TQ8\B-?<TTER03 BX#0;<!D\Y
M!(M82AV"YHD .*F? :?EVS&I-?,!W(9:,^]!,\=N@Z026ZPTN/$)W :.";(^
M>B059\X("5Z%7%G7^G)#OB?1S%]^YV!WXH H[QFL%NVJW^&<#83R!&FPB*]P
MTS1=>>CX2^_N+O;PRPW*RW82]7>G?913UC)PURB]"$I/\D%A%Z(P*B+&-:"T
M2@8YX@D2@9MDL)96LI5UQE=-IH;^N7W>A;3AB3=F:CRK\>QQS[%J/+L[GDV<
M6T6CJ/$*.9KK<0R FL89V32.5O, 5LD#GIE5+GZ:H.51\.R7W\YZT[*]7E6\
M:WNO;I$?>!-33EZ(&9J<FP/I^PC&'V"(-ZS^*$\8A#A>/Z+'^N0]A5&5W:1K
M5"RSZ&;(1F6BN9LH0+D3>LRG=WI!SL1M)N"7<2@>/4!J=*HZTWI#:R'78G=R
MJ]DP'H0/"4G!P;4@5B#KG4$2*^6Q"<DQ_3"ATBUTXWF$2S7*O224>_2PJ4:Y
MNZ+<.(#2/E@-411BGLG<?XTA:ZQ#4N(4-#&):ODP =0#HMPT@^5%I?MDG? =
M.:V6FQ[K6C+([7:QZ_N=7'$$6JBF>9RF^&CL1#5E23+PNMDYS;1.MG@#'VKV
MB^WVM]@;4@QN_UOL#5SQ]S_%;YGOB.(__RD_^[73+O\F?_Z>V7XRN5._T[>M
MZKJGW0Z$2*$LS5R0KHX1KI7P\)_@K-4)!"TX M;8*:YS#3)1@%VY!CG_\E-H
M\\]PE&^[G9/MX9');IJ[=?/4/':/7OJ_OR%V]S]^W]F':_TXXHV-0V>\-UA2
ME.OC$<<1(XT31L9H)\!_@N4P*^L<KUV50CQBMOLMB^:L,!47!>LCL:IHL.9\
M8,P36OZ>1;O71YUVQ:'5[(12&J\K=;^3F$T(%BBI?Q4&W1.XZ/$4B_WTP?,_
MY7":?DC6O#T<ZRX,M7KK14O55[:[<<BM]4*[@)01'G%'"#(Z:$0BQ%$1<RQM
M/K(0LQ!?E'.?J\?!"!T=3Q E9C>DHK(]CNTB_C>3OL&/+LQ]EI"+&KL+]K33
MUJ!W(4<7%[PHX,Q]-"M9O V[RA#VA]A<EHZ?=GK-_(%7)==/\UL<UG,/7;")
M;PV-)AY_Q;I>IS7H7_V5B<+UF3+UJL+SB6K^B;AD1:\VL9,_C[OC(MBCB%PW
MVJ^H;+/QRK;.['EOY8_IYX>'']Y9<!C:5?/T^!,SGY=C;QN]WFULK1;;C3=S
M:#J7;;B-W?VMO6)_MWBSV]C<:NQM;>;?]G;_WM[<V(<_WFXW-AIOMC?^+O;V
MX86=K<;^7O';Q[8=@",1P^^+/^'5 C*7[^5&_I89OI?<,2=I#2%,P-QF]+%4
M>!4HC3B1'/-?[_$]D7LWSPQZV^V6&^U%R=(UAK"N[9?Y'5<Z7N 7 ;+-^%XJ
MDU=!G$ ]YYPJ;)-A5.+ C1"449(#O,LN5\D8=EWRU<CH?8!![?4SM168OKSB
MH-X7[A6B+]@2@F+AG;-#+66($%4C[*7,O',".>822IH($ATG5H-_1<C:Y4CM
M/Q49:Z98B97W$VUE[.+0RE4&;/PW>$IMV^J?Y^R?XBQ35I9V<DAPVBV[H.?<
MH@N9"H-8-%-UA6;%3C8B^6QVX7V&AQ9Y%>1Q,<%CFH#VQ:2- GN?HDX*0[BJ
M?2+8"W:SX,WSO"Z>])_J06NAFQ6Z;;[[_C X0SA/ 25',FF=H\B"2XR,54%;
M;XR)<F7]\@[H?\8"!-(V],4805P/B8$7E $)TLVT-5$+PYWW3H(S'JG&DJF$
MI:IEX$%D8.>\\?XP!F^5#@K%Z WBT8K<D-(BL([&9MY(S!, S^UD@.<M] IM
M1KL/)6#D/8)!JU4YYA71<$E[>66(5^S8\]*7OYH5]H5L[>S/$&25*9X5[=4E
MEIFJ \<%I>CD7L_I-/%W-<]Y.?:B'W0S^^3&B&JTI-(*U0J8$<'\U";2D*Q[
MM,3E/M)>IV6[Q1M[FDGJBG\@XFIG_N'1OE'Y]CBX_^?VPUD=7GK83J2,^^T1
MO'N4'9UQ1#<FR%YDSRD JFCA&'8,_!Z:74@&OJ.5.@EG-*LVMK&@YB=:),PD
MI%L_FY'^DC>8&E^VON]N'#)A0XS1HA D1IP)AC1H!/S&L0<O-+?*O=4&TUCF
M)[>:*AFZ8INIVKN<ESR]G-)TN2KR7;?3Z]7B5(F3V-DX%%3ETWB))$G@VE@7
MD>.:H&0"R):@UN<:9+RF;Y"F64[>+%(SLE2< 3*.V7B'CG'F.<^$VOE0METF
MDI47<;95BE?O.,82Q^V05QWD(?.BYWM>$!_Z(0/&!+;EE[-P#QTMN/&8/J"\
MF@=0[K1C]>D+!SY6[-[%H.1D[^4^3V!B4#8WQ4GL'W="T?E6]0<H6LT41[>Z
M4*:UHMB&V?#Y(<L'N)B-ZRS)V#),'TG<P2E8+<Z.F_ZX#%?R,*K61]GWR-3T
M675!"^'A!LW><7GOYOSA#K];34/55J,W[;'DE3QJES.:OS"XGJ!A48APF=;=
M*@6Q#KC>WF@1K 1P"-Y%"5(Y2[3*?JHYSR=8D+B;4N9DK5"CM$7#)\C048-&
M"1K^Q\[1H<3.88$9,I%#-!.#0=;!#P=NL:24)B)M!HVK.BI/]FGJSX^XRUYD
ML>S%D7+SE*66GE&;R8K1=VM*OTJS4PM/)3P<A"=(L#*"<R0]98ACI9"6/B$M
MN"/"4PI>P6TLSH0#/R\V*D$^=](I.NUYN#=JEC<J_2JES)8&*N4N.)6=N&08
MQE9K;*MR%Y *QT%*.U4[TLQ 7Q[WPH?/(YC!+,MS6E)5PYBUE*[3C>-[YTYX
MU7;E:>['UP9I'.]$+;:#<#?'J]Z^_'GA_['QHW%V:+W@21"/4L(CRA>5=Y*P
M)3RJO$6O5M;-VIR6TO^ICN#^!G\)EKF<<6?;7XO=89>H//<78>3?VZ]W/XR<
M]]SKZ;PD82ZW'UIEYR%PF4 LP:27'P7G!F+O4EK!*<E-+;,L_];\?4'YB@+'
MB"$T2<QRR@.@K=(V>4=EBI*($G=+^4)W$K37MM?L[8&]L&&W_:_M-O-CY2<G
MM9A58K:%&T>'.#H3(19$01J.N)<!.:P9RCIN,8\0*/JRL][EUGK_R=U7?FO"
MRH-WC$J!&8K(;]F'+/UFVRVE":QV"V+T$OE*>,I;'O&B1]:X6UE)\MW/';P*
M (3L<U9><W7=LK460'7[**/;-]MLY:O_/G)DRROWCBUXP)FTO#\2XOG(>6/6
MP_C$9SZ_O^(^&.HCDQ9^$P9\".D-M4E9[+6>*\!UTL,]"S$\R_M#3[UQ0EDD
M*<2GG*:$C)6 FM0HEYPGVD-HRN1-20]_#2!X@\5BJ^.$A^$!37.4^C "QELG
M/E17K8RX6&B?[LI@K^I)]ZW3@K +D.WB9&I>++UZ$166S0'+'H!5![E2UINE
M(G2'#=26:7/FVA.(C7PVEY5_^V+PH P7,U=[T:5R'/"=C<- C 8%T: <F0G&
M!H4,UQYQP3BLE(6@K.2.NVD;<+7:&I@*P6#JF^!B9B=AU';ZR?S-ZT^LJI$>
M@".SVXZURSDK*66PSJSF(BJ'3 @ GAP< I<(0\DDJR/V)I;E[G,$Y3^CW:TQ
M*DX<;H-XE($-N FKRRH5^V>=6BHN207+7;9ATH/ "C'PT7-&H4>:ESGO8&AE
M-%&E?)RY1N?E4=Q&+/IGG<K>+JMH'(-5V>W^G?W26D9F9>3H'*((0A4 A0]@
MPYT%&8'?' ,;XRFQ@0>(]739GUO<%3KZ>0VR!U-&!_,=^KR/W<M.5!5.] 8N
M;T?G5K_@Y^2@8'BCV7;#M@>Q0N_B6/SQCZ2KH_&0CSO*_:!755^CRG]<62^>
M;F33W5?+@X)6KU-TJL;TU99:]COMF/MH;/^7QI.\+8O92W86=W/2W/M#*T-@
MAF/DN,RT@> QVHS]VC%"C%0&5#N#_4U'QN."@2=$\XL5WNB-<7LW;8Q2'2[Z
MP]18/A*!7$&@M2-1<&1=!"\P&(UL\ IAB*,#ELPXA5?6Z=RTR2'"7I],,C=(
M'1]%YECU/"=<#K>%JH]VJMWTF%)N6_^MZDXWNMKM8NBUXM.<YO.71M(_;O8F
MX*S:3\J;58-8WF.T0SH:D>VVFCG>'^Z"]LM>\_UJ&'F0J]4>V?"D-+:&F_Z3
M1\\79]C5AAI\.O<V+H/V<;2UFL\;R@2%9OMHM3)OS?Z@/U2WB2VVRCR.'^&L
M/)X8[G9-9)JVYC TE(\X/!&NZ.W*ONCW=^B]2";;Y2V[8F-P-("!Y*.XVZ7[
MO]!,MLO-Y>XUE6VX#(0.KSV9&+1UH:.;\-GQT<+-"6_-5A.,0O$O:%P\+U[G
M,XN+;+=_7\_+=2O!9IS6]N_K!TIJ8RPIFJS%1D7N;32*62=84+G_D.(C3@I-
M:)W4]E -DW<8."B,^AA,#,@G1Q&/*B*'.4,F<"$5]48DG.O;;DYJZTP)X%1F
M&XC1%7EMHX\/>G&4D#"NS"TA:_*[^2;5QNQ<D+O)$BY54LZ-I*>+JI2E2JLH
MM58A\6B#<TP0<#(H4T:+:(:)%VJJ/W*=MO/@6B9 RT0R7AJ34,(B(4ZH1EJ3
MA#!./)%@DE5T(;8+(J5USN!H5:;V4=8EB8DAG$1->.)SFV'7B_THBPW>?9!1
M:^2=Y "IW"('JXT4,Z",.$GK;8[Y+I\ /UG2UN-B1YVT=3MI>O\]2Q-1.H%;
MA)*G !U6<V2$]V"EE7(VY30/O,304:_U(FOML<'!:; + !]<.HR<( P)4,]$
M;(@2JW+;=U'DF(A39F/ !\_6FY=C?E/>7K4]G6_7+D/A*JV@2N2['(G=<XG$
M(\4F=8G$M?KP8V?CD!(*LQX-(BYYQ'EN!N5\0LY(:ZRGF#B2]>%R[=\M2B2F
M HN742"Q?^FYRYTU4.C)<&UGM-LVN=V0T2'"W,$-?K._7^Q75%DXY3Z;FWE5
MPG2<QG)79[2W=^FDR!\WX[<+(( GC]V^S;%=M2^7DX%BM]2J/.&PG# 1,#-7
M5!?2U:(\LNIG181E'BYC^: 7&RYKQ2CC:S2JZ1EI]B[E;.8LX':9_0L#JI+B
M8ID;/)NT:1=-VKP;U-1)P?<!,+BQ<9C[#EAP?U @'@RNI1(9S/,/[4(@G)%D
M5M;%FKJ*TR!+_6FW>1(KN0#Q.QVX%IC.,8I\ROO=>_UN!HN_.H-N#N_+S+;%
M1 7 CE@LO(J6<1\H. 34"T,31!I"139TVT!4T#R9N:$%49W=>Z.\D.R@.>-R
M6(1,8IF.(%?>Z&20QRFY0&VF";CB+&<MHQ],=3YMR,@S=F,J\&*K,QNXU2E)
M-_YWT.Q6KMN)_1KGY$L.K4=U"C)*GIS>FSJQYT5L#4]I)G,;IZ /+EG2Y)5O
M35F!?#KR9?CUJ8RUJ0/JQ03:8,D5R"^WGG,& 7/2-!(/&*@MUXS/QSY:$RK\
MG!0WS@Y]9C,).""(\1GBWGAD8>H!_Y@,00"R\#B?4*&9BMD=B([W@VYO6G9Z
M,;M.V6(VP2/IV>[YR!F9/LNX0Y82AG@X\. 9A+Y<<*8)4<XE9I)G*E(S7VIF
M>!=+/B+T(W8[M33]E#11P,24::H(2<B#VF9,Q,AJ9Y#V(27B:::^RGU$P>>C
M?\Z7J?DB59W#ELX7H%6VL27/VD(2-L_G;=Z0UC0!P___*)NIZ)2N;__8MF?>
MS_YY*T-K!L'3;@YF^^?3Z-N\*<UG].!W2O5YBJ.T.M5G>MN7E"=I)@$N@>!G
M0F-NC$7:"H&8PS2F9#AE\3:EN0NG^OQT$%&G^OPT6>CF]G<PK$2Z9 /SB$4M
M$*=6(6- (@0EA$A)!$YV/EO5[1-])J%L=+@) )-W*)JAS >XE/ #7_G)=)]_
M7V=$N\CC&>'5?>;RE,>Y$S9@<I^DRN$YS>>\_0R?$[8BW_4DG\?V.]U)0KEB
M<-JIJB@F<X3R]L IJ$#9 &@8GUWD.U390M]^O]@UR8?*$YE%%Q]\H-16>JL<
ME2?/7IT6@>:"J5#-!\N$6H#0]1FE(XTU=IH^<V)'_W(@5^KRS#[_;_%[7J8\
MN_D+9_E(%RS^62G>MTE6F'/J.#N(Z5O^7B9=+&;+-&?6<J7 8DK.-3?8*9&D
MH0XG@A6]X7#JAEV.R7VQ34"A]M&HXK,V8@>DL?GQ/!?*4YUX9 'I) +B*BCP
M8V1$-I'HM!2:Q73-@>/<9?W),\=Z67]^62./+BC'$>'4P[+&A+2.#I&88A26
M5X7I"R:9,^YBTC$9JD%9E4M&)@R^#L91<,=O2!NHE_4>EA4B#JT,1SY0#"XG
MH\A01C(KK_$2UL#ZZS*+YB[K3V:#U,MZ#\L:#(1RSB$1;0XF,4?&:8>H38%!
M? DA)6BKODTFP,TO_*<\=W>=X<GH70[?;^NFS"8?P$WF40@]@K,RY[9W<5AH
M\IY*Z2/\PIGT%@)P1J.D2EAK(QZR5@QU!=>Z<K^Z<K9S=$BER%?Q2#.G$.?$
M(4M4&75C0$ ;(@Z+.RQ!,F^B,S)RC84QFO(H&;=!A,SY72TKJ9?UP9;5BJ!)
M"@3YW'Z%8R61YH0@D13-9BAPRDN>A<MT95<<UBXF L*!5T2MPM0"%F,!SHVR
M@;"4DT^<4+4(/*0(O!>-]X?$J,3!]T FY7RX9#T"AX8BCX,+GD?O#5M4LP5E
M7G/GDY>!!TXL2]XQ[ZP6#*##U8#]X,OJ! F4))7;_ G$(01$L!X!7%CP82/6
MH%VL["0A;^N[+.RVX-51W2+X+)G1:H'>25<V7;EAJ^G%]UR2=<^ENN?2(_1<
M6JR'TE!;AGI6[L)/*)"95J GZ[)4SGPQ^N=:'CVK-/BL3#+%N3+$1!^2PO#T
MR1-NY-R]MFF;MN>/8QBTXFX:9@$U8V^Z\>1^/N;9AWN^;G7\UQ=FTN"ULYV-
M0Q.8Q5(:Q 0&!U4'@:PF&D4A<&16!F_9;'LO(DQP#)S7$'0^$'8B1XQ&:TQ(
MM!'\A B.PFG6A>X@5D< 92?9PL56YZSH#4Y .$%D>L-#LYR^.WE8F#/T+RH(
M+YCT!F5ET)R#@BMJFU]=ZEA[E<K>17NF3EBR.5RY0I%OG*WU_ZDFY\)6EKU]
M2]++TUY\-?KES]#LG;;L^:MFNZ*"R5_Z<WKHXO126]]RF-7;0QNBY1K3.IN1
MW.-WW&UX:&'62@LSTXEX^$V^9@B]\FV\1JY\[[K+$KJFJP'=>-FR+?%PV'.Z
ML,]T/KZI(3JL[N.;G]*"'PPYG?/FT&0&^&PCZ,6>L;(WC]/\W-SJ.7\KCU([
M [A$Z/T^]70W+.7EWM?>QYC2;'?K95CC^7W?*PZ$<9NWRK>O7/K?;]WQ>\Y3
MX^*6S_ZD;>__UT\]XNW;E3_%LRV0V0;@3_-Q(<=.YU8I+F+!")$,*T*4&24V
MS18HWICL.7)S)AV:L:/S8;1S#"[/19K3AU(4P;CLIK?-',IG%+H(ZMGS=(".
M#TZ^MW9SZ>&GCWSWW38Y^++Q?1>NF<?5^!*^@*,#UW@O=M[]V]JA6^>C[\"]
M!I_I1PGN__?/^T?\X,N_,-XMT7BWP^!SM$%WR&YVHC:_GGW^]!'&_%?:V</?
M_][?ZN?_'GK!/8ZP+,0GAKCT&!D1"/S)I(VPX"F)JW-&JWRYG]$1 (!B05VY
M&_"F\I]G!;ST2D-*%WO0N5A; ]+] -)VNP'#VC^+K6]QI[2+-1HM@D;-"322
MA$:*&<1P,1,V6".04Q$C1TE(PIOD<A78/:'1?$1X'#1ZAFX@NQ,:W=;SJ]'H
MIL3_A2!I2/Q<(]$B2'0^@41<>$\-SV0?V").<]H=L0:IR&(4A-*$^<JZ6J7F
M<A)Y[14]) [QVBMZ9CB4MPQJ)%H B1IO)I H"(MS(2CB(E>&:D&13<$B1EP,
M0D?/E5M9)VI5X*N8 6N7Z&&@2-0NT?."HK>=0;U7M! 23>X5)>63%,PCPGU"
M7-J +)<4>2JU)"9Q3'3. ULU^*K&E4OH%(U.I&"P<>7:0XMYG[PGCZO2?[I&
MQ3)#WGY)['73&>>BUF9X5C@\_6,P&:$SR&>)^8%&[^8SS#Q/)?E3]<ZO?)IP
MGU-3VY2[U]>_&9*&S139UZ;C%J9C,IP.3CA%<TH&!?^56PBLG<<8&4YY"N#>
M:I;[&(I5=6].['WHSD^9G#_*Y(9Y*8P+YFZ4?]\N>>.IBF.GF=U&A<B]PJ;4
MS*J7ZU'*A-!<4Y__\)UOL6US1HP]/6W!1.:5F6$NSU\8\=!E_KU^24L)MVZ7
M7"'-T+1=\/>JNI?).XTO/AS(:J[=SVQ/F3NDMSKQ@8K5:53>,KIS2?'4;)=W
MSK=MP;!;1?S>[/5C+F_)(SO*5=#M_+CP5B8*;#5SZ<LJ0$\K4Z',H=#KQM-.
MM]];'=;*CV[0[@VZPZH9^)X]&G*ES)FK*QXGYSEWF[YB[LRT!=VJ8 >NVLOD
MEOF/<?_9U>*T%</1S#-?1:"2YZ*B7,G]-6&Z<[N#(UM^'09_$KM',5/$= OK
M82JKS-A>V6ZY;-S0S#T+VJ'\Q(G]VAP-&][)@W:#X>?AT0;52+-$NWX,[=B#
MU\N'R$  [Y04"'FA6YE"<CB/9;I(]3T8ZFC2F^UO,"FE/U+V"8W6'Q?>]J8(
MM$8?CM]]/"W'L59L7)&(-4,*5C*M3BS[<&RM(>_IQ9)=DT7Z\TI/^9IZNJ+X
MA^8_**_XJ@GJU?379^F4PWFS\6%KK]CP_3LS#*@GF\K==K%CNR"A5(V2XK.T
M?5S;6P/7.I1=H\=X R)O_:B3S) J]$VGVVG;;\WNH%=L-,-J\0%0**920[;
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M&T*?R4CX0L?")PKL21#&/$PC]!0&T0O,"VN)NB)J(&>58KMY&;$L33,&?X?
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M']6W4?YE&E_5;J.-\5_#YFA(L<8ZU4$2,?A+J%C2.***IUP3IML8_VZSN>9
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MR15H)"7#+WK9<)TN>JHG@Y.\.LS/QO0OCGZ "9(F<9+&$0'-DL4^@U]]D<C
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M3C#@T9,V%WGHZPK&TXE 3[D56%/MV(;3CZQ.DSL$6#Y)Q4WW,!(P,??[KQG
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M=BH[O<IU<U[.*U<((8S\[X!T/\/OX]-'8W@-/MG'U(32]U$](9N,!)[0_OH
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M<B2%3S)D0F,&N B%7$W3I"$R<>FH@9SOLP N$UCY-0@)5 CILH %QB H0/R
M"' %2T/)^/C,6Y"W^%\-$P)T+U(0>+<9",^W87J;Y&L7-M@.^>&T%?GAR6_K
M5A>@YM1L <[0!L:P>CL;I%CW_/7/?WT3ZR\/?6+]?O'72RK_=GR43RRD02P+
MC%"^%[ G3TOJ%QY>#TMAO(I[#Z_O]T;CLR?'3A@,>^.+YQBQ?C8:=8L]K,5N
MA]#S=!@:!]5G>JP8&4^'$'%0Q[DE",13X3P<&FTZ*(<.RN'YH!SV ,A@;=;^
M);VK\?V-\W[3_=_!\=X3>,%.*>E&NC6)^84"VAA@96AF6.?Z^2Y=4^\AU 2>
M7_AGH\,??]8QW2$QW=G(O^Q?=DS7,=W+5C]?# \?,^/("YPW])8>;X'S*QXF
M^*O*E2G!"=6-BM,EECQL/2KX /E\[(_&ZU&CNC;J!T,JC#I(A6>1S?[H;'WE
M>D?9![;UG!YW[W\74&EI@E&)PM)0JH@-%U$2Y45&M1=;Z[UC,OP&E_[YY?H9
M>)UYOOM3.O5/+PX_7'3DIW3J#P?K-4IW2#L_I.%NH!3WWA@X9IW_-2VP&<14
MK:E:U5I[)J6;S_S4=-COZS(^\\\WA<</;$ASQ\JODY4OSOS18 ,Z>L?*'2L?
M "L/^_YPO"$[<6"L?!S!L^>%>=T3>[G14Z_7=.##H&U9T4==5F1Z.?:KO3YO
M%D 9^_UE>NY;!YSK)5+WH%HLX_1.80MT3*/'J4_2Q]<MHCRG;D;<05ZDTV]O
M)]3>B4N!35"O([5*7CC#SVW#J.T'G:L@G()CRNVVU4;2W/1"3^%=94Q4FBFE
MFS M2D!]/OHBS4P_M%=D043=ELLLO<Z"A:Q:_EI[=,^[RIM-E]@%7F31E%LX
M:>74TQ_$>4KGED78(6XV$&/>D98)+[_!CFUSS+Y=3\ MW]2\/PNF44P_T^K2
M@NG@$)XZT7FA<#AUV(.S7E]3XVAGO5=2NS_9U.Z>WO%L12;Z@1?]Z6YY$S)C
MY+8SM]_[]5=]\]5NOG3@OG0SL9I=W' $J&1A567(B!,KGV*O6F_C@/=#O1YN
M#NBJD@/:BX9&A@5P+\CURJ35"UZ1-I(TPZ4S^K\?7@SM0=_;71[86IDQJD(@
M/+G,\%<(C8JDLKH;/CZE[Y%>Q6^6852PL5 S#MB^__+I__(/A'T3(80-_SM3
M_RJCC%!20"T#.R%4#] AG<UR5>!J&8O'694+!Z'W+QP(7TVGQAK:K.0WZFZW
MZ]>55V<KNH#WIKOZ W:3@!5%._]$._^0 /&5=R+2Z8T/;R]VR?'?/[?]<$^:
MF>6\<-?V6>^2FV[OW;4-?[QXEG;=R\'#'KNAMWAXVBWVL!:[78MYU[7==6UW
M7=M=U_81=B-?=EW;3TBGO>[:WK];]X#Q\UVY;I.,QAF*R 7J>I^/H"/P[/ K
M63N..RB.\_N#PY^@W?'<(?'<R>7YY9L#YK8C+P,_N3Q[Z=/9DY*6UUD";NQ(
MR9<=<Y/SR:E_,;Y8Q=Y=O=L#J7H&5L1Y1]4GKB+<8)AU='VH#'@F3MU[+?8J
MPR2<)HXD3:Q,FCA1V\-Y')-Y-QSO9F)G9X%O+Z&&+VZ!=Z>S/33&H ,%V/,C
M.AD,S_N=$_N*G%CN8X[<^C"NC!.%OT;?MV8DN_:YHV^?.SGU1V<KO=9#ZYSK
MN/C5<G%_..RXN./B@^;BT6AE5.;0>/@XHF3KT3Z.PU0^UA9FD]'AYHC=SIS]
MZG:ZT!C72MG2RS4J5T=UZZFG.O<59 E\-=7#OF_@E]2^@TOFOEMNGU#3,I-V
M6]M,"$\/I+466W1JS\Z"0FUNRGD8LVTS-WG_N'0P=+GT?37O^,)<2FOIK693
M<2!?AD_KG6"MK;?PB3/SB2:[U?O8\>5?_O&C]U5E"^_O:9"0=_PEC8/,^9U,
M^IU%&3S"7:N>;5[?S^=YD"V";VGKX_)-SX,-2S,<CE .,M,4%^/$YY1&S8."
M*:-\3KVWV 6/^ZBMFOOY+NN#E.&.9O@M,YNYNO3U[[ ;J[_GK/Z>]A'WQ]H;
MO*;A;K=-\VZ*AP(]3C/H\[?'RZV$%\&:$N&]Z9TWB\MI4?+$[MU(_ZW'<'=S
MF6MSF<>KYS+C<J/P__PIFO3[8?]\,CP;C&>GPX&:7(R"41!<GH?!Y>!T&OR_
MR[,__67OASG7OOI\E&[O3OU[]*\R"G%>/6J1=\$2I9'WJ\K!#)O682C;5W^^
M!Y)T+3==D=)KBAM"?YD'H)^"?.[@^-0,358^YRY4C2NGOAN,SWNG#HH-?OXG
M-95W#5A*];S?\5TWJ)&3@&!FT- 5X$\$I"GF65I>S^G72_"OHREJ:-AQ<@VV
M;J@FA7R5NN.S#'M=I,$=EX[B$@&)\.WTB"P-0?XQ%D[K]@6!I;900Y3O1J<N
M.$^"OQE;%>RCO;U4",FAXCN?O=4(S?<B+^#3N$I<].%HX\?Q$)IUTVFY*!D(
M(%2S:!J13?/=\')@&:3G_53BF6ZM%.D-H$]1K<%K2+VR 06//AU:!);*D^_
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M%:)<"0*UF5\YN?-.RISF2[RIP?\VR#HX.T*9MWM\KSWEH$VM20@*?T,QDPY
MZ_#!%DZ&Y_[E8/SF,5O<\]Q+QW#[M+>3X="_N.QW#+=/AW+4#'?J]T?[). Z
M*_;!Z#0X7&8;&^0X"LY'Y_YP0R'2\W'I<=?RG_KC_JX:A8Z;LJ.!/QR/=T3:
M9Q6MK]+O^YEGISU,YAY3_^\)F*W#\STR([H&[1IDR,@?G:^7Z=TI[?R43L[/
M_?YE9XX?@6K@$==44*#^F%(,GPMR^&<JYUDY]O"8[?:3T<79*@;OS,H'@BVN
M[U_JR/K0X,C9RE#<@8K<ES'3I?YK7V0Q)OBB9)H1;-Q)J/BG-S0S]WXB>!,5
MNTZ&ER/0?LN.<W]XV;7)=;>ENRU;11S/_+/SKDVNNR[===G.AQK[PXO[QPGV
M]:H\@<F[LE7,:5.@MH6]Z,-H;UR@/HS?N.[,LS5%5R:V;+L-UFUS7+W7_RSS
M(IK=[5&#ABFXDQH[+VVIGZ(6#&R]2+#2>L&5UJI9:4U-3!AF^6YXWKOT=,M/
MIO(RQCZ-698N^&UI6<RPR<4+2X6-0H&7P$+B-*<HS7>GP]Y ?]WW@A#IAM^'
M97PWN.B=FD?#AX']WM(S(UA([EL/PKR#7HO/U_&>ZC9S:DC!K\51,(EBTV;W
MG;.*GO?DE.KS.X:/HM0(N&<EI0;V;VV46@8@'8(XOH,_SH (6&O)?T\<PMV7
M:/W>T!(-^W^,NP=/T&OWZ:?&FN[':&ZGV=8TOPUR;Q%$">Q:*#J'ZP"?L)M3
M?RQ5@AU(M']\,DCPV\(T($VPOT_EN<,355Z[#\GNM>-;E>F&J:BQ@2BY 7F2
M9N;W^-@B6N#+8>7VSY,RBL.WY1+8+:9^1?@LMC-&/P-KO_WZZ=?_\:(%B'9P
MO?DZV8? (T)8\%+&PS,/60:R2P-6LM_"EBLUE=;)&5R7*2A$H$6FI@J<?% 6
M/>_=HQCO7M>NG8IVN<M,Z0W2ZD&) L,8MO"!@^$1;=MHI[R[?5HX??W>QU4G
MMKZM=0FA@RHURKGD:FY9]KNZU5)WEF-_X3+-(]S.]\1 T8V23CBVB-QOB7G3
MMU\))F#)E,7JKS2*L7>D&4>#6MS)^=]Y9F-MU^KM!.C][6TP@\5^'\2WP5W^
MI_^J6@1@#K@$7+7WFH&TIIMU.]MJAU;'0^RMST[1OZVANEJ1SS]TB\MM<8A:
M*L8\*OS?5C. 6OMN=&YU;[4/^[0W-G_8_K%]1\-M7.T]57>21V2I@/!I@AO
M>7Y3NEMX*G\T-L-2D+G%5NQ; ZK=IJE\'O8!(K&X(TF,0>8E"CY^4N_<$,FJ
M!T=) O_ ;D/L6T?J@M^#XC]"DN9%5M*#6#WEH&3@#>!\14O,-&H;B$Q3Y=V
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M;B,V1.WZ@7\+ L1Q_Z($72D007&T(+.+XJ3V.^RDJVP:<1)<)\]08K"$Y)>
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MH($;S@F%:?LW5F4NM.ZC^4)"TBJ_D#"%_^4261IRV/,^Z)<1TF7["T%8ZKM
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MZDS?FO!A4 12XUSJ(N6E4ME;\"$C=:OD]U,-S<@--1:V"EYSP\C#NL@F=WR
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M:ZJS2WVNU<)$8L )V H:[FMOC/N=V4'B]+;P%UA/-T.8<BQ=7!CHRE]>8T7
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M3-A)U.L.E$0C=^9=7():R;*(NS?I4Y7AMF<7#CR>X%,Y4.XV)<_I"X:O*"6
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M6-=B_,?6-Z=H+T43T3DL.ZDN[EK^&9NU]^$L(%<S>+U"R"3/ESZ!> ),!(\
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MN@J+*)Q>*V.HB:JVKM@9?0Q_H@A.D=WNO$(KB\2-X!P=S4ETB8"<CMR[<QP
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M1:]X<U4'0WJU*AF62US"_>)MLWJ[+%=OI6\^G'/D@)3-5K/VS79)^IB1CTR
M1-$Z31_-W8B?RK'BQDXX2RK+9V;I WG+.Q)-E\I]'[;,!R B]=?I-**G-DI!
M2V8[EAEWY8%^O".<$>$M&C#T]R2IIT*)+I] AA)M%U0R$6>)*>IYED0*2>@
M"#XL+631N\W:9M80TI9V9>6)E4JQ0]C/(6:H/,6-%<@MIP)487>PX$!]]*4+
M[9"F#O$AMA>AN&NH7!.[+T#Y2XI$C)EB:2M<Q^@5!9U.#+4=TYVW=*XP>_YU
M^&K7J^Y=?)ID?ICR62B;>2>/F]H/8+,177DF:3Y<++YK!@4 <;&3\%DB +Q2
M_:\)CWGXX;IW@J-&^H\W%2DP@KB&*7^[D3:O_Q,^&+8<-%_V!CLB'KU6"D#4
MBJ./QJ/(%P[/PMTQ#H&8@D6MU%^<-AQSYDVJ!^[:^"GN[SM*]OTXT2DO2<>!
M[I%P6<1COX$7;Q5&;@<U*1[5!TT+F;@[?N2+O:@>3:U</U(WNL@RHM4!AZ-3
M:(QZZZ*S16BS;3+MR5IUYA@K+;+*6V6+$F2C0#YK!H("N X=,2^*'BXPQ!EU
M8/?H#S:M\GBCC75L&76 9<$B<A5VE;3DLV)F+Y$05+A8!H#A5YX[-.XG7:8I
M6I6N%X9Z)(3+L*^W@*WA,N4QQEF6-[+Y<4LF51E((!$L!LR[*-H&I_6CC$C:
M=31?(<N7KKU/=B[FRQGBG6-3P016];!KA!8:[$SA1<-MPG20V$%\W?-6581S
M^B.W%H7_MV/8J!1$'O&9,.H[;N2:.D79O'EGBMK5GZBO-'65Z+K,FL_^5IA,
MJ&"KI^>-OX 4LD_*HN6J=C%=+X2Y)84O,M:RB(-_MR.W<\+C; 5TDU@4^WFQ
M^!:D'"49QB*G#I&#44>-;[[ W9_3Z_]-7_]-&,MQ+_HX^G$NU'R+47G!H_)<
ML:WLL2Q>F23']V$-:TA*K_)\!022_BA\T62/_OKJ^^?/59'(#)O>]?NKP] $
MR]PNOI>.[#<CC6A;\]TA51'L/#L?#4F5AM%IE@SOJ4CK$**5KX)563Q=?*U;
M_<G">5G?VKIX3NM"N1?H!_*03[ZA;I3O^V#S5X=4&.#O8=SU&Z)[\KQM217D
M!QQ$%+&&60EW_^+)W\)YM*DK$UI8O'GY@@%+P>'BC,G3+Q2W=#PZ/8>-#T_X
MA;1D8G,/+#S.?<%M"3&*<"IMNDLR"%/6Z[ AW#&-I("N%K2G+[OKN,[,7*_2
M6YK>.>.+:GC"< 2<LE*_Z^!Y.,Q3V,Z7?;E%3D)091DC']=MF _<<$W7W8:V
M27_P'Z<C@Y@EX+RR;E].T2-NN&=_=WZWG6N%.G_F3(7?O%7:Q,1QNFS6^X%]
MK+H=7(Y&L]O;L94,RS3TC)9,56=8&"XL="\$XFPV,0:%R^+,YUD2YS8!J<&?
M8@ZR0Y2D8(80 P&22:(T(P9PQ<&Q&TTY8.U8_004T9]J9_^KO_>YZ/JPBHF4
M:YQW32X!Y'M555ABG,KIU8B=P"*5+M%E>A@G($H"/*-C-#C4A9R9"?[0LMW>
M^PB[.CC6K%\!,.EF'&+O-SG]H+P"DT:;'>"ZY\3<*#,,0TD);<E_:ZJC@8O[
MLJ<Z88,3(LT:!LD>G&,7Y''5(#71%MH^\Q(OV+)=VP3W"$D& (Y',K0;A0S"
MHHT:1$H1)4_B'LL>?QX^\J<[)W^N]5AT<I22M<A$J6#H6<_5_QA'TDZ=+?Z8
M6U_UKR0/3>E+OVR!U+RYZIB43O,T%PM*@=*9&3,@J\[U,\WD>/305=0G7529
M*8XP,!B# WWFU?>OT6"QI9ZA$"0L2<=I[5L2[?GB3:#!!A(FQIBRU"[8-YY>
M?/'_Y1?PLE&4,:"*W[Y;O2U\(X40EJB8>,7"B>&5MW;&,P-&JDS>BD8ZYP=6
MW$?&"=Z.#D9.:[%P'>\6 ;3JHX<='^)'/?0)=CYR"QAE#R,AB5L38:DQ3EW:
M,8AOY^>K9N.ELG*)>/![ZC[E9SH2(D^3U='7.A)LJ ?G S%SRR9):;D!DBTQ
MP\*)HHG:"<PV\6;,O50Y6"67++]?G"R 2_GZ9>TL5,WJ:Q4R-R#2X!\D6="(
M>I\_*U)[JN>#/S/2TV01[*IT9-(&N]'+:Z%,Z(IR3#0MP?7LF*!Q9=?7G 3Q
M<HM'XU;L2V812:J+()ZDI9Y(CF:SI<Q)6$11/VPVJ9.V]ND(HDMR7G9FYIBB
MV4@[$>3@H6*TA8Q^FI2U[OV/DP=PEOQ#),%=0"7[UB^B-FT)L$5ES#)(-4*M
MO'/IO]KEIVD.? YB/@&L"0$D?%Z$B2<==+L-$][L>YA4EI$+.WB@-8!XSSWB
MONLVU$/;Z4]G(S(?#Q;QQM]0U]1>&>'^DV9L5:.=URP VO-B:\.:]Y<:F66]
MOZG# [HS-0K 9X>M*_KP&J7[;*3'SYUN:5:U@%0YCFG\*SS8=>,Z8(9ZO]]H
MXR"/E+NG1J+TJN7&]$.SQ*TT'1%HX(DB_8,A6-5/8K<QK!DQUI":*Q'94>)X
M*\28. #+O90E(FF<5?H6SPU'0&Q11(TV';.#O R((Y-'C!,Y/V.6J45R8&8!
MXTAA63\9\$LAZ', AV!KD(1T"RB-GY,N33I?RGZOC4PME8(970'56U*:Y79+
M,E9N#J-[AL,EIAEH85WVB19F&#<:%3*?Z7@ .*L3'\M(0':(<J= -**6*%Q)
M<EIFD1=QJEY2RWRSUC0CQ>-&#3834\4T9>'S\]D24\3J4#,2;H8U$_.+CO<P
M(U0:R$@:=5%Z1L.]$P9&4^$*>"Y_!EP%)RT["@TJ(IHU6-'IY6%Q;$&+RQ@7
MO3#8[+05_<.(0#Z 8X::U(+[M*LG9XFYGC@0FL&QQ,&.17>J+W=-)4PKW.48
M?);U).$3M2%MQG1W+\=F4TE&272E^VY)#I]PCE/6CQR5X4!UJ4'E1812-'-?
M.(G%&\U;!LZXS1H'JH^30[X+]R"._:%2FVV[E DCR,,5B)>3%>Y'(JT(RQ<K
MKV4JD8ZW!+,HN'NA8$V$?7+&/:*?#/WTY2/ZZ7TV,9TN>ZZYSS68+K;T6=J@
M&PIZZS2<-HI%IU,]+6BE_D#D$62F[#VGT866B+$J2FMO5*P:4-0X^7'0DA7?
M]QT[J9]G*OAVS.MG WFCNJ@KTY=5L#I,,2#  ,HQ#'"=/ H#>:'4!:^ON\TU
M]T9>EIO%C):LG=(?6$KY7VURA!H$U )<[R$4GCH0$=**3$+8/@+G(,Y,:J1O
MR<1.6<V-:5X&GC@&9.A)GYK1)PU.-#<32"CH70 4>=M0SF6=3!?%T^$(8FG.
M!#>H['J%KSF-/56J*"S)V(RX!?NZN6Q$AH8S4?A2!T<JS/P-\C!H1D&I&?X7
MYX8YAM?1ROC_D"2L.LY.SE7 KR6\E4.P6,P6#@<C"MK78F2(%(0'$"0EN+>X
M)92:IV&0:-8-FI\:_91"YUC(34)<+>CA5JIF2@DF[L5!C]+1NQ!P:#Y^U&H
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M2^\G%2Q)6DB/P<Z*-'V1Y1*86H7V=1K*S('K9-YCA85;)8=P[FU"!!</\4;
M5?Z:!^ZS2THUSO\QU#G,%.KZ%2N0M8)H$BDZK"_N9'&+2Z/GB9OH5R=;>W/;
MW&]8'Q*ON!JIEQ<69-.\):R1@ S\L[#!F7T0RX^\?/F\,'R@#%W\Z$J8YYE_
MJ2:*)<8=SBQSI9O=@^-8"S(V\36Q6/==2]XSQY-=&Z4NA*TZXB ]]E'W'#\>
M6U7PN0@AEDPU!-GWWA>QALGO:B@#OMES'<ZU$N@[+KH5Y'>J$]7@\\-3_/'A
MXRD^(XO)8NS*=*%V##5(@:]F1BUFAA.KIAZ8QBTNX(R&,CQX< 2W0F3*:@B%
MT ZPV3YV^;UQ>.L-V)5A3O7)$>>\$J?%F.!R76HLIV<*HU K*4=N*:VL/#F%
M869/'<K1J1?(*RSG;/-FX0YPK8CHEV.S]WQ8QR\\N7UD]3GVR DGSERY$+1Z
M4N<L4E^2_4BFVTMX\XSVMI!(8<JEY7"Z?B)P-\+X/HD57M0RN#.>*7"+F/^]
M R_/.W/]/5A'Z;EC#SBU'>*J\1E.6IPL,),'OJ(A]T[;(*%*E(_K'OCPVX/+
MZLF.KCH^B8VZ>9DJ8N.1<L=H\+P,W)IYS:%V+^A?[_O;^;^B>#!CB&8 K]\(
M0K;(/I4+OXU(W;<E0.["CWE$U*-"Q_0B2?A^H3PJ$XE U>!PB92405['&136
M# G5642=/U9LI:=:LTN39_\-A@H<.!Y.5-66E9=(G,R$(&%W%-(5QA9Z1SU8
M3_LUC[%-K!R9E4^9UN>&I@<::C^7539- M5-LE0:WHQ:"&KZ*/HRDRY*,#[F
M;R3@ \DZSGZR<8SL26>1!C,)Y0IWO3C[,1/G?Z@(/Y=2GB!WC#G&$#SC?44^
M_.A*$AIPWS9M/"2P2N9EPOV-%B4NN!73@Y+0X#^=^=(3D<T^X0"4<)@T(%8-
M*Y@K6XE\06QQTE)5N_JV8MW(-S;W4SC!D7Q>$9$_CB8&W78"2KI8?.=1M&2W
MBJC?2F[73>NDD0I]OWB71CJI)F_!_KVKJJZ)&/NQ94A%0W&D1P-3'%]7I8XZ
M,A_!RUB62.;0<8(UO&Y:J<:P!>LQWIAYRB1W;9QYD&D[TDU6:*&C*LM5S^X%
M9FI[IVV0.^<?9NT3NZUC9.>V0$YPY0[-+._64: XFS[X=>2NE [(<GHG,2HY
MW(+< \9N#CE@NNY[P-CC*VDCF+YPI ).AP3B&3@/R >3,'"]<,SR68GES@'6
M1XV$T@-E/I+C!W^?*"Z11-G6]3ZAV!\DGQ<&DI;'  9V<U27:29V69>]90H&
MH5LF7S8%[)J:C9R-+4CJK^L,TBKA3&R=REY9 $^U8DL?C:(=QZ9%RD4^TT0L
MA\&15*&]EG?!4C/S/)%T#4DB/?V"%!B@Q%$1SAP9/V^=@/3A,*@BF3(3]\C2
M]%L2VRP3S3F(_KK'*&#3K':L6&I^,@T)Q=+;0CP>@QW+,HG]E/6EA4A#0$2X
M(EMB'_VZHP:AK'6M2HW3.98);3A73 ^+"(&(( ;+^WG8=XS0R4C+HZK;T+;!
M"1"G<W6T$Q%/8ON8D6JRT])69>RPF2(KO=CI3-]:VN.M^THSF#8%(9QL^=51
MRY >!%HI+V.UQ^$RF"95:_41!F,:)5(ESLI",6AX^5.2_'^P8.[O0"9EH*%N
M6@&W]1L>89839TIHI:OD9I[52I5($HK:@IV*0[:J-:_BVK!E^2*7DU-A"2 G
M/F 1'ZJXM>$?IH*1//6'<HX_159PZR:5ZXH\<4\4!29Q@,-NN, R[FJTPLP3
MADC03#8/WW=P&Y)M^:5371/@+?<.\@S(C=+EIHYDHGX]M]X6Q/HN6"/*=1,?
MD^@O^>.J1A#O6Q+YY'A;)P2^W(^4ZC*H46_Z88\>';HMV<[D:K1.HZ&74"\9
M=1Y5M/#,C>PQ&A9^/,&>!CL8W@9V\@Y#2@D_>I"VFQ\ZZO.JJ9FHI#(NC1?O
M-F*8EJ@QOJ&57ZMZU0R:+#,1(N!PW!'%GZ&S1L5Z-?\'(Y"8"V<D8%7LD70:
MS2WL^#73J'<Z[LDM$F!=,YCK\.C5$=8%!Z$9S2&<Z!JQ^.7B[:D%)*XOQR)>
M]A2P@#2Y'6M_-)678U,Q"Q%:$J+3ICMK.'ZLA*T].-]-IO%=O"7?L3THU'-<
MDAC,Z;NNC65Q<C :W=!DI!(Z;L9Y"$BMDHUYRU886]L,OHJ1$$!-3T.&=1P[
M$"< U=F-HJB.<.U5TP?C*)/C'\,+FKDDY&SBTD'X8AW!-0&F@,O4B=5P/.=H
MST5>(P_.(Q#_P9@H:I9-3]H<4%Y.G1NDW7+7YC=X->_ET.PE0,G\!,H1KDE3
M?0TPV1&?QEP:I'*G]+ 1UT\2[10 W4S.P2/V2G90S%X>?823]XV*N-RPK5&T
M6!4).B7L*S='[9PI,B1/"[XU^^XCCLIP5'^Z5SBJST8#*_9W2?(RPYL8<.DB
MP9BJ+E#JTLAFD69Q; )$$LV>F]C"0EZ32@IWP?$QA@^\JP=AA= 0'EL='K>0
M?M=<.!9)D61'LY69AG_'[VIE#':,]B2N)!"Q@]V_"Z-&M5 9F%7?H%)@XJ;X
M+F";C]E3*RDE"%D&!N/GJ3 /A^!EW]-/B V!$:ES61-9CRD2>F###,,-L ::
ME?4!3#)F0RN_2JI-CD62%J9*TS#(=H;)<J7G8_9%>P[GU,E)F[-DH-PT#-*3
MF2[GWK5]6K7 G[$<(*:C!PP)CEX>)QX]IW9*))WK@T6CG _FA_-8&KV?&W@\
M\$M[V!_\PW)<P2RE+N)A6=\?<4"+FG$(QDWKQW6WNEE5*:AU>=WU#)ILJ_C)
MF?>EYHYAK\-_]S%6OQL7R?GA:.$<RW"'A72Q^"X8@NZ:T7J'^86$9R;+!ZI/
M_?:J Y/*(9@=::GA\HPL=!*]0CENCH[V=+9.4NX]=[UQ2$I7#?%I,T0(-V^7
M;]@O_*81$,9#3>C^J!7GL/0NQQ)4Y*X5E4LR80$PM?0=/4&9#JD?>)RM=3G,
M+%3,2@H?/BW*AL)EI-H1Y]*BXI->Y=SSW8%7]2[\J?<=*"I-3D9[ 5-.8Q^L
M;;WI=E&ZPK'>&6, !A<S 7#GT0[6;/ O%F\DO42MK4EF?[+H7%.RA4DG)<H6
MK[G#-)MO?Y/I*LY*4S[[E4AL^*N8QM\^,JYZ\B/]=3 N52UTVR0C1O6K&<YA
M8]662"K2.Y%GID1JDHE);QW>V29A3N4M3RBU^6;+K:><4.P</P&9WS8YZID/
M9$/56BJ5N;O+9K9RXFU/4]SA<4[L55>L;X@:# @%FK+.%--32-?$X>>#3[HS
MW]$L)'EIH82@YF&X0O2^,E_>*DX-HGZ9;>*IQ1W)-%P4P[D/GR]G8,[0L,\@
M"I/*%>;A;LKT%BP1.?=[]S90&JC?6[8FTZ8I\*]$?Z4P2F,?!]6_-DQ6GR3X
MYL=,'I&F'B,W-0U#;AN^C2=(..MKJAG8F\1R(%<#CZ]'/5,2TW#CL)C' #IN
MM=:_[O3-=&']EE/FL_$Q!#*A'4=R3J.6)^",&6%1)YO26<22>9M9/?Y!'\EH
M&T1><GXPG/ZIB$CRULH65O+!6!JXR!14J45YJ%0?0(^WH=Z50M<Y,T_<;9Z&
M%^VXY5P HJM@A[+S*"7()3G?^M>2SC7$PO$-5.X6!V9=OTUU:=.7FA4US1=1
MLR6C:./W?&A*-G;?-545+.3+<M@[=K2WM8Z[6'BS:@Y%0N\GFIH1(Z*%4.7R
M3,)8ML,Q-G)I35.&539!=#?XZH[L(WL25)D;T'HC1M.V.0R?4(N0Q\PB#9&<
MU5\,X)M9GXUK1_*QTR;UP6[#%[,CD[JCT?$YK9L;Z_9U"PYA/](K^Q;EY(ZK
MG,]@DL*WD\TK#)NG+D[8VCD+'&EZ/N2CZIV21XYCR-OKQ($PO:F&*$+  :(/
M03 KL<8,VX+-T]$U?P?U8TVAIG0#C4OI-3&(P 9BTA)ZI!GLV[$]KL-Q=*^_
M\WZ^R[OYU\@BD>RYYO52G&>-' O(!C23_O-L@<B*7\<46)*9'Q*8B7IOT>=-
M?(BDIV.*6&[5P ,SD#1('[_L](%NO9$.67K"SHR5:Y=.>]3>#<8=R7;R".84
MRN5^)[5>9&%XG#H7;Y>+;RA?>MUI_-*97I^6,7F/S*?7[=RWE&QDX-%5Z;LJ
MZI9(JC4SOPF#69-WM"20++'^>&:@!;5;8TL8K:3 *F+U*"?<#LNT#]^Z"&^%
M&+PS"2FVO93[S89E-K/K5R\SH1\B3*3KLQ!.?N!C3RYK\2Z>A&YB2)"7?D?]
MHKO*%]UW)^.58->$A5[2/)Q,^T#+VA0!E89M+E/K+WG;%HAPA9,'BC&(X9R+
M.230\"2[!^0/XWY%23<"G0,&YJL*G"8V0QA..!0KTP%2.)@.%+6*AO4.JWN-
MA[.<E)/(0@6,1V)F@>OZ9L6]ZIK!DBW9_>SN>BXA_H_U&GWJACB5J:LAS]P]
M AH,T/!O]PK0<-\MSPMNDP %L$L.ZO(<]F.EA &?Y&3[GK_B;PB(8K;IG='D
MUAFY5<;SS^3FQ)C]9-PM6+0&CMB6#,!:96M2OLP!+IT0(^IENYTPBK%9:ID1
M6CZ%IX+:1!?F43I%]V EB-7+M*=\NV;^J;::CUTD5E"2\D%=5-"U\N!P\?Z7
MVE@3R^O@#&BND<K\Y,/N>K0PI2/HE"\Z:>#1@V#8AZ.Z6&A=Z-=F*U>SR?1F
M,%@;I0/%$\1$IV>A%W8LT6/@DT#_9<@1IKG,5!I0$4X?'2Z"3$M,19%/A,J5
MKE$2/T-_YCX&Q_E8Z(P-3&^V)7P?<E^"!<23IF!\WWJ6Q4N..$2J:*:X&>^B
MPQP#-A^Z7RR^99Z1A ;S6!H\X:ME$#.T>A!H7-+2(;0]=FDZ@42:3OC?OKEL
M-)?HE$]9#XG/^TW77B*@UTTD_.P1^X@E3;==T9KD[JT<QX'?E^%6!RK#.WR$
M(A;RPM8W5F3:30U"='LGZ]*E$.-:JJ5=-5U'-(;,=%>VD=,30BZ#[,Q8ZMK[
M="!F;+^OMSL:KDEA9=+QBU!7V1_02A*??KK LQ0I?>#%ZW^\^N;)TS\O*,5;
M;]$0/BAG8,+A:0],&]-:)&33S0RE1 UO7OW]'Z^>R\ PW%KH!R.&)MT3X7E7
MUMO\=5T%-_'M8E^OKMKF?\8Z2WN$*^[H>90*EJ=>F5S8*ZS%)DD7WG11W&%+
MT"Y,:(%YW<F^O.LFOUB\&5$:Y"5131>$C[M6[R74>BZ!#NF7A&.63P6M3]C$
M)OI+>IK(8-5"<^%R[TB ,:N 0H6 5^10W,A_PJ(D]+?J@%13[X:O_.SIXL6W
M/P2/@P[BK[[ 9?[MZ3,^S?YO%XR<Y1B^%UV0K/2K#_!UTU%75MF'9?,=*VNS
M.HUR5K%:M$G-)8/ +QWW6EY>.?J88F-D=)PD47Z\)1TR2OQ)G!36H9P_4^8>
M2(@55_&,W)4SZ@G]ZDT=LU.N862OV@QXJ#FI(,=:AXIOB4P=\SMPZK<WE0W;
MZR!BY1,V[6+B")G!_!E-EZZB6)>1=?)04V<_IG'U7-HHHE%D,!W!["HLM*9B
M1PK4U-:EZ\\X(4%5WOE$._WAVKN7PC(P-Z9E7QN@IX)&#$-PF5.$N7C"\<+=
M=(UL'>K(1_9<V^04MM?T-H=(M=UUICSL+[+(Y-Q71^![69<G=[/E?9X$[L(9
MBH(-9/CJ)Q,;C&-W-J.35Z+PQ+-I%$O+QE#6JAAQY.)%Z+7Y0O[[I$//F:PL
MX13"A:[W(>?<B_")D/F6OEJE-0;O>DR(H&VF>)F0:Y(Z)@8!HC &(JU1!(=A
M-1YLS7XM1P;E,EP(RVNZ+#2)C86G48L>HBAC"9T??X >P?52'K$=&%3^ O=-
M;YP6GCZ#ZP]@CNHPZ,T6T5.18V:.%EN280NO8KPMJF=]7(_"H@:+I6?2#'@3
M<D_[!H8LM6(.@45^IV$W]%!R:/+XH-99 FJ9S0G,\6=\@( M=%-?-@/G)6EA
MB&,^4RT,IW?7;X=3;3*<SQEH]&+'C-0?[X(EO)7%P;+A\PLG):Q5D=@B)>S,
MZGQ,5^,;R]^')N(!-+=\B^(T17/DUX7_%C3RX:2 ]1=PYA#7BQ+AS_5CNIQ"
M5%"A$18V ?;^HU[RI(!<I!/)!LYZH]>+&!6DD'6Z6+-=$BFR\$ $/[E;9X%L
M)NK,1D<;VL$4$A9%BZ8HH?,/5Z7D>C@Y]JG4$E''4BQIE%6SC:D) %7CIXBG
M3FLE5,3(>AM^L(==(,D/.T>'@B^ MHOOPOV?_;%8//OBV5,V^'0M_Z8=M_4/
M\1_V7I'SR4J!N5XS>M?2;E!E\=K4[27:=:23;(^E&<LV\679EN-2ID<LE1[K
MYO%&29M0K';;EBOAH)N(<^LD%DS:F+X97TA$7V_4D5!*L35G^>1NA1 N%I+S
M?FQ^^X^_UV4(MX>K9E= S;$+3B\GT50KUW4,.8)YL'_Z(' %[CZ6D&(1""Q?
M+B%J)F9>K<FOBS(*G/KCB>=334NX^?\>W!J9Z,DRR[&U?[-K.1%[GN8L9O.^
MZC#6 S>1">L5T^7!K^!21E;"Y3>^_4R-A^GQ7HU)S3]2_^EYF!^'D\I_\/K=
MF,=D)-<NCO:*6&5D?0*F/7G@?RD2^VPVZW/A4);\L[:$@!LV:?[[<=)(-_C3
MYG<B>?O=-S^(&NGOW^$$"M^*KL/1'E6D&98;TV]'7,IA4 ;6VZ8DNDXEV;_2
M2WYGZQ,TFQ1[)"'U;L_%Q_F09+P,G8@%K6J]__Y;,AX[.C?;RR>;>AVF[<\7
M7VD61%;,DV?/+C[=BL'T_O$O3%0^_=.GU5;]&.S%096 C_<UIZB3JW W9G/-
M&IU_$R_ZO1[58(/%;Q*_-DG\(A6:U."T-1E$K(]C>'P,N?@5:V;;F,Z/9W2,
M0KQ0:G-J,,\/U_/GAX;K.;K8CY_EG_7Z3X]/9CA+SDEXJ)P8)H9\XQYD-YJ8
MM9EEF9UZ\KQW5'Q=3N'=KE@D)7IF'K%4=O JPQ(O-[:![J74QKTVAT=G>EA<
MD5Q?"*$ %?'33"N$E$IEQIDDG1:'.>7@?3 :AI<_22AQOL,<806$#ZL=7"MG
M<3'G4?!3['9J,%HN?@+40C,]KQA.IRZU^M\_??-*_>]"B%S.=^R1U(+^9YY'
ME+-='('<1:)U_E$&[9Z>',D:;L,#]M 3<60S0JFMI:278]_MZO >Y)DN(:S1
M3M:[+MF7/WWS_+N7WUC8^.K5*U8 BT*JPD]SC4R07G- /5*FM0Y_[P@IQ: %
MP#Q/E@B*^5"D.()6$3A2V%Y&CY0*KYD<K<M!)U*D$2DON,U(0L^J'_>4;7J:
M&/!Y 93B7#R_4?*?X=A SVS(B\5S=.!VPN 41ID2KWO),P\+PMW0-"?I ;<Z
MP@(NPTV;/8*BB*(-CB962CC^0A# 4$/R3H?]NJZ9Q+C;UAP9''O<IEV$H*MG
M$:?@M8^EZM.E78)5O0_3SH4(3:R[1]Q'^99_QG!$P2JD7W1J7;H1US$)?VV[
M]DDX@G%^ ]@3#W-+BY6[7=> 7QH'?N[U96SY<JAS2X7W)L/_<KY\)-U<29_W
M#3<307"W':(G2OAL420G)"_R1DLBPU0,$>=Y(>9%QF""'"Z/#% 4"A"GI$%1
MNV^XC,2D.,Q6A9(__0V#%T<-F3 /D,H\:?^>M=0\1Q,3"G^1-S_O=.,7?R)C
M0>='$VVZJ^K-(6E-^>HHAQ<7:1K*XY'YIO7A"X^T.<O55;XV"TXYVWV/W2=)
M<5Z5D4L\MKQY"'*D6/49S'U\YWI-;0"L@/21.(N?W6D>%A_GYG=;!!E6F,PB
M'?@48'8W!GPJ&2L[3^*63(QF:I%B1CA#)"2T>E!-2.A@QAV ,%.ZP[Q,I H!
MGLM?4#&D5Q7G5'L?,@*^$\]KR&(O.*J]FK&'_5:>&[=LX]4O%HM\D]W^>'$_
MJ4MRXO'SNEN(Y?MQ9\WPOH+M:"@3;LC3Z.FY9NACK= G--<?I@5--D]I-4DK
MD&QAYJCZJCO'G/$00'J)74Y_TD'J>A/"9^BH_%M8@%58.F:D7_Y4Y,R-1RA?
M(GD5/@H\O2=.<:ICMDYBS_N</)<XT[[CGDOP1A*4ME#LQGX8R9LC:2]%:P@_
MI" R?OK;XO^:7%TN+"<?0/BQD9ZFJB]OS/F8&U7;-" JI[?X*W3H5J6OX#J]
MWN?L,5KA[*\_/+<0:%FORJW!8MJJW!"?QS:Y?!Y.V738!(1W*+&+_K-L1VHI
M?FJ(#Q@7&E<JAP=O2+L_%II&^-L+?9K%[\)UG-%YCEBIKGZ/ U'$VP@%&^MD
M=C@2U+)<\8L$4^8B+KIW>(XP0-UX>37SRSIV2WL#&*?1PU4;A7WXTQC"":ON
MLD6.2X6O_Q;^T^.>_SF&,0WC\64!>'D^GLJ*W),[P87,:#W#9!T;VQ<H-")V
MX(\W@T?70!&A#[-+6FBI C+#X-C5]!PC$WE  ]A;@W614_A)Z1Z&^=KZKJR"
M[S:<#<Q#XB4+ 9]#_U'*DJW)IAL&[9UH6F'E74#RET(/Z5L-QXSV$!$ZL4T"
M=GQ8''N^W,.%M[_V1CHL-@26O$QWW5X(AJ>C+.ASP\LV+:'K6NL5,!XLU8":
M8/A(2(ZA5F&TDDS FW+5=^$VY6KQ"P>N1N@57.NKL+##-@[!&ZDBT+=K475C
MIBZ/$3+]59%Y9C?)M.ECDW"8>"0#B-VP)W')]I>1!%J(. T=COS,4!RLZI)4
M?-_0G14-MVT&A(.$-#. ]^:P4.+%",,1,$/27#$B3!ZX>?E@37T&@T);#/^,
M'RS#,#9K:>I\0EAN^ZQO3'.09T693R#K#,%M#TY6%5GIB+ %22-3-'(D'^:U
MH_.(3WS.KG4JZYGB=8XW#B6H+EUAH!K23X-0 D>E? M0_LG.+V^H3YU.+ H0
M59WW=I'8-7W3-&*]+JPS$]3C'8R!MJCRW9]H%9X[OKM^\@N?X^0)X9.JY&E?
MUX[S!S>D^>5F5X:S7RR^/_&FR%K15BRL^7$3#E,1XY$OFF(F=W1LA!B8,R6*
MTM?E5J1:Y*87/(^^2I"L7K4V<_"D=UX^QL"U1&V2Z4EG*)( 09^)"AZL13:/
M"5UM0K7IU9.G*W]ZSG'N=,A:),1JEY<4/",@)4-4_[I"X]R5.R8W1!)@O63Q
M^KMNTZABM&])87U62HO4F_43?#Y<D@[/BX5V4#F&ENR\IB?%K24EV.9W/!1R
M'-O]]X<=G1H;$0;VV1@"9K>V=JH:);;E1MM-;VKI^4]JVW/;3(:+,DR_*INV
M:XJ<\2[>9^N\*S78PUWYD\#WB-^Q6,*]W[N%7$@+6X__DL1&L"S-OIBD,CPS
M0-; -+>?>LC"AN-V,M77I;@=@.2R)69D9<*)PLF>O(<MX^R_B71DF>;2S!I+
M%8DI)5,3V-G)I%,2;'#Z-X\0)H4P_?&+AP9A^HQ[RD21P'EZ=7O=]!TR,L&B
M 5SO<K(174\;21I,$B)^8VW@0&42IT1KJ7OY9,_W9VT,J>CJ@B;4!R5OGM50
M?""#TWI+;<B1D<)1^)'AN I_T?Y-/:(HY(L9%#6($L19[ZN&6/09J7XMFS <
MB-^*<.%_!N^RBZ0(?5DU'3,FN3O!$I8#[.KKW(449@G-)++DG+PO]4-OFEKH
M"]RRD@[%0CM)"G2:29RYZ5;'UIIOS)#WWM<&Q[D:P_ OKI#BL\%S*S@EF:+G
M3"$H8)M+PM[@[[)OIE-@[8A RH%1RE8W5S,DESL_>F&#D6PNW&=AV- E\NN3
MGCR[_QD;;OZ52,\-+P>B48JYZG81B$0SQS&+1!6THCY5.8LU.#]5/<N1GEB)
MB7%<(HL6!\A"WYMFX!V"U&"<!>KTKM$@KV%PW#.:OPN;MSO4]8R=B_Z)I/;E
MLWV6#N":$91/;C>X:50.6&".^F2SZS<+)PG"-:,(KV02B'^=2UX#1]S)=@8X
M- 8R6,=Q^3-M2BW1@N3__4W"Y[DQFVF2N,:Z>.YGQG.4:9]5E*VYP_DS:3DC
M2%+-"K>)P"VWB^$IA>Z(FQ^CJ^IC 7^,M?4E(R^TW_!CQ0,?L#SVV3@5+^;/
M0!P)8=F#3P\5'#;?DJW"XNM9S64F Y6DX=->X$3JX%_>!?XI$8-D\YIOR8I]
M3:4I=0J:86Z<E_01'FRA8W4%M_ 5-]AH I6B#\TDSNKL7%;B$;[XJD;VBB\O
M2:_PH_#Y'GV&^/D3%BQ/&A[_^N+'__,]\7ET!"FDI$A\'^KN)Z'I-I@+?"ZR
MQ]KSQP2:MIBS;7TC7L*7?WRJU<3O ?"3BF#X0(^B^W.ZG"J%,WE);5QZE5&G
ME\II!+M%]E?&*C[OQ>*OW4U][7D$YZ2U55UBJN[CU+MD4]C>81IV?<7PYO1>
M-G:IFI@72IC<@Y\(ZH#&!<<%JSK6MZ("G)PFVAC*56MWN1MY08SY2&@/#6]=
M]RK$,)65,4FR'TG&M-4M"9GI-K_W>SGQ#V@VQ]Z8U70?\E[K^LM23)\L$]2:
M 0JFJ$) 5\F.I@7Y7\KX]IHNP  5?('W0+C&?[W^\;E.37B$JV;9[-F/P=77
M3&DY]S3>TQ[>-JT89NE_$Z-#CWE=;D8L$:,EY#=>CGMJ:=GJ#2G]T[5":'O
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MN0SX6B[[KJP*JXVSH<D9OH+QO"3#6O<9:ZH%F\FIQN78K>+YY"&R%BJ&>4V
MA_0_T0#7_&'J%T3((/(CDA<UO!0<!)HN6>L%]UYEQ76T9ZV!-%$W.B%'?EO'
M5M=4LE;!DE$"H>0[@"0=\LM=A.T(C@:G;S+'/T+KM@_!?SL"^QN_Q&TD?;EK
M*K!A(38@D5:>=;HD6LT* 2T20?.O3/F@"($(#1,&F2JRT8RMH#<YT^P6F-%T
M<0*<F3Q/9F26-<TJ>R_\FA.KR*P-Z4G-G&*>2PP<%.R@9'1BM  \[QVST,[X
M4#&7),H3"6J(@'=-JX=D//]<D_1[.V'%<2_,4MA"(.(G6\0V#/1Z_/BY[+L;
MF6ZF%[0ZP;P+IHDE//.4@E#G>="R#<.[I 70LE*W%CERRY4"2GS//9U%?LKL
M7'*0^+Y>;CA=%<(7<(YK% \FP_2EFB$^\)(A&TAT*@\2\OK:=V./)"9!(;6T
MN_6T<_(8J$M0VXQV]FLJ7X)V+4R%=V/P8_)]0K-<=TV5/*^C+M&+S2'Q%K#R
MUBF-&(;%T(%3MCU\RI6^\:)()Y\4[W932I*1OY0 9>ZR +B*G6.?=>C:0UP&
M6GUCJ_Z6LYYM3><KG8:.<C]GR$U/#0E%8(3#AY5(?JJD'?%CTNPCQ\FR=KP&
M65-=BUF&"OB$\TN0XB>I#CZL2TZCNB,=+=%[WI0WA1W^D%Q/A%FDZXBJI1*;
M>D3IBZY%J4T>W1G'C8FPJ^&?=D<O#7W;^]C7#B6_.84L]X2,Q'UW$_-<1FQH
MH,?;AH$5W'C"N'LT2S,A(?&C*1!TGSJ2[/_MGN0,%#&LIGY_\H1('[P[GEW2
M>K%\GRFV4]K],$3"^"[E%BI*]RQAH:WXF]0](+MV56[6EB.[RZ/,,"VS S'$
M#!4_IH?!^)^SKR^H2#$3$1/I@JGW?$)G??S)*);2C"-&[21N"*=(-L]L?043
MJ<:74B=F7J/U;9W-@Q1I?MZ\P\*=C!,PU^,@AF+N@/T\%1'>L;?^IHUR,!1F
MO0@C&@;VS;Y;O?TLW^\]<B'$.E&[1#6]X$ OJ+-^C?!V4\?0PEK?X:YI#+B(
MP*%X#15_(H&Y^N'F$[Y+/7J\NV3EKQI"+ NE=E0+J'1<H:>I(TM9>?9M3DW*
M>D,,,&1PD]A=[;3^VJ'F.+("UR==Y:K;5#4#CI#JA<O32[Y#^>M/SRPI@ZT\
M%#O>)KF_RE;<^F)*=X,4@,KY_OO9ZN_N305*4^?UXL7K?[SZYLG3/X>)(O>C
M64%&*/,^'[YD\:?C*TW'Y^F?:21*/L"1IQ)93=+MDC"'DJK9=CC*4//P9^[8
M8O?#079!U4CWD9J7$=N3<JHDJ\SM..<Q-(VL<J4]2VF\D0?<Z5AZ!JA;QO+\
MH#Y?/C2HST/36:>8B%+>6^5J:I&A7P-0/!0NOS,PA>A,RLE5A'@QATT4O'_*
MW*Q"*,>+UH,_D68<F"]YNJ'.V!BQFT=V.WBY1%(ZYQ-"=X,X1L6Q1?*.DWE4
M\Q1NA;_\IO320UOFOM81 P@K+*C:IXZ^NMTR"X23B<J:"8Y*<UL"1UX[>/\M
M50LIE!)2N>S/=\F?BGKB\",$NRI[,3_4=8Z$M"2AF>MXO>G*_?F.I-&X\W"$
M]7V^8W%S57._RK&@(6S+>J_$9<'/TYZ6-1,9JD0 B2VRTQ=[J+$ *?Q/OLF1
MR_F.>%(HIZ(Z;>!1\J5J]. #$,KB?,?)Z[U'2MV$<JV84J$\#MQ?-L';>3+N
MR,5$=7ZAHJW8M0P666Z00)S)DWVD[,<=7^S_M7>E7VTC6_Y?T<FD9^ =8RPO
M8."\/H= DI<WZ20O=,_,MSYEJXS5+4MN+1"_OW[J+K5(7G (8&/TH=,):"G5
MO77W>W^P_A=+.)T*Y)E'C/YNBD1M13ND1+ 3"2PU6SQZ!I1^L;O']J4GATF<
M0.S2Y+]U6YJ$Z1_/L[-AO@',&.,CK$HW1C>G!K3QY[@^92O<P146WHC*BTQ-
MLM;A9J8%]+VN%V8O)61P<909A(J8U*:^UJIG2!8#R&+1VQJ9#&R]QDDB>CDX
MZH"B5]BI=F-K_711=Z7UN%(-:4".*.7+#^ 14U3Q;0O$"SM8!QHX&C;M &<V
M3 +\X#N\K$3WD8IX9B)HUO1JN&;8,!)0RD_?Y]@9&,4?Y3*F/HDJ"*>9=:->
M80K^:0]I#6'F).E,6MM@.^>@4O**2>A6[ETM^O'=_0R,L8;5=+"DE26$/->!
M:TI-@9WM[/QU'&9/4VZS"YE;R$:3S4"^I<5ZYAU03*RWI9PR1,0!'H.9VFE3
M,RG22MLY[7:^*D?\J!G=S4]*==.U//I%[2R-''0$M#,2!^816+!;.JE()KC]
M.DVH"W\4<J#KKT(9$1*[C?FOI:GE$,"'\:O0[<2_IWIO^\S%3J&95L9342!$
M&2LV26%6PH@2MTY59@/@*J" @P;"C"%D^CBIURT/NVU7:O''<\";!92L.6=3
MG#,5,[0.&=F:! 6C 8&"?APGKB;1=QYNITU IV6A@5@;FEH[+$ ,"5+$N>0*
M?R=^X.9X:RIOG,H5LBFO30PBC0+C#'ER1OO2_"G(M>2&L%AY69-SX^34$%W0
M+9SI+C5%*3O*VDDTVZ87[<"X!;;+A;.9F%T3?.,$=\QK4Y4$G>(B'3)V.94H
ML0$VWYSB0L730 $3*Z_)NW'R8C@G_#8'>HQ:>""IGI4=-J) QK/FR6/*\EKA
M;AE%0YPXIGMI><:"4PA4+N5QN]7(^W4K+#92WU.3^SL/<&6>9E9@FSF5MS,Z
MRSR@B!WZC=?/J .8 HZZG70R36)@@)K.6T%GJ;/Q<Z=Z06%P3;.MH!D,68QQ
MXD.#32$RH)-1HZQQ=0?,BM%9-4DW3M*1V_.#?:8V24 HP=5N:@=@G#H0S>S]
M01%<NV/S="MB779NR\Z[==EY?0SGCV$ T8$\'!H,BS06/-;,*<L:1LI-);1R
M0LI11I"(*&]_\=:[ "B6$8:9\!!>)#COS_0CFI$#-]*T,]%Q-T.0M*SFG#-A
MCIFRPEJ";R'K(+>DQ52C=%%!0UR 9"]2/?E!-W_S:)S:Q]TJ&J(QS+40HX5C
MMX900F2*8BS44JE4LZ;DQBE930]\FVH[^%HFUZF8CI60-Y.#R]4$=HP?3P:L
MZ;EQ>E)=3496K4[O4 : HPUAK,<XZ01 !4\5/=O(*2+AZVOJ;@5U>8A7:-R8
M(<-IVG 1GTZ.)=5TVPJZV52[GE83*!^IDFFO:;5Q6CEM="4L79QY-H0)*CS#
M#$9F9H]74E\3[7N<BLE4A"D!)AHP&Q@[@(6W8Z@_?MQAPINCA\8+6.0/(]P3
M0:$B3B1[ZWB5K(R[Q8I-/5;MW>6Y]=Y=Y]T;P#A .8]Q56Z[XO1%Y1*-]&A#
MK PPS<O'\8$T'S(*_Y21'?/FC$UWQTR4(PI+PPGTW4H[IKF#S7:N]"17KR)F
MC2Y9M:A'%K(&OGD(& LVG,P5_G;+-4Z\1>4V\V_G00GTR[B 2@\OL[73!&<D
M,ZK&U89Y!3%R**9D">!PMG,+]&5!]VR1L)-7;,!@2F=8#+1U\'@W> ,K(\)P
M$'&,XV7FJKI' C\A2FX7=G^6VCP7M((V5A=V5_I$*G.F>-PMS,]LX*8O6O*B
MN3<+B],)Q+1(%6DHX;YZ9< /RP9@_<NL@S#FPXRW8VX:L*F,1WAA#)@BMJ0M
MY<:VO+$9EXH#_7!\-0*$B8RFGP4,ZVQ>PB/498K@&8KR#RSXMJ8%P>*8V#&K
M!73*_)LFC8UD@ U?N(\Y$"N&+A3# =C,-!1I.E,[=2O2(.,9MH7!W*(6%O%M
ME?;8UKXP#."?(_-=RJ%$Z[/C-[QVJ]UB8)1@T8[LH89OG7WZ_!'_YI_M5W9)
M/?%UN]5J]CRUXD@WU[SVCWK-EOV1&39L-Y5Y4VTHXWK _M+@X7B&S;JD S3E
M+ $<(CH_G!8I@#!2!\Z4RA<C:E&"$\/,$#26L(/ZPLJ7#>1U&',@)"3<)+5=
M?;Q'_<4OOZCAHB[@2%M$\?$N%#>H1\:A\$:@0<<P"1[6&XE;/0'7!K*=J\VR
MH*L>VY:@<P)$;-/[HK27EJVD>N:73S*3UU[$#%T3\!%Q"9*,1AGT!A)!G"W5
MCC]JE-\4"Z>ET;\RIIFJN#'^,3:+3!*E,D/J\5AZ+? <KZA$8OQ8:CKD:V$5
MT S$U*#H!:25JFSL'V^HRP!/5L/;D F,;S> -4QL#6T$*!^*)1CD +@")P6/
M8$(N<NR@H&1I "<R=R:\HV56H@K1 CEF+7H B</,@!0H+NNW?D)V+9UW9:AP
MOA:Y/0+;M,'3QOD3=/=C0 D!:@I#3 '*ZM#R8)1NAK#/01ET@5=0L;H*9.8K
M1JKM]-O:[+Q( JE-UA3.=Q+K6-A-F)EI%K1:F(P=4LNEDCW4[D2/OD[0NO%8
M?"9F=BN=^ 8+4_X:.\D9(8<RW;2K/AUD"-3E\O*<%]G^3C1$S*C>WD]>::RF
M&;P/O\0AXXAXVP-R0/>=0/PB>0!DY<UN+'V7$QY&M/$<.LCD <NQ>2%D'3#G
M,A3A.>5T>/@Z22!\7)+E^D(61<P(AI)*UQ?3@##(BPH5*QO-%B8 /8VQD76>
M3ZE#V%QGD(<#KX2SZW;?K7ICQN*PI?5$"_";\B07.,C]M=_L&K7(5AIR,(;:
MU<8H8BDFK6YC6@'UF1CH,.NX:!ZIKFC%2/27 +"+(A)([.C6<^7B3 ;JO+T!
MT=GO>7OG;]3_]KU;M9_@&SG#[^'8O(>3$BNY\E[<*/*J1670,AQ[_RR4/](^
M<3G)U7HLDPB&PWD_'!06NB!1P-8AD4EV!7-.&W_!CB,PQU3,]'1L0IS.- Z,
ML?KUU<[+?E5<=8%<M?Q-\TL/PDQ  WKFRMKEG\ 22R\2K)]$N9C_!K&C8>/X
M../R(3 = )](W8G*OU5'4*/^H)Q2!\;8D;1*/!HHNK1J@*^JK$<OGV0B0KT9
M$6X<;L6>J#&:WON0L&#HP)/[RC ?T.Y/QK !M.;P!D,?<+<RQG45M[J;:#0S
M-TY2:9&]RZX)I1I>[K;U*C\3\: M"$M4Y2,N#R6IX? "A"N-]P>[M#.=YA#"
M _8(DF$Q,2F.2ZG.*LA)M*L9WCF#MG*!*N=/2=HNS^5DRO=$4@0$O63 =M1_
M$-H=(X#*SDX(AVT4$[*6N&\[ITG!-FY&<1O7LD'HKD5W#6: OH&<"[+'L96<
M<=R!(M#,Q2,4GE'S>&N:1&Z5#LZ7^%7'U?0#>1H S.E /)<PK\3HJB/%)8 :
M\+0-4RP(?%(7]IG"OMZN%?8]9:!JY4$#V0\#AF(^)R6],4%#U$0$!PEX:.H?
MEEE!] .7ZT$S=!:EGJGL)NNEB2$X=FAY$,J"X\1S[E_D>(6ED[5H- Z',>:)
M@L%]QV=20O#Z6B*T"F&9N'-+2.I5&D.J,LH!0F*>8)@/&#OS1Y(Z_23SZWF1
M:>)50 65#IP%% 2\&\!(-,-/H>5=CF0*1"1W6A#,F_$&G32 ]6D-WC.5F-+3
MRA4T\%09:^3*FX32#?!!P"B,.NCP@\ECE=EHP*C9@'93PM *0E Q%;\/.4<M
M"68P48M9FKS,<H)5?"*_*3)E4%",]%C-+V1&"/-#3/R N2Z\&Z%H,9R!#>Y*
M><S298Z;OT2^8Z@8B"HH-!6HIXP]'(4VP2PK4E/?H]F"C:BL+$MPC _A8^K@
M+BZ2EAA*.YNE%B.K58 ZA.-P$&ITL-()I>"/(O.MDLPP*$U9KQFBOA)M<#Y"
MMN@>\BA!I<?H5\8FHVHK%&"$+C>-5B%R:AI5CC"7!*#G1H;]HFTL'1$3&(\B
MB!_&2H8J2CJ*5LEHD^J%O M@KLZ=%HZ0CJ'01*PXX0W3J#L.Y4C)!#DLL(<A
M 9]%IFL8"XMPDI##D.W"@,=LD9@ Y+8D(X:"/!1"7@YY$J2%/<6M,]*EE@'K
M\!>7>4"R#HB.5-2\HDF3(&HJ3-+-O:,C>D[[L/.3#LVR_I\FMU3]Q^B>&#D;
MR_@ :F!R01D':YLX=R(C-/2_\N2:!G)C%!@*1R))QFL#(6'!5]>U0$[V(KF7
M]T\>,+Y5]VGHH(EF?QWH8YY?$2O0?$](VRAIJWP/PI%-%U3 U&* F2E\,(5^
MX#"((=R$?A&D7Y37#7/:P5JJ1'U>;('>\B'"-UC4I=Q4L&P5FPQE@&.$T<DA
M&I7%I_I$@O_&))#V;0$&,@@#H?,YR\V=A&44,)"B"LFS 4HI4\V"<MQYJ\95
M8IGN,H\3X\,YR#BA2ATPG/0)"7[-0F@:,7XZVD<>\XF1GFI=WT+I6'O(D'R_
MR8 I*]N#\*Z<^S2;<V1VX\/"T)A.B*NPP=B'98HU>>)'!V=O=6RSE.=%P6A"
MPXXX:V@(<B>MQFD]%MNMCI:]YO[W/#7ZPA&+'\7M@K@*L*8V(7F*NLO0C3).
MB6Y1O,5\NOJ**AZTJQ?*F@#9>B)3#9.LCN: FCSP!!>4'!$F+T3) /PRM>F[
M&^$^7TAU:@R=XE KHFXI+S3 &DG$J[8_5)N&B+[*20RAYG2ED@0\@9G53QAI
M4#???0\&T,GW)Q<RK/AV3>\?RFJX09.14]*(NSNE-'B.0PQP6AO-E[:XW-!D
M2=$,^^6-RJ?O+B/0T73K$)S@Y_U,H<;*+,B29)3.5N"Q7I&R@ 1)17NQDIS7
M(\O5K '!UNA[)NV13$'Y!AKA&\U.'9!>Y+]8K\$D<,+)5 8X$UO)'6!(S**F
MU''=H!1/\FV&*U6;XR"75',[-*(,*Y)-)=M<LD<C\$2SM:9 4V8/$J'XK6E>
MQ%1L/&*SM.I,I5)@F2@!"<, 1"?2GJ>*]V@3=[5T]G[)0!YBE#G#@-7FHE2]
M&(-1F6JT<^\JYR>88Z'[2DO5?]3G/<1\89I3T4LY3J<H6$R(D*52:_2CU.U3
MK"<:R/P6)M<7=@QY6?>2]0B?":_+YJ[0YJ93[#1(R6:$$UZ$=AJ^G<3ENOSD
MVY/S;X$X%&?]4:1A%H1\)O6 :\4$I9U9LB&[*Z,WP(%AMHBWR%C"OHTTO"$?
MGT-W)-6&4J(LU*@(.IPJQR(:G>&M?+URPF'QR#4#TS0MO%&H/)!0 %!1D<^6
MWJ*\^'#BLAFT#V#LH$BS0L2FS/@NX[1Q7QUWMQ-_YO%NK;-^)!(4]V IE0V3
M\\"0"&2["%/ QQ@JKH\E*0BG:,<T/X@I>Y]P%#-#"_#;8HJ,"=Q<6)[M7:Z$
MY]_JUKWS8:[Q'L8)ZQ1B!OMN,!M)I90<T__*%LD(^G34(W\HS8G12'H@[4$.
MO1]0M21NU&9#F-YV$.6S*<5\C#339OP=8H8A0+6PJ65%I70%"D;F!<9]] _#
MU&1LT@#_8SP$FKO*1T!PU9P^'GR"J?88Q9+MA$(NO(MH:U1+O.@ZEJ/E=2RP
MW##X^ZMPT&H%K:-!N^>?C+IM7PZ..Z(C1/\H$'V_.Q2_^^WC5\^Z^N71=W_.
MC,3=_Y#+B=>&/I$4*B!SK(BXTI/@WRI'1HG)*[?W+_!^HP/RA11K]L-"2TNH
MX^TH6<1]^4I]0&8GROMC]N,Q!?:&(M"Z\AH:BN&/.+'( (6["Y*8PVD,Y68/
M2HQ !ZUR[_)QYJ'<IP#=E9SF7,G/Y<R/JO0>>0^_DZF^%*DR7[)E9XMMG ]0
MY$*(#>?*6(A"5)3ZWO3ASMOV,%@JI^[66'3C[^0Q[T6S5T4N6X2T#QA7BA0/
M(3;T9YYY2RWV&(.Y O-X%ZU/W)C/L?=9F=^*+4@(^4?8?-AO,"8RB#0V.=$L
MI?1H[+U+THEW=>![>^^@)NM3TJ3[.YW.0;M]W.WV]DL)UE5[K7MR/WSY;'IR
M:>2/C8'!M/B)M#@>Y$RI.Y1W@N&_9,F'0/*-6^P ]OY64J5<X/4;[7ZKH7;7
M24S/A]YRZD.GA>N)R#96]]KO-=43II)QQ]&6-D!DQ&MXF:)RVW9]_"]UTX80
M&H\1[-#ERYR_#"SM*2;Q8-R1\A!?^W['=ELUN%&1FT3XY*,Q#G4\&.'$9"(E
MM%_WF\>EEF;RL/0W'6AX2C.; 1NAF[Y=]:<D-GU[S@2'+!F2'.8Z4EH\RJ^I
M"*GJ<)&31\BMF<D2M4I9(G1#$-%1_6-.UC5T/8ABYM2N(6L0\>F7Z.UK-9'=
M[8T\VT-,&@.0RA#A,DXLN*/M2, 8<R1B"%6P'[>8[?@? N:!9,,T'$@#F:1N
MP 9QR,*%D4ORJ[<7I4C.UT))A6Z[NS?8W^ON+W41EQY;G&"BECBOM1ISAZ+5
MM5RJ^;-TJF 6P( BJ-0ZK!M4G;BX[K9W\@-#D8WI%DBL6/@_[$\24U ^= Z"
M$*&*%^C3-3VT3NO5L_.,.DWO4HX$3OKX#:H<KF0<)NE#>@!/XOVL/%D@\GZ
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M-WO[]0Z+W.&5+4Z2;"IQI6,F>T?0^;+K]KUD<Z2Y#8DJP.@//5/)D2?!^$#
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MM/3]Z:WKDZZ1HU(I4BE<]?W!^V[V>8Q/>_[M]Q[2Z^D9GYY%5/RRBT3PLO0
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MP0"!)DDL#<CXQ*E!FYMR(W=N,[QW/#?2/&U]'UR[!\U68^$RV53VE;]O0W\
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MP!_FS^!';Z<S/X-SCVZ@0'HA)?(0) X5T/UV24LB1')&:Q95J).(O S14Z%
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M:LE#-(2IG(,204K8L]3+-4?X<S[M9#YUH-D^5=<\.,Y_M/JX&&<4CC-I JK
MN;)L,.(]TT2QR)V*G+KTV.RYZR/\.9UV,ITZT&R?2FP>'"=J(</PZE SU^AD
M%RO<\-+L)'E<.41&_FL>T.O6K%(GT"T.\N>DVLFDZD:V?2JX6=N\!0/*:1PH
MCY02Z2PN)<(EDDV$P((5TNQ9PY-N?M1>ZN+!<OUK4T@(A_])1'BIRLF1)"%;
M5"  9S;80!^=H;Z1(![16OEH0DG5B/BH/./5Q3$HC?8@@R(!%\K2>R\33ZDG
M@-KT-&7FH6*SB1V/_A'-P'V8 GLXG=?B[Z.:P^OVPV%9\!2L)MX&2:0RC+@
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M>S90QKN\A6_R@7-M7[WS6/]%KBUU^\ -_$[8?>W&V],]?_J,*1-@_@LV+)J
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MG>7OM2\]?81[[J&^ V3J7C$HSW>-_P_8!=P-^RWJ G1<GY4+J';^0ES25L?
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MXBP*($4H@@01(>(H$ EQTA/;AL>F+*\5'>VX!=('O3TKT>%HZ5YV0ES9&32
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M3QZ;RK7@+/-8[/%T6G4NLKYG-5D&__O+)GW4VE-C7]^T,>[UOW;'_/Y3ATD
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M17/RM8UH:Z+?7$L_^>UJ.]%[O0[L62<W^^Y$?.)FKY63([W\:VUE/]$F_72
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MN^47$W"UKK?B/Z^6Z_:O^HL_+S_-E_+C1CZ6,YQ@1@K)0%8H 9#2WUX]DW-
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M_@0_XMHU4G_S_)NDYO3:N'$?UO*_MG+)GZNNMC21>0QS!CC72V.4T120#,5
M0I46F&+!N5,)! N94Z.JCI[13E&O-L(V@-N156 8!V8I+P2="<D!DZ!,9"-W
M5 IR .(E][C<ZD<ZG^7F+2V_WZ]7/^9"BC?/O^L5Y,?EKA??+=_,?U0<-TM4
M#%,!,4AED9H=N02P)-4$1% A>()HG"&7 @?VHITH:(0B"*8K!M>J1]NRBF^)
M5KM6E72GM!L7.8R#'24-@^[ S&2 -5I'K=IF-^R7WVN4_Q;M.X+>7H;9F;#<
M$0O*6P[B1Z4O=UA>LIC'$SP]J.UZ.3==0[63]F'^T_S4+CIPD8E8(0)88=J
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M4V,4HVEIPFY/[G$[K0^M(+=::8<&<O#E=JUP9#2N,^KO5'3R>"8\H$ZK[M#
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MUD@;D>,,FMN69""4>S<FKY4QWO9D(#0.-BE#/?/:]MZ'FZ7E/G\GD2G-(5.
M0M,1A.4$,)0@D.4JRQ)")4J<:LQ?%CFUSUDW<ZJ;8OYFM5ZO_C2ED'S[:Y\%
MW<Z=#@OEP-^D+HJ?=FN1%Z<O8W6YOH370*VKSXI]I7[4EV XWV3ZXIU^?'3X
MV$^[8G\%R3.ALAR0-,, 02H!C5$",J6(++0KCE*GQ?L9.5-CGA>SXXJRB^>
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MOV 2%H!D' .!A4)(4I8*ZR".LU*F]K'998G7FK:Q3Y6N[GGTQZ!>CM,( M7
MQ.V%DE<Z_5D4KDJH/W[JZ"GU9PT[E51__F*/:.%]K9_R874KQ-SPB\G_G(N/
MR[?T:;ZAB]/4]8\Z$O9.O:?KQ7.;YU!'E35>_8PS(21*&9"9"2^.<P%8(1/
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MIB1ZH!8VJ=!%@7'3 CV@.4KL\WF&[]'!KNCJ/5W?K:MOJ*B2 ^_ENI(Z2Y2
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M :4WJ:[W >.EU-G8<9!09W6#YUDZ-?4E[E13=F*U+&<D%1(G FI7C5& ,!2
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M^N@O2Q+K)CY@* 5/,S'!8P#I:"16>4J$\L5PNR12I1CL27J:@=1!VEZ30CQ
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MF;(T&4F2*V.<3 HDF"")3B+& -:;2K-X^N1B6+#V JM9(SIN -^_H2-TN;(
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M_/DK(\LHA2B%)XR7F:?"!.)ED$3GG .())*I\]YZ>QK;@]H^J'C8)[J.BAH
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M 8^>S[_#Y#NL7J",C \*E/+ESK4,+O6.>&X2H3FFH)BF(.J4@1U$]K#ETZW
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M'K1$]5D[!?>3AB\S3G"/)G !-O( B@D+,7D+GBMNM2 DJ*GES/9DP=EGNL_
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M9A^EA]Y5-,=<' E7JH$3=>E%1^ U5#Z?N5%F>BEJ4:FF:VL8 TK%0(*(P*?
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M_^[B#)'Z"-1_?W'^X[M7E_\=O7I]>?'NXOWEL2SZZ(#Z?T,[BA"*A&AI-\P
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M78.1IFGN!>*CP6:E"I[)Z?W')_?_P[&W+Y"5U3=><MYA;Z1POLM*BU1RY!6
M,=6F_K/_6A!B2&;JWGP:O)D?$%WXZN9?.Z0$6<U C)31.16:S3=P/8MUI\ Y
MCI@NG4]63/A$9<3 #M^(2404,,B_9:*4]&+Y>P*>3JT/R:-;YKMV\;#A0%=
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M,=H&!OB+FT1]R/TWIP(/U>;6OI$W 2-J>%*^8K8D;28O\:IMWW$N4R>3'N\
MCR,76QCHC.]4)_@#'PD$G'G4@W)S;'D-Z\O?V,FE)WX#=ZO(YWN<*V?\'M+W
M-@Q!8/BEW.\RZ-Q6E9PRKF[-P7"FSA!PPO@Z Z9JW]#8OFU\;AT,1 649PGT
MN.;*N*)LSLEIZ9/[62\WYP^]\P,ZUV=S#E;>GG/45&?JS"/WO5&?,"5?._1)
MZ[+%$U9)*V6&_#\58I0;[ @QC?WX@[1;U%!*P0C((5&V38S=)5\B:0=N'F^>
M2K,P7G'2\X>C=-V?GP1MIN+I-IU5\K=1UJLU<7RT3DVD:&"]7. "C-^K*_%Q
MD>.G656,'$A*XZYBC\\:6S.6MWF9<KS%^EV)^3(N0<>)&R[::4+7SZPO2I[W
M*T2^>;!"$]#VW[4CUO39K7LS3K(QPP0M(E=.;JLTZKBK=XSZ8P8]Y>&8HT-?
ML'WF)RXF))\"#3N&BF^N1N6!ON61C:'XVUA2@9M(AB_V#2H(P C&5= ':SHL
M(;I2X6/.F-E45H%%=H.NN1I8^GT;6J7K']I=.V]AS]H:.I"_Q.0: IIVS_+0
MNT:M%<>F#5E-F/ /)^L)!2:%F(/EE9VX%CVQ\/TY13C0T_UIT03NI </S%Q)
M.9V!J3 ?ZW/,@5MFX%&F'_&DUC/WN^"FA'(F JAUK:6GUJ'98D<Z]61@:SLN
MB+]10U*6%VA/<9%C,[$[/,-@?I@7\H9Q[%,S'#I:S[.N=[?;,IYM LIWCJKO
M9_.:Q4JB-$=D#*Y#DVE\;9=6992%?';R:HKDW,0X2%$7=G6=:2$GF8. \^LL
M71=(0(VP":G6\2DV_W<?1UU8ET- EKRN"9A.U14VFB:<H6(;AYU#J:?:-B?R
M@= (:RJS1:G?(ZU:QZ]E3%D^>053)QP)BLG8>R3"W.WZAKB';VLP)S+ 7X1>
M2XO@S\J;ODC@Y$V-.;#/]HV"&^9=YEM(= <X"I/!W(]9WXZ?_#P-;'FL%.AF
MM^)HLIEV_$70L?5:3L^Z%&BOYID7>SD8DW]/'9,H!N+%K?#,#7383$:2$F2M
MY?\5V%K_7"VT/5DHPN%<:^++\JW\8G&S:_,C8KHA1';6A@05<<2E@/'V"70S
M;1H9V.7"]'JL^:_=Z8MTWY<OL1,@?)=:LRA)&!D;3?7%#MII!VT[<X*>YR#K
M5@G*;"BT@43KFRTJQH&(2K+;:JP!4AQJ==^E'O)F3^W04?O:0ZE,=WL( YDL
M@]?7T/#3DZ=PW*;!F>Z?YDS.^41[;;K2 ;VVG+.%]9SIZ7>Q!I(6H>]^UU7P
MES,, >SAI'_<VGZ*[,$1<7N<GOQ.#,7[H\R"V Z9Z<Z>/S3&[,5PKM9@E7T:
M*\")^V;7QN=RJ LWOY!HS:"S*;YIU\69A-LYJK;V/(\Y2@C6'[. 6$.2'';W
M<"5O(M1TCUN)TGF,0@*APZV,.<2-UD2]-!3!Y55[/3!W(NU*=/:=%@08?03'
MKQF<RR#0AD(.UQGR@ E56DXIQJH.4_Y#X)=H!DL0+9 @1)[MC0P+HK%8+K:9
M$:;O73[QH8E'C;L@V/I@<=<6RM ANEU $(8*CKF9L/+$CZ/ILH/(6OA)6IR9
MHIYL_4J?R.C]>L9'!Y>?S7OD&S%'@EP1U\L(*]^RLA'B"8^U9Y>%^[.UA,Q@
MP(>'-WFB--\JUF[*-LA2]HM&@^]>:#?:>85H(3*7J6R2@)O>\,1=W7Z-ON O
MK+IX^@5_\;LL=$@PB&PM!BVA1Q>)4L)>,=1GL6/]<;RI(4Y!6YK9H2+<7JP1
M<&H>8<G&Z<GSL=E /;%\\#Y=6@V4_8P=0+ FN>]E= +^C9L$X80H4C&OP<%M
MJ]I@YA4/F=@.KQPB%!A1N!1DZW/Q&9%BDW%$<+D00^2"+J7C$0L?Y.V,9*D]
MPP-]G)B6EOT47']@/&BVB/)RCFJ+([)A<I6A?Z:IZ$+""CEG4*^H K'V<<O8
M17G,LKD()S]52OQ3C/QB^,"T)POVP65X81JV5AQT<.JHG=A  GL-D>K&?@D+
M"'[-'A^-Z#B]/Q;9H2U>SET[H1%4Y'PGC<9*52NY!Q:B]0973'6*QF=6'%<@
M^[A@>W"/K\=&"AGPXKD\[XP#J*?/']UGED.\\1@EJ(34@+H,PA^$>A732#E2
M,&!(R;9FHSP;A2;XF!.U@Z-/!6T+9BCZ>WB()7C)T?B%.D?OLJNUN 4_AD8H
M_/ W2CA4WCQ]F:54"_<NP]H4,-@W39LM.:&KQ$JV,QN5T/'(+G"H),LX:I2T
MVJG023X$!"H_XC++6%Z A94O,9N\YHEVL>,7[UZ]/],R()&W,#Y:++31I;ZE
MQFI2)8T.:&?#]9#'*96A%@CIL(AKPS!@Z(*\1/?U^P3$3_0>DV>P@ UO<\V5
M);8'G3 T)[><!]<-B!6[Y4NB0: Y@XG0DG6UOKJF)^Y#YC0GX6_XAY O\F>,
MW[-XI=9=B8\'B,!V9<1#142&,QZK<Y46:W_$+&^W*!U<R+3FE=A*B. ^1!XG
MT4:A)A*TOBL.IS\PQI.V"9GEPWBX'28Y6',.RWK*=6VV-H"-B$4E4\>Q:,6'
MF:KFT,G$0"0#I5)JZDL4H(%'2'4)K)3OVA?CMMMP#3)*Y$4><H7;0OTMGY9@
MQ%NY?]^)7_PW[4E_7M5([Z+92VH=MYXC\$6*V_S*L$2@WMM%=+9NKZG _GCT
MYVAZ@3C]B4DC/%0]<OSKK"!U]%)8O>QE.W 7TLL UD?D<R[;N',N& \:FD\0
MF_&T\U@I]T->%'AP[ZK\>Q"[VC]40+[K--&_3QYW.7(]I AYAY*:B>IA<D?"
MB0:'?31$VGK8_Z$GY8S9''<=<=,*ZQ"G?,L1)P4L5)2W!NUPYZ'N58$*_:WK
M2P!O=2&2@1?CMX=>W.L;OV4-/_O#/!J&/SW,[_8L"3CP0;[PB+.-15,S+]!0
M-<0!JQO0KQ(6[ETE#GM6.!R)V?)T=+WT+OYQ\?KR??3F9?3BXN79C]]??FX+
M/7Q5SM ,+MU)]9B8?D>.4GP(Q$,(K\+$QPT."5;K\CV, J VQ.1X1#T&GXZO
MQZ!4-.@I.'!PSH/VDKR@4($+HW<JCX)23@\W+(=#314W0L=:)$=E2_RF0LW#
M3JV-/$OGC/8:3F$T>;BC<T:7VS25MN):W"7 XN$G(?F&PWEYVX][I%-_+HFG
MXU,Y3AY=@M[E'F8_($(9/7OL=#OUY0^VK05%FW3A<GZ01-2=:L75IH[JH-C7
M;74OS; NU];B8 U1262#^3S'G[D)VFU69]H\P'=X>)$ACYQD("B=[$BS" R/
MU6B]1R7!DUI'R%<S!JO/3X,890G<,/8T;Z0!UYI ZEM)YVBO$R$90UX;8MT#
M\^O%NE90M=D6QKV9)7)9'3D\ND1H7N1D;=@4)YTS7QT@G>N&)C3!+LAEU3^]
M1$@^R^#%*1ZOH4%RD<^Q2,G1.*2NLY.@WL<A)K^ /ZS+]^R/!OXX?&]Y7GE0
MS8>[!KWN\L]/<2$Z!@22^V176#)&QH3T!V35X-2V!;D]!@WE64'DMTWT^.1!
M-/$Q[\AG,T'K/CXYA;]^#_=&GG=>N8P(_QF>ZCKF<MKC'3<498HE^,23:/)2
M2MG/FF9-E,/-E!I"2<:H$62S""(+S--,RB<4_X<\5K,Q':N'C_8^5G'T(<N$
M=W'&>5%O6V("*O9 #E-7%?M-K2S>I&-6==O9$M%SIY$M$>@W&I]Q#F?0CP\[
M<GM+11_M</CJ@YFVIQ\_=,KJSN%U,S92P(9":PT7CV,^9+D(R(O&J.9VT ".
MC>Q.@DZ0(B'-'CP?MN>&:R(0>+\(G@Y#H<)'[K%54EV?&YLW];/@_:[ZHM;O
M\WC2'&X-=1AHL1\"]L\V3'3=IS(FI?_8.')M<724L U%_B%CP[_[G"0 1.=(
MS-T&76O8>>!,;FF+J60:6M_H? S)*A)#@"NHRK&QQ>2A[ !W].%INFVS8^99
MV*EV1JEO[YC0O?T/JE.1]91L^OUM9-,!QUK)7/YJS&2P\L_]CXWG:321AT;N
MPH [9D4P?I!P\.VUE<9@O:+/FLS@8T=EE(\FL.X9I"7#?29P!0:R'SB$<19M
M&1<+,>$'/9)\R]/QM04Y:]MD?NTI&K[/;IS-U;0UDGH3H$6",)\V]?7%&@^L
M<<0J88+4$1@O&!6&L:DL^R"XU81VC"G[:EC4++.$I/(%CN=PJ*@*NY5U@$)2
M.<,9T5_2QHZC@T25HAV4D)N4FFK440'G*:Q-_F7O $6S(',HN4JP9<1=31(&
MH%3R$<WWSC@<-0S-B5T3A"999L[("V!ECB)&Z9:X45^L"GZ1@P%$ILSC/2RT
MF%J_7L,=XF+'IDVP/;&KW500&]=E<F4490EG%5=].L+OZ59C;W]+@$Y/9_S6
M,G!HM".1!B-THB9"/N20::8:]Y>?^D]PW?-&9!">K2:#><+_PCU'!TD@[(@7
M%D)[.*MP81J7U#8R2TKX:R-!2J[:0@<);UQ6_E3EB).L11D)9+*F-&&S%_LT
MH1_1!UO/F:B+6^&%2YO4K7Y9H9I'98V.KE?4JY*ZQ)?SS1@ [N88!<B?H?,T
M092YD"W=7E=%-L4;L78D+ICGH.Q9-FL;RUT$!Q@%+/Y:N900PDK8>LI7V:8-
M_'N\0[Q.IM!ERZ$/1SG+X'A2IP*_THCE1L<5!A.@B;=]".<%SUF73NGN]6I)
M+J$G""IMF3=-H-%4.X(TV]QC%.$C59#[^JO@G!>9CD#HDA3)$M32:5(IF;I"
M;E<\!\9(7D3<9&[+[-WXCRMA-+KN1F\XE.N8) XL$RZ%^U'K48+F9?V>R=N3
MIV%K!;DT B"O*+N9D.YQ9CB&E%+Y%>5,:VXR0S$2$Z2T,;0)FY6F4^E5G<P#
M+C1CN353P<D+G5HBD+791@O"AD>@=B@U &@=\T@:<Y_9>59@#)_#5$M-M$MY
M0%"^WG$&=A=CA";*OFU*O'2;\;)A2FI.[>,&%O CML]O'7/)*-7>?O4)'U\W
MLM_0Y)?] W9'^<F *CL6"3>ZMEO_[SJ]DNIK/)MOLS(I\&(=6-*]*<GN(%@_
M%G-1ST@9&OYA09T^?M+!QVR7<V>3;%XC.8/C*_5HHV559J'7OT_9%0J+%AR)
M!-3TOC=]@K((0\PU8[?Q[*TR.H LR>ZQ)$,$#64))>'#%];7^F"^98;.+O>Z
MX8>1//3?Q*K /*NGMGL\J@<3E-C''_F8N$,WI+ MX0-/J3?421<NN::\'$_;
M0(0A-F!?DO(YEU'R(T&XS]>VT#B.C &WDMI)4#@9UC57DOYRIT2'O?M]OELV
MSN +2,."-)[_T4 :!UIHT,YY[=A]/(5FB\W[PL9^@UY) #4+SK,[^G$ [(>+
MY.BZY49%#F*/ ECE+]QFO4\B=+W,/2YG9'3<93_D39U)P2H;2F.!^>[0*O*G
M=\2ZUU!IB;1#3CCLM;"QC1T/^E 2.%^Z5S7:R,,L!V@C)I_>6'((^!N[1_!]
M"OPGS*?6P6+$?22&6 /X^]N:6R\+H[%AL^";)03)]!NL9RS;'OY]$.QAX ,?
M-9>\H;[>-7+$]>J*M4*&L+XD 28Y)N1)-^)P&&>;S'%)L2DT6Q4\>-]NI?I)
M85/2'2B;)TUK<NW[=>X+"8&9R0LY%+FXR+)O@5FP7'D -BKJFSQ#ZA "G<R%
M!XP)Y+BE-'LZC473>KB'@@.,&<98Z*U36U+_->K$[NAFY=-L'^A'LU1??5PR
M[PM7T1TB[]7"TP)9!A_;+SX.4509]?.;:_:JS^S#9OM"KA#?"+;B;ZH/?.[R
M\@9.3)K(,?3AV#G3 !'0"(.7:WX21UG4@;?(L;N:*3 L:&!6P:2F>N%%EMLW
M$ S?."/P1@ES*#L04Z:VTFV>95=9BLM $\TYR).5-!='?."_#RNZ$8P8EQ!P
M6IFAEX98P7;"Y.]3Y,RP,[G(2U4/%'E)BE(I1:9AN8*/PGV"<Q"+\]?'4E%\
MAKQ QI+!8V\3XIA65!G& ;MAMDY"% /JN+ZVSF7;R6OLV*JZ.Q06BSDYAKR3
MRQ77@4J5LAE+R ^E13[*XN27YZC$Z/AXF[Y'V,-;V;/#TTEP!R,3<LR7X'K7
M;-N4JL<7VB.D]L<-8XZVYDE(6DV#/_G^.<9D6F+SF=A"*H4O8ID1YF"<[>,>
M>557\&%$!B- E!MVHT,%PC5:@OO$*=OC4OSC8TI1.IL1I&&Q4/A*V77$'[=B
MU/&:<^OXC'J9=Z3J72I:^)BEK,_R'.VEL75X4Z/9@I2.:[I@BR?<]3-*DI2S
MH,&]?K/3[V@1>>-<4!)Y#9JPX:[<0<K356$\/7D8PW\>X7\>XW^>X'^>DKH$
MMYM?$;I.!+D<9"_P,YP(;Z-&.HP2HC03KK;5C(T0C4Z9E9AAS F2^1?YO]9H
M;+$?EG-4<<TE 9V.#)2\M8Q3)L>ABC>;?@I!1Q)<OC+WLLUZ8WXM?!S;,8I(
MLSWWQ=^@VN0+_4THP8)(.C%0)\6A8S9GO1"_#,Q6'I"MB9)/7!#".<US)C5L
MULU*^ V75>KJ3ZA:@?.&8LU+1K;.2G+BM[!@DYQDJ8AW2[.CYC)S?GF>:TOA
M9$N.@OV!5*N6T;ZXSIC&;4ARB'Q@F;0@V!<,%(7A0F,9=&>&5TM)#S6WJ@QO
M.,5MPTL^J/&OQ#_SW= 0JCX(2DQD%32U@?LS%T%%6]1P:0_O$?^;-VGNI#O2
MXNM4$<M'5E C\+C=B6+Z*/9SW(*-]X YE7=(%HNQI@YU+#.^%-D5/.)?:Y H
M"[<3 ZC@+?2#V%IZUQ;U':.?P%1LTERZTOG(VZ];Q+M6[8ZU$.:<I%W3Y F;
M_.O7I9_*ZRP+>^S!BFBS$]]0@C6IR\SO[/QP)/0[ST9'O_/=V>O_E-5^'[U[
M];>_7[Z/SEZ_B-Y=_'#QXM7%^V-9]]&X(!I\?(=_YQCQ.RQE.SPLXL>5D(<8
MG#Y1E!HVB8JX,Q)GD_:J[V(.]2^3#>?O*\(V<H$$1KJ6U PJ92V)HJ8H>AQ)
MGYK-YTO%35!Q XJ^P!P(+KWU-&T/MQY!#6)4MY"L##EBZ'VI9]5]#S7_V?$N
M/3:D7_EI$D6Y(RSR1T1-/+C_1T--C.9JC[!\IFFK%=J TOZ)(6F8>^ARO]O$
MN#>VA.QYB&'-T<T;^\ZG'V99>YO92G.\SQQA^+1QS$/N]WQ,^ZVB?.FRUAX:
MG6/_+>;4(AIE<E"U/8:'(6?H!'!QI0 0)V=3(BV\%@PB); 1E.B894_O/SX9
M))==$/B:'RP^[O=9VTJ[*@$1P1962\G\Y*5#-M8PBYQZ%>-[D]M2>@=]-S0:
M+L_S SH-!L2/-'S1GV:DB2/E/6?+:-,?=#3!#J[=_O*H_'P/%&SLQ9/CSEY2
M 0-_RY>:XU*<ARF2"=N^4:81]W1*,'1*4F36D++*MM?\I3=7ZFI@8G<NZ:$8
MUSHS*%=.A1(Y!LZ:FKL9-I"AIZ,H"!DHB!"!3J6>4]'__!#>'.T@1<T:$D;6
MDF3CN1;T)J(*%Y&&N%S?1]NTCV<>-K(MT&F52>GV<6!HRT$X)OF5CDE^L;[R
M35MQ]5_^%W<7)#2.AQ71\0+-5@FTB%%&)/-0U+%@X_R#I!IX^P5/I31X?&W#
M(A;*N,_EG=I/@>HSC;(SPXJ=8B,X#X%_*$R2_0SG&"^%9F:"N6 C;>ZT0@7,
M< VRHB!MK,.2X!Y)BAD_OOZ04=\J>AO2G33<:7!5H]TLB1&\')W+!:<>,0J%
MC 6O"E6C@M>5+,&>HW[M#5XOZ?526=L<LT8_8V2*P%4"15"IE-0YS6"XFZ/A
M;F'T)Y<$VL</+FHD<L8#L.4VFL_P=$4>Z*8'A# R9]OF4_<"<>JXPIX /7@]
M:T_=4^X&RB(7=A>GVS>4"'+RR9.TAQ0.V9B$ QLWN/H+P7RHNHXEA! %*BG5
MQ"-I!SIDJF4+9."*N)&2LGG"'_X&IBXJNU=EFY17B!QM8FF/35&)%/<'\<RK
M=:N].(LD7V)UI/3.Y0:_PEF*&!ML@$)'CM474;%2'I5J0R4P6K-IK2<.>:!S
M*BX!W98W>(1YY!@S66PL#(KIH]WA%MM^'\0"0Q.0%N.83NQB/"?VR<E].K%=
M$F+>>@EVD2;(6[/E8-!E38/I*DH0>5*L"C.OK8;O#=C$5#=2YYV[\2DG45<_
M8+W,DEX3/COGHT1-L[)&QDXS0OOL!H2[(&E5(VDJ#%^ATI/!R2NPKG+4(+>$
MQNF^J &--$^X73RO&+XH)RJ[+G4"+6;MS'C_F%AMQMAU,8L5^:=T#+"*2VU7
M0"EN:<Z(-3QUHR8B53!0THMR]XRY'EQ=M5)Q&7M:\L0O]%5-W%^L,T$SS?&3
M'KM-1?;S^7JUL9D6730?-]5:"FIB8SHO="]]S:%D.D0<23ZF>WXUGGNN9JOC
M>NMZ6[@[:)/.DH+8.?G^LX_3Z>3=4BJM,30@K..TCPT7 -R*Z\;P<#9EV=V1
MGX2C.DR>'<_F7X]O\YOK?(6Y7+('Z!\5T;E@(W.XK-B0N+F.G4"+R7_.:V3'
MA'^(BX"]UV/.UK9Y$_P.,\<9 A:Z<OQEQ8T3FZK L/EZ_W2--ZJWY6MR!BS!
MN2/9A=$62D-G/\^+=9,C4*"N-EBB=6^!'/4JTUSY"-?3PTFE)'Y7@O4L:- E
M60&'_RW,CES]\VJU83F&2]=\B&ZK^@-RX(AL6]#412.4"7%;$K5(@]5A^"W^
M$?\$/USB#^A#*>.IK#1%19&MLG:%XX9$#.0_B/N$U#3^&^M;]9I;S4/. 74-
MQ.?!%XEF1]H&VE?UMU5!&J%2CSLA'A>Q<POF%(!H"UD7$ZK5S,NSD].!!0\^
M3TXA[R"+* K*8,'O->D81TD!PQ*/+AB,!(J/2=#DXQ$T3TX>/\6%6!44J=1&
M,*@N7,=909^(\%=9(Z!],3R\K:B1$,M5YVZV=JSE(C78AQR<( GYIYGMA<RN
M#P-&:JE%D)_!!,.Z:X=_.N=GAOF#7B]EK?>B4(A\0SO!NOMQ3*?LI_&=,O&G
M\?\U]!6:X#U1\EU5?6A<0.9(=N;#>'9&#0UO\X-TKCU<1(U\XY1IP:CO)!W2
M?I.N:[6-,'9%QMI/TPP6WZ"/[?$=H_)+,]679Q[R]CT\SW!]8;BD:I*B[ZP%
M\L$#S*7F:KH=W?6'3.F?_J%3^@>%B8T&Y^UZ;S$F<Q&=P0+69;8Y< M(GSEA
M=R&O&>&*T%1PBZO<!SX:,E3!1F"_!(0/%CDE,@_8[GL+2JDP3QW).L[1E<7&
M-,S[]8BTMI*Z6O"RLS*M$%/<TVKH.*A=-;_.YN@YN)98KNRR,>80!IS),W&Q
MZ-K%C$QZ!L-DNU^7ES>5 .1F.:=QBR15_\'$K@E"5\.U;1SY3B< [=Y+&  &
MVTD0'#''XHA<H98'$<K%1&*RA4^2QL<E*H04OR?!<7:FMD;'DQFZ?;@Q+MR^
M,V"N87H-U5$/"5Q$:<"&[='+U$#!XDC\;DZO5T+^S.2%_/:.>V44U")G_XN?
M@5^^J5K[&XG28P:N7J_:N;0^R,O0_QD"S[!/JM'1^74%TVBT8BJ_X0YUNHRQ
M74?J!\G+QQJW]VQ/Q[2J"NR(IOM\,^4(J%8\TPF4?>*09^Q\<+@]Z^6,'A/W
M8YOF7+NE\,0NUOF5(ZE$+4*XP*J\](^A"O)6 ^*"XS/59XP'5<(8Q_YD$GTW
M<(;!J2^;A;-"? RYE)'Q/5HXOHR039 )1]E\65$KVL:\8(8U*%=)G19"M:=T
M?W>UDF/<Q9WW.G7FEX_T2RN8C-.>(KVR7JW6QQ>B2A3>9V,KF%LEE%4HEFFS
MDJ8_9)7(5$#HDMR")QD*-%,8'!]!J>3UJE"_DR@ ]#P1S--IATR81YEN$;M^
M)'UD:,@E '>(R1!!D)54M>8_.C6U1(3QT.)'C*,D&'_3L!9?J;)R!?RV9E\:
M]?4YCI20K&-&^Y>Z8XQQ_S 930D!.@">*V @O(.'U>;3)07NHCQ,)Z+JWVT2
M!9)\-15,+)Q0-U/ R&H]"P-NQ-&45HRN^<A;3N*ALI46JH>&^+\R&0C7/E40
M#XP_\;Q_!5YKM + RG.MS[""UGS5M;?$W-5ZJ5I@\#."&>4L1P>&DS<A= >_
MLPV%ZI_5(U3BIV(>DAA.P,T5-B5B/ZIONJG(N ?[Z+ ?H@V$ L*V.?7B41/]
M3<4RR,-DA*WI0G.$A #8#GF/8;Q<2^A3C6Q%4?^F:]A#_!U1S9J*LWX"2N/,
M3.4AA!D]'<$,;C0QDW7.%@C+:R3[C!$ OS\DL'SLD)4MK9CKH&3()F7H*.3S
MEO=6HI-5O;57%9\=<DEAF*]-6UN[K+[M4T!-S)ND@7S]HAQJ@2NBT6:5&;&<
MU!IO[.K[HY&*XVN^XTMC<;W?6JB$$)&/0$S^DF["Q@YP5#8N+\8YXP &Y+O5
MY-Q[V@=>/?5T@+5S$7]-,#L?M8G5$4+,+YS%?S.U64C9S*TFR!V4Y7=NFHGR
M-QHS&T)=6/L^'LJ!JQ25.39V6=*,[:9,9XRY3/("Z@R_?<(UY"!)$$OM 8TD
M7BVTSXV6P5$-E[46+G\A#@EY_F#N=R P#/ZUD$$<HCK;2,>$7:?G&TJZ?EP<
M8F>J52 VL<X>_-XE6FLT<B,/_8+$WGVFE(O^%#.41-J-$,]41L?2Q"+$FV/;
MEARIQ)B?I+8%.$/!8<J%)@4)^)Z*[)SJ:L6#LV$;>03W'<0$4\Z)X2Q=SW65
M[#D1[>2;M'M,/OU>QH8?T.)!G*,^BIYK#^F; &>*OH94P3.7WSS+5ZT'5BRX
M-()."6S\T8C[T?4\Z?",J$.$E\T8)H>5]QUGFV326OL3&&8'1I(W;95ND.%V
MD6$S5\[HP\V[WC2@UPHU-I-A"=J7];ZTBF6"9&/Y5VIY/[_WX/Y3_[0TZPAB
M)RH)^ ZOH;'G+E! S-K"G>$A?$G1Z =! ]R6'@1!*$77<$M-*Q,(=71KB!4\
MB0S,<$;@.DY:-735$("N\'.^R2YUW%^@H[F*HVLX D;U/\GHU5Z'DO [7___
M[+WI<MM8EBW\*HBJ[@HQ E);\I2NC'LC9%G.5+=M^4IR9>>O+T  E) & 18&
MR:RG__9X!@"DY"QF"J9YXW:611+ P1GWL/9:\Y;3:8_-^>L%L+B<('0/%@I)
M9H3PH5(-\O"@G7!$-!X&W*./%1BIBA,/<4"M=BMM7(<<AE"(-3@Z#<L"T5YT
M,5MZZAU9;X97)"79!QJJX6]6"@^TM$O@??P'^T/BKQB:2;ODF>:+BU:8BP[6
M@_7_.!1*N"X]/.5>$N4JR$?#K(N]DZ(-108ZIJ5O6@R'\Z(4V!H[W>SH86*A
MZ$8BAU+7@\Z]!MT&AH&KQF,[4<63O8GJE>GQ%7EL$I',H[M0B*PX&]YMM!N)
MPR)$&5V!V"ZUX B:F*HU;2-S1(6&",$VD4@ 6?%R3\/3(_81W6]5M,/[D8/"
M-LE\\P:V-ND^%W>7;7>S[4??6[;]D3KZC94PIY7CN,XR4;MK,(%IMV0Q)&_A
M=):@7!V:E<@YJAA615K'Z*QM5L#W48V*T6G\O.&CC0V+Q[8?3+P26U.;#+B-
M7#I\S.!DWY1%6;E?J_?,%5B%B?C:7SAZ9*'S$]R050 LU-1ZZ"6V.3'+]TLU
MTQ0&'6XX"<>$-GGHLC[7E,YMFA35.Q=:Y2;\F5C_[%</% -Q=@YZ;(F1_6IT
M?%H?SJ_.3KX]VJSA%77,MDP6<]%P4?,4U JQD N2D7A2ZS)=? Q&M]I"0[VB
M ,7&*/G2#[7 YPB28'Y;E<JPIM;4Y 14:X[2LT3T#@8M97U@!R##5! EHK)A
MN?9-)04XKGDF!I,?-V+3%"L?]IY.C#!\\,8J4BF3@?C;GPXN#Q"7G6-%2 4O
M$.=137UWC:2NPK0>8Z4 D5SB3^%+V$$*\U#I9VP_^03LG),0-CK25$^2)9:4
ME]\# WWSS$:1BZ FF,:2S\>JA"&AQUEN731P]P[]]^J\ED@UPB/;QC I%&04
M(]=FIDDB K,0I*/V&XAE3LF$&V3&@$*B-]"Y^U;\!!H*4QC:?$W[&\,0>!\S
M0PXKKTI)8E6B,F9:35,NG<TD1%^G%G0J5Q$$EOI;/\"X:LS\&VE>WOE2XE2M
M&Y*KH^R9TPDUG,+<O#[,\C"KPRX.4[.\8F6('4,M=2+*!;J(N54QO$%*4PV7
MP!3)%AEK C3KET(MQY.0+182TK'JB#QA"]AR_ G0?93Z7 [ZB5D0B)Z30DC8
MJT)QT)ELIJ^QQ"B[-0%UZ@]1 X7%C5IO<M@*./A>BFJO^.75P6I+S]NO7X[*
M-CZ;N=D-VIG^]M?#%T\&_GMYMO^Z1,FLLR)>?8J/^%U7O=BSEX?!:1Z<P#.+
M,K@@E;U+<&S3X/#)X3<YJBN'$(RU*#C)P6H+@Y/CX-7S)\_[-&[?\ L>-TW!
MQVOP+FJK*'B+R "4%CXY/;^_<N1;?..BOFGSX'UTD]8W=U&5P:N^/=^F-SP5
MDP$'-9_Q>/[MKR^>_5AG8,T6Z0$<:EL\M =V:+MO_4!;'\SX'^63IES0GR/N
M#;'WXG)!9M6>:X"Q_"PXI5G3-JF<UY/UK*TC?M55 W]2EGFZ#-Z]^[A-;_7\
M>?!SFR"AS*]1E=3;]&IX^U_+ZG,8V'\=0E,.]X\.G[_<IC>U!^S'"'-*GX.W
M>51$UU&Q36_I'#F+F;P?;;XQK<RU>^]7O.YPH/\;Z#?Q&IAF=8W' #X9;-?!
M/Q#2RZ'!;_%M5VYH3V!'*^%@3H++IDI3<(G?YB5XH$^WZ2W!9U K.B[9:WAV
M^.3Y-KVBXS6\CZK/P9OH-EM]/@T$4K_!=W:MZGF"+\S6Y>UT9UENKV7YYMUQ
M\#'#6"X8E\'>I\O)-KW=LR>'P6NS%TL(Y^63K8IPX';\)DNO<2M&)9VR*K(H
M>'5T^*1?O/\-OZ:W)3=-<!FC!]S\*PQ.ZW^N";5NX>8,KW]0R^O3'MW6!TD>
M+7 9XUZ]51'*'4+(10CU#<DM1PB-);U_^&0\^7V!NYS\?'YV<AJ<OPW>'?\2
M!O\X_?#IE 2S_OO3Q:_!U<79\;O@E^.S?YQ><##TOS^].3O!#R].WYY>G'XX
M.=T.:, I2\IB192I]D^_(/2]SI<V=ZKU3K.!:FKOZ$0TXS7EE.NAPFLE%.1Z
M?:Y1I+J1/*4D(!B-,_!RF2D0[T44RW<BGL<PX<;JMKK(<_AUS<B>OFJ=RYYK
MF-])W<'C/2D08XK2S;2S435/W4[GF<D\6[(U3Q-/6G#9, -^$KQ-$ZH1P)0Z
M%S ZN:+@!*%!2[?;_$QU&(BB?,BOCR_$1:5=M,5 PIAU^(1\N ==G6):FFL]
MA7N4]2:YRUA34*J+5DL #I53]'FJ"-A-!6R:FG:*)SR82$^IPJN$Y5NEA<@A
M6\(*)PW?5L)RQ]P'MV6E &YWY,V\#A\X[$*)(H 95[E"53B\?E$M2:/32YU,
MQ6%PC5E$(K(+;>Z(:@Q1\0RTC4%QIF8/Z1*PJIBP:(W08X@&B<_QQ<R )6FF
M6BG'AI+_C#,@"A""G^113"4?"ZK+@Q%SWS1$A6(&L=RF1<O\+3 ^[1RA=-AA
M\'&6"O_" U_+=+.\EP&Z*X<"ST[E/:.7 G,E2V=$452;FF(KKH!=8'O;G0K2
M)L$7FI=$F)$ ! DTW\[G- <)V8_DC%*9+7 '+-1$V$E=MSR\+'OBC[_1NJBY
MPYUGT,\?^!"IAI\C.>ITN1Y_Y,%J[,;7>.B9.FU8P"7(&%$%<[Y&S$O1N#N_
M6X'1AW"$%K$Q4(YA-(WTG>N27Z"[;PD+JTX^%\.%6QI6:PY2&';070HUH6U$
M05[)_=@N+KH=P&1M";SRZCRX^ODT>/OIW;O3RZO@]'^O3C]<!1]/+]Z?75V=
MO@E>_QH<?_SX[NSD^/6[4S:(7I]?7)S_<GI!-A&*BP:GQR<_LTET&9Q=B<AH
M +<^=FTF,*B./_P:G+P[/GL?G%\$)\>?+LG,.CZY.CO_$!Q?G%V>??@I./]T
MA9_"+UX?7T(3/GV$+Z]^/KL,CG^Z.#U]#PT,J='OSH\_!&_.3S[A1Y=X =W_
M_,/5Z?N/[XZQ^5<7QQ\NY?Z?/KR!1G=O=/;AY!T8</!<O/ "?@LW/[^ _[Z^
MH/>"IKSY=/4KO>WQ.W@->/0%OP7,$;H=6X,!WCAX#\^EUSW[\.;3"3TD>'M^
M00W^>'QQ=09]!#<XQ8X_#^!;O/ ##8/;,-B1Z.EXR:]ZP<_'T+>G_S@[_05?
MS7GR+V=7/U//GYQ_^G!Y^NZ;FYS#%BB^%LX&Z)_3#S1&9Q]HC'\Y_A5[[]T9
MS%*W9V7UVV[$7U$?X:_.+J#W+C^>PG2 #YQ)RO,3ICK.5L+]T6Z(ZME.@8U?
MZQ\T)'$\19JLRE0JB"W"C!^*6LQ2IM[&RW #Y(V/[ &A&3$\:T(85:&97&=I
M;>FPB>!"1?C@SG-#+>06SSF[9ZQ[-$(Z9RF7M%/+X02\Q2,0S25HYKS%G9*0
MM#F+3CM59=B&/430<Z<@6UI!)1GX(J'^\B,<&\SQ^]]X3V/UKK5L@TM58SC!
M,WBB+%9B#G4 @<YU7!L["TZR6SC1B% BP=[1\^;%TQ^PS1XC*1XCT RT#$R5
M(/7N3.QQ]"ADX&4TP%K,I7A63H7U-O[,L^PG80#G2:/J\<1:1U,E?*C-K[5R
M[A2:=MV.;D,\F^:*L)TZ]I9%SZ%=0$.KI4'W^9T'QX"+^=W>>_BHU#0L</:6
M[?5-\.+9<^0P)]Z^FHO]KI@IP,[,+B,!$66%R"&@7@E;NF0-VG;1H8^VG\M^
MJT.09]!WHM5. 2>6AYLOR@JIV[#2N1+*&W(:L#0#3#CF@$_QZ@)_)WI$L,$Q
M=^1O8+%:=2V9QT3&Q7S+%99/(]2>688&!R(O7;!S"WY.K#[&+,.=.&,B>6'R
MQ9%QM?]D@[%\&MH\6MA1CBQFR'KB$5JTE67<EUD?X@9!8%V4?ZF8/+).T\^#
M/3R5:8W#A86:K-0%.Y1=RY'(;]'?/99@N#1#=HSN/,6I4X=<NBK43-@F-'4]
M:8ZOVF*8K!_OQNTWL\[02TZ1*2)5UHK>7/06S'#9?:8QB6FJ=XO$#;5%JE4K
M08T4+6DJN?4XGTRO.%-%&RN[@2T--G0H);&*X-&Q[*+I-]MJ^YB'-WN@-^F0
M2U/W=B03M+0N/9^-\BT_GV'V+*AU[]-7O*Z>WOR&U*9.]SH'-5VO1R-&)\S4
MOG^[XLIP/(I9)A3=0=,HZPW:%EM6(#R;1#J/ UZA4Q,#/@CX9_ >-0:65"8-
MGU0;_5#X7W>U?<T!^NS97C2AFG0_O(1'*&RW"YU9M)TZAI$CY[3T[!*7M1#Z
M<@9V7KXP==Q4>I'2#FA8;^,.(1&3M_E[D+ ;KIYA45Z7#B.1,P2N:*H3-63J
MDI!I+V#'U[."1!/5MF-Z$_5I39]LB=%]Y19;'#Z1GJQ;<--E9BLQYC#1@IHM
MOJ:L3P.Z8X/WLD_/=MFG1\H^'8XN^_33Z8?3"_!&/UZ<_^/L\NS\PS=7:+JR
MJP_'TM>'4LE[Y6QD'U47$#_DG,5[J?8.WA@UWDO:!I%F\U'+X-&50*.HB*1:
MEPBIBL:1^+V+*HJ2IS7'55=EB P_M=(KL^6E]&K>%6CA6U9DS[H@'0 CA;H9
MUF>6&,[(<[DL@QS]/H?=FIIC?M,CB'OX,X7NU22=7#ECLJ,USI%5_([,?$V)
MGDV>BK8=YSU!9<K377*LW+FO) Z(.0?)[JS51.R0 SZ\GNQ/#P[[S42Y>;_=
MDEMP1UT7"K[.BL7BI@9"AW)H?7UUISH46^?TJ7(/*2":S#ZT&-WA,KUA$]5"
M;Z2NCS\JM0PAN\3N=R:1X+;A(:/875?.-($7PS% EJ5D@T_\.I36J(^(T8BS
MZ!%QV<:88T/A9QR*XQJ)MQZ;O/;*G\73# EFA:U6$^4BX&?SE=Y[V%1PQ&]$
MP8A(XRQN/A1W (KXT@\I@685&X8('JQ6;5\77F@&,!3G\0#QIJ(;@.1[%3@L
M>Y#*5@K#-/&@=&4[.F2SD\[.CKPJ\X5];6VV>2,WI6F")P4>BWBCVS)+7%HR
MX_A:.4PABJUEI9:5J74OG1V10FIY'IH'A]*@,"C2:[@@$G$4B6UB4 (95 V6
M(#<X"9%.-J(=CGQ$V)$T<4\:%>+$UY*I\CLHVPXP0M#9TAPM FT4!Q&471/S
M&QA$Q1@%-K*V1WM1]BF9G;#* YF9G=F:$3;#%]3HX%%$&T<DV.]N2KPS<H9$
ME#2 >=247HK9AF@PDE0(K(8%#N<+YGX63E^7T1='"E^-3F$1I3&*B)AB8DKE
M[LU8/7B*S;F%[L P#1)*"[U1(\G\))TV]/DW%X18>12,1NM!CX(SMAUG B[;
MZ*G[F+J(T9AT$5\=:F<EF.*@GOX[[4MX*;C'L%=ADJTS&(]Y'KN')6] XF7,
MEJ%5MTI(#-SHMM+.=#Q#N:I(!;8TV5=0WHEW#1+0*N%W,7T(IU=>+E,,F4;7
MC+!L*IA/_$E"7*6PN_)E<ZRGI,NBY#8S9[_K+=YR0']5J_;0),!#0A5J'V]-
M.NL/]CO>K1]SU$6G%_W5:DZ4K!*YYFH"BHX3_[/(F1EV9/B'B@9EJ8Y(3JY5
MJF(BCJ!97V6$W0'#)#^CL5=")N*LS^HI9O8$;ZF: "W<(3<4^/W>G 3!GBH'
MW*8(A1S!H)]0WXUBH!5O@69>.1O2\V9[IR;$A>HQH"(A8P=0\D[R/4*%M>Q[
MX.$Z\1N"C+CFMJ4-9'TX1 GB1!*H@#(,3Y<"1O'IDP?P*>PM9)5B>-%K=:UX
M2TVL]W;_(LNWG<\]\+4C2U#?VTJ24R1UOXY>ESZA945ZQ.11OEPDXQN;QA7-
M6<0TAR*3*-#;5M#%,,6O*9"!NR +#PB=(][J)OI75"5EBW$S! @@@;KH'2%,
M6GBFF4*]O!/)&X%6^YA(13*SG/ME.T6,#,RBM#;6>EK<9E5)?@AB4 QWONX(
M@@N^BY9=;8QU=R8Q0O^E47-1!U3D%7$#NI;\5E; 2:!_=B07W539D.*8M8<9
M),PP7QCVF(0YJP[S'_RG1!2,N8@0(0TCE5QEO[+RPTB\4PZ+^0WM9VC'*Y:A
M<:5"/-HWE3;2N*!Q(4CI45ZY?_.0..I<=69>Y 2TMO=]T!' \\\_ 5@)21*7
M N,2,/M,_!)\D@?_@1_-LD)0(@4<#XM%&G'[##)>>>-X@T+Y+Q6FNX89@C*&
MU[#:=5F@BA0JNLXQ!T\( H,QZG>)0%Q4,@L%L!R'TF04P;)W55^6BLD"OSRW
ME(1S.>DV+MWQF);V=$R6-BJ0K[.T?S' QQ.,9Q#Z&S$3;W0*GS;Q8\?!OK[,
MH6.I2Z@@U8(+#_S/9S%KI2HL8=5N('J@O+D18",S8 )"'6$4&K$,&@X0.DG3
MK817A!T(-VC9)8(]K+U:+!089F,*LJ_+[R:ZP>)N0Y4954GQG-]EL713 )NT
M2,*OMPB&C('0LP:&3O]RQHH* Z>"V7M$&\IH0DFG]Q0[\2%3I._'0%*!YX;A
MRS36=5:08:6G)_>6M1\H4I--6YF4A)EA(&2#P"*7*[0.75Y-<R_W 2[_:U O
MP?N;UT/RH_WP[*HXGG[W%2.S@W!X$(X^3<L.PO$(<"5K7&PV-2OY<+IQ$S6,
MU9\Y<.+!RL<3L?K4"B04F5IXCK"*,3Y-CM,)>E=ML3U!W=%(51H(2,;BXJ<U
M^8*/;="0H*JA@$ZY42:GY_KO W.TE]_>GGDS&LT[DQ?&(FP'"OK1E$4\\A0Z
MC;C"8*405H;UG=1X-'Y(M(A#45I3*E=FA7% -;'71\!ZJEO;,]U&H^NFT^T8
MABXQDL>_L$8"1S-<O;<S,(&NV95[Y&F(ZLZH(%91LEU;3VK;96+2-CJ%/&N4
MK'L5_,%</H6VR?3TSW$N6=?]3X(- [=;J:(FQ=2%+2=A%S)TX4-.+30*$8D\
MA=5?LZ@)":*"Y_&+6VZDJ^>:4U<&.^Z%T(H27I!K%^89QS@-M!^_K1S^ '3D
M]%\DH!2JDIXKF><=%I53[*.1'"G"$%*(B$.'6I!"21\S;M"'+3C2QH_0HLB*
M313K('(/JS?LC8,(_\JE"N9PO#'H*EL 943IXJR"ZT68S@Y+DM8Q>%0<(LT:
MMS:"?'JM$6)6!:U>=X@AG-O:6*2*8')R7?YB( ;.F@I'IBE['>5-PY+%'[)&
MXVV,X6 EZ(H>8[2PKOIP!).=DQVWP;&T+G8T990)[N(MT340;Y60E]18[E2G
M22J &@63<+E>9>^C]6C\,_NQ:)(JG*./+0T=8"EWNO<,IT#5EM),%1C3:?$@
M94PP3W&UD^AQ_]OM.6)&H_*E1PQ5SZ45CMICVS!7@QA4SJ#9I$C1SJ<\BV*G
MZ8QHPG+&&144-F8>8K DQ6J=)O6N"'D+5PD:4=0Q3Z.,JJ-FPYB?*KO&4'MH
MX,Y-])FPJ=>TDX0NQR5J[UB;/ C>.-F_R'D2GBE<Y[V(M(C:!_KU!'XZL:#^
M01?57K(Q0E  5WN;QSI]$4CL;&M6V0_C6V6VFA<U21]?C=<PT" !"VR[D<#D
M8K^E.'O.G"#D'LVL&6>G4%)I@E83,891^LO]K2Q@M.6XRAGA=8;76N");A:3
ML;8]=(R?EW:P, Y61F$Q<,2459$N\9^LN!<5LCL83V?&ZMR8,5. S/@0$!<^
M7&<$4(B %!=UJ^/(%PYE&(RN\Q@]@Q72V2BZ;A(.99^]5E+J5RTEM8:Q?+F[
M(!TF!H;26IDX8GBS"7]%&3-*C)"Q#!KBO(JTJ*HY"56!PU6GE0&&F15JM. #
M _JX/^M@EVYG(@=[ Z1V#HJ7<CM<]6NHT89?2AMHW\U^TGE%^X5Y3XN/KH8;
MJJ0RU@B74?'UR9R8"Q-FX8:3,;&*N!5TP<2*\D6U>FN)4:P&CY $L-&Y@[LL
MRK2(',5%JGR7.R3]352N+GDL/>I&\R2"&XCLX-  =D2R(^MRPQU;Z$UY?#H9
M'O[44];NZ8$/$0+ZW'@KL"</EY.4<*F$JS2D+W4)*R!,EG-E;S:1QU7)/COV
M2E+FK!0!33K@=:9LZ_V2/&1K3?:6L9U6IO>E)VEZ%?  A+L0-4FF9501GM%8
M_(1)NH@.8=X#P+P<P;;K'/XCV'3!I8P*%I%WTZC"S2(0&(\$E)+GU^*/(^*(
MD)@.^@I_H/**E%<G%R(F")E;=N@D;8E1$194AM^+,FDVT:($(7Q)2K3!9&?U
M*V0HAT3["PML&F-*]@#:)*:83$YKK0H9N+5;%MF!*N)+R6V);$HTAN&BVZS,
M5Z3/)@K9L1=:Q1(1!44,7J^]/< 7<4S1-TF9,I7,YZ*\LR0<+CB,-]R;;)H9
M$),\0<-M3N=OCS_S:FS^S*GU1T\MPG4V$+%YK%!"&MP159)LBP:'&^KN(%]P
M1'?H4_+)'=M7;DCYW\\I$IXBR#$;B'D.L? RM#MU/7GSD-H@6SZGZ4(83I7K
M"7<9>PU.[D[DPCY-B_[0;&1N5(X(A*R:3,=.G]&$MH-^?,"&)7S43<0"Y?N,
M^N16:K,%E<(8RIN4=T9V \,.6)("*+4UBV>\^6%?=L%;!A4?#A)ZD9E(1,M(
MYF; J/BL3P5RW\P#9[I>N5B7XWB+DJ6'3T:S2PBIQ86R UVF33F;/?*>T./Z
MI0A];0ZF*'B7I5QZ'5EBHYJ:3H:>2TK=3<*;TUAS"GB$I5^RNA'59'PF'YF*
M-"-B6^8"%I ATEXQ(:UQ8>K0*>[G&EY!H8?T"._.:E08FP$NAFE:)O#C.IJE
M9G>I; GBS$@_,S"]P3>T1KO^;@?[<F%?+[XWV-<C=;3.3J<P*B(GFR*&2YV]
M$[&<*3:0-7[%PMSESG:+6LH[\3#=!4#>'*\"S)4Y7&:\Q A*R?7(Q-^'60*7
M6I$JDPU2I^C5-=LCS$K'J] \M0-/2]ESS%GNUGP+SE49)_.E_9F\MBTG@>O.
MG0SES"&^)T:-&\*BML6<SOEDH-2".-*2])]M%!O@AU+LFUV)-T;I H^@@EA[
ME4&9F'<OD7KWXO3_?3J[.&46::1#_M_3BY.SRU/+(DVTSA>G[T_?('$R\1P+
MAR]1]\)=A8_Y_!TR/B-STB\_GYW\'%R>GGR"7Q([\/GK=V<_'2,)]&48?+PX
M0SIF\S"B%3:DU>=OX<JK\[=O>\^Z_ 1W?7/Z\?P2?AT&)Q?0)&X>M^#CQ?G'
M4R1KAELH1788',/;(7OSZU^#__EP_@L\[-VO8?"/\W>?/EP=7YR]XUXYN[@X
M_<<Y<FS_RG3%;[;(&AD/[9,*O$0+RY.DT-$+Y1\=@\=RDT9,7]G6P[PU%8,"
MC9P";C.%J"<X* A&8[ W[!(:]MUX6**?"!-#!0HQ8;Y-[##$E2TQ$^TEB3<9
M)B1E^>W?>7MF\GC8:9Z:;"*66QCVYWZG/]X<[E26&I;Q*,:H3IXB2Z>&=I9.
MFL D[CAR:KE/+'DM23!4EB#)@: ,SNRS@AQ0FIQM@8H8F.A<=E>5RY:+W0H/
M[(L2L:>MH35YQSBBA4K.L7O_DBW_+5H"XV'E4-<RY<AD?9,M1C#K*Z<YW5G2
MSV&0-(TI\D3R(E@@6IGM$:WWYK2[Q)*2MGNN3R*V>W :FE2JLV"[!K=/B26@
M76'P&W%QHT4*YIY02(3!+$O:F,UI33=YKT-9B:35FE44YTHH1FZQ-E(T57*$
MR'EQC#97<XUFPQ 6U\V-J1/>H@4RG@H'62!7%#7_R$/QZ*C@%7)E-EPB$$^:
M8/-%G@GFRM3>41$WYDZB":72!/*K'%:A0S_623UR/3DS9PR JP2SRE6"M9O&
MX6 E-\N9TIF;W'9P*;;^M$.Z)E1K-DU/+/2WJ<!-!>=,CJ4')W7\N)G+544F
M7N$U;=G?9&P:)IXPC/6K;V%IW;C\>UJ5MG62MW4+9%?<9HM6^7CJ4625'Q=-
MMG^5@E=?9?4<P^5C@)9)?!7C&C-<-2;L@(9?V!.#$(B"X:WIOY03&YDZD 9D
M+B&H2 B'&C1X*1$,3$D,9&$I^^XU*#2E>#YJ39,UV+H"0RNTCD4FS8VCV,A2
M[W%(HH AW?*.&X];![=@K7[:P-L?]"+7%KN'^%,71U&DN/7@84X2B91$T<>3
MIMK2XC7N[_>MH1@]&AWA]_$)BG9=81CJZO3B_24%A#BD].;T[=F'LZLM(@$_
M&A\)^#&C0RFD#(OXG!8Q\AH_MK&T):0GHZ,7](9<05:- 3.OD=*U<8%9B?LY
MWN"GX^./!OD\HR!^L4\;;&:W\K?'E\'AT=.+7I7X'%[@)F?>GH+$:TS55WV
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M/J.:5323)9@<PD?Q@95I\Y(XSDE%7:7I*1FDA[\G_MXI&X:3FE"T,A?@&"W
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MB=?5=9MA J<0 8I*5JSQHUF1T W <68/A8^CN\E#FN53!</=,)]E#DNXFO5
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MU(1<#^]R,UGN)G0U#$\3'IW7+DLP;F@5D]?5$X^19P%&2VNHOF]<#!%NCDQ
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M.::OZ&+>#6L:-'^DC$*]IZ72IWX+AQ3:F%3O\.!%:/JPVSLZQ.@LH.ZC]K'
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M)1C=%_JIIS&YY]=@JGRLD_NJ>?G'47U#R"S8X21RT;G6Z,TQ2[BCV>A4D=A
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M-%R\43D?6GXC[=C[8ELPF3Z4#4X[HK'DAKJ5HL2++C@C.,RR1!D!D[*=-N&
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M:YON_I3-A4NG2M:H7_0$7YB$%\Z/*L9@KNZ>TF<4,B7;$-V*I?^N@P#EE#B
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M8)+L;(Y%!?!1A7R\%4R%&B6:^$*J7%N)A5X2$Y9A8F)5UYTZ^Q^!%S99@S'
MA6$:K9=R_2Z!'*]V0(X=W-OBYLR*]9B AYBM?8Z(>P#$8F/B3OZ=08A'B/RF
ME"W2I+C#39:=#.&,P^=H%YS@/TZ-J$QM^ SE%A;![][,0_GT/)W,_)(+U/A
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MA54Z@,EU&=^D20MGXEG 7OC!;N0W/_*PP+#KOHT)L'+\=X.]9K#_'QR1K.Z
M'LD81GJ>$CO33=HYH=;K**]VK @$3[$XQH786D[\VV <+:^)5QA:6)I81ZDY
M0D&IIBISIZX'K8[HMB2,@*6%6S\K^U-P.$.VV\I^]^Q&1L-\&;QE%"+8/9=&
M<&4,L]T)+"+CI$DT/]V+)NNJ.W?#OF;8+](DG2\8P *F)K,OC&&T:6\+!U$7
ME6VSX6]3MKA91SZJJV87!HC-KF=1K.4[*14KS 1YG^?E'8:-")!?4TDI06N+
MLI\W92HF@@TQI):P4)3KP+P(>!W320 ;T$V0S>=I@CLF(:AF6 I$G'QDZ)-?
M8-\I[ ,+_9-'GCO%1$Z08_"3<(S.,6"0']!A['!P_-0):I[[&ESD!(H6$NON
MS?KMLJ1M^'SW;M95ZOI(=2@E4W&%6N[XUFU!7%L^U!#OCS]\2Z[71W:10H,J
M]AWR8$]1-&%P SUUBYZCD8F_+3,F,T5^M[*=4HE?U_ER\3&JV( OKA"8>#,C
M=T%U)MA%[V'FW]3!NPP>FA#?X? HWJ4YN'-[AT>3-7;Z[D3\4[;&:UC9A'@_
M=P)]8]@<)>PIG539AKH125,:[YV;N$2P0E6@<83R2F3?IPH76@FX?(6C U<G
M3_<I1SI6NP_?)8#KZ+L&<'WO6\2J[7T,NP2[AQWC@1(E4@'V^NSJS7&P![^K
MJ;*(*,.;*@+O#FL6[%&$==;(Q(,<XNO.I=W\^=KYLT#"@J*A[7$4=O>PEW5X
M>/##+KVTN6&O%\@JB4[).;-ICV3HB:Z+3?B3FRR=!:=?TKBE#(,T-$1;'"LK
MT#SGW]B @?D-?_&.*D+,AQ1SXF!0SKZ:VLN[J;7!J47@0>)FHL*6$<TLQ?YI
MS8VE)C#?&)+VGN??X7[):K>J*)7ZU\@6N=5>#M2@*FM["P(OFE*XH2JX;(!$
MIE>!X;Q,Y%(76>H[Q4,R:\=TXG#91+C;.BAL=&(Q>%%8.G,JP^I@)3EJ*BTB
M_"A7IZ,7[W;T"6*=X-]1OEMBFUIBE[#9X>"D23 >( S;>I&TB%:"#5[!6LDS
MXJXHA1)<7H$_=VMYP"P\?WM\HO-747EK+[ 3_2<#28&Y=]PV-US'=!/=X@KS
M&"#QEQT&1UP9V%14M<#0CCBS_,] 3QT#2<90%]9TF0I!^=EU)AV@>X1F(XC-
MJKI.*8AGWHB?C0LSIL?/""UH8 +/GQP03*!B!I_RKF#"H%@/,NH"A$SL'=J?
M*=6*5Z(?YU&+H'X<$@HRP?NR@/AN<6YZ<8["EK;Y.<1QE/,L#FJ[D*([Q/ZG
MUVVNBO?I? K#77(1NRD# -M+/#3D.8.C08(]B 6+8L:AP3_A3(DM.8-7[^I!
MQ42#%K7MD=0)D6,9*Q2L%5.F74'#L9\.+@_XWL&;%+%U'*WU#KW?NQ?LUL+&
MUL+IR1A6@>S"ETYA+$RCTR_Q#8J*@8DRGV<U$Y0(_5Y,I%1:-1*:.1L545Y>
MEVV]8G+MIL[&IHX=K&-.ZH]D)CEA[WZE]9\?\=[-JZ^<5R5:DR?1 LZ5? Q3
MBH]HKUG!NR8Y(,'WV'A/=$[*X5D3UP7#5?5 %+(N^I04>QJ18$8>#7#]D&R.
M<)AXP:7ZF181,V7.KVB.='J<JQ16#Y?H/ P2PIU'5 ?W'J;JT:LP.'IR],33
MIW= .17#QI/);@IO; JW4RY$PI% 2,$8IG%6^P1;AG',I315\VS6QX35[DLA
MS"+/!RF.5M]"P6%%><=\JKJ'>NU"<#31_+N<$9'S> $:P(6LNX5,2B9*U%/R
M(^A"B3LW$QYQV;N%>"!MC#Z2DH1T(A"!17.'Q+Z*<W,6L3YW$A+)"YP+*FE-
MY:9RNX/@[4J\0;@&?^+H=YFZ_#3HS:G=<MW@<A7ULW&L4]JI!<BD5&"17P7T
ML&(ENRRT)&@F,4688A6S.U$-4>>&(LE)_S:WP+ &?6;#F_;V/7U.\>%,/>9M
M21'4!>TR+K?:'_M\/B=Y:T.RV>E2F*HTA7&#I:B%\"E&%+*!/[!4:D+%HLA[
MA=+ET6_LFVJQ.:J!TFI6?5,W4"WJI@J06C5RO>$AQFD78861I% Y[OF^AE2T
MKWANXTVJNYK3%,#2-_E+Z1\Q&*6!*.I.@C!5Y.7#YXAK"K&S')ZY@R#X5 @*
MB9\%&X@7/2>L%,8H(L(\82@:]SS:OAVA>*:-L^"F:,UO.S*O1G)XM_EM:O.[
M0O+^,>Q[$I[.L:J*$MXXX+.6.(Y%84 % XBB%FDQDK:A#\"D;6.)D*$+=U/F
MS*3LJ,A.H_ASNW"_GGAJ!2Q@8->D"A4X?+BXI0Z'%3SD8V'30Z'O1\)[D)8H
M<4B3Z6Y)*IK[*B^^2^C4TQUTZOO=FKI5E&/8IE: 7PX.,673H[/;G5-_P&0
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M*!AVS=3=;4#_Y@9D0ER_<_O9Q!CM=JAO?X<R\VA$^U,E:1T3KK51Y!X)1;!
M:HOZQ@I6P.:5+ND>R#)EQ.K'64^!(?A?,*:'O"!I$_QWV5;%X^H[& $SHR9#
M7<R,2DK'2E3<EN%D0=.HLML1?EG@B*1D1[-2F$K/B\284"9U1YM(1VS>O3_B
MNW'>4'AB"DW%&[9%Q*"R/#6A8*$#)ST8EE44282H^!RZ0]\[B21(C<&@^U8S
M_+=LB]C>&9^'\@AV/MDYA.DE^4ZR5"75Q>I\8%$M>- )JC:759%%P1[-,)$J
MT&<YZ2&&O&&V"EM'-#?,O4 "F>4=-K?7?F9 MFW.#-\73D'*':4:0:>8/.LB
MX)U1SZ&LZLG >@CU/=);-!D'EP9I_#'5.'3NO]*JM+DQ%MLS?1LZ=S!9@P2+
M>/05UUY.\V#15LCQ7-_+WVIMP_\BC/R.,X9)2/8/5Q8E.&TDXV1M)</C%E)]
MY2:%RV]:9?_6LT=9#+6Z=NL;ZZ%-//^!96(CJ?C:%?U\,T4_WZ43+SB572AQ
MYZC?ZZC+7!F+OWY7$J($<5I@9LYZF"W8R\"R'$7.\]L 4 UL%&MJ"[I;QFZS
MV&T6WX HQ&6Z:$C-+#BD7.;372G%IG:(?GW@;H_8[1'?I%C(%=>-O448QOLL
MSVD30S^MJH.]_WCZ/(26X/_]6^;%+EOYASLZ*ZIL=JG+W0:VK?HV"M4BZ^:Y
M'^\/@YOR+KU%5?+,$?*,XIL,/JU7U[R&G%9;4[BFE3DMS*V(IF&^%+V5H@QF
M;46J*1&G*BJ5%9@N!PBJ0^:@UK2(**1Z[_5BG=762P7\+K[T?^.[[SOU<#1J
MJC9JY)BXSZA!WPY56[^Y&Z%J>[D!JK9G+P]>/-M@['Y$K&9_^;^G__OSV>NS
MJ^!XW)1L*T@KSM]_?'=V_.'D-+B\.KXZ?7_ZX>HA"<I'KE(])T+4O_WU\,63
M@?\.4!BO^BG;G$BN.E*4R*J&K_KOOT>1^DCC^?;B_/T](_I[A1/&H$<R_-*?
M<)!9P1X,MUH)850#6PHWUQ"O@C'6W*5@_%ES$7Y'^),]*](4!O,RR689_JMN
M%XN<KN6B3V*I+I$DJD:DS("@DX?K>4S3OD<W^XC&_,1AV &[GL ^<^A8IKI8
MY!F9Z/]_>U?6V[81A/_*H@X*"9 )*;(.-T  6K9;(XVLQ&Z#/ 4TN;*94J3*
MP[+^?7=FE]1AGK)L+E7ZP0ETK'=GN;-S?#,?P&70A&9_RS$(Y07U/S9_!!D@
M-ND1EK?N/%);@_XG](F3>F'_'+#)J>4LH+.7[VM CTF@B@SQ5.%W#4</>.\4
M"FX%[[F!J)_5Q%J I,-R?(ZF8PZ!'EB"_A!;9K@<.;E=_?Z[JD[@"?6 .]'V
MK27G50P?&Y'B@;6*DGZ;';2U1="GN:6%U'<:'W_&_/DES(5)#ZO_H?+8\6&]
M'GN*V?,LO@_2W.:(#&PM8,<%)A 1(^"#S$40;@"ST"DL@IVHU=C(OQC<_11#
M0<WS,84R:!B1: 8H"QRFJ9"1-D?B+B!JY&<5&7KN I\W-@(':F%Z-*+V V^)
MK9$[7DCJ@^A$J@'#FT?NF8>!+MLL!'@59L$N [W [#:ES6VWHO"%DPXS 'M[
MAR\P;[/7Z>XT;-I[[Y5^>[CWR7;:RN 5(!R=KC(<Y)MM;/"STRL23).S14)<
M#]%?/DXLJGF !34 J;RAFT%+!!X$.733U2U00-\I)VT8@UZ!FUE<>B/\%KS)
M SEL]L',EJ;U ?<>9!%ZFB7[E6*+22;J47C#[3']=.BRXQ=\HL!.JQ,1KX[4
MPZ-?=_[*2#]_X=V9F$6X8JBZ61EB:+>-5MHW>JN$\U\Q>8+HF(UXTN,->\!J
MO?Q^$;Y\VL:7:ZVP_RU@Y@ A9.S49S]#4*IM0V>I6 ^L,9JH1.4^6K,^[/$"
M7#O/G6%]H.L#73:6K'W\I478[T]XW0R//]4G-UY2W_BI[9&SP&-O>AXYQTL:
M&W9/370K>=_(BU%]I%_I2#-_G8S1<U?KHYTAL#-'<PV(VKK, S< ?/*3EZ@6
M\,3?$AM7":&NW=_=]LI,WWP)*]A%1@8?UF .G:H-+/'%!BLZQ*K@0^'N" 0.
M[EE^[5&KAH*W_3,)OAK*;P/2UU4ZSQ!]^%HN_K)"0[UMJBXMH'*-4+//&J1Z
MM@A:LQ5/YKZT"5_SOH?*>&SB=-:)LIU\EDMG_2%R4BXE=Y!!AO8.,VB_;6*G
M;Z:FN ,G$GG7<^KR#M[G48+16<$4?SWJ=S^0JRE94B#?X)!&)JJYR1L%B-8A
M#^LC.RXT3;#OJ0@/83.!N!B1DN-JJI9B.JP%Q>O8+:!E9\#SE:D'*,?Y?>E'
MTQM2[$@^+ V,)@D] YUF5O0:(6B )]8QZ[^=6(>WU\(XVATS2#A*JL%.N>VL
M?Y<^F="@!S\>YLS&&Y]@ T+.70G1$YFHW'Y9D-S<^UP69H]'W&)ZB-2\RC6O
M\N!'KRTA6+<O#58WS30-4;QG^0$X6R;W\?O8FUJZE?YYK8[)1/T.4%\>-SG_
M&P' 7R^^_'5Q<TLNK[]^?H$4VLIP4 E!G%/-@/\A4,QCMBDV/&7F*_2XPP9@
M;!*.8Y.)IIM34R<PKR+8TPTO[:2M=)]+JS.4"8<[U9[8;8TW?9E8SRQL<QFB
M60'%?\3]['!>A._>[971B*BO]/O]79!\IT/EM)W\=O&.0?*&NXL'=6+K-(\[
M/?S#)96G((!<=)W>.-G%57L?UR%-[4K.H@")=BBA^@'0TZJN([_:4:QZ6?M)
M=/*<:(RL(7955H,A:BNYI-<XI^CXK2383!)1@_<VB#ZWJQQD?(@F40O4=UG;
MG_84K16%1 QCZ0-6]]RI@?_@N(CJOV'*#&JFZ1O:/ONJ!"NW("9^3I,'J 89
M(]L<MYJJ*=/"5KZ,SSFH!I^,F8.#1_O6]"U:_4W)$<_=V!GTM IY7^G1P(P[
MXA0S0+5A7UG#7FH;(,74%WR\NYKZ*8OK*U(%*T9AS>4K:S$<\3<L -1S3.LZ
M\.\=B!Y],UU*H'"#V5"EDC>$3 A8/@KM9: J$7KZ$RS(X1P)2 +$E+ G:H A
M'6MA[;'@=X:T$6<"  I8OL0%6V)RQ6*>\\+4U>'X79ECY+":LURPKM*7SL#8
M]JN*]BPH^CO&Y3LD5TZ-F-:?LZRG^6+[-5H[&*Z61MNK3&>M<Q]W!A\\XM(Y
M\U"I[8OJ=<3=::ZKV=BT2A17I[50P&2X&] 6L+&Z2"F";1C$U0*%ZD!<$D)C
M1([<"SFV#<'&$1;A@[LLE*06W</Q;;Z0\ 91,>'H,+-_ V J,:DKBL<Y&PDO
MM-?1D@2B'21C25TZCJY9+M6,)2XR'-@ S1]VA ",X?I?%P*#3>?H(&?*YP^C
MK]80]@S#/\)\:(]F38<^P=N>!?.>4M>%RP,60D"<F%LQ-EA)8$O$3O!=2=P(
M#1%&*$<C#-$74 ;B%; BJZ$;ZIA%';.H8Q85W92R8Q9B,<.!<M)]+8R53"T%
M:Y32VZ&4Y (<U4GV.A97:BQN(T82^@;IUJGT:XHB;H[-+/F$0-)&$(ENQ9
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M,"XC@Q3/G1[<X<QR^7P]T%Q2A]N*(<RP5Z]J!38*R.M@BU%2,'>88LJ!$4S
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MSS(JHO01#&QAPS"UCL*FP2IMIJ3'W0"562:LY?R>FC500*NPG0FPSRE9@TB
M$F&P!,%_W+I,PI?_50HPWX5JF;N?J\SZ/]\JWXG'GZPB/,/-\[X$)@RS)0#.
M>/Z!)RFQX "^BJU,-[$C3J^0?GAF[ B(X_3N3'YR_O@H2%?[37_ZM"3M4@8=
M#9]FW3OA7^T$H M@& A[W7,@ P3(E%D&F^:_N7.FJG9+3VK?^,W+W]WN XU)
M-&2_.F"+NYP-Z'2_TU0PKGL6(/*ADD..5""GE]7/3;I*\SPKI!IS:!VERB=V
M>B-( -1/PI.:JQ3_&\\G+(?04Z] ]!4_FUNW8:],&$ 0<MT 2R0M#.]-ONQ
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MOU!+ 0(4 Q0    ( %6!:5-(4+C=S:8" &X=&P 1              "  0
M  !S:6)N+3(P,C$P.3,P+FAT;5!+ 0(4 Q0    ( %6!:5,[\FZK?PX  )>1
M   1              "  ?RF @!S:6)N+3(P,C$P.3,P+GAS9%!+ 0(4 Q0
M   ( %6!:5/$YWK8]!@  #7L   5              "  :JU @!S:6)N+3(P
M,C$P.3,P7V-A;"YX;6Q02P$"% ,4    " !5@6E3H[!6J'<W  !G8@( %0
M            @ '1S@( <VEB;BTR,#(Q,#DS,%]D968N>&UL4$L! A0#%
M  @ 58%I4R-SV4EKO   .>\' !4              ( !>P8# '-I8FXM,C R
M,3 Y,S!?;&%B+GAM;%!+ 0(4 Q0    ( %6!:5,&-QJ75&<  /O%!  5
M          "  1G# P!S:6)N+3(P,C$P.3,P7W!R92YX;6Q02P$"% ,4
M" !5@6E3<G,;_<[X  ##SP8 '@              @ &@*@0 <VEB;BUE>#$P
M,6QO86YA;F1S96-U<FET>6$N:'1M4$L! A0#%     @ 58%I4ZR;@DP8"
M2#$  !X              ( !JB,% '-I8FXM97@Q,#)S96-O;F1A;65N9&UE
M;G1T+FAT;5!+ 0(4 Q0    ( %6!:5.X81$.;@@  )LR   :
M  "  ?XK!0!S:6)N+65X,S$Q7SDS,#(P,C$Q,'AQ+FAT;5!+ 0(4 Q0    (
M %6!:5/IIT0*F0@  (8S   :              "  :0T!0!S:6)N+65X,S$R
M7SDS,#(P,C$Q,'AQ+FAT;5!+ 0(4 Q0    ( %6!:5-.UQFF"P8  "0A   :
M              "  74]!0!S:6)N+65X,S(Q7SDS,#(P,C$Q,'AQ+FAT;5!+
4!08     "P + /H"  "X0P4    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
